Document:

EX-10.1

 Exhibit 10.1 

Execution Version 
  

 
  

CREDIT AGREEMENT 
 by and
among 
 DEERFIELD ELGX REVOLVER, LLC, 

as Agent, 
 THE LENDERS THAT ARE
PARTIES HERETO, 
 as the Lenders, 

ENDOLOGIX, INC., 
 each
of its direct and indirect subsidiaries listed on the signature pages hereto and any additional borrower that hereafter becomes party hereto, each as Borrower, and collectively as Borrowers 

Closing Date: August 9, 2018 
  

 
  

 TABLE OF CONTENTS 

 

							
	 	 	 	  	Page	 
	 ARTICLE I. DEFINITIONS AND CONSTRUCTION
	  	 	1	 
			
	 1.01
	 	Definitions	  	 	1	 
	 1.02
	 	Accounting Terms	  	 	48	 
	 1.03
	 	Code	  	 	48	 
	 1.04
	 	Construction	  	 	48	 
	 1.05
	 	Time References	  	 	49	 
	 1.06
	 	Schedules and Exhibits	  	 	49	 
		
	 ARTICLE II. LOANS AND TERMS OF PAYMENT
	  	 	49	 
			
	 2.01
	 	Revolving Loans	  	 	49	 
	 2.02
	 	Borrowing Procedures and Settlements	  	 	50	 
	 2.03
	 	Payments; Reductions of Commitments; Prepayments	  	 	53	 
	 2.04
	 	Promise to Pay; Promissory Notes	  	 	56	 
	 2.05
	 	Interest Rates: Rates, Payments, and Calculations	  	 	56	 
	 2.06
	 	[Reserved]	  	 	58	 
	 2.07
	 	Designated Account	  	 	58	 
	 2.08
	 	Maintenance of Loan Account; Statements of Obligations	  	 	59	 
	 2.09
	 	Fees, Changes, Damages and Revolver Exit Payment	  	 	59	 
	 2.10
	 	[Reserved]	  	 	62	 
	 2.11
	 	Capital Requirements	  	 	62	 
	 2.12
	 	Collections; Crediting Payments	  	 	63	 
	 2.13
	 	Appointment of Borrower Representative	  	 	64	 
	 2.14
	 	Joint and Several Liability of Borrowers	  	 	65	 
		
	 ARTICLE III. CONDITIONS; TERM OF AGREEMENT
	  	 	68	 
			
	 3.01
	 	Conditions Precedent to the Initial Extension of Credit	  	 	68	 
	 3.02
	 	Conditions Precedent to all Extensions of Credit	  	 	70	 
	 3.03
	 	Effect of Maturity	  	 	71	 
	 3.04
	 	Conditions Subsequent	  	 	71	 
		
	 ARTICLE IV. REPRESENTATIONS AND WARRANTIES
	  	 	71	 
			
	 4.01
	 	Due Organization and Qualification; No Event of Default; Solvency	  	 	72	 
	 4.02
	 	Existence; Power and Authority	  	 	72	 
	 4.03
	 	Litigation	  	 	72	 
	 4.04
	 	Due Authorization; No Conflict	  	 	73	 
	 4.05
	 	Permits and Authorizations	  	 	74	 
	 4.06
	 	Title to Assets; No Encumbrances	  	 	74	 
	 4.07
	 	Intellectual Property	  	 	74	 
	 4.08
	 	No Default	  	 	75	 
	 4.09
	 	Taxes	  	 	75	 
	 4.10
	 	Compliance with Laws	  	 	75	 
	 4.11
	 	SEC Filings	  	 	76	 
	 4.12
	 	Financial Statements	  	 	76	 

  
 -i- 

 TABLE OF CONTENTS 

(continued) 
  

							
	 	 	 	  	Page	 
	 4.13
	 	Internal Controls	  	 	77	 
	 4.14
	 	ERISA	  	 	77	 
	 4.15
	 	Subsidiaries	  	 	78	 
	 4.16
	 	No Dividends	  	 	78	 
	 4.17
	 	Stock	  	 	78	 
	 4.18
	 	Material Contracts	  	 	79	 
	 4.19
	 	Use of Proceeds	  	 	79	 
	 4.20
	 	Environmental Condition	  	 	79	 
	 4.21
	 	Governmental Regulation	  	 	80	 
	 4.22
	 	Employee and Labor Matters	  	 	80	 
	 4.23
	 	Name and Address; Properties	  	 	81	 
	 4.24
	 	Sanctions	  	 	81	 
	 4.25
	 	Anti-Money Laundering	  	 	81	 
	 4.26
	 	Anti-Corruption	  	 	81	 
	 4.27
	 	Anti-Terrorism	  	 	81	 
	 4.28
	 	Sarbanes-Oxley	  	 	82	 
	 4.29
	 	Accounting Practices	  	 	82	 
	 4.30
	 	Common Stock	  	 	82	 
	 4.31
	 	DTC	  	 	82	 
	 4.32
	 	Fees	  	 	82	 
	 4.33
	 	Products; Regulatory Required Permits	  	 	83	 
	 4.34
	 	No Violation of Healthcare Laws	  	 	83	 
	 4.35
	 	No Third Party Payor Program	  	 	84	 
	 4.36
	 	Conduct of Business at Facilities	  	 	84	 
	 4.37
	 	No Adulteration; Product Manufacturing	  	 	84	 
	 4.38
	 	FDA	  	 	84	 
	 4.39
	 	Margin Stock	  	 	85	 
	 4.40
	 	Complete Disclosure	  	 	85	 
	 4.41
	 	Investments	  	 	85	 
	 4.42
	 	Schedules	  	 	85	 
	 4.43
	 	Eligible Accounts	  	 	86	 
	 4.44
	 	Eligible Inventory	  	 	86	 
	 4.45
	 	Location of Inventory	  	 	86	 
	 4.46
	 	Inventory and Equipment Records	  	 	86	 
	 4.47
	 	No Violation of Usury Laws	  	 	86	 
	 4.48
	 	Eligible Equipment	  	 	86	 
		
	 ARTICLE V. AFFIRMATIVE COVENANTS
	  	 	87	 
			
	 5.01
	 	Existence; Permits	  	 	87	 
	 5.02
	 	Compliance with Laws	  	 	87	 
	 5.03
	 	Insurance	  	 	87	 
	 5.04
	 	Taxes	  	 	88	 
	 5.05
	 	Reports, Notices	  	 	88	 
	 5.06
	 	Inspection	  	 	90	 
	 5.07
	 	Disclosure Updates	  	 	90	 

  
 -ii- 

 TABLE OF CONTENTS 

(continued) 
  

							
	 	 	 	  	Page	 
	 5.08
	 	Cash Management	  	 	91	 
	 5.09
	 	Further Assurances	  	 	91	 
	 5.10
	 	Environmental	  	 	92	 
	 5.11
	 	ERISA	  	 	92	 
	 5.12
	 	FDA; Healthcare Laws	  	 	93	 
	 5.13
	 	Regulatory Required Permits	  	 	93	 
	 5.14
	 	Material Contracts	  	 	93	 
	 5.15
	 	Notices Regarding Indebtedness	  	 	93	 
	 5.16
	 	Reporting	  	 	93	 
	 5.17
	 	Lender Meetings	  	 	95	 
	 5.18
	 	Location of Collateral	  	 	95	 
	 5.19
	 	Updated Borrowing Base Certificate	  	 	95	 
	 5.20
	 	Announcing Form 8-K	  	 	95	 
	 5.21
	 	Eligible Equipment	  	 	97	 
	 5.22
	 	Maximum Revolver Related Notices	  	 	97	 
		
	 ARTICLE VI. NEGATIVE COVENANTS
	  	 	98	 
			
	 6.01
	 	Restrictions on Fundamental Changes	  	 	98	 
	 6.02
	 	Joint Ventures; Restricted Payments	  	 	98	 
	 6.03
	 	Liens	  	 	99	 
	 6.04
	 	Disposal of Assets	  	 	99	 
	 6.05
	 	Indebtedness	  	 	99	 
	 6.06
	 	Investments	  	 	99	 
	 6.07
	 	Transactions with Affiliates	  	 	99	 
	 6.08
	 	ERISA	  	 	100	 
	 6.09
	 	Nature of Business	  	 	100	 
	 6.10
	 	Amendments to Organizational Documents and Material Contracts	  	 	100	 
	 6.11
	 	Changes to Fiscal Year; GAAP	  	 	101	 
	 6.12
	 	Prepayments and Amendments	  	 	101	 
	 6.13
	 	Restrictions on Distributions	  	 	101	 
	 6.14
	 	Sanctions; Anti-Corruption	  	 	101	 
	 6.15
	 	Sale Leaseback Transactions	  	 	102	 
	 6.16
	 	Environmental	  	 	102	 
	 6.17
	 	Investment Company	  	 	102	 
	 6.18
	 	Intercreditor Agreement; Term Debt	  	 	102	 
	 6.19
	 	Payment of Convertible Notes	  	 	102	 
	 6.20
	 	Commingling of Assets	  	 	103	 
	 6.21
	 	Limitation on Issuance of Stock	  	 	103	 
	 6.22
	 	Use of Proceeds	  	 	103	 
	 6.23
	 	Anti-Layering	  	 	103	 
	 6.24
	 	Convertible Notes Restrictions	  	 	103	 
		
	 ARTICLE VII. FINANCIAL COVENANTS
	  	 	104	 
			
	 7.01
	 	Financial Covenants	  	 	104	 

  
 -iii- 

 TABLE OF CONTENTS 

(continued) 
  

							
	 	 	 	  	Page	 
	 ARTICLE VIII. EVENTS OF DEFAULT
	  	 	105	 
			
	 8.01
	 	Payments	  	 	105	 
	 8.02
	 	Covenants	  	 	106	 
	 8.03
	 	Representations, etc.	  	 	106	 
	 8.04
	 	Insolvency; Bankruptcy	  	 	106	 
	 8.05
	 	Judgments	  	 	107	 
	 8.06
	 	No Governmental Authorization	  	 	107	 
	 8.07
	 	Agreement Invalid Under Applicable Law	  	 	107	 
	 8.08
	 	Cross-Default	  	 	107	 
	 8.09
	 	Loan Documents; Security Interests	  	 	107	 
	 8.10
	 	ERISA	  	 	108	 
	 8.11
	 	Product Withdrawal	  	 	108	 
	 8.12
	 	Change in Law	  	 	108	 
	 8.13
	 	Material Contract Default	  	 	108	 
	 8.14
	 	Other Default or Breach	  	 	108	 
	 8.15
	 	Criminal Proceedings	  	 	109	 
	 8.16
	 	Payment of Subordinated Debt	  	 	109	 
	 8.17
	 	Any Intercreditor Agreement Provisions Invalid	  	 	109	 
	 8.18
	 	Guaranty	  	 	109	 
	 8.19
	 	Subordination Provisions	  	 	109	 
	 8.20
	 	Change in Control	  	 	109	 
	 8.21
	 	Not Publicly Traded	  	 	109	 
	 8.22
	 	Term Debt Defaults	  	 	109	 
		
	 ARTICLE IX. RIGHTS AND REMEDIES
	  	 	110	 
			
	 9.01
	 	Rights and Remedies	  	 	110	 
	 9.02
	 	Remedies Cumulative	  	 	110	 
		
	 ARTICLE X. WAIVERS; INDEMNIFICATION
	  	 	111	 
			
	 10.01
	 	Demand; Protest; etc.	  	 	111	 
	 10.02
	 	The Lender Group’s Liability for Collateral	  	 	111	 
	 10.03
	 	Indemnification	  	 	111	 
		
	 ARTICLE XI. NOTICES
	  	 	112	 
		
	 ARTICLE XII. CHOICE OF LAW AND VENUE; JURY TRIAL WAIVER; JUDICIAL REFERENCE
PROVISION
	  	 	113	 
		
	 ARTICLE XIII. ASSIGNMENTS AND PARTICIPATIONS; SUCCESSORS
	  	 	115	 
			
	 13.01
	 	Assignments and Participations	  	 	115	 
	 13.02
	 	Successors	  	 	118	 

  
 -iv- 

 TABLE OF CONTENTS 

(continued) 
  

							
	 	 	 	  	Page	 
	 ARTICLE XIV. AMENDMENTS; WAIVERS
	  	 	119	 
			
	 14.01
	 	Amendments and Waivers	  	 	119	 
	 14.02
	 	[Reserved]	  	 	120	 
	 14.03
	 	No Waivers; Cumulative Remedies	  	 	120	 
		
	 ARTICLE XV. AGENT; THE LENDER GROUP
	  	 	120	 
			
	 15.01
	 	Appointment and Authorization of Agent	  	 	120	 
	 15.02
	 	Delegation of Duties	  	 	121	 
	 15.03
	 	Liability of Agent	  	 	121	 
	 15.04
	 	Reliance by Agent	  	 	122	 
	 15.05
	 	Notice of Default or Event of Default	  	 	122	 
	 15.06
	 	Credit Decision	  	 	122	 
	 15.07
	 	Costs and Expenses; Indemnification	  	 	123	 
	 15.08
	 	Agent in Individual Capacity	  	 	123	 
	 15.09
	 	Assignment by Agent; Resignation of Agent; Successor Agent	  	 	123	 
	 15.10
	 	Lender in Individual Capacity	  	 	124	 
	 15.11
	 	Collateral Matters	  	 	124	 
	 15.12
	 	Restrictions on Actions by Lenders; Sharing of Payments	  	 	126	 
	 15.13
	 	Agency for Perfection	  	 	126	 
	 15.14
	 	Payments by Agent to the Lenders	  	 	127	 
	 15.15
	 	Concerning the Collateral and Related Loan Documents	  	 	127	 
	 15.16
	 	Several Obligations; No Liability	  	 	127	 
	 15.17
	 	Right to Request and Act on Instructions	  	 	127	 
		
	 ARTICLE XVI. WITHHOLDING TAXES
	  	 	128	 
			
	 16.01
	 	Payments	  	 	128	 
	 16.02
	 	Exemptions	  	 	128	 
	 16.03
	 	Refunds	  	 	130	 
		
	 ARTICLE XVII. GENERAL PROVISIONS
	  	 	130	 
			
	 17.01
	 	Effectiveness	  	 	130	 
	 17.02
	 	Article and Section Headings	  	 	130	 
	 17.03
	 	Interpretation	  	 	130	 
	 17.04
	 	Severability of Provisions	  	 	131	 
	 17.05
	 	Debtor-Creditor Relationship	  	 	131	 
	 17.06
	 	Counterparts; Electronic Execution	  	 	131	 
	 17.07
	 	Revival and Reinstatement of Obligations; Certain Waivers	  	 	131	 
	 17.08
	 	Confidentiality	  	 	131	 
	 17.09
	 	Survival	  	 	132	 
	 17.10
	 	Patriot Act	  	 	133	 
	 17.11
	 	Integration	  	 	133	 
	 17.12
	 	No Setoff	  	 	133	 

  
 -v- 

 TABLE OF CONTENTS 

(continued) 
  

							
	 	 	 	  	Page	 
	 17.13
	 	 Intercreditor Agreement
	  	 	133	 

  
 -vi- 

 EXHIBITS AND SCHEDULES 
  

			
	 Exhibit A-1
	  	Form of Assignment and Acceptance
	 Exhibit B-1
	  	Form of Borrowing Base Certificate (Agent)
	 Exhibit B-2
	  	Form of Borrowing Base Certificate (Third Party Agent)
	 Exhibit C-1
	  	Form of Compliance Certificate
	 Exhibit P-1
	  	Form of Perfection Certificate
		
	 Schedule A-1
	  	Agent’s Account
	 Schedule A-2
	  	Authorized Person
	 Schedule C-1
	  	Commitments
	 Schedule D-1
	  	Designated Account
	 Schedule E-1
	  	Approved Account Debtor
	 Schedule P-1
	  	Existing Investments
	 Schedule 4.01(d)
	  	Existing Liens
	 Schedule 4.01(f)
	  	Existing Indebtedness
	 Schedule 4.03
	  	Litigation
	 Schedule 4.06
	  	Real Estate
	 Schedule 4.07
	  	Intellectual Property
	 Schedule 4.15
	  	Borrower’s Subsidiaries
	 Schedule 4.17
	  	Borrower’s Outstanding Shares of Stock, Options and Warrants
	 Schedule 4.18
	  	Material Contracts
	 Schedule 4.20
	  	Environmental
	 Schedule 4.22
	  	Labor Relations
	 Schedule 4.23
	  	Jurisdiction of Organization, Legal Name, Organizational Identification Number and Chief Executive Office
	 Schedule 4.33(a)
	  	FDA/Governmental Notices
	 Schedule 4.41
	  	Stock of the Subsidiaries of the Loan Parties
	 Schedule 4.45
	  	Inventory Location
	 Schedule 5.20
	  	Other Loan Documents to be Form 8-K Exhibits
	 Schedule 6.05
	  	Contingent Obligations
	 Schedule 6.07
	  	Transactions with Affiliates

  
 -vii- 

 CREDIT AGREEMENT 

THIS CREDIT AGREEMENT (this “Agreement”), is entered into as of August 9, 2018, by and among the lenders
identified on the signature pages hereof (each of such lenders, together with its successors and permitted assigns, is referred to hereinafter as a “Lender”, as that term is hereinafter further defined), DEERFIELD ELGX REVOLVER,
LLC, a Delaware limited liability company, as Agent for each member of the Lender Group, Endologix, Inc., a Delaware corporation (“Endologix”), each of its direct and indirect Subsidiaries set forth on the signature pages
hereto and any additional borrower that may hereafter be added to this Agreement (individually as a “Borrower”, and collectively with any entities that become party hereto as Borrower and each of their successors and permitted
assigns, the “Borrowers”). 
 RECITALS 

Borrowers have requested that Lenders make available to Borrowers the financing facility described herein. Lenders are willing to extend such
credit to Borrowers under the terms and conditions set forth. 
 AGREEMENT 

NOW, THEREFORE, in consideration of the mutual covenants and agreements set forth herein, and for other good and valuable
consideration, the receipt and sufficiency of which is hereby acknowledged, the parties agree as follows: 
 ARTICLE I. 

DEFINITIONS AND CONSTRUCTION. 

1.01 Definitions. As used in this Agreement, the following terms shall have the meanings set forth below: 

“2.25% Convertible Note Documents” means the 2.25% Convertible Notes, the 2.25% Senior Note Indenture and each other document
or agreement from time to time entered into in connection with the foregoing. 
 “2.25% Convertible Notes” means those
certain 2.25% senior unsecured notes, governed by the terms of a base indenture, as supplemented by the first supplemental indenture relating to the 2.25% senior notes (together, the “2.25% Senior Notes Indenture”), between
Endologix and Wells Fargo Bank, National Association, as trustee, each of which were entered into on December 10, 2013. 

“2.25% Senior Notes Indenture” has the meaning provided therefor in the definition of “2.25% Convertible Notes.”

 “3.25% Convertible Notes” means those certain 3.25% senior unsecured notes, governed by the terms of a base indenture,
as supplemented by the second supplemental indenture relating to the 3.25% senior notes (together, the “3.25% Senior Notes Indenture”), between Endologix and Wells Fargo Bank, National Association, as trustee, each of which were
entered into on November 2, 2015, as the same may be amended, restated, refinanced, supplemented or otherwise modified in connection with a Permitted 3.25% Convertible Note Refinancing. 

“3.25% Convertible Note Documents” means the 3.25% Convertible Notes, the 3.25% Senior Note Indenture and each other document
or agreement from time to entered into in connection with the 

 
foregoing, as the same may be amended, restated, refinanced, supplemented or otherwise modified in on with a Permitted 3.25% Convertible Note Refinancing. 

“3.25% Senior Notes Indenture” has the meaning provided therefor in the definition of “3.25% Convertible Notes.”

 “10-K” means an annual report on Form
10-K (or successor form thereto), as required to be filed pursuant to the Exchange Act. 
 “10-Q” means a quarterly report on Form 10-Q (or successor form thereto), as required to be filed pursuant to the Exchange Act. 

“Account” means an account (as that term is defined in the Code). 

“Account Debtor” means any Person who is obligated on an Account, chattel paper, or a general intangible. 

“Acquisition” means any transaction or series of related transactions for the purpose of or resulting, directly or
indirectly, in (a) the acquisition of all or substantially all of the assets of a Person, or of any business or division of a Person, (b) the acquisition of in excess of fifty percent (50%) of the Stock of any Person or otherwise causing
any Person to become a Subsidiary of the Borrower, (c) a merger or consolidation or any other combination with another Person or (d) the acquisition (including through licensing) of any Product or Intellectual Property of or from another
Person if the Acquisition Consideration paid in connection with such acquisition is in excess of $5,000,000 individually or in the aggregate with respect to all such acquisitions in any twelve (12) month period. 

“Acquisition Consideration” has the meaning specified therefor in the definition of “Permitted Acquisitions.” 

“Administrative Questionnaire” has the meaning specified therefor in Section 13.01(a). 

“Affected Lender” has the meaning specified therefor in Section 2.11(b). 

“Affiliate” means, with respect to any Person, (a) any Person that directly or indirectly controls such Person,
(b) any Person which is controlled by or is under common control with such controlling Person, and (c) each of such Person’s (other than, with respect to any Lender, any Lender’s) officers or directors (or Persons functioning in
substantially similar roles) and the spouses, parents, descendants and siblings of such officers, directors or other Persons. As used in this definition, the term “control” of a Person means the possession, directly or indirectly, of the
power to vote five percent (5%) or more of any class of voting securities of such Person or to direct or cause the direction of the management or policies of a Person, whether through the ownership of voting securities, by contract or otherwise.

 “Agent” means Deerfield Revolver, in its capacity as administrative agent for itself and for the other members of the
Lender Group hereunder, as such capacity is established in, and subject to the provisions of, Article XV, and the successors and assigns of Deerfield Revolver in such capacity, and including, when the context may require, during any Third
Party Agent Retention Period, any Third Party Agent. 
 “Agent-Related Persons” means Agent (including, for the avoidance
of doubt, any Third Party Agent), together with its Affiliates, controlling persons and their respective directors, officers, employees, 

  
 2 

 
partners, advisors, agents and other representatives of each of the foregoing and their respective successors. 

“Agent’s Account” means the Deposit Account of Agent (or, during a Third Party Agent Retention Period, any Third Party
Agent) identified on Schedule A-1 (or such other Deposit Account of Agent (or, during a Third Party Agent Retention Period, such Third Party Agent) that has been designated as such, in writing, by Agent
(or, during a Third Party Agent Retention Period, such Third Party Agent) to Borrowers and the Lenders). 
 “Agent’s
Liens” means the Liens granted by Borrowers or their Subsidiaries to Agent (or any Third Party Agent) under the Loan Documents and securing the Obligations. 

“Agreement” means this Credit Agreement. 

“All-in Yield” means the interest rate (including margins and floors), original issue
discount and fees paid to all lenders (or consenting lenders) of such debt or their Affiliates (based on the remaining life to maturity), but not including any fees not paid to all lenders (such as fees to initial purchasers (i.e., investment banks
in Rule 144A offerings), underwriters or lead agents). 
 “Announcing Form 8-K” has
the meaning specified therefor in Section 5.20. 
 “Anti-Corruption Laws” means any and all laws,
rules, and regulations of any jurisdiction applicable to any Loan Party or any Subsidiary of any Loan Party from time to time concerning or relating to bribery or corruption, including, without limitation, the FCPA, as amended, the UK Bribery Act
2010 and other similar legislation in any other jurisdictions. 
 “Anti-Money Laundering Laws” means any and all laws,
rules, and regulations in effect from time to time related to terrorism or money laundering, including, without limitation, (i) all applicable requirements of the Currency and Foreign Transactions Reporting Act of 1970 (31 U.S.C. 5311 et. seq.,
(the Bank Secrecy Act)), as amended by Title III of the USA Patriot Act, (ii) the Trading with the Enemy Act, (iii) Executive Order No. 13224 on Terrorist Financing, effective September 24, 2001 (66 Fed. Reg. 49079), and any
other enabling legislation, executive order or regulations issued pursuant or relating thereto and (iv) other applicable federal or state laws relating to “know your customer” or anti-money laundering rules and regulations. 

“Anti-Terrorism Laws” means any and all laws, regulations, rules, orders, etc. in effect from time to time relating to
anti-money laundering and terrorism, including, without limitation, Executive Order No. 13224 (effective September 24, 2001), Trading with the Enemy Act, as amended, and each of the foreign assets control regulations of the United States
Treasury Department (31 CFR, Subtitle B, Chapter V, as amended), and the USA Patriot Act (Pub. L. No. 107-56 (Oct. 12, 2001)). 

“Applicable Laws” means, with respect to any Person, the common law and any federal, state, local, foreign, multinational or
international laws, statutes, codes, treaties, standards, rules and regulations, guidelines, ordinances, orders, judgments, writs, injunctions, decrees (including administrative or judicial precedents or authorities) and the interpretation or
administration thereof by, and other determinations, directives, requirements or requests of, any Governmental Authority, in each case whether or not having the force of law and that are applicable to or binding upon such Person or any of its
property or to which such Person or any of its property is subject. “Applicable Laws” includes Healthcare Laws and Environmental Laws. 

“Applicable Revolver Reduction Premium” has the meaning specified in Section 2.09(d)(iii). 

  
 3 

 “Application Event” means the occurrence of (a) a failure by Borrowers
to repay all of the Obligations in full in cash on the Maturity Date, or (b) an Event of Default and the election by Agent or the Required Lenders to require that payments and proceeds of Collateral be applied pursuant to
Section 2.03(b)(ii). 
 “Approved Fund” means any (a) investment company, fund, trust,
securitization vehicle or conduit that is (or will be) engaged in making, purchasing, holding or otherwise investing in commercial loans and similar extensions of credit, or (b) any Person (other than a natural person) which temporarily
warehouses loans for any Lender or any entity described in the preceding clause (a) and that, with respect to each of the preceding clauses (a) and (b), is administered or managed by (i) a Lender, (ii) an Affiliate of a Lender,
or (iii) a Person (other than a natural person) or an Affiliate of a Person (other than a natural person) that administers or manages a Lender. 

“Assignee” has the meaning specified therefor in Section 13.01(a). 

“Assignment and Acceptance” means an Assignment and Acceptance Agreement substantially in the form of Exhibit A-1 or any other form agreed by the Agent. 
 “Authorizations” means, with respect to
any Person, any permits (including Regulatory Required Permits), approvals, authorizations, licenses, registrations, certificates, clearances, concessions, grants, franchises, variances or permissions from, and any other contractual obligations
with, any Governmental Authority, in each case whether or not having the force of law and applicable to or binding upon such Person or any of its property or to which such Person or any of its property is subject, and any supplements or amendments
with respect to the foregoing. 
 “Authorized Person” means any one of the individuals identified on Schedule A-2, as such schedule is updated from time to time by written notice from Borrowers to Agent (and, during any Third Party Agent Retention Period, also to the Third Party Agent). 

“Authorized Officer” means the chief executive officer, the president or the chief financial officer of the Borrower
Representative or any other officer of the Borrower Representative having substantially the same authority and responsibility. 

“Availability” means, as of any date of determination, the amount that Borrowers are entitled to borrow as Revolving Loans
under Section 2.01 (after giving effect to the then outstanding Revolver Usage). 
 “Average
Availability” means, with respect to any period, the sum of the aggregate amount of Availability for each Business Day in such period (calculated as of the end of each respective Business Day) divided by the number of Business Days in such
period. 
 “Average Revolver Usage” means, with respect to any period, the sum of the aggregate amount of Revolver Usage
for each Business Day in such period (calculated as of the end of each respective Business Day) divided by the number of Business Days in such period. 

“Bank of America Cash Collateral Account” means that certain deposit account #1453234066 of Borrower at Bank of America, N.A.
(or such replacement deposit account provided by Bank of America, N.A. or by another commercial bank) established and maintained for the sole purpose of providing cash collateral in favor of Bank of America, N.A. (or such replacement commercial
bank) for obligations of the Borrower in respect of certain commercial credit cards (or with respect to a replacement commercial bank, similar commercial credit cards to those provided by Bank of America, N.A. as of the Closing

  
 4 

 
Date) provided to the Borrower by Bank of America, N.A. (or such replacement commercial bank); provided that the aggregate amount on deposit in such deposit account (or such replacement deposit
account) shall not at any time exceed $2,500,000. 
 “Bankruptcy Code” means title 11 of the United States Code, as in
effect from time to time. 
 “Blocked Account” has the meaning specified therefor in
Section 2.12(a). 
 “Board of Governors” means the Board of Governors of the Federal Reserve
System of the United States (or any successor). 
 “Borrowers” has the meaning specified therefor in the preamble. 

“Borrower Representative” means Endologix, in its capacity as Borrower Representative pursuant to the provisions of
Section 2.13, or any successor Borrower Representative selected by Borrowers and approved by Agent. 

“Borrowing” means a borrowing consisting of Loans made on the same day by the Lenders (or Agent on behalf thereof), or by
Agent in the case of an Extraordinary Advance. 
 “Borrowing Base” means, as of any date of determination, an amount
equal to: 
 (a) the lesser of: 

(i) the Maximum Revolver Amount, and 

(ii) an amount equal to: 

(A) an amount not to exceed 85% of the aggregate amount of Eligible Accounts; less 

(B) the amount, if any, of the Dilution Reserve; plus 

(C) the least of (1) the product of 50% multiplied by the value (calculated at the lower of cost or market based on the
Borrowers’ historical accounting practices) of Eligible Inventory at such time, (2) the product of 85% multiplied by the Net Orderly Liquidation Value of Eligible Inventory (such determination may be made as to different categories of
Eligible Inventory based upon the Net Orderly Liquidation Value applicable to such categories) at such time, (3) the Inventory Cap and (4) an amount equal to 40% of the Borrowing Base; plus 

(D) an amount not to exceed 50% of the Net Book Value of Eligible Equipment; 

less 
 (b) the aggregate
amount of all Reserves in effect at such time; 
 provided, that, the Borrowing Base will be automatically adjusted down, if
necessary, such that (1) availability from Eligible Foreign Accounts shall never exceed the lesser of (x) $5,000,000 and (y) 20% of the Borrowing Base and (2) availability from Eligible Equipment shall never exceed $2,000,000;
and 

  
 5 

 provided, further, that, as of any date of determination prior to the Trigger
Date, the Borrowing Base shall never exceed an amount equal to (i) 75% of the Borrowing Base plus (ii) Qualified Cash as of such date. 

“Borrowing Base Certificate” means each of the Borrowing Base Certificate (Agent) and Borrowing Base Certificate (Third Party
Agent), as the context may require. 
 “Borrowing Base Certificate (Agent)” means a certificate in the form of Exhibit B-1, which Borrowing Base Certificate (Agent) shall be delivered to Agent in accordance with the terms of this Agreement. 

“Borrowing Base Certificate (Third Party Agent)” means a certificate in the form of Exhibit
B-2, which Borrowing Base Certificate (Third Party Agent) shall be delivered to a Third Party Agent during a Third Party Agent Retention Period in accordance with the terms of this Agreement. 

“Business Day” means any day excluding Saturday, Sunday, and any day which is a legal holiday under the laws of the State of
New York or which is a day on which Agent (or, during any Third Party Agent Retention Period, the Third Party Agent) is otherwise closed for transacting business with the public, except that, if a determination of a Business Day shall relate to
amounts accruing interest at the LIBOR Rate, the term “Business Day” also shall exclude any day on which banks are closed for dealings in Dollar deposits in the London interbank market. 

“Capital Expenditures” means, with respect to any Person for any period, the amount of all expenditures by such Person and
its Subsidiaries during such period that are capital expenditures as determined in accordance with GAAP, whether such expenditures are paid in cash or financed, but excluding, without duplication (a) expenditures made during such period in
connection with the replacement, substitution, or restoration of assets or properties, (b) with respect to the purchase price of assets that are purchased substantially contemporaneously with the trade-in
of existing assets during such period, the amount that the gross amount of such purchase price is reduced by the credit granted by the seller of such assets for the assets being traded in at such time, (c) expenditures made during such period
to consummate one or more Permitted Acquisitions, (d) expenditures made during such period to the extent made with the identifiable proceeds of an equity investment in Borrowers which equity investment is made substantially contemporaneously
with the making of the expenditure, and (e) expenditures during such period that, pursuant to a written agreement, are reimbursed by a third Person (excluding the Loan Parties and their Affiliates). 

“Capital Lease” means, with respect to any Person, any lease of or other arrangement conveying the right to use, any property
by such Person as lessee that has been or should be accounted for as a capital lease on a balance sheet of such Person prepared in accordance with GAAP. 

“Capital Lease Obligations” means, at any time, with respect to any Capital Lease, any lease entered into as part of any sale
leaseback transaction of any Person or any synthetic lease, the amount of all obligations of such Person that is (or that would be, if such synthetic lease or other lease were accounted for as a Capital Lease) capitalized on a balance sheet of such
Person prepared in accordance with GAAP. 
 “Capped Call” means the capped call transactions referenced in Schedule
6.05 in respect of the 2.25% Convertible Notes and any like transactions that are economically similar to such transactions entered into in connection with any Indebtedness contemplated under clause (j) of the definition of Permitted
Indebtedness. 

  
 6 

 “Cash Equivalents” means (a) any readily-marketable securities
(i) issued by, or directly, unconditionally and fully guaranteed or insured by the United States federal government or (ii) issued by any agency of the United States federal government the obligations of which are fully backed by the full
faith and credit of the United States federal government, (b) any readily-marketable direct obligations issued by any other agency of the United States federal government, any state of the United States or any political subdivision of any such
state or any public instrumentality thereof, in each case having a rating of at least “A-1” from S&P or at least “P-1” from Moody’s,
(c) any commercial paper rated at least “A-1” by S&P or “P-1” by Moody’s and issued by any Person organized under the laws of any state
of the United States, (d) any United States dollar-denominated time deposit, insured certificate of deposit, overnight bank deposit or bankers’ acceptance issued or accepted by any commercial bank that is (A) organized under the laws
of the United States, any state thereof or the District of Columbia, (B) “adequately capitalized” (as defined in the regulations of its primary federal banking regulators) and (C) has Tier 1 capital (as defined in such regulations) in
excess of $250,000,000, (e) shares of any United States money market fund that (i) has substantially all of its assets invested continuously in the types of investments referred to in clause (a), (b), (c) or (d) above with maturities as
set forth in the proviso below, (ii) has net assets in excess of $500,000,000 and (iii) has obtained from either S&P or Moody’s the highest rating obtainable for money market funds in the United States; provided,
however, that the maturities of all obligations specified in any of clauses (a), (b), (c) or (d) above shall not exceed one year and (f) investments made in accordance with Endologix’ investment policy in effect as of the
Closing Date that was provided to the Agent’s counsel on March 14, 2017 at 12:15 p.m. New York time, and any amendments thereto that do not, when taken as a whole, materially increase the risk of the investments made by Endologix from time
to time from Endologix’ investment policy in effect as of the Closing Date. 
 “Cash Management Services” means any
cash management or related services including treasury, depository, return items, overdraft, controlled disbursement, merchant store value cards, e-payables services, electronic funds transfer, interstate
depository network, automatic clearing house transfer (including the Automated Clearing House processing of electronic funds transfers through the direct Federal Reserve Fedline system) and other customary cash management arrangements. 

“Change in Law” means the occurrence after the Closing Date of: (a) the adoption or effectiveness of any law, rule,
regulation, judicial ruling, judgment or treaty, (b) any change in any law, rule, regulation, judicial ruling, judgment or treaty or in the administration, interpretation, implementation or application by any Governmental Authority of any law,
rule, regulation, guideline or treaty, or (c) the making or issuance by any Governmental Authority of any request, rule, guideline or directive, whether or not having the force of law; provided that notwithstanding anything in the
Agreement to the contrary, (i) the Dodd-Frank Wall Street Reform and Consumer Protection Act and all requests, rules, guidelines or directives thereunder or issued in connection therewith and (ii) all requests, rules, guidelines or
directives concerning capital adequacy promulgated by the Bank for International Settlements, the Basel Committee on Banking Supervision (or any successor or similar authority) or the United States or foreign regulatory authorities shall, in each
case, be deemed to be a “Change in Law,” regardless of the date enacted, adopted or issued. 
 “Change in
Control” or “Change of Control” means any of the following events: (a) any Person or two or more Persons acting in concert shall have acquired beneficial ownership, directly or indirectly, of, or shall have acquired by
contract or otherwise, or shall have entered into a contract or arrangement that, upon consummation, will result in its or their acquisition of or control over, voting Stock of Endologix (or other securities convertible into such voting Stock)
representing more than 50% of the combined voting power of all voting Stock of Endologix; (b) Endologix shall have ceased to own, directly or indirectly, 100% of the Stock of any of its Subsidiaries (with the exception of any Subsidiaries
permitted to be dissolved or merged to the extent otherwise permitted by this Agreement and other than, 

  
 7 

 
solely with respect to Foreign Subsidiaries, directors qualifying shares as necessary to comply with foreign law); (c) the occurrence of a “Change of Control”, “Change in
Control”, “Fundamental Change” or terms of similar import under the 2.25% Convertible Note Documents, the 3.25% Convertible Note Documents, the Term Debt Documents or any Permitted Japan Lifeline Unsecured Debt Documents; or
(d) the occurrence of any “Major Transaction” (as defined in any Warrant). As used herein, “beneficial ownership” shall have the meaning provided in Rule 13d-3 of the SEC under the
Exchange Act; provided that no Change in Control shall be deemed to have occurred with respect to a “Permitted Successor Transaction” (as defined in the Term Loan Credit Agreement as in effect on the Closing Date) which prohibits
the Term Lenders from delivering a “Put Notice” (as defined in the Term Loan Credit Agreement as in effect on the Closing Date) under the Term Loan Credit Agreement as in effect on the Closing Date. 

“Closing Date” means the date of this Agreement. 

“CMS” means the federal Centers for Medicare and Medicaid Services (formerly the federal Health Care Financing
Administration), and any successor Governmental Authority. 
 “Code” means the New York Uniform Commercial Code, as in
effect from time to time. 
 “Collateral” means all assets and interests in assets and proceeds thereof now owned or
hereafter acquired by Borrowers or any of their Subsidiaries in or upon which a Lien is granted by such Person in favor of Agent (or, during any Third Party Agent Retention Period, the Third Party Agent) or the Lenders under any of the Loan
Documents, including the “Collateral” (as defined in the Guaranty and Security Agreement). 
 “Collateral Access
Agreement” means a landlord waiver, bailee letter, or acknowledgement agreement of any lessor, warehouseman, processor, consignee, or other Person in possession of, having a Lien upon, or having rights or interests in the Loan Parties’
or their Subsidiaries’ Collateral or books and records, in each case, in form and substance reasonably satisfactory to Agent and the Lenders. 

“Commitment” means, with respect to each Lender, its Revolver Commitment and, with respect to all Lenders, their Revolver
Commitments, in each case as such Dollar amounts are set forth beside such Lender’s name under the applicable heading on Schedule C-1 or in the Assignment and Acceptance pursuant to which such
Lender became a Lender hereunder, as such amounts may be reduced or increased from time to time pursuant to assignments made in accordance with the provisions of Section 13.01. 

“Commitment Fee” has the meaning specified therefor in Section 2.09(e). 

“Common Stock” means the “Common Stock” of Endologix, with a $0.001 par value per share. 

“Compliance Certificate” means a certificate, duly executed by an Authorized Officer of the Borrower Representative,
appropriately completed and substantially in the form of Exhibit C-1 hereto. 

“Contingent Obligation” means, with respect to any Person, any direct or indirect liability of such Person: (a) with
respect to any Indebtedness of another Person (a “Third Party Obligation”) if the purpose or intent of such Person incurring such liability, or the effect thereof, is to provide assurance to the obligee of such Third Party
Obligation that such Third Party Obligation will be paid or discharged, or that any agreement relating thereto will be complied with, or that any holder of such Third Party Obligation will be protected, in whole or in part, against loss with respect
thereto; (b) with respect to any undrawn portion of any letter of credit issued for the account of such Person or as to which such Person is otherwise liable for the reimbursement of any drawing; (c) under any Swap Contract, to the extent
not yet 

  
 8 

 
due and payable; (d) to make take-or-pay or similar payments if required regardless of nonperformance by any
other party or parties to an agreement; or (e) for any obligations of another Person pursuant to any Guarantee or pursuant to any agreement to purchase, repurchase or otherwise acquire any obligation or any property constituting security
therefor, to provide funds for the payment or discharge of such obligation or to preserve the solvency, financial condition or level of income of another Person. The amount of any Contingent Obligation shall be equal to the amount of the obligation
so Guaranteed or otherwise supported or, if not a fixed and determinable amount, the maximum amount so Guaranteed or otherwise supported. 

“Control Agreement” means a control agreement, in form and substance reasonably satisfactory to Agent and the Lenders,
executed and delivered by Borrowers or one of their Subsidiaries, Agent, Term Agent and the applicable securities intermediary (with respect to a Securities Account) or bank (with respect to a Deposit Account). 

“Convertible Note Documents” means, collectively the 2.25% Convertible Note Documents and the 3.25% Convertible Note
Documents (which, for the avoidance of doubt, shall include the indenture and each other document or agreement from time to time entered into in connection with any Permitted 3.25% Convertible Note Refinancing, in each case, to the extent such
indenture, documents or agreements are permitted pursuant to the terms of the definition of “Permitted 3.25% Convertible Note Refinancing”). 

“Copyrights” has the meaning specified therefor in the Guaranty and Secured Agreement. 

“Copyright Security Agreement” has the meaning specified therefor in the Guaranty and Security Agreement. 

“Correction” means the repair, modification, adjustment, relabeling, destruction, or inspection (including patient
monitoring) of a product or device without its physical removal from its point of use to some other location. 
 “Cortland”
means Cortland Capital Market Services LLC, a Delaware limited liability company, and its Affiliates and its and their successors and assigns. 

“DEA” means the Drug Enforcement Administration of the United States of America, any comparable state or local Governmental
Authority, any comparable Governmental Authority in any non-United States jurisdiction, and any successor agency of any of the foregoing. 

“Deerfield Revolver” means Deerfield ELGX Revolver, LLC and its successors and assigns. 

“Default” means an event, condition, or default that, with the giving of notice, the passage of time, or both, would be an
Event of Default. 
 “Deposit Account” means any deposit account (as that term is defined in the Code). 

“Depositary Bank” has the meaning specified therefor in Section 2.12(a). 

“Designated Account” means the Deposit Account of Borrower Representative identified on Schedule D-1 (or such other Deposit Account of Borrower Representative located at Designated Account Bank that has been designated as such, in writing, by Borrowers to Agent (and, during any Third Party Agent Retention
Period, also to the Third Party Agent)). 

  
 9 

 “Designated Account Bank” has the meaning specified therefor in Schedule
D-1 (or such other bank that is located within the United States that has been designated as such, in writing, by Borrowers to Agent (and, during any Third Party Agent Retention Period, also to the Third
Party Agent)). 
 “Dilution” means, as of any date of determination, a percentage, based upon the experience of the
immediately prior three (3) months, that is the result of dividing the Dollar amount of (a) bad debt write-downs, discounts, advertising allowances, credits, or other dilutive items with respect to Borrowers’ Accounts during such
period, by (b) Borrowers’ billings with respect to Accounts during such period. 
 “Dilution Reserve” means, as
of any date of determination, an amount sufficient to reduce the advance rate against Eligible Accounts by one (1) percentage point for each percentage point by which Dilution is in excess of 5%. 

“Dispose” and “Disposition” mean (a) the sale, lease, license, transfer, assignment, conveyance or
other disposition of any assets or property (including any transfer or conveyance of any assets or property pursuant to a division or split of a limited liability company or other entity or Person into two or more limited liability companies or
other entities or Persons), and (b) the sale or transfer by the Borrower or any Subsidiary of the Borrower of any Stock issued by any Subsidiary of the Borrower. 

“Disqualified Stock” means any Stock which, by its terms (or by the terms of any security or other Stock into which it is
convertible or for which it is exchangeable), or upon the happening of any event or condition, (a) matures or is mandatorily redeemable (other than solely for Stock that does not constitute Disqualified Stock), pursuant to a sinking fund
obligation or otherwise, or is redeemable (in each case, other than solely for Stock that does not constitute Disqualified Stock) at the option of the holder thereof, in whole or in part, on or prior to the date that is one year and one day
following the Maturity Date (excluding any provisions requiring redemption upon a “change in control” or similar event, provided that such “change in control” or similar event results in the occurrence of the payment in full in
cash of all of the Obligations (other than unasserted contingent indemnification obligations) and the termination of all of the Commitments, (b) is convertible into or exchangeable for (i) debt securities or (ii) any Stock referred to
in (a) above, in each case, at any time on or prior to the date that is one year and one day following the Maturity Date at the time such Stock was issued, or (c) is entitled to receive scheduled dividends or distributions in cash prior to
the date that is one year and one day following the Maturity Date. 
 “Dollars” or “$” means United States
dollars. 
 “Domestic Subsidiary” means, with respect to any Person, a Subsidiary of such Person, which is organized,
incorporated or otherwise formed under the laws of the United States or any state thereof or the District of Columbia. 

  
 10 

 “Drug Application” means a new drug application, an abbreviated drug
application, or a product license application for any Product, as appropriate, as those terms are defined in the FDCA. 

“DTC” has the meaning specified therefor in Section 4.31. 

“EBITDA” means, for any period, Borrowers and their Subsidiaries’ net income, plus (to the extent deducted from net
income in the determination thereof) interest expense, taxes, depreciation and amortization for such period, all calculated on a consolidated basis in accordance with GAAP, consistently applied and determined as of and at the end of such period. For
purposes of this Agreement, EBITDA for any period shall be determined by disregarding any extraordinary, unusual or non-recurring items of income during such period. 

“Eligible Accounts” means Eligible Domestic Accounts and Eligible Foreign Accounts. 

“Eligible Domestic Accounts” means those Accounts created by a Borrower in the ordinary course of its business, that arise
out of its sale of goods or rendition of services in the United States that have been acknowledged as accepted by the applicable Account Debtor, that comply with each of the representations and warranties respecting Eligible Domestic Accounts made
in the Loan Documents, and that are not excluded as ineligible by virtue of one or more of the excluding criteria set forth below; provided, that such criteria may be revised from time to time by Agent in Agent’s (including, during any
Third Party Agent Retention Period, the Third Party Agent’s) Permitted Discretion to address the results of any field examination performed by (or on behalf of) Agent (or, during any Third Party Agent Retention Period, the Third Party Agent)
from time to time after the Closing Date. In determining the amount to be included, Eligible Domestic Accounts shall be calculated net of customer deposits, unapplied cash, taxes, discounts, credits, allowances, and rebates. Subject to the proviso
to the first sentence of this definition, Eligible Domestic Accounts shall not include the following: 
 (a) Accounts that the Account Debtor
has failed to pay within 90 days of original invoice date, Accounts that are more than 60 days past due or have a credit balance that is more than 60 days past due, or Accounts with selling terms of more than 60 days (or, with respect to
Twins & Martin, 120 days), 
 (b) Accounts owed by an Account Debtor (or its Affiliates) where 50% or more of all Accounts owed by
that Account Debtor (or its Affiliates) are deemed ineligible under clause (a) above, 
 (c) Accounts with respect to which the Account
Debtor is an Affiliate of a Loan Party or an employee or agent of a Loan Party or any Affiliate of a Loan Party, 
 (d) Accounts arising in a
transaction wherein goods are placed on consignment or are sold pursuant to a guaranteed sale, a sale or return, a sale on approval, a bill and hold, or any other terms by reason of which the payment by the Account Debtor may be conditional, 

(e) Accounts that are not payable in Dollars, 

(f) Accounts with respect to which the Account Debtor either (i) does not maintain its chief executive office in the United States or
(ii) is not organized under the laws of the United States or any state thereof, 
 (g) Accounts of a Loan Party with respect to which
the Account Debtor is either (i) the United States or any department, agency, or instrumentality of the United States (exclusive, however, of (x) Accounts with respect to which such Loan Party has complied, to the reasonable satisfaction
of Agent 

  
 11 

 
(or, at the sole option of Agent during any Third Party Agent Retention Period, the Third Party Agent), with the Assignment of Claims Act, 31 USC §3727 and (y) up to $1,000,000, in the
aggregate, of Accounts where the Account Debtor is satisfactory to Agent (including, during any Third Party Agent Retention Period, the Third Party Agent) in its Permitted Discretion), or (ii) any state of the United States, 

(h) Accounts with respect to which the Account Debtor is a creditor of a Loan Party, has or has asserted a right of recoupment or setoff, or
has disputed its obligation to pay all or any portion of the Account, but only to the extent of such claim, right of recoupment or setoff, or dispute, 

(i) Accounts with respect to an Account Debtor whose total obligations owing to the Loan Parties exceed 20% of all Eligible Accounts, to the
extent of the obligations owing by such Account Debtor in excess of such percentage; provided, that, in each case, the amount of Eligible Accounts that are excluded because they exceed the foregoing percentage shall be determined by Agent
(or, at the sole option of Agent during any Third Party Agent Retention Period, the Third Party Agent) based on all of the otherwise Eligible Accounts prior to giving effect to any eliminations based upon the foregoing concentration limit, 

(j) Accounts with respect to which the Account Debtor is subject to an Insolvency Proceeding, is not Solvent, has gone out of business, or as
to which a Loan Party has received notice of an imminent Insolvency Proceeding or a material impairment of the financial condition of such Account Debtor, 

(k) Accounts, the collection of which, Agent (including, during any Third Party Agent Retention Period, the Third Party Agent), in its
Permitted Discretion, believes to be doubtful, including by reason of the Account Debtor’s financial condition, 
 (l) Accounts that are
not subject to a valid and perfected first priority Agent’s Lien, 
 (m) Accounts with respect to which (i) the goods giving rise
to such Account have not been shipped and billed to the Account Debtor, or (ii) the services giving rise to such Account have not been performed and billed to the Account Debtor, 

(n) Accounts with respect to which the Account Debtor is a Sanctioned Person or Sanctioned Entity, 

(o) Accounts with respect to which the Account Debtor is an individual, 

(p) Accounts that represent the right to receive progress payments or other advance billings that are due prior to the completion of
performance by a Loan Party of the subject contract for goods or services, or 
 (q) Accounts where the Account or the applicable Account
Debtor fails to meet such other specifications and requirements which may be from time to time established by Agent (including, during any Third Party Agent Retention Period, the Third Party Agent) in its Permitted Discretion. 

“Eligible Assignee” means (a) a Lender, (b) an Affiliate of a Lender, (c) a Related Fund, and (d) any
other Person (other than a natural person) approved by Agent; provided, however, that solely with respect to clause (d) above, no such Person shall include (i) Borrowers or any of Borrowers’ Affiliates or
(ii) unless an Event of Default has occurred and is continuing, (A) any direct competitor of the Loan Parties, in each case, as determined by Agent in its reasonable discretion, (B) any investor or fund that has

  
 12 

 
publicly announced in writing its intention to obtain control of Endologix publicly or otherwise to the knowledge of the assigning Lender, or (D) any Person listed in the email delivered by
prior counsel to Endologix to counsel to the Agent on March 16, 2017 at 5:00 p.m. (Pacific time) and any Affiliates or Approved Funds of any such Person actually known to the assigning Lender and to the Agent to be Affiliates or Approved Funds
of any such Person. 
 “Eligible Foreign Accounts” means those Accounts created by a Borrower in the Ordinary Course of
Business, have been acknowledged as accepted by the applicable Account Debtor, that comply with each of the representations and warranties respecting Eligible Foreign Accounts made in the Loan Documents, and with respect to which the applicable
Account Debtor does not have its principal place of business in the United States (but is not located in an OFAC sanctioned country), and in each case that are: (i) supported by an irrevocable letter of credit reasonably satisfactory to Agent
and the Lenders (as to form, substance, and issuer or domestic confirming bank) that has been delivered to Agent and is directly drawable by Agent, (ii) covered by credit insurance in form, substance, and amount, and by an insurer, reasonably
satisfactory to Agent and the Lenders or (iii) generated by an Account Debtor with its principal place of business in a jurisdiction approved by Agent (including, during any Third Party Agent Retention Period, the Third Party Agent) on a case-by-case basis in its Permitted Discretion; provided, that it is understood that the Account Debtors set forth on Schedule
E-1 are in approved jurisdictions as of the date hereof. In addition, Eligible Foreign Accounts shall only include Accounts that are not excluded as ineligible by virtue of one or more of the excluding
criteria set forth below; provided, that such criteria may be revised from time to time by Agent in Agent’s (including, during any Third Party Agent Retention Period, the Third Party Agent’s) Permitted Discretion to address the
results of any field examination performed by (or on behalf of) Agent (or, during any Third Party Agent Retention Period, the Third Party Agent) from time to time after the Closing Date. In determining the amount to be included, Eligible Foreign
Accounts shall be calculated net of customer deposits, unapplied cash, taxes, discounts, credits, allowances, and rebates. Subject to the proviso to the second sentence of this definition, Eligible Foreign Accounts shall not include the following:

 (a) Accounts that the Account Debtor has failed to pay within 90 days of original invoice date, Accounts that are more than 60 days past
due or have a credit balance that is more than 60 days past due, or Accounts with selling terms of more than 60 days, 
 (b) Accounts owed by
an Account Debtor (or its Affiliates) where 50% or more of all Accounts owed by that Account Debtor (or its Affiliates) are deemed ineligible under clause (a) above, 

(c) Accounts with respect to which the Account Debtor is an Affiliate of a Loan Party or an employee or agent of a Loan Party or any Affiliate
of a Loan Party, 
 (d) Accounts arising in a transaction wherein goods are placed on consignment or are sold pursuant to a guaranteed sale,
a sale or return, a sale on approval, a bill and hold, or any other terms by reason of which the payment by the Account Debtor may be conditional, 

(e) Accounts that are not payable in US Dollars, 

(f) Accounts with respect to which the Account Debtor is the government of any foreign country or sovereign state, or of any state, province,
municipality, or other political subdivision thereof, or of any department, agency, public corporation, or other instrumentality thereof, 

(g) Accounts of a Loan Party with respect to which the Account Debtor is either (i) the United States or any department, agency, or
instrumentality of the United States (exclusive, however, of 

  
 13 

 
Accounts with respect to which such Loan Party has complied, to the reasonable satisfaction of Agent (or, at the sole option of Agent during any Third Party Agent Retention Period, the Third
Party Agent), with the Assignment of Claims Act, 31 USC §3727), or (ii) any state of the United States, 
 (h) Accounts with
respect to which the Account Debtor is a creditor of a Loan Party, has or has asserted a right of recoupment or setoff, or has disputed its obligation to pay all or any portion of the Account, but only to the extent of such claim, right of
recoupment or setoff, or dispute, 
 (i) Accounts with respect to an Account Debtor whose total obligations owing to the Loan Parties exceed
20% of all Eligible Accounts, to the extent of the obligations owing by such Account Debtor in excess of such percentage; provided, that, in each case, the amount of Eligible Accounts that are excluded because they exceed the foregoing
percentage shall be determined by Agent (or, at the sole option of Agent during any Third Party Agent Retention Period, the Third Party Agent) based on all of the otherwise Eligible Accounts prior to giving effect to any eliminations based upon the
foregoing concentration limit, 
 (j) Accounts with respect to which the Account Debtor is subject to an Insolvency Proceeding, is not
Solvent, has gone out of business, or as to which a Loan Party has received notice of an imminent Insolvency Proceeding or a material impairment of the financial condition of such Account Debtor, 

(k) Accounts, the collection of which, Agent (including, during any Third Party Agent Retention Period, the Third Party Agent), in its
Permitted Discretion, believes to be doubtful, including by reason of the Account Debtor’s financial condition, 
 (l) Accounts that are
not subject to a valid and perfected first priority Agent’s Lien, 
 (m) Accounts with respect to which (i) the goods giving rise
to such Account have not been shipped and billed to the Account Debtor, or (ii) the services giving rise to such Account have not been performed and billed to the Account Debtor, 

(n) Accounts with respect to which the Account Debtor is a Sanctioned Person or Sanctioned Entity, 

(o) Accounts with respect to which the Account Debtor is an individual, 

(p) Accounts that represent the right to receive progress payments or other advance billings that are due prior to the completion of
performance by a Loan Party of the subject contract for goods or services, or 
 (q) Accounts where the Account or the applicable Account
Debtor fails to meet such other specifications and requirements which may be from time to time established by Agent (including, during any Third Party Agent Retention Period, the Third Party Agent) in its Permitted Discretion. 

“Eligible Equipment” means, subject to the criteria below, all Equipment that is: (a) owned by a Borrower (and for which
a Borrower has good and lawful title thereto) free and clear of all Liens other than Liens in favor of Agent securing the Obligations, (b) installed in a facility in the United States (i) owned by a Borrower or (ii) leased by a Loan
Party and subject to a landlord’s agreement in favor of Agent that is in form and substance reasonably satisfactory to Agent and the Lenders, (c) in good working order and operating condition (ordinary wear and tear excepted), (d) not
obsolete, outdated or surplus 

  
 14 

 
Equipment, (e) subject to a first priority Lien in favor of Agent (for the benefit of itself and the Lenders), (f) not “fixtures” under the Applicable Laws of the jurisdiction
in which such Equipment is located, (g) subject to liability and property and casualty insurance with insurers reasonable acceptable to Agent and the Lenders and in an amount reasonably acceptable to Agent and the Lenders naming Agent as an
additional insured and lender’s loss payee on such insurance policies with evidence reflecting such that is reasonably satisfactory to Agent and the Lenders, and (h) not determined by Agent (or, during any Third Party Agent Retention
Period, the Third Party Agent) in its Permitted Discretion to be unacceptable due to age, type, category, quality or quantity and/or for any other reason whatsoever. In addition, Agent (and, during any Third Party Agent Retention Period, the Third
Party Agent) reserves the right, at any time and from time to time after the Closing Date (including on the basis of any appraisal conducted after the Closing Date), to adjust any of the applicable criteria, to establish new criteria and to adjust
advance rates with respect to Eligible Equipment in its reasonable and good faith credit judgment and discretion, subject to the approval of Required Lenders in the case of adjustments or new criteria or changes in advance rates which have the
effect of making more credit available. 
 “Eligible Inventory” means Inventory of a Loan Party, that complies with each of
the representations and warranties respecting Eligible Inventory made in the Loan Documents, and that is not excluded as ineligible by virtue of one or more of the excluding criteria set forth below; provided, that such criteria may be
revised from time to time by Agent in Agent’s (including, during any Third Party Agent Retention Period, the Third Party Agent’s) Permitted Discretion to address the results of any field examination or appraisal performed by (or on behalf
of) Agent (or, during any Third Party Agent Retention Period, the Third Party Agent) from time to time after the Closing Date. In determining the amount to be so included, Inventory shall be valued at the lower of cost or market on a basis
consistent with Borrowers’ historical accounting practices. Subject to the proviso to the first sentence of this definition, an item of Inventory shall not be included in Eligible Inventory if: 

(a) such Loan Party does not have good, valid, and marketable title thereto, 

(b) such Loan Party does not have actual and exclusive possession thereof (either directly or through a bailee or agent of such Loan Party),

 (c) it is not located at one of the locations in the continental United States set forth on Schedule 4.45 or is Trunk Inventory,

 (d) it is in-transit, 

(e) it is located on Real Property leased by such Loan Party or in a contract warehouse, in each case, unless it is subject to a Collateral
Access Agreement executed by the lessor or warehouseman, as the case may be, and unless it is segregated or otherwise separately identifiable from goods of others, if any, stored on the premises, or Agent (or, during any Third Party Agent Retention
Period, the Third Party Agent) has established a Landlord Reserve with respect to such location, 
 (f) it is not held for sale in the
Borrowers’ Ordinary Course of Business (unless it consists of first quality raw materials) or is not of good and merchantable quality, or it has not been approved for sale by the Borrowers, or it is quarantined from Borrowers’ general
Inventory population or is rejected by Borrowers’ Material Review Board, 
 (g) it is not subject to a valid and perfected first
priority Agent’s Lien, 

  
 15 

 (h) it consists of goods returned or rejected by such Loan Party’s customers or is
subject to a Recall, 
 (i) it consists of goods that are obsolete or slow moving, restrictive or custom items, display or demo items,
discontinued items, work-in-process, items used in research and development, or goods that constitute spare parts, packaging and shipping materials, supplies used or
consumed in such Loan Party’s business, bill and hold goods, defective goods, “seconds,” or Inventory acquired on consignment, or Inventory on consignment with third parties, 

(j) such Inventory is not covered by casualty insurance reasonably acceptable to Agent and the Lenders, 

(k) it consists of goods that can be transported or sold only with licenses that are not readily available or of any substances defined or
designated as hazardous or toxic waste, hazardous or toxic material, hazardous or toxic substance, or similar term, by any environmental law or any Governmental Authority applicable to Borrowers or their business, operations or assets, 

(l) it does not meet all standards imposed by any Governmental Authority in all material respects, including with respect to its production,
acquisition, sale or importation (as the case may be, 
 (m) it has expired or is obsolete, 

(n) such Inventory is located at the Santa Rosa location and a reserve has been established on the books of the Borrowers against such
Inventory in accordance with Endologix’s standards in place regarding aged Inventory, 
 (o) it is held for rental or lease by or on
behalf of Borrowers, 
 (p) it is subject to third party trademark, licensing or other proprietary rights, unless Agent is satisfied that
such Inventory can be freely sold by Agent on and after the occurrence of an Event of a Default despite such third party rights, or 
 (q) it
fails to meet such other specifications and requirements which may from time to time be established by Agent (including, during any Third Party Agent Retention Period, the Third Party Agent) in its Permitted Discretion. Notwithstanding the
foregoing, the valuation of Inventory shall be subject to any legal limitations on sale and transfer of such Inventory. 

“Employee” means any employee of any Loan Party or any Subsidiary of any Loan Party. 

“Employee Benefit Plan” means any “employee benefit plan” within the meaning of Section 3(3) of ERISA, under
which (A) any current or former employee, director or independent contractor of the Borrower or any of its Subsidiaries has any present or future right to benefits or compensation and which is contributed to, sponsored by or maintained by the
Borrower or any of its Subsidiaries or (B) the Borrower or any of its Subsidiaries has had or has or could reasonably be expected, individually or in the aggregate, to have any present or future obligation or liability. 

“Environmental Action” means any written complaint, summons, citation, notice, directive, order, claim, litigation,
investigation, judicial or administrative proceeding, judgment, letter, or other written communication from any Governmental Authority, or any third party involving violations of or liability under Environmental Laws or releases of Hazardous
Materials, including, without limitation, (a) from any 

  
 16 

 
assets, properties, or businesses of any Borrower, any Subsidiary of a Borrower, or any of their predecessors in interest, (b) from adjoining properties or businesses, or (c) from or
onto any facilities which received Hazardous Materials generated by any Borrower, any Subsidiary of any Borrower, or any of their predecessors in interest. 

“Environmental Laws” means all Applicable Laws, Authorizations and permits imposing liability or standards of conduct for or
relating to the regulation and protection of human health, safety, the workplace, the environment and natural resources, and including public notification requirements and environmental transfer of ownership, notification or approval statutes. 

“Environmental Liabilities” means all Liabilities (including costs of removal and remedial actions, natural resource damages
and costs and expenses of investigation and feasibility studies, including the cost of environmental consultants and attorneys’ costs) that may be imposed on, incurred by or asserted against any Loan Party or any Subsidiary of any Loan Party as
a result of, or related to, any claim, suit, action, investigation, proceeding or demand by any Person, whether based in contract, tort, implied or express warranty, strict liability, criminal or civil statute or common law or otherwise, arising
under any Environmental Law resulting from the ownership, lease, sublease or other operation or occupation of property by any Loan Party or any Subsidiary of any Loan Party, whether on, prior or after the date hereof. 

“Environmental Permits” has the meaning specified therefor in Section 4.20(a). 

“Equipment” means all “equipment,” as such term is defined in the UCC, now owned or hereafter acquired by any Loan
Party, wherever located. 
 “ERISA” means the Employee Retirement Income Security Act of 1974, as amended and applicable
published guidance thereunder. 
 “ERISA Affiliate” means collectively the Borrower, any Subsidiary of Borrower and any
Person under common control or treated as a single employer with, Borrower or any Subsidiary of Borrower within the meaning of IRC Section 414 (b), (c), (m) or (o) or under ERISA. 

“ERISA Event” means any of the following: (a) a reportable event described in Section 4043(b) or (c) of ERISA
(other than an event for which the 30-day notice period is waived) with respect to a Title IV Plan; (b) the withdrawal of any ERISA Affiliate from a Title IV Plan subject to Section 4063 of ERISA
during a plan year in which it was a substantial employer, as defined in Section 4001(a)(2) of ERISA; (c) the complete or partial withdrawal of any ERISA Affiliate from any Multiemployer Plan; (d) with respect to any Multiemployer
Plan, the filing of a notice of insolvency or termination, or treatment of a plan amendment as termination, under Section 4041A of ERISA; (e) the filing of a notice of intent to terminate a Title IV Plan, or treatment of a plan amendment
as termination, under Section 4041 of ERISA; (f) the institution of proceedings to terminate a Title IV Plan or Multiemployer Plan by the PBGC; (g) the failure to make any required contribution to any Title IV Plan or Multiemployer
Plan when due; (h) the imposition of a Lien under Section 412 or 430(k) of the IRC or Section 303 or 4068 of ERISA on any property (or rights to property, whether real or personal) of any ERISA Affiliate; (i) the failure of an
Employee Benefit Plan or any trust thereunder intended to qualify for tax exempt status under Section 401 or 501 of the IRC or other Applicable Law to qualify thereunder; (j) a Title IV plan is in “at risk” status within the
meaning of IRC Section 430(i); (k) a Multiemployer Plan is in “endangered status” or “critical status” within the meaning of Section 432(b) of the IRC; and (l) any other event or condition that constitutes grounds
under Section 4042 of ERISA for the termination of, or the appointment of a trustee to administer, any Title IV Plan or Multiemployer Plan or for the imposition of 

  
 17 

 
any Liability upon any ERISA Affiliate under Title IV of ERISA other than for contributions to Title IV Plans and Multiemployer Plans in the ordinary course and PBGC premiums due but not
delinquent 
 “Event of Default” has the meaning specified therefor in Article VIII. 

“Excess Availability” means, as of any date of determination, the amount equal to Availability minus the aggregate amount, if
any, of all trade payables of Borrowers and their Subsidiaries aged in excess of thirty (30) days with respect thereto and all book overdrafts of Borrowers and their Subsidiaries in excess of historical practices with respect thereto, in each
case as determined by Agent (including, during any Third Party Agent Retention Period, the Third Party Agent) in its Permitted Discretion. 

“Exchange Act” means the Securities Exchange Act of 1934, as amended, including the rules and regulations promulgated
thereunder. 
 “Excluded Accounts” has the meaning specified therefor in Section 5.08. 

“Excluded Domestic Holdco” means a wholly-owned Domestic Subsidiary of a Borrower substantially all of the assets of which
consist of Stock of Excluded Foreign Subsidiaries held directly or indirectly by such Subsidiary and which does not engage in any business, operations or activity other than that of a holding company, excluding for purposes of such determination,
Indebtedness of such Excluded Foreign Subsidiaries. 
 “Excluded Foreign Subsidiary” means any Foreign Subsidiary which is
a controlled foreign corporation (as defined in the IRC) that has not guaranteed or pledged any of its assets to secure, or with respect to which there shall not have been pledged two-thirds or more of the
voting Stock to secure, any Indebtedness (other than the Obligations) of a Loan Party. 
 “Excluded Property” means,
collectively: 
 (a) voting shares of any (A) Excluded Foreign Subsidiary of Borrower or (B) Excluded Domestic Holdco, in each
case, in excess of 65% of all of the issued and outstanding voting shares of capital stock of such subsidiary; 
 (b) any lease, license,
contract, property right or agreement as to which, if and to the extent that, and only for so long as, the grant of a security interest therein shall (1) constitute or result in a breach, termination or default under any such lease, license,
contract, property right or agreement or render it unenforceable, (2) be prohibited by any applicable law or (3) require the consent of any third party (in each case of clauses (1), (2) and (3), other than to the extent that any such
breach, termination, default, prohibition or requirement for consent would be rendered ineffective pursuant to Sections 9-406, 9-407,
9-408 or 9-409 of the UCC of any relevant jurisdiction or any other applicable Law), provided that such security interest shall attach immediately to each portion of
such lease, license, contract, property rights or agreement that does not result in any of the consequences specified above; 
 (c) any
“intent to use” trademark applications for which a statement of use has not been filed (but only until such statement is filed); 

(d) motor vehicles and other assets, in each instance, in which perfection of a security requires notation on certificates of title with a
value, individually, of less than $250,000; 
 (e) without in any way limiting clause (a) above, equity interests in any Person (other
than wholly owned Subsidiaries) to the extent not permitted by the terms of such Person’s organizational or 

  
 18 

 
joint venture documents (so long as such joint venture was not entered into (or such Subsidiary was not formed) in contravention of the terms of the Loan Documents and such prohibition did not
arise in anticipation of the restrictions under the Loan Documents); 
 (f) any assets financed by purchase money Indebtedness or Capital
Leases, to the extent such purchase money Indebtedness or Capital Lease is permitted hereunder, if the documentation governing such purchase money Indebtedness or Capital Leases securing such purchase money Indebtedness or Capital Leases prohibits
the creation of a security interest or lien thereon or requires the consent of any Person as a condition to the creation of any other security interest or lien on such property or if such contract or other agreement would be breached or give any
party the right to terminate it as a result of creation of such security interest or lien; 
 (g) those assets as to which Agent determines
(in its sole discretion) that the cost of obtaining such a security interest or perfection thereof are excessive in relation to the benefit to the Lender Group of the security to be afforded thereby; and 

(h) the Bank of America Cash Collateral Account; 

provided, however, notwithstanding anything to the contrary herein or under the other Loan Documents, “Excluded
Property” shall not include (i) any proceeds, products, substitutions, receivables or replacements of Excluded Property (unless such proceeds, products, substitutions, receivables or replacements would otherwise constitute Excluded
Property), or (ii) any assets or property provided as security or collateral for the Term Debt or for which a Lien has been granted in favor of Term Agent, any Term Lender or any other Person party to the Term Debt Documents. 

“Excluded Subsidiary” means (a) any Excluded Domestic Holdco and (b) any Excluded Foreign Subsidiary. 

“Excluded Taxes” means (i) any Tax imposed on or measured by the net income (however denominated) of any Recipient
(including any branch profits Taxes and franchise Taxes), in each case (A) imposed by the jurisdiction (or by any political subdivision or taxing authority thereof) in which such Recipient is organized or the jurisdiction (or by any political
subdivision or taxing authority thereof) in which such Recipient’s principal office is located or, in the case of any Lender or Participant, the jurisdiction (or by any political subdivision or taxing authority thereof) in which such
Lender’s or such Participant’s applicable lending office is located, or (B) imposed as a result of a present or former connection between such Recipient and the jurisdiction (or any political subdivision or taxing authority thereof)
imposing such Tax (other than any such connection arising from such Recipient having executed, delivered, become a party to, performed its obligations under, received payment under, received or perfected a security interest under, engaged in any
other transaction pursuant to, or enforced its rights or remedies hereunder or any other Loan Document, or sold or assigned an interest in any Loan or Loan Document); (ii) Taxes resulting from a Recipient’s failure to comply with the
requirements of Section 16.02, (iii) any United States federal withholding Taxes imposed on amounts payable to or for the account of a Foreign Lender based upon the applicable withholding rate pursuant to the law in effect
at the time such Foreign Lender acquires its interest in the Loan or Commitment (or designates a new lending office), except to the extent such Foreign Lender (or its assignor, if any) was previously entitled to receive amounts pursuant to
Section 16.01, if any, with respect to such withholding Tax at the time such Foreign Lender changed its lending office (or became a party hereto), and (iv) any withholding Taxes imposed under FATCA on amounts payable
to or for the account of such Recipient. 
 “Extraordinary Advances” has the meaning specified therefor in
Section 2.02(c)(iii). 

  
 19 

 “FATCA” means Sections 1471 through 1474 of the IRC, as of the Closing Date
(or any amended or successor version that is substantively comparable and not materially more onerous to comply with) and (a) any current or future regulations or official interpretations thereof (b) any agreements entered into pursuant to
Section 1471(b)(1) of the IRC, and (c) any intergovernmental agreement entered into by the United States (or any fiscal or regulatory legislation, rules, or practices adopted pursuant to any such intergovernmental agreement entered into in
connection therewith). 
 “FCPA” means the U.S. Foreign Corrupt Practices Act of 1977. 

“FDA” means the Food and Drug Administration of the United States of America, any comparable state or local Governmental
Authority, any comparable Governmental Authority in any non- United States jurisdiction, and any successor agency of any of the foregoing. 

“FDCA” means the Federal Food, Drug and Cosmetic Act, as amended, 21 U.S.C. Section 301 et seq., and all regulations
promulgated thereunder. 
 “Federal Reserve Board” means the Board of Governors of the Federal Reserve System or any entity
succeeding to any of its principal functions. 
 “First Period” has the meaning specified in
Section 2.09(d)(ii). 
 “Fixed Charge Coverage Ratio” means, as of any date of determination and
with respect to Borrowers determined on a consolidated basis in accordance with GAAP, the ratio of (a) for the applicable Measurement Period ending on such date, EBITDA minus Capital Expenditures (other than Capital Expenditures financed with
Indebtedness (other than Revolving Loans)) made or incurred during such Measurement Period or the proceeds of Stock, to (b) Fixed Charges for such Measurement Period. 

“Fixed Charges” means, with respect to any fiscal period and with respect to Borrowers determined on a consolidated basis in
accordance with GAAP, the sum, without duplication, of (a) Interest Expense accrued (other than interest paid-in-kind, amortization of financing fees, and other non-cash Interest Expense) during such period, (b) principal payments in respect of Indebtedness that are required to be paid during such period, (c) all federal, state, and local income taxes accrued
during such period, and (d) all Restricted Payments paid (whether in cash or other property, other than common Stock) during such period. 

“Foreign Benefit Plan” means any employee benefit plan that is subject to the laws of a jurisdiction outside the United
States, including those mandated by a government other than that of the United States of America. 
 “Foreign Lender” means
any Lender or Participant that is not a United States person within the meaning of IRC section 7701(a)(30). 
 “Foreign
Subsidiary” means, with respect to any Person, a Subsidiary of such Person, which Subsidiary is not a Domestic Subsidiary. 

“Funding Date” means the date on which a Borrowing occurs. 

“GAAP” means generally accepted accounting principles as in effect from time to time in the United States, consistently
applied, subject to the provisions of Section 1.02 . 

  
 20 

 “Global Excess Liquidity” means, as of any date of determination by Agent
(or, during any Third Party Agent Retention Period, the Third Party Agent), the sum of (a) without duplication of clause (b) of this definition, Qualified Cash plus (b) without duplication of clause (a) of this definition,
unrestricted cash and Cash Equivalents of Loan Parties that is in Excluded Accounts maintained by a branch office of the bank or securities intermediary located outside the United States in an aggregate amount not to exceed the lesser of (i)
$10,000,000 and (ii) 20% of clause (a) of this definition, plus (c)(i) without duplication of any cash or Cash Equivalents from any Borrowing or Loan made hereunder or under the other Loan Documents that would count towards either of
clause (a) or clause (b) of this definition and (ii) solely to the extent the applicable conditions in Article III (and any additional conditions to Borrowing or the making of Loans hereunder or under the
Loan Documents that may be added or included from time to time after the Closing Date) have been satisfied (or would be satisfied if a Borrowing or a Loan would have been made hereunder or under the other Loan Documents) as of such date of
determination (after giving effect to any such Borrowing or Loan hereunder or thereunder and any Revolver Usage as of such date), the amount of Availability.1 

“Good Manufacturing Practices” means current good manufacturing practices, as set forth in 21 C.F.R. Parts 210, 211, 820 and
any comparable foreign requirements. 
 “Governmental Authority” means any nation, sovereign, government,
quasi-governmental agency, governmental department, ministry, cabinet, commission, board, bureau, agency, court, tribunal, regulatory authority, instrumentality, judicial, legislative, fiscal or administrative or public body or entity, whether
domestic or foreign, federal, state, local or other political subdivision thereof, having jurisdiction over the matter or matters and Person or Persons in question or having the authority to exercise executive, legislative, taxing, judicial,
regulatory or administrative functions of or pertaining to government, including any central bank, securities exchange, regulatory body, arbitrator, public sector entity, supra-national entity and any self-regulatory organization. 

“Guarantee” by any Person means any obligation, contingent or otherwise, of such Person directly or indirectly guaranteeing
any Indebtedness or other obligation of any other Person and, without limiting the generality of the foregoing, any obligation, direct or indirect, contingent or otherwise, of such Person (a) to purchase or pay (or advance or supply funds for
the purchase or payment of) such Indebtedness or other obligation (whether arising by virtue of partnership arrangements, by agreement to keep-well, to purchase assets, goods, securities or services, to take-or-pay, or to maintain financial statement conditions or otherwise), or (b) entered into for the purpose of assuring in any other manner the obligee of such Indebtedness or other obligation of the
payment thereof or to protect such obligee against loss in respect thereof (in whole or in part), provided, however, that the term Guarantee shall not include endorsements for collection or deposit in the Ordinary Course of Business. The term
“Guarantee” used as a verb has a corresponding meaning. 
 “Guarantor” means (a) each Subsidiary of
Borrowers (other than any Excluded Subsidiary), and (b) each other Person that becomes a guarantor after the Closing Date pursuant to Section 5.09. 

 

	1 	 DLA: as mentioned by email yesterday, if we cannot get the control agreements and landlord waivers done by this
morning, then we will provide up to a 20 day post-closing period to allow the company to get them in place where availability with still count for the global liquidity test (but not under any circumstance for any borrowing purposes).

  
 21 

 “Guaranty and Security Agreement” means the Guaranty and Security
Agreement, dated as of the Closing Date, in form and substance reasonably satisfactory to Agent and the Lenders, executed and delivered by Borrowers and each of the Guarantors to Agent. 

“Hazardous Materials” means any substance, material or waste that is classified, regulated or otherwise characterized under
any Environmental Law as hazardous, toxic, a contaminant or a pollutant or by other words of similar meaning or regulatory effect, including petroleum or any fraction thereof, asbestos, polychlorinated biphenyls and radioactive substances. 

“Healthcare Laws” means all Applicable Laws relating to the procurement, development, provision, clinical and non-clinical evaluation or investigation, product approval or clearance, manufacture, production, analysis, distribution, dispensing, importation, exportation, use, handling, quality, reimbursement, sale, labeling,
advertising, promotion, or post-market requirements of any drug, medical device, clinical laboratory service, food, dietary supplement or other product (including, without limitation, any ingredient or component of, or accessory to, the foregoing
products) subject to regulation under the FDCA or otherwise regulated by the FDA, or subject to regulation under the Clinical Laboratory Improvement Amendments of 1988 (42 U.S.C. §263a et seq) and its implementing regulations (42 C.F.R. Part
493) and similar state or foreign laws, controlled substances laws, pharmacy laws, consumer product safety laws, Medicare, Medicaid, and all laws, policies, procedures, requirements and regulations pursuant to which Regulatory Required Permits are
issued, in each case, as the same may be amended from time to time. 
 “Immaterial Subsidiaries” shall mean, as of any date
of determination, any Subsidiary of the Borrower that is not a Loan Party that, when measured as of the most recent fiscal quarter end or fiscal year end for which Endologix has filed its 10-K or 10-Q, when taken together with all other Immaterial Subsidiaries as of such date, (i) did not have assets with a value in excess of 5.0% of the total property and assets of the Loan Parties and their
Subsidiaries on a consolidated basis set forth in the balance sheet included in such 10-K or 10-Q in accordance with GAAP and on a pro forma basis and (ii) did not
have revenues representing in excess of 5.0% of total revenues of the Loan Parties and their Subsidiaries on a consolidated basis. 

“Indebtedness” means the following with respect to any Person: 

(a) all indebtedness for borrowed money of such Person; 

(b) the deferred purchase price of assets or services (other than trade payables entered into in the Ordinary Course of Business and which are
not more than 120 days past due and other than items covered by clause (xiv) of this definition) of such Person, which in accordance with GAAP should be shown to be a liability on the balance sheet; 

(c) all guarantees of Indebtedness by such Person; 

(d) the face amount of all letters of credit issued or acceptance facilities established for the account of such Person (or for which such
Person is liable), including without duplication, all drafts drawn thereunder; 
 (e) all Capital Lease Obligations of such Person; 

(f) all indebtedness (including indebtedness of other types covered by the other clauses of this definition) of such Person or another Person
secured by any Lien on any assets or property of such Person, whether or not such indebtedness has been assumed or is recourse (with the amount thereof, in the 

  
 22 

 
case of any such indebtedness that has not been assumed by such Person, being measured as the lower of (y) fair market value of such property and (z) the amount of the indebtedness
secured); 
 (g) all indebtedness created or arising under any conditional sale or title retention agreement, or incurred as financing, in
either case with respect to assets or property acquired by such Person (even if the rights and remedies of the seller or lender under such agreement in the event of default are limited to repossession or sale of such assets or property); 

(h) all obligations of such Persons evidenced by notes, bonds, debentures or similar instruments, including obligations so evidenced incurred
in connection with the acquisition of property, assets or businesses; 
 (i) all obligations of such Person, whether or not contingent, in
respect of Disqualified Stock, valued at, in the case of redeemable preferred Stock, the greater of the voluntary liquidation preference and the involuntary liquidation preference of such Stock plus accrued and unpaid dividends; 

(j) all direct or indirect liability, contingent or otherwise, of such Person with respect to any other Indebtedness, lease, dividend or other
obligation of another Person if the primary purpose or intent of the Person incurring such liability, or the primary effect thereof, is to provide assurance to the obligee of such liability that such liability will be paid or discharged, or that any
agreements relating thereto will be complied with, or that the holders of such liability will be protected (in whole or in part) against loss with respect thereto; 

(k) all direct or indirect liability, contingent or otherwise, of such Person under Swap Contracts; 

(l) all direct or indirect liability, contingent or otherwise, of such Person to make take-or-pay or similar payments if required regardless of nonperformance by any other party or parties to an agreement; 

(m) all direct or indirect liability, contingent or otherwise, of such Person for the obligations of another Person through any agreement to
purchase, repurchase or otherwise acquire such obligation or any assets or property constituting security therefor, to provide funds for the payment or discharge of such obligation or to maintain the solvency, financial condition or any balance
sheet item or level of income of another Person; 
 (n) earn-outs, all purchase price adjustments, profit sharing arrangements, deferred
purchase money amounts and similar payment obligations (or continuing obligations of any nature of such Person arising out of purchase and sale contracts) (including in connection with Permitted Acquisitions), but only to the extent the same
(x) have become due and payable and are recorded as a liability on the balance sheet of such Person and (y) are payable in cash; 

(o) all off-balance sheet liabilities of such Person; or 

(p) all obligations arising under non-compete agreements, bonus, deferred compensation, incentive
compensation or similar arrangements, other than those arising in the Ordinary Course of Business. 
 “Indemnified
Liabilities” has the meaning specified therefor in Section 10.03. 
 “Indemnified
Person” has the meaning specified therefor in Section 10.03. 

  
 23 

 “Indemnified Taxes” means, any Taxes other than Excluded Taxes, imposed on
or with respect to any payment made by or on account of any obligation of Borrowers under any Loan Document. 
 “Insolvency
Proceeding” means any proceeding commenced by or against any Person under any provision of the Bankruptcy Code or under any other state or federal bankruptcy or insolvency law, assignments for the benefit of creditors, formal or informal
moratoria, compositions, extensions generally with creditors, or proceedings seeking reorganization, arrangement, or other similar relief. 

“Intellectual Property” means all Intellectual Property Licenses and all Copyrights, copyright rights, copyright
applications, copyright registrations and like protections in each work of authorship and derivative work, whether published or unpublished, any Patents, patents, patent applications and like protections, including improvements, divisions,
continuations, renewals, reissues, extensions, and continuations-in-part of the same, Trademarks, trademarks, trade names, service marks, mask works, rights of use of
any name, domain names, or any other similar rights, any applications therefor, whether registered or not, know-how, operating manuals, trade secret rights, clinical and
non-clinical data, rights to unpatented inventions, and any claims for damage by way of any past, present, or future infringement of any of the foregoing. 

“Intellectual Property Licenses” has the meaning specified therefor in the Guaranty and Security Agreement. 

“Intercompany Subordination Agreement” means an intercompany subordination agreement, dated as of the Closing Date, executed
and delivered by Borrowers, each of their Subsidiaries, and Agent, the form and substance of which is reasonably satisfactory to Agent and the Lenders. 

“Intercreditor Agreement” means that certain Intercreditor Agreement, dated as of the Closing Date, by and between Agent and
the Term Agent and acknowledged and agreed by the Loan Parties, as amended, restated, supplemented or otherwise modified from time to time in accordance with the terms thereof. 

“Interest Expense” means, for any period, the aggregate of the interest expense of Borrowers for such period, determined on a
consolidated basis in accordance with GAAP. 
 “Internal Controls” has the meaning ascribed to it in
Section 4.13(a). 
 “Inventory” means inventory (as that term is defined in the Code). 

“Inventory Cap” means, initially, $10,000,000; provided, that, (x) after the first anniversary of the Closing
Date, such cap may be increased to $15,000,000 to the extent the following conditions have been met: (i) Agent (or, during any Third Party Agent Retention Period, the Third Party Agent) shall have received an appraisal detailing the value of
Borrowers’ Intellectual Property, in scope and with results acceptable to Agent (and, during any Third Party Agent Retention Period, also the Third Party Agent) and (ii) Borrowers’ shall have achieved TTM EBITDA of greater than $0 for
two consecutive fiscal quarters and (y) the Inventory Cap shall be reduced to $0 in the event that Market Capitalization of Endologix is less than $200,000,000. 

“Investment” has the meaning specified therefor in Section 6.06. 

“Investment Company Act” means the Investment Company Act of 1940, as amended, including the rules and regulations
promulgated thereunder. 

  
 24 

 “IP” means all Intellectual Property that is necessary for the conduct of
the Loan Parties’ business as currently conducted. 
 “IRC” means the Internal Revenue Code of 1986, as in effect from
time to time. 
 “Landlord Reserve” means, as to each location at which Borrowers have Collateral or books and records
located and as to which a Collateral Access Agreement has not been received by Agent, a reserve in an amount equal to the greater of (a) the number of months’ rent for which the landlord will have, under applicable law, a Lien in the
Collateral of Borrowers to secure the payment of rent or other amounts under the lease relative to such location, or (b) three (3) months’ rent under the lease relative to such location. 

“Latest Balance Sheet Date” has the meaning specified therefor in Section 4.12. 

“Lender” has the meaning specified therefor in the preamble, shall include any other Person made a party hereto pursuant to
the provisions of Section 13.01 and “Lenders” means each of the Lenders or any one or more of them. 

“Lender Group” means each of the Lenders and Agent (including, during any Third Party Agent Retention Period, the Third Party
Agent), any other Secured Party or any one or more of them. 
 “Lender Group Expenses” means all (a) costs or expenses
(including taxes and insurance premiums) required to be paid by Borrowers or their Subsidiaries under any of the Loan Documents that are paid, advanced, or incurred by the Lender Group, (b) documented out-of-pocket fees or charges paid or incurred by Agent or any Third Party Agent in connection with the Lender Group’s transactions with Borrowers or their Subsidiaries under any of the Loan Documents,
including, without limitation, the fees and out-of-pocket expenses of Agent’s and any Third Party Agent’s outside counsel and reasonable out-of-pocket costs incurred in connection with travel and due diligence, photocopying, notarization, couriers and messengers, telecommunication, public record searches,
filing fees, recording fees, publication, real estate surveys, real estate title policies and endorsements, and environmental audits, (c) Agent’s or any Third Party Agent’s customary fees and charges imposed or incurred in connection
with any background checks or OFAC/PEP searches related to Borrowers or their Subsidiaries, (d) Agent’s and any Third Party Agent’s fees and charges (as adjusted from time to time) with respect to the disbursement of funds (or the
receipt of funds) to or for the account of Borrowers (whether by wire transfer or otherwise), together with any out-of-pocket costs and expenses incurred in connection
therewith, (e) customary charges imposed or incurred by Agent or any Third Party Agent resulting from the dishonor of checks payable by or to any Loan Party, (f) costs and expenses paid or incurred by the Lender Group to correct any
default or enforce any provision of the Loan Documents, or during the continuance of an Event of Default, in gaining possession of, maintaining, handling, preserving, storing, shipping, selling, preparing for sale, or advertising to sell the
Collateral, or any portion thereof, irrespective of whether a sale is consummated, (g) reasonable consulting or advisory fees and expenses of Agent and any Third Party Agent and fees and expenses related to any field examination, appraisal, or
valuation to the extent of the fees and charges, and due diligence expenses, including in connection with periodic reviews of insurance and Collateral, (h) Agent’s, any Third Party Agent’s and Lenders’ reasonable costs and
expenses (including reasonable documented attorneys’ fees and expenses) relative to third party subpoenas, claims or any other lawsuit or adverse proceeding paid or incurred, whether in enforcing or defending the Loan Documents or otherwise in
connection with the transactions contemplated by the Loan Documents, Agent’s Liens in and to the Collateral, or the Lender Group’s relationship with Borrowers or any of their Subsidiaries, (i) Agent’s and any Third Party
Agent’s reasonable documented costs and expenses (including reasonable documented attorneys’ fees and due diligence expenses) incurred in advising, structuring, drafting, reviewing, administering (including travel, meals, and lodging),
syndicating (including reasonable costs and 

  
 25 

 
expenses relative to the rating of any Loan, CUSIP, DXSyndicateTM, SyndTrak or other communication costs incurred in connection with a syndication of the loan facilities), or amending,
restating, supplementing, waiving, or modifying the Loan Documents and (j) Agent’s, any Third Party Agent’s and each Lender’s costs and expenses (including reasonable documented attorneys, accountants, consultants, and other
advisors fees and expenses) incurred in terminating, enforcing (including attorneys, accountants, consultants, and other advisors fees and expenses incurred in connection with a “workout,” a “restructuring,” or an Insolvency
Proceeding concerning Borrowers or any of their Subsidiaries or in exercising rights or remedies under the Loan Documents), or defending the Loan Documents, irrespective of whether a lawsuit or other adverse proceeding is brought, or in taking any
enforcement action or any Remedial Action with respect to the Collateral. 
 “Lender-Related Person” means, with respect to
any Lender, such Lender, together with such Lender’s Affiliates, officers, directors, employees, attorneys, and agents. 

“Liabilities” means all claims, actions, suits, judgments, damages, losses, liabilities, obligations, responsibilities,
fines, penalties, sanctions, costs, fees, Taxes, commissions, charges, disbursements and expenses (including those incurred upon any appeal or in connection with the preparation for and/or response to any subpoena or request for document production
relating thereto), in each case of any kind or nature (including interest accrued thereon or as a result thereto and fees, charges and disbursements of financial, legal and other advisors and consultants), whether joint or several, and whether or
not indirect, contingent, consequential, actual, punitive, treble or otherwise. 
 “LIBOR Adjustment Date” means the first
calendar day of such calendar month. 
 “LIBOR Rate” means the greater of (a) 1.00% and (b) the rate per annum equal
to the London interbank offered rate administered by ICE Benchmark Administration Limited or a comparable, replacement or successor rate, which rate is approved by Agent, as published on the applicable Bloomberg screen (or such other commercially
available source providing such quotations as may be designated by Agent from time to time), for deposits in Dollars for a term of thirty (30) days on or about 11:00 a.m. (London time) two (2) Business Days prior to the LIBOR Adjustment
Date. The LIBOR Rate may not be the lowest or best rate at which Agent calculates interest or extends credit. The LIBOR Rate for each calendar month shall be adjusted (if necessary) on each LIBOR Adjustment Datewhich determination shall be
conclusive in the absence of manifest error; provided that to the extent a comparable, replacement or successor rate is approved by Agent in connection herewith, the approved rate shall be applied in a manner consistent with market practice.

 “Lien” means any lien, pledge, preferential arrangement, mortgage, security interest, deed of trust, charge, assignment,
hypothecation, title retention or other encumbrance on or with respect to property or interest in property having the practical effect of constituting a security interest, in each case with respect to the payment of any obligation with, or from the
proceeds of, any asset or revenue of any kind. For purposes of this Agreement and the other Loan Documents, any Loan Party or any Subsidiary shall be deemed to own subject to a Lien any asset which it has acquired or holds subject to the interest of
a vendor or lessor under any conditional sale agreement, capital lease or other title retention agreement relating to such asset. 

“Liquidated Damages” has the meaning specified in Section 2.09(d)(i). 

“Loan” means any Revolving Loan or Extraordinary Advance made (or to be made) hereunder. 

“Loan Account” has the meaning specified therefor in Section 2.08. 

  
 26 

 “Loan Documents” means the Agreement, any Notes, the Control Agreements,
any Borrowing Base Certificate, each Compliance Certificate, the Intercreditor Agreement, the Guaranty and Security Agreement, the Intercompany Subordination Agreement, the Patent Security Agreement, the Trademark Security Agreement, the Copyright
Security Agreement, any note or notes executed by Borrowers in connection with the Agreement and payable to any member of the Lender Group, and any other instrument or agreement entered into, now or in the future, by Borrowers or any of their
Subsidiaries and any member of the Lender Group in connection with the Agreement. 
 “Loan Party” means any Borrower or any
Guarantor. 
 “Lockbox” has the meaning specified therefor in Section 2.12(a). 

“Margin Stock” means “margin stock” as such term is defined in Regulation T, U or X of the Federal Reserve Board.

 “Market Capitalization” shall mean, on any date of determination, an amount equal to (i) the total number of issued
and outstanding shares of common Stock of Endologix on the date of measurement multiplied by (ii) the arithmetic mean of the closing prices per share of such Stock on the Nasdaq Stock Market for the 30 consecutive trading days immediately
preceding such date of determination. 
 “Market Withdrawal” means a Person’s Removal or Correction of a distributed
product which involves a minor violation that would not be subject to legal action by the FDA or which involves no violation (e.g., normal stock rotation practices and routine equipment adjustments and repairs, etc.). 

“Material Adverse Effect” means a material adverse effect on (a) the business, operations, results of operations,
financial condition or properties of the Loan Parties and their Subsidiaries, taken as a whole, (b) the legality, validity or enforceability of any provision of any Loan Document, (c) the ability of any Loan Party to timely perform the
Obligations, (d) the creation, perfection or priority of the Liens, taken as a whole for the Collateral, granted under the Loan Documents, or (e) the rights and remedies of the Secured Parties under any Loan Document. 

“Material Contracts” means (a) the Operative Documents, (b) the Term Debt Documents, (c) the Convertible Note
Documents, (d) the agreements listed on Schedule 4.18, (e) the Permitted Japan Lifeline Unsecured Debt Documents and (f) each other agreement or contract to which such Loan Party or its Subsidiaries is a party the termination of
which could reasonably be expected, individually or in the aggregate, to result in a Material Adverse Effect; provided that Capped Calls shall not be considered Material Contracts. 

“Material Intangible Assets” means all of (i) each Loan Party’s Intellectual Property and (ii) license or
sublicense agreements or other agreements with respect to rights in Intellectual Property (including each Intellectual Property License), in each case that are material to the financial condition, business or operations of the applicable Loan Party.

 “Maturity Date” means April 2, 2022. 

“Maximum Revolver Amount” means $40,000,000 (provided that such amount shall be increased to $50,000,000 during any
Maximum Revolver Increased Amount Period), decreased by the amount of reductions in the Revolver Commitments made in accordance with Section 2.03(c). 

  
 27 

 “Maximum Revolver Decreased Market Capitalization Event” means any time,
after a Maximum Revolver Increased Amount Trigger Event occurs, the Market Capitalization of Endologix decreases to an amount less than or equal to $350,000,000. 

“Maximum Revolver Decreased Market Capitalization Notice Trigger Event” means the first occurrence of a Maximum Revolver
Decreased Market Capitalization Event after a Maximum Revolver Increased Amount Trigger Event has occurred and was continuing immediately before such Maximum Revolver Decreased Market Capitalization Event occurred. 

“Maximum Revolver Decreased Market Capitalization Overadvance Amount” means, at any time a Maximum Revolver Decreased Market
Capitalization Overadvance Event occurs, if Revolver Usage at such time is in excess of $40,000,000, the result of (a) the amount of the Revolver Usage, minus (b) $40,000,000. 

“Maximum Revolver Decreased Market Capitalization Overadvance Event” means any time that the Market Capitalization of
Endologix is less than or equal to $350,000,000 and the Revolver Usage is more than $40,000,000. 
 “Maximum Revolver Increased
Amount Period” means from the time a Maximum Revolver Increased Amount Trigger Event occurs until the time that the Market Capitalization of Endologix is less than or equal to $350,000,000. 

“Maximum Revolver Increased Amount Trigger Event” means, at any time that the Market Capitalization of Endologix is in excess
of $350,000,000 for at least ten (10) consecutive Business Days, the Borrower Representative delivers an officer’s certificate executed by an Authorized Officer of the Borrower Representative to the Agent (and, during a Third Party Agent
Retention Period, also the Third Party Agent) certifying as such and providing reasonable detail thereof, all in form and substance reasonably satisfactory to the Agent (and, during a Third Party Agent Retention Period, also the Third Party Agent).

 “Measurement Period” means, at any date of determination, the most recently completed twelve (12) fiscal months of
Borrowers for which financial statements have been delivered pursuant to Section 5.05(a). 

“Medicaid” means the medical assistance programs administered by state agencies and approved by CMS pursuant to the terms of
Title XIX of the Social Security Act, codified at 42 U.S.C. 1396 et seq. 
 “Medicare” means the program of health benefits
for the aged and disabled administered by CMS pursuant to the terms of Title XVIII of the Social Security Act, codified at 42 U.S.C. 1395 et seq. 

“Monthly Cash Burn Amount” means, with respect to Borrowers, an amount equal to Borrower’s change in cash and Cash
Equivalents, without giving effect to any increase resulting from contributions or proceeds of financings, for either (a) the immediately preceding eighteen (18) month period as determined as of the last day of the month immediately
preceding the proposed consummation of the Permitted Acquisition or voluntary prepayment, as applicable, and based upon the financial statements delivered to Agent (and, during any Third Party Agent Retention Period, also the Third Party Agent) in
accordance with this Agreement for such period, not including unusual or non-recurring expenses or (b) the immediately succeeding eighteen (18) month period based upon the projections delivered to
Agent (or any Third Party Agent, as applicable) prior to the Closing Date, not including unusual or non-recurring expenses, using whichever calculation as between clause (a) and clause
(b) demonstrates a higher burn rate (or, in other words, more cash used), in either case, divided by eighteen (18). 

  
 28 

 “Monthly Collateral Monitoring Fee” has the meaning specified therefor in
Section 2.09(f). 
 “Moody’s” has the meaning specified therefor in the definition of Cash
Equivalents. 
 “Multiemployer Plan” means any multiemployer plan, as defined in Section 3(37) or 4001(a)(3) of ERISA,
as to which any ERISA Affiliate incurs or otherwise has, or could reasonably be expected to have, any obligation or Liabilities (including under Section 4212 of ERISA). 

“Necessary Documents” has the meaning specified therefor in Section 4.05. 

“Net Book Value of Eligible Equipment” means, at any time, the then-current book value of all Eligible Equipment (giving
effect to any adjustments to such book value on or prior to the date of measurement thereof) less all accumulated depreciation and amortization of such Equipment through the date of measurement, all as determined in accordance with GAAP. 

“Net Orderly Liquidation Value” means, at any time, the orderly liquidation value with respect to the applicable asset as set
forth in the most recent appraisal acceptable to Agent (and, during any Third Party Agent Retention Period, also the Third Party Agent), upon which Agent (and any Third Party Agent) is expressly entitled to rely, prepared by an appraiser acceptable
to Agent (and, during any Third Party Agent Retention Period, also the Third Party Agent), net of operating expenses, liquidation expenses and commissions set forth in such appraisal; provided, that to the extent operating expenses,
liquidation expenses and commissions set forth in such appraisal are not allocated to specific categories of Inventory, such operating expenses, liquidation expenses and commissions may be allocated by Agent (or, during any Third Party Agent
Retention Period at the sole option of Agent, the Third Party Agent) to specific assets as determined in Agent’s (including, during any Third Party Agent Retention Period, the Third Party Agent’s) Permitted Discretion; and provided
further, that the liquidation timeframe is acceptable to Agent (and, during any Third Party Agent Retention Period, also the Third Party Agent). 

“Net Revenue” means, for any period, (a) the Loan Parties’ gross revenues during such period, less (b)(i) trade,
quantity and cash discounts allowed by the Loan Parties, (ii) discounts, refunds, rebates, charge backs, retroactive price adjustments and any other allowances which effectively reduce net selling price, (iii) product returns and
allowances, (iv) allowances for shipping or other distribution expenses, (v) set-offs and counterclaims, and (vi) any other similar and customary deductions used by the Loan Parties in
determining net revenues, all, in respect of (a) and (b), as determined in accordance with GAAP and in the Ordinary Course of Business. 

“Non-Third Party Agent Retention Period” means any period of time that is not during
a Third Party Agent Retention Period. 
 “Note” means any promissory note evidencing any of the Obligations and/or the
Commitments issued by the Borrowers in favor of the Agent or any Lender. 
 “Obligations” means all loans (including the
Revolving Loans (inclusive of Extraordinary Advances)), debts, principal, interest (including any interest that accrues after the commencement of an Insolvency Proceeding, regardless of whether allowed or allowable in whole or in part as a claim in
any such Insolvency Proceeding), premiums, liabilities (including all amounts charged to the Loan Account pursuant to this Agreement), obligations (including indemnification obligations), fees (including the fees and other amounts set forth in
Section 2.09), Lender Group Expenses (including any fees or expenses that accrue after the commencement of an Insolvency Proceeding, regardless of whether allowed or allowable in whole or in part as a claim in any such
Insolvency Proceeding), guaranties, and all covenants and duties of any other kind and description owing by any Loan Party arising out of, under, pursuant to, in 

  
 29 

 
connection with, or evidenced by the Agreement or any of the other Loan Documents and irrespective of whether for the payment of money, whether direct or indirect, absolute or contingent, due or
to become due, now existing or hereafter arising, and including all interest not paid when due and all other expenses or other amounts that Borrowers are required to pay or reimburse by the Loan Documents or by law or otherwise in connection with
the Loan Documents. Without limiting the generality of the foregoing, the Obligations of Borrowers under the Loan Documents include the obligation to pay (i) the principal of the Loans, (ii) interest accrued on the Loans, (iii) [reserved],
(iv) Third Party Agent commissions, fees and charges, (v) Lender Group Expenses, (vi) fees payable hereunder or any of the other Loan Documents, and (vii) indemnities and other amounts payable by any Loan Party under any Loan
Document. Any reference in the Agreement or in the Loan Documents to the Obligations shall include all or any portion thereof and any extensions, modifications, renewals, or alterations thereof, both prior and subsequent to any Insolvency
Proceeding. 
 “OFAC” means The Office of Foreign Assets Control of the U.S. Department of the Treasury. 

“Operating Expenditures” means, with respect to any Person for any period, the amount of all expenditures (whether such
expenditures are paid in cash, financed or otherwise) by such Person and its Subsidiaries during such period that are reported as operating expenses (including expenditures related to research and development, clinical and regulatory affairs,
marketing and sales, and general and administrative) on the income statements of such Person and its Subsidiaries that are included in such Person’s financial statements (including those financial statements required by
Section 5.05(a)), which amount shall (i) be in compliance and accordance with GAAP and any SEC requirements and regulations, but (ii) exclude one-time non-recurring expenditures that are not regularly incurred in the Ordinary Course of Business of such Person and its Subsidiaries. 

“Operative Documents” means the Loan Documents and the Term Debt Documents. 

“Ordinary Course of Business” means, in respect of any transaction involving any Loan Party, the ordinary course of business
of such Loan Party, as conducted by such Loan Party in accordance with past practices, as applicable. 
 “Organizational
Documents” means, with respect to any Loan Party, the documents by which such Person was organized (such as a certificate of incorporation, certificate of limited partnership or articles of organization, and including, without limitation,
any certificates of designation for preferred stock or other forms of preferred equity) and which relate to the internal governance of such Person (such as by-laws, a partnership agreement or an operating,
limited liability company or members agreement), including any and all shareholder agreements or voting agreements relating to the capital stock or other equity interests of such Person. 

“Originating Lender” has the meaning specified therefor in Section 13.01(e). 

“Overadvance” means, as of any date of determination, that the Revolver Usage is greater than any of the limitations set
forth in Section 2.01. 
 “Participant” has the meaning specified therefor in
Section 13.01(e). 
 “Participant Register” has the meaning specified therefor in
Section 13.01(i). 
 “Patents” has the meaning specified therefor in the Guaranty and Security
Agreement. 

  
 30 

 “Patent Security Agreement” has the meaning specified therefor in the
Guaranty and Security Agreement. 
 “Patriot Act” means Uniting and Strengthening America by Providing Appropriate Tools
Required to Intercept and Obstruct Terrorism (USA Patriot Act of 2001). 
 “Perfection Certificate” means a certificate in
the form of Exhibit P-1. 
 “Permitted 3.25% Convertible Note Refinancing”
has the meaning provided therefor in the definition of “Permitted Indebtedness.” 
 “Permitted Acquisition” means
any Acquisition by a Loan Party, in each case, to the extent that each of the following conditions shall have been satisfied: 
 (a) the
Borrower Representative shall have delivered to (x) during any Non-Third Party Agent Retention Period, subject to Section 5.20, Agent, or (y) during any Third Party Agent
Retention Period, the Third Party Agent, in each case, (i) at least ten (10) Business Days prior to the closing of the proposed Acquisition: (A) a description of the proposed Acquisition; (B) to the extent available, a due
diligence package (including, to the extent available, a quality of earnings report); and (C) the most recent drafts (or, if available, executed counterparts) of the respective agreements, documents or instruments pursuant to which such
Acquisition is to be consummated, any available schedules and exhibits to such agreements, documents or instruments and all other material ancillary agreements, instruments and documents to be executed or delivered in connection therewith, and to
the extent required under the related acquisition agreement, all required regulatory and third party approvals and copies of any environmental assessments and (ii) at the earlier of (A) the time of closing of the proposed Acquisition or
(B) as early before the closing of the proposed Acquisition as available, in each case, final, fully executed copies of the respective agreements, documents or instruments pursuant to which such Acquisition is to be consummated and all
schedules and exhibits to such agreements, documents or instruments and all other material ancillary agreements, instruments and documents executed or delivered in connection therewith; 

(b) the Loan Parties (including any new Subsidiary to the extent required by Section 5.09 shall execute and deliver
the agreements, instruments and other documents to the extent required by Section 5.09; 
 (c) no Event of Default
or Default has occurred and is continuing, or would exist after giving pro forma effect to, the proposed Acquisition; 
 (d) all transactions
in connection with such Acquisition shall be consummated, in all material respects, in accordance with applicable laws; 
 (e) the assets
acquired in such Acquisition are for use in the same line of business as the Loan Parties are currently engaged or a line of business reasonably related thereto; 

(f) such Acquisition shall not be hostile and, if applicable, shall have been approved by the board of directors (or other similar body) and/or
the stockholders or other equity holders of any Person being acquired in such Acquisition; 
 (g) no Indebtedness or Liens are assumed or
created (other than Permitted Liens and Permitted Indebtedness) in connection with such Acquisition; 

  
 31 

 (h) all conditions to “Permitted Acquisition” (as defined in the Term Credit
Agreement as of the Closing Date) have been satisfied and (i) during any Non-Third Party Agent Retention Period, Agent shall have received, subject to Section 5.20, any requested
evidence showing satisfaction thereof and (ii) during any Third Party Agent Retention Period, the Third Party Agent shall have received any requested evidence showing satisfaction thereof; and 

(i) the total consideration paid or payable (including without limitation, costs and expenses, deferred purchase price, seller notes and other
liabilities incurred, assumed or to be reflected on a consolidated balance sheet of the Loan Parties and their Subsidiaries after giving effect to such Acquisition but excluding (A) any equity interests issued as consideration for such
Acquisition and (B) the net proceeds of any issuance of equity interests made after the Closing Date that are used for purposes of such Acquisition) (such amounts, collectively, the “Acquisition Consideration”) shall be in an
amount not to exceed $15,000,000 in the aggregate for all such Acquisitions during the term of this Agreement; provided, however, that, in the case of each Acquisition, (1) during any Non-Third Party
Agent Retention Period, subject to Section 5.20, to the extent requested by Agent, Agent, and (2) during any Non-Third Party Agent Retention Period, the Third Party Agent, in
each case, has received prior to the consummation of such Acquisition evidence satisfactory to Agent (or such Third Party Agent) that Borrowers have, immediately before and immediately after giving effect to the consummation of such Acquisition,
unrestricted cash (it being understood and agreed that cash and Cash Equivalents shall not be considered “restricted” cash for purposes of this proviso solely due to compliance by the Loan Parties with the requirements set forth in
Section 5.08) in one or more deposit accounts subject to a Control Agreement in an aggregate amount equal to or greater than the positive value of the product of (x) eighteen (18) multiplied by (y) the Monthly
Cash Burn Amount, as determined as of the last day of the month immediately preceding such Acquisition. 
 Notwithstanding the foregoing, no
Accounts, Inventory or Equipment acquired by a Loan Party in a Permitted Acquisition shall be included as Eligible Accounts, Eligible Equipment or Eligible Inventory until a field examination (and, if required by Agent (or, during any Third Party
Agent Retention Period, the Third Party Agent), an Inventory appraisal or an Equipment appraisal, as applicable) with respect thereto has been completed to the reasonable satisfaction of Agent (and, during any Third Party Agent Retention Period, the
Third Party Agent), including the establishment of reserves required in Agent’s (or, during any Third Party Agent Retention Period, the Third Party Agent’s) reasonable discretion; provided that field examinations and appraisals in
connection with Permitted Acquisitions shall not count against the limited number of field examinations or appraisals for which expense reimbursement may be sought. 

“Permitted Contingent Obligations” means: 

(a) Contingent Obligations arising in respect of the Indebtedness under the Loan Documents; 

(b) Contingent Obligations resulting from endorsements for collection or deposit in the Ordinary Course of Business; 

(c) Contingent Obligations outstanding on the date of this Agreement and set forth on Schedule 6.05 (but not including any refinancings,
extensions, increases or amendments to the indebtedness underlying such Contingent Obligations other than extensions of the maturity thereof without any other material change in terms adverse to the Lenders); 

(d) Contingent Obligations incurred in the Ordinary Course of Business with respect to surety and appeal bonds, performance bonds and other
similar obligations not to exceed $2,000,000 in the aggregate at any time outstanding; 

  
 32 

 (e) Contingent Obligations arising under indemnity agreements with title insurers to cause
such title insurers to issue to Agent mortgagee title insurance policies; 
 (f) Contingent Obligations arising with respect to customary
indemnification obligations in favor of purchasers in connection with dispositions of personal property assets permitted under Section 6.04; 

(g) so long as there exists no Event of Default both immediately before and immediately after giving effect to any such transaction, Contingent
Obligations existing or arising under any Swap Contract or Capped Call; provided, however, that such obligations are (or were) entered into by Borrower or an Affiliate of Borrower for the purpose of directly mitigating risks associated with
liabilities, commitments, investments, assets, or property held or reasonably anticipated by such Person and not for purposes of speculation and either (i) with respect to a Swap Contract or a Capped Call, are (or were) entered into in the
Ordinary Course of Business or (ii) with respect to a Capped Call, are (or were) entered into in connection with the 2.25% Convertible Notes, the 3.25% Convertible Notes, any refinancings thereof permitted hereunder or in connection with this
Agreement or any of the other Loan Documents; 
 (h) guarantees by (i) one or more Loan Parties of the obligations of Foreign
Subsidiaries up to $1,000,000 in the aggregate at any time outstanding, (ii) any Loan Party of the obligations of any other Loan Party (but, for the avoidance of doubt, excluding any Immaterial Subsidiary that may be a Loan Party where, before
and immediately after giving effect to such guarantee (including any rights of contribution set forth in the Loan Documents or otherwise), the Loan Parties cannot represent and warrant that such Immaterial Subsidiary is Solvent on an individual
basis) and (iii) any Foreign Subsidiary of the obligations of any other Foreign Subsidiary; 
 (i) Contingent Obligations arising in
respect of the Indebtedness under, subject to the terms of the Intercreditor Agreement and this Agreement, the Term Debt Documents; and 

(j) other Contingent Obligations not permitted by clauses (a) through (i) above, not to exceed $2,500,000 in the aggregate at any time
outstanding. 
 “Permitted Discretion” means a determination made in the exercise of reasonable (from the perspective of a
secured asset-based lender) business judgment. 
 “Permitted Dispositions” means: 

(a) dispositions of inventory in the Ordinary Course of Business; 

(b) dispositions of furniture, fixtures and equipment (excluding any Collateral included in the Borrowing Base) in the Ordinary Course of
Business that the applicable Loan Party or Subsidiary determines in good faith is no longer used or useful in the business of such Loan Party and its Subsidiaries (or such Subsidiary and its subsidiaries); 

(c) to the extent constituting a Disposition, Permitted Investments and Permitted Licenses; 

(d) disposals of obsolete, worn out or surplus tangible personal property; 

(e) without limiting transactions permitted under Article VI hereof, dispositions by any Loan Party to any other Loan Party so long as each
Loan Party (other than, with respect to any transferring Person, an Immaterial Subsidiary) will remain Solvent after giving effect to the transfer; 

  
 33 

 (f) abandonment of Intellectual Property that does not constitute a Material Intangible
Asset; 
 (g) the unwinding or terminating of Swap Contracts or any Capped Call permitted by clause (g) of the definition of
“Permitted Contingent Obligations” either (i) with respect to a Swap Contract or a Capped Call, in the Ordinary Course of Business or (ii) with respect to a Capped Call, that were entered into in connection with the 2.25%
Convertible Notes, the 3.25% Convertible Notes, any Permitted 3.25% Convertible Note Refinancing permitted hereunder or in connection with this Agreement or any of the other Loan Documents; 

(h) dispositions of equipment (excluding any Collateral included in the Borrowing Base) or real property to the extent that (i) such
property is exchanged for credit against the purchase price of replacement property or (ii) the proceeds of such disposition are promptly applied to the purchase price of such replacement property; 

(i) the entering into of any Permitted License; 

(j) Dispositions by any Foreign Subsidiary to any other Foreign Subsidiary or to any Loan Party; 

(k) Dispositions approved by the Required Lenders in writing; 

(l) to the extent constituting a Disposition, the payment of cash and Cash Equivalents in the Ordinary Course of Business; and 

(m) other Dispositions (excluding dispositions of Intellectual Property) the proceeds of which, when aggregated with the proceeds of all other
Dispositions made pursuant to this clause (m) are less than $2,500,000 during the term of this Agreement; provided that (i) the consideration received for such assets shall be in an amount at least equal to the fair market value thereof
(determined in good faith by the board of directors (or similar governing body) of the applicable Loan Party that owned such assets), (ii) no less than 75% thereof shall be paid in cash, and (iii) no Default or Event of Default then exists or
would arise therefrom; provided, that, with respect to any such Disposition not in the Ordinary Course of Business under this clause (m) involving Collateral that is included in the Borrowing Base, Borrower Representative shall
have provided (x) during a Non-Third Party Agent Retention Period, Agent with a certificate from an Authorized Officer of the Borrower Representative at least five (5) Business Days prior to such
Disposition certifying that such Disposition shall not result in an Overadvance, together with, subject to Section 5.20, such evidence thereof that is reasonably requested by Agent, and (y) during a Third Party Agent
Retention Period, the Third Party Agent with a Borrowing Base Certificate (Third Party Agent) at least five (5) Business Days prior to such Disposition evidencing to Agent’s (and, during any Third Party Agent Retention Period, also the
Third Party Agent’s) reasonable satisfaction that such Disposition shall not result in an Overadvance; and 
 (n) to the extent
constituting Dispositions, Recalls of Products (or components of Products) returned to suppliers in the Ordinary Course of Business as required by Applicable Law or the FDA with the consideration paid for such Products (or such components of
Products) returned to the Loan Party or Subsidiary that purchased and returned such Product (or such components of Products); and 
 (o)
(i) Recalls of Products (or components of Products) that are not included as Eligible Inventory and are not included in the Borrowing Base from customers to the extent required by Applicable Law or the FDA and (ii) the Dispositions of such
Products that were Recalled in the Ordinary Course of Business and for fair market value and on fair market terms. 

  
 34 

 “Permitted Indebtedness” means each of the following: 

(a) Indebtedness evidenced by this Agreement and the other Loan Documents; 

(b) Indebtedness incurred as a result of endorsing negotiable instruments received in the Ordinary Course of Business; 

(c) Capital Leases and purchase money Indebtedness not to exceed $5,000,000 at any time (whether in the form of a loan or a lease) used solely
to acquire equipment used in the Ordinary Course of Business and secured only by such equipment; provided that no such equipment shall be included as “Eligible Equipment” or in the Borrowing Base. 

(d) Indebtedness existing on the Closing Date and described on Schedule 4.01(f) (but not including any refinancings, extensions,
increases or amendments to such Indebtedness other than Permitted Refinancings); 
 (e) so long as there exists no Event of Default both
immediately before and immediately after giving effect to any such transaction, Indebtedness existing or arising under any Swap Contract or Capped Call; provided, however, that such obligations are (or were) entered into by a Borrower or an
Affiliate of a Borrower for the purpose of directly mitigating risks associated with liabilities, commitments, investments, assets, or property held or reasonably anticipated by such Person and not for purposes of speculation and either
(i) with respect to a Swap Contract or a Capped Call, are (or were) entered into in the Ordinary Course of Business or (ii) with respect to a Capped Call, are (or were) entered into in connection with the 2.25% Convertible Notes, the 3.25%
Convertible Notes, any Permitted 3.25% Convertible Note Refinancing permitted hereunder or in connection with this Agreement or any of the other Loan Documents; 

(f) Indebtedness in the form of insurance premiums financed through the applicable insurance company; 

(g) trade accounts payable arising and paid within 120 days of the date when due and in the Ordinary Course of Business; 

(h) Subordinated Debt; 
 (i) the
Term Debt under the Term Credit Facility, in accordance with the terms of the Intercreditor Agreement and this Agreement; 
 (j) Indebtedness
of the Loan Parties incurred under the 3.25% Convertible Notes in an aggregate principal amount not to exceed the aggregate principal amount outstanding on the Closing Date after giving effect to any repayments or prepayments thereon on the Closing
Date, and, so long as no Event of Default has occurred and is continuing, any refinancing or extension thereof or new issuance in connection with the exchange thereof and/or a new issuance all or any portion of the proceeds of which will be used in
connection with the repurchase or other refinancing of all or any portion thereof therewith that (i) has an aggregate outstanding principal amount not greater than $200,000,000 (when taking into account all such existing, refinanced, extended
and newly issued Indebtedness), and does not provide for any amortization payments or other principal payments of any kind in advance of the date that is one year and one day after the Maturity Date, (ii) has a maturity no shorter than the date
that is one year and one day after the Maturity Date (in the case of clause (i) and clause (ii), it being understood that, in each case, any provision requiring an offer to purchase such Indebtedness as a result of a change in control,

  
 35 

 
fundamental change, delisting, asset sale or similar provision or any exercise or conversion of Stock (other than Disqualified Stock) shall not violate the foregoing restrictions in clause
(i) or clause (ii)), (iii) is unsecured, (iv) does not have one or more obligors that are not Loan Parties, (v) contains terms that are prevailing market terms at the time of issuing or initial borrowing for the type of financing and
for the quality of issuer or borrower, as determined by Endologix and its advisors in their reasonable business judgment, (vi) does not have an All-in Yield greater than the lesser of (A) 6% per annum and
(B) an All-in Yield that would result in more than $10,000,000 per annum being paid in interest thereunder, (vii) does not cause Endologix either on an individual basis or together with its
Subsidiaries (on a consolidated basis), immediately before, at the time of and immediately after giving effect to such Indebtedness (and after giving effect to the use of the proceeds thereof), to be no longer be Solvent (or such Persons are not
Solvent immediately prior to giving effect thereto), and (vii) if in existence at such time or on the same date, is permitted under the Term Debt Documents (collectively, a “Permitted 3.25% Convertible Note Refinancing”); 

(k) Indebtedness of the Borrowers incurred under the 2.25% Convertible Notes in an aggregate principal amount not to exceed the aggregate
principal amount outstanding on the Closing Date minus any prepayments, repayments, redemptions or payments thereon made on the Closing Date or from time to time thereafter; 

(l) without limiting the provisions of Article VI with respect to any Investment by a Loan Party, Indebtedness consisting of unsecured
intercompany loans and advances (i) incurred by any Loan Party owing to one or more other Loan Parties, (ii) incurred by any Foreign Subsidiaries owing to any Loan Party solely to the extent constituting a Permitted Investment made by such
Loan Party, or (iii) incurred by any Foreign Subsidiaries owing to any other Foreign Subsidiary; 
 (m) Indebtedness related to
commercial credit cards provided by Bank of America, N.A. (or such other commercial bank permitted under the definition of “Bank of America Cash Collateral Account) that, in the aggregate outstanding at any one time, does not exceed $2,500,000,
which Indebtedness may be secured by Liens permitted pursuant to clause (r) of the definition of Permitted Liens; 
 (n) to the extent
constituting Indebtedness, any Permitted Contingent Obligations; 
 (o) unsecured Indebtedness incurred in respect of netting services,
overdraft protection and other like services, in each case, incurred in the Ordinary Course of Business; 
 (p) unsecured earn-out obligations and other similar contingent purchase price obligations incurred in connection with a Permitted Acquisition to the extent earned and payable and permitted pursuant to the definition of Permitted
Acquisition and the other terms of this Agreement; 
 (q) any other unsecured Indebtedness incurred by the Loan Parties or any of their
Subsidiaries in an aggregate outstanding amount not to exceed $2,500,000 at any one time; and 
 (r) unsecured Indebtedness in an amount not
to exceed $4,280,500 pursuant to a promissory note dated on or around the Agreement Date, by the Borrower in favor of Japan Lifeline Co., Ltd. (the “Permitted Japan Lifeline Unsecured Debt”), so long as (i) no prepayments,
repayment, redemptions or payments shall be made with respect to the Permitted Japan Lifeline Unsecured Debt at any time until ninety-one (91) days after all of the Obligations have been paid in full,
(ii) the all-in interest rate and pricing charged thereon shall not exceed 2.5% per annum and such interest shall not be paid more frequently than annually in arrears, (iii) no fees shall be paid
thereon, (iv) such unsecured Indebtedness 

  
 36 

 
shall not be assigned or otherwise transferred by Japan Lifeline Co., Ltd. without the consent of the Agent, (v) Japan Lifeline Co., Ltd. (and any successor or assign thereof) shall enter
into a subordination agreement with the Agent, in form and substance reasonably satisfactory to the Agent and the Lenders, and (vi) subordination provisions are included in such promissory note and any related documents (collectively, the
“Permitted Japan Lifeline Unsecured Debt Documents”) in a manner, and in form and substance, reasonably satisfactory to the Agent and the Lenders and such Permitted Japan Lifeline Unsecured Debt Documents shall be in form and substance
reasonably satisfactory to the Agent and the Lenders. 
 “Permitted Investments” means: 

(a) Investments (i) shown on Schedule P-1 and existing on the Closing Date and
(ii) Subsidiaries made prior to the Closing Date; 
 (b) Investments in cash and Cash Equivalents; 

(c) Investments consisting of the endorsement of negotiable instruments for deposit or collection or similar transactions in the Ordinary
Course of Business; 
 (d) Investments consisting of (i) travel advances and employee relocation loans and other employee loans and
advances in the Ordinary Course of Business, and (ii) loans to employees, officers or directors relating to the purchase of equity securities of a Loan Party or its Subsidiaries pursuant to employee stock purchase plans or agreements approved
by such Borrower’s board of directors (or other governing body), but the aggregate of all such loans outstanding may not exceed $500,000 at any time; 

(e) Investments (including debt obligations) received in connection with the bankruptcy or reorganization of customers or suppliers and in
settlement of delinquent obligations of, and other disputes with, customers or suppliers arising in the Ordinary Course of Business; 
 (f)
Investments consisting of notes receivable of, or prepaid royalties and other credit extensions, to customers and suppliers who are not Affiliates, in the Ordinary Course of Business, provided, however, that this subpart (f) shall not apply to
Investments of Loan Parties in any Subsidiary; 
 (g) Investments consisting of (i) deposit accounts in which Agent has received a
Control Agreement, and (ii) deposit accounts that are Excluded Accounts (subject to any caps and applicable restrictions set forth in such definition); 

(h) Investments by any Loan Party in any Subsidiary now owned or hereafter created by such Loan Party, which Subsidiary is a Loan Party or has
otherwise provided a Guarantee of the Obligations of the Loan Party which Guarantee is secured by a Lien granted by such Subsidiary to Agent in all or substantially all of its property of the type described in the Guaranty and Security Agreement and
otherwise made in compliance with Section 5.09; 
 (i) Investments by (A) any Loan Party consisting solely of
cash and Cash Equivalents in a Foreign Subsidiary; provided that at the time of the making of such Investment and immediately after giving effect thereto (i) no Event of Default has occurred and is continuing and (ii) Loan Parties have
unrestricted (it being understood and agreed that cash and Cash Equivalents shall not be considered “restricted” cash for purposes of this proviso solely due to compliance by the Loan Parties with the requirements set forth in
Section 7.01(b)) cash and Cash Equivalents in an aggregate amount of not less than $10,000,000, which cash and Cash Equivalents (x) are subject to a first priority perfected lien in

  
 37 

 
favor of Agent for the benefit of Lender Group (subject to Permitted Liens), (y) are held in a deposit account that is subject to a Control Agreement or a securities account subject to a Control
Agreement and (z) unless the same could not be reasonably expected to reduce the amounts in such accounts below $10,000,000 at the time of such Investment and immediately after giving effect thereto, do not include any drawn or committed but
unpaid drafts, ACH or EFT transactions and (B) a non-Loan Party Foreign Subsidiary in another non-Loan Party Foreign Subsidiary; provided, that,
Investments pursuant to clause (i)(A) above shall be subject to the proviso at the end of this definition; 
 (j) Investments by any Loan
Party consisting solely of inventory in any wholly-owned Foreign Subsidiaries, to the extent (i) such Investments are made in the Ordinary Course of Business consistent with its customary practices as in effect on and immediately prior to the
Closing Date and (ii) no Event of Default exists or would arise therefrom and (iii) no “Event of Default” (as defined in the Term Credit Agreement as in effect as of the Closing Date) then exists or would arise therefrom;
provided, that (x) no such Investment shall result in an Overadvance and (y) such Investments shall be subject to the proviso at the end of this definition; 

(k) so long as no Default or Event of Default shall have occurred and be continuing at the time thereof or would result therefrom, Investments
consisting solely of cash and Cash Equivalents in joint ventures or similar arrangements in an amount not to exceed $5,000,000 in the aggregate during the term of this Agreement; provided, that, such Investments shall be subject to the
proviso at the end of this definition; 
 (l) Permitted Acquisitions; 

(m) Investments deemed to exist under any Swap Contracts or Capped Calls; provided, however, that such obligations are (or were) entered into
by a Borrower or an Affiliate of a Borrower for the purpose of directly mitigating risks associated with liabilities, commitments, investments, assets, or property held or reasonably anticipated by such Person and not for purposes of speculation and
are (or were) entered into either (i) with respect to a Swap Contract or a Capped Call, in the Ordinary Course of Business or (ii) with respect to a Capped Call, in connection with the 2.25% Convertible Notes, the 3.25% Convertible Notes,
any Permitted 3.25% Convertible Note Refinancing permitted hereunder or in connection with this Agreement or any of the other Loan Documents; and 

(n) other Investments in an amount not exceeding $5,000,000 in the aggregate; provided, that, such Investments shall be subject
to the proviso at the end of this definition; 
 provided, that, that Investments pursuant to clauses (i), (j), (k), and (n) of this
definition of “Permitted Investments” shall not exceed $12,000,000 in the aggregate in any calendar year and, provided, further, that with respect to clause (j) above, such Investments consisting solely of Inventory in
Foreign Subsidiaries shall be valued at the lesser of cost and book value. 
 “Permitted Japan Lifeline Unsecured Debt” has
the meaning specified therefor in clause (r) of the definition of “Permitted Indebtedness”. 
 “Permitted Japan
Lifeline Unsecured Debt Documents” has the meaning specified therefor in clause (r) of the definition of “Permitted Indebtedness”. 

“Permitted License” means (a) any non-exclusive license of patent rights of a
Loan Party or its Subsidiaries so long as all such Permitted Licenses are granted to third parties in the Ordinary Course of Business, do not result in a legal transfer of title to the licensed property, and have been granted in exchange for fair
consideration, and (b) any exclusive license of patent rights of Borrower or its Subsidiaries so long as such Permitted Licenses do not result in a legal transfer of title to the licensed 

  
 38 

 
property, are exclusive solely as to discrete geographical areas outside of the United States, and have been granted in exchange for fair consideration. 

“Permitted Liens” means: 

(a) Liens set forth on Schedule 4.01(d); provided, that to qualify as a Permitted Lien, any such Lien described on Schedule
4.01(d) shall only secure the Indebtedness that it secures on the Closing Date; 
 (b) Liens in favor of the Secured Parties under the
Loan Documents; 
 (c) carriers’, warehousemen’s, mechanics’, landlords’, materialmen’s, repairmen’s or other
similar Liens arising in the Ordinary Course of Business which are not delinquent or remain payable without penalty or which are being contested in good faith and by appropriate proceedings, which proceedings have the effect of preventing the
forfeiture or sale of the assets or property subject thereto and for which adequate reserves in accordance with GAAP are being maintained; 

(d) Liens for Taxes, assessments or governmental charges or levies not past due or payable or that are being contested in good faith by
appropriate proceedings and for which adequate reserves in accordance with GAAP are being maintained; 
 (e) (i) Liens arising from
judgments, decrees or attachments in circumstances not constituting an Event of Default or Default and (ii) pledges or cash deposits made in lieu of, or to secure the performance of, judgment or appeal bonds in respect to such judgments and
proceedings; 
 (f) Liens in favor of financial institutions arising in connection with the Borrower’s or its Subsidiaries’ deposit
accounts maintained in the Ordinary Course of Business held at such institutions to secure standard fees for services charged by, but not financing made available by, such institutions; 

(g) Liens (other than any Lien imposed by ERISA) consisting of pledges or deposits required in the Ordinary Course of Business in connection
with workers’ compensation, unemployment insurance and other social security legislation or to secure the performance of tenders, statutory obligations, surety, stay, customs and appeals bonds, bids, leases, governmental contract, trade
contracts, performance and return of money bonds and other similar obligations (exclusive of obligations for the payment of borrowed money or other funded Indebtedness) or to secure liability to insurance carriers; 

(h) easements, rights of way, restrictions and other similar encumbrances affecting real property which, in the aggregate, are not substantial
in amount, do not materially affect the value or marketability of such real property and which do not in any case materially interfere with the conduct of the business of any Loan Party or its Subsidiaries; 

(i) (i) any interest or title of a lessor, sublessor, licensor or sublicensor under any lease or license not prohibited by this Agreement or (ii) non-exclusive licenses and sublicenses granted by a Loan Party or any Subsidiary of a Loan Party and leases and subleases (by a Loan Party or any Subsidiary of a Loan Party as lessor or sublessor) to third
parties in the Ordinary Course of Business not materially interfering with the business of the Loan Parties or any of their Subsidiaries; 

(j) Liens of a collection bank arising under Section 4-210 of the UCC (or equivalent in foreign
jurisdictions) on items in the course of collection; 

  
 39 

 (k) Liens on any assets or property acquired or held by any Loan Party or any Subsidiary of
any Loan Party securing Indebtedness incurred or assumed for the purpose of financing (or refinancing) all or any part of the cost of acquiring such assets or property and permitted under clause (c) of the definition of “Permitted
Indebtedness”; provided that (i) such Lien attaches solely to the assets or property so acquired in such transaction and the proceeds thereof and (ii) the principal amount of the Indebtedness secured thereby does not exceed 100% of
the cost of such assets or property; 
 (l) Liens securing Capital Leases permitted under clause (d) of the definition of
“Permitted Indebtedness”; 
 (m) Liens arising from the filing of precautionary uniform commercial code financing statements with
respect to any lease not prohibited by this Agreement; 
 (n) Liens arising out of consignment or similar arrangements for the sale of goods
entered into by a Borrower or any Subsidiary of a Borrower in the Ordinary Course of Business; 
 (o) Liens in favor of customs and revenue
authorities arising as a matter of law which secure payment of customs duties in connection with the importation of goods in the Ordinary Course of Business; 

(p) Liens on unearned insurance premiums securing the financing thereof to the extent permitted under clause (f) of the definition of
“Permitted Indebtedness”; 
 (q) [reserved]; 

(r) Liens on assets of the Loan Parties and their Subsidiaries arising in connection with seller notes, earn-outs and other similar payment
obligations constituting Acquisition Consideration in connection with Permitted Acquisitions so long as such Liens are subject at all times to a Subordination Agreement; 

(s) Liens granted under the Term Credit Facility, to the extent subject to the terms of the Intercreditor Agreement and this Agreement
(“Permitted Term Facility Liens”); and 
 (t) Liens in favor of Bank of America, N.A. (or such other commercial bank
permitted under the definition of “Bank of America Cash Collateral Account”) on the Bank of America Cash Collateral Account; provided that if Endologix is using credit card services from the Agent or a Lender that are required to be
secured, Endologix shall promptly use commercially reasonable efforts to terminate the Liens in respect of the Bank of America Cash Collateral Account. 

“Permitted Priority Liens” means (a) solely with respect to the specific assets or property covered thereby, the Liens
granted pursuant to, and in accordance with, clause (u) of the definition of “Permitted Liens ,” (b) Permitted Liens granted over specific property pursuant to clauses (f) (solely with respect to such applicable deposit accounts), (i)
(solely with respect to the interest in such applicable lease, sublease, license or sublicense or the assets owned by such lessor, sublessor, licensor or sublicensor underlying same), (k) (solely with respect to the property permitted to be secured
by such Indebtedness permitted pursuant to clause (c) of the definition of “Permitted Indebtedness”), (l) (solely with respect to the property that is part of the Capital Lease), (m) (solely with respect to the specific assets covered
by such lease that are owned by such lessor), (n) (with respect to the goods permitted to be consigned thereby), (p) (solely with respect to such cash held by such insurance agency for such insurance premiums), and (t) (solely with respect to the
Bank of America Cash Collateral Account) of the definition of “Permitted 

  
 40 

 
Liens”, but, in each case, only to the extent only such Lien (i) attaches solely to the assets or property so acquired in such transaction and the proceeds thereof and (ii) has
prior priority to the Permitted Term Facility Liens, and (c) to the extent not otherwise covered by clause (b) above, non-consensual Permitted Liens that are solely provided by operation of (and in
compliance with) Applicable Law. 
 “Permitted Refinancing” means Indebtedness constituting a refinancing or extension of
Indebtedness evidenced by the permitted under clause (d) of the definition of “Permitted Indebtedness” and that (a) has an aggregate outstanding principal amount not greater than the aggregate principal amount of the Indebtedness
being refinanced or extended, (b) has a weighted average maturity (measured as of the date of such refinancing or extension) and maturity no shorter than that of the Indebtedness being refinanced or extended, (c) is not entered into as
part of a sale leaseback transaction, (d) is not secured by a Lien on any assets other than the collateral securing the Indebtedness being refinanced or extended, (e) the obligors of which are the same as the obligors of the Indebtedness
being refinanced or extended and (f) is otherwise on terms no less favorable to Loan Parties and their Subsidiaries, taken as a whole, than those of the Indebtedness being refinanced or extended. 

“Permitted Term Facility Liens” has the meaning provided therefor in clause (s) of the definition of “Permitted
Liens”. 
 “Person” means and includes any natural person, individual, partnership, joint venture, corporation, trust,
limited liability company, limited liability partnership, joint stock company, unincorporated organization, government entity or any political subdivision or agency thereof, or any other entity. 

“Prime Rate” means, at any time, the prime rate published in the “Money Rates” column of The Wall Street Journal at
such time, and in the event that The Wall Street Journal is not available at such time, the prime rate published in another publication as determined by Agent in its discretion. 

“Principal Market” means the NASDAQ Global Select Market (or any successor to the foregoing). 

“Pro Rata Share” means, as of any date of determination: 

(a) with respect to a Lender’s obligation to make all or a portion of the Revolving Loans, with respect to such Lender’s right to
receive payments of interest, fees, and principal with respect to the Revolving Loans, and with respect to all other computations and other matters related to the Revolver Commitments or the Revolving Loans, the percentage obtained by dividing
(i) the Revolving Loan Exposure of such Lender by (ii) the aggregate Revolving Loan Exposure of all Lenders, 
 (b) [reserved], or

 (c) with respect to all other matters and for all other matters as to a particular Lender (including the indemnification obligations
arising under Section 15.07), the percentage obtained by dividing (i) the Revolving Loan Exposure of such Lender by (ii) the aggregate Revolving Loan Exposure of all Lenders, in any such case as the applicable
percentage may be adjusted by assignments permitted pursuant to Section 13.01; provided, that if all of the Loans and other Obligations have been repaid in full in cash and all Commitments have been terminated, Pro
Rata Share under this clause shall be determined as if the Revolving Loan Exposures had not been repaid, collateralized, or terminated and shall be based upon the Revolving Loan Exposures as they existed immediately prior to their repayment,
collateralization, or termination. 

  
 41 

 “Products” means, from time to time, any products currently manufactured,
sold, developed, tested or marketed by any Loan Party or any of a Loan Party’s Subsidiaries. 
 “Protective Advances”
has the meaning specified therefor in Section 2.02(c)(i). 
 “Qualified Cash” means, as of any
date of determination, the amount of unrestricted cash and Cash Equivalents of Loan Parties that is in Deposit Accounts or in Securities Accounts, or any combination thereof, and which such Deposit Account or Securities Account is the subject of a
Control Agreement and is maintained by a branch office of the bank or securities intermediary located within the United States. 

“Real Property” means any real property owned, leased, subleased or otherwise operated or occupied by any Loan Party or any
Subsidiary of any Loan Party. 
 “Recall” means a Person’s Removal or Correction of a marketed product that the FDA
considers to be in violation of the laws it administers and against which the FDA would initiate legal action (e.g., seizure). 

“Recipient” means (a) Agent, (b) any Lender, or (c) during any Third Party Agent Retention Period, the Third Party
Agent, as applicable. 
 “Record” means information that is inscribed on a tangible medium or that is stored in an
electronic or other medium and is retrievable in perceivable form. 
 “Register” has the meaning specified therefor in
Section 13.01(i). 
 “Registered Loan” has the meaning specified therefor in
Section 13.01(i). 
 “Regulation D” means Regulation D of the Board of Governors of the Federal
Reserve System as in effect from time to time and any successor to all or a portion thereof establishing reserve requirements. 

“Regulatory Required Permit” means any and all licenses, clearances, exemptions, approvals, registrations, and permits issued
by the FDA, DEA or any other applicable Governmental Authority, including, without limitation, Drug Applications, any 510(k) premarket clearance, grant of a de novo request, premarket approval application (“PMA”), or investigational device
exemption (“IDE”), or the foreign equivalent to any of the foregoing necessary for the design, testing, manufacture, processing, assembly, packaging, labeling, marketing, distribution, commercialization, import, export, or sale of any
Product by any applicable Loan Party (or Loan Parties) and its (or their) Subsidiaries as such activities are being conducted by such Loan Party (or Loan Parties) and its (or their) Subsidiaries with respect to such Product at such time; and any
device listings and device establishment registrations under 21 C.F.R. Part 807, and any drug listings and drug establishment registrations under 21 U.S.C. Section 510, registrations issued by DEA under 21 U.S.C. Section 823 (if applicable
to any Product) and those issued by State governments for the conduct of the Loan Parties’ or any of their Subsidiaries’ business. 

“Related Fund” means (a) any Person (other than a natural person) that is engaged in making, purchasing, holding or
investing in bank loans and similar extensions of credit in the ordinary course and that is administered, advised or managed by (i) a Lender, (ii) an Affiliate of a Lender or (iii) an entity or an Affiliate of an entity that
administers, advises or manages a Lender, or (b) any Approved Fund. 

  
 42 

 “Related Parties” means, with respect to any Person, such Person’s
Affiliates and the partners, directors, officers, employees, agents, trustees, administrators, managers, attorneys, advisors and representatives of such Person and of such Person’s Affiliates. 

“Releases” means any release, threatened release, spill, emission, leaking, pumping, pouring, emitting, emptying, escape,
injection, deposit, disposal, discharge, dispersal, dumping, leaching or migration of Hazardous Material into or through the environment. 

“Removal” means the physical removal of a product from its point of use to some other location for repair, modification,
adjustment, relabeling, destruction or inspection. 
 “Required Lenders” means, at any time, Lenders the aggregate Pro Rata
Shares of which (calculated under clause (d) of the definition of Pro Rata Shares) exceed 50%. 
 “Reserves” means, as
of any date of determination, those reserves that Agent (including, during any Third Party Agent Retention Period, the Third Party Agent) deems necessary or appropriate, in its Permitted Discretion and subject to
Section 2.01(c), to establish and maintain (including reserves with respect to (a) sums that Borrowers or their Subsidiaries are required to pay under any Section hereof or any other Loan Document (such as taxes,
assessments, insurance premiums, or, in the case of leased assets, rents or other amounts payable under such leases) and has failed to pay, and (b) amounts owing by Borrowers or their Subsidiaries to any Person to the extent secured by a Lien
on, or trust over, any of the Collateral (other than a Permitted Lien), which Lien or trust, in the Permitted Discretion of Agent (including, during any Third Party Agent Retention Period, the Third Party Agent) likely would have a priority superior
to Agent’s Liens (such as Liens or trusts in favor of landlords, warehousemen, carriers, mechanics, materialmen, laborers, or suppliers, or Liens or trusts for ad valorem, excise, sales, or other taxes where given priority under applicable law)
in and to such item of the Collateral) with respect to the Borrowing Base or the Maximum Revolver Amount. Without limiting the foregoing, to the extent that any Accounts, Inventory or Equipment are included in the most recently delivered Borrowing
Base Certificate and such Accounts, Inventory or Equipment are no longer eligible in accordance with the definitions of “Eligible Domestic Accounts”, “Eligible Foreign Accounts”, “Eligible Inventory” and “Eligible
Equipment”, as applicable, Agent (and, during any Third Party Agent Retention Period, the Third Party Agent) may establish Reserves against the Borrowing Base in the amount of any such Accounts, Inventory or Equipment prior to delivery of an
updated Borrowing Base Certificate that removes such items. 
 “Restricted Payment” means, with respect to any Person,
(i) the declaration or making of any dividend payment or other distribution of assets, properties, cash, rights, obligations or securities on account of any of its Stock, (ii) the purchasing, redemption or other acquisition for value of
any of its Stock (other than, when no Default or Event of Default has occurred or is continuing (or would occur after giving effect to any such purchase, redemption or other acquisition) and to the extent there would be pro forma compliance with the
financial covenants in Article VII (after giving effect to any such purchase, redemption or other acquisition), solely pursuant to Endologix’ stock option exchange program on the terms set forth, and specifically
described (and without giving effect to any changes thereto that would be adverse to the Lender Group), in that certain proxy statement of Endologix filed with the SEC on April 20, 2018, Endologix shall have the ability to provide certain
qualified employees of Endologix (which shall not include name executive officers or board of directors of Endologix and only with respect to “Eligible Participants” (as described therein)) the option to surrender certain “out-of-the-money” or “underwater” options with an exercise price of $6.50 or greater that are “Eligible
Options” (as described therein) for cancellation in exchange for a grant of a lesser number of new restricted stock units of Endolgoix that may be settled for shares of Endologix’ common stock under Endologix’ amended and restated
2015 stock incentive plan of Endologix that is attached to such aforementioned proxy statement 

  
 43 

 
(and without giving effect to any material changes thereto), all as further specifically described (and without giving effect to any material changes thereto) in such proxy statement) now or
hereafter outstanding or (iii) the making of any payment or prepayment of principal of, premium, if any, interest, fees, redemption, exchange, purchase, retirement, defeasance, sinking fund or similar payment with respect to, any Indebtedness
subordinated to the Obligations as to right and time of payment or as to other rights and remedies thereunder. For the avoidance of doubt, the entry into, any payments or deliveries in respect of, and the performance, exercise and/or settlement of
the Borrower’s 2.25% Convertible Notes, 3.25% Convertible Notes (including, for the avoidance of doubt, any Permitted 3.25% Convertible Note Refinancing), Capped Calls, or under the Term Debt Facility are not Restricted Payments. 

“Revolver Commitment” means, with respect to each Revolving Lender, its Revolver Commitment, and, with respect to all
Revolving Lenders, their Revolver Commitments, in each case as such Dollar amounts are set forth beside such Revolving Lender’s name under the applicable heading on Schedule C-1 or in the
Assignment and Acceptance pursuant to which such Revolving Lender became a Revolving Lender hereunder, as such amounts may be reduced or increased from time to time pursuant to assignments made in accordance with the provisions of
Section 13.01. Notwithstanding anything to the contrary in this Agreement, the Revolver Commitment shall never be more than the Maximum Revolver Amount. 

“Revolver Exit Payment” has the meaning specified thereof in Section 2.09(g). 

“Revolver Usage” means, as of any date of determination, the amount of outstanding Revolving Loans (inclusive of Protective
Advances). 
 “Revolving Facility” means, at any time, the aggregate amount of the Revolving Lenders’ Revolver
Commitments at such time. 
 “Revolving Lender” means a Lender that has a Revolver Commitment or that has an outstanding
Revolving Loan. 
 “Revolving Loan Exposure” means, with respect to any Revolving Lender, as of any date of determination
(a) prior to the termination of the Revolver Commitments, the amount of such Lender’s Revolver Commitment, and (b) after the termination of the Revolver Commitments, the aggregate outstanding principal amount of the Revolving Loans of
such Lender. 
 “Revolving Loans” has the meaning specified therefor in Section 2.01(a). 

“Sanctioned Entity” means (a) a country or a government of a country, (b) an agency of the government of a country,
(c) an organization directly or indirectly controlled by a country or its government, (d) a Person resident in or determined to be resident in a country, in each case, that is subject to a country sanctions program administered and
enforced by OFAC. 
 “Sanctioned Person” means a Person named on the list of Specially Designated Nationals maintained by
OFAC. 
 “Sanctions” means all economic or financial sanctions or trade embargoes imposed, administered or enforced from
time to time by (a) the U.S. government, including those administered by OFAC or the U.S. Department of State, or (b) the United Nations Security Council, the European Union or Her Majesty’s Treasury of the United Kingdom. 

“S&P” has the meaning specified therefor in the definition of Cash Equivalents. 

  
 44 

 “SEC” means the United States Securities and Exchange Commission and any
successor thereto. 
 “Second Period” has the meaning specified in Section 2.09(d)(ii). 

“Secured Parties” means Agent (including any Third Party Agent), the Lenders and all Indemnified Persons. 

“Securities Account” means a securities account (as that term is defined in the Code). 

“Securities Act” means the Securities Act of 1933, as amended, including the rules and regulations promulgated thereunder.

 “Securitization” has the meaning specified therefor in Section 13.01(h). 

“Settlement” has the meaning specified therefor in Section 2.02(d)(i). 

“Settlement Date” has the meaning specified therefor in Section 2.02(d)(i). 

“Solvent” means, with respect to any Person as of any date of determination, that, as of such date, (a) the value of the
assets of such Person at a “fair valuation”’ (as referenced in the Bankruptcy Code) is greater than the total amount of liabilities (including contingent and unliquidated liabilities) of such Person, (b) such Person is able to
pay all liabilities of such Person as such liabilities mature, and (c) such Person does not have unreasonably small capital in relation to such Person’s business as contemplated as of the Closing Date. In computing the amount of contingent
or unliquidated liabilities at any time, such liabilities shall be computed at the amount that, in light of all the facts and circumstances existing at such time, represents the amount that can reasonably be expected to become an actual or matured
liability. 
 “Stock” means (a) all shares of capital stock (whether denominated as common stock or preferred stock),
equity interests, beneficial, partnership or membership interests, joint venture interests, participations or other ownership or profit interests in or equivalents (regardless of how designated) of or in a Person (other than an individual), whether
voting or non-voting; and (b) all securities convertible into or exchangeable for any other Stock and all warrants, options or other rights (other than the 2.25% Convertible Notes, the 3.25% Convertible
Notes, any Permitted 3.25% Convertible Note Refinancing permitted hereunder, any Capped Call transactions, and the Warrants) to purchase, subscribe for or otherwise acquire any other Stock, whether or not presently convertible, exchangeable or
exercisable. 
 “Subordinated Debt” means any Indebtedness of the Loan Parties incurred pursuant to the terms of the
Subordinated Debt Documents and with the prior written consent of Agent and the Lenders, all of which documents must be in form and substance acceptable to Agent and the Lenders in their sole discretion. As of the Closing Date, there is no
Subordinated Debt. 
 “Subordinated Debt Documents” means any documents evidencing and/or securing Indebtedness governed by
a Subordination Agreement, all of which documents must be in form and substance acceptable to Agent and the Lenders in their sole discretion. As of the Closing Date, there are no Subordinated Debt Documents. 

“Subordination Agreement” means any agreement between Agent and another creditor of one or more Loan Parties, as the same may
be amended, supplemented, restated or otherwise modified from time to time in accordance with the terms thereof, pursuant to which the Indebtedness owing from any Loan Party or Loan Parties and/or the Liens securing such Indebtedness granted by any
Loan Party or Loan Parties to such creditor are subordinated in any way to the Obligations and the Liens created under the 

  
 45 

 
Guaranty and Security Agreement, the terms and provisions of such Subordination Agreements to have been agreed to by, and be acceptable to, Agent in the exercise of its sole discretion. 

“Subordination Provisions” has the meaning specified therefor in Section 8.19. 

“Subsidiary” or “Subsidiaries” means, with respect to any Person, (a) any corporation of which an
aggregate of more than fifty percent (50%) of the outstanding capital stock having ordinary voting power to elect a majority of the board of directors of such corporation (irrespective of whether, at the time, capital stock of any other class or
classes of such corporation shall have or might have voting power by reason of the happening of any contingency) is at the time, directly or indirectly, owned legally or beneficially by such Person or one or more Subsidiaries of such Person, or with
respect to which any such Person has the right to vote or designate the vote of more than fifty percent (50%) of such capital stock whether by proxy, agreement, operation of law or otherwise, and (b) any partnership or limited liability company
in which such Person and/or one or more Subsidiaries of such Person shall have an interest (whether in the form of voting or participation in profits or capital contribution) of more than fifty percent (50%) or of which any such Person is a general
partner or may exercise the powers of a general partner. Unless the context otherwise requires, each reference to a Subsidiary shall be a reference to a Subsidiary of a Loan Party. 

“Swap Contract” means any agreement, contract or transaction that constitutes a “swap” within the meaning of
Section 1a(47) of the Commodity Exchange Act, not including Capped Calls. 
 “Taxes” means any taxes, levies, imposts,
duties, fees, assessments or other charges of whatever nature now or hereafter imposed by any jurisdiction or by any political subdivision or taxing authority thereof or therein, and all interest, penalties or similar liabilities with respect
thereto. 
 “Tax Affiliate” means (a) the Borrower and its Subsidiaries and (b) any Affiliate of the Borrower
with which the Borrower files or is required to file consolidated, combined or unitary tax returns. 
 “Term Agent” has the
meaning ascribed to such term in the definition of “Term Credit Agreement” herein. 
 “Term Credit Agreement”
means that certain Amended and Restated Facility Agreement, dated as of August 9, 2018, by and among Endologix, the other Persons party thereto from time to time as “Loan Parties” (as defined therein), Deerfield Private Design Fund
IV, L.P., in its capacity as “Agent” (as defined therein, in such capacity, the “Term Agent”) and the financial institutions or other entities from time to time party thereto, each as a “Lender (as defined therein,
the “Term Lenders”), as amended, restated, supplemented or otherwise modified in accordance and in compliance with the Intercreditor Agreement and this Agreement. 

“Term Debt” means the “Facility Obligations” as defined in the Intercreditor Agreement. 

“Term Debt Documents” means the “Facility Documents” as defined in the Intercreditor Agreement. 

“Term Lenders” has the meaning ascribed to such term in the definition of “Term Credit Agreement” herein. 

“Third Period” has the meaning specified in Section 2.09(d)(ii). 

  
 46 

 “Third Party Agent” means any Person other than Deerfield Revolver and its
Affiliates that (a) (i) becomes the Agent under the Loan Documents or (ii) is retained or hired as an agent or a subagent of the Agent to perform certain duties and responsibilities of (or receive certain rights and benefits provided
to) the Agent under the Loan Documents, (b) Borrower Representative has been informed of as being a Third Party Agent, and (c) has not (i) been removed from such role or position of the type set forth in clause (a)(i) or
clause (a)(ii) by Deerfield Revolver (or any such succeeding Agent to Deerfield Revolver”) or (ii) had such role or position be terminated pursuant to the terms of any agreement between the Third Party Agent and Agent (each of the
events in clause (c)(i) and clause (c)(ii) above, a “Third Party Agent Termination Event”). It being understood and agreed that as of the Closing Date, Cortland shall be deemed to be a Third Party Agent so long as a Third
Party Agent Termination Event has not occurred. 
 “Third Party Agent Retention Period” means any period of time when any
Person is acting or performing as a Third Party Agent pursuant to the definition of “Third Party Agent.” 
 “Third Party
Agent Termination Event” has the meaning specified therefor in the definition of “Third Party Agent”. 
 “Third
Party Obligation” has the meaning provided therefor in the definition of “Contingent Obligation.” 
 “Third Party
Payor” means Medicare, Medicaid, TRICARE, and other state or federal health care program, Blue Cross and/or Blue Shield, private health care insurers and managed care organizations. 

“Third Party Payor Programs” means all private or governmental programs providing health care benefits, whether directly
through insurance or otherwise, that are sponsored by a Third Party Payor. 
 “Title IV Plan” means an Employee Benefit
Plan subject to Title IV of ERISA, other than a Multiemployer Plan, to which any ERISA Affiliate incurs or otherwise has or could reasonably be expected to have any obligation or Liabilities (including under Section 4069 of ERISA). 

“Trademarks” has the meaning specified therefor in the Guaranty and Security Agreement. 

“Trademark Security Agreement” has the meaning specified therefor in the Guaranty and Security Agreement. 

“Trigger Date” means the date that Borrowers shall have delivered quarterly financial statements to Agent (and, during any
Third Party Agent Retention Period, also to the Third Party Agent) in accordance with Section 5.05(a) that demonstrate that Endologix and its Subsidiaries shall have achieved TTM EBITDA of $20,000,000 or greater. 

“TRICARE” means the program administered pursuant to 10 U.S.C. Section 1071 et. seq), Sections 1320a-7 and 1320a-7a of Title 42 of the United States Code and the regulations promulgated pursuant to such statutes. 

“Trunk Inventory” means “trunk stock inventory” that is in the possession of sales personnel of the Borrowers. 

“TTM EBITDA” means, as of any date of determination, EBITDA for the 12-month period
most recently ended. 

  
 47 

 “UCC” means the Uniform Commercial Code of any applicable jurisdiction and,
if the applicable jurisdiction shall not have any Uniform Commercial Code, the Uniform Commercial Code as in effect from time to time in the State of New York. 

“United States” and “U.S.” means the United States of America. 

“Unused Line Fee” has the meaning specified therefor in Section 2.09(b). 

“Voidable Transfer” has the meaning specified therefor in Section 17.07. 

“Withholding Agent” means any Borrower and Agent. 

1.02 Accounting Terms. All accounting terms not specifically defined herein shall be construed in accordance with GAAP;
provided, that if Borrowers notifies Agent that Borrowers request an amendment to any provision hereof to eliminate the effect of any Accounting Change occurring after the Closing Date or in the application thereof on the operation of such
provision (or if Agent notifies Borrowers that the Required Lenders request an amendment to any provision hereof for such purpose), regardless of whether any such notice is given before or after such Accounting Change or in the application thereof,
then Agent and Borrowers agree that they will negotiate in good faith amendments to the provisions of this Agreement that are directly affected by such Accounting Change with the intent of having the respective positions of the Lenders and Borrowers
after such Accounting Change conform as nearly as possible to their respective positions prior to giving effect to such Accounting Change and, until any such amendments have been agreed upon and agreed to by the Required Lenders, the provisions in
this Agreement shall be calculated as if no such Accounting Change had occurred; provided, further, that all obligations of any Person that are or would be characterized as an operating lease as determined in accordance with GAAP as in
effect on the Closing Date (whether or not such operating lease was in effect on such date) shall continue to be accounted for as an operating lease (and not as a capital lease obligation) for purposes of this Agreement regardless of any change in
GAAP following the Effective Date that would otherwise require such obligation to be recharacterized as a capital lease obligation, to the extent that financial reporting shall not be affected hereby. When used herein, the term “financial
statements” shall include the notes and schedules thereto. Whenever the term “Borrowers” is used in respect of a financial covenant or a related definition, it shall be understood to mean Borrowers and their Subsidiaries on a
consolidated basis, unless the context clearly requires otherwise. Notwithstanding anything to the contrary contained herein, all financial statements delivered hereunder shall be prepared, and all financial covenants contained herein shall be
calculated, without giving effect to any election under the Statement of Financial Accounting Standards No. 159 (or any similar accounting principle) permitting a Person to value its financial liabilities or Indebtedness at the fair value
thereof. 
 1.03 Code. Any terms used in this Agreement that are defined in the Code shall be construed and defined as set
forth in the Code unless otherwise defined herein; provided, that to the extent that the Code is used to define any term herein and such term is defined differently in different Articles of the Code, the definition of such term contained in
Article 9 of the Code shall govern. 
 1.04 Construction. Unless the context of this Agreement or any other Loan Document
clearly requires otherwise, references to the plural include the singular, references to the singular include the plural, the terms “includes” and “including” are not limiting, and the term “or” has, except where
otherwise indicated, the inclusive meaning represented by the phrase “and/or.” The words “hereof,” “herein,” “hereby,” “hereunder,” and similar terms in this Agreement or any other Loan Document
refer to this Agreement or such other Loan Document, as the case may be, as a whole and not to any particular provision of this Agreement or such other Loan Document, as the case may be. Section, subsection,

  
 48 

 
clause, schedule, and exhibit references herein are to this Agreement unless otherwise specified. Any reference in this Agreement or in any other Loan Document to any agreement, instrument, or
document shall include all alterations, amendments, changes, extensions, modifications, renewals, replacements, substitutions, joinders, and supplements, thereto and thereof, as applicable (subject to any restrictions on such alterations,
amendments, changes, extensions, modifications, renewals, replacements, substitutions, joinders, and supplements set forth herein). The words “asset” and “property” shall be construed to have the same meaning and effect and to
refer to any and all tangible and intangible assets and properties. Unless expressly stated otherwise herein or in any other Loan Document, any reference herein or in any other Loan Document to the satisfaction, repayment, or payment in full of the
Obligations shall mean (a) the payment or repayment in full in cash of (i) the principal amount of, and interest accrued and unpaid with respect to, all outstanding Loans, together with the payment of any premium applicable to the
repayment of the Loans, (ii) all Lender Group Expenses that have accrued and are unpaid regardless of whether demand has been made therefor, (iii) all fees or charges that have accrued (or are owed) hereunder or under any other Loan
Document and are unpaid, (b) [reserved], (c) the receipt by Agent of cash collateral in order to secure any other contingent Obligations for which a claim or demand for payment has been made on or prior to such time or in respect of matters or
circumstances known to Agent or a Lender at such time that are reasonably expected to result in any loss, cost, damage, or expense (including attorneys’ fees and legal expenses), such cash collateral to be in such amount as Agent reasonably
determines is appropriate to secure such contingent Obligations, (d) the payment or repayment in full in cash of all other outstanding Obligations (other than unasserted contingent indemnification Obligations), and (e) the termination of
all of the Commitments. Any reference herein to any Person shall be construed to include such Person’s successors and assigns; provided that no assign of any Loan Party of any of its rights or obligations under this Agreement or the
other Loan Documents is permitted and any such assignment shall be absolutely void ab initio. Any requirement of a writing contained herein or in any other Loan Document shall be satisfied by the transmission of a Record. The terms
“shall” and “will” are used interchangeably in this Agreement and the other Loan Documents and mean for the Loan Parties and their Subsidiaries to have an absolute obligation to perform or do (or not perform or do) a certain
action or event, as the context may require. 
 1.05 Time References. Unless the context of this Agreement or any other Loan
Document clearly requires otherwise, all references to time of day refer to Eastern standard time or Eastern daylight saving time, as in effect in New York, New York on such day. For purposes of the computation of a period of time from a specified
date to a later specified date, the word “from” means “from and including” and the words “to” and “until” each means “to and including”; provided that, with respect to a computation of fees or
interest payable to Agent (including any Third Party Agent), any Lender or any other member of the Lender Group, such period shall in any event consist of at least one full day. 

1.06 Schedules and Exhibits. All of the schedules and exhibits attached to this Agreement shall be deemed incorporated herein by
reference. 
 ARTICLE II. 

LOANS AND TERMS OF PAYMENT. 

2.01 Revolving Loans. 

(a) Subject to the terms and conditions of this Agreement, and during the term of this Agreement, each Revolving Lender agrees (severally, not
jointly or jointly and severally) to make revolving loans (all such loans, collectively, the “Revolving Loans”) to Borrowers under a revolving credit facility in an amount at any one time outstanding not to exceed the lesser of:

  
 49 

 (i) such Lender’s Revolver Commitment, or 

(ii) such Lender’s Pro Rata Share of an amount equal to the lesser of: 

(A) the amount equal to (1) the Maximum Revolver Amount less (2) the Revolver Usage at such time, and 

(B) the amount equal to (1) the Borrowing Base as of such date (based upon (x) during a Non-Third Party Agent Retention Period, the most recent Borrowing Base Certificate (Agent) delivered by Borrowers to Agent or (y) during a Third Party Agent Retention Period, the most recent Borrowing Base
Certificate (Third Party Agent) delivered by Borrowers to Third Party Agent, less (2) the Revolver Usage at such time. 
 (b) Amounts
borrowed pursuant to this Section 2.01 may be repaid and, subject to the terms and conditions of this Agreement, reborrowed at any time during the term of this Agreement. The outstanding principal amount of the Revolving
Loans, together with interest accrued and unpaid thereon, shall constitute Obligations and shall be due and payable on the Maturity Date or, if earlier, on the date on which they are declared due and payable pursuant to the terms of this Agreement.

 (c) Notwithstanding anything to the contrary in this Section 2.01, Agent may at any time establish one or more
Reserves against the Borrowing Base or the Maximum Revolver Amount as Agent (or, during any Third Party Agent Retention Period, a Third Party Agent) may deem proper and appropriate in Agent’s (including, during any Third Party Agent Retention
Period, a Third Party Agent’s) Permitted Discretion in its capacity as an asset based lender. A Reserve may limit the Availability, reduce the Borrowing Base (by reduction of an advance rate set forth in the Borrowing Base or otherwise), or
otherwise restrict a Borrower’s ability to borrow hereunder. Agent (or, during any Third Party Agent Retention Period, a Third Party Agent) shall endeavor to notify Borrower Representative promptly after the establishment of any Reserve;
provided, however, under no circumstance shall the delivery or receipt of any such notice constitute a condition to Agent’s (or, during any Third Party Agent Retention Period, a Third Party Agent’s) establishment of any Reserve. For the
avoidance of doubt, Agent (or, during any Third Party Agent Retention Period, a Third Party Agent) may in Agent’s (including, during any Third Party Agent Retention Period, such Third Party Agent’s) Permitted Discretion (but Agent (or such
Third Party Agent, as applicable) shall have no obligation in any circumstance to) increase, reduce or release any Reserve that was previously established under this Section 2.01(c). 

2.02 Borrowing Procedures and Settlements. 

(a) Procedure for Borrowing Loans. Each Borrowing shall be made by a written request by an Authorized Person delivered to Agent (and,
during any Third Party Agent Retention Period, also to the Third Party Agent) and received by Agent (and, during any Third Party Agent Retention Period, also to the Third Party Agent) no later than 1:00 p.m. on the Business Day that is three
(3) Business Days prior to the requested Funding Date, specifying (i) the amount of such Borrowing, and (ii) the requested Funding Date (which shall be a Business Day); provided, that Agent may, in its sole discretion, elect to
accept as timely requests that are received later than 1:00 p.m. on the applicable Business Day. 
 (b) Making of Loans. 

(i) After receipt of a request for a Borrowing pursuant to Section 2.02(a), Agent (or, during any Third Party Agent
Retention Period, the Third Party Agent) shall promptly notify the Lenders 

  
 50 

 
by telecopy, telephone, email, or other electronic form of transmission, of the requested Borrowing. If Agent has notified the Lenders of a requested Borrowing on the Business Day that is one
(1) Business Day prior to the Funding Date, then each Lender shall make the amount of such Lender’s Pro Rata Share of the requested Borrowing (or such lesser Availability amount) available to the Borrowers on the applicable Funding Date by
transferring immediately available funds equal to such amount to the Borrowers; provided, that, subject to the provisions of Section 2.02(c)(ii), no Lender shall have an obligation to make any Revolving Loan, if
(1) one or more of the applicable conditions precedent set forth in Article III will not be satisfied on the requested Funding Date for the applicable Borrowing unless such condition has been waived, or (2) the requested Borrowing
would exceed the Availability on such Funding Date. Agent shall charge to the Loan Account usual and customary fees for the wire transfer of each Borrowing. 

(ii) Each Borrower and each Lender hereby authorizes Agent to make Revolving Loans on behalf of the Lenders, at any time in its sole
discretion, to pay principal owing in respect of the Loans and interest, fees, expenses and other charges payable by any Loan Party from time to time arising under this Agreement or any other Loan Document. 

(c) Protective Advances and Optional Overadvances. 

(i) Any contrary provision of this Agreement or any other Loan Document notwithstanding, but subject to
Section 2.02(c)(iv), at any time (A) after the occurrence and during the continuance of a Default or an Event of Default, or (B) that any of the other applicable conditions precedent set forth in Article
III are not satisfied, Agent hereby is authorized by Borrowers and the Lenders, from time to time, in Agent’s sole discretion, to make Revolving Loans to, or for the benefit of, Borrowers, on behalf of the Revolving Lenders, that Agent, in
its Permitted Discretion, deems necessary or desirable (1) to preserve or protect the Collateral, or any portion thereof, or (2) to enhance the likelihood of repayment of the Obligations (the Revolving Loans described in this
Section 2.02(c)(i) shall be referred to as “Protective Advances”). Notwithstanding the foregoing, no Protective Advance shall be made which would cause (A) the aggregate amount of all Protective
Advances outstanding at any one time to exceed 10% of the Maximum Revolver Amount unless the Required Lenders otherwise agree or (B) the aggregate amount of Revolver Usage outstanding at any one time to exceed the Maximum Revolver Amount. 

(ii) Any contrary provision of this Agreement or any other Loan Document notwithstanding, but subject to
Section 2.02(c)(iv), the Lenders hereby authorize Agent, and Agent may, but is not obligated to, knowingly and intentionally, continue to make Revolving Loans to Borrowers notwithstanding that an Overadvance exists or would
be created thereby, so long as (A) after giving effect to such Revolving Loans, the outstanding Revolver Usage does not exceed the Borrowing Base by more than 10% of the Maximum Revolver Amount (unless Required Lenders agree to a higher
amount), and (B) after giving effect to such Revolving Loans, the outstanding Revolver Usage (except for and excluding amounts charged to the Loan Account for interest, fees, or Lender Group Expenses) does not exceed the Maximum Revolver
Amount. In the event Agent obtains actual knowledge that an Overadvance exists, regardless of the amount of, or reason for, such excess, Agent shall notify the Lenders as soon as practicable and the Lenders with Revolver Commitments thereupon shall,
together with Agent, jointly determine the terms of arrangements that shall be implemented with Borrowers intended to eliminate the Overadvance within thirty (30) days. In such circumstances, if any Lender with a Revolver Commitment objects to
the proposed terms of reduction or repayment of any Overadvance, the terms of reduction or repayment thereof shall be implemented according to the determination of the Required Lenders. The foregoing provisions are meant for the benefit of the
Lenders and Agent and are not meant for the benefit of Borrowers, which shall continue to be bound by the provisions of Section  

  
 51 

 
2.03(e). Each Lender with a Revolver Commitment shall be obligated to make Revolving Loans in accordance with Section 2.02(b) in, or settle Overadvances made by
Agent with Agent as provided in Section 2.02(d), as applicable) for, the amount of such Lender’s Pro Rata Share of any unintentional Overadvances by Agent reported to such Lender, any intentional Overadvances made as
permitted under this Section 2.02(c)(ii), and any Overadvances resulting from the charging to the Loan Account of interest, fees, or Lender Group Expenses. 

(iii) Each Protective Advance and each Overadvance (each, an “Extraordinary Advance”) shall be deemed to be a Revolving Loan
hereunder. Prior to Settlement with respect to Extraordinary Advances, all payments on the Extraordinary Advances made by Agent, including interest thereon, shall be payable to Agent solely for its own account. The Extraordinary Advances shall be
repayable on demand, secured by Agent’s Liens, constitute Obligations hereunder, and bear interest at the rate applicable from time to time to Revolving Loans. The provisions of this Section 2.02(c) are for the
exclusive benefit of Agent and the Lenders and are not intended to benefit Borrowers (or any other Loan Party) in any way. 
 (iv)
Notwithstanding anything contained in this Agreement or any other Loan Document to the contrary: (A) no Extraordinary Advance may be made by Agent if such Extraordinary Advance would cause the aggregate principal amount of Extraordinary
Advances outstanding to exceed an amount equal to 10% of the Maximum Revolver Amount; and (B) to the extent that the making of any Extraordinary Advance causes the aggregate Revolver Usage to exceed the Maximum Revolver Amount, such portion of
such Extraordinary Advance shall be for Agent’s sole and separate account and not for the account of any Lender and shall be entitled to priority in repayment in accordance with Section 2.03(b). 

(d) Settlement. It is agreed that each Lender’s funded portion of the Revolving Loans is intended by the Lenders to equal, at all
times, such Lender’s Pro Rata Share of the outstanding Revolving Loans. Such agreement notwithstanding, Agent and the Lenders agree (which agreement shall not be for the benefit of Borrowers) that in order to facilitate the administration of
this Agreement and the other Loan Documents, settlement among the Lenders as to any Extraordinary Advances shall take place on a periodic basis in accordance with the following provisions: 

(i) Solely when any Extraordinary Advances are outstanding, Agent shall request settlement (“Settlement”) with the Lenders on
a weekly basis, or on a more frequent basis if so determined by Agent in its sole discretion (A) for itself, with respect to the outstanding Extraordinary Advances, and (B) with respect to Borrowers’ or their Subsidiaries’
payments or other amounts received, as to each by notifying the Lenders by telecopy, telephone, or other similar form of transmission, of such requested Settlement, no later than 2:00 p.m. on the Business Day immediately prior to the date of such
requested Settlement (the date of such requested Settlement being the “Settlement Date”). Such notice of a Settlement Date shall include a summary statement of the amount of outstanding Extraordinary Advances for the period since
the prior Settlement Date. Subject to the terms and conditions contained herein (including Section 2.02(g)): (1) if the amount of the Revolving Loans (including Extraordinary Advances) made by a Lender that is not a
Defaulting Lender exceeds such Lender’s Pro Rata Share of the Revolving Loans (including Extraordinary Advances) as of a Settlement Date, then Agent shall, by no later than 12:00 p.m. on the Settlement Date, transfer in immediately available
funds to a Deposit Account of such Lender (as such Lender may designate), an amount such that each such Lender shall, upon receipt of such amount, have as of the Settlement Date, its Pro Rata Share of the Revolving Loans (including Extraordinary
Advances), and (2) if the amount of the Revolving Loans (including Extraordinary Advances) made by a Lender is less than such Lender’s Pro Rata Share of the Revolving Loans (including Extraordinary Advances) as of a Settlement Date, such
Lender shall no later than 12:00 p.m. on the Settlement Date transfer in immediately available funds to Agent’s Account, an amount such 

  
 52 

 
that each such Lender shall, upon transfer of such amount, have as of the Settlement Date, its Pro Rata Share of the Revolving Loans (including Extraordinary Advances). Such amounts made
available to Agent under clause (2) of the immediately preceding sentence shall be applied against the amounts of the applicable Extraordinary Advances and shall constitute Revolving Loans of such Lenders. 

(ii) In determining whether a Lender’s balance of the Revolving Loans (including Extraordinary Advances) is less than, equal to, or
greater than such Lender’s Pro Rata Share of the Revolving Loans (including Extraordinary Advances) as of a Settlement Date, Agent shall, as part of the relevant Settlement, apply to such balance the portion of payments actually received in
good funds by Agent with respect to principal, interest, fees payable by Borrowers and allocable to the Lenders hereunder, and proceeds of Collateral. 

(iii) Between Settlement Dates, Agent, solely to the extent Extraordinary Advances for the account of Agent are outstanding, may apply any
payments or other amounts received by Agent, that in accordance with the terms of this Agreement would be applied to the reduction of the Revolving Loans, to the Extraordinary Advances. During the period between Settlement Dates, Agent with respect
to Extraordinary Advances, and each Lender with respect to the Revolving Loans other than Extraordinary Advances, shall be entitled to interest at the applicable rate or rates payable under this Agreement on the daily amount of funds employed by
Agent, or the Lenders, as applicable. 
 (e) Notation. During any Third Party Agent Retention Period, Agent, as a non-fiduciary agent for Borrowers, shall maintain a register showing the principal amount of the Loans owing to each Lender and/or Extraordinary Advances owing to Agent, and the interests therein of each Lender,
from time to time and such register shall, absent manifest error, conclusively be presumed to be correct and accurate. During any Non-Third Party Agent Retention Period, the Borrower Representative shall
maintain such Loan Account and shall make such Loan Account available to Agent and the Lenders upon request therefrom. Upon the request of any Third Party Agent upon the commencement of any Third Party Agent Retention Period, the Borrower
Representative shall share such Loan Account and any of its applicable books and records with the Third Party Agent, and with respect to any discrepancies between the books, records or Loan Account of the Borrower Representative, on the one hand,
and the books, records or Loan Account of any Lender, the Agent or the Third Party Agent, on the other hand, the books, records and Loan Account of such Lender, Agent or Third Party Agent shall govern and control in the absence of demonstrable
error. 
 (f) [Reserved]. 

(g) Independent Obligations. All Loans (other than Extraordinary Advances) shall be made by the Lenders contemporaneously and in
accordance with their Pro Rata Shares. It is understood that (i) no Lender shall be responsible for any failure by any other Lender to perform its obligation to make any Loan (or other extension of credit) hereunder, nor shall any Commitment of
any Lender be increased or decreased as a result of any failure by any other Lender to perform its obligations hereunder, and (ii) no failure by any Lender to perform its obligations hereunder shall excuse any other Lender from its obligations
hereunder. 
 2.03 Payments; Reductions of Commitments; Prepayments. 

(a) Payments by Borrowers. Except as otherwise expressly provided herein, all payments by Borrowers shall be made to each Lender based
on such Lender’s Pro Rata Share and shall be made in immediately available funds, no later than 1:30 p.m. on the date specified herein. Any payment received by Agent (or, during any Third Party Agent Retention Period, any Third Party Agent) or
any Lender later 

  
 53 

 
than 1:30 p.m. may be deemed to have been received on the following Business Day and any applicable interest or fee shall continue to accrue until such following Business Day. 

(b) Apportionment and Application. 

(i) So long as no Application Event has occurred and is continuing, all principal and interest payments shall be paid by the Borrowers (and any
such amounts received by Agent (or, during any Third Party Agent Retention Period, the Third Party Agent) shall be apportioned) ratably among the Lenders (according to the unpaid principal balance of the Obligations to which such payments relate
held by each Lender) and all payments of fees and expenses shall be paid by the Borrowers (and any such amounts received by Agent (or, during any Third Party Agent Retention Period, the Third Party Agent) (other than fees or expenses that are for
Agent’s or such Third Party Agent’s (as applicable) separate account) shall be apportioned) ratably among the Lenders having a Pro Rata Share of the type of Commitment or Obligation to which a particular fee or expense relates. Subject to
Section 2.03(b)(iv), all payments to be made hereunder by Borrowers shall be remitted to the Lenders (other than amounts owed specifically to Agent or any Third Party Agent (as applicable)) and all such payments, and all
proceeds of Collateral paid by the Borrowers to the Lenders or received by Agent (or any Third Party Agent (as applicable)), shall be applied, so long as no Application Event has occurred and is continuing, to reduce the balance of the Loans and
other Obligations outstanding and, thereafter, to Borrowers (to be wired to the Designated Account) or such other Person entitled thereto under Applicable Law. 

(ii) At any time that an Application Event has occurred and is continuing, all payments remitted to Agent (or any Third Party Agent (as
applicable)) or the Lenders and all proceeds of Collateral received by Agent (or any Third Party Agent (as applicable)) or the Lenders shall be applied as follows: 

(A) first, to pay any Lender Group Expenses (including cost or expense reimbursements) or indemnities then due to Agent
under the Loan Documents, until paid in full in cash, 
 (B) second, to pay any fees or premiums then due to Agent
under the Loan Documents until paid in full in cash, 
 (C) third, to pay interest due in respect of all Protective
Advances until paid in full in cash, 
 (D) fourth, to pay the principal of all Protective Advances until paid in full
in cash, 
 (E) fifth, ratably, to pay any Lender Group Expenses (including cost or expense reimbursements) or
indemnities then due to any of the Lenders under the Loan Documents, until paid in full in cash, 
 (F) sixth,
ratably, to pay any fees or premiums then due to any of the Lenders under the Loan Documents until paid in full in cash, 

(G) seventh, ratably, to pay interest accrued in respect of the Loans (other than Protective Advances) until paid in
full in cash, 
 (H) eighth, ratably, to pay the principal of all Loans until paid in full in cash, 

  
 54 

 (I) ninth, to pay any other Obligations until paid in full in cash,
and 
 (J) tenth, to Borrowers (to be wired to the Designated Account) or such other Person entitled thereto under
Applicable Law. 
 (iii) Agent (or the Third Party Agent, as applicable) promptly shall distribute to each Lender, pursuant to the applicable
wire instructions received from each Lender in writing, such funds as it may be entitled to receive that have been delivered to Agent (or the Third Party Agent, as applicable) instead of such Lender, subject to a Settlement delay as provided in
Section 2.02(d). 
 (iv) In each instance, so long as no Application Event has occurred and is continuing,
Section 2.03(b)(i) shall not apply to any payment made by Borrowers to Agent and specified by Borrowers to be for the payment of specific Obligations then due and payable (or prepayable) under any provision of this
Agreement or any other Loan Document. 
 (v) For purposes of Section 2.03(b)(ii), “paid in full” of a
type of Obligation means payment in cash or immediately available funds of all amounts owing on account of such type of Obligation, including interest accrued after the commencement of any Insolvency Proceeding, default interest, interest on
interest, any premium or prepayment penalty, Commitment Fee, Liquidated Damages and expense reimbursements, irrespective of whether any of the foregoing would be or is allowed or disallowed in whole or in part in any Insolvency Proceeding. 

(vi) In the event of a direct conflict between the priority provisions of this Section 2.03 and any other provision
contained in this Agreement or any other Loan Document, it is the intention of the parties hereto that such provisions be read together and construed, to the fullest extent possible, to be in concert with each other. In the event of any actual,
irreconcilable conflict that cannot be resolved as aforesaid then the terms and provisions of this Section 2.03 shall control and govern. 

(c) Reduction of Revolver Commitments. The Revolver Commitments shall terminate on the Maturity Date. The Revolver Commitments may be
reduced by the Borrower subject to payment of Liquidated Damages in accordance with Section 2.09(d), to an amount (which may be zero) not less than the sum of (i) the Revolver Usage as of such date, plus (ii) the
principal amount of all Revolving Loans not yet made as to which a request has been given by Borrowers under Section 2.02(a). Each such reduction pursuant to clause (i) shall be in an aggregate amount of
$5,000,000 or any whole multiple of $1,000,000 in excess thereof (unless the Revolver Commitments are being reduced to zero and the amount of the Revolver Commitments in effect immediately prior to such reduction are less than $5,000,000), shall be
made by providing not less than 10 Business Days prior written notice to Agent (and, during any Third Party Agent Retention Period, the Third Party Agent) and the Lenders, and shall be irrevocable. Each such reduction of the Revolver Commitments
shall be permanent, shall be accompanied by any payment of Liquidated Damages required pursuant to Section 2.09(d) and shall reduce the Revolver Commitments of each Lender proportionately in accordance with its ratable
share thereof. 
 (d) Optional Prepayments. Upon at least one (1) Business Day prior written notice the Borrowers may prepay the
Loans at any time, in whole or in part, plus accrued and unpaid interest on the principal amount being prepaid to the prepayment date and all fees, costs, expenses and other amounts related thereto. No prepayment of Revolving Loans under this
Section 2.03(d) shall result in a permanent reduction of the Revolver Commitments. 
 (e) Mandatory
Prepayments. 

  
 55 

 (i) If, at any time, (i) the Revolver Usage on such date exceeds (ii) either
(A) the Borrowing Base reflected in the Borrowing Base Certificate most recently delivered by Borrower to Agent (or, during the Third Party Agent Retention Period, the Third Party Agent) (as adjusted by Agent (or the Third Party Agent, as
applicable) for Reserves established by Agent (or the Third Party Agent, as applicable) from time to time) or (B) the Maximum Revolver Amount, then Borrower shall immediately prepay the Obligations in accordance with
Section 2.03(f) in an aggregate amount equal to the amount of such excess. No prepayment pursuant to this Section 2.03(e) shall result in a reduction in the Maximum Revolver Amount. 

(ii) If, at any time, a Maximum Decreased Market Capitalization Overadvance Event occurs, then Borrower shall immediately prepay the
Obligations in accordance with Section 2.03(f) in an aggregate amount equal to the Maximum Decreased Market Capitalization Overadvance Amount. 

(f) Application of Payments. Each prepayment pursuant to Section 2.03(e) shall, (i) so long as no
Application Event shall have occurred and be continuing, be applied to the outstanding principal amount of the Revolving Loans until paid in full in cash, and (ii) if an Application Event shall have occurred and be continuing, be applied in the
manner set forth in Section 2.03(b)(ii). 
 2.04 Promise to Pay; Promissory Notes. 

(a) Borrowers promise to pay all of the Obligations (including principal, interest, premiums, if any, fees, costs, and expenses (including
Lender Group Expenses)) in cash to Agent and the Lenders in full on the Maturity Date or, if earlier, on the date on which the Obligations become due and payable pursuant to the terms of this Agreement. 

(b) Any Lender may request that any portion of its Commitments or the Loans made by it be evidenced by one or more Notes. In such event,
Borrowers (on a joint and several basis) shall execute and deliver to such Lender the requested Notes payable to the order of such Lender in a form furnished by Agent. Thereafter, the portion of the Commitments and Loans evidenced by such Notes and
interest thereon shall at all times be represented by one or more Notes in such form payable to the order of the payee named therein. 

2.05 Interest Rates: Rates, Payments, and Calculations. 

(a) Interest Rates. Except as provided in Section 2.05(c), all Revolving Loans and other Obligations shall
bear interest at a per annum rate equal to the LIBOR Rate plus 5.50%; provided, that, notwithstanding anything to the contrary in this Agreement, to the extent that the aggregate Revolver Usage was less than $9,750,000 for any month, then, on
the interest payment date in respect of such month, additional Revolving Loans shall be deemed outstanding in order to increase Aggregate Revolving Usage for such month to $9,750,000 for purposes of this Section 2.05(a).

 (b) [Reserved]. 
 (c)
Default Rate. Upon the occurrence and during the continuation of (i) an Event of Default described in Section 8.04, automatically, and (ii) any other Event of Default, at the election of Agent or the
Required Lenders in its (or their) sole discretion, all Obligations that have been charged to the Loan Account pursuant to the terms hereof shall bear interest at a per annum rate equal to two (2) percentage points above the per annum
rate otherwise applicable hereunder or thereunder. 

  
 56 

 (d) Payment. Except to the extent provided to the contrary in
Section 2.09, (i) all interest and all other fees payable hereunder or under any of the other Loan Documents shall be due and payable in cash, in arrears for the preceding calendar month, on the first Business Day of each
month and (ii) all costs and expenses payable hereunder or under any of the other Loan Documents, and all Lender Group Expenses shall be due and payable on the earlier of (A) the first day of the month following the date on which the
applicable costs, expenses, or Lender Group Expenses were first incurred or (B) the date on which demand therefor is made by Agent (including, during any Third Party Agent Retention Period, the Third Party Agent) or any Lender (it being
acknowledged and agreed that (1) any charging of such costs, expenses or Lender Group Expenses to the Loan Account pursuant to the provisions of the following sentence shall be deemed to constitute a demand for payment thereof for the purposes
of this subclause (B) and (2) Agent (and, during any Third Party Agent Retention Period, the Third Party Agent) and each Lender is authorized and directed to deduct and retain sufficient amounts from any deposits paid
by Borrowers to Agent (including, during any Third Party Agent Retention Period, the Third Party Agent) or any Lender on or prior to the Closing Date or pursuant to the terms hereof or of any other Loan Document, as applicable). Borrowers agree that
(x) its obligations contained in the first sentence of this Section 2.05(d) shall survive payment or satisfaction in full of all other Obligations and a termination of all of the Commitments and (y) all payments
of the Lender Group Expenses shall be non-refundable under all circumstances. Borrowers hereby authorize Agent (including, during any Third Party Agent Retention Period, the Third Party Agent), from time to
time without prior notice to Borrowers, to charge to the Loan Account (I) on the first day of each month, all interest accrued during the prior month on the Loans hereunder, (II) [reserved], (III) as and when incurred or accrued, all fees
and costs provided for in Section 2.09(a), (IV) on the first day of each month, the Unused Line Fee accrued during the prior month pursuant to Section 2.05(b), (V) as and when due and payable, all
other fees payable hereunder or under any of the other Loan Documents, (VI) [reserved], (VII) as and when incurred or accrued, all other Lender Group Expenses, and (VIII) as and when due and payable, all other payment obligations payable
under any Loan Document. All amounts (including interest, fees, costs, expenses, Lender Group Expenses, or other amounts payable hereunder or under any other Loan Document) charged to the Loan Account shall thereupon constitute Revolving Loans
hereunder, shall constitute Obligations hereunder, and shall initially accrue interest at the rate then applicable to Revolving Loans. 
 (e)
Computation. All interest and fees chargeable under the Loan Documents shall be computed on the basis of a 360 day year, in each case, for the actual number of days elapsed in the period during which the interest or fees accrue. 

(f) Intent to Limit Charges to Maximum Lawful Rate. In no event shall the interest rate or rates payable under this Agreement, plus any
other amounts paid in connection herewith, exceed the highest rate permissible under any law that a court of competent jurisdiction shall, in a final determination, deem applicable. Borrowers and the Lender Group, in executing and delivering this
Agreement, intend legally to agree upon the rate or rates of interest and manner of payment stated within it; provided, that, anything contained herein to the contrary notwithstanding, if such rate or rates of interest or manner of payment
exceeds the maximum allowable under applicable law, then, ipso facto, as of the date of this Agreement, Borrowers are and shall be liable only for the payment of such maximum amount as is allowed by law, and payment received from Borrowers in excess
of such legal maximum, whenever received, shall be applied to reduce the principal balance of the Obligations to the extent of such excess. 

(g) Inability to Determine Interest Rate. If, at any applicable time, the basis for determining the LIBOR Rate ceases to be reported on
the applicable page of the Bloomberg screen and if Agent shall have reasonably determined (which determination shall be conclusive and binding upon the Lenders) that, by reason of circumstances affecting the relevant market, other adequate and
reasonable means do not 

  
 57 

 
exist for ascertaining the interest rate applicable to the offering of Dollar deposits to major banks in the London interbank eurodollar market for the applicable period, then Agent shall
forthwith give notice thereof to the Borrower Representative. If such notice is given, (i) the interest rate applicable to the Revolving Loans and other Obligations shall be the Prime Rate plus 4.50% determined and effective immediately,
(ii) each reference herein to the “LIBOR Rate” shall be deemed thereafter to be a reference to the Prime Rate, and (iii) subject to Section 2.05(i), such substituted rate shall thereafter be determined
by Agent in accordance with the terms hereof. Until notice contemplated by Section 2.05(i) is furnished by Agent, the LIBOR Rate shall not apply to any Loan or any other Obligations. 

(h) LIBOR Rate Unlawful or Impractical. In the event that any change in market conditions or any Change in Law shall at any time after
the date hereof, in the reasonable opinion of any Lender, make it unlawful or impractical for such Lender to fund or maintain Loans bearing interest at the LIBOR Rate or to continue such funding or maintaining, or to determine or charge interest
rates at the LIBOR Rate, such Lender shall give notice of such changed circumstances to Agent, the other Lenders and the Borrower Representative and (i) in the case of any outstanding Loans of such Lender bearing interest at the LIBOR Rate, the
date specified in such Lender’s notice shall be deemed to be the last day such Loans shall bear interest at the LIBOR Rate, and interest upon the Loans of such Lender thereafter shall accrue interest at the Prime Rate, and (y) such Prime
Rate shall continue to be applicable to the Obligations until such Lender determines that it would no longer be unlawful or impractical to fund or maintain Loans bearing interest at the LIBOR Rate. 

(i) Reinstatement of LIBOR Rate. If there has been at any time an interest rate substituted for the LIBOR Rate in accordance with this
Section 2.05 and if in the reasonable opinion of Agent, the circumstances causing such substitution have ceased, then Agent shall promptly notify Borrower Representative in writing of such cessation, and thereafter the
LIBOR Rate shall be determined as originally defined hereby. Nevertheless, thereafter the provisions of Sections 2.05(a), (g) and (h) shall continue to be effective. 

(j) Special Provisions Applicable to LIBOR Rate. The LIBOR Rate may be adjusted by Agent with respect to any Lender on a prospective
basis to take into account any additional or increased costs to such Lender of maintaining or obtaining any eurodollar deposits or increased costs (other than Taxes which shall be governed by Article XVI), in each case, due to changes in
applicable law, including any Changes in Law and changes in the reserve requirements imposed by the Board of Governors, which additional or increased costs would increase the cost of funding or maintaining loans bearing interest at the LIBOR Rate.
In any such event, the affected Lender shall give the Borrower Representative, Agent and the other Lenders notice of such a determination and adjustment and, upon its receipt of the notice from the affected Lender, Borrowers may, by notice to such
affected Lender (i) require such Lender to furnish to the Borrower Representative a statement setting forth in reasonable detail the basis for adjusting such LIBOR Rate and the method for determining the amount of such adjustment, or
(ii) repay the Loans of such Lender with respect to which such adjustment is made. 
 2.06 [Reserved]. 

2.07 Designated Account. Agent (including, during any Third Party Agent Retention Period, the Third Party Agent) and the Lenders
are authorized to make the Loans under this Agreement based upon written or other instructions received from anyone purporting to be an Authorized Person or, without instructions, if pursuant to Section 2.05(d). Borrower
Representative agrees to establish and maintain the Designated Account with the Designated Account Bank for the purpose of receiving the proceeds of the Loans requested by Borrowers and made by Agent (including, during any Third Party Agent
Retention Period, the Third Party Agent) or the Lenders hereunder. Unless otherwise agreed by 

  
 58 

 
Agent and Borrowers, any Loan requested by Borrowers and made by Agent (including, during any Third Party Agent Retention Period, the Third Party Agent) or the Lenders hereunder shall be made to
the Designated Account. 
 2.08 Maintenance of Loan Account; Statements of Obligations. During any Third Party Agent Retention
Period, the Third Party Agent, as a non-fiduciary agent for Borrowers, shall maintain an account on its books in the name of Borrower Representative (the “Loan Account”) on which Borrowers
will be charged with the Loans (including Extraordinary Advances) made by Agent (including by such Third Party Agent, as applicable) or the Lenders to Borrowers or for Borrowers’ account, and with all other payment Obligations hereunder or
under the other Loan Documents, including, accrued interest, fees and expenses, and Lender Group Expenses. During any Non-Third Party Agent Retention Period, the Borrower Representative shall maintain such
Loan Account and shall make such Loan Account available to Agent and the Lenders upon request therefrom. Upon the request of any Third Party Agent upon the commencement of any Third Party Agent Retention Period, the Borrower Representative shall
share such Loan Account and any of its applicable books and records with the Third Party Agent, and with respect to any discrepancies between the books, records or Loan Account of the Borrower Representative, on the one hand, and the books, records
or Loan Account of any Lender, the Agent or the Third Party Agent, on the other hand, the books, records and Loan Account of such Lender, Agent or Third Party Agent shall govern and control in the absence of manifest error. In accordance with
Section 2.12, the Loan Account will be credited with all payments received by Agent or any Lender from Borrowers or for Borrowers’ account (and, during any Third Party Agent Retention Period, that the Third Party Agent
is aware of or has been notified of). During any Third Party Agent Retention Period, the Third Party Agent shall make available to Borrower Representative monthly statements regarding the Loan Account, including the principal amount of the Loans,
interest accrued hereunder, fees accrued or charged hereunder or under the other Loan Documents, and a summary itemization of all charges and expenses constituting Lender Group Expenses accrued hereunder or under the other Loan Documents, and each
such statement, absent manifest error, shall be conclusively presumed to be correct and accurate and constitute an account stated between Borrowers and the Lender Group unless, within 30 days after Agent first makes such a statement available to
Borrower Representative, Borrower Representative shall deliver to Agent written objection thereto describing the error or errors contained in such statement. 

2.09 Fees, Changes, Damages and Revolver Exit Payment. 

(a) Agent and Third Party Agent Fees. Borrowers shall pay in cash to Agent, for the account of Agent (or the Lenders set forth in such
agreement), as and when due and payable under the terms of any agreement between the Borrowers and Agent (or such Lenders), the fees set forth in such agreement. At any time there is a Third Party Agent, Borrowers shall timely pay in cash (or timely
reimburse in cash the paying Person for) such fees, costs and expenses of the Third Party Agent that are charged to (or incurred on behalf of) the Agent, any Lender, any other member of the Lender Group or any Loan Party (or any Agent-Related
Persons or Lender-Related Persons). 
 (b) Unused Line Fee. Borrowers shall pay in cash to the Lenders, based on their Pro Rata Share
of the Revolver Commitments, an unused line fee (the “Unused Line Fee”) in an amount equal to 0.50% times the result of (i) the aggregate amount of the Revolver Commitments, less (ii) the greater of
(A) $9,750,000 and (B) the Average Revolver Usage during the immediately preceding month (or portion thereof), which Unused Line Fee shall be due and payable on the first Business Day of each month from and after the Closing Date up to the
first day of the month prior to the date on which all of the Obligations are paid in full in cash and all of the Revolver Commitments are terminated and on the date on which all of the Obligations are paid in full in cash and all of the Revolver
Commitments are terminated. 

  
 59 

 (c) Field Examination and Other Fees. Borrowers shall pay in cash to Agent
(including, during any Third Party Agent Retention Period, the Third Party Agent) and the Lenders, field examination, appraisal, and valuation fees and charges as and when incurred or chargeable; provided, that for so long as no Default or
Event of Default shall have occurred and be continuing, Borrowers shall not be obligated to reimburse Agent for more than (A) two field examinations in any twelve month period, (B) two Inventory appraisals, and (C) two Equipment
appraisals; provided that any additional field examinations or appraisals required by Agent in any given twelve month period shall be performed at the expense of Agent; and, provided, further, that if a Default or Event of
Default shall have occurred and be continuing, Agent may conduct additional field examinations and appraisals at Borrowers’ sole expense. For the avoidance of doubt, the reimbursement limitations set forth in this
Section 2.09(c) shall not apply to field examinations and appraisals conducted in connection with a Permitted Acquisition. 

(d) Liquidated Damages. 

(i) Borrowers shall pay in cash liquidated damages in connection with any termination or reduction of the Revolver Commitments prior to the
third anniversary of the Closing Date or any acceleration (including in connection with an Insolvency Proceeding) of the Obligations, in each case in accordance with this Section 2.09(d) (“Liquidated
Damages”). 
 (ii) If, prior to the third anniversary of the Closing Date, (A) the Commitments are terminated and the
Obligations prepaid in full or (B) pursuant to the terms of this Agreement or any other Loan Document, either (1) Agent or the Required Lenders demand prepayment of the outstanding Obligations in whole or in part during the continuation of
an Event of Default, or (2) repayment of the outstanding Obligations is otherwise accelerated in whole or in part (including in connection with an Insolvency Proceeding) under Section 9.01, then, at the time of
such termination (in accordance with clause (A)) or the time of such demand or acceleration (in accordance with clause (B)), and in addition to the principal balance of the Loans, all accrued and unpaid interest thereon, all fees, costs, expenses,
and other amounts payable to Agent and Lenders in connection with the Revolving Facility and all other Obligations paid to Agent and Lenders under this Agreement and the other Loan Documents, Borrowers shall pay in cash Liquidated Damages to the
Lenders (or, during any Third Party Agent Retention Period, the Third Party Agent for the benefit of the Lenders), based on their Pro Rata Share, in an amount equal to the (y) Maximum Revolver Amount multiplied by (z)(I) 2.50% if
such prepayment, demand or acceleration occurs prior to August 9, 2019 (the “First Period”), (II) 1.50% if such prepayment, demand or acceleration occurs on or after the First Period but prior to the August 9, 2020
(the “Second Period”), (III) 0.50% if such prepayment, demand or acceleration occurs at Second Period but prior to August 9, 2021 (the “Third Period”), and (IV) 0% if such prepayment, demand or
acceleration occurs on or after August 9, 2021. 
 (iii) If, prior to the third anniversary of the Closing Date, Borrower Representative
has sent a notice of partial reduction of the Revolving Facility pursuant to the provisions of Section 2.03(c), then on the date set forth as the date of reduction in such notice, Borrower shall pay to the Lenders (or,
during any Third Party Agent Retention Period, the Third Party Agent for the benefit of the Lenders), in cash, the applicable Revolver Reduction Premium determined as of such date. For purposes of this Section, “Applicable Revolver Reduction
Premium” means, as of any date of determination, an amount equal to (A) during the First Period, 2.50% times the amount of the reduction of the Revolving Commitments on such date, (B) during the Second Period, 1.50% times the
amount of the reduction of the Revolving Commitments on such date, (C) during the Third Period, 0.50% times the amount of the reduction of the Revolving Commitments on such date and (D) 0% times the amount of the reduction of the Revolving
Commitment on or after August 9, 2021. 

  
 60 

 (iv) Borrower acknowledges and agrees that it would be difficult or impractical to calculate
Lenders’ actual damages from early termination of the Revolving Facility and Lenders’ compensation from Loans hereunder following such early termination or reduction, the Liquidated Damages provided in this
Section 2.09(d) are intended to be fair and reasonable approximations of such damages, and that the Liquidated Damages are not intended to be penalties. 

(e) Commitment Fee. On the Closing Date, Borrowers shall pay in cash to the Lenders (or, during any Third Party Agent Retention Period,
the Third Party Agent for the benefit of the Lenders), based on their Pro Rata Share, an amount equal to $500,000 (the “Commitment Fee”), which shall be fully-earned on the Closing Date and payable on the following schedule:
(i) $200,000 shall be payable in cash on the Closing Date, (ii) $200,000 shall be payable on the one-year anniversary of the Closing Date, and (iii) $100,000 shall be payable on the two-year anniversary of the Closing Date. Notwithstanding the foregoing, if (A) the Revolver Commitments are terminated and the Loans repaid or (B) the Revolver Commitments are terminated or the
Obligations become due and payable, in each case of clause (A) and clause (B), on any date prior to the two-year anniversary of the Closing Date for any reason (such as an acceleration of the Loans
following the occurrence of an Event of Default, an exercise of Agent’s (including, any Third Party Agent’s) or any Lender’s rights or remedies available under the Loan Documents or an exercise of any rights or remedies by the Term
Agent, a Term Lender or any other party to the Term Debt Documents, upon the consummation of a Change in Control, by any optional prepayment or otherwise), then, on such date, any portion of the Commitment Fee that has not previously been paid shall
be automatically, due and payable. The Commitment Fee shall be non-refundable upon any payment thereof. The parties hereto acknowledge and agree that Agent and the Lenders would not have entered into this
Agreement and the Lenders would not provide the Revolver Commitments, the financial accommodations and other accommodations under this Agreement and the other Loan Documents without the Loan Parties agreeing to pay the Commitment Fee in the
aforementioned instances. The parties hereto also acknowledge and agree that the Commitment Fee set forth in this Section 2.09(e) is not intended to act as a penalty or to punish any Borrower or any other Loan Party for any
such payment, repayment, redemption or prepayment. 
 (f) Collateral Monitoring Fee. Borrowers shall pay in cash to the Lenders (or,
during any Third Party Agent Retention Period, the Third Party Agent for the benefit of the Lenders), based on their Pro Rata Share, an amount equal to $5,000 (the “Monthly Collateral Monitoring Fee”) monthly in advance on the first
Business Day of each month from and after the Closing Date, commencing with the first such date after the Closing Date, until all of the Revolver Commitments have been terminated, all of the Obligations have been repaid and this Agreement has
terminated. The Monthly Collateral Monitoring Fee shall be fully-earned on each such date such amount is due or payable under this Agreement and is non-refundable upon being paid. 

(g) Exit Payment. Notwithstanding anything to the contrary in the Loan Documents, on the date when the Revolver Commitments (in each
case, whether before, at the time of or after the Maturity Date or any acceleration, bankruptcy, insolvency or otherwise) are reduced or terminated in an amount that causes (or such lesser amount of Revolver Commitments that are so reduced or
terminated that the Lenders have agreed to cause) the remaining amount of outstanding Revolver Commitments to be less than $10,000,000, the Borrowers shall pay in cash at such time to the Lenders (based on their Pro Rata Share of such Revolver
Commitments) a non-refundable exit payment (the “Revolver Exit Payment”) in a total amount equal to $1,000,000. The parties to this Agreement acknowledge and agree that the Agent and the
Lenders would not have entered into this Agreement and the other Loan Documents without the Borrowers agreeing to pay the Revolver Exit Payment in the aforementioned instances. The parties to this Agreement further acknowledge and agree that the
Revolver Exit Payment set forth in this 

  
 61 

 
Section 2.09(g) is not intended to act as a penalty or to punish the Borrowers or any other Loan Parties for any such Revolver Commitment reduction or termination. 

2.10 [Reserved]. 

2.11 Capital Requirements. 

(a) If, after the date hereof, any Lender determines that (i) any Change in Law regarding capital or reserve requirements for banks or
bank holding companies, or (ii) compliance by such Lender, or their respective parent bank holding companies, with any guideline, request or directive of any Governmental Authority regarding capital adequacy (whether or not having the force of
law), has the effect of reducing the return on such Lender’s or such holding companies’ capital as a consequence of such Lender’s commitments, Loans, participations or other obligations hereunder to a level below that which such
Lender or such holding companies could have achieved but for such Change in Law or compliance (taking into consideration such Lender’s or such holding companies’ then existing policies with respect to capital adequacy and assuming the full
utilization of such entity’s capital) by any amount deemed by such Lender to be material, then such Lender may notify Borrower Representative and Agent thereof. Following receipt of such notice, Borrowers agree to pay such Lender on demand the
amount of such reduction of return of capital as and when such reduction is determined, payable within 30 days after presentation by such Lender of a statement in the amount and setting forth in reasonable detail such Lender’s calculation
thereof and the assumptions upon which such calculation was based (which statement shall be deemed true and correct absent manifest error). In determining such amount, such Lender may use any reasonable averaging and attribution methods. Failure or
delay on the part of any Lender to demand compensation pursuant to this Section shall not constitute a waiver of such Lender’s right to demand such compensation; provided that Borrowers shall not be required to compensate a Lender
pursuant to this Section for any reductions in return incurred more than 180 days prior to the date that such Lender notifies Borrower Representative or any other Borrower of such Change in Law giving rise to such reductions and of such
Lender’s intention to claim compensation therefor; provided further that if such claim arises by reason of the Change in Law that is retroactive, then the 180-day period referred to above
shall be extended to include the period of retroactive effect thereof. 
 (b) If any Lender requests additional or increased costs referred
to in Section 2.05(j) or amounts under Section 2.11(a) or sends a notice under Section 2.05(h) relative to changed circumstances (such Lender, an “Affected
Lender”), then such Affected Lender shall use reasonable efforts to promptly designate a different one of its lending offices or to assign its rights and obligations hereunder to another of its offices or branches, if (i) in the
reasonable judgment of such Affected Lender, such designation or assignment would eliminate or reduce amounts payable pursuant to Section 2.05(j) or Section 2.11(a), as applicable, or would
eliminate the illegality or impracticality of funding or maintaining Loans bearing interest at the LIBOR Rate and (ii) in the reasonable judgment of such Affected Lender, such designation or assignment would not subject it to any material
unreimbursed cost or expense and would not otherwise be materially disadvantageous to it. Borrowers agree to pay all reasonable out-of-pocket costs and expenses incurred
by such Affected Lender in connection with any such designation or assignment. 
 (c) Notwithstanding anything herein to the contrary, the
protection of Sections 2.05(h) and 2.05(j) and this Section 2.11 shall be available to each Lender (as applicable) regardless of any possible contention of the invalidity or inapplicability of the law, rule,
regulation, judicial ruling, judgment, guideline, treaty or other change or condition which shall have occurred or been imposed, so long as it shall be customary for lenders affected thereby to comply therewith. Notwithstanding any other provision
herein, no Lender shall demand compensation pursuant to this Section 2.11 if it shall not at the time be 

  
 62 

 
the general policy or practice of such Lender (as the case may be) to demand such compensation in similar circumstances under comparable provisions of other credit agreements, if any. 

2.12 Collections; Crediting Payments. 

(a) The Loan Parties shall establish and maintain cash management services of a type, number, with a financial institution (the
“Depositary Bank”) and on terms, in each case, reasonably satisfactory to Agent (including, during any Third Party Agent Retention Period, the Third Party Agent), and shall open a lockbox (the “Lockbox”) with the
Depositary Bank. Collected funds in the Lockbox shall be deposited into an account with the Depository Bank established by Agent (or, during any Third Party Agent Retention Period, the Third Party Agent) and subject to Agent’s (or, during any
Third Party Agent Retention Period, the Third Party Agent’s) sole dominion and control (including, but not limited to the sole power of withdrawal) (the “Blocked Account”). Each Loan Party shall take reasonable steps to
(i) ensure that all of its Account Debtors forward payment of the amounts owed by such Account Debtors directly to the Lockbox or to the Blocked Account, and (ii) deposit or cause to be deposited promptly, and in any event no later than
the first Business Day after the date of receipt thereof, all of the Loan Parties’ collections and proceeds of Collateral (including those sent directly by Account Debtors to any Loan Party) into the Blocked Account. Each Deposit Account
(excluding any Excluded Account) of a Loan Party and each Securities Account (excluding any Excluded Account) of a Loan Party shall be subject to a Control Agreement among such Loan Party, the applicable bank or securities intermediary, Agent and
Term Agent, and no Loan Party will permit any Investment consisting of cash, Cash Equivalents or amounts credited to a Deposit Account (excluding any Excluded Account) or a Securities Account (excluding any Excluded Account) to be maintained in a
Deposit Account or Securities Account unless such Deposit Account or Securities Account, as applicable, is subject to a Control Agreement among such Loan Party, the applicable bank or securities intermediary, and Agent. The agreement(s) relating to
the Blocked Account between Agent, such financial institution and Borrowers shall be in form and content satisfactory to Agent. 
 (b) The
Loan Parties shall cause Persons processing or collecting any credit card payments or proceeds of receivables on behalf of the Loan Parties to deliver such payments or proceeds to the Blocked Account promptly, but not less frequently than once every
week. 
 (c) On each Business Day, Agent (or, during any Third Party Agent Retention Period, the Third Party Agent) shall withdraw available
funds from the Blocked Account, deposit such funds in the Agent’s Account, and credit available funds received in the Agent’s Account to the payment of the Obligations. Agent shall credit to the payment of the Obligations any other form of
funds received by Agent (or Third Party Agent, as applicable) in the Agent’s Account for which Agent (or Third Party Agent, as applicable) has received notice that such funds are collected and available to Agent (or Third Party Agent, as
applicable) (i) on the same day of Agent’s (or Third Party Agent, as applicable) receipt of such notice if such notice is received by Agent (or Third Party Agent, as applicable) on or before 2 p.m. Eastern Time on a Business Day, and
(ii) on the Business Day immediately following Agent’s (or Third Party Agent’s, as applicable) receipt of such notice if such notice is received by Agent (or Third Party Agent, as applicable) after 2 p.m. Eastern Time on a Business
Day, or if such notice is received by Agent (or the Third Party Agent, as applicable) on a day that is not a Business Day. It is understood and agreed that transfer of funds from the Blocked Account to the Agent’s Account may take up to
two (2) Business Days. Aggregate principal and interest payments shall be apportioned ratably among the Lenders (according to the unpaid principal balance of the Obligations to which such payments relate held by each Lender) and payments of
fees and expenses (other than fees or expenses that are for Agent’s (or Third Party Agent’s, as applicable) separate account) shall be apportioned ratably among the Lenders having a Pro Rata Share of the type of Obligation or Commitment to
which a particular fee relates. All payments 

  
 63 

 
and proceeds of Collateral received by Agent (or the Third Party Agent, as applicable) shall be applied in accordance with Section 2.03(b). 

(d) All funds credited to the payment of the Obligations in accordance with Section 2.12(a) above are conditional
upon final payment to Agent (or the Third Party Agent, as applicable) in cash or solvent credits of the items giving rise to such funds. If any item credited to the payment of the Obligations is not paid to Agent (or the Third Party Agent, as
applicable) (or payment thereof is rescinded or required to be returned by the Agent (or the Third Party Agent, as applicable)), the amount of any credit given for such item shall be charged to the balance of the Obligations whether or not the item
is returned. 
 (e) For purposes of computing interest on the Obligations, Borrowers acknowledge that interest shall continue to accrue on
the amount of any funds credited to the payment of the Obligations in accordance with this Section 2.12 for three Business Days after the date so credited. The parties acknowledge and agree that the economic benefit of the
foregoing provisions of this Section 2.12(e) shall be for the exclusive benefit of Agent (and the Third Party Agent, as applicable) and the Lenders. 

2.13 Appointment of Borrower Representative. 

(a) Each Borrower hereby irrevocably appoints and constitutes Borrower Representative as its agent and attorney-in-fact to request and receive Loans and other Obligations in the name or on behalf of such Borrower and any other Borrowers, deliver requests for Borrowings Notices of Borrowing, and Borrowing Base
Certificates, give instructions with respect to the disbursement of the proceeds of the Loans, giving and receiving all other notices and consents hereunder or under any of the other Loan Documents and taking all other actions (including in respect
of compliance with covenants) in the name or on behalf of any Borrower or Borrowers pursuant to this Agreement and the other Loan Documents. Agent (including any Third Party Agent, as applicable) and Lenders may disburse the Loans to such bank
account or Deposit Account of Borrower Representative or a Borrower or otherwise make such Loans to a Borrower, in each case as Borrower Representative may designate or direct, without notice to any other Borrower. Notwithstanding anything to the
contrary contained herein, Agent (or, during any Third Party Agent Retention Period, the Third Party Agent) may at any time and from time to time require that Loans to or for the account of any Borrower be disbursed directly to an operating account
of such Borrower. 
 (b) Borrower Representative hereby accepts the appointment by Borrowers to act as the agent and attorney-in-fact of Borrowers pursuant to this Section 2.13. Borrower Representative shall ensure that the disbursement of any Loans that are at any
time requested by or to be remitted to or for the account of a Borrower, shall be remitted or issued to or for the account of such Borrower. 

(c) Each Borrower hereby irrevocably appoints and constitutes Borrower Representative as its agent to receive statements on account and all
other notices from Agent and/or Lenders with respect to the Obligations or otherwise under or in connection with this Agreement and the other Loan Documents. 

(d) Any notice, election, representation, warranty, agreement or undertaking made or delivered by or on behalf of any Borrower by Borrower
Representative shall be deemed for all purposes to have been made or delivered by such Borrower, as the case may be, and shall be binding upon and enforceable against such Borrower to the same extent as if made or delivered directly by such
Borrower. 
 (e) No resignation by or termination of the appointment of Borrower Representative as agent and
attorney-in-fact as aforesaid shall be effective, except after ten (10) Business Days’ prior written notice to Agent (and, during any Third Party Agent
Retention Period, also to the Third Party Agent) and 

  
 64 

 
the Lenders. If the Borrower Representative resigns under this Agreement, Borrowers shall be entitled to appoint a successor Borrower Representative (which shall be a Borrower and shall be
reasonably acceptable to Agent as such successor). Upon the acceptance of its appointment as successor Borrower Representative hereunder, such successor Borrower Representative shall succeed to all the rights, powers and duties of the retiring
Borrower Representative and the term “Borrower Representative” shall mean such successor Borrower Representative for all purposes of this Agreement and the other Loan Documents, and the retiring or terminated Borrower Representative’s
appointment, powers and duties as Borrower Representative shall be thereupon terminated. 
 2.14 Joint and Several Liability of
Borrowers. 
 (a) Each Borrower is accepting joint and several liability hereunder and under the other Loan Documents in consideration of
the financial accommodations to be provided by the Lender Group under this Agreement, for the mutual benefit, directly and indirectly, of each Borrower and in consideration of the undertakings of the other Borrowers to accept joint and several
liability for the Obligations. 
 (b) Each Borrower, jointly and severally, hereby irrevocably and unconditionally accepts, not merely as a
surety but also as a co-debtor, joint and several liability with the other Borrowers, with respect to the payment and performance of all of the Obligations (including any Obligations arising under this
Section 2.14), it being the intention of the parties hereto that all the Obligations shall be the joint and several obligations of each Borrower without preferences or distinction among them. 

(c) If and to the extent that any Borrower shall fail to make any payment with respect to any of the Obligations as and when due or to perform
any of the Obligations in accordance with the terms thereof, then in each such event the other Borrowers will make such payment with respect to, or perform, such Obligation. 

(d) The Obligations of each Borrower under the provisions of this Section 2.14 constitute the absolute and
unconditional, full recourse Obligations of each Borrower enforceable against each Borrower to the full extent of its properties and assets, irrespective of the validity, regularity or enforceability of this Agreement or any other circumstances
whatsoever. 
 (e) Except as otherwise expressly provided in this Agreement, each Borrower hereby waives notice of acceptance of its joint
and several liability, notice of any Advances issued under or pursuant to this Agreement, notice of the occurrence of any Default, Event of Default, or of any demand for any payment under this Agreement or any other Loan Document, notice of any
action at any time taken or omitted by Agent (including any Third Party Agent), the Lenders or any other member of the Lender Group under or in respect of any of the Obligations, any requirement of diligence or to mitigate damages and, generally, to
the extent permitted by applicable law, all demands, notices and other formalities of every kind in connection with this Agreement (except as otherwise provided in this Agreement) and the other Loan Documents. Each Borrower hereby assents to, and
waives notice of, any extension or postponement of the time for the payment of any of the Obligations, the acceptance of any payment of any of the Obligations, the acceptance of any partial payment thereon, any waiver, consent or other action or
acquiescence by Agent (including any Third Party Agent), the Lenders or any other member of the Lender Group at any time or times in respect of any default by any Borrower in the performance or satisfaction of any term, covenant, condition or
provision of this Agreement, any and all other indulgences whatsoever by Agent (including any Third Party Agent), the Lenders or any other member of the Lender Group in respect of any of the Obligations, and the taking, addition, substitution or
release, in whole or in part, at any time or times, of any security for any of the Obligations or the addition, substitution or release, in whole or in part, of any Borrower. Without limiting the generality of the

  
 65 

 
foregoing, each Borrower assents to any other action or delay in acting or failure to act on the part of Agent (including any Third Party Agent), any Lender or any other member of the Lender
Group with respect to the failure by any Borrower to comply with any of its respective Obligations, including, without limitation, any failure strictly or diligently to assert any right or to pursue any remedy or to comply fully with applicable laws
or regulations thereunder, which might, but for the provisions of this Section 2.14 afford grounds for terminating, discharging or relieving any Borrower, in whole or in part, from any of its Obligations under this
Section 2.14, it being the intention of each Borrower that, so long as any of the Obligations hereunder and under the other Loan Documents remain unsatisfied and unpaid in full in cash and the Revolver Commitments have not
been terminated, the Obligations of each Borrower under this Section 2.14 shall not be discharged except by performance and then only to the extent of such performance. The Obligations of each Borrower under this
Section 2.14 shall not be diminished or rendered unenforceable by any winding up, reorganization, arrangement, liquidation, reconstruction, division, split, merger, consolidation or similar proceeding with respect to any
Borrower or any other Loan Party or Agent (including any Third Party Agent), any Lender or any other member of the Lender Group. 
 (f) Each
Borrower represents and warrants to Agent (including any Third Party Agent), the Lenders and the other members of the Lender Group that such Borrower is currently informed of the financial condition of the other Borrowers and of all other
circumstances which a diligent inquiry would reveal and which bear upon the risk of nonpayment of the Obligations. Each Borrower further represents and warrants to Agent (including any Third Party Agent), the Lenders and the other members of the
Lender Group that such Borrower has read and understands the terms and conditions of the Loan Documents. Each Borrower hereby covenants that such Borrower will continue to keep informed of the other Borrowers’ financial condition, the financial
condition of other Guarantors and Loan Parties, if any, and of all other circumstances which bear upon the risk of nonpayment or nonperformance of the Obligations. 

(g) Each Borrower waives all rights and defenses arising out of an election of remedies by Agent (including any Third Party Agent), any Lender
or any other member of the Lender Group, even though that election of remedies, such as a nonjudicial foreclosure with respect to security for a guaranteed obligation, has destroyed Agent’s (including any Third Party Agent’s), such
Lender’s or such other member of the Lender Group’s rights of subrogation and reimbursement against any Borrower by the operation of Section 580(d) of the California Code of Civil Procedure, any comparable statute, or otherwise. 

(h) Each Borrower waives all rights and defenses that such Borrower may have because the Obligations are or become secured by Real Property.
This means, among other things: 
 (i) Agent (including any Third Party Agent), the Lenders and the other members of the Lender Group may
collect from such Borrower without first foreclosing on any Real Property Collateral or personal property Collateral pledged by Borrowers. 

(ii) If Agent (including any Third Party Agent), any Lender or any other member of the Lender Group forecloses on any Real Property Collateral
pledged by any Borrower or any Guarantor: 
 (A) the amount of the Obligations may be reduced only by the price for which
such Collateral is sold at the foreclosure sale, even if such Collateral is worth more than the sale price; and 

  
 66 

 (B) Agent (including any Third Party Agent), the Lenders and the other
members of the Lender Group may collect from such Borrower even if Agent or Lenders, by foreclosing on the Real Property Collateral, has destroyed any right such Borrower may have to collect from the other Borrowers. 

This is an unconditional and irrevocable waiver of any rights and defenses such Borrower may have because the Obligations are secured by Real Property. These
rights and defenses include, but are not limited to, any rights or defenses based upon Section 580a, 580b, 580d or 726 of the California Code of Civil Procedure or any comparable statutes or Applicable Laws. 

(i) The provisions of this Section 2.14 are made for the benefit of Agent (including any Third Party Agent), Lenders,
the other members of the Lender Group and their respective successors and assigns, and may be enforced by it or them from time to time against any or all Borrowers as often as occasion therefor may arise and without requirement on the part of Agent
(including any Third Party Agent), any Lender, any other member of the Lender Group, any of their respective successors or assigns first to marshal any of its or their claims or to exercise any of its or their rights against any Borrower or to
exhaust any remedies available to it or them against any Borrower or to resort to any other source or means of obtaining payment of any of the Obligations hereunder or to elect any other remedy. The provisions of this
Section 2.14 shall remain in effect until all of the Obligations shall have been paid in full in cash, and all of the Commitments have been terminated, in accordance with the terms of this Agreement. If at any time, any
payment, or any part thereof, made in respect of any of the Obligations, is rescinded or must otherwise be restored or returned by Agent (including any Third Party Agent), any Lender or any other member of the Lender Group upon the insolvency,
bankruptcy or reorganization of any Borrower, or otherwise, the provisions of this Section 2.14 will forthwith be reinstated in effect, as though such payment had not been made. 

(j) Until the Obligations have been paid in full in cash and all of the Commitments have been terminated, each Borrower hereby agrees that it
will not enforce any of its rights of contribution or subrogation against any other Borrower with respect to any liability incurred by it hereunder or under any of the other Loan Documents, any payments made by it to Agent (including any Third Party
Agent), any Lender or any other member of the Lender Group with respect to any of the Obligations or any collateral security therefor. Any claim which any Borrower may have against any other Borrower with respect to any payments to Agent (including
any Third Party Agent), any Lender or any other member of the Lender Group hereunder or under any other Loan Documents are hereby expressly made subordinate and junior in right of payment, without limitation as to any increases in the Obligations
arising hereunder or thereunder, to the prior payment in full in cash of the Obligations and a termination of all of the Commitments, and, in the event of any Insolvency Proceeding or any insolvency, bankruptcy, receivership, liquidation,
reorganization or other similar proceeding under the laws of any jurisdiction relating to any Borrower, its debts or its assets, whether voluntary or involuntary, all such Obligations shall be paid in full in cash and all Commitments shall be
terminated before any payment or distribution of any character, whether in cash, securities or other property, shall be made to any other Borrower therefor. 

(k) Each Borrower hereby agrees that, after the occurrence and during the continuance of any Default or Event of Default, the payment of any
amounts due with respect to the indebtedness owing by any Borrower to any other Borrower is hereby subordinated to the prior payment in full in cash of the Obligations and a termination of all of the Commitments. Each Borrower hereby agrees that
after the occurrence and during the continuance of any Event of Default and direction from Agent or the Required Lenders, such Borrower will not demand, sue for or otherwise attempt to collect any indebtedness of any other Borrower owing to such
Borrower until all of the Obligations shall have been paid in full in cash 

  
 67 

 
and all of the Commitments have been terminated. If, notwithstanding the foregoing sentence, such Borrower shall collect, enforce or receive any amounts in respect of such indebtedness, such
amounts shall be collected, enforced and received by such Borrower as trustee for Agent (or, during any Third Party Agent Retention Period, the Third Party Agent), and such Borrower shall deliver any such amounts to Agent (or, during any Third Party
Agent Retention Period, the Third Party Agent) for application to the Obligations in accordance with Section 2.03(b). 

ARTICLE III. 

CONDITIONS; TERM OF AGREEMENT. 

3.01 Conditions Precedent to the Initial Extension of Credit. The effectiveness of this Agreement is subject to the fulfillment,
to the satisfaction of Agent (including any Third Party Agent) and each Lender, of each of the following conditions precedent: 
 (a) a Third
Party Agent Retention Period shall exist with Cortland as the Third Party Agent; 
 (b) Agent shall have received appropriate financing
statements on Form UCC-1 duly filed (or to be filed) in such office or offices as may be necessary or, in the opinion of Agent, desirable to perfect Agent’s Liens in and to the Collateral; 

(c) Agent (including any Third Party Agent) and the Lenders shall have received each of the following documents, in form and substance
satisfactory to Agent (including any Third Party Agent) and the Lenders, duly executed and delivered, and each such document shall be in full force and effect: 

(i) this Agreement; 
 (ii) a
completed Borrowing Base Certificate (Third Party Agent) dated as of July 31, 2018; 
 (iii) the Control Agreements required by
Agent or the Lenders to be delivered on the Closing Date; 
 (iv) the Notes; 

(v) the Guaranty and Security Agreement; 

(vi) the Intercompany Subordination Agreement; 

(vii) a Perfection Certificate; 

(viii) the Copyright Security Agreement; 

(ix) the Patent Security Agreement; 

(x) the Intercreditor Agreement; and 

(xi) the Trademark Security Agreement; 

(d) Agent shall have received a certificate from an Authorized Officer of each Loan Party: 

  
 68 

 (i) attesting to the resolutions of such Loan Party’s board of directors authorizing
its execution, delivery, and performance of the Loan Documents to which it is a party, 
 (ii) authorizing specific officers of such Loan
Party to execute the same, attesting to the incumbency and signatures of such specific officers of such Loan Party, 
 (iii) attesting to
copies of each Loan Party’s Organizational Documents, as amended, modified, or supplemented to the Closing Date, which Organizational Documents shall be (A) certified by an Authorized Officer of such Loan Party, and (B) with respect
to Organizational Documents that are charter documents, certified as of a recent date (not more than thirty (30) days prior to the Closing Date) by the appropriate governmental official, 

(iv) attesting to certificates of status with respect to each Loan Party, dated within ten (10) days of the Closing Date, such
certificates to be issued by the appropriate officer of the jurisdiction of organization of such Loan Party, which certificates shall indicate that such Loan Party is in good standing in such jurisdiction, and 

(v) attesting to certificates of status with respect to each Loan Party, each dated within thirty (30) days of the Closing Date, such
certificates to be issued by the appropriate officer of the jurisdictions (other than the jurisdiction of organization of such Loan Party) in which such Loan Party’s failure to be duly qualified or licensed would constitute a Material Adverse
Effect, which certificates shall indicate that such Loan Party is in good standing in such jurisdictions; 
 (e) after giving effect to any
Loans funded on the Closing Date, the payment of all fees, costs and expenses required to be paid by Borrowers, Excess Availability plus Qualified Cash shall be greater than or equal to $22,500,000; 

(f) since December 31, 2017, there shall not have occurred a Material Adverse Effect; 

(g) [reserved]; 
 (h) Agent and
the Lenders shall have received all requested Collateral Access Agreements in favor of Agent, from all mortgagees, landlords and operators of warehouses in which a Loan Party operates or maintains any Collateral; provided that any locations
not subject to such Collateral Access Agreements shall be subject to a Landlord Reserve at Agent’s (including, during any Third Party Agent Retention Period, the Third Party Agent’s) Permitted Discretion; 

(i) Agent and the Lenders shall have received a certificate of insurance, together with the endorsements thereto, as are required by
Section 5.03, the form and substance of which shall be satisfactory to Agent and the Lenders; 
 (j) Agent and the
Lenders shall have received an opinion of the Loan Parties’ counsel in form and substance reasonably satisfactory to Agent and the Lenders; 

(k) Agent (including any Third Party Agent) and the Lenders shall have completed its business, legal, and collateral due diligence, including
(i) a collateral audit and review of Borrowers’ and their Subsidiaries books and records and verification of Borrowers’ representations and warranties to Agent (including any Third Party Agent) and the Lenders, the results of which
shall be satisfactory to Agent (including any Third Party Agent) and the Lenders, (ii) an inspection of each of the locations where the Loan Parties’ and their Subsidiaries’ Inventory and Equipment is located, the results of which
shall be 

  
 69 

 
satisfactory to Agent (including any Third Party Agent) and the Lenders, (iii) satisfactory review by Agent (including any Third Party Agent) and the Lenders of all contracts with Federal,
state, municipal and governmental agencies, and (iv) a review of the Loan Parties’ and their Subsidiaries’ insurance, which shall in each case be satisfactory to Agent and the Lenders; 

(l) Agent (including any Third Party Agent) and the Lenders shall have received completed reference and background checks with respect to
Borrowers’ senior management, the results of which are satisfactory to Agent (including any Third Party Agent) and the Lenders in Agent’s (including any Third Party Agent’s) and each Lender’s sole discretion; 

(m) Agent (including any Third Party Agent) and the Lenders shall have received an audit of Eligible Accounts, and an appraisal of the Eligible
Inventory (and, if requested by Agent (or any Third Party Agent), Eligible Equipment), in each case the results of which shall be satisfactory to Agent (including any Third Party Agent) and the Lenders; 

(n) Borrowers shall have paid in cash all Lender Group Expenses incurred in connection with the transactions evidenced by this Agreement or any
other Loan Documents and paid all fees in cash required to be paid in accordance with the terms of this Agreement and the other Loan Documents; 

(o) Borrowers and each of their Subsidiaries shall have received all licenses, approvals or evidence of other actions required by any
Governmental Authority in connection with the execution and delivery by Borrowers or their Subsidiaries of the Loan Documents or with the consummation of the transactions contemplated thereby; 

(p) Agent and the Lenders shall have received the Term Debt Documents, in form and substance reasonably satisfactory to Agent and the Lenders;

 (q) the final corporate and capital structure of Borrowers and their Subsidiaries shall be reasonably satisfactory to Agent (including any
Third Party Agent) and the Lenders; 
 (r) all other documents and legal matters in connection with the transactions contemplated by this
Agreement or any other Loan Document shall have been delivered, executed, or recorded and shall be in form and substance satisfactory to Agent and the Lenders. 

3.02 Conditions Precedent to all Extensions of Credit. The obligation of the Lender Group (or any member thereof) to make any
Loans hereunder (or to extend any other credit hereunder) at any time shall be subject to the following conditions precedent: 
 (a) the
representations and warranties of Borrowers or their Subsidiaries contained in this Agreement or in the other Loan Documents shall be true and correct in all material respects (except that such materiality qualifier shall not be applicable to any
representations and warranties that already are qualified or modified by materiality in the text thereof) on and as of the date of such extension of credit, as though made on and as of such date (except to the extent that such representations and
warranties relate solely to an earlier date, in which case such representations and warranties shall be true and correct in all material respects (except that such materiality qualifier shall not be applicable to any representations and warranties
that already are qualified or modified by materiality in the text thereof) as of such earlier date); 
 (b) no Default or Event of Default
shall have occurred and be continuing on the date of such extension of credit, nor shall either result from the making thereof; 

  
 70 

 (c) the receipt by Agent (and/or the Third Party Agent, as applicable) from Borrower
Representative of (A) a request for Borrowing pursuant to the requirements of Section 2.02(a), and (B) in the case of clause (i) (solely with respect to Revolving Loans or Revolver Commitments), (x) during a Non-Third Party Agent Retention Period, if requested by Agent within one Business Day of receipt of such request for Borrowing, an updated Borrowing Base Certificate (Agent), and (y) during a Third Party Agent
Retention Period, an updated Borrowing Base Certificate (Third Party Agent) no later than 12:00 p.m. on the date of such request; 
 (d)
after giving effect to the making of any such Loan, (i) the Revolver Usage on such date (after giving effect to any such proposed Loan or credit extension) does not exceed (ii) either (A) the Borrowing Base reflected in the Borrowing
Base Certificate referred to in Section 3.02(c) above (as adjusted by Agent (or the Third Party Agent, as applicable) for Reserves established by Agent (or the Third Party Agent, as applicable) from time to time) or
(B) the Maximum Revolver Amount; and 
 (e) after giving effect to the making of any such Loan, a Maximum Decreased Market
Capitalization Overadvance Event shall not have occurred. 
 3.03 Effect of Maturity. On the Maturity Date, all commitments
(including the Commitments) of the Lender Group to provide additional credit hereunder shall automatically be terminated and all of the Obligations immediately shall become due and payable without notice or demand and Borrowers shall be required to
repay all of the Obligations in full in cash. No termination of the obligations of the Lender Group in accordance with this Agreement (other than payment in full in cash of all of the Obligations and termination of all of the Commitments) shall
relieve or discharge any Loan Party of its duties, obligations, or covenants hereunder or under any other Loan Document and Agent’s Liens in the Collateral shall continue to secure the Obligations and shall remain in effect until all
Obligations have been paid in full in cash and the Commitments have been terminated. When all of the Obligations have been paid in full in cash and the Lender Group’s obligations to provide additional credit under the Loan Documents (and all of
the Commitments) have been terminated irrevocably, Agent will, at Borrowers’ sole expense, execute and deliver any termination statements, lien releases, discharges of security interests, and other similar discharge or release documents (and,
if applicable, in recordable form) as are reasonably necessary to release, as of record, Agent’s Liens and all notices of security interests and liens previously filed by Agent. 

3.04 Conditions Subsequent. The obligation of the Lender Group (or any member thereof) to continue to make Revolving Loans (or
otherwise extend credit hereunder) is subject to the fulfillment, on or before the date applicable thereto, of the conditions subsequent set forth on Schedule 3.04 (the failure by Borrowers to so perform or cause to be performed such
conditions subsequent as and when required by the terms thereof (unless such date is extended, in writing, by Agent in its sole discretion, which Agent may do without obtaining the consent of the other members of the Lender Group), shall constitute
an immediate Event of Default). 
 ARTICLE IV. 

REPRESENTATIONS AND WARRANTIES. 

In order to induce the Agent and the Lenders to enter into this Agreement, each of the Borrowers make the following representations and
warranties to the Lender Group which shall be true, correct, and complete, in all material respects (except that such materiality qualifier shall not be applicable to any representations and warranties that already are qualified or modified by
materiality in the text thereof), as of the Closing Date, and shall be true, correct, and complete, in all material respects (except that such materiality qualifier shall not be applicable to any representations and warranties that already are
qualified 

  
 71 

 
or modified by materiality in the text thereof), as of the date of the making of each Loan (or other extension of credit) made thereafter, as though made on and as of the date of such Loan (or
other extension of credit) (except to the extent that such representations and warranties relate solely to an earlier date, in which case such representations and warranties shall be true and correct in all material respects (except that such
materiality qualifier shall not be applicable to any representations and warranties that already are qualified or modified by materiality in the text thereof) as of such earlier date) and such representations and warranties shall survive the
execution and delivery of this Agreement: 
 4.01 Due Organization and Qualification; No Event of Default; Solvency. 

(a) Each Loan Party is (i) conducting its business in compliance with its Organizational Documents and (ii) not in violation of its
Organizational Documents. Each Loan Party’s Organizational Documents are in full force and effect. 
 (b) No Default or Event of Default
has occurred or will result from the transactions contemplated by the Loan Documents. 
 (c) Each Loan Party (i) is Solvent and
(ii) has not taken action, and no such action has been taken by a third party, for its winding up, dissolution or liquidation or similar executory or judicial proceeding or for the appointment of a liquidator, custodian, receiver, trustee,
administrator or other similar officer for any Loan Party or any or all of its assets or revenues; provided, however, that, for the avoidance of doubt, no such representation in this Section 4.01(c) is made in respect of
any Immaterial Subsidiary. 
 (d) No Lien exists on any Loan Party’s assets, except for Permitted Liens. 

(e) The obligation of the Loan Parties to make any payment under this Agreement or the other Loan Documents (together with all charges in
connection therewith) is absolute and unconditional. 
 (f) No Indebtedness of any Loan Party exists other than Permitted Indebtedness. 

4.02 Existence; Power and Authority. Each Loan Party is validly existing as a corporation, limited liability company or
limited partnership, as applicable, and is in good standing under the laws of the jurisdiction of its incorporation, organization or formation, as applicable. Each Loan Party (i) has full power and authority (and all governmental licenses,
authorizations, Permits, consents and approvals) to (A) own its properties and conduct its business (solely with respect to governmental licenses, authorizations, Permits, consents and approvals, except where the failure to have such
governmental licenses, authorizations, Permits, consents and approvals could not reasonably be expected, individually or in the aggregate, to result in a Material Adverse Effect) and (B) to enter into, and perform its obligations under, the
Loan Documents and consummate the transactions contemplated under the Loan Documents, and (ii) is duly qualified as a foreign corporation, limited liability company or limited partnership, as applicable, and licensed and in good standing, under
the laws of each jurisdiction where its ownership, lease or operation of property or the conduct of its business requires such qualification or license, in each case of this clause (ii), where the failure to be so qualified, licensed or in good
standing could reasonably be expected, individually or in the aggregate, to result in a Material Adverse Effect. 
 4.03
Litigation. 
 (a) Other than as set forth on Schedule 4.03, there is no pending or, to the knowledge of the Loan Parrties,
threatened, any action, suit or other proceeding before any Governmental Authority (i) to 

  
 72 

 
which any Loan Party is a party, (ii) which purports to affect or pertain to the Loan Documents, the Transactions or any other transaction contemplated hereby or thereby or (iii) which
has as the subject thereof any assets owned by any Loan Party or any of its Subsidiaries, in each case which could reasonably be expected to result in monetary judgments or relief, individually or in the aggregate, in excess of $2,000,000. 

(b) Other than as set forth on Schedule 4.03, there are no current or, to the knowledge of any of the Loan Parties, pending, legal
actions, suits or other proceedings, in each case which could reasonably be expected to result in monetary judgments or relief, individually or in the aggregate, in excess of $2,000,000, to which any Loan Party or any of its Subsidiaries or any of
their respective assets is subject. With respect to each action suit, proceeding, claim, event or disclosure listed on Schedule 4.03, none of them could reasonably be expected, individually or in the aggregate, to result in a Material Adverse
Effect. 
 (c) No injunction, writ, temporary restraining order or any order of any nature has been issued by any court or other Governmental
Authority purporting to enjoin or restrain the execution, delivery or performance of this Agreement or any other Loan Document or directing that the transactions provided for herein or therein not be consummated as herein or therein provided. 

(d) Other than as set forth on Schedule 4.03, none of the current directors (or equivalent persons) or current officers of any of the
Borrowers and their respective Subsidiaries have been involved as a defendant in securities-related litigation or other securities-related legal proceedings during the past five years. 

(e) No Loan Party is subject to any proceeding, suit or, to any Loan Party’s knowledge, investigation by any federal, state or local
government or quasi-governmental body, agency, board or authority or any other administrative or investigative body (including the Office of the Inspector General of the United States Department of Health and Human Services) which would reasonably
be expected, individually or in the aggregate, to have a Material Adverse Effect on any Loan Party. 
 4.04 Due Authorization; No
Conflict. 
 (a) As to each Loan Party, the execution, delivery, and performance by such Loan Party of the Loan Documents to which it is
a party have been duly authorized by all necessary action on the part of such Loan Party and no further consent or authorization is required by the Loan Party, the Loan Party’s board of directors (or other equivalent governing body) or the
holders of the Loan Party’s Stock. Each of this Agreement and the other Loan Documents has been duly executed and delivered by each of the Loan Parties and constitutes a valid, legal and binding obligation of each Loan Party, enforceable in
accordance with its respective terms, except as such enforceability may be limited by applicable insolvency, bankruptcy, reorganization, moratorium or other similar laws affecting creditors’ rights generally. 

(b) The execution, delivery and performance of this Agreement and the other Loan Documents by each Loan Party party thereto and the
consummation of the transactions contemplated herein and therein will not (i) conflict with or result in a breach or violation of any of the terms or provisions of, or constitute a default under, or result in the creation or imposition of any
Lien (other than pursuant to the Loan Documents) upon any assets of any such Loan Party pursuant to, any agreement, document or instrument to which such Loan Party is a party or by which any Loan Party is bound or to which any of the assets or
property of any Loan Party is subject, except, with respect to this clause (i), as could not reasonably be expected, individually or in the aggregate, to have a Material Adverse Effect, (ii) result in any violation of or conflict with the
provisions of the Organizational Documents, (iii) result in 

  
 73 

 
the violation of any Applicable Law, (iv) result in the violation of any judgment, order, rule, regulation or decree of any Governmental Authority, or (v) violate, conflict with or
cause a breach or a default under any agreement or instrument binding upon it, except, with respect to clauses (iii) and (v) only, as could not reasonably be expected, individually or in the aggregate, to have a Material Adverse Effect. No
consent, approval, Authorization or order of, or registration or filing with any Governmental Authority is required for (x) the execution, delivery and performance of this Agreement or any of the other Loan Documents, and the issuance of the
Securities hereunder and thereunder, and (y) the consummation by any Loan Party of the Transactions or the other transactions contemplated hereby or thereby, except for (A) the filings necessary to perfect the Liens created by the
applicable Loan Documents and (B) any necessary filings with the SEC. 
 (c) Other than has been obtained, no Authorization is required
for (i) the execution and delivery of this Agreement or the other Loan Documents, or (ii) the consummation of the Transactions and the other transactions contemplated hereby and thereby. 

(d) Each Loan Party and its Subsidiaries are in compliance with Applicable Law except as could not reasonably be expected, individually or in
the aggregate, to have a Material Adverse Effect. 
 4.05 Permits and Authorizations. Except as could not reasonably be
expected, individually or in the aggregate, to have a Material Adverse Effect, (a) (i) each Loan Party holds, and is operating in compliance in all material respects with, all franchises, grants, Authorizations, licenses, permits, easements,
consents, certificates and orders of any Governmental Authority (collectively, “Necessary Documents”) required for the conduct of its business and (ii) all Necessary Documents are valid and in full force and effect and
(b) no Loan Party has (i) received written notice of any revocation, non-renewal, amendment, expiration, suspension, limitation, withdrawal, cancellation or other modification of any of the Necessary
Documents and (ii) reason to believe that any of the Necessary Documents will not be renewed in the ordinary course of business. 

4.06 Title to Assets; No Encumbrances. As of the Closing Date, the Real Property listed in Schedule 4.06 constitutes all
of the Real Property of each Loan Party and each of its Subsidiaries. Each Loan Party has good and marketable title to all of its assets and property free and clear of all Liens, except Permitted Liens. Except as could not reasonably be expected,
individually or in the aggregate, to have a Material Adverse Effect, the property held under lease by each Loan Party is held under valid, subsisting and enforceable leases with only such exceptions with respect to any particular lease as do not
interfere in any material respect with the conduct of the business of such Loan Party. 
 4.07 Intellectual Property. Each Loan
Party owns, or, to the knowledge of the Loan Parties and their Subsidiaries, has the right to use pursuant to a valid and enforceable written license, all IP, in each case (and without any knowledge qualifier applicable thereto) free and clear of
any Liens other than Permitted Licenses and Permitted Liens. All IP that is registered with or issued by a Governmental Authority that is currently in the name of a Loan Party is, to the knowledge of the Loan Parties and their Subsidiaries, valid
and enforceable. Each patent constituting a Material Intangible Asset is, to the knowledge of the Loan Parties and their Subsidiaries, valid and enforceable and no part of the Material Intangible Assets has been judged invalid or unenforceable, in
whole or in part. Except as set forth on Schedule 4.07, as of the Closing Date, there is no pending or, to the knowledge of the Loan Parties, threatened action, suit, other proceeding or claim by any Person challenging or contesting the
validity, ownership, or enforceability of any Material Intangible Asset, the use thereof by any Loan Party, or other rights of any Loan Party in or to any Material Intangible Asset, and no Loan Party has received any written notice regarding any
such action, suit, other proceeding or claim. At all times after the Closing Date when this representation is made or deemed made, there is no pending or, to the knowledge of the 

  
 74 

 
Borrowers, threatened action, suit, other proceeding or claim by any Person challenging or contesting the validity, ownership, or enforceability of any Material Intangible Asset, the use thereof
by any Loan Party, or other rights of any Loan Party in or to any Material Intangible Asset, and no Borrower has received any written notice regarding any such action, suit, other proceeding or claim, except that could not reasonably be expected,
individually or in the aggregate, to have a Material Adverse Effect. With respect to each action, suit, proceeding, claim, challenge, contest, event and disclosure listed on Schedule 4.07, none of them could reasonably be expected,
individually or in the aggregate, to result in a Material Adverse Effect. Neither the conduct of the business of any Loan Party, nor any Loan Party, has infringed, misappropriated or otherwise violated, or is infringing, misappropriating or
otherwise violating, any Intellectual Property of any Person, except as could not reasonably be expected, individually or in the aggregate, to result in a Material Adverse Effect. Other than as set forth on Schedule 4.03, on the Agreement
Date, there is no pending or, to the knowledge of the Loan Parties, threatened action, suit, other proceeding or claim by any Person alleging that any Loan Party is infringing, misappropriating or violating, or otherwise using without authorization,
any Intellectual Property of any Person, and no Loan Party has received any written notice regarding, any such action, suit, other proceeding or claim. With respect to each action, suit, proceeding, claim, event or disclosure listed on
Schedule 4.03, none of them could reasonably be expected, individually or in the aggregate, to result in a Material Adverse Effect. Other than as set forth in Section 3.b. of the Perfection Certificate dated as of (and
delivered by the Loan Parties on) the Closing Date, no Loan Party is a party to, or bound by, any options, licenses, franchise or other agreements, written or oral, relating to trademarks, patents, copyrights, other
know-how or IP (or granting any right, title or interest in or to any IP) that require annual payments in excess of $25,000 individually. 

4.08 No Default. No Loan Party is, except as could not reasonably be expected, individually or in the aggregate, to have a
Material Adverse Effect, in breach of or otherwise in default under, and no event has occurred which, with notice or lapse of time or both, would constitute such breach or other default in the performance of any agreement or condition contained in
any agreement under which it may be bound, or to which any of its assets is subject 
 4.09 Taxes. All U.S. federal, state and
local income and franchise and other material Tax returns, reports and statements (collectively, the “Tax Returns”) required to be filed by any Tax Affiliates have been filed with the appropriate Governmental Authorities, all such
Tax Returns are true and correct in all material respects, and all Taxes, assessments and other governmental charges and impositions reflected therein or otherwise due and payable have been paid prior to the date on which any material Liability may
be added thereto for non-payment thereof except for those contested in good faith by appropriate proceedings diligently conducted and for which adequate reserves are maintained on the books of the appropriate
Tax Affiliate in accordance with GAAP. As of the Closing Date, no material Tax Return is under audit or examination by any Governmental Authority, and no Tax Affiliate has received written notice from any Governmental Authority of any audit or
examination or any assertion of any claim for material Taxes. To the extent material, proper and accurate amounts have been withheld by each Tax Affiliate from their respective employees for all periods in full and complete compliance with the Tax,
social security and unemployment withholding provisions of Applicable Law and such withholdings have been timely paid to the respective Governmental Authorities. No Tax Affiliate has participated in a “listed transaction” within the
meaning of Treasury Regulation Section 1.6011-4(b)(2) or has been a member of an affiliated, combined or unitary group other than the group of which a Tax Affiliate is the common parent. 

4.10 Compliance with Laws. Except as could not reasonably be expected, individually or in the aggregate, to have a
Material Adverse Effect after the Closing Date, each Loan Party: (a) at all times has complied with all Applicable Laws; (b) has not received any warning letter or other correspondence 

  
 75 

 
or notice from the any Governmental Authority alleging or asserting noncompliance with any Applicable Laws or any Authorizations; (c) possesses and complies with the Authorizations, which
are valid and in full force and effect; (d) has not received written notice that any Governmental Authority has taken, is taking or intends to take action to limit, suspend, cancel, withdraw, modify or revoke any Authorization and has no
knowledge that any Governmental Authority is considering such action; (e) has filed, obtained, maintained or submitted all reports, documents, forms, notices, applications, records, claims, submissions, renewals and supplements or amendments as
required by any Applicable Laws or Authorizations and (f) has not received any notice, and are not aware, of any violation of applicable antitrust laws, employment or landlord-tenant laws of any federal, state or local government or
quasi-governmental body, agency, board or other authority with respect to the Loan Parties. 
 4.11 SEC Filings. Endologix has
filed all of the SEC Documents, within the time frames prescribed by the SEC for the filing of such SEC Documents such that each filing was timely filed with the SEC. Endologix has filed and made publicly available on the SEC’s Electronic Data
Gathering, Analysis, and Retrieval system (including any successor thereto, “EDGAR”) on or prior to the date this representation is made, true, correct and complete copies of the SEC Documents. As of their respective dates, each of
the SEC Documents complied in all material respects with the requirements of the Securities Act and/or the Exchange Act (as applicable) applicable to the SEC Documents. None of the SEC Documents, at the time they were filed with the SEC, contained
any untrue statement of a material fact or omitted to state a material fact required to be stated therein or necessary in order to make the statements therein, in the light of the circumstances under which they were made, not misleading. Since the
filing of the SEC Documents, no event has occurred that would require an amendment or supplement to any of the SEC Documents and as to which such an amendment or a supplement has not been filed and made publicly available on EDGAR (and true, correct
and complete copies of such amendment or supplement, if any, have been delivered to the Secured Parties or their respective representatives) on or prior to the date this representation is made. Endologix has not received any written comments from
the SEC staff that have not been resolved, to the knowledge of Endologix, to the satisfaction of the SEC staff. 
 4.12 Financial
Statements. As of their respective dates, the consolidated financial statements of Endologix and its Subsidiaries included in the SEC Documents complied as to form in all material respects with applicable accounting requirements and the
published rules and regulations of the SEC with respect thereto. Such financial statements have been prepared in accordance with GAAP, consistently applied (subject, in the case of unaudited quarterly financial statements, to normal year-end adjustments and lack of footnote disclosures), and fairly present in all material respects the consolidated financial position of Endologix and its Subsidiaries as of the dates thereof and the consolidated
results of their operations, cash flows and changes in stockholders equity for the periods then ended (subject, in the case of unaudited quarterly financial statements, to normal year-end audit adjustments and
lack of footnote disclosures). The accounting firm that expressed its opinion with respect to the consolidated financial statements included in Endologix’s most recently filed annual report on 10-K, and
reviewed the consolidated financial statements included in the Endologix’s most recently filed quarterly report on 10-Q, was independent of Endologix pursuant to the standards set forth in Rule 2-01 of Regulation S-X promulgated by the SEC and as required by the applicable rules and guidance from the Public Company Accounting Oversight Board (United States), and such
firm was otherwise qualified to render such opinion under Applicable Law and the rules and regulations of the SEC. There is no transaction, arrangement or other relationship between Endologix (or any of its Subsidiaries) and an unconsolidated or
other off-balance-sheet Person that is required to be disclosed by Endologix in the SEC Documents that has not been so disclosed in the SEC Documents. Neither Endologix nor any of its Subsidiaries is required
to file or will be required to file any agreement, note, lease, mortgage, deed or other instrument entered into prior to the date this representation is made and to which the Borrower or any of its Subsidiaries is a party or by which Endologix or
any of its Subsidiaries is bound that has not been 

  
 76 

 
previously filed as an exhibit (including by way of incorporation by reference) to the Borrower’s reports filed or made with the SEC under the Exchange Act. Other than (i) the
liabilities assumed or created pursuant to this Agreement and the other Loan Documents and any fees and expenses in connection therewith, (ii) liabilities accrued for in the latest balance sheet included in Endologix’s most recent periodic
report (on 10-Q or 10-K) filed prior to the date this representation is made (the date of such balance sheet, the “Latest Balance Sheet Date”), (iii)
liabilities incurred in the ordinary course of business consistent with past practice since the later of the (A) Closing Date and (B) the Latest Balance Sheet Date and (iv) liabilities set forth on the Schedules to this Agreement,
Endologix and its Subsidiaries do not have any other material liabilities (whether fixed or unfixed, known or unknown, absolute or contingent, asserted or unasserted, choate or inchoate, liquidated or unliquidated, or secured or unsecured, and
regardless of when any action, claim, suit or proceeding with respect thereto is instituted). Since December 31, 2016, there has been no Material Adverse Effect or any event or circumstance which could reasonably be expected, individually or in
the aggregate, to result in a Material Adverse Effect. All financial performance projections delivered to any Secured Party, including the financial performance projections delivered on or prior to the Closing Date, if any, represent
Endologix’s and its Subsidiaries’ good faith estimate of future financial performance and are based on assumptions believed by Endologix and its Subsidiaries to be fair and reasonable in light of current market conditions, it being
acknowledged and agreed by Agent and the Lenders that projections as to future events are not to be viewed as facts and that the actual results during the period or periods covered by such projections may differ from the projected results and such
differences may be material. 
 4.13 Internal Controls. 

(a) Each Borrower and its respective Subsidiaries maintain a system of internal accounting controls sufficient to provide reasonable assurance
that (i) transactions are executed in accordance with management’s general or specific authorizations, (ii) transactions are recorded as necessary to permit preparation of financial statements in conformity with GAAP and to maintain
asset and liability accountability, (iii) access to assets or incurrence of liability is permitted only in accordance with management’s general or specific authorization and (iv) the recorded accountability for assets and liabilities
is compared with the existing assets and liabilities at reasonable intervals and appropriate action is taken with respect to any differences (such internal accounting controls (including clauses (i) – (iv) above), collectively,
“Internal Controls”). 
 (b) Endologix and its Subsidiaries has timely filed and made publicly available on EDGAR all
certifications, statements and documents required by Rule 13a-14 or Rule 15d-14 under the Exchange Act. Endologix and its Subsidiaries maintain disclosure controls and
procedures required by Rule 13a-15 or Rule 15d-15 under the Exchange Act; such controls and procedures are effective to ensure that the information required to be
disclosed by Endologix and its Subsidiaries in the reports that they file with or submit to the SEC (i) is recorded, processed, summarized and reported accurately within the time periods specified in the SEC’s rules and forms and
(ii) is accumulated and communicated to Endologix’s (and, to the extent applicable, its Subsidiaries’) management, including its or their principal executive officer and principal financial officer, as appropriate to allow timely
decisions regarding required disclosure. Endologix and its Subsidiaries maintain internal control (including Internal Controls) over financial reporting required by Rule 13a-15 or Rule 15d-15 under the Exchange Act; such internal control (including Internal Controls) over financial reporting is effective and does not contain any material weaknesses. 

4.14 ERISA. (i) No Loan Party has engaged, and to the knowledge of the Loan Parties, no other Person has engaged in any
“prohibited transaction” as defined under Section 406 of ERISA or Section 4975 of the IRC that is not exempt under ERISA Section 408 or Section 4975 of the IRC, under 

  
 77 

 
any applicable regulations and published interpretations thereunder or under any applicable prohibited transaction, individual or class exemption issued by the Department of Labor, with respect
to any Employee Benefit Plan, except as for such transaction that could not be expected, individually or in the aggregate, to have a Material Adverse Effect, (ii) (A) at no time within the last seven years has the Borrower or any ERISA
Affiliate maintained, sponsored, participated in, contributed to or had any Liability with respect to, and (B) no Loan Party or any ERISA Affiliate has any Liability or obligation in respect of, any Title IV Plan, Multiemployer Plan or any
multiple employer plan for which the Borrower or any ERISA Affiliate has incurred or could incur Liability under Section 4063 or 4064 of ERISA, (iii) each Employee Benefit Plan is and has been operated in compliance with its terms and all
Applicable Laws, including ERISA and the IRC, except for such failures to comply that could not reasonably be expected, individually or in the aggregate, to have a Material Adverse Effect, (iv) (A) no ERISA Event has occurred and (B) no
event or condition exists or existed that could reasonably be expected to subject the Borrower or any ERISA Affiliate to any tax, fine, lien, penalty or Liability imposed by ERISA, the IRC or other Applicable Law, except for any such ERISA Event or
tax, fine, lien, penalty or liability that could not be expected, individually or in the aggregate, to have a Material Adverse Effect, and (v) no Loan Party maintains or has any obligation or Liability with respect to any Foreign Benefit Plan
that, individually or in the aggregate, could be expected to have a Material Adverse Effect. 
 4.15 Subsidiaries. As of the
Closing Date, the Borrower’s Subsidiaries are set forth in Schedule 4.15 and the information set forth in Schedule 4.15 is true, correct and complete. 

4.16 No Dividends. Subsequent to December 31, 2015, the Borrower has not declared or paid any dividends or made any
distribution of any kind with respect to its Stock, except as permitted hereunder. 
 4.17 Stock. 

(a) All of the issued and outstanding shares of Stock of Endologix are duly authorized and validly issued, fully paid and nonassessable, have
been issued in compliance with all applicable federal and state and foreign securities laws, were not issued in violation of or subject to any preemptive rights or other rights to subscribe for or purchase securities that have not been waived in
writing. 
 (b) As of the Closing Date, all of Endologix’s authorized, issued and outstanding shares of Stock of Endologix and each of
its Subsidiaries are set forth in Schedule 4.17, and, except as set forth in Schedule 4.17, there are no (i) Stock options or other Stock incentive plans, employee Stock purchase plans or other plans, programs or arrangements of
Endologix or any of its Subsidiaries under which Stock options, Stock or other Stock-based or Stock-linked awards are issued or issuable to officers, directors, employees, consultants or other Persons, (ii) outstanding options, warrants, scrip,
rights to subscribe to, calls or commitments of any character whatsoever relating to, or securities or rights convertible into or exchangeable or exercisable for, any Stock of Endologix or any of its Subsidiaries, or contracts, commitments,
understandings or arrangements by which Endologix or any of its Subsidiaries is or may become bound to issue additional Stock of Endologix or any of its Subsidiaries, or options, warrants or scrip for rights to subscribe to, calls or commitments of
any character whatsoever relating to, or securities or rights convertible into or exercisable or exchangeable for, any shares of Stock of Endologix or any of its Subsidiaries, (iii) agreements or arrangements under which Endologix or any of its
Subsidiaries is obligated to register the sale of any of their securities or Stock under the Securities Act (except the Registration Rights Agreement), (iv) outstanding Stock, securities or instruments of Endologix or any of its Subsidiaries that
contain any redemption or similar provisions, or contracts, commitments, understandings or arrangements by which Endologix or any of its Subsidiaries is or may become bound to redeem a security of Endologix other than under the Convertible Note
Documents, (v) Stock or other 

  
 78 

 
securities or instruments containing anti-dilution or similar provisions that may be triggered by the issuance of securities of Endologix or any of its Subsidiaries other than under the
Convertible Note Documents or (vii) stock appreciation rights or “phantom stock” plans or agreements or any similar plans or agreements to which Endologix or any of its Subsidiaries is a party or by which Endologix or any of its
Subsidiaries is otherwise subject or bound. There are no (X) stockholders’ agreements, voting agreements or similar agreements to which Endologix or any of its Subsidiaries is a party or by which Endologix or any of its Subsidiaries is
otherwise subject or bound, other than in connection with clauses (i), (k) and (n) of the definition of “Permitted Investments”, (Y) preemptive rights or any other similar rights to which any Stock of the Endologix or any of its
Subsidiaries is subject or (Z) any restrictions upon the voting or transfer of any Stock of Endologix or any of its Subsidiaries (other than restrictions on transfer imposed by U.S. federal and state securities laws and other than as set forth
in the Loan Documents, the Term Debt Documents and, if such instrument is permitted hereunder to be secured, the documents governing the Permitted 3.25% Convertible Note Refinancing). 

(c) Endologix has furnished to Agent and each Lender true, correct and complete copies of each Loan Party’s Organizational Documents and
any amendments, restatements, supplements or modifications thereto, and all documents, agreements and instruments containing the terms of all securities and Stock convertible into, or exercisable or exchangeable for, Common Stock or other Stock of
any Loan Party or its Subsidiaries, and the material rights of the holders thereof in respect thereto. 
 4.18 Material
Contracts. 
 (a) Except for the Operative Documents, the Convertible Note Documents and the agreements set forth on Schedule
4.18, as of the Closing Date there are no Material Contracts. The consummation of the transactions contemplated by the Loan Documents will not give rise to a right to termination in favor of any party to any Material Contract (other than any
Loan Party), except for such Material Contracts the noncompliance with which would not reasonably be expected, individually or in the aggregate, to have a Material Adverse Effect. 

(b) None of the Borrowers nor any of their respective Subsidiaries are in breach or default under any Material Contract, and, to the knowledge
of the Borrowers, no other party to a Material Contract is in default or breach thereunder, except where any breach or default would not reasonably be expected, individually or in the aggregate, to have a Material Adverse Effect. 

4.19 Use of Proceeds. The proceeds of the Loans are intended to be and shall be used (a) on the Closing Date, to pay the
fees, costs, and expenses incurred in connection with this Agreement, the other Loan Documents, and the transactions contemplated hereby and thereby, and (b) thereafter, consistent with the terms and conditions hereof, for general working
capital and other corporate purposes (including that no part of the proceeds of the loans made to Borrowers will be used to purchase or carry any such Margin Stock or to extend credit to others for the purpose of purchasing or carrying any such
Margin Stock or for any purpose that violates the provisions of Regulation T, U or X of the Board of Governors). 
 4.20
Environmental Condition. Except as set forth in Schedule 4.20 and except where any failures to comply could not reasonably be expected, either individually or in the aggregate, to result in a Material Adverse Effect, each Loan Party
and each Subsidiary of each Loan Party: 
 (a) is and has been in compliance with all applicable Environmental Laws, including obtaining and
maintaining all permits, licenses, consents, Authorizations and registrations required by any applicable Environmental Law (“Environmental Permits”), 

  
 79 

 (b) is not party to, and no Real Property currently (or to the knowledge of any Loan Party
previously) owned, leased, subleased, operated or otherwise occupied by or for any such Person is subject to or the subject of, any contractual obligation or any pending or, to the knowledge of any Loan Party, threatened, order, action,
investigation, suit, proceeding, audit, Lien, claim, demand, dispute or notice of violation or of potential liability or similar notice relating in any manner to any Environmental Law, 

(c) has not caused or suffered to occur a Release of Hazardous Materials at, to or from any Real Property, 

(d) does not currently (or to the knowledge of any Loan Party, did not previously) own, lease, sublease operate or otherwise occupy any Real
Property that is contaminated by any Hazardous Materials and 
 (e) is not, and has not been, engaged in, and has not permitted any current
or former tenant to engage in, operations in violation of any Environmental Law and knows of no facts, circumstances or conditions reasonably constituting notice of a violation of any Environmental Law, including receipt of any information request
or notice of potential responsibility under the Comprehensive Environmental Response, Compensation and Liability Act or similar Environmental Laws. 

4.21 Governmental Regulation. None of any Loan Party, any Person controlling any Loan Party or any Subsidiary of any Loan Party
is (a) a company registered or required to be registered as an “investment company,” or a company “controlled” by a “registered investment company” or a “principal underwriter” of an “investment
company” within the meaning of the Investment Company Act, or otherwise registered or required to be registered, or subject to the restrictions imposed, by the Investment Company Act, or (b) subject to regulation under the Federal Power
Act, the Interstate Commerce Act, any state public utilities code, or any other federal or state statute, rule or regulation limiting its ability to incur Indebtedness, pledge its assets, perform its obligations under the Loan Documents or which may
otherwise render all or any portion of the Obligations unenforceable. 
 4.22 Employee and Labor Matters. There are no strikes,
boycotts, grievances, work stoppages, slowdowns, lockouts or other job actions existing, pending (or, to the knowledge of any Loan Party, threatened) against or involving any Loan Party or any Subsidiary of any Loan Party, except for those that
could not reasonably be expected, individually or in the aggregate, to have a Material Adverse Effect. Except as set forth on Schedule 4.22, or except as could not reasonably be expected, individually or in the aggregate, to have a Material
Adverse Effect, as of the Closing Date, (a) there is no memorandum of understanding, collective bargaining or similar agreement, and there is no ongoing negotiation or duty to negotiate, with any union, labor organization, works council or
similar representative covering any Employee or otherwise binding any Loan Party or any Subsidiary of any Loan Party, (b) to the Loan Parties’ knowledge, no petition for certification or election of any such representative is existing or
pending with respect to any Employee, (c) to the Loan Parties’ knowledge, no such representative has sought certification or recognition with respect to any Employee, and (d) to the Loan Parties’ knowledge, no Employee or his or
her representative is engaged in any organizing efforts. Except as could not reasonably be expected, individually or in the aggregate, to have a Material Adverse Effect, all current and former Employees are and have been correctly classified as
exempt or non-exempt under, and are and have been paid in accordance with, all applicable federal, state, and local wage and hour laws. Further, all individuals who perform or have performed services for any
Loan Party or any Subsidiary of any Loan Party are or were correctly classified under each Employee Benefit Plan, ERISA, the Internal Revenue Code and other Applicable Law as common law employees, independent contractors or other non-employee basis, or leased employees, except as could not reasonably be expected, individually or in the aggregate, to have a Material Adverse Effect. Each Loan Party and Subsidiary of

  
 80 

 
any Loan Party are in material compliance with all Applicable Laws concerning employment, including without limitation hiring, background checks, compensation, benefits, wages (including payment
of overtime), wage deductions and withholdings, classification, immigration, work authorization, employment eligibility verification, reporting, taxation, occupational health and safety, equal rights, labor relations, accommodations, breaks,
notices, employment policies, paid or unpaid time off work, accessibility, privacy, and workers’ compensation, except for such noncompliance that could not reasonably be expected, individually or in the aggregate, to have a Material Adverse
Effect. 
 4.23 Name and Address; Properties. During five (5) years preceding the Closing Date, no Loan Party has been
known by and has used any other name, whether corporate, fictitious or otherwise, except as set forth on Schedule 4.23. Schedule 4.23 also lists (a) each Loan Party’s jurisdiction of organization and legal name and
(b) each Loan Party’s organizational identification number. Each Loan Party’s chief executive office or sole place of business, in each case as of the Closing Date, is at the chief executive office or sole place of business address
identified as such in Schedule 4.23 and no Loan Party maintains any other offices or facilities except as described therein. 

4.24 Sanctions. Each Loan Party and each Subsidiary of each Loan Party is in compliance in all material respects with all
Sanctions laws as administered by OFAC and the U.S. State Department. No Loan Party and no Subsidiary of a Loan Party (i) is a Person on the list of the Specially Designated Nationals and Blocked Persons (the “SDN List”), (ii)
is a Person who is otherwise the target of Sanctions laws such that a U.S. Person cannot deal or otherwise engage in business transactions with such Person, (iii) is a Sanctioned Entity, (iv) is owned or controlled by (including by virtue
of such Person being a director or owning voting shares or interests), or acts, directly or indirectly, for or on behalf of, any Person on the SDN List or a Sanctioned Entity such that the entry into, or performance under, this Agreement or any
other Loan Document would be prohibited by U.S. law, (v) has its assets located in Sanctioned Entities., (vi) derives revenues from investments in, or transactions with Sanctioned Persons or Sanctioned Entities. No proceeds of any Loan will be
used to fund any operations in, finance any investments or activities in, or make any payments to, a Sanctioned Person or a Sanctioned Entity. 

4.25 Anti-Money Laundering. Each Loan Party and each Subsidiary of each Loan Party is in compliance with all Anti-Money
Laundering Laws. No action, suit or proceeding by or before any court or Governmental Authority with respect to compliance with such Anti-Money Laundering Laws is pending or threatened to the knowledge of each Loan Party and each Subsidiary of each
Loan Party. 
 4.26 Anti-Corruption. Each Loan Party and each Subsidiary of each Loan Party is in compliance in all
material respects with all applicable Anti-Corruption Laws, including the FCPA. None of any Loan Party or any Subsidiary of a Loan Party, nor to the knowledge of any Loan Party or any Subsidiary thereof, any director, officer, agent, employee or
other Person acting on behalf of the Loan Party or any Subsidiary of a Loan Party, has taken any action, directly or indirectly, that would result in a violation of applicable Anti-Corruption Laws. No part of the proceeds of the Loans will be used
by any Loan Party or any of their Affiliates, directly or indirectly, for any payments to any governmental official or employee, political party, official of a political party, candidate for political office, or anyone else acting in an official
capacity, in order to obtain, retain or direct business or obtain any improper advantage, in violation of the FCPA. The Loan Partiesand each Subsidiary of a Loan Party maintains and implements policies and procedures designed to ensure compliance by
the Loan Parties, their Subsidiaries and their respective directors, officers, employees and agents with Sanctions, Anti-Money Laundering Laws and Anti-Corruption Laws. 

4.27 Anti-Terrorism. To the extent applicable, each Loan Party and each of its Affiliates is in compliance, in all material
respects, with all Anti-Terrorism Laws. 

  
 81 

 4.28 Sarbanes-Oxley. Each Borrower and its Subsidiaries are in all material
respects in compliance with applicable provisions of the Sarbanes-Oxley Act of 2002, as amended, and the rules and regulations thereunder (collectively, “Sarbanes-Oxley”). 

4.29 Accounting Practices. No Borrower, any their respective Subsidiaries nor, to the Borrowers’ or such Subsidiaries’
knowledge, any director, officer or employee, of any of the Borrowers or any of their respective Subsidiaries, has received or otherwise obtained any material complaint, allegation, assertion or claim, whether written or oral, regarding the
accounting or auditing practices, procedures, methodologies or methods of such Borrower or any of its Subsidiaries or its internal accounting controls, including any complaint, allegation, assertion or claim that such Borrower or any of its
Subsidiaries has engaged in questionable accounting or auditing practices. No attorney representing any Borrower or any of its Subsidiaries, whether or not employed by such Borrower or any of its Subsidiaries, has reported evidence of a material
violation of securities laws or breach of fiduciary duty or similar violation by such Borrower or any of its Subsidiaries or any of their respective officers, directors, employees or agents to the Borrower’s or any of its Subsidiaries’
board of directors (or equivalent governing body) or any committee thereof or to any director (or equivalent person) or officer of such Borrower or any of its Subsidiaries pursuant to Section 307 of Sarbanes-Oxley, and the SEC’s rules and
regulations promulgated thereunder. There have been no internal or SEC investigations regarding accounting or revenue recognition discussed with, reviewed by or initiated at the direction of the chief executive officer, the principal financial
officer or the principal accounting officer (in each case, or officer holding such equivalent position) of any Borrower or any of their respective Subsidiaries, any Borrower’s or any of their respective Subsidiaries’ board of directors (or
equivalent governing body) or any committee thereof. 
 4.30 Common Stock. The Common Stock is registered pursuant to
Section 12(b) of the Exchange Act, and neither Endologix nor any of its Subsidiaries has taken, or will take, any action designed to terminate, or which to the knowledge of Endologix and its Subsidiaries is likely to have the effect of
terminating, the registration of the Common Stock under the Exchange Act, nor has Endologix or any of its Subsidiaries received any notification that the SEC is contemplating terminating such registration. Neither Endologix nor any of its
Subsidiaries is in violation of any of the rules, regulations or requirements of the Principal Market, and, to the knowledge of Endologix and its Subsidiaries, there are no facts or circumstances that could reasonably lead to suspension or
termination of trading of the Common Stock on the Principal Market. For not less than the five (5) years preceding the Closing Date, (i) the Common Stock has been listed or designated for quotation, as applicable, on the Principal Market,
(ii) trading in the Common Stock has not been suspended or deregistered by the SEC or the Principal Market, and (iii) neither Endologix nor any of its Subsidiaries has received any communication, written or oral, from the SEC or the
Principal Market regarding the suspension or termination of trading of the Common Stock on the Principal Market. 
 4.31 DTC.
The Common Stock is eligible for clearing through The Depository Trust Company (“DTC”), through its Deposit/Withdrawal At Custodian (DWAC) system, and Endologix is eligible for and participating in the Direct Registration System
(DRS) of DTC with respect to the Common Stock. The transfer agent for the Common Stock is a participant in, and the Common Stock is eligible for transfer pursuant to, DTC’s Fast Automated Securities Transfer Program. The Common Stock is not,
and has not at any time been, subject to any DTC “chill,” “freeze” or similar restriction with respect to any DTC services, including the clearing of transactions in shares of Common Stock through DTC. 

4.32 Fees. The Borrowers and the other Loan Parties are solely and jointly and severally responsible for the payment of any fees,
costs, expenses and commissions of any placement agent, broker 

  
 82 

 
or financial adviser relating to or arising out of the transactions contemplated by the Loan Documents. The Borrowers and the other Loan Parties will pay, and hold each of the Secured Parties
harmless against, any liability, loss or expense (including attorneys’ fees, costs and expenses) arising in connection with any claim for any such payment, other than those arising from the gross negligence or willful misconduct of Agent or any
Lender as determined by a final, non-appealable judgment of a court of competent jurisdiction. 

4.33 Products; Regulatory Required Permits. 

(a) Except as could not reasonably be expected, individually or in the aggregate, to have a Material Adverse Effect, each Loan Party and its
Subsidiaries has made all notifications, submissions, and reports required by the FDA, any other Governmental Authority or any Healthcare Law, and all such notifications, submissions and reports were true, complete, and correct in all respects as of
the date of submission to FDA, any other Governmental Authority or to such other Person required by any Healthcare Law. There has not been any violation of any Healthcare Laws by any Loan Party or its Subsidiaries in its product development efforts,
submissions, record keeping and reports to the FDA or any other Governmental Authority that could reasonably be expected, individually or in the aggregate, to have a Material Adverse Effect. To the knowledge of each Loan Party and each of its
Subsidiaries, there are no civil or criminal proceedings relating to any Loan Party or any of its Subsidiaries or any officer, director or employee of any Loan Party or Subsidiary of any Loan Party that involve a matter within or related to the
FDA’s or any other Governmental Authority’s jurisdiction or any off-label promotion or allegations of non-compliance with Healthcare Laws. Other than as
expressly set forth on Section 4.33(a), as of the Agreement Date, no Loan Party nor any Affiliate thereof has received any material adverse notice (written or oral) from the FDA or any other Governmental Authority that has
not been finally and fully resolved in accordance and compliance with Applicable Law and all FDA and other Governmental Authority standards, regulations and requirements regarding any Product or regarding (i) any actions or inactions of any
Loan Party or any of its Subsidiaries or any officer, director or employee of any Loan Party or Subsidiaries of any Loan Party, including with respect to any off-label promotion or (ii) alleging non-compliance with Healthcare Laws. At all times after the Closing Date when this representation is made or deemed made, except as could not reasonably be expected, individually or in the aggregate, to have a
Material Adverse Effect, no Loan Party nor any Affiliate thereof has received (A) any notice (written or oral) from the FDA or any other Governmental Authority regarding (y) any Product or (z) any actions or inactions of any Loan
Party or any of its Subsidiaries or any officer, director or employee of any Loan Party or Subsidiaries of any Loan Party, and (B) any material adverse notice (written or oral) from the FDA or any Governmental Authority (i) any actions or
inactions of any Loan Party or any of its Subsidiaries or any officer, director or employee of any Loan Party or Subsidiaries of any Loan Party, including with respect to any off-label promotion or
(ii) alleging non-compliance with Healthcare Laws. 
 (b) With respect to any Product,
(i) the Loan Parties and their respective Subsidiaries have received, and such Product is the subject of, all Regulatory Required Permits needed in connection with the design, testing, manufacture, processing, assembly, packaging, labeling,
marketing, distribution, commercialization, import, export or sale of such Product as currently being conducted by or on behalf of such Loan Parties or Subsidiaries, except where the failure to have such Regulatory Required Permits would not have a
Material Adverse Effect, and (ii) such Product is being designed, tested, manufactured, processed, assembled, packaged, labeled, marketed, distributed, commercialized, imported, exported or sold, as the case may be, except as would not
reasonably be expected, individually or in the aggregate, to have a Material Adverse Effect, in compliance with all Applicable Laws and Authorizations. 

4.34 No Violation of Healthcare Laws. 

  
 83 

 (a) No Loan Party is in violation of any Healthcare Laws, except where any such violation
would not have a Material Adverse Effect. 
 (b) Except as could not reasonably be expected, individually or in the aggregate, to have a
Material Adverse Effect, each Loan Party and its Subsidiaries is in compliance with the written procedures, record-keeping and reporting requirements required by (or of) (i) the FDA or any comparable Governmental Authority pertaining to the
reporting of adverse events involving the Products or concerning the actions or inactions of the Loan Parties and their Subsidiaries and the directors, officers and employees of the Loan Parties and their Subsidiaries, including with respect to off-label promotion, as applicable, and (ii) Healthcare Laws. 
 4.35 No Third Party Payor
Program. No Loan Party is a participating provider under contract to provide health care services and receive payment or reimbursement for such services under any Third Party Payor Program. 

4.36 Conduct of Business at Facilities. No Loan Party has received any written notice that any Governmental Authority, including,
without limitation, the FDA, the Office of the Inspector General of the United States Department of Health and Human Services or the United States Department of Justice has commenced or threatened to initiate any investigation or action against a
Loan Party; or any action to enjoin a Loan Party, or any of its officers, directors, employees, equityholders, agents or Affiliates, from conducting their businesses at any facility owned or used by them or for any civil penalty, injunction, seizure
or criminal action, in each case, which could reasonably be expected, individually or in the aggregate, to result in a Material Adverse Effect. 

4.37 No Adulteration; Product Manufacturing. Each Product, except as would not be reasonably be expected, individually or in the
aggregate, to have a Material Adverse Effect, (a) is not adulterated or misbranded within the meaning of the FDCA; (b) is not an article prohibited from introduction into interstate commerce under the provisions of Sections 404, 505 or 512
of the FDCA; (c) has been and/or shall be manufactured, imported, possessed, owned, warehoused, marketed, promoted, sold, labeled, furnished, distributed and marketed, and each service has been conducted, in accordance with all applicable
Authorizations and Applicable Laws; and (d) has been and/or shall be manufactured in accordance with Good Manufacturing Practices. 

4.38 FDA. 
 (a) To
the knowledge of the Loan Parties’ Authorized Officers, neither any of the Loan Parties nor any of the Loan Parties’ officers, directors, employees, equityholders, agents or Affiliates has ever (i) made an untrue statement of material
fact, fraudulent statement to the FDA or any other Governmental Authority or in any documents or records prepared or maintained to comply with the FDCA; (ii) failed to disclose a material fact required to be disclosed to the FDA or any other
Governmental Authority; (iii) been investigated by the FDA, National Institutes of Health, Office of the Inspector General for the Department of Health and Human Services, Department of Justice, or other comparable Governmental Authority for
data or healthcare program fraud; or (iv) committed an act, made a statement, or failed to make a statement that could reasonably be expected to provide a basis for the FDA to invoke its policy respecting “Fraud, Untrue Statements of
Material Facts, Bribery, and Illegal Gratuities,” set forth in 56 Fed. Regulation 46191 (September 10, 1991). 
 (b) No Loan Party has
received from the FDA a Warning Letter, Form FDA-483, “Untitled Letter,” other correspondence or notice setting forth allegedly objectionable observations or alleged violations of laws or regulations
enforced by the FDA, or any comparable correspondence from any state 

  
 84 

 
or local authority responsible for regulating drug or device products and establishments, or any comparable correspondence from any foreign counterpart of the FDA, or any comparable
correspondence from any foreign counterpart of any state or local authority with regard to any Product or the manufacture, processing, packing, or holding thereof, in each case, which could reasonably be expected, individually or in the aggregate,
to result in a Material Adverse Effect. 
 (c) As of the Closing Date, none of the Loan Parties has engaged in any material Recalls, Market
Withdrawals or other forms of product retrieval from the marketplace of any Products that has not been finally and fully completed prior to the Closing Date in accordance and compliance with Applicable Law and all FDA and other Governmental
Authority standards, regulations and requirements. After the Closing Date on each date that this representation and warranty is made or deemed made, none of the Loan Parties has engaged in any Recalls, Market Withdrawals or other forms of product
retrieval from the marketplace of any Products that has not been finally and fully completed prior to the date such representation and warranty is made of deemed made in accordance and compliance with Applicable Law and all FDA and other
Governmental Authority standards, regulations and requirements, except to the extent any such engagement or action could not reasonably be expected, individually or in the aggregate, to result in a Material Adverse Effect. None of the Products (for
the avoidance of doubt, including those in the immediately preceding two sentences that have been so finally and fully completed) have been subject to a Recall, Market Withdrawal, or other Correction or Removal, nor is any such action currently
under consideration by Endologix or, to the knowledge of Endologix, any manufacturer or supplier of a Product, that could reasonably be expected, individually or in the aggregate, to result in a Material Adverse Effect. Endologix has not been
restrained in its ability to manufacture, process, distribute, supply, import, export, market, or sell any of the Products, except to the extent that would not reasonably be expected, individually or in the aggregate, to have a Material Adverse
Effect. 
 4.39 Margin Stock. None of the proceeds from the Loans have been or will be used, directly or indirectly, for the
purpose of purchasing or carrying any Margin Stock, for the purpose of reducing or retiring any Indebtedness which was originally incurred to purchase or carry any Margin Stock or for any other purpose which might cause any of the Loans to be
considered a “purpose credit” within the meaning of Regulation T, U or X of the Federal Reserve Board. No Loan Party nor any of their Subsidiaries is engaged principally, or as one of its important activities, in the business of extending
credit for the purpose of purchasing or carrying any Margin Stock. 
 4.40 Complete Disclosure. None of the written information
(financial or otherwise) (other than projections, other forward-looking information and industry information) furnished by or on behalf of any Borrower to Agent (including any Third Party Agent), any Lender or any other member of the Lender Group in
connection with the consummation of the transactions contemplated by the Loan Documents contains any untrue statement of a material fact or omits to state a material fact necessary to make the statements contained herein or therein not materially
misleading in light of the circumstances under which such statements were made. 
 4.41 Investments. The Loan Parties do not
own any stock, partnership interests, limited liability company interest or other equity securities or Subsidiaries except for Permitted Investments. As of the Closing Date, set forth on Schedule P-1
(as such Schedule may be updated from time to time to reflect changes resulting from transactions permitted under this Agreement) is a complete and accurate description of the authorized Stock of the Subsidiaries of the Loan Parties, by class, and,
as of the Closing Date, a description of the number of shares of each such class that are issued and outstanding. 
 4.42
Schedules. All information set forth in the Schedules to this Agreement is true, accurate and complete in all material respects as of the Closing Date and any other subsequent date in which the

  
 85 

 
Loan Parties are requested to update such Schedules. All information set forth in the Perfection Certificate is true, accurate and complete in all material respects as of the Closing Date and any
other subsequent date in which the Loan Parties are requested to update such certificate. 
 4.43 Eligible Accounts. As
to each Account that is identified by the Borrowers as Eligible Account in a Borrowing Base Certificate submitted to Agent (or to any Third Party Agent, as applicable), such Account is (a) a bona fide existing payment obligation of the
applicable Account Debtor created by the sale and delivery of Inventory or the rendition of services to such Account Debtor in the ordinary course of a Loan Party’s business, (b) owed to a Loan Party without any known defenses, disputes,
offsets, counterclaims, or rights of return or cancellation, and (c) not excluded as ineligible by virtue of one or more of the excluding criteria (other than any Agent-discretionary criteria) set forth in the definition of Eligible Accounts.

 4.44 Eligible Inventory. As to each item of Inventory that is identified by the Borrowers as Eligible
Inventory in a Borrowing Base Certificate submitted to Agent (or any Third Party Agent), such Inventory is (a) of good and merchantable quality, free from known defects, and (b) not excluded as ineligible by virtue of one or more of the
excluding criteria (other than any Agent-discretionary criteria) set forth in the definition of Eligible Inventory. 
 4.45
Location of Inventory and Equipment. The Inventory and Equipment of the Borrowers is located only at, or in-transit between, the locations identified on Schedule 4.45 (as such Schedule may
be updated pursuant to Section 5.18). With respect to any Inventory and Equipment listed at locations that are outside the United States (and with respect to any Inventory and Equipment on consignment at any location (other
than, with respect to clause (ii), in which case such clause shall not apply to all consignment locations but only those outside the United States)), (i) any failure of the Agent and the other Secured Parties to (A) be fully protected
on the Inventory or be fully protected or perfected with respect to any Liens granted to the Agent (for the benefit of the Secured Parties) on any such Inventory, or (B) have absolute or full access to such locations when exercising rights and
remedies after the occurrence and during the continuance of an Event of Default, in each case of clause (i)(A) and clause (i)(B), does not, individually or in the aggregate, cause a Material Adverse Effect to occur, and (ii) as of the
Agreement Date, the cost paid by the Borrowers and its Subsidiaries for such Inventory and Equipment listed at such locations outside the United States, or on consignment at any location outside the United States, does not exceed $10,000,000. 

4.46 Inventory and Equipment Records. Each Loan Party keeps correct and accurate records itemizing and describing the type,
quality, and quantity of its and their Subsidiaries’ Inventory and Equipment and the book value thereof. 
 4.47 No
Violation of Usury Laws. The rate of interest paid on any of the Obligations, and the method and manner of the calculation thereof, do not violate any usury laws or other Applicable Laws, any of the Organizational Documents, or any of the Loan
Documents. 
 4.48 Eligible Equipment. As to each item of Equipment that is identified by the Borrowers as Eligible Equipment
in a Borrowing Base Certificate submitted to Agent (or any Third Party Agent), such Equipment is (a) of good and merchantable quality, free from known defects, and (b) not excluded as ineligible by virtue of one or more of the excluding
criteria (other than any Agent-discretionary criteria) set forth in the definition of Eligible Equipment. 

  
 86 

 ARTICLE V. 

AFFIRMATIVE COVENANTS. 

Borrowers covenant and agree that, until termination of all of the Commitments and payment in full in cash of the Obligations: 

5.01 Existence; Permits. 

(a) The Loan Parties shall and shall cause their Subsidiaries to (i) preserve and maintain in full force and effect its organizational
existence and good standing under the Applicable Laws of its jurisdiction of incorporation, organization or formation, as applicable, other than as permitted under Section 6.01, and (ii) preserve and maintain all
qualifications to do business in each other jurisdiction not covered by clause (i) above that the failure to be so qualified could reasonably be expected, individually or in the aggregate, to have a Material Adverse Effect. 

(b) The Loan Parties shall, and shall cause their Subsidiaries to, obtain, make and keep in full force and effect all licenses, certificates,
approvals, registrations, clearances, Authorizations and permits required to conduct their businesses, except where the failure to make and keep such licenses, certificates, approvals, registrations, clearances, authorizations and permits in full
force and effect could not reasonably be expected, individually or in the aggregate, to result in a Material Adverse Effect. 
 (c) Each Loan
Party shall, except as otherwise permitted by this Agreement, maintain, and shall cause each of its Subsidiaries to maintain, and preserve all its assets and property which is used or useful in its business in good working order and condition,
ordinary wear and tear excepted and shall make all necessary repairs thereto and renewals and replacements thereof, except, in each case, where the failure to do so could not reasonably be expected, individually or in the aggregate, to have a
Material Adverse Effect. 
 5.02 Compliance with Laws. The Loan Parties will, and will cause each of their Subsidiaries to,
(a) comply in all material respects with all Applicable Laws, except where the necessity of compliance therewith is contested in good faith by appropriate proceedings or where failure to do so could not reasonably be expected, individually or
in the aggregate, to have a Material Adverse Effect, and (b) maintain in effect and enforce policies and procedures designed to ensure compliance by the Borrowers, their Subsidiaries and their respective directors, officers and employees with
Anti-Corruption Laws, Anti-Money Laundering Laws, Anti-Terrorism Laws and applicable Sanctions. 
 5.03 Insurance. The Loan
Parties shall, and shall cause each of their Subsidiaries to, maintain with financially sound and reputable insurance companies with respect to their assets, properties and business, against such hazards and liabilities, of such types and in such
amounts, as is customarily maintained by companies in the same or similar businesses similarly situated. All property insurance policies covering the Collateral are to be made payable to Agent for the benefit of Agent, the Lenders and the other
members of the Lender Group, as their interests may appear, in case of loss, pursuant to a standard lender’s loss payable endorsement with a standard noncontributory “lender” or “secured party” clause and are to contain such
other provisions as Agent may reasonably require to fully protect the Lenders’ interest in the Collateral and to any payments to be made under such policies. All certificates and endorsements of property and general liability insurance are to
be delivered to Agent by the Loan Parties, with the lender’s loss payable (but only in respect of Collateral) and additional insured endorsements in favor of Agent and shall provide for not less than 30 days (10 days in the case of non-payment) prior written notice to Agent of the exercise of any right of cancellation or any modification thereof; provided, however, that, for the avoidance of doubt, Agent need not be named on any workers

  
 87 

 
compensation or D&O policies. If Loan Parties or their Subsidiaries fail to maintain such insurance, Agent may arrange for such insurance, but at Borrowers’ expense and without any
responsibility on Agent’s part for obtaining the insurance, the solvency of the insurance companies, the adequacy of the coverage, or the collection of claims. The Loan Parties shall give Agent prompt written notice of any loss exceeding
$500,000 covered by any of the Loan Parties’ or any of their Subsidiaries’ casualty or business interruption insurance. Upon the occurrence and during the continuance of an Event of Default, Agent shall have the sole right to file claims
under any property and general liability insurance policies in respect of the Collateral, to receive, receipt and give acquittance for any payments that may be payable thereunder, and to execute any and all endorsements, receipts, releases,
assignments, reassignments or other documents that may be necessary to effect the collection, compromise or settlement of any claims under any such insurance policies. A true and complete listing of such insurance, including issuers, coverages and
deductibles, shall be provided by the Loan Parties to Agent promptly following Agent’s request (or to the Third Party Agent promptly following the Third Party Agent’s request during any Third Party Agent Retention Period). 

5.04 Taxes. Each Loan Party shall, and shall cause each of its Subsidiaries to, pay, discharge and perform as the same shall
become due and payable or required to be performed all Tax liabilities, assessments and governmental charges or levies upon it or its property, unless the same are being contested in good faith by appropriate proceedings diligently prosecuted which
stay the enforcement of any Lien and for which adequate reserves in accordance with GAAP are being maintained by such Person. 
 5.05
Reports, Notices. 
 (a) Endologix and its Subsidiaries shall (i) timely (without giving effect to any extensions pursuant to
Rule 12b-25 of the Exchange Act) file all reports required to be filed with the SEC pursuant to the Exchange Act, and Endologix and its Subsidiaries shall not terminate the registration of the Common Stock
under the Exchange Act or otherwise terminate its status as an issuer required to file reports under the Exchange Act, even if the securities laws would otherwise permit any such termination, and (ii) deliver to Agent (and, during any Third
Party Agent Retention Period, also the Third Party Agent) a Compliance Certificate with each of its 10-Q and 10-K filings on the date such filings are made (or, if
earlier, are required by the SEC to be made) with the SEC; provided that, with respect to clause (ii) only, solely to the extent any earnings or revenue report for the same period is publicly reported or is filed
with the SEC prior to the time when any 10-Q or 10-K containing the applicable quarterly or annual financial statements is filed with the SEC and to the extent the
earnings or revenue set forth in any such earnings or revenue report would result in a financial covenant default under Article VII, the Compliance Certificate shall instead be delivered by the Loan Parties to the Agent
(and, during any Third Party Agent Retention Period, also the Third Party Agent) and the Lenders on the same day as such earnings or revenue report is publicly reported or is filed with the SEC. Each of such reports in clause (i) of the
immediately preceding sentence will comply in all material respects with the applicable requirements of the Exchange Act and each of such reports and such Compliance Certificate will not contain any untrue statement of a material fact or omit to
state a material fact required to be stated therein or necessary in order to make the statements therein, in the light of the circumstances under which they were made, not misleading. The consolidated financial statements included in such reports
will comply as to form in all material respects with applicable accounting requirements and the published rules and regulations of the SEC with respect thereto, will be prepared in accordance with GAAP, consistently applied (subject, in the case of
unaudited quarterly financial statements, to normal year-end adjustments and lack of footnote disclosures), and will fairly present in all material respects the consolidated financial position of Endologix and
its Subsidiaries as of the dates thereof and the consolidated results of their operations, cash flows and changes in stockholders equity for the periods presented (subject, in the case of unaudited quarterly financial

  
 88 

 
statements, to normal year-end audit adjustments and lack of footnote disclosures). Each Borrower hereby agrees that the Borrower Representative shall send
to each Secured Party copies of (A) any notices and other information made available or given to the holders of the Stock of Endologix generally, contemporaneously with Endologix making available or giving such notices and other information to
such holders of Stock (it being understood and agreed that delivery shall be deemed to have occurred if such notices or other information is posted to EDGAR) and (B) all other documents, reports, financial data and other information not
available on EDGAR that does not contain any material nonpublic information of the Borrower, that any Secured Party may reasonably request. 

(b) Each of the Borrowers and their Subsidiaries will deliver to (x) during any Non-Third Party
Agent Retention Period, subject to Section 5.20, Agent, and (y) during any Third Party Agent Retention Period, the Third Party Agent, each of the reports, certificates or other items set forth below at the following
times in form satisfactory to Agent (or such Third Party Agent): 
 (i) (A) within five (5) Business Days after the filing of its 10-K or 10-Q, as the case may be, an updated Perfection Certificate (provided that Endologix shall include in the 10-K or 10-Q, as the case may be, any material nonpublic information included in the Perfection Certificate delivered during any Non-Third Party Agent Retention Period (or delivered
to Agent (other than the Third Party Agent) or any Lender at any time) that would not otherwise be included in such 10-Q or 10-K); and (B) upon the reasonable
request of any Secured Party, the such additional business, financial, corporate affairs, perfection certificates, items or documents related to creation, perfection or priority of Agent’s Liens in the Collateral and other information as any
Secured Party may from time to time reasonably request; 
 (ii) promptly, but in any event within two (2) Business Days after the
knowledge of the occurrence of (A) written notice of any Default or Event of Default and (B) so long as such type of notification would not be material nonpublic information of the Borrower (except during a Third Party Agent Retention
Period, in which case, such material nonpublic information shall be provided but only to the Third Party Agent), written notice of any claims (other than in connection with the denial of plan claims in the ordinary course of business), litigation,
arbitration, mediation or administrative or regulatory proceedings that are instituted or threatened against any Loan Party, or claims of infringement by any Person with respect to any Intellectual Property rights of a Loan Party, in each case of
this clause (B), to the extent such claim, litigation, arbitration, mediation or administrative or regulatory proceeding could reasonably be expected, individually or in the aggregate, to have a Material Adverse Effect; and 

(iii) during any Third Party Agent Retention Period, as soon as available, but in any event within thirty (30) days after the end of each
fiscal month during each fiscal year, an unaudited consolidated and consolidating balance sheet and income statement of Endologix and its Subsidiaries’ operations during such month and for the portion of the fiscal year then ended, including
comparisons to the figures in the corresponding month and year-to-date portion of the immediately preceding fiscal year of Endologix and its Subsidiaries. 

(c) Further, if Endologix is not required to file reports pursuant to Section 13 or 15(d) of the Exchange Act, the Loan Parties will
provide to Agent (and, during any Third Party Agent Retention Period, also the Third Party Agent) and each Lender (A) quarterly financial statements for Endologix and its Subsidiaries within 45 days after the end of each fiscal quarter of
Endologix, and an audited annual financial statements within 120 days after the end of each fiscal year of Endologix prepared in accordance with GAAP with a report thereon by Endologix’s independent certified public accountants, which
accountants shall be reasonably acceptable to Agent, and (B) on the same day as delivery to Term Agent, any Term Lender or any other secured party under the Term Debt Documents, any additional financial

  
 89 

 
statements, certificates, reports, notices, agreements, instruments and documents provided under (or in connection with) the Term Debt Documents. Any such annual audited financial statements,
audit or report of Endologix’s independent certified public accountants (and any annual audited financial statements, audit or report of Endologix’s independent certified public accountants on any consolidated financial statements included
in any SEC Document) shall (i) contain an unqualified opinion (subject to the exception set forth below in clause (ii) of this sentence), stating that such consolidated financial statements present fairly in all material respects the
financial position and condition and results of operations of the Borrower and its Subsidiaries as of the dates and for the periods and have been prepared in conformity with GAAP applied on a basis consistent with prior years, and (ii) not
include any explanatory paragraph expressing substantial doubt as to going concern status (other than any such paragraph arising from the impending maturity of the Loans solely in the case of the audit delivered with respect to the fiscal year
immediately prior to the fiscal year during which the applicable maturity is scheduled). 
 (d) Endologix and its Subsidiaries shall, prior
to making any prepayment pursuant to Section 6.18(a), deliver to Agent, subject to Section 5.20 (or, during any Third Party Agent Retention Period, the Third Party Agent), a budget and projections
of cash flows for the one-year period following such prepayment reflecting such prepayment and showing sources and uses for all required repayments of Indebtedness coming due during such one-year period. 
 5.06 Inspection. The Loan Parties will, and will cause each of
their Subsidiaries to, permit Agent (including any Third Party Agent), any Lender, and each of their respective duly authorized representatives or agents to, with respect to each owned, leased or controlled property, at all times and without notice,
at the sole option of Agent or any Lender: (i) provide access to such property to Agent (including any Third Party Agent), the Lenders and their respective representatives and agents, as frequently as Agent or any Lender determines to be
appropriate; and (ii) permit Agent (including any Third Party Agent) or any Lender to conduct field examinations, appraise, inspect, and make extracts and copies (or take originals if reasonably necessary) from all of such Loan Party’s and
its Subsidiaries’ books and records, and evaluate and conduct appraisals and evaluations in any manner and through any medium that Agent or any Lender considers advisable, in each instance, subject to Section 2.09(c),
at the Loan Parties’ sole expense. Any Lender may accompany Agent (including any Third Party Agent) or its representatives in connection with such inspection. Notwithstanding the foregoing, the Loan Parties shall (and shall cause each of their
respective Subsidiaries to) comply with (and coordinate with Agent and the Lenders and their representatives and agents to make sure of compliance with) Section 5.20 in connection with any such inspection, examination,
audit or analysis. 
 5.07 Disclosure Updates. Each Loan Party shall ensure that all written information, exhibits and reports
furnished to any Agent (including any Third Party Agent), any Lender or any other member of the Lender Group, when taken as a whole, do not and will not contain any untrue statement of a material fact and do not and will not omit to state any
material fact or any fact necessary to make the statements contained therein not materially misleading in light of the circumstances in which made, and will promptly disclose, after knowledge of any defect of a material fact, untrue statement of
material fact, material misstatement or error of a material fact, to Agent (including, during any Third Party Agent Retention Period, the Third Party Agent) and the Lenders and correct any such defect, untrue statement of material fact, material
misstatement or error of a material fact that has been discovered therein or in any Loan Document or in the execution, acknowledgement or recordation thereof; it being acknowledged and agreed that any projections provided to the Lender Group are not
to be viewed as facts, are not a guarantee of financial performance, and are subject to uncertainties and contingencies. 

  
 90 

 5.08 Cash Management. Each Loan Party shall enter into, and cause each
depository, securities intermediary or commodities intermediary to enter into, Control Agreements with respect to each deposit, securities, commodity or similar account maintained by such Person (other than (i) deposit accounts exclusively used
for payroll, payroll taxes and other employee wage and benefit payments to or for the benefit of the Borrowers’ employees and identified to Agent by the Borrower Representative as such, (ii) zero balance accounts; provided that such
accounts have been identified to Agent by the Borrower Representative as such, (iii) such other petty cash deposit accounts, amounts on deposit in which do not exceed $100,000 in the aggregate at any one time, (iv) escrow, trust and
fiduciary accounts, (v) each account of Excluded Foreign Subsidiaries, (vi) deposit account #XXXXX7912 of TriVascular Canada LLC at Bank of Montreal; provided the aggregate amount on deposit in such deposit account(s) does not exceed
1,000,000 Canadian dollars at any time, (vii) the Bank of America Cash Collateral Account (such accounts in clauses (i) through (vii), the “Excluded Accounts”)) as of and after the Closing Date; provided that (x) the
Loan Parties shall have until the date that is forty-five (45) days following the closing date of any Permitted Acquisition (or such later date as may be agreed to by Agent in its sole reasonable discretion) to comply with the provisions of
this Section 5.08) with regard to such accounts (other than Excluded Accounts) of the Borrowers acquired in connection with such Permitted Acquisition, and (y) for deposit accounts, securities accounts and commodities
accounts opened after the Closing Date, the Loan Parties shall have until the date that is thirty (30) days following the opening of any such new account (or such later date as may be agreed to by Agent in its sole reasonable discretion) to
comply with this Section 5.08. 
 5.09 Further Assurances. Promptly upon request by Agent (or, during
any Third Party Agent Retention Period, the Third Party Agent), the Borrowers shall (and, subject to the limitations set forth herein and in the other Loan Documents, shall cause each of their Subsidiaries to) take such additional actions and
execute such documents as Agent (or, during any Third Party Agent Retention Period, the Third Party Agent) may reasonably require from time to time in order (i) to carry out more effectively the purposes of this Agreement or any other Loan
Document, (ii) to subject to the Liens created by any of the Loan Documents on any of the assets or properties, rights or interests covered by any of the Loan Documents, (iii) to perfect and maintain the validity, effectiveness and
priority of any of the Loan Documents and the Liens intended to be created thereby, and (iv) to better assure, grant, preserve, protect and confirm to the Secured Parties the rights granted or now or hereafter intended to be granted to the
Secured Parties under any Loan Document. The Loan Parties will notify Agent in writing prior to (and on) (x) the date of formation or acquisition of any Subsidiary and (y) any division or split of any Loan Party into two or more
Subsidiaries, limited liability companies, other entities or other Persons. Without limiting the generality of the foregoing, the Loan Parties shall cause (y) each of their Subsidiaries (other than Excluded Subsidiaries) promptly after (but, in
any event, (A) within fifteen (15) days thereof for any Subsidiary that is not an Immaterial Subsidiary and (B) within thirty (30) days thereof for any Immaterial Subsidiary) after the date of the formation or acquisition thereof
(and any Subsidiaries, limited liability companies, other entities or other Persons for which any Loan Party divides or splits itself into), to guaranty the Obligations and to cause each such Subsidiary to grant to Agent, for the benefit of the
Secured Parties, a security interest in, subject to the limitations set forth herein and in the Loan Documents, all of such Subsidiary’s (and, with respect to any such division or split of a Loan Party, all such Subsidiary’s limited
liability company’s, other entity’s or other Person’s) assets and property (including any assets or property allocated, distributed, conveyed or otherwise transferred pursuant to any division or split of any Loan Party into any
Subsidiaries, limited liability companies, other entities or other Persons for which any Loan Party divides or splits itself into) assets and property to secure such guaranty and (z) any holder (that is a Loan Party) of the Stock of such
Subsidiary to provide, promptly after (but, in any event, (A) within fifteen (15) days thereof for any Loan Party or any Subsidiary that is not an Immaterial Subsidiary and (B) within thirty (30) days thereof for any Immaterial
Subsidiary) the date (x) of the formation or acquisition of such Subsidiary or (y) any division or split of any Loan Party 

  
 91 

 
into two or more Subsidiaries, limited liability companies, other entities or other Persons, in each case, supplements and further pledges to the Loan Documents as are necessary (or requested by
Agent) to evidence Agent’s Lien in such Stock of such Subsidiary. Furthermore, the Borrower shall notify Agent and the Lenders in writing promptly after (but, in any event, (A) within fifteen (15) days thereof for any Loan Party or
any Subsidiary that is not an Immaterial Subsidiary and (B) within thirty (30) days thereof for any Immaterial Subsidiary) the date of the issuance by or to any Loan Party (other than by Endologix) of any Stock of any corporation or any
other Person that has “opted into” Article 8 of the UCC (in each case, other than Excluded Property) to have its Stock constitute “securities” under Article 8 of the UCC and each Loan Party shall pledge, and shall cause each of
its Subsidiaries (other than Excluded Subsidiaries but including any Subsidiaries, limited liability companies, other entities or other Persons for which any such Loan Party divides or splits itself into) to pledge, all of the Stock of each of its
Subsidiaries (other than Excluded Subsidiaries), and sixty-five percent (65%) of the outstanding voting Stock and one hundred percent (100%) of the outstanding non-voting Stock of each Excluded Foreign
Subsidiary and each Excluded Domestic Holdco, directly owned by a Loan Party, in each instance, to Agent, for the benefit of the Secured Parties, to secure the Obligations, promptly after formation or acquisition (or division or split) of such
Subsidiary. The Loan Parties shall deliver, or cause to be delivered, to Agent, appropriate resolutions, secretary certificates, certified Organizational Documents and, if reasonably requested by Agent, legal opinions relating to the matters
described in this Section 5.09 (which opinions shall be in form and substance reasonably acceptable to Agent and, to the extent applicable, substantially similar to the opinions delivered on the Closing Date), in each
instance with respect to (1) each Loan Party or Subsidiary formed or acquired (and each Subsidiary, limited liability company, other entity or other Person for which a Loan Party divides or splits itself into), (2) and each Loan Party or Person
(other than a Loan Party) whose Stock is being pledged, and (3) the assets and property that are allocated distributed, conveyed or otherwise transferred pursuant to any division or split of any Loan Party into any Subsidiaries, limited
liability companies, other entities or other Persons for which any Loan Party divides or splits itself into, in each case of clauses (1) through (3), after the Closing Date. In connection with each pledge of Stock, the Loan Parties shall
deliver, or cause to be delivered, to Agent, irrevocable proxies and Stock powers and/or assignments, as applicable, duly executed in blank. 

5.10 Environmental. The Loan Parties will, and will cause each of their Subsidiaries to, comply with, and maintain its Real
Property, whether owned, leased, subleased or otherwise operated or occupied, in compliance with all applicable Environmental Laws and Healthcare Laws or that is required by orders and directives of any Governmental Authority, except where the
failure to comply could not reasonably be expected, individually or in the aggregate, to result in a Material Adverse Effect. 
 5.11
ERISA. Promptly upon becoming aware that any of the following events has occurred, the Borrowers will provide written notice to the Agent (and, during any Third Party Agent Retention Period, also the Third Party Agent) specifying the nature
of such event, what action the Loan Party or any ERISA Affiliates has taken, is taking or proposes to take with respect thereto and, when known, if applicable, any action taken or threatened by the Internal Revenue Service, the Department of Labor
or the PBGC with respect thereto: (i) any ERISA Event which could reasonably be expected, individually or in the aggregate, to have a Material Adverse Effect, (ii) a “prohibited transaction” as defined under Section 406 of
ERISA or Section 4975 of the IRC that is not exempt under ERISA Section 408 or Section 4975 of the IRC, under any applicable regulations and published interpretations thereunder or under any applicable prohibited transaction,
individual or class exemption issued by the Department of Labor, with respect to any Employee Benefit Plan, which could reasonably be expected, individually or in the aggregate, to have a Material Adverse Effect, or (iii) the imposition of any
Lien on any asset of a Loan Party or a Subsidiary of a Loan Party with respect to any Title IV Plan or Multiemployer Plan. 

  
 92 

 5.12 FDA; Healthcare Laws. Each Loan Party and its Subsidiaries will comply
with (a) in all respects with all Healthcare Laws and their implementation by any applicable Governmental Authority, except as could not reasonably be expected, individually or in the aggregate, to have a Material Adverse Effect, and (b)
(i) in all respects with all lawful requests of any Governmental Authority applicable to its Products, except as could not reasonably be expected, individually or in the aggregate, to have a Material Adverse Effect, and (ii) in all
material respect with requests of any Governmental Authority applicable to its Products that is required by Applicable Law (or court order or proceeding) to be complied with. Except as could not reasonably be expected, individually or in the
aggregate, to have a Material Adverse Effect, all Products developed, manufactured, tested, distributed, promoted or marketed by or on behalf of any Loan Party or any of its Subsidiaries that are subject to the jurisdiction of the FDA or comparable
Governmental Authority shall be (A) developed, tested, manufactured, distributed, promoted and marketed in compliance with the Healthcare Laws and each other Applicable Law, including Healthcare Laws and other Applicable Laws governing or
relating to product approval or premarket notification, good manufacturing practices, promoting, labeling, advertising, record-keeping, and adverse event reporting, and (B) tested, investigated, distributed, labeled, promoted, marketed, and
sold in compliance with Healthcare Laws and all other Applicable Laws. 
 5.13 Regulatory Required Permits. Except as could not
reasonably be expected, individually or in the aggregate to have a Material Adverse Effect, Endologix shall, and shall cause each Loan Party to, (a) obtain all Regulatory Required Permits necessary for compliance in all respects with Applicable
Laws with respect to the design, testing, manufacturing, developing, processing, assembly, packaging, labeling, distribution, commercialization, import, export, selling or marketing of Products, and (ii) maintain and comply fully and completely
in all respects with all such Regulatory Required Permits. 
 5.14 Material Contracts. Each Loan Party will comply, and cause
each Subsidiary to comply, with the requirements of all Applicable Laws and Material Contracts, except to the extent that failure to so comply could not reasonably be expected to (a) individually or in the aggregate, have a Material Adverse
Effect, or (b) result in any Lien upon either (i) a material portion of the assets of any such Person in favor of any Governmental Authority, or (ii) any Collateral (other than Permitted Liens). 

5.15 Notices Regarding Indebtedness. Borrowers shall within two (2) Business Days after delivery by a Loan Party or receipt
or knowledge thereof, provide written notice to Agent (and, during any Third Party Agent Retention Period, also the Third Party Agent) of (a) any default or event of default under any of the Convertible Note Documents or any Term Debt
Documents, and of any amendments, restatements, supplements, waivers or other modifications to (or any consents to any events or actions under) any of the Convertible Note Documents or any Term Debt Documents, and (b) any prepayment of any
Indebtedness. 
 5.16 Reporting. 

(a) Borrower Representative will deliver, on behalf of each of the Borrowers, each of the documents set forth below at the following times in
form satisfactory to Agent (and, during any Third Party Agent Retention Period, also the Third Party Agent): 
 (i) (A) subject to
Section 5.20, during any Non-Third Party Agent Retention Period, upon the request of Agent, to Agent, monthly (no later than the fifteenth (15th) Business Day of each month), and with
each request for a Borrowing, an executed Borrowing Base Certificate (Agent), together with all supporting documentation that is not material nonpublic information unless expressly requested in writing by Agent; and (B) during any Third Party
Agent Retention Period, to the Third Party Agent, monthly (no later than the fifteenth (15th) Business Day of each month), and with each request for a 

  
 93 

 
Borrowing, an executed Borrowing Base Certificate (Third Party Agent), together with all supporting documentation; 

(ii) during any Third Party Agent Retention Period, to the Third Party Agent, monthly (no later than the fifteenth (15th) Business Day of each
month), and with each request for a Borrowing, (A) a detailed aging, by total, of each Borrower’s Accounts, together with a reconciliation and supporting documentation for any reconciling items noted (delivered electronically in an
acceptable format, if such Borrower has implemented electronic reporting), (B) a general ledger trial balance and a detailed calculation of those Accounts that are not eligible for the Borrowing Base, if such Borrower has not implemented electronic
reporting, and (C) a summary aging, by vendor, of such Borrower’s accounts payable and any book overdraft (delivered electronically in an acceptable format, if each Loan Party has implemented electronic reporting) and an aging, by vendor,
of any held checks; 
 (iii) during any Third Party Agent Retention Period, to the Third Party Agent, monthly (no later than the fifteenth
(15th) Business Day of each month), and with each request for a Borrowing, an Account roll-forward from the previous Borrowing Base Certificate delivered or most recent request for a Borrowing, in a format acceptable to Agent and such Third Party
Agent in their discretion, with supporting details supplied from sales journals, collection journals, credit registers and any other records, tied to the beginning and ending account receivable balances of each Loan Party’s general ledger; 

(iv) during any Third Party Agent Retention Period, to the Third Party Agent, monthly (no later than the fifteenth (15th) Business Day of each
month), (A) a detailed report regarding each Borrower’s and its Subsidiaries’ cash and Cash Equivalents, (B) a perpetual Inventory report and Equipment report, and a calculation of the net book value (calculated in accordance with
GAAP on a basis consistent with such Borrower’s historical accounting practices) of Eligible Inventory and Eligible Equipment at the end of such period and (C) a determination of the Market Capitalization of Endologix as of the last day of
the previous month; 
 (v) during any Third Party Agent Retention Period, to the Third Party Agent, monthly (no later than the thirtieth
(30th) day of each month), a reconciliation of Accounts and trade accounts payable of each Loan Party’s general ledger accounts to its monthly financial statements including any book reserves related to each category; 

(vi) during any Third Party Agent Retention Period, to the Third Party Agent, (A) on the last day of each fiscal quarter, (I) a
report regarding each Borrower’s and its Subsidiaries’ accrued but unpaid, ad valorem taxes and (II) unless required to be provided under Section 5.05(b)(i) for the same fiscal quarter, a Perfection
Certificate or a supplement to the Perfection Certificate, and (B) no later than the fifteenth (15th) Business Day after the end of each fiscal quarter, an updated report of the reserves established on the Borrowers’ books regarding excess
and obsolete Inventory and excess and obsolete Equipment; 
 (vii) during any Third Party Agent Retention Period, to the Third Party Agent,
on the last day of each fiscal year, a detailed list of each Borrower’s customers, with address and contact information; 
 (viii)
during any Third Party Agent Retention Period, to the extent a Borrower conducts any physical inventory audits or physical equipment audits during the course of any fiscal year, it shall provide the Third Party Agent with a certified report of such
audit within ten (10) Business Days after the completion thereof; 

  
 94 

 (ix) (A) promptly, and in any event within two (2) Business Days after the knowledge
that Borrowers do not maintain Global Excess Liquidity in an amount of at least $22,500,000, notice thereof and (B) promptly within one (1) Business Day after written request by the Agent (or, during any Third Party Agent Retention Period,
the Third Party Agent), to Agent (or such Third Party Agent, as applicable) written evidence reasonably satisfactory to the Agent (or such Third Party Agent, as applicable) demonstrating compliance with Section 7.01(b); and

 (x) promptly, upon request by Agent, subject to (other than with respect to the Third Party Agent during any Third Party Agent Retention
Period) Section 5.20, (A) an insurance claim report, (B) a detailed report describing accrued expenses or (C) such other reports as to the Collateral or the financial condition of each Borrower and its
Subsidiaries, as Agent may reasonably request. 
 (b) Notwithstanding clause (a) above, to the extent (i) Borrowers do not have at
least $22,500,000 of Global Excess Liquidity, or (ii) any Event of Default then exists, the items, certificates and information set forth in clause (a)(i), (a)(ii), (a)(iii) and (a)(iv) shall be delivered to the Agent (or Third Party Agent, as
applicable) on a weekly basis (on the second (2nd) Business Day of such week). 
 5.17 Lender Meetings. Borrowers will, within
ninety (90) days after the close of each fiscal year of Borrowers, at the request of Agent (or, during any Third Party Agent Retention Period, the Third Party Agent) or of the Required Lenders and upon reasonable prior notice, hold a meeting
(at a mutually agreeable location and time or, at the option of Agent, by conference call) with Agent (or, during any Third Party Agent Retention Period, the Third Party Agent) and any Lenders who choose to attend such meeting at which meeting shall
be reviewed the financial results of the previous fiscal year and the financial condition of Borrowers and their Subsidiaries and the projections presented for the current fiscal year of Borrowers. 

5.18 Location of Collateral. The Loan Parties will keep its Inventory and Equipment (other than Inventory or Equipment that is in-transit, Trunk Inventory or subject to consignment) only at the locations identified on Schedule 4.45 and their chief executive offices only at the locations identified on Schedule
4.23; provided, that Borrowers may amend Schedule 4.45 or Schedule 4.23 so long as such amendment occurs by written notice to Agent not less than ten (10) days prior to the date on which such Inventory and Equipment is
moved to such new location or such chief executive office is relocated and so long as such new location is within the continental United States. 

5.19 Updated Borrowing Base Certificate. Within three (3) Business Days of the written request of Required Lenders, Borrower
Representative shall deliver an updated executed Borrowing Base Certificate reflecting changes in the Eligible Accounts availability since the last Borrowing Base Certificate. 

5.20 Announcing Form 8-K. At or prior to 7:30 a.m. (New York City time) on the first
(1st) Business Day following the Closing Date, Endologix shall file a Form 8-K with the SEC describing the terms of the transactions contemplated by the Loan Documents and the Term Debt Documents and including
as exhibits to such Form 8-K this Agreement (including the schedules, annexes and exhibits hereto), the other Loan Documents listed on Schedule 5.20 (other than the Perfection
Certificated executed and delivered on the Closing Date to the Agent), the Term Credit Agreement and the other agreements and instruments required to be filed pursuant to Section 5.1(q) of the Term Credit Agreement (such Form 8-K, the “Announcing Form 8-K”). Subject to the foregoing, no Borrower or its Subsidiaries shall issue any press releases or any other public statements
with respect to the transactions contemplated by any Loan Document or disclosing the name of Agent, any Lender or any other member of the Lender Group; provided, however, that Endologix shall be entitled, without the prior approval of
Agent or any 

  
 95 

 
Lender, to make any press release or other public disclosure with respect to such transactions (i) in substantial conformity with the Announcing Form
8-K and contemporaneously therewith and (ii) as is required by Applicable Laws (provided that each of the Agent and Lenders shall be consulted by Endologix in connection with any such press release
or other public disclosure prior to its release and shall be provided with a copy thereof other than filings required by the Exchange Act to be made with the SEC, which Endologix may make without such consultation or notice). From and after
Endologix’s filing of the Announcing Form 8-K, no member of the Lender Group shall be (or shall be deemed to be) in possession of any material nonpublic information received from the Borrowers or any of
their respective Subsidiaries or Affiliates or any of its or their respective officers, directors, employees, attorneys, representatives or agents, except, during any Third Party Agent Retention Period, information provided solely to the Third Party
Agent as and to the extent required hereby that is marked as material nonpublic information by the Borrower Representative in good faith at the time such information is provided to the Third Party Agent. Without limiting the foregoing, the Loan
Parties represent and warrant that no Loan Document or other agreement, instrument, certificate, information or other document provided by any Loan Party or any of its Related Parties to any member of the Lender Group on or about the Closing Date
that is not filed as an exhibit to the Announcing Form 8-K constitutes, or contains, reflects or references any information that constitutes material nonpublic information with respect to the Loan Parties or
any of their Subsidiaries or Affiliates (except to the extent the same information is expressly set forth in the Announcing Form 8-K or an exhibit thereto). Notwithstanding any other requirement of this
Agreement or other Loan Document, each Borrower shall not, and shall cause each of its Subsidiaries and Affiliates and its and each of their respective officers, directors, employees, attorneys, representatives and agents (it being understood and
agreed that the Third Party Agent is not an agent, employee, attorney or representative of any Borrower, its Subsidiaries or its Affiliates) to not, provide any member of the Lender Group with any material nonpublic information regarding the
Borrowers or any of their Subsidiaries or Affiliates from and after the filing of the Announcing Form 8-K with the SEC without the express prior written consent of such member of the Lender Group;
provided, however, that a Borrower may provide material nonpublic information to the Third Party Agent during any Third Party Agent Retention Period as and to the extent required hereby and to the extent such information is marked as
material nonpublic information by the Borrower Representative in good faith at the time such information is provided to the Third Party Agent. Each of the parties hereto acknowledges and agrees that no member of the Lender Group nor any
Affiliate of any member of the Lender Group (other than the Third Party Agent) shall be deemed to be in possession of any material nonpublic information provided to any Third Party Agent unless and until such Third Party Agent actually provides such
information to such member of the Lender Group or Affiliate thereof (as applicable); and the Borrowers agree not to (and the Borrowers agree to not have their Subsidiaries or Affiliates) assert any contrary position. Each Borrower hereby
acknowledges and agrees that no member of the Lender Group (nor any Affiliate thereof) shall have any duty of trust or confidence with respect to, or obligation not to trade in any securities on the basis of, any material nonpublic information
regarding the Borrowers or any of their respective Subsidiaries or Affiliates (A) provided by, or on behalf of, the Borrowers or any of their respective Subsidiaries or Affiliates, or any of its or their respective officers, directors,
employees, attorneys, representatives or agents, in breach or violation of any of the representations, covenants, provisions or agreements set forth in this Section 5.20 or otherwise or (B) otherwise possessed (or
continued to be possessed) by any member of the Lender Group (or any Affiliate thereof) as a result of a breach or violation of any representation, covenant, provision or agreement set forth in this Section 5.20.
Notwithstanding anything to the contrary herein or in any other Loan Document, in the event that a Borrower believes in good faith that a notice or communication to any member of the Lender Group contains material nonpublic information relating to
the Borrowers or any other Loan Party or any of their Affiliates or Subsidiaries (other than material nonpublic information being contemporaneously publicly disclosed through the filing with the SEC of a Form
8-K, 10-K or 10-Q or issuance of a broadly disseminated press release, in any such case as identified to any member of the Lender
Group, as 

  
 96 

 
applicable), such Borrower shall so indicate to such member of the Lender Group contemporaneously with delivery of such notice or communication, and such indication shall provide such member of
the Lender Group (other than the Third Party Agent during any Third Party Agent Retention Period) the means to refuse to receive such notice or communication; and in the absence of any such indication, such member of the Lender Group shall be
allowed to presume that all matters relating to such notice or communication do not constitute material nonpublic information relating to the Borrowers, any other Loan Party or any of their Affiliates or Subsidiaries, or any of their respective
property or Stock. Upon receipt or delivery by any Loan Party or any of its Subsidiaries of any notice or other communication in accordance with the terms of the Loan Documents, unless the Borrower Representative has in good faith determined
that the matters relating to such notice do not constitute material, nonpublic information relating to the Borrowers or any other Loan Party or any of their Affiliates or Subsidiaries or their respective property or Stock (and other than a notice or
communication delivered to the Third Party Agent during any Third Party Agent Retention Period), Endologix shall, within one Business Day after any such receipt or delivery publicly disclose the material, nonpublic information contained in the
notice or communication; provided, however, that Endologix shall in no event be obligated to make public disclosure of any material nonpublic information contained in any Borrowing Base Certificate (Agent) delivered solely at the
written request of Agent or any Lender in accordance herewith at a time when the Borrower Representative notifies Agent or such Lender in writing in good faith that such Borrowing Base Certificate (Agent) would contain material nonpublic information
and Agent or such Lender agrees in writing to accept such Borrowing Base Certificate (Agent) notwithstanding such material nonpublic information included therein (in each case, other than, for the avoidance of doubt, a Borrowing Base Certificate
(Agent) delivered in connection with the filing of a 10-Q or 10-K or with respect to any other filing with the SEC)). In the event of a breach of any of the
foregoing covenants by any Borrower or any of its Subsidiaries or Affiliates, or any of its or their respective officers, directors (or equivalent persons), employees, attorneys, representatives or agents (it being understood and agreed that the
Third Party Agent is not an agent, employee, attorney or representative of any Borrower, its Subsidiaries or its Affiliates), in addition to any other remedies provided in the Loan Documents or otherwise available at law or in equity, the members of
the Lender Group shall have the right to make a public disclosure in the form of a press release, public advertisement or otherwise, of the applicable material nonpublic information regarding the Borrowers or its Subsidiaries or Affiliates without
the prior approval by any Borrower or its Subsidiaries or Affiliates, or any of its or their respective officers, directors (or equivalent persons), employees, attorneys, representatives or agents, and no member of the Lender Group shall have any
liability to any Borrower, any of its Subsidiaries or Affiliates or any of its or their respective officers, directors (or equivalent persons), employees, equityholders, attorneys, representatives or agents for any such disclosure. 

5.21 Eligible Equipment. Each Borrower will use commercially reasonable efforts to at all times keep its furniture, fixtures and
Equipment in good repair and physical condition. In addition to the foregoing, from time to time, Agent (including, during any Third Party Agent Retention Period, the Third Party Agent) may require Borrowers to obtain and (a) subject to
Section 5.20, deliver to Agent, or (b) during any Third Party Agent Retention Period, deliver to the Third Party Agent, in each case of clause (a) and clause (b), appraisal reports in form and substance
and from appraisers reasonably satisfactory to Agent (or, as applicable, the Third Party Agent) stating the then current fair market values of all or any portion of furniture, fixtures and equipment owned by each Borrower or any of its Subsidiaries.

 5.22 Maximum Revolver Related Notices. Each Borrower will provide written notice to Agent (and, during any Third Party Agent
Retention Period, also the Third Party Agent) immediately upon the occurrence of: (a) any Maximum Revolver Decreased Market Capitalization Notice Trigger Event (including reasonable details related thereto) and (b) any Maximum Revolver
Decreased Market 

  
 97 

 
Capitalization Overadvance Event (including reasonable details related thereto and reasonable details and calculations of the Maximum Revolver Decreased Market Capitalization Overadvance Amount).

 ARTICLE VI. 

NEGATIVE COVENANTS. 

Borrowers covenant and agree that, until termination of all of the Commitments and payment in full in cash of the Obligations: 

6.01 Restrictions on Fundamental Changes. The Loan Parties will not, and will not permit any of their Subsidiaries to,
directly or indirectly, (I) merge with, consolidate with or into, dissolve or liquidate into or convey, transfer, lease or otherwise dispose of (whether in one transaction or in a series of transactions) all or substantially all of its assets
(whether now owned or hereafter acquired) to or in favor of any Person, except (a) a Subsidiary that is not a Loan Party may merge into any Loan Party or any Subsidiary of a Loan Party (provided that, (w) to the extent such Subsidiary that
is not a Loan Party has its equity pledged to Agent, then any Person it merges with must also have its equity pledged to Agent by at least the same percentage and (x) if such merger is with a Loan Party, such Loan Party must be the surviving
entity of any such merger), (b) a Loan Party may merge into any other Loan Party (provided that, (y) to the extent such Loan Party being merged has its equity pledged to Agent, then any Person it merges with must also have its equity pledged to
Agent by at least the same percentage and (z) to the extent the Borrower is part of such transaction, the Borrower must be the surviving Person), (c) any Subsidiary of Endologix may liquidate or dissolve if (i) the Borrowers determine in
good faith that such liquidation or dissolution is in the best interests of the Borrowers and it is not materially disadvantageous to the Secured Parties and (ii) to the extent such Subsidiary is a Loan Party, any such assets or business held
by such subject Subsidiary shall be transferred to, or otherwise owned or conducted by, a Loan Party after giving effect to such liquidation or dissolution, and (d) in connection with Permitted Acquisitions, or (II) divide (or otherwise
split) itself or themselves into two or more limited liability companies or other entities or Persons. None of the Loan Parties shall establish or form any Subsidiary, unless such Subsidiary complies with Section 5.09, if
applicable, and such Subsidiary (if not an Excluded Subsidiary) executes and/or delivers all other documents, agreements and instruments reasonably requested by Agent or the Required Lenders to perfect a Lien in favor of Agent (for the benefit of
the Secured Parties and Lender Group) on such Subsidiary’s (if not an Excluded Subsidiary) assets and to make such Subsidiary (if not an Excluded Subsidiary) a Loan Party under the Loan Documents. 

6.02 Joint Ventures; Restricted Payments. The Loan Parties will not, and will not permit any of its Subsidiaries to,
(a) enter into any joint venture or any similar arrangement, other than as may be permitted under Permitted Investments, or (b) make any Restricted Payments, other than (i) dividends by any direct or indirect Subsidiary of any Loan
Party (A) that are not Loan Parties to such Loan Party’s parent or parent entities or (B) that are Loan Parties, to such Loan Party’s parent or parent entities that are Loan Parties; (ii) dividends payable solely in common
Stock; (iii) repurchases of Stock of former employees, directors or consultants so long as an Event of Default does not exist at the time of such repurchase and would not exist after giving effect to such repurchase, provided, however, that
such repurchase does not exceed $2,500,000 in the aggregate per fiscal year; (iv) any Restricted Payments made under Subordinated Debt Documents to the extent permitted under the terms of the applicable Subordination Agreement; and (v) any
Restricted Payments made to the “Secured Parties” (as defined in the Term Credit Agreement) pursuant to the terms of the Term Debt Documents, the “Warrants” (as defined in the Term Credit Agreement) and the “Registration
Rights Agreement” (as defined in the Term Credit Agreement). 

  
 98 

 6.03 Liens. The Loan Parties will not, and will not permit any of their
Subsidiaries to directly or indirectly make, create, incur, assume or suffer to exist any Lien upon or with respect to any of its assets or property, of any kind, whether now owned or hereafter acquired, or any income or profits therefrom, except
Permitted Liens. 
 6.04 Disposal of Assets. Other than Permitted Dispositions or transactions expressly permitted by
Section 6.01, Borrowers will not, and will not permit any of their Subsidiaries to directly or indirectly Dispose of (whether in one or a series of transactions) any assets or property (including the Stock of any Subsidiary
of any Loan Party, whether in a public or private offering or otherwise, and accounts and notes receivable, with or without recourse). 

6.05 Indebtedness; Contingent Obligations. The Loan Parties will not, and will not permit any of its Subsidiaries to,
directly or indirectly, create, incur, assume, guarantee, permit to exist or be liable with respect to any Indebtedness, other than Permitted Indebtedness. The Loan Parties will not, and will not permit any of their Subsidiaries to, directly or
indirectly, create, assume, incur or suffer to exist any Contingent Obligations, except for Permitted Contingent Obligations. 
 6.06
Investments. The Loan Parties will not, and will not permit any of its Subsidiaries to, directly or indirectly, (a) purchase or acquire any Stock, or any obligations or other securities of, or any interest in, any Person, including the
establishment or creation of a Subsidiary, (b) make or commit to make any Acquisitions, or any other acquisition of any of the assets of another Person other than (i) Permitted Investments or (ii) in the Ordinary Course of Business,
or of any business or division of any Person, including by way of merger, consolidation, other combination or otherwise other than Permitted Investments, (c) make, purchase or acquire any advance, loan, extension of credit (other than trade
payables in the ordinary course of business) or capital contribution to or any other investment in, any Person including the Borrower, any Affiliate of the Borrower or any Subsidiary of the Borrower or (d) enter into any joint venture or any
similar arrangement (the items described in clauses (a), (b), (c) and (d) are referred to as “Investments”), except for Permitted Investments. 

6.07 Transactions with Affiliates. Except as otherwise disclosed on Schedule 6.07, and except for transactions that
contain terms that are no less favorable to the applicable Loan Party or any Subsidiary of a Loan Party, as the case may be, than those which might be obtained from a third party not an Affiliate of any Loan Party, no Loan Party will, or permit any
Subsidiary to, directly or indirectly, enter into or permit to exist any transaction (including the purchase, sale, lease or exchange of any property or the rendering of any service) with any Affiliate of any Loan Party that is not itself a Loan
Party; provided that, Loan Parties may enter into and maintain written agreements between any Loan Party and any Foreign Subsidiary of a Loan Party for management services for compensation in the Ordinary Course of Business consistent with
past practices that are customary and reasonably appropriate to do for companies in the same industry as the Loan Parties provided by management and officers of the Loan Parties to such Foreign Subsidiaries that do not have certain management or
officers, and such transactions may result in non-interest bearing accounts payables for the unpaid compensation owed by such Foreign Subsidiaries to the Loan Parties for such management services in an amount
not to exceed $40,000,000 (which payables may be equitized by the Loan Parties, provided that (y) equitization of such payables shall not reduce the outstanding amount of payables that count towards the $40,000,000 cap above for purposes of
determining whether the Loan Parties have complied with this provisions (with such equitized amounts deemed to be outstanding at all times thereafter for purposes of the $40,000,000 capped amount) and (z) at the time of any such equitization,
any such Stock received by any Loan Party in connection with such equitization shall be pledged, and a first priority security interest and Lien thereon shall be granted, to the Agent (for the benefit of the Lender Group) and such Loan Party shall
take such perfection and priority actions reasonably requested by the Agent in accordance with the Loan 

  
 99 

 
Documents), in each case of the foregoing in this proviso, so long as (a) any such management or officers of the Loan Parties involved in such transactions, agreements and arrangements will
have sufficient and reasonable time, energy and resources to still represent and service such Loan Parties themselves after taking into such transactions, agreements and arrangements, (a) any such agreement, instrument, arrangement or document
evidencing any of the foregoing transactions, equitization or actions shall be entered into (i) in good faith by such Loan Party, (A) in a manner to not contravene or impair the Collateral and benefits that are intended to be provided and
afforded to the Lender Group under the Loan Documents, and (B) without (I) the intention of such Loan Party of causing (or resulting in) the Collateral to be taken from the Secured Parties and provided to Foreign Subsidiaries that are not
Loan Parties at the detriment of the Secured Parties and for the benefit of such Foreign Subsidiaries, and (II) the effect of defrauding the Secured Parties, (C) the upstream economics received (or potentially to be received) by any
applicable Loan Party in connection with any such transaction, agreement or arrangement described above in this proviso, when combined with the potential downstream economics, time, energy and recourses exhausted or disposed of in connection
therewith shall be reasonably adequate and sufficient to enable the Loan Parties to timely satisfy all of the Obligations and all of their other obligations and agreements under the Loan Documents, (D) all cash, Cash Equivalents, other assets
and proceeds received or provided to the Loan Parties in connection with the foregoing shall all be part of the (and constitute) Collateral and the Agent (for the benefit of the Lender Group) shall have a first priority security interest and Lien
thereon, (E) at the reasonable request of the Agent, all such account payables will be evidenced by a promissory note issued to the applicable Loan Party by the applicable Foreign Subsidiary and pledged to the Agent and the original thereof
delivered, along with an executed allonge to the Agent in form and substance satisfactory to the Agent, (F) no Default or Event of Default has occurred and is continuing or would result therefrom, and (G) no such agreement, arrangement,
transaction or action could reasonable be expected, individually or in the aggregate, to result in a Material Adverse Effect. 
 6.08
ERISA. No ERISA Affiliate shall cause or suffer to exist (a) any event that could result in the imposition of a Lien on any asset of a Loan Party or a Subsidiary of a Borrower with respect to any Title IV Plan or Multiemployer Plan, or
(b) any other ERISA Event, which other ERISA Event could reasonably be expected, individually or in the aggregate, to have a Material Adverse Effect. 

6.09 Nature of Business. The Loan Parties will not, and will not permit any of their Subsidiaries to engage in any line of
business different from those lines of business carried on by it on the Closing Date and businesses reasonably related thereto. 

6.10 Amendments to Organizational Documents and Material Contracts. Except as permitted under
Section 6.01, no Loan Party shall, and no Loan Party shall permit any of its Subsidiaries to, directly or indirectly amend or otherwise modify any of its Organizational Documents or, after the execution thereof, any
agreements or documents evidencing or contemplating any Permitted Acquisition in any respect materially adverse to any Secured Party. No Loan Party will, or will permit any Subsidiary to, directly or indirectly, amend, restate, supplement, change,
waive or otherwise modify any Material Contract, which amendment, restatement, supplement, change, waiver or modification in any case: (a) is contrary to (or is in violation or breach of) the terms and provisions of this Agreement or any other
Loan Document (including the Intercreditor Agreement); or (b) could reasonably be expected to be materially adverse to the rights, interests or privileges of Agent or the Lenders or their ability to enforce the same (it being understood that
any modification that changes the stated maturity date of the 3.25% Convertible Notes to an earlier date shall be materially adverse to the Agent and the Lenders); provided, however, that the foregoing shall not restrict (x) any changes
expressly required under the terms of the 2.25% Convertible Notes as of the Closing Date, the 3.25% Convertible Notes as of the Closing Date or any indenture governing any Permitted 3.25% Convertible Note Refinancing meeting the requirements set

  
 100 

 
forth in the definition of “Permitted 3.25% Convertible Note Refinancing”, or (y) any modifications of the Term Credit Agreement expressly permitted by the Intercreditor Agreement
and not otherwise materially adverse to Agent or the Lenders. 
 6.11 Changes to Fiscal Year; GAAP. No Loan Party shall, and no
Loan Party shall suffer or permit any of its Subsidiaries to, (a) make any significant change in accounting treatment or reporting practices, except as required by GAAP, (b) change the fiscal year or method for determining the fiscal
quarters of any Loan Party or of any Subsidiary of any Loan Party, (c) change its name as it appears in official filings in its jurisdiction of organization or formation, or (d) change its jurisdiction of organization or formation, in the
case of clauses (c) and (d), without, subject to Section 5.20, at least ten (10) days’ prior written notice to Agent (or such shorter period as may be agreed by Agent in its sole reasonable discretion). 

6.12 Prepayments and Amendments. The Loan Parties will not, and will not permit any of their Affiliates to (A) declare, pay,
make or set aside any amount for payment in respect of Subordinated Debt, except for payments made in full compliance with and permitted under the Subordination Agreement, (B) amend or otherwise modify the terms of any Subordinated Debt, except
for amendments and modifications made in full compliance with the Subordination Agreement; or (C) declare, pay, make or set aside any amount for payment in respect of any Indebtedness hereinafter incurred that, by its terms, or by separate
agreement, is subordinated to the Obligations, except for payments made in full compliance with and permitted under the subordination provisions applicable thereto. 

6.13 Restrictions on Distributions. No Loan Party shall, and no Loan Party shall permit any of its Subsidiaries to, directly or
indirectly, create or otherwise cause or suffer to exist or become effective any consensual restriction or encumbrance of any kind on the ability of any Loan Party or Subsidiary to pay dividends or make any other distribution on any of such Loan
Party’s or Subsidiary’s Stock or to pay fees, including management fees, or make other payments and distributions to any Loan Party or any other Loan Party, except for those in the Loan Documents and the Term Debt Documents. No Loan Party
shall, and no Loan Party shall permit any of its Subsidiaries to, directly or indirectly (a) enter into, assume or become subject to any contractual obligation prohibiting or otherwise restricting the existence of any Lien upon any of its
assets in favor of Agent, whether now owned or hereafter acquired or (b) create or otherwise suffer to exist or become effective any consensual encumbrance or restriction of any kind on the ability of any Subsidiary to (i) pay any
Indebtedness owed to any Borrower or any of its Subsidiaries, (ii) make loans or advances to any Borrower or any of their Subsidiaries or (iii) transfer any of its property or assets to any Borrower or any of their Subsidiaries, except
(A) those in the Loan Documents and the Term Debt Documents, (B) an encumbrance or restriction consisting of customary non-assignment provisions in leases or licenses entered into in the Ordinary
Course of Business, (C) customary provisions in joint venture agreement and other similar agreements that restrict the transfer of ownership interests in such joint ventures or provisions limiting the disposition or distribution of assets or
property (other than dividends on a pro rata basis based on ownership percentage) of the applicable joint venture, which limitation is applicable only to the assets that are the subject of such agreements; provided that such agreement was not
entered into in contravention of the terms of this Agreement, and (D) limitations set forth in Subordinated Debt (if acceptable to the Agent in its sole discretion). 

6.14 Sanctions; Anti-Corruption. No Loan Party shall, and no Loan Party shall permit any of its Subsidiaries to fail to comply
with the Anti-Money Laundering Laws and Anti-Terrorism Laws. No Loan Party or Subsidiary of a Loan Party, nor to the knowledge of any Loan Party or any of its Subsidiaries, any director, officer, agent, employee or other Person acting on behalf of
any Loan Party or any such Subsidiary, will request or use the proceeds of any Loan, directly or indirectly, (a) for any payments to any Person, including any government official or employee, political party, official of a

  
 101 

 
political party, candidate for political office or anyone else acting in an official capacity, in order to obtain, retain or direct business or obtain any improper advantage, or otherwise take
any action, directly or indirectly, that would result in a violation of any Anti-Corruption Laws, (b) for the purpose of funding, financing or facilitating any activities, business or transaction of or with any Person on the SDN List or a
government of a country or territory subject to comprehensive Sanctions, to the extent such activities, business or transaction would be prohibited by Sanctions if conducted by a corporation incorporated in the United States or in a European Union
member state, (c) in any manner that would result in the violation of any Sanctions applicable to any party hereto, or (d) to fund any activities or business of or with any Person, or in any country or territory, that, at the time of such
funding, is, or whose government is, the subject of sanctions pursuant to any Anti-Terrorism Laws. Furthermore, the Loan Parties will not, directly or indirectly, use the proceeds of the Transaction, or lend, contribute or otherwise make available
such proceeds to any Subsidiary, Affiliate, joint venture partner or other Person, to fund any activities of or business with any Person, or in any country or territory, that, at the time of such funding, is the subject of Sanctions, or in any other
manner that will result in a violation by any Person participating in the Transaction of any Sanctions. No Loan Party shall, and no Loan Party shall permit any of its Subsidiaries to directly or indirectly, knowingly enter into any Material
Contracts with any Person on the SDN List. 
 6.15 Sale Leaseback Transactions. No Loan Party shall, and no Loan Party shall
permit any of its Subsidiaries to, engage in a sale leaseback, synthetic lease or similar transaction involving any of its assets, including pursuant to a substantially contemporaneous transaction, whereby a Loan Party or one of its Subsidiaries
sells or transfers all or substantially all of its right, title and interest in an asset and, in connection therewith, acquires or leases back the right to use such asset. 

6.16 Environmental. No Loan Party shall, and no Loan Party shall permit any of its Subsidiaries to, cause or suffer to exist any
Release of any Hazardous Material at, to or from any Real Property that would violate or form the basis of Liability under any Environmental Law or Healthcare Law, other than such violations or liabilities that could not reasonably be expected,
individually or in the aggregate, to result in a Material Adverse Effect. 
 6.17 Investment Company. No Loan Party shall, and
no Loan Party shall permit any of its Subsidiaries to, be an “investment company” or a company “controlled” by an “investment company,” as such terms are defined in the Investment Company Act, or to otherwise be
registered or required to be registered, or be subject to the restrictions imposed by, the Investment Company Act. 
 6.18
Intercreditor Agreement; Term Debt. No Loan Party shall, and no Loan Party shall permit any of its Subsidiaries to, (a) make any prepayment, payment, redemption or repayment or take any action, with respect to the Term Debt that is in
violation or breach of the Intercreditor Agreement, (b) make any amendment, restatement, supplement or modification of any Term Debt Document in violation or breach of the Intercreditor Agreement or that is materially adverse to Agent or the
Lenders; or (c) join any Subsidiary or any Affiliate of any Loan Party as a borrower, guarantor or obligor, or have such Person pledge or grant a Lien on any of its property or assets, under the Term Debt Documents, unless, in each case, the
same Person becomes a Loan Party in the same capacity (and/or pledges and grants Liens on the same property or assets (and with the same Lien priority and which such Liens shall be subject to the terms of the Intercreditor Agreement) under the Loan
Documents and such Person executes and delivers such agreements, instruments and documents reasonably requested by Agent to effectuate any of the foregoing in this clause (c) and such Subsidiary or Affiliate shall be
subject to the terms of the Intercreditor Agreement. 
 6.19 Payment of Convertible Notes and Permitted Japan Lifeline
Unsecured Debt. No Loan Party will, or will permit any Subsidiary to, declare, pay, make any payment in respect of (I) the 

  
 102 

 
3.25% Convertible Notes or the 2.25% Convertible Notes, except for: (a) regularly scheduled payments of interest and principal as set forth in the applicable Convertible Note Documents (in
addition to allowing any cash principal payments at maturity of the applicable 3.25% Convertible Notes and the 2.25% Convertible Notes, such amounts may also be paid in the applicable Stock of the Borrower or through any other conversion feature
that does not effectively cause more payments to be made at maturity thereof than the cash principal payments currently provided for in the applicable Convertible Note Documents as of the Closing Date), (b) in connection with any Permitted 3.25%
Convertible Note Refinancing, (c) the issuance of shares of common stock of the Borrower in connection with any conversion of the 3.25% Convertible Notes, the 2.25% Convertible Notes or any convertible notes that are not Disqualified Stock
issued in a Permitted 3.25% Convertible Note Refinancing, and any cash solely in lieu of fractional shares (but no other cash settlement other than as otherwise permitted by this Section 6.19), (d) payments and conversions
(other than for any Disqualified Stock) made in connection with the repurchase (whether for cash, upon exchange and/or for other consideration), redemption and retirement in respect of the 2.25% Convertible Notes or 3.25% Convertible Notes in a
single or series of related transactions; provided that (i) no Event of Default exists at the time such payments are made or would exist immediately after giving effect thereto and (ii) such cash payments are made solely (A) with
proceeds received by Endologix from the issuance of its common Stock after the Closing Date for the purpose of making such payment, and (B) regarding the 3.25% Convertible Notes, with the proceeds of Indebtedness raised in a Permitted 3.25%
Convertible Note Refinancing, and (e) if the foregoing conditions do not otherwise permit such payment, then, with the express prior written consent of the Agent (which may be withheld in its sole discretion), payments in connection with the
retirement, redemption and repurchase of the 2.25% Convertible Notes or the 3.25% Convertible Notes or (II) the Permitted Japan Lifeline Unsecured Debt, except with respect to any interest payments expressly permitted under the definition of
“Permitted Japan Lifeline Unsecured Debt”. 
 6.20 Commingling of Assets. (a) No Loan Party will, or permit any
Subsidiary to commingle any of its assets (including any bank accounts, cash or Cash Equivalents) with the assets of any Person; and (b) no Loan Party will, or permit any Subsidiary to enter into or own any interest in a joint venture that is
not itself a corporation or limited liability company or other legal entity in respect of which the equity holders are not liable for the obligations of such entity as a matter of law. 

6.21 Limitation on Issuance of Stock. Endologix shall not issue any Stock (a) senior to its shares of Common Stock or
(b) convertible into or exercisable or exchangeable for Stock senior to its Common Stock. 
 6.22 Use of Proceeds. The
Loan Parties will not, and will not permit any of their Subsidiaries to use the proceeds of any Loan or other extension of credit made hereunder for any purpose other than as described in Section 4.19. 

6.23 Anti-Layering. No Loan Party shall, or permit any Subsidiary to, create, incur or suffer to exist any Indebtedness which is
subordinated or junior (either in respect of Lien priority or in right of payment or any combination thereof) to any of the Term Debt unless such Indebtedness is expressly subordinated or junior to the Obligations (both in terms of Lien Priority and
in right of payment) on terms and conditions acceptable to Agent and the Lenders (it being understood and agreed that this Section 6.23 shall in no way limit the incurrence of unsecured Indebtedness otherwise permitted
under this Agreement that is not payment subordinated to the Term Debt when not also payment subordinated to the same extent to the Obligations). 

6.24 Convertible Notes Restrictions. No Loan Party shall, or shall permit any Subsidiary to, amend, restate, supplement, change,
waive or otherwise modify the terms of any Indebtedness referred to 

  
 103 

 
in Section 6.19 above (other than with respect to 3.25% Convertible Notes, in connection with a Permitted 3.25% Convertible Note Refinancing) if the effect of such
amendment, restatement, supplement, change, waiver or modification is to (a) increase the interest rate or fees on, or change the manner or timing of payment of, such Indebtedness if in any way adverse to the Agent or the Lenders,
(b) accelerate or shorten the dates upon which payments of principal or interest are due on, or the principal amount of, such Indebtedness, (c) change in a manner adverse to any Loan Party, any of its Subsidiaries, Agent or any Lender any
event of default or add or make more restrictive any covenant with respect to such Indebtedness, (d) change the prepayment provisions of such Indebtedness or any of the defined terms related thereto in a manner adverse to Agent or the Lenders,
or (e) change or amend any other term if such change or amendment would materially increase the obligations of the obligor or confer additional material rights on the holder of such Indebtedness in a manner adverse to any Loan Party, any of its
Subsidiaries, Agent or the Lenders; provided, however, that (y) the foregoing shall not restrict any changes expressly required under the terms of the 3.25% Convertible Notes as in effect as of the Prior Agreement Date, the 2.25%
Convertible Notes as in effect as of the Closing Date or any changes that are permitted to be made hereunder in connection with a Permitted 3.25% Convertible Note Refinancing or any changes expressly required under any indenture governing any
Permitted 3.25% Convertible Note Refinancing that satisfies the conditions and requirements set forth in the definition of “Permitted 3.25% Convertible Note Refinancing” and (z) the exchange of the “Exchanged Deerfield
Convertible Notes” (as defined in the Term Credit Agreement) for the “Last Out Waterfall Loans” (as defined in the Term Credit Agreement) under the Term Credit Agreement on the Closing Date shall not be restricted by this
Section 6.24. The Loan Parties will, prior to entering into any such amendment, restatement, supplement, change, waiver or modification, deliver to Agent (and, during any Third Party Agent Retention Period, also the Third
Party Agent) reasonably in advance of the execution thereof, any final or execution form copy thereof. 
 ARTICLE VII. 

FINANCIAL COVENANTS. 

7.01 Financial Covenants. Each of the Borrowers covenant and agree that, until termination of all of the Commitments and
payment in full in cash of the Obligations, the Loan Parties will not permit: 
 (a) Fixed Charge Coverage Ratio. Commencing as of the
Trigger Date, the Fixed Charge Coverage Ratio for any Measurement Period, tested quarterly beginning with the fiscal quarter ending September 30, 2018, to be less than 1.00:1.00. 

(b) Minimum Global Excess Liquidity. On the (i) the last Business Day of each month and (ii) each date that a Borrowing Base
Certificate is required to be delivered in accordance with Section 5.16, Global Excess Liquidity to be less than $22,500,000. 

(c) TTM Minimum Net Revenue. Their consolidated Net Revenue for any Measurement Period, tested quarterly beginning with the fiscal
quarter ending September 30, 2018, to be less than the amounts set forth below: 
  

					
	 Measurement Period Ending
	  	Minimum Net
Revenue for
Measurement Period	 
	 September 30, 2018
	  	$	155,000,000	 
	 December 31, 2018
	  	$	145,000,000	 

  
 104 

					
	 March 31, 2019 and the last day of each fiscal quarter ending thereafter through (and
including) December 31, 2019
	  	$	130,000,000	 
	 March 31, 2020 and the last day of each fiscal quarter ending thereafter
	  	$	140,000,000	 

 (d) Quarterly Minimum Net Revenue. Their consolidated Net Revenue for any fiscal quarter of Endologix,
tested quarterly beginning with the fiscal quarter ending March 31, 2019 and on the last day of each fiscal quarter ending thereafter, to be less than $30,000,000. 

(e) Maximum Consolidated Capital Expenditures. The aggregate amount of consolidated Capital Expenditures made by the Loan Parties and
their Subsidiaries to exceed the amounts set forth below: 
  

					
	 Fiscal Year
	  	Amount	 
	 2018
	  	$	2,500,000	 
	 2019
	  	$	3,000,000	 
	 2020
	  	$	5,000,000	 
	 2021
	  	$	2,000,000	 

 (f) Maximum Consolidated Operating Expenditures. The aggregate amount of Operating Expenditures made by
the Loan Parties and their Subsidiaries for any Measurement Period, tested for the fiscal quarters of Endologix ending December 31 2018 and December 31, 2019, to exceed the amounts set forth below: 

 

					
	 Fiscal Year
	  	Amount	 
	 December 31, 2018
	  	$	160,000,000	 
	 December 31, 2019
	  	$	140,000,000	 

 ARTICLE VIII. 

EVENTS OF DEFAULT. 
 Any
one or more of the following events shall constitute an event of default (each, an “Event of Default”) under this Agreement: 

8.01 Payments. Any Borrower or any other Loan Party shall have failed (i) to pay when and as required to be paid herein or
in any other Loan Document, any amount of principal of any Loan, including after maturity of the Loans, or (ii) to pay within three (3) Business Days after the same shall become due, all or any portion of the Obligations consisting of
interest, fees, or charges due the Lender Group, reimbursement of Lender Group Expenses, or other amounts (other than any portion thereof constituting principal) constituting Obligations (including Liquidated Damages or any remaining Commitment Fee,
as applicable, and any portion of the Obligations that accrues after the commencement 

  
 105 

 
of an Insolvency Proceeding, regardless of whether allowed or allowable in whole or in part as a claim in any such Insolvency Proceeding). 

8.02 Covenants. If any Loan Party or any of their Subsidiaries shall have failed to comply with or observe (a)(i) Section
3.04, 5.01(a)(i), 5.01(b), 5.02, 5.03, 5.04, 5.05, 5.06, 5.08, 5.09, 5.10, 5.13, 5.14, 5.15, 5.16, 5.17, 5.19, 5.20,
5.21 or 5.22 of this Agreement, Article VI of this Agreement, Article VII of this Agreement, (ii) Sections 5.2(a), 5.2(c), 5.2(d), 5.3, 5.4, 5.5, 5.7, 5.9 and 5.10 of the Guaranty and Security Agreement or (iii) any provision
of any Note, (b) Section 5.1 of the Guaranty and Security Agreement and such failure, with respect to this Section 8.02(b) only, shall not have been cured within ten (10) days after the earlier to occur of
(y) the date upon which any officer of any Loan Party or any of its Subsidiaries becomes aware of such failure and (z) the date upon which written notice thereof is given to any Loan Party or any of its Subsidiaries by any Secured Party or
(c) any covenant contained in any Loan Document (other than the covenants described in Section 8.01, Section 8.02(a) or Section 8.02(b) above), and such failure, with
respect to this Section 8.02(c) only, shall not have been cured within thirty (30) days after the earlier to occur of (y) the date upon which any officer of any Loan Party or any of its Subsidiaries becomes aware
of such failure and (z) the date upon which written notice thereof is given to any Loan Party or any of its Subsidiaries by any Secured Party. 

8.03 Representations, etc. Any representation, warranty, or certification, made by any Loan Party in any Loan Document or
delivered in writing to Agent (including any Third Party Agent), any Lender or any other member of the Lender Group in connection with this Agreement or any other Loan Document shall have been incorrect, false or misleading in any material respect
(except to the extent that such representation or warranty is qualified by reference to materiality or Material Adverse Effect, to which extent it shall have been incorrect, false or misleading in any respect) as of the date it was made; it being
acknowledged and agreed that any projections provided to the Secured Parties are not to be viewed as facts, are not a guarantee of financial performance, and are subject to uncertainties and contingencies. 

8.04 Insolvency; Bankruptcy. (a) Any Loan Party or any of its Subsidiaries (other than Immaterial Subsidiaries) shall
generally be unable to pay its debts as such debts become due, or shall admit in writing its inability to pay its debts as they come due or shall make a general assignment for the benefit of creditors; (b) any Loan Party or any of its
Subsidiaries (other than Immaterial Subsidiaries) shall declare a moratorium on the payment of its debts; (c) the commencement by any Loan Party or any of its Subsidiaries (other than Immaterial Subsidiaries) of proceedings to be adjudicated
bankrupt or insolvent, or the consent by it to the commencement of bankruptcy or insolvency proceedings against it, or the filing by it of a petition or answer or consent seeking reorganization, intervention or other similar relief under any
Applicable Law, or the consent by it to the filing of any such petition or to the appointment of an intervenor, receiver, liquidator, assignee, trustee, sequestrator or other similar official of all or substantially all of its assets; (d) the
commencement against any Loan Party or any of its Subsidiaries (other than Immaterial Subsidiaries) of a proceeding in any court of competent jurisdiction under any bankruptcy or other Applicable Law (as now or hereafter in effect) seeking its
liquidation, winding up, dissolution, reorganization, arrangement or adjustment, or the appointment of an intervenor, receiver, liquidator, assignee, trustee, sequestrator or other similar official, and any of the following events occur:
(i) such Loan Party or such Subsidiary consents to the institution of such Insolvency Proceeding against it, (ii) the petition commencing the Insolvency Proceeding is not timely controverted, (iii) the petition commencing any such
proceeding shall continue undismissed, or any order, judgment or decree approving or ordering any of the foregoing shall continue unstayed or otherwise in effect, for a period of sixty (60) calendar days of the date of filing thereof, or
(iv) an interim trustee is appointed to take possession of all or any substantial portion of the properties or assets of, or to operate all or any substantial portion of the business of, such Loan Party or its Subsidiary; (e) the making by
any Loan Party or any of its Subsidiaries (other than Immaterial Subsidiaries) of an assignment for the benefit of 

  
 106 

 
creditors, or the admission by it in writing of its inability to pay its debt generally as they become due; or (f) any other event shall have occurred which under any Applicable Law would
have an effect analogous to any of those events listed above in this Section 8.04. 
 8.05 Judgments.
One or more judgments, orders or decrees or settlements shall be rendered against any Loan Party or any Subsidiary of a Loan Party that exceeds by more than $1,000,000 any insurance coverage applicable thereto (to the extent the relevant insurer has
been notified of such claim and has not denied coverage therefor) or one or more non-monetary judgments, orders or decrees or settlements shall be rendered against any Loan Party or any Subsidiary of a Loan
Party that could reasonably be expected, individually or in the aggregate, to result in a Material Adverse Effect, and in either case (i) enforcement proceedings shall have been commenced by any creditor upon any such judgment, order or decree
or (ii) there shall be any period of twenty (20) consecutive days during which such judgment, order or decree shall not have been vacated or discharged or there shall not be in effect (by reason of a pending appeal or otherwise) any stay
of enforcement thereof. 
 8.06 No Governmental Authorization. Any authorization of a Governmental Authority necessary for the
execution, delivery or performance of any Loan Document or for the validity or enforceability of any of the Obligations under any Loan Document is not given or is withdrawn or ceases to remain in full force or effect. 

8.07 Agreement Invalid Under Applicable Law. Any Applicable Law shall purport to render any material provision of any Loan
Document invalid or unenforceable or shall purport to prevent or materially delay the performance or observance by any Loan Party or any of its Subsidiaries of the Obligations (which, for the avoidance of doubt, shall not apply to the process of SEC
comments in respect of share registration). 
 8.08 Cross-Default. Any Loan Party or any Subsidiary of any Loan Party
(a) shall fail to make any payment in respect of any Indebtedness having an individual principal amount (including undrawn committed or available amounts and including amounts owing to all creditors under any combined or syndicated credit
arrangement) in excess of $3,000,000 or having an aggregate principal amount (including undrawn committed or available amounts and including amounts owing to all creditors under any combined or syndicated credit arrangement) of more than $8,000,000
when due (whether by scheduled maturity, required prepayment, acceleration, demand or otherwise) and such failure continues after the applicable grace or notice period, if any, specified in the documents relating thereto on the date of such failure;
or (b) shall fail to perform or observe any other condition or covenant, or any other event shall occur or condition exist, under any agreement or instrument relating to any such Indebtedness of the type covered in
Section 8.08(a) above, if the effect of such failure, event or condition is to cause, or to permit the holder or holders of such Indebtedness or beneficiary or beneficiaries of such Indebtedness (or a trustee or agent on
behalf of such holder or holders or beneficiary or beneficiaries) to cause, such Indebtedness to be declared to be due and payable (or otherwise required immediately to be prepaid, redeemed, purchased or defeased) prior to its stated maturity
(without regard to any subordination terms with respect thereto) or cash collateral in respect thereof to be demanded; provided however that, notwithstanding the foregoing, any event or condition that occurs that permits holders of convertible
Indebtedness permitted hereunder to convert such Indebtedness into Stock (other than Disqualified Stock) or such other consideration permitted pursuant to Section 6.19 pursuant to the terms of the applicable indenture shall
not constitute a Default or Event of Default hereunder on such basis alone. 
 8.09 Loan Documents; Security Interests. Any
material provision of any Loan Document shall for any reason cease to be valid and binding on or enforceable against any Loan Party or any Subsidiary of any Loan Party party thereto or any Loan Party or any Subsidiary of any Loan Party shall so

  
 107 

 
state in writing or bring an action to limit its obligations or liabilities thereunder or otherwise contest the validity, binding effect or enforceability of the Loan Documents; or any Loan
Document shall for any reason (other than pursuant to the terms thereof) cease to create a valid security interest in any of the Collateral in excess of such Collateral that has a fair market value of $50,000 as determined by the Agent in its sole
reasonable discretion (to the extent that such perfection or priority is required hereby) purported to be covered thereby or such security interest shall for any reason cease to be a perfected and first priority security interest (subject only to
the prior priority of the Permitted Priority Liens). 
 8.10 ERISA. (a) The occurrence of any ERISA Event that could
reasonably be expected, individually or in the aggregate, to have a Material Adverse Effect or (b) the imposition of a Lien on any asset of a Loan Party or a Subsidiary of a Loan Party with respect to any Title IV Plan or Multiemployer Plan.

 8.11 Product Withdrawal. The voluntary withdrawal or institution of any action or proceeding by the FDA or similar
Governmental Authority to order the withdrawal of any Product or Product category from the market or to enjoin a Loan Party, such Loan Party’s Subsidiaries or any representative of a Loan Party or its Subsidiaries from testing, manufacturing,
processing, assembly, packaging, labeling, marketing, importing, exporting, selling or distributing any Product or Product category that has, individually or in the aggregate, resulted (or could reasonably be expected, individually or in the
aggregate, to result) in a Material Adverse Effect, (ii) the institution of any action or proceeding by the DEA, the FDA, or any other Governmental Authority to revoke, suspend, reject, withdraw, limit, or restrict any Regulatory Required
Permit held by a Loan Party, its Subsidiaries or any representative of a Loan Party or its Subsidiaries, which, in each case of this clause (ii), has, individually or in the aggregate resulted (or could reasonably be expected, individually or
in the aggregate, to result) in a Material Adverse Effect, (iii) the commencement of any enforcement action against a Loan Party, a Loan Party’s Subsidiaries or any representative of a Loan Party or its Subsidiaries (with respect to the
business of a Loan Party or its Subsidiaries) by the DEA, the FDA, or any other Governmental Authority which has, individually or in the aggregate, resulted (or could reasonably be expected, individually or in the aggregate, to result) in a Material
Adverse Effect, or (iv) the occurrence of adverse test results in connection with a Product which has, individually or in the aggregate, resulted (or could reasonably be expected, individually or in the aggregate, to result) in a Material
Adverse Effect. 
 8.12 Change in Law. The introduction of, or any change in, any law or regulation governing or affecting the
healthcare industry, including any Healthcare Laws, that has or could reasonably be expected, individually or in the aggregate, to have a Material Adverse Effect. 

8.13 Material Contract Default. Any Loan Party defaults under or breaches any Material Contract (after any applicable grace
period contained therein), or a Material Contract shall be terminated by a third party or parties party thereto prior to the expiration thereof (other than in accordance with its terms), the 3.25% Convertible Notes, any Permitted 3.25% Convertible
Note Refinancing, the 2.25% Convertible Notes, any Term Debt Document or any Permitted Japan Lifeline Unsecured Debt Documents or there is a loss of a material right of a Loan Party under any Material Contract to which it is a party, in each case
which could reasonably be expected, individually or in the aggregate, to result in a Material Adverse Effect. 
 8.14 Other Default
or Breach. The occurrence of any breach or default under any terms or provisions of any Convertible Note Document, any Term Debt Document, any Permitted Japan Lifeline Unsecured Debt Documents or any Subordinated Debt Document or the occurrence
of any event requiring the prepayment or mandatory redemption of any 3.25% Convertible Note (or any Permitted 3.25% Convertible Note Refinancing thereof or any indenture or related document governing any Permitted

  
 108 

 
3.25% Convertible Note Refinancing), any 2.25% Convertible Note, any Term Debt Document, any Permitted Japan Lifeline Unsecured Debt Documents or of any Subordinated Debt; provided,
however, that, notwithstanding the foregoing, any event or condition that occurs that permits holders of convertible Indebtedness permitted hereunder to convert such Indebtedness into Stock (other than Disqualified Stock) or such other
consideration permitted pursuant to Section 6.19 pursuant to the terms of the applicable agreement shall not constitute a Default or Event of Default hereunder on such basis alone. 

8.15 Criminal Proceedings. The institution by any Governmental Authority of criminal proceedings against any Loan Party. 

8.16 Payment of Subordinated Debt. Any Loan Party makes any payment on account of any Indebtedness that has been subordinated to
any of the Obligations, other than payments specifically permitted by the terms of such subordination. 
 8.17 Any Intercreditor
Agreement Provisions Invalid. Any provisions of the Intercreditor Agreement shall for any reason be revoked or invalidated, or otherwise cease to be in full force and effect, other than in accordance with the terms thereof, or any Person shall
contest in any manner the validity or enforceability thereof or deny that it has any further liability or obligation thereunder. 

8.18 Guaranty. If the obligation of any Guarantor under the guaranty contained in the Guaranty and Security Agreement is limited
or terminated by operation of law or by such Guarantor (other than in accordance with the terms of this Agreement). 
 8.19
Subordination Provisions. (a) Any subordination provisions in respect of the documents evidencing or governing any Subordinated Debt (the “Subordination Provisions”) shall, in whole or in part, terminate, cease to be effective
or cease to be legally valid, binding and enforceable against any holder of the applicable Subordinated Debt; or (b) any Borrower or any other Loan Party shall, directly or indirectly, disavow or contest in any manner (i) the
effectiveness, validity or enforceability of any of the Subordination Provisions, (ii) that the Subordination Provisions exist for the benefit of the Lender Group or (iii) that all payments of principal of or premium and interest on the
applicable Subordinated Indebtedness, or realized from the liquidation of any property of any Loan Party, shall be subject to any of the Subordination Provisions. 

8.20 Change in Control. A Change in Control shall occur. 

8.21 Not Publicly Traded. The Common Stock shall cease to be registered under the Exchange Act or to be listed on the Principal
Market. 
 8.22 Term Debt Defaults. Any Loan Party or any Subsidiary (a) fails to make any payment when due (whether by
scheduled maturity, required prepayment, acceleration, demand, or otherwise) in respect of the Term Debt, or (b) fails to observe or perform any other agreement or condition relating to the Term Debt or contained in any instrument or agreement
evidencing, securing or relating thereto, or any other event occurs, the effect of which default or other event is to cause, or to permit the holder or holders of such Term Debt or the beneficiary or beneficiaries of any Guarantee related thereto
(or a trustee or agent on behalf of such holder or holders or beneficiary or beneficiaries) to cause, such Term Debt to be demanded or to become due or to be repurchased, prepaid, defeased or redeemed (automatically or otherwise), or an offer to
repurchase, prepay, defease or redeem such Term Debt to be made, prior to its stated maturity, or such Guarantee to become payable or cash collateral in respect thereof to be demanded. 

  
 109 

 ARTICLE IX. 

RIGHTS AND REMEDIES. 

9.01 Rights and Remedies. Upon the occurrence and during the continuation of an Event of Default, Agent may, and, at the
instruction of the Required Lenders, shall (in each case under clauses (a) or (b) by written notice to Borrower Representative), in addition to any other rights or remedies provided for hereunder or under any other Loan Document or by
applicable law, do any one or more of the following: 
 (a) declare the principal of, and any and all accrued and unpaid interest and fees
(including Liquidated Damages, as applicable) in respect of, the Loans and all other Obligations, whether evidenced by this Agreement or by any of the other Loan Documents to be immediately due and payable, whereupon the same shall become and be
immediately due and payable and Borrowers shall be obligated to repay all of such Obligations in full in cash, without presentment, demand, protest, or further notice or other requirements of any kind, all of which are hereby expressly waived by
Borrowers; 
 (b) declare the Commitments terminated, whereupon the Commitments shall immediately be terminated together with any obligation
of any Revolving Lender to make Revolving Loans; and 
 (c) exercise all other rights and remedies available to Agent or the Lenders under
the Loan Documents, under applicable law, or in equity. 
 Notwithstanding anything to the contrary in this Agreement, and the other Loan Documents, each
Borrower hereby irrevocably and unconditionally constitutes and appoints Agent and any of Agent’s Affiliates, attorneys, representatives or agents, with full power of substitution, as such Borrower’s true and lawful attorney-in-fact with full irrevocable and unconditional power and authority in the place and stead of such Borrower and in the name of such Borrower or in its own name, for
the purpose of carrying out the terms of this Agreement, and the other Loan Documents, to take any appropriate steps or actions and to execute and deliver (and perform under on such Borrower’s behalf) any agreement, document or instrument that
may be necessary or desirable to accomplish the purposes and/or effectuate the items and actions set forth in this Agreement, and the other Loan Documents, in each case, (i) that any such Loan Party fails to take that are required under such
documents, agreements or instruments or (ii) during the existence of any Event of Default. 
 The foregoing to the contrary notwithstanding, upon the
occurrence of any Event of Default described in Section 8.04, in addition to the remedies set forth above, without any notice to Borrower Representative or any other Person or any act by the Lender Group, the Commitments
shall automatically terminate and the Obligations, inclusive of the principal of, and any and all accrued and unpaid interest and fees (including Liquidated Damages, as applicable) in respect of, the Loans and all other Obligations, whether
evidenced by this Agreement or by any of the other Loan Documents, shall automatically become and be immediately due and payable and Borrowers shall automatically be obligated to repay all of such Obligations in full in cash, without presentment,
demand, protest, or notice or other requirements of any kind, all of which are expressly waived by Borrowers. 
 9.02 Remedies
Cumulative. The rights and remedies of the Lender Group under this Agreement, the other Loan Documents, and all other agreements shall be cumulative. The Lender Group shall have all other rights and remedies not inconsistent herewith as provided
under the Code, by law, or in equity. No exercise by the Lender Group of one right or remedy shall be deemed an election, and no waiver by the Lender Group of any Event of Default shall be deemed a continuing waiver. No delay by the Lender Group
shall constitute a waiver, election, or acquiescence by it. 

  
 110 

 ARTICLE X. 

WAIVERS; INDEMNIFICATION. 

10.01 Demand; Protest; etc. Borrowers waive demand, protest, notice of protest, notice of default or dishonor, notice of payment
and nonpayment, nonpayment at maturity, release, compromise, settlement, extension, or renewal of documents, instruments, chattel paper, and guarantees at any time held by the Lender Group on which Borrowers may in any way be liable. 

10.02 The Lender Group’s Liability for Collateral. Borrowers hereby agree that: (a) so long as Agent
complies with its obligations, if any, under the Code, the Lender Group shall not in any way or manner be liable or responsible for: (i) the safekeeping of the Collateral, (ii) any loss or damage thereto occurring or arising in any manner
or fashion from any cause, (iii) any diminution in the value thereof, or (iv) any act or default of any carrier, warehouseman, bailee, forwarding agency, or other Person, and (b) all risk of loss, damage, or destruction of the
Collateral shall be borne by Borrowers. 
 10.03 Indemnification. Borrowers shall pay, indemnify, defend, and hold the
Agent-Related Persons, the Lender-Related Persons, and each Participant (each, an “Indemnified Person”) harmless (to the fullest extent permitted by law) from and against any and all losses, claims, demands, suits, actions,
investigations, proceedings, liabilities, fines, costs, penalties, and damages, and all reasonable fees and disbursements of attorneys, experts, or consultants and all other costs and expenses, joint and several, actually incurred in connection
therewith or in connection with the enforcement of this indemnification (as and when they are incurred and irrespective of whether suit is brought), at any time asserted against, imposed upon, or incurred by any of them (a) in connection with
or as a result of or related to the execution and delivery, enforcement, performance, or administration (including any restructuring or workout with respect hereto) of this Agreement, any of the other Loan Documents, or any claim, litigation,
investigation or proceeding relating to any of the foregoing, regardless of whether any Indemnified Person is a party thereto, whether or not such claim, litigation, investigation or proceeding are brought by Borrowers or their equity holders,
affiliates, creditors or any other person, or the transactions contemplated hereby or thereby or the monitoring of Borrowers’ and their Subsidiaries’ compliance with the terms of the Loan Documents, and to reimburse each Indemnified Person
within thirty (30) days after written demand for any reasonable, actual documented out-of-pocket expenses incurred in connection with investigating or defending any
of the foregoing (provided, that the indemnification in this clause (a) shall not extend to any Taxes other than any Taxes that represent losses, claims, damages, etc. arising from any non-Tax
claim), (b) with respect to any actual or prospective investigation, litigation, or proceeding related to this Agreement, any other Loan Document, the making of any Loans hereunder, or the use of the proceeds of the Loans provided hereunder
(irrespective of whether any Loan Party or Indemnified Person is a party thereto), or any act, omission, event, or circumstance in any manner related thereto, and (c) in connection with or arising out of any presence or release of Hazardous
Materials at, on, under, to or from any assets or properties owned, leased or operated by Borrowers or any of their Subsidiaries or any Environmental Actions, Environmental Liabilities or Remedial Actions related in any way to Borrowers, any of
their Subsidiaries or any assets, properties, operations or actions of Borrowers or any of their Subsidiaries or any other violations of or liabilities arising under Environmental Law or Environmental Permits by or relating to Borrowers or any of
their Subsidiaries or any assets or properties owned, leased or operated by Borrowers or any of their Subsidiaries (each and all of the foregoing, the “Indemnified Liabilities”). The foregoing to the contrary notwithstanding,
Borrowers shall have no obligation to any Indemnified Person under this Section 10.03 with respect to any Indemnified Liability (A) that a court of competent jurisdiction finally determines to have resulted from the
gross negligence, bad faith or willful misconduct of such Indemnified Person or its Affiliates or any officers, directors, employees, controlling persons or members of the foregoing or (B) arising out of a material breach by such Indemnified
Person of its obligations hereunder. This provision 

  
 111 

 
shall survive the termination of this Agreement, the termination of the Commitments and the repayment in full in cash of the Obligations. If any Indemnified Person makes any payment to any other
Indemnified Person with respect to an Indemnified Liability as to which Borrowers were required to indemnify the Indemnified Person receiving such payment, the Indemnified Person making such payment is entitled to be indemnified and reimbursed by
Borrowers with respect thereto. WITHOUT LIMITATION, THE FOREGOING INDEMNITY SHALL APPLY TO EACH INDEMNIFIED PERSON WITH RESPECT TO INDEMNIFIED LIABILITIES WHICH IN WHOLE OR IN PART ARE CAUSED BY OR ARISE OUT OF ANY NEGLIGENT ACT OR OMISSION OF
SUCH INDEMNIFIED PERSON OR OF ANY OTHER PERSON. THE PROVISIONS OF THIS SECTION 10.03 SHALL SURVIVE THE RESIGNATION OR TERMINATION OF AGENT AND TERMINATION OF THIS AGREEMENT. 

ARTICLE XI. 
 NOTICES.

 Unless otherwise provided in this Agreement, all notices or demands relating to this Agreement or any other Loan Document shall be in
writing and (except for financial statements and other informational documents which may be sent by first-class mail, postage prepaid) shall be personally delivered or sent by registered or certified mail (postage prepaid, return receipt requested),
overnight courier, electronic mail (at such email addresses as a party may designate in accordance herewith), or telefacsimile. In the case of notices or demands to Borrower Representative or Agent, as the case may be, they shall be sent to the
respective address set forth below: 
 If to Borrower 

Representative:
                          Endologix, Inc. 

2 Musick 
 Irvine, CA 92618 

E-mail: vmahboob@endologix.com 

E-mail: jtejedor@endologix.com 

Attn: Vaseem Mahboob, CFO 

Attn: James Tejedor, Treasury Manager 
 with
copies to:                            DLA Piper LLP 

1251 Avenue of the Americas 

New York, New York 10020-1104 

Email: gregory.ruback@dlapiper.com 

Attn: Greg Ruback, Esq. 
 Fax
No.: (212) 884-8682 
 If to Agent:
                                Deerfield ELGX Revolver, LLC 

c/o Deerfield Management Company, L.P. 

780 Third Avenue, 37th Floor 

New York, NY 10017 
 Facsimile: 212-599-3075 
 E-mail:
dclark@deerfield.com 
 Attn: David J. Clark, Esq 

with copies to:
                           Katten Muchin Rosenman LLP 

2029 Century Park East, Suite 2600 

Los Angeles, CA 90067-3012 

  
 112 

 Facsimile: (310) 788-4471 

E-mail: kristopher.ring@kattenlaw.com and 

mark.wood@kattenlaw.com 
 Attn:
Kristopher J. Ring, Esq. 
 Attn: Mark D. Wood, Esq. 

and, solely to the extent that Cortland Capital Market Services 

LLC is the Third Party Agent during any Third Party Agent 

Retention Period: 
 Cortland
Capital Market Services LLC 
 225 W. Washington Street, 9th Floor 

Chicago, IL 60606 
 E-mail: CortlandABLServices@cortlandglobal.com and 
 legal@cortlandglobal.com 

Attn: ABL Services 
 Any party hereto may change
the address at which they are to receive notices hereunder, by notice in writing in the foregoing manner given to the other party (or, in the case of any Third Party Agent, in the notice delivered to Borrower Representative pursuant to
clause (b) of the definition of “Third Party Agent” herein). All notices or demands sent in accordance with this Article XI, shall be deemed received on the earlier of the date of actual receipt or three (3) Business Days
after the deposit thereof in the mail; provided, that (a) notices sent by overnight courier service shall be deemed to have been given when received, (b) notices by facsimile shall be deemed to have been given when sent (except
that, if not given during normal business hours for the recipient, shall be deemed to have been given at the opening of business on the next Business Day for the recipient) and (c) notices by electronic mail shall be deemed received upon the
sender’s receipt of an acknowledgment from the intended recipient (such as by the “return receipt requested” function, as available, return email or other written acknowledgment). 

ARTICLE XII. 
 CHOICE OF
LAW AND VENUE; JURY TRIAL WAIVER; 
 JUDICIAL REFERENCE PROVISION. 

(a) THE VALIDITY OF THIS AGREEMENT AND THE OTHER LOAN DOCUMENTS (UNLESS EXPRESSLY PROVIDED TO THE CONTRARY IN ANOTHER LOAN DOCUMENT IN RESPECT
OF SUCH OTHER LOAN DOCUMENT), THE CONSTRUCTION, INTERPRETATION, AND ENFORCEMENT HEREOF AND THEREOF, THE RIGHTS OF THE PARTIES HERETO AND THERETO WITH RESPECT TO ALL MATTERS ARISING HEREUNDER OR THEREUNDER OR RELATED HERETO OR THERETO, AND ANY
CLAIMS, CONTROVERSIES OR DISPUTES ARISING HEREUNDER OR THEREUNDER OR RELATED HERETO OR THERETO SHALL BE DETERMINED UNDER, GOVERNED BY, AND CONSTRUED IN ACCORDANCE WITH THE LAWS OF THE STATE OF NEW YORK. 

(b) THE PARTIES AGREE THAT ALL ACTIONS OR PROCEEDINGS ARISING IN CONNECTION WITH THIS AGREEMENT AND THE OTHER LOAN DOCUMENTS SHALL BE TRIED AND
LITIGATED ONLY IN THE STATE AND, TO THE EXTENT PERMITTED BY APPLICABLE LAW, FEDERAL COURTS LOCATED IN THE COUNTY OF NEW YORK, STATE OF NEW YORK; PROVIDED, THAT ANY SUIT SEEKING ENFORCEMENT AGAINST ANY COLLATERAL OR OTHER PROPERTY MAY BE
BROUGHT, AT AGENT’S OPTION, IN THE COURTS OF ANY JURISDICTION WHERE AGENT ELECTS TO BRING SUCH ACTION OR 

  
 113 

 
WHERE SUCH COLLATERAL OR OTHER PROPERTY MAY BE FOUND. BORROWERS AND EACH MEMBER OF THE LENDER GROUP WAIVE, TO THE EXTENT PERMITTED UNDER APPLICABLE LAW, ANY RIGHT EACH MAY HAVE TO ASSERT THE
DOCTRINE OF FORUM NON CONVENIENS OR TO OBJECT TO VENUE TO THE EXTENT ANY PROCEEDING IS BROUGHT IN ACCORDANCE WITH THIS SECTION 12(b). 

(c) TO THE MAXIMUM EXTENT PERMITTED BY APPLICABLE LAW, BORROWERS AND EACH MEMBER OF THE LENDER GROUP HEREBY WAIVE THEIR RESPECTIVE RIGHTS, IF
ANY, TO A JURY TRIAL OF ANY CLAIM, CONTROVERSY, DISPUTE OR CAUSE OF ACTION DIRECTLY OR INDIRECTLY BASED UPON OR ARISING OUT OF ANY OF THE LOAN DOCUMENTS OR ANY OF THE TRANSACTIONS CONTEMPLATED THEREIN, INCLUDING CONTRACT CLAIMS, TORT CLAIMS, BREACH
OF DUTY CLAIMS, AND ALL OTHER COMMON LAW OR STATUTORY CLAIMS (EACH A “CLAIM”). BORROWERS AND EACH MEMBER OF THE LENDER GROUP REPRESENT THAT EACH HAS REVIEWED THIS WAIVER AND EACH KNOWINGLY AND VOLUNTARILY WAIVES ITS JURY TRIAL
RIGHTS FOLLOWING CONSULTATION WITH LEGAL COUNSEL. IN THE EVENT OF LITIGATION, A COPY OF THIS AGREEMENT MAY BE FILED AS A WRITTEN CONSENT TO A TRIAL BY THE COURT. 

(d) BORROWERS HEREBY IRREVOCABLY AND UNCONDITIONALLY SUBMITS TO THE EXCLUSIVE JURISDICTION OF THE COMMERCIAL DIVISION, NEW YORK STATE SUPREME
COURT AND THE FEDERAL COURTS, IN EACH CASE, SITTING IN THE CITY OF NEW YORK, BOROUGH OF MANHATTAN (AND, IN EACH CASE, THE APPLICABLE STATE AND FEDERAL APPEALS COURTS SITTING IN THE CITY OF NEW YORK OR, IF NOT AVAILABLE OR APPLICABLE, THE STATE OF
NEW YORK), IN ANY ACTION OR PROCEEDING ARISING OUT OF OR RELATING TO ANY LOAN DOCUMENTS, OR FOR RECOGNITION OR ENFORCEMENT OF ANY JUDGMENT. EACH OF THE PARTIES HERETO AGREES THAT A FINAL JUDGMENT IN ANY SUCH ACTION OR PROCEEDING SHALL BE CONCLUSIVE
AND MAY BE ENFORCED IN OTHER JURISDICTIONS BY SUIT ON THE JUDGMENT OR IN ANY OTHER MANNER PROVIDED BY LAW. NOTHING IN THIS AGREEMENT OR ANY OTHER LOAN DOCUMENT SHALL AFFECT ANY RIGHT THAT AGENT MAY OTHERWISE HAVE TO BRING ANY ACTION OR PROCEEDING
RELATING TO THIS AGREEMENT OR ANY OTHER LOAN DOCUMENT AGAINST ANY LOAN PARTY OR ITS PROPERTIES IN THE COURTS OF ANY JURISDICTION. 
 (e) NO
CLAIM MAY BE MADE BY ANY LOAN PARTY AGAINST AGENT (INCLUDING ANY THIRD PARTY AGENT), ANY LENDER OR ANY AFFILIATE, DIRECTOR, OFFICER, EMPLOYEE, COUNSEL, REPRESENTATIVE, AGENT, OR
ATTORNEY-IN-FACT OF ANY OF THEM FOR ANY SPECIAL, INDIRECT, CONSEQUENTIAL, PUNITIVE OR EXEMPLARY DAMAGES OR LOSSES IN RESPECT OF ANY CLAIM FOR BREACH OF CONTRACT OR ANY
OTHER THEORY OF LIABILITY ARISING OUT OF OR RELATED TO THE TRANSACTIONS CONTEMPLATED BY THIS AGREEMENT OR ANY OTHER LOAN DOCUMENT, OR ANY ACT, OMISSION, OR EVENT OCCURRING IN CONNECTION THEREWITH, AND EACH LOAN PARTY HEREBY WAIVES, RELEASES, AND
AGREES NOT TO SUE UPON ANY CLAIM FOR SUCH DAMAGES, WHETHER OR NOT ACCRUED AND WHETHER OR NOT KNOWN OR SUSPECTED TO EXIST IN ITS FAVOR. 

  
 114 

 ARTICLE XIII. 

ASSIGNMENTS AND PARTICIPATIONS; SUCCESSORS. 

13.01 Assignments and Participations. 

(a) Subject to the conditions set forth in clause (a)(ii) below, any Lender may assign and delegate all or any portion of its rights and duties
under the Loan Documents (including the Obligations owed to it and its Commitments) to one or more Eligible Assignee (each, an “Assignee”), without the prior written consent of any other Person (other than as expressly required in
the definition of “Eligible Assignee”). 
  

	 	(i)	 Assignments shall be subject to the following additional conditions: 

(A) [reserved]; 

(B) the amount of the Commitments and the other rights and obligations of the assigning Lender hereunder and under the other
Loan Documents subject to each such assignment (determined as of the date the Assignment and Acceptance with respect to such assignment is delivered to Agent) shall be in a minimum amount (unless waived by Agent) of $1,000,000 (except such minimum
amount shall not apply to (I) an assignment or delegation by any Lender to any other Lender, an Affiliate of any Lender, or a Related Fund of such Lender, (II) an assignment or delegation of all remaining Commitments held by such assigning
Lender or (III) a group of new Lenders, each of which is an Affiliate of each other or a Related Fund of such new Lender to the extent that the aggregate amount to be assigned to all such new Lenders is at least $1,000,000); 

(C) each partial assignment shall be made as an assignment of a proportionate part of all the assigning Lender’s rights
and obligations under this Agreement; 
 (D) the parties to each assignment shall execute and deliver to Agent an Assignment
and Acceptance; provided, that Borrowers and Agent may continue to deal solely and directly with the assigning Lender in connection with the interest so assigned to an Assignee until (1) such Lender and the Assignee have delivered Agent
an Assignment and Acceptance, and (2) unless waived by Agent, the assigning Lender or Assignee has paid to Agent, for Agent’s separate account, a processing fee in the amount of $3,500; and 

(E) the assignee, if it is not a Lender, unless waived by Agent, shall deliver to Agent an Administrative Questionnaire in a
form approved by Agent (the “Administrative Questionnaire”) and all documentation and other information required by regulatory authorities under applicable “know your customer” and anti-money laundering rules and
regulations, including, without limitation, the USA PATRIOT Act. 
 (b) From and after the date that Agent receives the executed Assignment
and Acceptance and, if applicable, payment of the required processing fee, (i) the Assignee thereunder shall be a party hereto and, to the extent that rights and obligations hereunder have been assigned to it pursuant to such Assignment and
Acceptance, shall be a “Lender” and shall have the rights and obligations of a Lender under the Loan Documents, and (ii) the assigning Lender shall, to the extent that rights and obligations hereunder and under the other Loan
Documents have been assigned by it pursuant to such Assignment 

  
 115 

 
and Acceptance, relinquish its rights (except with respect to Section 10.03) and be released from any future obligations under this Agreement (and in the case of an
Assignment and Acceptance covering all or the remaining portion of an assigning Lender’s rights and obligations under this Agreement and the other Loan Documents, such Lender shall cease to be a party hereto and thereto); provided, that
nothing contained herein shall release any assigning Lender from obligations that survive the termination of this Agreement, including such assigning Lender’s obligations under Article XV and Section 17.08(a).

 (c) By executing and delivering an Assignment and Acceptance, the assigning Lender thereunder and the Assignee thereunder confirm to and
agree with each other and the other parties hereto as follows: (i) other than as provided in such Assignment and Acceptance, such assigning Lender makes no representation or warranty and assumes no responsibility with respect to any statements,
warranties or representations made in or in connection with this Agreement or the execution, legality, validity, enforceability, genuineness, sufficiency or value of this Agreement or any other Loan Document furnished pursuant hereto, (ii) such
assigning Lender makes no representation or warranty and assumes no responsibility with respect to the financial condition of any Loan Party or the performance or observance by any Loan Party of any of its obligations under this Agreement or any
other Loan Document furnished pursuant hereto, (iii) such Assignee confirms that it has received a copy of this Agreement, together with such other documents and information as it has deemed appropriate to make its own credit analysis and
decision to enter into such Assignment and Acceptance, (iv) such Assignee will, independently and without reliance upon Agent, such assigning Lender or any other Lender, and based on such documents and information as it shall deem appropriate
at the time, continue to make its own credit decisions in taking or not taking action under this Agreement, (v) such Assignee appoints and authorizes Agent (and, during any Third Party Agent Retention Period, the Third Party Agent) to take such
actions and to exercise such powers under this Agreement and the other Loan Documents as are delegated to Agent (or the Third Party Agent, as applicable), by the terms hereof and thereof, together with such powers as are reasonably incidental
thereto, and (vi) such Assignee agrees that it will perform all of the obligations which by the terms of this Agreement are required to be performed by it as a Lender. 

(d) Immediately upon Agent’s receipt of the required processing fee, if applicable, and delivery of notice to the assigning Lender
pursuant to Section 13.01(b), this Agreement shall be deemed to be amended to the extent, but only to the extent, necessary to reflect the addition of the Assignee and the resulting adjustment of the Commitments arising
therefrom. The Commitment allocated to each Assignee shall reduce such Commitments of the assigning Lender pro tanto. 
 (e) Any
Lender may at any time sell to one or more commercial banks, financial institutions, or other Persons (a “Participant”) participating interests in all or any portion of its Obligations, its Commitment, and the other rights and
interests of that Lender (the “Originating Lender”) hereunder and under the other Loan Documents; provided, that (i) the Originating Lender shall remain a “Lender” for all purposes of this Agreement and the
other Loan Documents and the Participant receiving the participating interest in the Obligations, the Commitments, and the other rights and interests of the Originating Lender hereunder shall not constitute a “Lender” hereunder or under
the other Loan Documents and the Originating Lender’s obligations under this Agreement shall remain unchanged, (ii) the Originating Lender shall remain solely responsible for the performance of such obligations, (iii) Borrowers, Agent
(any Third Party Agent), and the Lenders shall continue to deal solely and directly with the Originating Lender in connection with the Originating Lender’s rights and obligations under this Agreement and the other Loan Documents, (iv) no
Lender shall transfer or grant any participating interest under which the Participant has the right to approve any amendment to, or any consent or waiver with respect to, this Agreement or any other Loan Document, except to the extent such amendment
to, or consent or waiver with respect to this Agreement or of any other Loan Document would (A) extend the final maturity date of the Obligations hereunder in which such Participant is participating, (B) reduce the interest rate

  
 116 

 
applicable to the Obligations hereunder in which such Participant is participating, (C) release all or substantially all of the Collateral or guaranties (except to the extent expressly
provided herein or in any of the Loan Documents) supporting the Obligations hereunder in which such Participant is participating, (D) postpone the payment of, or reduce the amount of, the interest or fees payable to such Participant through
such Lender (other than a waiver of default interest), or (E) decreases the amount or postpones the due dates of scheduled principal repayments or prepayments or premiums payable to such Participant through such Lender, (v) no
participation shall be sold to a natural person, (vi) no participation shall be sold to a Loan Party or an Affiliate of a Loan Party, and (vii) all amounts payable by Borrowers hereunder shall be determined as if such Lender had not sold
such participation, except that, if amounts outstanding under this Agreement are due and unpaid, or shall have been declared or shall have become due and payable upon the occurrence of an Event of Default, each Participant shall be deemed to have
the right of set off in respect of its participating interest in amounts owing under this Agreement to the same extent as if the amount of its participating interest were owing directly to it as a Lender under this Agreement. The rights of any
Participant only shall be derivative through the Originating Lender with whom such Participant participates and no Participant shall have any rights under this Agreement or the other Loan Documents or any direct rights as to the other Lenders, Agent
(or any Third Party Agent), Borrowers, the Collateral, or otherwise in respect of the Obligations. No Participant shall have the right to participate directly in the making of decisions by the Lenders among themselves. 

(f) In connection with any such assignment or participation or proposed assignment or participation or any grant of a security interest in, or
pledge of, its rights under and interest in this Agreement, a Lender may, subject to the provisions of Section 17.08, disclose all documents and information which it now or hereafter may have relating to Borrowers and their
Subsidiaries and their Affiliates and their respective businesses and Stock and properties. 
 (g) Any other provision in this Agreement
notwithstanding, any Lender may at any time create a security interest in, or pledge, all or any portion of its rights under and interest in this Agreement in favor of any Federal Reserve Bank in accordance with Regulation A of the Federal Reserve
Bank or U.S. Treasury Regulation 31 CFR §203.24, and such Federal Reserve Bank may enforce such pledge or security interest in any manner permitted under applicable law. Notwithstanding anything to the contrary herein, (i) any Lender shall
be permitted to pledge or grant a security interest in all or a portion of such Lender’s rights hereunder including, but not limited to, any Loans (without the consent of, or notice to or any other action by, any other party hereto) to secure
the obligations of such Lender or any of its Affiliates to any Person providing any loan, letter of credit or other extension of credit to or for the account of such Lender or any of its Affiliates and any agent, trustee or representative of such
Person and (ii) Agent shall be permitted to pledge or grant a security interest in all or any portion of its rights hereunder or under the other Loan Documents, including, but not limited to, rights to payment (without the consent of, or notice
to or any other action by, any other party hereto), to secure the obligations of Agent or any of its Affiliates to any Person providing any loan, letter of credit to or for the account of Agent or any of its Affiliates and any agent, trustee or
representative of such Person; provided in each case, that no such pledge or assignment of a security interest shall release such Lender or Agent from its obligations hereunder or substitute any such pledgee or assignee for such Lender or
Agent as a party hereto. 
 (h) The Loan Parties hereby acknowledge that the Lenders and their Affiliates may securitize the Loans (a
“Securitization”) through the pledge of the Loans as collateral security for loans to the Lenders or their Affiliates or through the sale of the Loans or the issuance of direct or indirect interests in the Loans to their controlled
Affiliates, which loans to the Lenders or their Affiliates or direct or indirect interests may be rated by Moody’s, S&P or one or more other rating agencies. The Loan Parties shall, to the extent commercially reasonable, cooperate with the
Lenders and their Affiliates to effect any and all 

  
 117 

 
Securitizations. Notwithstanding the foregoing, no such Securitization shall release the Lender party thereto from any of its obligations hereunder except in accordance with
Section 13.01(a). 
 (i) During any Third Party Agent Retention Period, the Third Party Agent (as a non-fiduciary agent on behalf of Borrowers) shall maintain, or cause to be maintained, a register (the “Register”) on which it enters the name and address of each Lender as the registered owner of
the Loans and/or Revolver Commitments (and the principal amount thereof and stated interest thereon) held by such Lender (each, a “Registered Loan”). During any Non-Third Party Agent Retention
Period, the Borrower Representative shall maintain such Register and shall make such Register available to any member of the Lender Group at any reasonable time upon reasonable prior notice to the Borrower Representative. Upon the request of any
Third Party Agent upon the commencement of any Third Party Agent Retention Period, the Borrower Representative shall share such Register with the Third Party Agent, and with respect to any discrepancies between the records or Register of the
Borrower Representative, on the one hand, and the records or Register of any Lender, the Agent or the Third Party Agent, on the other hand, the records and Register of such Lender, Agent or Third Party Agent shall govern and control absent manifest
error. Other than in connection with an assignment by a Lender of all or any portion of its portion of the Loans and/or Revolver Commitments to an Affiliate of such Lender or a Related Fund of such Lender (i) a Registered Loan (and the
registered note, if any, evidencing the same) may be assigned or sold in whole or in part only by registration of such assignment or sale on the Register (and each registered note shall expressly so provide) and (ii) any assignment or sale of
all or part of such Registered Loan (and the registered note, if any, evidencing the same) may be effected only by registration of such assignment or sale on the Register, together with the surrender of the registered note, if any, evidencing the
same duly endorsed by (or accompanied by a written instrument of assignment or sale duly executed by) the holder of such registered note, whereupon, at the request of the designated assignee(s) or transferee(s), one or more new registered notes in
the same aggregate principal amount shall be issued to the designated assignee(s) or transferee(s). Prior to the registration of assignment or sale of any Registered Loan (and the registered note, if any evidencing the same), Borrowers shall treat
the Person in whose name such Registered Loan (and the registered note, if any, evidencing the same) is registered as the owner thereof for the purpose of receiving all payments thereon and for all other purposes, notwithstanding notice to the
contrary. In the case of any assignment by a Lender of all or any portion of its Loans and/or Revolver Commitments to an Affiliate of such Lender or a Related Fund of such Lender, and which assignment is not recorded in the Register, the assigning
Lender, on behalf of Borrowers, shall maintain a register comparable to the Register. 
 (j) In the event that a Lender sells participations
in the Registered Loan, such Lender, as a non-fiduciary agent on behalf of Borrowers, shall maintain (or cause to be maintained) a register on which it enters the name of all participants in the Registered
Loans held by it (and the principal amount (and stated interest thereon) of the portion of such Registered Loans that is subject to such participations) (the “Participant Register”). A Registered Loan (and the Registered Note, if
any, evidencing the same) may be participated in whole or in part only by registration of such participation on the Participant Register (and each registered note shall expressly so provide). Any participation of such Registered Loan (and the
registered note, if any, evidencing the same) may be effected only by the registration of such participation on the Participant Register. 

(k) Agent shall make a copy of the Register (and each Lender shall make a copy of its Participant Register to the extent it has one) available
for review by Borrowers from time to time as Borrowers may reasonably request. 
 13.02 Successors. This Agreement shall bind
and inure to the benefit of the respective successors and assigns of each of the parties; provided, that Borrowers and other Loan Parties may not 

  
 118 

 
assign this Agreement or any of the other Loan Documents or any rights, obligations or duties hereunder or thereunder without Agent’s and all the Lenders’ prior written consent and any
prohibited assignment shall be absolutely void ab initio. No consent to assignment by Agent and/or the Lenders shall release Borrowers from their Obligations. A Lender may assign this Agreement and the other Loan Documents and its rights and
duties hereunder and thereunder pursuant to Section 13.01 and, except as expressly required pursuant to Section 13.01, no consent or approval by Borrowers is required in connection with any such
assignment. For the avoidance of doubt, Agent may delegate any of its rights, duties and obligations to any Third Party Agent during any Third Party Agent Retention Period. 

ARTICLE XIV. 

AMENDMENTS; WAIVERS. 

14.01 Amendments and Waivers. 

(a) No amendment, waiver or other modification of any provision of this Agreement or any other Loan Document, and no consent with respect to
any departure by Borrowers therefrom, shall be effective unless the same shall be in writing and signed by the Agent, the Required Lenders (or by Agent at the written request of the Required Lenders) and the Loan Parties that are party thereto and
then any such waiver or consent shall be effective, but only in the specific instance and for the specific purpose for which given; provided, that no such waiver, amendment, or consent shall, unless in writing and signed by all of the Lenders
directly affected thereby and all of the Loan Parties that are party thereto, do any of the following: 
 (i) increase the amount of or
extend the expiration date of any Commitment of any Lender or amend, modify, or eliminate the last sentence of Section 2.03(c)(i), 

(ii) postpone or delay any date fixed by this Agreement or any other Loan Document for any payment of principal, interest, fees (including
Liquidated Damages), or other amounts due hereunder or under any other Loan Document, 
 (iii) reduce the principal of, or the rate of
interest on, any loan or other extension of credit hereunder, or reduce any fees or other amounts payable hereunder or under any other Loan Document (except (A) in connection with the waiver of applicability of
Section 2.05(c) (which waiver shall be effective with the written consent of the Required Lenders) and (B) that any amendment or modification of defined terms used in the financial covenants in this Agreement shall not
constitute a reduction in the rate of interest or a reduction of fees for purposes of this clause (iii)), 
 (iv) amend, modify, or eliminate
this Section or any provision of this Agreement providing for consent or other action by all Lenders, 
 (v) amend, modify, or eliminate
3.02, 
 (vi) amend, modify, or eliminate Section 15.11, 

(vii) other than as permitted by Section 15.11, release Agent’s Lien in and to all or substantially all of the
Collateral, 
 (viii) amend, modify, or eliminate the definitions of “Required Lenders” or “Pro Rata Share”, 

  
 119 

 (ix) contractually subordinate any of Agent’s Liens, 

(x) other than in connection with a merger, liquidation, dissolution or sale of such Person expressly permitted by the terms hereof or the
other Loan Documents, release Borrowers or any Guarantor from any obligation for the payment of money or consent to the assignment or transfer by Borrowers or any Guarantor of any of its rights or duties under this Agreement or the other Loan
Documents, 
 (xi) amend, modify, or eliminate any of the provisions of Section 2.03(b)(i) or
(ii) Section 2.03(e), or 
 (xii) amend, modify, or eliminate any of the provisions of
Section 13.01 with respect to assignments to, or participations with, Persons who are Loan Parties or Affiliates of Loan Parties; 

(b) No amendment, waiver, modification, or consent shall amend, modify, waive, or eliminate, 

(i) [reserved], and 
 (ii) any
provision of Article XV pertaining to Agent, or any other rights or duties of Agent under this Agreement or the other Loan Documents, without the written consent of Agent, Borrowers, and the Required Lenders. 

14.02 [Reserved]. 

14.03 No Waivers; Cumulative Remedies. No failure by Agent (including any Third Party Agent), any Lender or any other member of
the Lender Group to exercise any right, remedy, or option under this Agreement or any other Loan Document, or delay by Agent (including any Third Party Agent), any Lender or any other member of the Lender Group in exercising the same, will operate
as a waiver thereof. No waiver by Agent (including any Third Party Agent), any Lender or any other member of the Lender Group will be effective unless it is in writing, and then only to the extent specifically stated. No waiver by Agent (including
any Third Party Agent), any Lender or any other member of the Lender Group on any occasion shall affect or diminish Agent’s (including any Third Party Agent’s), each Lender’s and each other member of the Lender Group’s rights
thereafter to require strict performance by Borrowers and the other Loan Parties of any provision of this Agreement or any other Loan Document. Agent’s (including any Third Party Agent’s), each Lender’s and each other member of the
Lender Group’s rights under this Agreement and the other Loan Documents will be cumulative and not exclusive of any other right or remedy that Agent (including any Third Party Agent), any Lender or any other member of the Lender Group may have.

 ARTICLE XV. 
 AGENT;
THE LENDER GROUP. 
 15.01 Appointment and Authorization of Agent (and any Third Party Agent). Each Lender hereby
irrevocably appoints and authorizes Agent (including any Third Party Agent) to enter into each of the Loan Documents to which it is a party (other than this Agreement) on its behalf and to take such actions as Agent (or such Third Party Agent) on
its behalf and to exercise such powers under the Loan Documents as are delegated to Agent (or such Third Party Agent) by the terms thereof, together with all such powers as are reasonably incidental thereto. Subject to the terms of
Section 14.01 and to the terms of the other Loan Documents, Agent is authorized and empowered to amend, modify, or waive any 

  
 120 

 
provisions of this Agreement or the other Loan Documents on behalf of Lenders. The provisions of this Article XV are solely for the benefit of Agent (including any Third
Party Agent) and Lenders and neither any Borrower nor any other Loan Party shall have any rights as a third party beneficiary of any of the provisions hereof. In performing its functions and duties under this Agreement, Agent (and any Third Party
Agent) shall act solely as agent of Lenders and does not assume and shall not be deemed to have assumed any obligation toward or relationship of agency or trust with or for any Borrower or any other Loan Party. Agent may perform any of its duties
hereunder, or under the Loan Documents, by or through its agents, subagents, servicers, trustees, investment managers or employees or any Third Party Agent. Agent shall have the same rights and powers under the Loan Documents as any other Lender and
may exercise or refrain from exercising the same as though it were not Agent, and Agent and its Affiliates may lend money to, invest in and generally engage in any kind of business with each Loan Party or Affiliate of any Loan Party as if it were
not Agent hereunder. The duties of Agent shall be mechanical and administrative in nature. Agent shall not have by reason of this Agreement or the other Loan Documents a fiduciary relationship in respect of any Lender. Nothing in this Agreement or
any of the other Loan Documents is intended to or shall be construed to impose upon Agent any obligations in respect of this Agreement or any of the other Loan Documents except as expressly set forth herein or therein. 

15.02 Delegation of Duties. Agent may execute any of its duties under this Agreement or any other Loan Document by or through
agents, employees, attorneys in fact or any Third Party Agent and shall be entitled to advice of counsel concerning all matters pertaining to such duties. Agent shall not be responsible for the negligence or misconduct of any agent, attorney in fact
or Third Party Agent that it selects as long as such selection was made without a final, non-appealable binding decision of a court of competent jurisdiction to be from the gross negligence or willful
misconduct of Agent. 
 15.03 Liability of Agent. Neither Agent nor any of its directors, officers, agents, subagents,
trustees, investment managers, servicers or employees shall be liable to any Lender for any action taken or not taken by it in connection with the Loan Documents, except that Agent shall be liable with respect to its specific duties set forth
hereunder but only to the extent of its own gross negligence or willful misconduct in the discharge thereof as determined by a final non-appealable judgment of a court of competent jurisdiction. Neither Agent
nor any of its directors, officers, agents, subagents, trustees, investment managers, servicers or employees shall be responsible for or have any duty to ascertain, inquire into or verify (a) any statement, warranty or representation made in
connection with any Loan Document or any borrowing hereunder; (b) the performance or observance of any of the covenants or agreements specified in any Loan Document; (c) the satisfaction of any condition specified in any Loan Document;
(d) the validity, effectiveness, sufficiency or genuineness of any Loan Document, any Lien purported to be created or perfected thereby or any other instrument or writing furnished in connection therewith; (e) the existence or non-existence of any Default or Event of Default; or (f) the financial condition of any Loan Party. Agent shall not incur any liability by acting in reliance upon any notice, consent, certificate, statement, or
other writing (which may be a bank wire, facsimile or electronic transmission or similar writing) believed by it to be genuine or to be signed by the proper party or parties. Agent shall not be liable for any apportionment or distribution of
payments made by it in good faith and if any such apportionment or distribution is subsequently determined to have been made in error the sole recourse of any Lender to whom payment was due but not made, shall be to recover from other Lenders any
payment in excess of the amount to which they are determined to be entitled (and such other Lenders hereby agree to return to such Lender any such erroneous payments received by them). Agent may consult with legal counsel, independent public
accountants and other experts selected by it and shall not be liable for any action taken or omitted to be taken by it in good faith in accordance with the advice of such counsel, accountants or experts. 

  
 121 

 15.04 Reliance by Agent. Agent shall be entitled to rely, and shall be fully
protected in relying, upon any writing, resolution, notice, consent, certificate, affidavit, letter, telegram, telefacsimile or other electronic method of transmission, telex or telephone message, statement or other document or conversation believed
by it to be genuine and correct and to have been signed, sent, or made by the proper Person or Persons, and upon advice and statements of legal counsel (including counsel to Borrowers or any other Loan Party or counsel to any Lender), independent
accountants and other experts selected by Agent. Agent shall be fully justified in failing or refusing to take any action under this Agreement or any other Loan Document unless Agent shall first receive such advice or concurrence of the Lenders as
it deems appropriate and until such instructions are received, Agent shall act, or refrain from acting, as it deems advisable. If Agent so requests, it shall first be indemnified to its reasonable satisfaction by the Lenders against any and all
liability and expense that may be incurred by it by reason of taking or continuing to take any such action. Agent shall in all cases be fully protected in acting, or in refraining from acting, under this Agreement or any other Loan Document in
accordance with a request or consent of the Required Lenders and such request and any action taken or failure to act pursuant thereto shall be binding upon all of the Lenders. 

15.05 Notice of Default or Event of Default. Agent shall not be deemed to have knowledge or notice of the occurrence of any
Default or Event of Default, except with respect to defaults in the payment of principal, interest, fees, and expenses required to be paid to Agent for the account of the Lenders and, except with respect to Events of Default of which Agent has
actual knowledge, unless Agent shall have received written notice from a Lender or Borrowers referring to this Agreement, describing such Default or Event of Default, and stating that such notice is a “notice of default.” Agent promptly
will notify the Lenders of its receipt of any such notice or of any Event of Default of which Agent has actual knowledge. If any Lender obtains actual knowledge of any Event of Default, such Lender promptly shall notify the other Lenders and Agent
of such Event of Default. Each Lender shall be solely responsible for giving any notices to its Participants, if any. Subject to Section 15.04, Agent shall take such action with respect to such Default or Event of Default
as may be requested by the Required Lenders in accordance with Article IX; provided, that unless and until Agent has received any such request, Agent may (but shall not be obligated to) take such action, or refrain from taking such
action, with respect to such Default or Event of Default as it shall deem advisable. 
 15.06 Credit Decision. Each Lender
acknowledges that none of the Agent-Related Persons has made any representation or warranty to it, and that no act by Agent hereinafter taken, including any review of the affairs of Borrowers and their Subsidiaries or Affiliates, shall be deemed to
constitute any representation or warranty by any Agent-Related Person to any Lender. Each Lender represents to Agent that it has, independently and without reliance upon any Agent-Related Person and based on such due diligence, documents and
information as it has deemed appropriate, made its own appraisal of an investigation into the business, prospects, operations, property, financial and other condition and creditworthiness of Borrowers or any other Person party to a Loan Document,
and all applicable bank regulatory laws relating to the transactions contemplated hereby, and made its own decision to enter into this Agreement and to extend credit to Borrowers. Each Lender also represents that it will, independently and without
reliance upon any Agent-Related Person and based on such documents and information as it shall deem appropriate at the time, continue to make its own credit analysis, appraisals and decisions in taking or not taking action under this Agreement and
the other Loan Documents, and to make such investigations as it deems necessary to inform itself as to the business, prospects, operations, property, financial and other condition and creditworthiness of Borrowers or any other Person party to a Loan
Document. Except for notices, reports, and other documents expressly herein required to be furnished to the Lenders by Agent, Agent shall not have any duty or responsibility to provide any Lender with any credit or other information concerning the
business, prospects, operations, property, financial and other condition or creditworthiness of Borrowers or any other Person party to a Loan Document that may come 

  
 122 

 
into the possession of any of the Agent-Related Persons. Each Lender acknowledges that Agent does not have any duty or responsibility, either initially or on a continuing basis (except to the
extent, if any, that is expressly specified herein) to provide such Lender with any credit or other information with respect to Borrowers, their Affiliates or any of their respective business, legal, financial or other affairs, and irrespective of
whether such information came into Agent’s or its Affiliates’ or representatives’ possession before or after the date on which such Lender became a party to this Agreement. 

15.07 Costs and Expenses; Indemnification. Agent may incur and pay Lender Group Expenses to the extent Agent reasonably deems
necessary or appropriate for the performance and fulfillment of its functions, powers, and obligations pursuant to the Loan Documents, including with respect to due diligence expenses and periodic reviews of insurance and Collateral, court costs,
attorneys’ fees and expenses, fees and expenses of financial accountants, advisors, consultants, and appraisers, costs of collection by outside collection agencies, auctioneer fees and expenses, and costs of security guards or insurance
premiums paid to maintain the Collateral, whether or not Borrowers or the other Loan Parties are obligated to reimburse Agent or Lenders for such expenses pursuant to this Agreement or otherwise. Agent is authorized and directed to deduct and retain
sufficient amounts from (a) any deposits paid on or prior to the Closing Date and any subsequent deposits paid by Borrowers or any other Loan Party to Agent hereunder or under any other Loan Document, or (b) payments or proceeds of the
Collateral received by Agent to reimburse Agent for such out-of-pocket costs and expenses prior to the distribution of any amounts to Lenders. In the event Agent is not
reimbursed for such costs and expenses by Borrowers, any other Loan Party or their Subsidiaries, each Lender hereby agrees that it is and shall be obligated to pay to Agent such Lender’s ratable thereof. Whether or not the transactions
contemplated hereby are consummated, (i) Agent is authorized and directed to deduct and retain sufficient amounts from any deposits paid on or prior to the Closing Date and any subsequent deposits paid by Borrowers or any other Loan Party to
Agent hereunder or under any other Loan Document for the payment of the Indemnified Liabilities and (ii) each of the Lenders, on a ratable basis, shall indemnify and defend the Agent-Related Persons (to the extent not reimbursed by or on behalf
of Borrowers and without limiting the obligation of Borrowers to do so) from and against any and all Indemnified Liabilities; provided, that no Lender shall be liable for the payment to any Agent-Related Person of any portion of such
Indemnified Liabilities resulting solely from such Person’s gross negligence or willful misconduct as determined by a final, non-appealable and binding decision of a court of competent jurisdiction.
Without limitation of the foregoing, each Lender shall reimburse Agent upon demand for such Lender’s ratable share of any costs or out of pocket expenses (including attorneys, accountants, advisors, and consultants fees and expenses) incurred
by Agent in connection with the preparation, execution, delivery, administration, modification, amendment, or enforcement (whether through negotiations, legal proceedings or otherwise) of, or legal advice in respect of rights or responsibilities
under, this Agreement or any other Loan Document to the extent that Agent is not reimbursed for such expenses by or on behalf of Borrowers and the other Loan Parties. The undertaking in this Section shall survive the payment of all Obligations
hereunder and the resignation or replacement of Agent (and any resignation, replacement or termination of any Third Party Agent). 

15.08 Agent in Individual Capacity. Agent and its Affiliates may make loans to, issue letters of credit for the account of,
accept deposits from, acquire Stock in, and generally engage in any kind of banking, trust, financial advisory, underwriting, or other business with Borrowers and their Subsidiaries and Affiliates and any other Person party to any Loan Document as
though Agent were not Agent hereunder, and, in each case, without notice to or consent of the other members of the Lender Group. The terms “Lender” and “Lenders” include Agent in its individual capacity. 

15.09 Assignment by Agent; Resignation of Agent; Successor Agent. 

  
 123 

 (a) Agent may resign as Agent upon thirty (30) days’ notice to the Lenders (or
such lesser period agreed to by the Required Lenders). If Agent resigns under this Agreement, Agent may appoint, with the consent of the Required Lenders, a successor Agent. If no successor Agent is appointed prior to the effective date of the
resignation of Agent, the Required Lenders may appoint a successor Agent from among the Lenders or may appoint another Person as a successor Agent. Upon the acceptance of its appointment as successor Agent hereunder, such successor Agent shall
succeed to all the rights, powers and duties of the retiring Agent and the term “Agent” shall mean such successor Agent, and the retiring Agent’s appointment, powers and duties as Agent shall be terminated. If no successor Agent has
accepted appointment as Agent by the date which is 30 days (or such lesser period agreed to by the Required Lenders) following a retiring Agent’s notice of resignation, the retiring Agent’s resignation shall nevertheless thereupon become
effective and the Required Lenders shall perform all of the duties of Agent hereunder (and all payments, communications and determinations provided to be made by, to or through Agent shall instead be made by or to each Lender directly) until such
time, if any, as the Required Lenders appoint a successor Agent as provided for above. 
 (b) Upon (i) an assignment permitted by
Section 15.09(a) above, or (ii) the acceptance of a successor’s appointment as Agent pursuant to Section 15.09(a) above, such successor shall succeed to and become vested with all of the
rights, powers, privileges and duties of the retiring (or retired) Agent, and the retiring Agent shall be discharged from all of its duties and obligations hereunder and under the other Loan Documents (if not already discharged therefrom as provided
above in this Section 15.09). The fees payable by Borrowers to a successor Agent shall be the same as those payable to its predecessor unless otherwise agreed between Borrowers and such successor. After the retiring
Agent’s resignation hereunder and under the other Loan Documents, the provisions of this Article XV and Section 15.09 shall continue in effect for the benefit of such retiring Agent and its
agents and subagents and its Third Party Agents in respect of any actions taken or omitted to be taken by any of them while the retiring Agent was acting or was continuing to act as Agent. 

(c) Notwithstanding anything to the contrary in any of the Loan Documents, any Third Party Agent that becomes the Agent or a subagent of Agent
and any delegation, assignment or other transfer of duties, responsibilities or rights of Agent to any Third Party Agent, in each case, does not require the consent of any Person (other than Agent) and shall be permitted at all times under the Loan
Documents. 
 15.10 Lender in Individual Capacity. Any Lender and its respective Affiliates may make loans to, issue letters of
credit for the account of, accept deposits from, acquire Stock in and generally engage in any kind of banking, trust, financial advisory, underwriting, or other business with Borrowers and their Subsidiaries and Affiliates and any other Person party
to any Loan Documents as though such Lender were not a Lender hereunder without notice to or consent of the other members of the Lender Group. 

15.11 Collateral Matters. 

(a) Lenders irrevocably authorize Agent, at its sole option and in its sole discretion, to release any Lien granted to or held by Agent under
any Loan Document (a) upon termination of all of the Commitments and payment in full in cash of all Obligations; (b) constituting property sold or disposed of as part of or in connection with any disposition permitted by
Section 6.04 that is not to another Loan Party (it being understood and agreed that Agent may (but is not required to) conclusively rely without further inquiry on a certificate of an Authorized Officer as to the sale or
other disposition of property being made in full compliance with Section 6.04 and the other provisions of the Loan Documents); or (c) in connection with a credit bid or purchase authorized under this
Section 15.11. Upon request by 

  
 124 

 
Agent at any time, Lenders will confirm Agent’s authority to release particular types or items of Collateral pursuant to this Section 15.11. 

(b) The Loan Parties and the members of the Lender Group hereby irrevocably authorize Agent, based upon the instruction of the Required
Lenders, to (A) consent to, credit bid or purchase (either directly or indirectly through one or more entities) all or any portion of the Collateral at any sale thereof conducted under the provisions of the Bankruptcy Code, including
Section 363 of the Bankruptcy Code, (B) credit bid or purchase (either directly or indirectly through one or more entities) all or any portion of the Collateral at any sale or other disposition thereof conducted under the provisions of the
Code, including pursuant to Sections 9-610 or 9-620 of the Code, or (C) credit bid or purchase (either directly or indirectly through one or more entities) all or
any portion of the Collateral at any other sale or foreclosure conducted or consented to by Agent in accordance with applicable law in any judicial action or proceeding or by the exercise of any legal or equitable remedy. In connection with any such
credit bid or purchase, (1) the Obligations owed to the Lenders shall be entitled to be, and shall be, credit bid on a ratable basis (with Obligations with respect to contingent or unliquidated claims being estimated for such purpose if the
fixing or liquidation thereof would not impair or unduly delay the ability of Agent to credit bid or purchase at such sale or other disposition of the Collateral and, if such contingent or unliquidated claims cannot be estimated without impairing or
unduly delaying the ability of Agent to credit bid at such sale or other disposition, then such claims shall be disregarded, not credit bid, and not entitled to any interest in the Collateral that is the subject of such credit bid or purchase) and
the Lenders whose Obligations are credit bid shall be entitled to receive interests (ratably based upon the proportion of their Obligations credit bid in relation to the aggregate amount of Obligations so credit bid) in the Collateral that is the
subject of such credit bid or purchase (or in the Stock of the any entities that are used to consummate such credit bid or purchase), and (2) Agent, based upon the instruction of the Required Lenders, may accept
non-cash consideration, including debt and equity securities issued by any entities used to consummate such credit bid or purchase and in connection therewith Agent may reduce the Obligations owed to the
Lenders (ratably based upon the proportion of their Obligations credit bid in relation to the aggregate amount of Obligations so credit bid) based upon the value of such non-cash consideration. Except as
provided above, Agent will not execute and deliver a release of any Lien on any Collateral without the prior written authorization of (y) if the release is of all or substantially all of the Collateral, all of the Lenders, or
(z) otherwise, the Required Lenders. Upon request by Agent at any time, the Lenders will confirm in writing Agent’s authority to release any such Liens on particular types or items of Collateral pursuant to this
Section 15.11; provided, that (x) anything to the contrary contained in any of the Loan Documents notwithstanding, Agent shall not be required to execute any document or take any action necessary to evidence
such release on terms that, in Agent’s opinion, could expose Agent to liability or create any obligation or entail any consequence other than the release of such Lien without recourse, representation, or warranty, and (y) such release
shall not in any manner discharge, affect, or impair the Obligations or any Liens (other than those expressly released) upon (or obligations of Borrowers and the other Loan Parties in respect of) any and all interests retained by Borrowers and the
other Loan Parties, including, the proceeds of any sale, all of which shall continue to constitute part of the Collateral. Each Lender further hereby irrevocably authorizes Agent, at its option and in its sole discretion, to subordinate any Lien
granted to or held by Agent under any Loan Document to the holder of any Permitted Lien on such property if such Permitted Lien secures Permitted Purchase Money Indebtedness. 

(c) Agent shall have no obligation whatsoever to any of the Lenders (i) to verify or assure that the Collateral exists or is owned by
Borrowers, the other Loan Parties or their Subsidiaries or is cared for, protected, or insured or has been encumbered, (ii) to verify or assure that Agent’s Liens have been properly or sufficiently or lawfully created, perfected,
protected, or enforced or are entitled to any particular priority, (iii) to verify or assure that any particular items of Collateral meet the eligibility 

  
 125 

 
criteria applicable in respect thereof, (iv) to impose, maintain, increase, reduce, implement, or eliminate any particular reserve hereunder or to determine whether the amount of any reserve
is appropriate or not, or (v) to exercise at all or in any particular manner or under any duty of care, disclosure or fidelity, or to continue exercising, any of the rights, authorities and powers granted or available to Agent pursuant to any
of the Loan Documents, it being understood and agreed that in respect of the Collateral, or any act, omission, or event related thereto, subject to the terms and conditions contained herein, Agent may act in any manner it may deem appropriate, in
its sole discretion given Agent’s own interest in the Collateral in its capacity as one of the Lenders and that Agent shall have no other duty or liability whatsoever to any Lender as to any of the foregoing, except as otherwise expressly
provided herein. 
 15.12 Restrictions on Actions by Lenders; Sharing of Payments. 

(a) Each of the Lenders agrees that it shall not, without the express written consent of Agent, and that it shall, to the extent it is lawfully
entitled to do so, upon the written request of Agent, set off against the Obligations, any amounts owing by such Lender to Borrowers, the other Loan Parties or their Subsidiaries or any deposit accounts of Borrowers, the other Loan Parties or their
Subsidiaries now or hereafter maintained with such Lender. Each of the Lenders further agrees that it shall not, unless specifically requested to do so in writing by Agent, take or cause to be taken any action, including, the commencement of any
legal or equitable proceedings to enforce any Loan Document against Borrowers or any Guarantor or to foreclose any Lien on, or otherwise enforce any security interest in, any of the Collateral. 

(b) If, at any time or times any Lender shall receive (i) by payment, foreclosure, setoff, or otherwise, any proceeds of Collateral or any
payments with respect to the Obligations, except for any such proceeds or payments received by such Lender from Agent pursuant to the terms of this Agreement, or (ii) payments from Agent in excess of such Lender’s Pro Rata Share of all
such distributions by Agent, such Lender promptly shall (A) turn the same over to Agent, in kind, and with such endorsements as may be required to negotiate the same to Agent, or in immediately available funds, as applicable, for the account of
all of the Lenders and for application to the Obligations in accordance with the applicable provisions of this Agreement, or (B) purchase, without recourse or warranty, an undivided interest and participation in the Obligations owed to the
other Lenders so that such excess payment received shall be applied ratably as among the Lenders in accordance with their Pro Rata Shares; provided, that to the extent that such excess payment received by the purchasing party is thereafter
recovered from it, those purchases of participations shall be rescinded in whole or in part, as applicable, and the applicable portion of the purchase price paid therefor shall be returned to such purchasing party, but without interest except to the
extent that such purchasing party is required to pay interest in connection with the recovery of the excess payment. 
 15.13
Agency for Perfection. Agent and each other member of the Lender Group hereby appoint each other member of the Lender Group and any Third Party Agent as agent for the purpose of perfecting Agent’s security interest and Liens in the
Collateral and assets which, in accordance with the Uniform Commercial Code in any applicable jurisdiction, can be perfected by possession or control. Should any member of the Lender Group (other than Agent) obtain possession or control of any such
assets, such member of the Lender Group shall notify Agent thereof, and, promptly upon Agent’s request therefor, shall deliver such assets to Agent or in accordance with Agent’s instructions or transfer control to Agent in accordance with
Agent’s instructions. Each member of the Lender Group (other than Agent) agrees that it will not have any right individually to enforce or seek to enforce any Loan Document or to realize upon any Collateral unless instructed to do so by Agent
(or consented to by Agent), it being understood and agreed by the members of the Lender Group that such rights and remedies may be exercised only by Agent. 

  
 126 

 15.14 Payments by Agent to the Lenders. All payments to be made by Agent (or
any Third Party Agent) to the Lenders shall be made by bank wire transfer of immediately available funds pursuant to such wire transfer instructions as each party may designate for itself by written notice to Agent (or such Third Party Agent).
Concurrently with each such payment, Agent (or, during any Third Party Agent Retention Period, the Third Party Agent with the approval of Agent) shall identify whether such payment (or any portion thereof) represents principal, premium, fees,
interest or other amounts of the Obligations. 
 15.15 Concerning the Collateral and Related Loan Documents. Each member of the
Lender Group authorizes and directs Agent to enter into this Agreement and the other Loan Documents. Each member of the Lender Group agrees that any action taken by Agent in accordance with the terms of this Agreement or the other Loan Documents
relating to the Collateral and the exercise by Agent of its powers set forth therein or herein, together with such other powers that are reasonably incidental thereto, shall be binding upon all of the members of the Lender Group. 

15.16 Several Obligations; No Liability. Notwithstanding that certain of the Loan Documents now or hereafter may have been or
will be executed only by or in favor of Agent in its capacity as such, and not by or in favor of the Lenders, any and all obligations on the part of Agent (if any) to make any credit available hereunder shall constitute the several (and not joint)
obligations of the respective Lenders on a ratable basis, according to their respective Commitments, to make an amount of such credit not to exceed, in principal amount, at any one time outstanding, the amount of their respective Commitments.
Nothing contained herein shall confer upon any Lender any interest in, or subject any Lender to any liability for, or in respect of, the business, assets, profits, losses, or liabilities of any other Lender. Each Lender shall be solely responsible
for notifying its Participants of any matters relating to the Loan Documents to the extent any such notice may be required, and no Lender shall have any obligation, duty, or liability to any Participant of any other Lender. Except as provided in
Section 15.07, no member of the Lender Group shall have any liability for the acts of any other member of the Lender Group. No Lender shall be responsible to Borrowers, any other Loan Party, any of their Subsidiaries or
Affiliates or any other Person for any failure by any other Lender to fulfill its obligations to make credit available hereunder, nor to advance for such Lender or on its behalf, nor to take any other action on behalf of such Lender hereunder or in
connection with the financing contemplated herein. 
 15.17 Right to Request and Act on Instructions. Agent may at any time
request instructions from Lenders with respect to any actions or approvals which by the terms of this Agreement or of any of the other Loan Documents Agent is permitted or desires to take or to grant, and if such instructions are promptly requested,
Agent shall be absolutely entitled to refrain from taking any action or to withhold any approval and shall not be under any liability whatsoever to any Person for refraining from any action or withholding any approval under any of the Loan Documents
until it shall have received such instructions from Required Lenders or all or such other portion of the Lenders as shall be prescribed by this Agreement. Without limiting the foregoing, no Lender shall have any right of action whatsoever against
Agent as a result of Agent acting or refraining from acting under this Agreement or any of the other Loan Documents in accordance with the instructions of Required Lenders (or all or such other portion of the Lenders as shall be prescribed by this
Agreement) and, notwithstanding the instructions of Required Lenders (or such other applicable portion of the Lenders), Agent shall have no obligation to take any action if it believes, in good faith, that such action would violate Applicable Law or
exposes Agent to any liability for which it has not received satisfactory indemnification in accordance with the provisions of Section 15.07. 

  
 127 

 ARTICLE XVI. 

WITHHOLDING TAXES. 

16.01 Payments. 

(a) All payments by or on account of any obligation of any Loan Party under any Loan Document will be made free and clear of, and without
deduction or withholding for, any present or future Taxes except as otherwise required by applicable law, and in the event any deduction or withholding of Indemnified Taxes is required, Borrowers shall comply with the next sentence of this
Section 16.01. If any Applicable Law requires the deduction or withholding of any Tax from any such payment by a Withholding Agent, then (a) the applicable Withholding Agent shall be entitled to make such deduction or
withholding and shall timely pay the full amount deducted or withheld to the relevant Governmental Authority in accordance with Applicable Law, and (b) if such Taxes are Indemnified Taxes, then the sum payable by the applicable Loan Party shall
be increased as necessary so that after such deduction or withholding has been made (including such deductions and withholdings applicable to additional sums payable under this Section 16.01) the applicable Recipient
receives an amount equal to the sum it would have received had no such deduction or withholding been made. Borrowers will furnish to Agent (including any Third Party Agent) and the Lenders as promptly as possible after the date the payment of any
Indemnified Tax is due pursuant to Applicable Law, the original or certified copy of tax receipts issued by such Governmental Authority evidencing such payment by Borrowers, a copy of the return reporting such payment or other evidence of such
payment reasonably satisfactory to Agent and the Lenders. Borrowers agree to pay any present or future stamp, value added or documentary Taxes or any other excise or property Taxes, charges, or similar levies that arise from any payment made
hereunder or from the execution, delivery, performance, recordation, or filing of, or otherwise with respect to this Agreement or any other Loan Document. 

(b) Borrowers shall reimburse and indemnify, within ten days after receipt of demand therefor, each Recipient for all Indemnified Taxes
(including all Indemnified Taxes imposed on amounts payable under this Section 16.01(b)) paid or payable by such Recipient, whether or not such Indemnified Taxes were correctly or legally asserted. A certificate of the
applicable Recipient(s) setting forth the amounts to be paid thereunder and delivered to the Borrowers shall be conclusive, absent manifest error. 

16.02 Exemptions. 

(a) If a Lender or Participant is entitled to claim an exemption or reduction from United States withholding tax, such Lender or Participant
agrees with and in favor of Agent, to deliver to Agent (or, in the case of a Participant, to the Lender granting the participation only) one of the following before receiving its first payment under this Agreement: 

(i) if such Lender or Participant is entitled to claim an exemption from United States withholding tax pursuant to the portfolio interest
exception, (A) a statement (a “Portfolio Interest Certificate”) of the Lender or Participant, signed under penalty of perjury, that it is not a (I) a “bank” as described in Section 881(c)(3)(A) of the IRC,
(II) a 10% shareholder of Borrowers (within the meaning of Section 871(h)(3)(B) of the IRC), or (III) a controlled foreign corporation related to Borrowers within the meaning of Section 864(d)(4) of the IRC, and (B) a
properly completed and executed IRS Form W-8BEN, Form W-8BEN-E or Form W-8IMY (with
proper attachments). If such Lender or Participant is a partnership and one or more direct or indirect partners of such Lender or Participant are claiming the portfolio interest exemption, such Lender or Participant may provide a Portfolio Interest
Certificate on behalf of such partners. 

  
 128 

 (ii) if such Lender or Participant is entitled to claim an exemption from, or a reduction
of, withholding tax under a United States tax treaty, a properly completed and executed copy of IRS Form W-8BEN or Form W-8BEN-E;

 (iii) if such Lender or Participant is entitled to claim that interest paid under this Agreement is exempt from United States withholding
tax because it is effectively connected with a United States trade or business of such Lender, a properly completed and executed copy of IRS Form W-8ECI; 

(iv) if such Lender or Participant is entitled to claim that interest paid under this Agreement is exempt from United States withholding tax
because such Lender or Participant serves as an intermediary, a properly completed and executed copy of IRS Form W-8IMY (with proper attachments); 

(v) a properly completed and executed copy of any other form or forms, including IRS Form W-9, as may
be required under the IRC or other laws of the United States as a condition to exemption from, or reduction of, United States withholding or backup withholding tax; or 

(vi) a properly completed form or forms, and other required documentation (to be designated under Sections 1471 and 1472 of the IRC) to claim
an exemption from any withholding tax imposed under FATCA. 
 (b) Each Lender or Participant shall provide new forms (or successor forms) to
Agent (or, in the case of a Participant, to the Lender granting the participation only) at the time or times reasonably requested by Agent (or, in the case of a Participant, the Lender granting the participation only), but only if such Lender or
such Participant is legally able to deliver such forms, and shall promptly notify of any change in circumstances which would modify or render invalid any claimed exemption or reduction. 

(c) If a Lender or Participant claims an exemption from withholding tax in a jurisdiction other than the United States, such Lender or such
Participant agrees with and in favor of Agent, to deliver to Agent (or, in the case of a Participant, to the Lender granting the participation only) any such form or forms, as may be required under the laws of such jurisdiction as a condition to
exemption from, or reduction of, foreign withholding or backup withholding tax before receiving its first payment under this Agreement, and at the time or times reasonably requested by Agent, but only if such Lender or such Participant is legally
able to deliver such forms, provided, that nothing in this Section 16.02(c) shall require a Lender or Participant to disclose any information that it deems to be confidential (including without limitation, its tax
returns). Each Lender and each Participant shall provide new forms (or successor forms) and shall promptly notify Agent (or, in the case of a Participant, to the Lender granting the participation only) of any change in circumstances which would
modify or render invalid any claimed exemption or reduction. 
 (d) If a Lender or Participant claims exemption from, or reduction of,
withholding tax and such Lender or Participant sells, assigns, grants a participation in, or otherwise transfers all or part of the Obligations of Borrowers and the other Loan Parties to such Lender or Participant, such Lender or Participant agrees
to notify Agent (or, in the case of a sale of a participation interest, to the Lender granting the participation only) of the percentage amount in which it is no longer the beneficial owner of Obligations of Borrowers and the other Loan Parties to
such Lender or Participant. To the extent of such percentage amount, Agent will treat such Lender’s or such Participant’s documentation provided pursuant to Section 16.02(a) or 16.02(c) as no longer valid.
With respect to such percentage amount, such Participant or Assignee may provide new documentation, pursuant to Section 16.02(a) or 16.02(c), if applicable. Borrowers and the other Loan Parties agree that each
Participant shall be entitled to the 

  
 129 

 
benefits of this Article XVI with respect to its participation in any portion of the Commitments and the Obligations so long as such Participant complies with the obligations set forth in this
Article XVI with respect thereto. 
 (e) If a payment made to a Lender under any Loan Document would be subject to U.S. federal withholding
Tax imposed by FATCA if such Lender were to fail to comply with the applicable reporting requirements of FATCA (including those contained in Section 1471(b) or 1472(b) of the IRC, as applicable), such Lender shall deliver to Agent (or, in the
case of a Participant, to the Lender granting the participation only) at the time or times prescribed by law and at such time or times reasonably requested by Agent (or, in the case of a Participant, the Lender granting the participation) such
documentation prescribed by applicable law (including as prescribed by Section 1471(b)(3)(C)(i) of the IRC) and such additional documentation reasonably requested by Agent (or, in the case of a Participant, the Lender granting the
participation) as may be necessary for Agent or Borrowers to comply with their obligations under FATCA and to determine that such Lender has complied with such Lender’s obligations under FATCA or to determine the amount to deduct and withhold
from such payment. Solely for purposes of this clause (e), “FATCA” shall include any amendments made to FATCA after the date of this Agreement. 

16.03 Refunds. If Agent or a Lender determines, in its sole discretion, that it has received a refund of any Indemnified Taxes to
which Borrowers have paid additional amounts pursuant to this Article XVI, so long as no Default or Event of Default has occurred and is continuing, it shall pay over such refund to Borrowers (but only to the extent of payments made, or
additional amounts paid, by Borrowers under this Article XVI with respect to Indemnified Taxes giving rise to such a refund), net of all out-of-pocket expenses of
Agent or such Lender and without interest (other than any interest paid by the applicable Governmental Authority with respect to such a refund); provided, that Borrowers, upon the request of Agent or such Lender, agree to repay the amount
paid over to Borrowers (plus any penalties, interest or other charges, imposed by the applicable Governmental Authority, other than such penalties, interest or other charges imposed as a result of the willful misconduct or gross negligence of Agent
hereunder) to Agent or such Lender in the event Agent or such Lender is required to repay such refund to such Governmental Authority. Notwithstanding anything in this Agreement to the contrary, this Article XVI shall not be construed to
require Agent or any Lender to make available its tax returns (or any other information which it deems confidential) to Borrowers, the other Loan Parties, their Subsidiaries, their Affiliates or any other Person. 

ARTICLE XVII. 
 GENERAL
PROVISIONS. 
 17.01 Effectiveness. This Agreement shall be binding and deemed effective when executed by Borrowers,
Agent, and each Lender whose signature is provided for on the signature pages hereof. 
 17.02 Article and Section Headings.
Headings and numbers have been set forth herein for convenience only. Unless the contrary is compelled by the context, everything contained in each Article and Section applies equally to this entire Agreement. 

17.03 Interpretation. Neither this Agreement nor any uncertainty or ambiguity herein shall be construed against the Lender Group
or Borrowers, whether under any rule of construction or otherwise. On the contrary, this Agreement has been reviewed by all parties and shall be construed and interpreted according to the ordinary meaning of the words used so as to accomplish fairly
the purposes and intentions of all parties hereto. 

  
 130 

 17.04 Severability of Provisions. Each provision of this Agreement shall be
severable from every other provision of this Agreement for the purpose of determining the legal enforceability of any specific provision. 

17.05 Debtor-Creditor Relationship. The relationship between the members of the Lender Group, on the one hand, and the Loan
Parties, on the other hand, is solely that of creditor and debtor. No member of the Lender Group has (or shall be deemed to have) any fiduciary relationship or duty to any Loan Party arising out of or in connection with the Loan Documents or the
transactions contemplated thereby, and there is no agency or joint venture relationship between the members of the Lender Group, on the one hand, and the Loan Parties, on the other hand, by virtue of any Loan Document or any transaction contemplated
therein. 
 17.06 Counterparts; Electronic Execution. This Agreement may be executed in any number of counterparts and by
different parties on separate counterparts, each of which, when executed and delivered, shall be deemed to be an original, and all of which, when taken together, shall constitute but one and the same Agreement. Delivery of an executed counterpart of
this Agreement by telefacsimile or other electronic method of transmission shall be equally as effective as delivery of an original executed counterpart of this Agreement. Any party delivering an executed counterpart of this Agreement by
telefacsimile or other electronic method of transmission also shall deliver an original executed counterpart of this Agreement but the failure to deliver an original executed counterpart shall not affect the validity, enforceability, and binding
effect of this Agreement. The foregoing shall apply to each other Loan Document mutatis mutandis. 
 17.07 Revival and
Reinstatement of Obligations; Certain Waivers. If any member of the Lender Group repays, refunds, restores, or returns in whole or in part, any payment or property (including any proceeds of Collateral) previously paid or transferred to such
member of the Lender Group in full or partial satisfaction of any Obligation or on account of any other obligation of any Loan Party under any Loan Document, because the payment, transfer, or the incurrence of the obligation so satisfied is asserted
or declared to be void, voidable, or otherwise recoverable under any law relating to creditors’ rights, including provisions of the Bankruptcy Code relating to fraudulent transfers, preferences, or other voidable or recoverable obligations or
transfers (each, a “Voidable Transfer”), or because such member of the Lender Group elects to do so on the reasonable advice of its counsel in connection with a claim that the payment, transfer, or incurrence is or may be a Voidable
Transfer, then, as to any such Voidable Transfer, or the amount thereof that such member of the Lender Group elects to repay, restore, or return (including pursuant to a settlement of any claim in respect thereof), and as to all reasonable costs,
expenses, and attorneys’ fees of such member of the Lender Group related thereto, the liability of the Loan Parties with respect to the amount or property paid, refunded, restored, or returned will automatically and immediately be revived,
reinstated, and restored and will exist. If, prior to any of the foregoing, any provision of this Agreement or any other Loan Document shall have been terminated or cancelled, such provision of this Agreement or such other Loan Document, shall be
reinstated in full force and effect and such prior release, termination, cancellation or surrender shall not diminish, release, discharge, impair or otherwise affect the obligation of any Loan Party in respect of such liability or any Collateral
securing such liability. 
 17.08 Confidentiality. 

(a) Each of the Agent and the Lenders agrees to maintain the confidentiality of the Information (as defined below), except that Information may
be disclosed (a) to its Affiliates and to the Agent-Related Persons and Lender-Related Persons (it being understood that the Persons to whom such disclosure is made will be informed of the confidential nature of such Information and instructed
to keep 

  
 131 

 
such Information confidential), (b) to the extent required or requested by any regulatory authority purporting to have jurisdiction over such Person, the Agent-Related Persons or Lender-Related
Persons (including any self-regulatory authority), (c) to the extent required by Applicable Laws or regulations or by any subpoena or similar legal process, (d) to any member of the Lender Group or any other party hereto, (e) in connection
with the exercise of any remedies hereunder or under any other Loan Document or any action or proceeding relating to this Agreement or any other Loan Document or the enforcement of rights hereunder or thereunder, (f) subject to an agreement
containing provisions substantially the same as those of this Section 17.08, to (i) any Assignee of or Participant in, or any prospective assignee of or Participant in, any of its rights and obligations under this
Agreement or the other Loan Documents or (ii) any actual or prospective party (or the Agent-Related Persons or the Lender-Related Persons or any Related Party) to any transaction under which payments are to be made by reference to the Loan
Parties and their obligations, this Agreement, the other Loan Documents or payments hereunder or thereunder, (g) on a confidential basis to (i) any rating agency in connection with rating any Loan Party or its Subsidiaries or the credit
facilities provided hereunder or (ii) the CUSIP Service Bureau or any similar agency in connection with the issuance and monitoring of CUSIP numbers or other market identifiers with respect to the credit facilities provided hereunder,
(h) with the consent of any Loan Party or any of its Affiliates, (i) to the extent such Information (x) becomes publicly available other than as a result of a breach of this Section 17.08(a) or
(y) becomes available to any member of the Lender Group or any of its Affiliates on a nonconfidential basis from a source other than Endologix, or (j) as provided in Section 5.20. In addition, Agent (including any
Third Party Agent) and the Lenders may disclose the existence of this Agreement and the other Loan Documents and information about this Agreement and the other Loan Documents to market data collectors, similar service providers to the lending
industry and service providers to Agent (including any Third Party Agent) and the Lenders in connection with the administration of the Loans and other Obligations and this Agreement and the other Loan Documents 

(b) For purposes of this Section, “Information” means all information received from a Loan Party relating to the Loan Parties
or any Subsidiary thereof or any of their respective businesses, other than any such information that is available to the Agent, any Lender or any other member of the Lender Group on a nonconfidential basis prior to disclosure by such Loan Party or
any Subsidiary of such Loan Party; provided that, notwithstanding anything to the contrary in the Loan Documents, in the case of information received from the Borrowers, the Loan Parties or any of their Subsidiaries after the Closing Date,
such Information is both (y) clearly identified at the time of delivery as confidential and (z) provided to Agent and the Lenders at a time when Agent and such Lenders have requested in writing to receive material nonpublic information.
Any Person required to maintain the confidentiality of Information as provided in this Section 17.08 shall be considered to have complied with its obligation to do so if such Person has exercised the same degree of care to
maintain the confidentiality of such Information as such Person would accord to its own confidential information. 
 17.09
Survival. All representations and warranties made by the Loan Parties in the Loan Documents and in the certificates or other instruments delivered in connection with or pursuant to this Agreement or any other Loan Document shall be considered
to have been relied upon by the other parties hereto and shall survive the execution and delivery of the Loan Documents and the making of any Loans and the providing of the Commitments, regardless of any investigation made by any such other party or
on its behalf and notwithstanding that Agent, any Third Party Agent, any Lender or any other member of the Lender Group may have had notice or knowledge of any Default or Event of Default or incorrect representation or warranty at the time any
credit is extended hereunder, and shall continue in full force and effect as long as the principal of, or any accrued interest on, any Loan or any fee or any other amount payable under this Agreement or any of the other Loan Documents or any other
Obligations are outstanding or unpaid and so long as all of the Commitments have not expired or been terminated. 

  
 132 

 17.10 Patriot Act. Agent (including any Third Party Agent) and each Lender
that is subject to the requirements of the Patriot Act hereby notifies Borrowers that pursuant to the requirements of the Act, they are required to obtain, verify and record information that identifies the Loan Parties, which information includes
the names, address and tax identification numbers of the Loan Parties and other information that will allow Agent (or such Third Party Agent) or such Lender to identify the Loan Parties in accordance with the Patriot Act. In addition, if Agent
(including any Third Party Agent) or any Lender is required by law or regulation or internal policies to do so, it shall have the right to periodically conduct (a) Patriot Act searches, OFAC/PEP searches, and customary individual background
checks for the Loan Parties and (b) OFAC/PEP searches and customary individual background checks for the Loan Parties’ senior management and key principals, and Borrowers and the other Loan Parties agree to cooperate in respect of the
conduct of such searches and further agree that the reasonable costs and charges for such searches shall constitute Lender Group Expenses hereunder and be for the account of Borrowers and the other Loan Parties. This notice is given in accordance
with the requirements of the Patriot Act and is effective for Agent. 
 17.11 Integration. This Agreement, together with the
other Loan Documents, reflects the entire understanding of the parties with respect to the transactions contemplated hereby and shall not be contradicted or qualified by any other agreement, oral or written, before the date hereof. 

17.12 No Setoff. All payments made by each Loan Party hereunder or under any note or other Loan Document will be made in
immediately available funds and without setoff, counterclaim, or other defense. 
 17.13 Intercreditor Agreement.
Notwithstanding anything to the contrary in this Agreement or in any other Loan Document: (i) the Liens granted to the Agent pursuant to the Loan Documents and the exercise of any right related to any Collateral shall be subject, in each case,
to the terms of the Intercreditor Agreement, (ii) in the event of any conflict between the express terms and provisions of this Agreement or any other Loan Document, on the one hand, and of the Intercreditor Agreement, on the other hand, the
terms and provisions of the Intercreditor Agreement, shall control, and (iii) each Lender hereunder authorizes and instructs Agent to execute the Intercreditor Agreement on behalf of such Lender, and such Lender agrees to be bound by the terms
thereof. 
 [Signature pages to follow.] 

  
 133 

 IN WITNESS WHEREOF, the parties hereto have caused this Agreement to be executed and
delivered as of the date first above written. 
  

							
	BORROWERS:	  		 	ENDOLOGIX, INC., a Delaware corporation
				
		  		 	By:	 	 /s/ Vaseem Mahboob

		  		 		 	Name: Vaseem Mahboob
		  		 		 	Title: Chief Financial Officer
			
		  		 	CVD/RMS ACQUISITION CORP., a Delaware corporation
				
		  		 	By:	 	 /s/ Vaseem Mahboob

		  		 		 	Name: Vaseem Mahboob
		  		 		 	Title: Chief Financial Officer and Secretary
			
		  		 	NELLIX, INC., a Delaware corporation
				
		  		 	By:	 	 /s/ Vaseem Mahboob

		  		 		 	Name: Vaseem Mahboob
		  		 		 	Title: Chief Financial Officer and Secretary
			
		  		 	TRIVASCULAR TECHNOLOGIES, INC., a Delaware corporation
				
		  		 	By:	 	 /s/ Vaseem Mahboob

		  		 		 	Name: Vaseem Mahboob
		  		 		 	Title: Chief Financial Officer and Secretary
			
		  		 	TRIVASCULAR, INC., a California corporation

				
		  		 	By:	 	 /s/ Vaseem Mahboob

		  		 		 	Name: Vaseem Mahboob
		  		 		 	Title: Chief Financial Officer and Secretary

 ABL Credit Agreement 

 
			
	TRIVASCULAR SALES LLC, a Texas limited liability company
		
	By:	 	 /s/ Vaseem Mahboob

	Name:	 	Vaseem Mahboob
	Title:	 	Chief Financial Officer and Secretary
	
	ENDOLOGIX CANADA, LLC, a Delaware limited liability company
		
	By:	 	 /s/ Vaseem Mahboob

	Name:	 	Vaseem Mahboob
	Title:	 	Chief Financial Officer and Secretary
	
	RMS/ENDOLOGIX SIDEWAYS MERGER CORP., a Delaware corporation
		
	By:	 	 /s/ Vaseem Mahboob

	Name:	 	Vaseem Mahboob
	Title:	 	Chief Financial Officer and Secretary

 ABL Credit Agreement 

  

			
	DEERFIELD ELGX REVOLVER, LLC, a Delaware limited liability company, as Agent
	
	By: Deerfield Management Company, L.P. (Series C), Manager
	
	By: Flynn Management LLC, General Partner
		
	By:	 	 /s/ David J. Clark

	Name:	 	David J. Clark
	Title:	 	Authorized Signatory

 ABL Credit Agreement 

 
			
	DEERFIELD PRIVATE DESIGN FUND IV, L.P., as a Lender
	
	By: Deerfield Mgmt IV, L.P., General Partner
	
	By: J.E. Flynn Capital IV, LLC, General Partner
		
	By:	 	 /s/ David J. Clark

	Name:	 	David J. Clark
	Title:	 	Authorized Signatory
	
	DEERFIELD PRIVATE DESIGN FUND III, L.P., as a Lender
	
	By: Deerfield Mgmt III, L.P., General Partner
	
	By: J.E. Flynn Capital III, LLC, General Partner
		
	By:	 	 /s/ David J. Clark

	Name:	 	David J. Clark
	Title:	 	Authorized Signatory
	
	DEERFIELD PARTNERS, L.P., as a Lender
	
	By: Deerfield Mgmt, L.P., General Partner
	
	By: J.E. Flynn Capital, LLC, General Partner
		
	By:	 	 /s/ David J. Clark

	Name:	 	David J. Clark
	Title:	 	Authorized Signatory

 ABL Credit Agreement 

 EXHIBIT A-1 

FORM OF ASSIGNMENT AND ACCEPTANCE AGREEMENT 

This ASSIGNMENT AND ACCEPTANCE AGREEMENT (“Assignment Agreement”) is entered into as of
                                         
                                between
                                         
                                    (“Assignor”) and
                                         
                            (“Assignee”). Reference is made to the Credit Agreement described in
Annex I hereto (the “Credit Agreement”). Capitalized terms used herein and not otherwise defined shall have the meanings ascribed to them in the Credit Agreement. 

1. In accordance with the terms and conditions of Article XIII of the Credit Agreement, the Assignor hereby sells and assigns to the
Assignee, and the Assignee hereby purchases and assumes from the Assignor, that interest in and to the Assignor’s rights and obligations under the Loan Documents as of the date hereof with respect to the Obligations owing to the Assignor, and
Assignor’s portion of the Commitments, all to the extent specified on Annex I (the “Assigned Interest”). 
 2.
The Assignor (a) represents and warrants that (i) it is the legal and beneficial owner of the interest being assigned by it hereunder and that such interest is free and clear of any lien, encumbrance or other adverse claim and (ii) it
has full power and authority, and has taken all action necessary, to execute and deliver this Assignment Agreement and to consummate the transactions contemplated hereby; (b) makes no representation or warranty and assumes no responsibility
with respect to (i) any statements, representations or warranties made in or in connection with the Loan Documents, or (ii) the execution, legality, validity, enforceability, genuineness, sufficiency or value of the Loan Documents or any
other instrument or document furnished pursuant thereto; (c) makes no representation or warranty and assumes no responsibility with respect to the financial condition of any Borrower, its Subsidiaries or any Guarantor or the performance or
observance by any Borrower, its Subsidiaries or any Guarantor of any of their respective obligations under the Loan Documents or any other instrument or document furnished pursuant thereto, and (d) represents and warrants that the amount set
forth as the Purchase Price on Annex I represents the amount owed by the Borrowers to Assignor with respect to Assignor’s share of the Revolving Loans assigned hereunder, as reflected on Assignor’s books and records. 

3. The Assignee (a) represents and warrants that (i) it has full power and authority, and has taken all action necessary, to execute
and deliver this Assignment Agreement and to consummate the transactions contemplated hereby; (ii) it satisfies the requirements, if any, specified in the Credit Agreement that are required to be satisfied by it in order to acquire the Assigned
Interest and become a Lender (including, without limitation, the requirements set forth in Section 13.01 of the Credit Agreement); (iii) from and after the Effective Date, it shall be bound by the provisions of the
Credit Agreement as a Lender thereunder and, to the extent of the Assigned Interest, shall have the obligations of a Lender thereunder; (iv) it is sophisticated with respect to decisions to acquire assets of the type represented by the assigned
interest and either it, or the person exercising discretion in making its decision to acquire such assigned interest, is experienced in acquiring assets of such type; (b) confirms that it has received copies of the Credit Agreement and the
other Loan Documents, together with copies of the financial statements referred to therein and such other documents and information as it has deemed appropriate to make its own credit analysis and decision to enter into this Assignment Agreement;
(c) agrees that it will, independently and without reliance upon Agent, Assignor, or any other Lender, based upon such documents and information as it shall deem appropriate at the time, continue to make its own credit decisions in taking or
not taking any action under the Loan Documents; (d) appoints and authorizes the Agent to take such action as agent on its behalf and to exercise such powers under the Loan Documents as are delegated to Agent by the terms thereof, together with
such powers as are reasonably 

 
incidental thereto; (e) agrees that it will perform in accordance with their terms all of the obligations which by the terms of the Loan Documents are required to be performed by it as a
Lender; [and (f) attaches the forms prescribed by the Internal Revenue Service of the United States certifying as to the Assignee’s status for purposes of determining exemption from United States withholding taxes with
respect to all payments to be made to the Assignee under the Credit Agreement or such other documents as are necessary to indicate that all such payments are subject to such rates at a rate reduced by an applicable tax treaty.] 

4. Following the execution of this Assignment Agreement by the Assignor and Assignee, the Assignor will deliver this Assignment Agreement to
the Agent for recording by the Agent. The effective date of this Assignment (the “Settlement Date”) shall be the latest to occur of (a) the date of the execution and delivery hereof by the Assignor and the Assignee,
(b) the receipt by Agent for its sole and separate account a processing fee in the amount of $3,500 (if required by the Credit Agreement), (c) the receipt of any required consent of the Agent, and (d) the date specified in Annex
I. 
 5. As of the Settlement Date (a) the Assignee shall be a party to the Credit Agreement and, to the extent of the interest
assigned pursuant to this Assignment Agreement, have the rights and obligations of a Lender thereunder and under the other Loan Documents, and (b) the Assignor shall, to the extent of the interest assigned pursuant to this Assignment Agreement,
relinquish its rights and be released from its obligations under the Credit Agreement and the other Loan Documents, provided, however, that nothing contained herein shall release any assigning Lender from obligations that survive the
termination of this Agreement, including such assigning Lender’s obligations under Article XV of the Credit Agreement. 
 6. Upon
the Settlement Date, Assignee shall pay to Assignor the Purchase Price (as set forth in Annex I). From and after the Settlement Date, Agent shall make all payments that are due and payable to the holder of the interest assigned hereunder
(including payments of principal, interest, fees and other amounts) to Assignor for amounts which have accrued up to but excluding the Settlement Date and to Assignee for amounts which have accrued from and after the Settlement Date. On the
Settlement Date, Assignor shall pay to Assignee an amount equal to the portion of any interest, fee, or any other charge that was paid to Assignor prior to the Settlement Date on account of the interest assigned hereunder and that are due and
payable to Assignee with respect thereto, to the extent that such interest, fee or other charge relates to the period of time from and after the Settlement Date. 

7. This Assignment Agreement may be executed in counterparts and by the parties hereto in separate counterparts, each of which when so executed
and delivered shall be an original, but all of which shall together constitute one and the same instrument. This Assignment Agreement may be executed and delivered by telecopier or other electronic transmission all with the same force and effect as
if the same were a fully executed and delivered original manual counterpart. 
 8. THIS ASSIGNMENT AGREEMENT SHALL BE SUBJECT TO THE
PROVISIONS REGARDING CHOICE OF LAW AND VENUE, JURY TRIAL WAIVER, AND JUDICIAL REFERENCE SET FORTH IN ARTICLE XII OF THE CREDIT AGREEMENT, AND SUCH PROVISIONS ARE INCORPORATED HEREIN BY THIS REFERENCE, MUTATIS MUTANDIS. 

[Remainder of page intentionally left blank. Signature page to follow.] 

 IN WITNESS WHEREOF, the parties hereto have caused this Assignment Agreement and
Annex I hereto to be executed by their respective officers, as of the first date written above. 
  

	
	   

	[NAME OF ASSIGNOR]
	as Assignor
	
	   

	
	   

 
			
	By	 	 

 
			
	Name:	 	
	Title	 	

  

	
	   

	  

[NAME OF ASSIGNOR]

	as Assignor
	
	   

	
	   

 
			
	By	 	 

 
			
	Name:	 	
	Title	 	

 [Signature Page to Assignment and Acceptance Agreement] 

 [ACCEPTED THIS          DAY OF
                             

 

			
	DEERFIELD ELGX REVOLVER, LLC,
	as Agent
		
	By:	 	  

	Name:
	Title:]2

  
  

	2	 NTD: Agent’s consent to be provided solely to the extent required by
Section 13.01 of the Credit Agreement 

  
 [Signature Page to
Assignment and Acceptance Agreement] 

 ANNEX FOR ASSIGNMENT AND ACCEPTANCE 

ANNEX I 
 Borrowers: 

Endologix, Inc., a Delaware corporation 

CVD/RMS Acquisition Corp., a Delaware corporation 

Nellix, Inc., a Delaware corporation 

TriVascular Technologies, Inc., a Delaware corporation, 

TriVascular, Inc., a California corporation 

TriVascular Canada, LLC, a Delaware limited liability company 

TriVascular Sales, LLC, a Texas limited liability company 

RMS/Endologix Sideways Merger Corp., a Delaware corporation 

Name and Date of Credit Agreement: 
 Credit
Agreement dated as of August 9, 2018 (as amended, restated, supplemented, or otherwise modified from time to time, the “Credit Agreement”) by and among Borrowers, the lenders party thereto as “Lenders”, and
Deerfield ELGX Revolver, LLC, as administrative agent for each member of the Lender Group (in such capacity, together with its successors and assigns in such capacity, “Agent”). 

 

									
	Date of Assignment Agreement:	  	__________	  	
			
	Amounts:	  		  	
					
		 	(a)	 	Assigned Amount of Revolver Commitment	  	$__________	  	
					
		 	(b)	 	Assigned Amount of Revolving Loans	  	$__________	  	
			
	Settlement Date:	  	__________	  	
			
	Purchase Price	  	$__________	  	
			
	Notice and Payment Instructions, etc.	  		  	

  

									
		 	Assignee:	  	Assignor:
					
		 	  
	  		  	  
	  	
		 	  
	  		  	  
	  	
		 	  
	  		  	  
	  	

 

 

 

 

 EXHIBIT C-1 

FORM OF COMPLIANCE CERTIFICATE 

This Compliance Certificate (this “Compliance Certificate”) is given by
                                    , an Authorized Officer of
Endologix, Inc., a Delaware corporation (the “Borrower Representative”), pursuant to that certain Credit Agreement dated as of August 9, 2018, by and among the Borrower Representative, the other Borrowers signatory thereto and
any additional Borrower that may hereafter be added thereto, collectively, “Borrowers”), Deerfield ELGX Revolver, LLC, as Agent, and the financial institutions or other entities from time to time parties hereto, each as a Lender (as
such agreement may have been amended, restated, supplemented or otherwise modified from time to time, the “Credit Agreement”). Capitalized terms used herein without definition shall have the meanings set forth in the Credit
Agreement. 
 The undersigned Authorized Officer hereby certifies to Agent and Lenders that: 

(a) the financial statements delivered with this Compliance Certificate in accordance with Section 5.05 of the Credit
Agreement fairly present in all material respects the results of operations and financial condition of Borrowers and their Consolidated Subsidiaries as of the dates and the accounting period covered by such financial statements; 

(b) I have reviewed the terms of the Credit Agreement and have made, or caused to be made under my supervision, a review in reasonable detail
of the transactions and conditions of Borrowers and their Subsidiaries during the accounting period covered by such financial statements, and such review has not disclosed the existence during or at the end of such accounting period, and I have no
knowledge of the existence as of the date hereof (or at any time during the term of the period covered by this Compliance Certificate), of any condition or event that constitutes a Default or an Event of Default, except as set forth in
Schedule 1 hereto, which includes a description of the nature and period of existence of such Default or an Event of Default and what action Borrowers have taken, are undertaking and propose to take with respect thereto; 

(c) except as noted on Schedule 2 attached hereto, (i) Schedule 4 to the Guaranty and Security Agreement contains a
complete and accurate list of all business locations of Borrowers and Guarantors and all other information that is required to be included thereon in Section 4.4 of the Guaranty and Security Agreement (and without giving effect to any
“Closing Date” qualifier therein) and (ii) Schedule 3 to the Guaranty and Security Agreement contains all legal names under of the Borrowers and Guarantors as they appear on their organizational documents and such other
information that is required to be included thereon in Section 4.3 of the Guaranty and Security Agreement (and without giving effect to any “Closing Date” qualifier therein); and in each case of clause (i) and clause (ii)
above, Schedule 2 specifically notes any changes in such locations, legal names and other information; 
 (d) except as noted
on Schedule 3 attached hereto, the undersigned has no knowledge of (i) any federal or state Tax Liens having been filed against any Borrower, any Guarantor or any Collateral, or (ii) any failure of any Borrower or any
Guarantor to make required payments of withholding or other Tax obligations of any Borrower or any Guarantor during the accounting period to which the attached statements pertain or any subsequent period; 

(e) [reserved]; 
 (f) except as
noted on Schedule 4 attached hereto, Schedule 4.03 to the Credit Agreement is true, correct and complete in all material respects as it relates to the representations and warranties set

 
forth in Section 4.03 of the Credit Agreement (except that such materiality qualifier shall not be applicable to any such representation and warranty in Section 4.03 of the Credit
Agreement that already is qualified or modified by materiality in the text thereof); 
 (g) [reserved]; 

(h) except as noted on Schedule 6 attached hereto, no Borrower or Guarantor has acquired, by purchase or otherwise, any
Chattel Paper, Letter of Credit Rights, Instruments in excess of $250,000 in the aggregate, Documents or Investment Property (other than in the equity interests of Subsidiaries of the Borrowers) that has not previously been reported to Agent on any
Schedule 6 to any previous Compliance Certificate delivered by Borrower Representative to Agent; 
 (i) except as noted
on Schedule 7 attached hereto, no Borrower or Guarantor is aware of any commercial tort claim that has not previously been reported to Agent on any Schedule 7 to any previous Compliance Certificate delivered by Borrower
Representative to Agent; and 
 (j) Borrowers and any Guarantors are in compliance with the covenants contained in Article VII of the
Credit Agreement, and in any Guarantee constituting a part of the Loan Documents, as demonstrated by the calculation of such covenants set forth in Schedule 8 hereto, except as expressly set forth in
Schedule 8; in determining such compliance, the calculations set forth therein have been made: and such calculations and the certifications contained therein are true, correct and complete. 

To the extent any schedule attached hereto contains updated information, such schedule shall be amended with respect to the Credit Agreement,
Guaranty and Security Agreement or the Term Credit Agreement, as applicable. 
 The foregoing certifications are made as of the date hereof,
and the foregoing computations are made and calculated as of
                                , 20     (end of the applicable
period). 
  

	
	Sincerely,
	
	ENDOLOGIX, INC.
	
	By: ________________________________
	Name: ______________________________
	Title: ______________________________

 SCHEDULE 2 

BUSINESS LOCATIONS; LEGAL NAMES 

 SCHEDULE 3 

TAX 

 SCHEDULE 4 

LITIGATION 

 SCHEDULE 6 

CHATTEL PAPER, LETTER OF CREDIT RIGHTS, INSTRUMENTS, DOCUMENTS AND 

INVESTMENT PROPERTY 

 SCHEDULE 7 

FINANCIAL COVENANTS 

 1. EXHIBIT P-1 

2. FORM OF PERFECTION CERTIFICATE 

August 9, 2018 
 Each of the
parties signatory hereto hereby represents and warrants to (i) the Agent (as defined in the Facility Agreement defined below) and the Lenders (as defined in the Facility Agreement defined below) with reference to that certain Amended and
Restated Facility Agreement dated as of the date hereof, by and among the Loan Parties (as defined in the Facility Agreement defined below), the Lenders (as defined in the Facility Agreement defined below) party thereto, and Deerfield Private Design
Fund IV, L.P., as the Agent (as amended, restated, supplemented or otherwise modified, the “Facility Agreement”), and (ii) the Agent (as defined in the Credit Agreement defined below) and the Lenders (as defined in the Credit
Agreement defined below) with reference to that certain Credit Agreement dated as of the date hereof, by and among the Borrowers (as defined in the Credit Agreement defined below; such Borrowers, collectively with the “Loan Parties” under
the Facility Agreement, are referred to as the “Loan Parties” herein except in clause (i) above), the Lenders (as defined in the Credit Agreement defined below) party thereto, and Deerfield ELGX Revolver, LLC, as the Agent (as
amended, restated, supplemented or otherwise modified, the “Credit Agreement”) (terms that are not defined herein but are defined in such Facility Agreement and/or such Credit Agreement have the same meanings herein as specified
therein, as applicable), as follows: 
 3. 1. NAMES AND OTHER ORGANIZATIONAL RELATED INFORMATION OF LOAN PARTIES AND THEIR
SUBSIDIARIES 
 a. The name of each Loan Party and each of its Subsidiaries, as it appears in such Loan Party’s or
Subsidiary’s current Certificate of Incorporation, Certificate of Formation or similar organizational document as in effect on this date, is: 
  

			
	 Entity Name
	  	 Parent/Subsidiary

		
		  	 Sub Parent of ________________

		
		  	 Sub Parent of ________________

		
		  	 Sub Parent of ________________

 b. The federal employer identification number of each Loan Party and each of its Subsidiaries is: 

 

			
	 Loan Party/Subsidiary
	  	 Federal Employer Identification
Number

		
		  	
		
		  	
		
		  	

  
 6 

 c. The Loan Parties and their Subsidiaries, respectively, are formed under the laws
of the following jurisdictions: 
  

			
	 Loan Party/Subsidiary
	  	 State/Country

		  	
		  	
		  	

 d. The organizational identification number of each Loan Party issued by its respective jurisdiction of
formation is: 
  

			
	 Loan Party 
	  	 Organizational Identification Number 

		  	
		  	
		  	

 e. Each Loan Party, respectively, transacts business in the following jurisdictions (list jurisdictions other
than jurisdictions of formation): 
  

			
	 Loan Party
	  	 Jurisdiction(s) 

		  	
		  	
		  	

 f. Each Loan Party, respectively, is duly qualified to transact business as a foreign entity in the following
jurisdictions (list jurisdictions other than jurisdictions of formation): 
  

			
	 Loan Party
	  	 Jurisdiction(s) 

		  	
		  	
		  	

 g. The following is a list of all other names (including fictitious names, d/b/a’s, trade names or
similar names and including former legal names (as defined in Section 9-503(a) of the UCC)) currently used by a Loan Party or any of its Subsidiaries or used by a Loan Party or any of its Subsidiaries
within the past five years: 
  

					
	 Loan Party/Subsidiary
	  	 Name
	  	 Period of
Use

  
 7 

 h. The following are the names of all entities which have been merged into any Loan Party or
any of its Subsidiaries during the past five years: 
  

					
	 Loan Party/Subsidiary
	  	 Name of Merged Entity
	  	 Year of Merger

		  		  	

 i. The following are the names and addresses of all entities from whom any Loan Party or any of its
Subsidiaries has acquired any personal property in a transaction not in the ordinary course of business during the past five years, together with the date of such acquisition and the type of personal property acquired (e.g., equipment, inventory,
etc.): 
  

							
	 Name
	  	 Address
	  	 Date of Acquisition
	  	
Type of Property

		  		  		  	

 4. 2. LOCATIONS OF LOAN PARTIES AND THEIR SUBSIDIARIES 

a. The chief executive offices of each Loan Party and each of the Loan Parties’ Subsidiaries, respectively, are presently located at the
following addresses: 
  

			
	 Complete Street and Mailing Address, including County and
Zip Code
	  	 Loan Party/Subsidiary

		  	

 b. The books and records of each Loan Party and those of their Subsidiaries, respectively, are located at the
following additional addresses (complete this clause b only if different from clause a above): 
  

			
	 Complete Street and Mailing Address, including Zip
Code
	  	 Loan Party/Subsidiary

		  	

 c. The following are all the locations where a Loan Party or any of the Loan Parties’ Subsidiaries,
respectively, owns or leases, or occupies any real property: 
  

					
	 Complete Mailing Address, including Zip
Code
	  	 Leased/
Owned/
Occupied
	  	 Loan
Party/Subsidiary

  
 8 

					
	 	  	 	  	 
	 	  	 	  	 

 d. The following are all of the locations where a Loan Party or any of the Loan Parties’ Subsidiaries,
respectively, maintains any inventory, equipment or other property: 
  

			
	 Complete Address
	  	 Loan

Party/Subsidiary

		  	
		  	

 e. The following are the names and addresses of all warehousemen, bailees, or other third-parties who have
possession of any of the Loan Parties’ inventory or equipment or the inventory or equipment of any of the Loan Parties’ Subsidiaries: 
  

					
	 Name
	  	 Complete Street and Mailing Address, including Zip
Code
	  	 Loan Party/Subsidiary

		  		  	

 5. f.The following is a complete list of all other offices or other facilities (other than those
described above) where a Loan Party or any of the Loan Parties’ Subsidiaries has done business in the past 5 years. 
 6. 

 

			
	 Complete Address
	  	Loan
Party/Subsidiary
	7.	  	8.
	9.	  	10.

 11. 3. INTELLECTUAL PROPERTY 

a. Set forth below is a list of all patents, copyrights, trademarks, trade names and service marks registered or for which applications are
pending in the name of a Loan Party or any of the Loan Parties’ Subsidiaries, excluding those that are expired or abandoned to the extent permitted pursuant to clause (f) of the definition of “Permitted Dispositions” in each of
the Facility Agreement and the Credit Agreement. Please include the name of such intellectual property, the grant date or application date, as applicable, the registration or application number, as applicable, and the country of such registration or
application. 
  

											
	 Loan

Party/

Subsidiary
	  	 Name of

Intellectual

Property
	  	 Registered/

Application

Pending
	  	 Grant/
Application

Date
	  	 Registration/
Application

Number
	  	 Country
of
Registration/
Application

  
 9 

											
	 	  	 	  	 	  	 	  	 	  	 
	 	  	 	  	 	  	 	  	 	  	 

 b. Set forth below is a list of all licenses, franchise or other agreements relating to trademarks, patents,
copyrights and other know-how to which a Loan Party or any of the Loan Parties’ Subsidiaries is a party and that require annual payments in excess of $25,000 individually. 

12. 4. INVESTMENT PROPERTY; INSTRUMENTS; ACCOUNTS 

a. The following is a complete list of all stocks, bonds, debentures, notes, commodity contracts and other securities (as defined in Article 8
of the Uniform Commercial Code), owned by a Loan Party or any of the Loan Parties’ Subsidiaries: 
  

					
	 Name of Issuer
	  	 Description and Value of Security
	  	 Loan Party/Subsidiary

		  		  	
		  		  	
		  		  	

 b. The following are all banks and other financial institutions, securities intermediary or commodity
intermediary at which any Loan Party or any of the Loan Parties’ Subsidiaries maintains deposit, securities, commodities or similar accounts, which correctly identifies the name, address and any other relevant contact information with respect
to each depository or intermediary, the name in which the account is held, a description of the purpose of the account, and the complete account number therefor: 
  

									
	 Bank Name
	  	 Address and

Other Contact

Information
	  	 Name in Which

Account is Held
	  	 Purpose of
Account
	  	 Complete Account
Number

		  		  		  		  	
		  		  		  		  	

 c. The following are all securities or commodity intermediaries at which a Loan Party or any of the Loan
Parties’ Subsidiaries maintains securities accounts or commodities accounts: 

  
 10 

									
	 Securities or

Commodities
 Intermediary

Name
	  	 Address and

Other Contact

Information
	  	 Name in Which

Account is Held
	  	 Purpose of
Account
	  	 Complete Account
Number

		  		  		  		  	

 d. Does any Loan Party or any of the Loan Parties’ Subsidiaries or is it contemplated that any Loan Party
or any of the Loan Parties’ Subsidiaries will regularly receive letters of credit from customers or other third parties to secure payments of sums owed to such company? 

e. The following is a list of letters of credit naming a Loan Party or any of the Loan Parties’ Subsidiaries as “beneficiary”
thereunder: 
  

							
	 LC Number
	  	 Name of LC Issuer
	  	 LC Applicant
	  	 Loan
Party/
Subsidiary

		  		  		  	

 f. The approximate aggregate total amount of funds, amounts, and other assets of any kind in the
            Account is $                     . 

13. 5. INDEBTEDNESS 

Set forth below is a list and attached hereto are copies of, all agreements, promissory notes, indentures and other documents relating to any
indebtedness for borrowed money of a Loan Party or any of the Loan Parties’ Subsidiaries, including without limitation loan agreements, note indentures, letters of credit, reimbursement agreements, mortgages and guaranties of the indebtedness
for borrowed money of others. 
  

							
	 Debtor
	  	 14.Creditor
	  	 15.Amount of
Indebtedness
Outstanding
	  	 16.Maturity Date

		  	17.	  	18.	  	19.
		  	20.	  	21.	  	22.

 23. 6. ENCUMBRANCES 

Other than the Liens already described in Section 1.j. above, the property of the Loan Parties and/or any of the Loan Parties’
Subsidiaries is subject to the following Liens or encumbrances: 
  

					
	 Loan Party/Subsidiary
	  	 Name of Holder of Lien
	  	 Description of Property Encumbered

		  		  	

  
 11 

					
		  		  	
		  		  	
		  		  	

  

	7.	 LITIGATION; COMMERCIAL TORT CLAIMS 

a. The following is a complete list of pending and threatened litigation or claims involving amounts claimed against a Loan Party or any of
the Loan Parties’ Subsidiaries in an indefinite amount or in excess of $25,000 in each case: 
 b. The following are the only claims
(including, without limitation, commercial tort claims) which a Loan Party or any of the Loan Parties’ Subsidiaries has against others (other than claims on accounts receivable), which such Loan Party or Subsidiary is asserting or intends to
assert, and in which the potential recovery exceeds $25,000: 
 8. TAXES 

The following tax assessments against any of the Loan Parties or any of the Loan Parties’ Subsidiaries are currently outstanding and
unpaid: 
  

			
	 Assessing Authority
	  	 Amount and Description

		  	

 24. 9. INSURANCE BROKER 

The following brokers handle the Loan Parties’ and the Loan Parties’ Subsidiaries’ property and liability insurance: 

 

									
	 25. Broker
	  	 Contact
	  	 26. Telephone
	  	 27. Fax
	  	 28. Email

		  	29.	  	30.	  	31.	  	32.

 [remainder of page intentionally left blank] 

  
 12 

 The Loan Parties agree to advise you of any change or modification to any of the foregoing
information or any supplemental information provided on any continuation pages attached hereto, and, until such notice is received by you, you shall be entitled to rely upon such information and presume it is correct. The Loan Parties acknowledge
that your acceptance of this Perfection Certificate and any continuation pages does not imply any commitment on your part to enter into a loan transaction with the Loan Parties, and that any such commitment may only be made by an express written
loan commitment, signed by one of your authorized officers. The Loan Parties agree that this Perfection Certificate shall constitute a “Loan Document” under the Facility Agreement and a “Loan Document” under the Credit Agreement.

 Dated as of the date first written above 
  

							
	LOAN PARTIES:	 		 	ENDOLOGIX, INC., a Delaware corporation
				
		 		 	By:	 	  

		 		 	Name:	 	
		 		 	Title:	 	
			
		 		 	 CVD/RMS ACQUISITION CORP.,
 a
Delaware corporation

				
		 		 	By:	 	  

		 		 	Name:	 	
		 		 	Title:	 	
			
		 		 	NELLIX, INC., a Delaware corporation
				
		 		 	By:	 	  

		 		 	Name:	 	
		 		 	Title:	 	
			
		 		 	 TRIVASCULAR TECHNOLOGIES, INC.,
 a
Delaware corporation

				
		 		 	By:	 	  

		 		 	Name:	 	
		 		 	Title:	 	

 [Signature Page to Perfection Certificate] 

							
	LOAN PARTIES CONTINUED:	 		 	TRIVASCULAR, INC., a California corporation
				
		 		 	By:	  	  

		 		 	Name:	  	
		 		 	Title:	  	
			
		 		 	 ENDOLOGIX CANADA, LLC,
 a Delaware
limited liability company

				
		 		 	By:	  	  

		 		 	Name:	  	
		 		 	Title:	  	
			
		 		 	 TRIVASCULAR SALES LLC,
 a Texas
limited liability company

				
		 		 	By:	  	  

		 		 	Name:	  	
		 		 	Title:	  	
			
		 		 	 RMS/ENDOLOGIX SIDEWAYS MERGER CORP.,

a Delaware corporation

				
		 		 	By:	  	  

		 		 	Name:	  	
		 		 	Title:	  	

 [Signature Page to Perfection Certificate] 

 Schedule A-1 

Agent’s Account 

Beneficiary Bank: The Northern Trust International Banking Corporation, New Jersey 

SWIFT: CNORUS33 
 Fedwire ABA:
026001122 
 CHIPS ABA: 0112 

Beneficiary Name: Deerfield ELGX Revolver 

LLC Beneficiary account:143057-20010 

 Schedule A-2 

Authorized Person 
 Vaseem Mahboob 

Cindy Pinto 
 Tim Brady 

James Tejedor 

 Schedule C-1 

Commitments 
  

					
	 Lender
	  	Revolver Commitment	 
	 Deerfield Private Design Fund III, L.P.
	  	$	16,666,666.66	 
	 Deerfield Private Design Fund IV, L.P.
	  	$	16,666,666.67	 
	 Deerfield Partners, L.P.
	  	$	16,666,666.67	 
		  	  
	  
	 
	 Total
	  	$	50,000,000	 
		  	  
	  
	 

 Schedule D-1 

Designated Account 
  

			
	Wire Payment Instruction:	  	
		
	Beneficiary: Endologix, Inc.	  	
	Beneficiary Address: 2 Musick, lrvine, CA 92618, USA	  	
	Account Number: 1453531702	  	
		  	
	Bank Name: Bank of America	  	
	Bank Address: 333 South Hope Street, Los Angeles, CA 90071, USA	  	
	Domestic ABA/Routing Account Number: 026009593	  	
	International Swift Code: BOFAUS3N	  	

 Schedule E-1 

Approved Account Debtors 
  

	
	Angiocor S.A.
	Endo T&D Limited LTD
	Japan Lifeline Co., Ltd

 Schedule P-1 

Existing Investments 
  

					
	Name of Issuer	  	Description and Value of Security	  	Loan Party/Subsidiary
	 Cianna Medical, Inc.
	  	8,677 Shares of Series A Preferred Stock	  	Endologix, Inc.

 Schedule 4.01(d) 

Existing Liens 
 None. 

 Schedule 4.01(f) 

Existing Indebtedness 
 None. 

 Schedule 4.03 

Litigation 
 Vicky Nguyen v.
Endologix, Inc., et al.: (Filed January 3, 2017 in the United States District Court, Central District of California; Case No. 2:17-cv-00017). A putative
shareholder class action pending in the U.S. District Court for the Central District of California. Lead plaintiff in Nguyen asserts multiple causes of action for securities fraud based on allegations that Borrower and two of its executives
misled investors by opining optimistically about Borrower’s prospects for FDA pre-market approval of the Nellix EVAS System. On December 5, 2017, the District Court granted Borrower’s
motion to dismiss lead plaintiff’s First Amended Complaint, with leave to amend. On January 9, 2018, lead plaintiff filed a Second Amended Complaint. Borrower intends to move for dismissal of the Second Amended Complaint with prejudice.
The hearing on Borrower’s Motion to Dismiss lead plaintiff’s Second Amended Complaint has been set for August 10, 2018. 
 Derivative
Lawsuits: As of June 11, 2017, Four shareholders have filed derivative lawsuits on behalf of Borrower, the nominal plaintiff, based on allegations substantially similar to those alleged by lead plaintiff in Nguyen. Those actions
consist of: Sindlinger v. McDermott et al., Case No. BC662280 (Los Angeles Superior Court); Abraham v. McDermott et al., Case No. 30-2018-00968971-CU-BT-CSC (Orange County Superior Court); and Green v. McDermott et al., Case No. 8:17-cv-01155-AB (PLAx), consolidated with Cocco v. McDermott et al., Case No.
8:17-cv-01183-AB (PLAx) (U.S. District Court for the Central District of California). Plaintiffs in the Sindlinger and Green
derivative actions have agreed to stay litigation pending resolution of the Nguyen action. Endologix is currently negotiating a similar agreement with the Abraham plaintiff. A related case, Ahmed v. Endologix, Inc., et al. (Filed
January 11, 2017 in the United States District Court, Central District of California; Case No. 8:17-cv-00061) was consolidated into Nguyen v. Endologix, Inc. 

SEC Investigation: In July 2017, Borrower learned that the United States Securities and Exchange Commission (“SEC”) issued a Formal
Order of Investigation to investigate, among other things, events surrounding the Nellix EVAS System and the prospect of its FDA pre-market approval. Borrower is fully cooperating with the investigation.
Borrower continues to produce materials responsive to the SEC’s subpoenas. 
 Certain Notices: The Loan Parties have received three
unrelated notices from individuals claiming that certain of our products read on certain issued patents held by such individuals. The Loan Parties, after consultation with independent patent counsel, strongly disagree with these claims; however, it
is possible that should these claims proceed to litigation, that Borrower’s aggregate liability arising for monetary judgements or other reliefs arising out of these matters could exceed $2,000,000. Since it is presently not possible to
determine the outcome of any future discussions with these individuals in regard to their patents, and whether or not litigation will ensue, or the outcomes associated with potential litigation, no provision has been made in Borrower’s
financial statements for the ultimate resolution. 

 Schedule 4.06 

Real Estate 
 Owned Real Property:

  

			
	 Loan Party or Subsidiary
	  	 Complete street and mailing address, including zip
code

	N.A.	  	

 Leased Real Property: 
  

					
	 Loan Party or Subsidiary
	  	 Complete street and mailing address,

including zip code
	  	 Landlord name and contact information

	Endologix, Inc.	  	2 Musick, Irvine, County of Orange, California 92618 U.S.A.; 33 and 35 Hammond, Irvine, County of Orange, California 92618 U.S.A.	  	The Northwestern Mutual Life Insurance Company
			
	Endologix International Holdings B.V.	  	Burgemeester Burgerslaan 40, 5245 NH Rosmalen, The Netherlands	  	N.A.
			
	TriVascular Technologies, Inc.	  	3910 Brickway Blvd., Santa Rosa, County of Sonoma, CA 95403 U.S.A.	  	Sonoma Airport Properties LLC
			
	Endologix Singapore Private Limited	  	 10 Anson Road #21-04 & #21-04A

International Plaza Singapore 079903
	  	Stamcorp International Pte Ltd.
			
	Endologix International B.V.	  	 Rahmannstraße 11, 65760
 Eschborn,
Germany
	  	N.A.

 Subleased Real Property: 
  

					
	 Loan Party or Subsidiary
	  	 Complete street and mailing address,

including zip code
	  	 Landlord and sublandlord name and

contact information

Other Real Property Operated or Occupied: 
  

					
	 Loan Party or Subsidiary
	  	 Complete street and mailing address,

including zip code
	  	 Nature of use

	ELGX South Korea Ltd.	  	A-311, M-Sate, 114 Beopwon-ro, Songpa-gu, Seoul, South Korea	  	Office

 Schedule 4.07 

Intellectual Property 
 The items disclosed
in Schedule 4.03 with the lead-in “Certain Notices”. 
 On May 7, 2018, Borrower received notice from
Medtronic, Inc. (“Medtronic”) that Medtronic believes Borrower’s Ovation product appears to use one or more claims of certain Medtronic patents. Borrower is assessing this claim. Medtronic has invited Borrower to engage in discussions
to obtain a non-exclusive license to these patents. Borrower has a robust patent portfolio at its disposal, and after conducting analysis believes that one or more of Medtronic’s products appears to use
one or more claims of Borrower’s patents. Since it is presently not possible to determine the outcome of any future discussions with Medtronic in regard to the respective parties’ patents, and whether or not litigation will ensue, or the
outcomes associated with potential litigation, no provision has been made in Borrower’s financial statements for the ultimate resolution. 

 Schedule 4.15 

Borrower’s Subsidiaries 
  

													
	 Parent
	  	 Percentage
ownership
	  	 Name of
Subsidiary
	  	 Jurisdiction of
Subsidiary
	  	 Date of formation
of Subsidiary
	  	 Federal employer
ID no. of
Subsidiary
	  	 Organizational
identification no.
of
Subsidiary

	Endologix, Inc.	  	100%	  	Nellix, Inc.	  	Delaware	  	03/20/2001	  	94-3398416	  	3359980
							
	Endologix, Inc.	  	100%	  	CVD/RMS Acquisition Corp.	  	Delaware	  	12/13/1998	  	33-0928438	  	2955166
							
	Endologix, Inc.	  	100%	  	RMS/Endologix Sideways Merger Corp.	  	Delaware	  	05/30/2002	  	03-0512974	  	3530477
							
	Endologix, Inc.	  	100%	  	Endologix Singapore Private Limited	  	Singapore	  	01/13/2015	  	N.A.	  	N.A.
							
	Endologix, Inc.	  	100%	  	ELGX International Holdings GP	  	Cayman Islands	  	07/05/2011	  	N.A.	  	N.A.
							
	Endologix, Inc.	  	100%	  	Endologix New Zealand Co.	  	New Zealand	  	05/31/2012	  	N.A.	  	N.A.
							
	Endologix, Inc.	  	100%	  	ELGX South Korea Ltd.	  	South Korea	  	12/07/2017	  	N.A.	  	N.A.
							
	 Endologix, Inc.
 ELGX International Holdings
GP
	  	 99%
  

1%
	  	Endologix Bermuda L.P.	  	Bermuda	  	07/24/2012	  	N.A.	  	N.A.
							
	Endologix International Holdings B.V.	  	100%	  	Endologix Poland spolkda z ograniczona odpowiedzialnoscia	  	Poland	  	03/26/2015	  	N.A.	  	N.A.
							
	Endologix Bermuda L.P.	  	100%	  	Endologix International Holdings B.V.	  	The Netherlands	  	08/22/2011	  	N.A.	  	N.A.
							
	Endologix International Holdings B.V.	  	100%	  	Endologix Italia S.r.l.	  	Italy	  	06/04/2012	  	N.A.	  	N.A.
							
	Endologix International holdings B.V.	  	100%	  	Endologix International B.V.	  	The Netherlands	  	08/22/2011	  	N.A.	  	N.A.
							
	Endologix, Inc.	  	100%	  	TriVascular Technologies, Inc.	  	Delaware	  	07/11/2007	  	87-0807313	  	4387054
							
	TriVascular Technologies, Inc.	  	100%	  	TriVascular, Inc.	  	California	  	01/05/1998	  	68-0402620	  	C2065374
							
	TriVascular, Inc.	  	100%	  	TriVascular Sales, LLC	  	Texas	  	08/23/2012	  	46-0859179	  	0801644988

													
	 Parent
	  	 Percentage
ownership
	  	 Name of
Subsidiary
	  	 Jurisdiction of
Subsidiary
	  	 Date of formation
of Subsidiary
	  	 Federal employer
ID no. of
Subsidiary
	  	 Organizational
identification no.
of
Subsidiary

	TriVascular, Inc.	  	100%	  	Endologix Canada, LLC	  	Delaware	  	11/25/2014	  	N.A.	  	5647226
							
	TriVascular, Inc.	  	100%	  	TriVascular Germany GmbH	  	Germany	  	05/14/2012	  	N.A.	  	N.A.
							
	TriVascular, Inc.	  	100%	  	TriVascular Switzerland Sarl	  	Switzerland	  	04/30/2010	  	N.A.	  	N.A.
							
	TriVascular, Inc.	  	100%	  	TriVascular Italia S.R.L.	  	Italy	  	04/08/2010	  	N.A.	  	N.A.

 Schedule 4.17 

Borrower’s Outstanding Shares of Stock, Options and Warrants 

 

									
	 Name of Issuer
	  	 Authorized Securities
	  	 Issued and Outstanding Securities
	  	 Certificated
(Yes or No)
	  	 Loan Party/
Subsidiary Owner

	Endologix, Inc. 	  	 170,000,000 Shares of Common Stock, $0.001 par value
  
	  	 84,946,471 Shares of Common Stock Issued and 84,557,225 Outstanding3

 
	  	Yes	  	N.A.
	  	5,000,000 Shares of Preferred Stock, $0.001 par value, undesignated	  	Zero Shares of Preferred Stock	  	Yes, when issued	  	N.A.
					
	Nellix, Inc.	  	1,000 Shares of Common Stock, $0.001 par value	  	100 Shares of Common Stock	  	Yes	  	Endologix, Inc.
					
	CVD/RMS Acquisition Corp.	  	100 Shares of Common Stock, $0.001 par value	  	100 Shares of Common Stock	  	Yes	  	Endologix, Inc.
					
	ELGX South Korea, Ltd.	  	20,000 Contribution Units, KRW 5,000 par value	  	20,000 Contribution Units	  	No	  	Endologix, Inc.
					
	RMS/Endologix Sideways Merger Corp.	  	100 Shares of Common Stock, $0.001 par value	  	100 Shares of Common Stock	  	Yes	  	Endologix, Inc.
					
	TriVascular Technologies, Inc.	  	1,000 Shares of Common Stock, $0.001 par value	  	100 Shares of Common Stock	  	Yes	  	Endologix, Inc.
					
	ELGX International Holdings GP	  	Unspecified Number of Partnership Interests	  	Unspecified Number of Partnership Interests	  	No	  	Endologix, Inc.
					
	Endologix Bermuda, L.P.	  	Unspecified Number of Partnership Interests	  	Unspecified Number of Partnership Interests	  	No	  	Endologix, Inc.
					
	Endologix Singapore Private Limited	  	Unspecified Number of Company Interests	  	Unspecified Number of Company Interests	  	No	  	Endologix, Inc.
					
	Endologix New Zealand Co.	  	Unspecified Number of Company Interests	  	Unspecified Number of Company Interests	  	No	  	Endologix, Inc.

  

	3 	 As of August 7, 2018. There have been no material changes to such amount as of the Agreement Date.

									
	 Name of Issuer
	  	 Authorized Securities
	  	 Issued and Outstanding Securities
	  	 Certificated
(Yes or No)
	  	 Loan Party/
Subsidiary Owner

	TriVascular, Inc.	  	100 Shares of Common stock, $0.01 par value	  	100 Shares of Common Stock	  	No	  	TriVascular Technologies, Inc.
					
	Endologix International Holdings B.V.	  	Unspecified Number of Company Interests	  	Unspecified Number of Company Interests	  	No	  	Endologix Bermuda, L.P.
					
	Endologix Poland spolkda z ograniczona odpowiedzialnoscia	  	Unspecified Number of Company Interests	  	Unspecified Number of Company Interests	  	No	  	Endologix International Holdings B.V.
					
	Endologix International B.V.	  	Unspecified Number of Company Interests	  	Unspecified Number of Company Interests	  	No	  	Endologix International Holdings B.V.
					
	Endologix Italia S.r.l	  	Unspecified Number of Company Interests	  	Unspecified Number of Company Interests	  	No	  	Endologix International Holdings B.V.
					
	TriVascular Sales LLC	  	1,000 Units of Membership Interests	  	1,000 Units of Membership Interests	  	No	  	TriVascular, Inc.
					
	Endologix Canada, LLC	  	1,000 Units of Membership Interests	  	1,000 Units of Membership Interests	  	No	  	TriVascular, Inc.
					
	TriVascular Italia Sarl	  	Unspecified Number of Company Interests	  	Unspecified Number of Company Interests	  	No	  	TriVascular, Inc.
					
	TriVascular Germany GmbH	  	Unspecified number of Company Interests	  	Unspecified number of Company Interests	  	No	  	TriVascular, Inc.
					
	TriVascular Switzerland Sárl	  	Unspecified number of Company Interests	  	Unspecified number of Company Interests	  	No	  	TriVascular, Inc.

 Options and Equity Incentive/Compensation Plans: 

Equity Awards: Borrower’s 2015 Stock Incentive Plan as amended (the “2015 Plan”) authorizes the grant of equity awards to
purchase up to 10.3 million shares of Common Stock. As of July 31, 2018, approximately 9.6 million shares were reserved for issuance under outstanding stock options, including stock options granted under equity compensation plans
preceding the 2015 Plan, and 1.6 million shares were subject to unvested restricted stock awards. The outstanding stock options have exercise prices ranging from $1.64 to $17.58 and a weighted average exercise price of $7.28. There have been no
material changes to the items discussed in this paragraph as of the Agreement Date. 
 Amended and Restated 2006 Employee Stock Purchase
Plan (the “ESPP”): As of July 31, 2018, approximately 0.7 million shares of Common Stock were available for issuance under the ESPP. There have been no material changes to such amount as of the Agreement Date. 

 2017 Inducement Stock Incentive Plan: The Board has reserved 2,000,000 shares of
Borrower’s Common Stock for issuance pursuant to awards granted under the 2017 Inducement Stock Incentive Plan. As of July 31, 2018, approximately 1.5 million shares of Common Stock were available for issuance under this plan. There
have been no material changes to such amount as of the Agreement Date. 
 Non-Plan Inducement
Grants: In connection with its merger with TriVascular Technologies, Inc., on February 4, 2016 Borrower issued non-plan inducement stock options to purchase 1.4 million shares of Common Stock at
an exercise price of $7.53 per share, and non-plan inducement restricted stock units for 0.3 million shares of Common Stock. 

Warrants: 
 In connection with its
merger with TriVascular Technologies, Inc. on February 3, 2016, Borrower assumed unexercised out-of-the-money warrants of
TriVascular Technologies, Inc., which converted into warrants to purchase 35,094 shares of Common Stock, 24,272 at an exercise price of $12.58 per share and 10,822 at an exercise price of $28.21 per share. 

Pursuant to the terms of the Prior Facility Agreement, Borrower issued warrants to Lenders to purchase an aggregate of 6,470,000 shares of
Common Stock of Borrower at an exercise price of $9.23 per share. The number of shares of Common Stock of Borrower into which the warrants are exercisable and the exercise price of the warrants will be adjusted to reflect any stock splits,
recapitalizations or similar adjustments in the number of outstanding shares of Common Stock of Borrower. 
 Pursuant to the Agreement,
Borrower is issuing warrants to Lenders to purchase an aggregate of 8,750,000 shares of Common Stock of Borrower at an exercise price equal to the closing bid price on the date of grant. The number of shares of Common Stock of Borrower into which
the warrants are exercisable and the exercise price of the warrants will be adjusted to reflect any stock splits, recapitalizations or similar adjustments in the number of outstanding shares of Common Stock of Borrower. 

Convertible Notes: 
 2.25%
Convertible Notes: On December 10, 2013, Borrower issued $86.3 million aggregate principal amount of 2.25% Convertible Notes. The initial conversion rate of the 2.25% Convertible Notes is 41.6051 shares of Common Stock per $1,000
principal amount of 2.25% Convertible Notes, which represents an initial conversion price of approximately $24.04 per share. On April 3, 2017, Borrower entered into the Prior Facility Agreement with Deerfield and used proceeds from the
Deerfield loan to repurchase $68 million aggregate principal amount of outstanding 2.25% Senior Notes, plus the accrued but unpaid interest thereon, from the holders thereof in privately negotiated transactions. As of the Agreement Date, there
is currently $18.278 million aggregate principal amount of 2.25% Convertible Notes outstanding. 
 3.25% Convertible Notes: On
November 2, 2015, Borrower issued $125.0 million aggregate principal amount of 3.25% Convertible Notes. The initial conversion rate of the 3.25% Convertible Notes is 89.4314 shares of Common Stock per $1,000 principal amount of 3.25%
Convertible Notes, which represents an initial conversion price of approximately $11.18 per share. Pursuant to the terms of the Facility Agreement with Deerfield, $40.5 million of the aggregate principal amount of the 3.25% Convertible Notes
will be cancelled on the Agreement 

 
Date, and $84.5 million aggregate principal amount of 3.25% Convertible Notes will remain outstanding thereafter. 

Pursuant to this Agreement the Borrower may issue, upon exercise under the Notes by Lenders, Conversion Shares in accordance with the terms of
the Notes and Interest Payment Shares in accordance with this Agreement. 
 Other Rights to Securities of Borrower: 

In connection with its merger with Nellix, Inc. (“Nellix”), Borrower agreed to issue shares of Common Stock to the former
stockholders of Nellix upon Borrower’s receipt of FDA approval to sell its Nellix EVAS System in the United States (the “PMA Milestone”). The number of shares of Common Stock issuable to the former stockholders of Nellix upon
achievement of the PMA Milestone shall equal the quotient obtained by dividing $15.0 million by the average per share closing price of Common Stock on The Nasdaq Global Select Market for each of the 30 consecutive trading days ending with the
fifth trading day immediately preceding the date of Borrower’s receipt of FDA approval to sell its Nellix EVAS System in the United States, subject to a stock price floor of $4.50 per share, but not subject to a stock price ceiling.

 In June 2018, Borrower received the approval of its stockholders to conduct an exchange program (“Exchange Program”) in which
eligible employee stock option holders would have the ability to exchange certain “out-of-the-money” stock options for
restricted stock units (“RSUs”) of Borrower pursuant to fixed exchange ratios. Borrower intends to consummate this Exchange Program. The material terms of the Exchange Program are as set forth in proposal 6 of the Company’s definitive
proxy statement in respect of its annual meeting of stockholders held on June 14, 2018. 
 Registration Rights 

Registration Rights Agreements dated as of April 3, 2017 and the Agreement Date, respectively, by and among the Borrower the Lenders and
Agent. . 
 Agreement and Plan of Merger and Reorganization, dated October 27, 2010, by and among Borrowerthe, Nepal Acquisition
Corporation, Nellix, Inc., certain of Nellix, Inc.’s stockholders listed therein and Essex Woodlands Health Ventures, Inc., as representative of Nellix, Inc.’s stockholders (Section 6.12 contains registration obligation) 

At-the-Market Equity Offering Sales Agreement, dated
May 31, 2018, by and between Borrower and Stifel, Nicolaus & Company, Incorporated pursuant to which Stifel has agreed to use commercially reasonable efforts to sell on the Company’s behalf up to $50,000,000 in aggregate gross
process of the Company’s common stock pursuant to the terms instructed by the Company. The Company is obligated to pay Stifel at a fixed commission rate of up to 3.0% of the gross sales price of its common stock sold pursuant to the agreement.

 Schedule 4.18 

Material Contracts 
  

	•	 	 Cross License Agreement dated as of October 26, 2011, by and between Borrower and Bard Peripheral Vascular,
Inc. 

  

	•	 	 Settlement Agreement, dated October 16, 2012 by and among Borrower, Cook Incorporated, Cook Group and Cook
Medical, Inc. 

  

	•	 	 Standard Industrial/Commercial Multi-Tenant Lease—Net, for 2 Musick, Irvine, California and 33 & 35
Hammond, Irvine, dated June 12, 2013, by and between Borrower and The Northwestern Mutual Life Insurance Company. 

  

	•	 	 Lease for Santa Rosa facility for the building located at 3910 Brickway Boulevard, Santa Rosa, California as set
forth in the Third Amendment to Lease, by and between Trivascular, Inc. and Sonoma Airport Properties LLC and the earlier agreements described herein. 

 Schedule 4.20 

Environmental 
 None. 

 Schedule 4.22 

Labor Relations 
 None. 

 Schedule 4.23 

Jurisdiction of Organization, Legal Name, Organizational Identification Number and Chief Executive Office 

 

													
	 Loan Party
	  	 Jurisdiction of
organization
	  	 All other
jurisdictions of
organization
of Loan
Party
for 5 years
preceding the
Agreement
Date
	  	 Legal name
	  	
All other legal
names of Loan
Party for 5 years
preceding the
Agreement Date
	  	 Organizational
identification
no.
	  	 Location of chief
executive office or sole
place of
business: other
offices or facilities

	Endologix, Inc.	  	Delaware	  	N.A.	  	Same as loan party name at left	  	N.A.	  	2338745	  	2 Musick, Irvine, County of Orange, California 92618 U.S.A.
							
	Endologix, Inc.	  	Delaware	  	N.A.	  	Same as loan party name at left	  	N.A.	  	2338745	  	33 and 35 Hammond, Irvine, County of Orange, California 92618 U.S.A.
							
	Nellix, Inc.	  	Delaware	  	N.A.	  	Same as loan party name at left	  	N.A.	  	3359980	  	2 Musick, Irvine, County of Orange, California 92618 U.S.A.
							
	CVD/RMS Acquisition Corp.	  	Delaware	  	N.A.	  	Same as loan party name at left	  	N.A.	  	2955166	  	2 Musick, Irvine, County of Orange, California 92618 U.S.A.
							
	TriVascular Technologies, Inc.	  	Delaware	  	N.A.	  	Same as loan party name at left	  	N.A.	  	4387054	  	3910 Brickway Blvd., Santa Rosa, County of Sonoma, CA 95403 U.S.A
							
	TriVascular, Inc.	  	California	  	N.A.	  	Same as loan party name at left	  	N.A.	  	C2065374	  	3910 Brickway Blvd., Santa Rosa, County of Sonoma, CA 95403 U.S.A
							
	Endologix Canada, LLC	  	Delaware	  	N.A.	  	Same as loan party name at left	  	Trivascular Canada LLC	  	5647226	  	3910 Brickway Blvd., Santa Rosa, County of Sonoma, CA 95403 U.S.A

													
	RMS/Endologix Sideways Merger Corp.	  	Delaware	  	N.A.	  	Same as loan party name at left	  	N.A.	  	3530477	  	2 Musick, Irvine, County of Orange, California 92618 U.S.A.
							
	Trivascular Sales LLC	  	Texas	  	N.A.	  	Same as loan party name at left	  	N.A.	  	801644988	  	3910 Brickway Blvd., Santa Rosa, County of Sonoma, CA 95403 U.S.A

 Schedule 4.33(a) 

Governmental Notices Regarding Products 

Ovation® System 

On August 2018, Borrower intends to issue a global field safety notice related to reinforce information contained within the IFU in order to reduce the
occurrence of polymer leaks. 

 Schedule 4.41 

See above Schedule 4.17. 

 Schedule 4.45 

Inventory Location 
 The following are all
of the locations where a Loan Party or any of the Loan Parties’ Subsidiaries, respectively, maintains Inventory: 
  

			
	 Complete Address
	  	 Loan Party/Subsidiary

		
	2 Musick, Irvine, County of Orange, CA 92618 U.S.A.	  	Endologix, Inc.
		
	33 & 35 Hammond, Irvine, County of Orange, CA 92618 U.S.A	  	Endologix, Inc.
		
	3910 Brickway Blvd., Santa Rosa, County of Sonoma, CA 95403 U.S.A.	  	 TriVascular Technologies, Inc.
 TriVascular,
Inc.

		
	 10 Anson Road #21-04 & #21-04A

International Plaza Singapore 079903
	  	Endologix, Inc.
		
	A-311, M-Sate, 114 Beopwon-ro, Songpa-gu, Seoul, South Korea	  	Endologix, Inc.
		
	Burgemeester Burgerslaan 40, 5245 NH Rosmalen, The Netherlands	  	Endologix International Holdings B.V.
		
	Rahmannstraße 11, 65760 Eschborn, Germany	  	Endologix International B.V.

 The following are the names and addresses of all warehousemen, bailees, or other third parties who have possession of any of
the Loan Parties’ Inventory or the Inventory of any of the Loan Parties’ Subsidiaries: 
  

					
	 Name
	  	 Complete Street and Mailing Address, including Zip
Code
	  	 Loan Party/Subsidiary

	UPS	  	 378 Commercial Street, Malden, MA 02148
 165
Chubb Avenue, Lyndhurst, NJ 07071
 1130 Commerce Blvd, Swedesboro, NJ 08085

2250 Outerloop Drive, Louisville, KY 40219
	  	Endologix, Inc.
			
	Rhenus	  	Centaurusweg 123, 5015 TC Tilburg, The Netherlands	  	Endologix International Holdings B.V.

					
	 Name
	  	 Complete Street and Mailing Address, including Zip
Code
	  	 Loan Party/Subsidiary

	STOK UK Limited	  	One Fleet Place, London EC4M 7Ws	  	Endologix International B.V.
			
	TNT Express Korea	  	54 Yangcheon-ro, Gangseo-gu, Seoul 07522	  	Endologix, Inc.

 In addition to the foregoing: 
  

	 	•	 	 In the Ordinary Course of Business, the Loan Party or any of the Loan Parties Subsidiaries’ sales
representatives hold Trunk Inventory in their possession for sales calls and procedures, which Trunk Inventory is not held at a specific location or locations. 

 

	 	•	 	 Certain Inventory of the Loan Party or any of the Loan Parties’ Subsidiaries is held by numerous third
parties on a consignment basis at various locations. 

 Schedule 6.05 

Contingent Obligations 
  

	•	 	 Base Capped Call Confirmation, dated December 4, 2013, between the Borrower and Bank of America, N.A.

  

	•	 	 Additional Capped Call Confirmation, dated December 5, 2013, between the Borrower and Bank of America, N.A.

 The capped call transactions contemplated by the documents listed above relate to the 2.25% Convertible Notes. The capped call
transactions are expected to reduce the potential dilution and/or offset the potential cash payments that the Borrower may be required to make in excess of the principal amount upon conversion of the 2.25% Convertible Notes in the event that the
market price per share of the Borrower’s common stock, as measured under the terms of the capped call transactions, is greater than the strike price of the capped call transactions, which initially corresponds to the $24.04 conversion price of
the 2.25% Convertible Notes. The Borrower will not be required to make any cash payments to Bank of America, N.A. upon the exercise of the options that are a part of the capped call transactions, but rather will be entitled to receive from Bank of
America, N.A. a number of shares of the Borrower’s common stock and/or an amount of cash based on the amount by which the market price per share of Common Stock of the Borrower, as measured under the terms of the capped call transactions, is
greater than the strike price of the capped call transactions during the relevant valuation period. 

 Schedule 5.20 

Other Loan Documents to Be Form 8-K Exhibits 

Each of the following agreements, instruments and documents, including the schedules, exhibits and annexes thereto: 

 

	 	•	 	 the Agreement 

  

	 	•	 	 the Notes; 

  

	 	•	 	 the Guaranty and Security Agreement; 

 

	 	•	 	 the Intercompany Subordination Agreement; 

 

	 	•	 	 the Intercreditor Agreement; 

 

	 	•	 	 the Patent Security Agreement; and 

 

	 	•	 	 the Trademark Security Agreement. 

 Schedule 6.07 

Transactions with Affiliates 
 Investments
of Inventory pursuant to clause (j) of the definition of Permitted InvestmentsEX-10.2

 Exhibit 10.2 

Execution Version 

AMENDED AND RESTATED 

FACILITY AGREEMENT 

dated as of August 9, 2018 

by and among 

Endologix, Inc., 
 as the
Borrower, 
 the other Loan Parties party hereto from time to time, 

the Lenders 
 and

 Deerfield Private Design Fund IV, L.P., 

as agent for itself and the Lenders 

 Table of Contents 

 

							
	 ARTICLE 1 DEFINITIONS
	  	 	2	 
			
	 Section 1.1
	  	General Definitions	  	 	2	 
	 Section 1.2
	  	Interpretation	  	 	41	 
	 Section 1.3
	  	Business Day Adjustment	  	 	42	 
	 Section 1.4
	  	Loan Records	  	 	42	 
	 Section 1.5
	  	Accounting Terms and Principles	  	 	43	 
	 Section 1.6
	  	Tax Treatment	  	 	43	 
	 Section 1.7
	  	Officers	  	 	44	 
	 Section 1.8
	  	Joint Drafting and Negotiation	  	 	44	 
		
	 ARTICLE 2 AGREEMENT FOR THE LOANS
	  	 	44	 
			
	 Section 2.1
	  	Use of Proceeds	  	 	44	 
	 Section 2.2
	  	Disbursements	  	 	44	 
	 Section 2.3
	  	Payments; Prepayments; No Call; Non-Callable Make Whole Amount	  	 	45	 
	 Section 2.4
	  	Payment Details	  	 	49	 
	 Section 2.5
	  	Taxes	  	 	49	 
	 Section 2.6
	  	Interest	  	 	51	 
	 Section 2.7
	  	Yield Enhancement Payment; Default Interest	  	 	52	 
	 Section 2.8
	  	Delivery of Warrants	  	 	53	 
		
	 ARTICLE 3 REPRESENTATIONS AND WARRANTIES
	  	 	54	 
			
	 Section 3.1
	  	Representations and Warranties of the Loan Parties	  	 	54	 
	 Section 3.2
	  	Borrower Acknowledgment	  	 	69	 
	 Section 3.3
	  	Representations and Warranties of the Lenders	  	 	69	 
		
	 ARTICLE 4 CLOSING CONDITIONS
	  	 	70	 
			
	 Section 4.1
	  	Conditions to the Disbursement	  	 	70	 
		
	 ARTICLE 5 PARTICULAR COVENANTS AND EVENTS OF DEFAULT
	  	 	73	 
			
	 Section 5.1
	  	Affirmative Covenants	  	 	73	 
	 Section 5.2
	  	Negative Covenants	  	 	81	 
	 Section 5.3
	  	Change of Control	  	 	89	 
	 Section 5.4
	  	General Acceleration Provision upon Events of Default	  	 	90	 
	 Section 5.5
	  	Additional Remedies	  	 	95	 
	 Section 5.6
	  	Recovery of Amounts Due	  	 	95	 
	 Section 5.7
	  	Credit Bidding	  	 	95	 
		
	 ARTICLE 6 MISCELLANEOUS
	  	 	96	 
			
	 Section 6.1
	  	Notices	  	 	96	 
	 Section 6.2
	  	Waiver of Notice	  	 	97	 
	 Section 6.3
	  	Fees, Charges, Costs and Expenses Reimbursement	  	 	97	 
	 Section 6.4
	  	Governing Law	  	 	98	 
	 Section 6.5
	  	Successors and Assigns    	  	 	98	 

  
 i 

							
	 Section 6.6
	  	Entire Agreement; Amendments	  	 	99	 
	 Section 6.7
	  	Severability	  	 	100	 
	 Section 6.8
	  	Counterparts	  	 	100	 
	 Section 6.9
	  	Survival	  	 	100	 
	 Section 6.10
	  	No Waiver	  	 	102	 
	 Section 6.11
	  	Indemnity	  	 	102	 
	 Section 6.12
	  	No Usury	  	 	103	 
	 Section 6.13
	  	Specific Performance	  	 	103	 
	 Section 6.14
	  	Further Assurances	  	 	104	 
	 Section 6.15
	  	Agent	  	 	104	 
	 Section 6.16
	  	USA Patriot Act	  	 	106	 
	 Section 6.17
	  	Placement Agent	  	 	107	 
	 Section 6.18
	  	No Fiduciary Relationship	  	 	107	 
	 Section 6.19
	  	Joint and Several	  	 	107	 
	 Section 6.20
	  	No Third Parties Benefited	  	 	107	 
	 Section 6.21
	  	Binding Effect	  	 	107	 
	 Section 6.22
	  	Marshaling; Payments Set Aside	  	 	107	 
	 Section 6.23
	  	No Waiver; Cumulative Remedies	  	 	107	 
	 Section 6.24
	  	Right of Setoff	  	 	107	 
	 Section 6.25
	  	Independent Nature of Secured Parties	  	 	108	 
	 Section 6.26
	  	Sharing of Payments, Etc.	  	 	108	 
	 Section 6.27
	  	Confidentiality	  	 	108	 
	 Section 6.28
	  	Intercreditor Agreement	  	 	109	 
	 Section 6.29
	  	Acknowledgment of Prior Obligations and Continuation Thereof	  	 	110	 
	 Section 6.30
	  	No Novation	  	 	110	 
	 Section 6.31
	  	Survival of Any Existing Unmatured Events of Default and Events of Default	  	 	111	 
	
	Annex	  

		
	Annex A	  	Disbursement Amount and Warrants	  

	
	Exhibits	  

		
	Exhibit 2.6	  	Share Payment Provisions	  

	Exhibit A-1	  	Form of First Out Waterfall Note	  

	Exhibit A-2	  	Form of Last Out Waterfall Note	  

	Exhibit B	  	Form of Perfection Certificate	  

	Exhibit C-1	  	Form of Initial Warrant	  

	Exhibit C-1	  	Form of Additional Warrant	  

	Exhibit D	  	Closing Checklist	  

	Exhibit E	  	Form of Amended and Restated Registration Rights Agreement	  

	Exhibit F	  	Form of Compliance Certificate	  

	
	Schedules	  

		
	Schedule P-1	  	Existing Investments	  

	Schedule 2.4	  	List of Agreement Date Lenders and Such Lenders’ Wire Instructions and Information for Notices	  

  
 ii 

					
	Schedule 3.1(d)	  	Existing Liens
	Schedule 3.1(f)	  	Existing Indebtedness
	Schedule 3.1(h)	  	Litigation
	Schedule 3.1(m)	  	Real Estate
	Schedule 3.1(x)	  	Borrower’s Subsidiaries
	Schedule 3.1(z)	  	Borrower’s Outstanding Shares of Stock, Options and Warrants
	Schedule 3.1(aa)	  	Material Contracts
	Schedule 3.1(dd)	  	Environmental
	Schedule 3.1(ff)	  	Labor Relations
	Schedule 3.1(gg)	  	Jurisdiction of Organization, Legal Name, Organizational Identification Number and Chief Executive Office
	Schedule 3.1(hh)	  	Inventory Locations
	Schedule 3.1(jjj)	  	Stock of the Subsidiaries of the Loan Parties
	Schedule 5.1(q)	  	Other Loan Documents to Be Form 8-K Exhibits
	Schedule 5.2(iv)	  	Contingent Obligations
	Schedule 5.2(vii)	  	Transactions with Affiliates

  

  
 iii 

 AMENDED AND RESTATED 

FACILITY AGREEMENT 
 This
AMENDED AND RESTATED FACILITY AGREEMENT (this “Agreement”), dated as of August 9, 2018, by and among Endologix, Inc., a Delaware corporation (the “Borrower”), the other Loan Parties (as defined below) party
hereto from time to time, the lenders party hereto from time to time (including the First Out Waterfall Lenders (as defined below) and the Last Out Waterfall Lenders (as defined below)), Deerfield Private Design Fund IV, L.P. (“Deerfield
Facility Entity”), as agent for itself and the Lenders (in such capacity, together with its successors and assigns in such capacity, “Agent,” and, together with the Lenders, the Borrower and the other Loan Parties party
hereto, the “Parties”). 
 W I T N E S S E T H: 

WHEREAS, the Loan Parties party thereto, Agent and the lenders party thereto are parties to that certain Facility Agreement dated as of the
Prior Agreement Date (as amended, restated, supplemented or otherwise modified from time to time prior to the effectiveness hereof, the “Prior Facility Agreement”); 

WHEREAS, Agent, the Lenders party hereto and the Loan Parties party hereto have agreed to amend and restate the Prior Facility Agreement in
its entirety to read as set forth in this Agreement, and it has been agreed by such parties that the “Loans”, “Disbursements” and other “Obligations” outstanding under the Prior Facility Agreement or any Prior Loan
Document shall continue under and be governed by and deemed to be outstanding under this Agreement, it being agreed and understood that this Agreement does not constitute a novation, satisfaction, payment or
re-borrowing of any obligation or “Obligation” under the Prior Facility Agreement or any other Prior Loan Document, nor does this Agreement operate as a waiver of any right, power or remedy of Agent,
any Lender or any other Secured Party under any Loan Document; 
 WHEREAS, pursuant to a recapitalization of the Borrower involving and in
consideration of, among other things, (a) the amendment and restatement of the Prior Facility Agreement and the entry into this Agreement, (b) certain accommodations under the Prior Facility Agreement and this Agreement made in favor of
the Loan Parties with respect to certain actions previously taken by the Loan Parties and their Subsidiaries, and (c) Deerfield Partners, L.P. (as the sole Last Out Waterfall Lender as of the Agreement Date) agreeing to extend the date of
payment of the principal that would have otherwise been due until the Maturity Date with respect to such 3.25% Convertible Notes that it held and to forgo certain other benefits it had under such 3.25% Convertible Notes, it and the Loan Parties have
agreed to exchange $40,500,000 of the 3.25% Convertible Notes held by Deerfield Partners, L.P. (but, for the avoidance of doubt, not any other 3.25% Convertible Notes) (the “Exchanged Deerfield Convertible Notes”) for a new tranche
of loans in the principal amount of $40,500,000 under this Agreement, which shall constitute the Last Out Waterfall Loans and part of the Last Out Waterfall Obligations, Loans and Obligations hereunder and which such new tranche of loans shall
receive the interest and other amounts and payments applicable to such loans under this Agreement and the other Loan Documents and shall be afforded the security, the Liens (including the priority thereof), the Guarantees and the other benefits
applicable to such loans hereunder and under the other Loan Documents; 
 WHEREAS, Borrower desires to continue to secure all of the
Obligations (including the Last Out Waterfall Loans) by continuing to grant to Agent, for the benefit of the Secured Parties, a first priority (subject only to the prior priority of the Permitted Priority Liens) perfected Lien upon substantially all
of its personal and real property including all of the issued and outstanding Stock of its direct Subsidiaries (in each case, other than Excluded Property); and 

 WHEREAS, each of the Loan Parties is willing to continue to guaranty all of the Obligations
(including the Last Out Waterfall Loans), and to continue to grant to Agent, for the benefit of the Secured Parties, a first priority (subject only to the prior priority of the Permitted Priority Liens) perfected Lien upon all of its respective
personal and real property, including all of the issued and outstanding Stock of its direct Subsidiaries (in each case, other than Excluded Property) which are issued to a Loan Party. 

NOW, THEREFORE, in consideration of the mutual covenants and agreements set forth herein, and for other good and valuable consideration, the
receipt and sufficiency of which is hereby acknowledged, the Parties hereby agree to amend and restate the Prior Facility Agreement and to provide for the Last Out Waterfall Loans hereunder, and the Prior Facility Agreement is hereby amended and
restated in its entirety (and the Last Out Waterfall Loans are provided for hereunder) pursuant to the terms hereof, as follows: 

ARTICLE 1 
 DEFINITIONS

 Section 1.1 General Definitions. Wherever used in this Agreement, the Exhibits or the
Schedules attached hereto, unless the context otherwise requires, the following terms have the following meanings: 
 “2.25%
Convertible Note Documents” means the 2.25% Convertible Notes, the 2.25% Senior Note Indenture and each other document or agreement from time to time entered into in connection with the foregoing. 

“2.25% Convertible Notes” means those certain 2.25% senior unsecured notes, governed by the terms of a base indenture, as
supplemented by the first supplemental indenture relating to the 2.25% senior notes (together, the “2.25% Senior Notes Indenture”), between the Borrower and Wells Fargo Bank, National Association, as trustee, each of which were
entered into on December 10, 2013. 
 “2.25% Senior Notes Indenture” has the meaning provided therefor in the
definition of “2.25% Convertible Notes.” 
 “3.25% Convertible Notes” means those certain 3.25% senior unsecured
notes, governed by the terms of a base indenture, as supplemented by the second supplemental indenture relating to the 3.25% senior notes (together, the “3.25% Senior Notes Indenture”), between the Borrower and Wells Fargo Bank,
National Association, as trustee, each of which were entered into on November 2, 2015, as the same may be amended, restated, refinanced, supplemented or otherwise modified in connection with a Permitted 3.25% Convertible Note Refinancing. 

“3.25% Convertible Note Documents” means the 3.25% Convertible Notes, the 3.25% Senior Note Indenture and each other document
or agreement from time to entered into in connection with the foregoing, as the same may be amended, restated, refinanced, supplemented or otherwise modified in on with a Permitted 3.25% Convertible Note Refinancing. 

“3.25% Senior Notes Indenture” has the meaning provided therefor in the definition of “3.25% Convertible Notes.”

 “10-K” means an annual report on Form
10-K (or successor form thereto), as required to be filed pursuant to the Exchange Act. 

  
 2 

 “10-Q” means a quarterly report on
Form 10-Q (or successor form thereto), as required to be filed pursuant to the Exchange Act. 

“ABL Agent” has the meaning assigned to such term in the definition of “ABL Credit Facility” herein. 

“ABL Credit Agreement” and “ABL Credit Facility” mean that certain Credit Agreement, dated as of the
Agreement Date, by and among the Borrower, the other Persons party thereto from time to time as “Borrowers” (as defined therein) or guarantors therein, Deerfield ELGX Revolver, LLC, in its capacity as Agent (as defined therein (including
any Third Party Agent (as defined therein)), in such capacity, together with its successors and assigns in such capacity, the “ABL Agent”) and the financial institutions or other entities from time to time parties thereto, each as a
Lender (as defined therein), as amended, restated, supplemented or otherwise modified in accordance and in compliance with the Intercreditor Agreement. 

“ABL Debt” means “ABL Obligations” as defined in the Intercreditor Agreement. 

“ABL Debt Documents” means “ABL Documents” as defined in the Intercreditor Agreement. 

“ABL Lenders” means the lenders under the ABL Debt Documents. 

“Accounts” means, collectively, (a) any right to payment of a monetary obligation, whether or not earned by performance,
(b) without duplication, any “account” (as defined in the UCC), any accounts receivable (whether in the form of payments for services rendered or goods sold, rents, license fees or otherwise), any “health-care-insurance
receivables” (as defined in the UCC), any “payment intangibles” (as defined in the UCC) and all other rights to payment and/or reimbursement of every kind and description, whether or not earned by performance, (c) all accounts,
“general intangibles” (as defined in the UCC), Intellectual Property, rights, remedies, Guarantees, “supporting obligations” (as defined in the UCC),
“letter-of-credit rights” (as defined in the UCC) and security interests in respect of the foregoing, all rights of enforcement and collection, all books and
records evidencing or related to the foregoing, and all rights under the Loan Documents in respect of the foregoing, (d) all information and data compiled or derived by any Loan Party or to which any Loan Party is entitled in respect of or
related to the foregoing, and (e) all proceeds of any of the foregoing. 
 “Acquisition” means any transaction or
series of related transactions for the purpose of or resulting, directly or indirectly, in (a) the acquisition of all or substantially all of the assets of a Person, or of any business or division of a Person, (b) the acquisition of in
excess of fifty percent (50%) of the Stock of any Person or otherwise causing any Person to become a Subsidiary of the Borrower, (c) a merger or consolidation or any other combination with another Person or (d) the acquisition (including
through licensing) of any Product or Intellectual Property of or from another Person if the Acquisition Consideration paid in connection with such acquisition is in excess of $5,000,000 individually or in the aggregate with respect to all such
acquisitions in any twelve (12) month period. 
 “Acquisition Consideration” has the meaning set forth in the
definition of “Permitted Acquisitions.” 
 “Additional Amounts” has the meaning set forth in Section 2.5(a).

 “Additional Warrants” has the meaning set forth in Section 2.8(d). 

“Affiliate” means, with respect to any Person, (a) any Person that directly or indirectly controls such Person,
(b) any Person which is controlled by or is under common control with such controlling 

  
 3 

 
Person, and (c) each of such Person’s (other than, with respect to any Lender, any Lender’s) officers or directors (or Persons functioning in substantially similar roles) and the
spouses, parents, descendants and siblings of such officers, directors or other Persons. As used in this definition, the term “control” of a Person means the possession, directly or indirectly, of the power to vote five percent (5%) or
more of any class of voting securities of such Person or to direct or cause the direction of the management or policies of a Person, whether through the ownership of voting securities, by contract or otherwise. 

“Agent” has the meaning set forth in the preamble to this Agreement. 

“Agreement” has the meaning set forth in the preamble to this Agreement. 

“Agreement Date” means the date of this Agreement. 

“All-in Yield” means the interest rate (including margins and floors), original issue
discount and fees paid to all lenders (or consenting lenders) of such debt or their Affiliates (based on the remaining life to maturity), but not including any fees not paid to all lenders (such as fees to initial purchasers (i.e., investment banks
in Rule 144A offerings), underwriters or lead agents). 
 “Amortization Payments” means (i) with respect to the First
Out Waterfall Loans, the three principal payments due on April 2, 2021, April 2, 2022 and on the Maturity Date that are set forth in the second column of the table in Section 2.3(a) and (ii) with respect to the Last Out Waterfall
Loans, the two principal payments due on April 2, 2022 and on the Maturity Date that are set forth in the third column of the table in Section 2.3(a). 

“Announcing Form 8-K” has the meaning set forth in Section 5.1(q). 

“Anti-Corruption Laws” means any and all laws, rules, and regulations of any jurisdiction applicable to any Loan Party or any
Subsidiary of any Loan Party from time to time concerning or relating to bribery or corruption, including, without limitation, the FCPA, as amended, the UK Bribery Act 2010 and other similar legislation in any other jurisdictions. 

“Anti-Money Laundering Laws” means any and all laws, rules, and regulations in effect from time to time related to terrorism
or money laundering, including, without limitation, (i) all applicable requirements of the Currency and Foreign Transactions Reporting Act of 1970 (31 U.S.C. 5311 et. seq., (the Bank Secrecy Act)), as amended by Title III of the USA Patriot
Act, (ii) the Trading with the Enemy Act, (iii) Executive Order No. 13224 on Terrorist Financing, effective September 24, 2001 (66 Fed. Reg. 49079), and any other enabling legislation, executive order or regulations issued
pursuant or relating thereto and (iv) other applicable federal or state laws relating to “know your customer” or anti-money laundering rules and regulations. 

“Anti-Terrorism Laws” means any and all laws, regulations, rules, orders, etc. in effect from time to time relating to
anti-money laundering and terrorism, including, without limitation, Executive Order No. 13224 (effective September 24, 2001), Trading with the Enemy Act, as amended, and each of the foreign assets control regulations of the United States
Treasury Department (31 CFR, Subtitle B, Chapter V, as amended), and the USA Patriot Act (Pub. L. No. 107-56 (Oct. 12, 2001)). 

“Applicable Laws” means, with respect to any Person, the common law and any federal, state, local, foreign, multinational or
international laws, statutes, codes, treaties, standards, rules and regulations, guidelines, ordinances, orders, judgments, writs, injunctions, decrees (including administrative or judicial precedents or authorities) and the interpretation or
administration thereof by, and other determinations, directives, requirements or requests of, any Governmental Authority, in each case whether or not having 

  
 4 

 
the force of law and that are applicable to or binding upon such Person or any of its property or to which such Person or any of its property is subject. “Applicable Laws” includes
Healthcare Laws and Environmental Laws. 
 “Application Event” means the occurrence of (a) a failure by the Loan
Parties to repay all of the Obligations (other than (y) unasserted contingent indemnification obligations and (z) those Obligations under any Warrant or the Registration Rights Agreement that are not (or do not become) due or payable on
the Maturity Date) in full in cash on the Maturity Date, (b) any Insolvency Proceeding or any event of the type set forth in Section 5.4(d), (c) any acceleration of the Obligations, (d) a foreclosure or an exercise of rights or
remedies on any of the Collateral at the time of, or after, an Event of Default has occurred and is continuing, (e) any exercise of remedies by the Agent or the Required Lenders at the time of, or after, an Event of Default has occurred and is
continuing or (f) any “Application Event” (as defined in the Intercreditor Agreement). 
 “Approved Fund”
means any (a) investment company, fund, trust, securitization vehicle or conduit that is (or will be) engaged in making, purchasing, holding or otherwise investing in commercial loans and similar extensions of credit, or (b) any Person
(other than a natural person) which temporarily warehouses loans for any Lender or any entity described in the preceding clause (a) and that, with respect to each of the preceding clauses (a) and (b), is administered or managed by
(i) a Lender, (ii) an Affiliate of a Lender, or (iii) a Person (other than a natural person) or an Affiliate of a Person (other than a natural person) that administers or manages a Lender. 

“Authorizations” means, with respect to any Person, any permits (including Regulatory Required Permits), approvals,
authorizations, licenses, registrations, certificates, clearances, concessions, grants, franchises, variances or permissions from, and any other contractual obligations with, any Governmental Authority, in each case whether or not having the force
of law and applicable to or binding upon such Person or any of its property or to which such Person or any of its property is subject, and any supplements or amendments with respect to the foregoing. 

“Authorized Officer” means the chief executive officer, the president or the chief financial officer of the Borrower or any
other officer of the Borrower having substantially the same authority and responsibility. 
 “Bank of America Cash Collateral
Account” means that certain deposit account #1453234066 of Borrower at Bank of America, N.A. (or such replacement deposit account provided by Bank of America, N.A. or by another commercial bank) established and maintained for the sole
purpose of providing cash collateral in favor of Bank of America, N.A. (or such replacement commercial bank) for obligations of the Borrower in respect of certain commercial credit cards (or with respect to a replacement commercial bank, similar
commercial credit cards to those provided by Bank of America, N.A. as of the Prior Agreement Date) provided to the Borrower by Bank of America, N.A. (or such replacement commercial bank); provided that the aggregate amount on deposit
in such deposit account (or such replacement deposit account) shall not at any time exceed $2,500,000. 
 “Bankruptcy Code”
means title 11 of the United States Code, as in effect from time to time. 
 “Bloomberg” has the meaning set forth in the
definition of “Volume Weighted Average Price.” 
 “Borrower” has the meaning set forth in the preamble to this
Agreement. 
 “Business Day” means a day other than Saturday or Sunday on which banks are open for business in New York,
New York. 

  
 5 

 “Capital Expenditures” means, with respect to any Person for any period,
the amount of all expenditures by such Person and its Subsidiaries during such period that are capital expenditures as determined in accordance with GAAP, whether such expenditures are paid in cash or financed, but excluding, without duplication
(a) expenditures made during such period in connection with the replacement, substitution, or restoration of assets or properties, (b) with respect to the purchase price of assets that are purchased substantially contemporaneously with the
trade-in of existing assets during such period, the amount that the gross amount of such purchase price is reduced by the credit granted by the seller of such assets for the assets being traded in at such
time, (c) expenditures made during such period to consummate one or more Permitted Acquisitions, (d) expenditures made during such period to the extent made with the identifiable proceeds of an equity investment in the Borrower which
equity investment is made substantially contemporaneously with the making of the expenditure, and (e) expenditures during such period that, pursuant to a written agreement, are reimbursed by a third Person (excluding the Loan Parties and their
Affiliates). 
 “Capital Lease” means, with respect to any Person, any lease of or other arrangement conveying the right to
use, any property by such Person as lessee that has been or should be accounted for as a capital lease on a balance sheet of such Person prepared in accordance with GAAP. 

“Capital Lease Obligations” means, at any time, with respect to any Capital Lease, any lease entered into as part of any sale
leaseback transaction of any Person or any synthetic lease, the amount of all obligations of such Person that is (or that would be, if such synthetic lease or other lease were accounted for as a Capital Lease) capitalized on a balance sheet of such
Person prepared in accordance with GAAP. 
 “Capped Call” means the capped call transactions referenced in Schedule 5.2(iv)
in respect of the 2.25% Convertible Notes and any like transactions that are economically similar to such transactions entered into in connection with any Indebtedness contemplated under clause (k) of the definition of Permitted Indebtedness.

 “Cash Equivalents” means (a) any readily-marketable securities (i) issued by, or directly, unconditionally and
fully guaranteed or insured by the United States federal government or (ii) issued by any agency of the United States federal government the obligations of which are fully backed by the full faith and credit of the United States federal
government, (b) any readily-marketable direct obligations issued by any other agency of the United States federal government, any state of the United States or any political subdivision of any such state or any public instrumentality thereof,
in each case having a rating of at least “A-1” from S&P or at least “P-1” from Moody’s, (c) any commercial paper rated at least “A-1” by S&P or “P-1” by Moody’s and issued by any Person organized under the laws of any state of the United States, (d) any United States
dollar-denominated time deposit, insured certificate of deposit, overnight bank deposit or bankers’ acceptance issued or accepted by any commercial bank that is (A) organized under the laws of the United States, any state thereof or the
District of Columbia, (B) “adequately capitalized” (as defined in the regulations of its primary federal banking regulators) and (C) has Tier 1 capital (as defined in such regulations) in excess of $250,000,000, (e) shares of any
United States money market fund that (i) has substantially all of its assets invested continuously in the types of investments referred to in clause (a), (b), (c) or (d) above with maturities as set forth in the proviso below,
(ii) has net assets in excess of $500,000,000 and (iii) has obtained from either S&P or Moody’s the highest rating obtainable for money market funds in the United States; provided, however, that the maturities of all
obligations specified in any of clauses (a), (b), (c) or (d) above shall not exceed one year and (f) investments made in accordance with the Borrower’s investment policy in effect as of the Prior Agreement Date that was provided to
the Agent’s counsel on March 14, 2017 at 12:15 p.m. New York time, and any amendments thereto that do not, when taken as a whole, materially increase the risk of the investments made by the Borrower from time to time from Borrower’s
investment policy in effect as of the Prior Agreement Date. 

  
 6 

 “Cash Interest Rate” means 5.00% per annum for the principal amount of the
Loans and any overdue interest thereon, plus any additional amounts set forth in Section 2.7(b). 
 “Change of
Control” or “Change in Control” means any of the following events: (a) any Person or two or more Persons acting in concert shall have acquired beneficial ownership, directly or indirectly, of, or shall have acquired by
contract or otherwise, or shall have entered into a contract or arrangement that, upon consummation, will result in its or their acquisition of or control over, voting Stock of the Borrower (or other securities convertible into such voting Stock)
representing more than 50% of the combined voting power of all voting Stock of the Borrower; (b) the Borrower shall have ceased to own, directly or indirectly, 100% of the Stock of any of its Subsidiaries (with the exception of any Subsidiaries
permitted to be dissolved or merged to the extent otherwise permitted by this Agreement and other than, solely with respect to Foreign Subsidiaries, directors qualifying shares as necessary to comply with foreign law); (c) the occurrence of a
“Change of Control”, “Change in Control”, “Fundamental Change” or terms of similar import under the 2.25% Convertible Note Documents, the 3.25% Convertible Note Documents, the ABL Debt Documents or any Permitted Japan
Lifeline Unsecured Debt Documents; or (d) the occurrence of any “Major Transaction” (as defined in any Warrant). As used herein, “beneficial ownership” shall have the meaning provided in Rule
13d-3 of the SEC under the Exchange Act. 
 “CMS” means the federal Centers for
Medicare and Medicaid Services (formerly the federal Health Care Financing Administration), and any successor Governmental Authority. 

“CoC Fee” means: 

(a) if both (1) principal on the Loans are (or are obligated or required to be) prepaid, repaid, redeemed or paid (in each case, for the
avoidance of doubt, other than any Amortization Payments) in full (or in part) prior to the Maturity Date and (2) a Change of Control is consummated (or a first public announcement of a potential Change of Control is made) prior to the Maturity
Date (and, for the avoidance of doubt, with respect to any such public announcement, where a Change of Control is ultimately consummated (whether before, on the date of or after the Maturity Date)), $4,200,000 (or, if such amount is prepaid, repaid,
redeemed or paid in connection with a partial (as opposed to full) prepayment, repayment, redemption or payment of the Loans (in each case, for the avoidance of doubt, other than any Amortization Payments), then such ratable portion of such amount
based on the principal amount of such Loans prepaid, repaid, redeemed or repaid (in each case, for the avoidance of doubt, other than any Amortization Payments)); 

(b) if both (1) principal on the Loans are (or are obligated or required to be) prepaid, repaid, redeemed or paid (in each case, for the
avoidance of doubt, other than any Amortization Payments) in full (or in part) prior to the Maturity Date and (2) a potential Change of Control is first publicly announced (or a Change of Control is consummated) both (A) on or after the
Maturity Date and (B) within 150 days after such prepayment, repayment, redemption or payment in full (or in part) of principal on the Loans (in each case, for the avoidance of doubt, other than any Amortization Payments) prior to the Maturity
Date, an amount in cash equal to all interest payments that would have been required on the prepaid, repaid, redeemed or paid Loans (or the Loans obligated or required to be prepaid, repaid, redeemed or paid) from the date of such prepayment,
repayment, redemption or payment (or the date such prepayment, repayment, redemption or payment was obligated or required to be made) through and including the Maturity Date (in each case, for the avoidance of doubt, other than any Amortization
Payments); or 
 (c) if both (1) principal on the Loans are (or are obligated or required to be) prepaid, repaid, redeemed or paid (in
each case, for the avoidance of doubt, other than any Amortization Payments) in full prior to the Maturity Date and (2) a potential Change of Control is first publicly announced (or a 

  
 7 

 
Change of Control is consummated) both (A) on or after the Maturity Date and (B) more than 150 days after such prepayment, repayment, redemption or payment (in each case, for the
avoidance of doubt, other than any Amortization Payments) in full of the Loans prior to the Maturity Date, $0. 
 “Code”
means the Internal Revenue Code of 1986, as amended, and any Treasury Regulations promulgated thereunder. 
 “Collateral”
has the meaning given to it in the Security Agreement. 
 “Collateral Access Agreement” means a landlord waiver, bailee
letter, or acknowledgement agreement of any lessor, warehouseman, processor, consignee, or other Person in possession of, having a Lien upon, or having rights or interests in the Loan Parties’ or their Subsidiaries’ Collateral or books and
records, in each case, in form and substance reasonably satisfactory to Agent. 
 “Common Stock” means the “Common
Stock” of the Borrower, with a $0.001 par value per share. 
 “Compliance Certificate” means a certificate, duly
executed by an Authorized Officer of the Borrower, appropriately completed and substantially in the form of Exhibit F hereto. 

“Contingent Obligation” means, with respect to any Person, any direct or indirect liability of such Person: (a) with
respect to any Indebtedness of another Person (a “Third Party Obligation”) if the purpose or intent of such Person incurring such liability, or the effect thereof, is to provide assurance to the obligee of such Third Party
Obligation that such Third Party Obligation will be paid or discharged, or that any agreement relating thereto will be complied with, or that any holder of such Third Party Obligation will be protected, in whole or in part, against loss with respect
thereto; (b) with respect to any undrawn portion of any letter of credit issued for the account of such Person or as to which such Person is otherwise liable for the reimbursement of any drawing; (c) under any Swap Contract, to the extent
not yet due and payable; (d) to make take-or-pay or similar payments if required regardless of nonperformance by any other party or parties to an agreement; or
(e) for any obligations of another Person pursuant to any Guarantee or pursuant to any agreement to purchase, repurchase or otherwise acquire any obligation or any property constituting security therefor, to provide funds for the payment or
discharge of such obligation or to preserve the solvency, financial condition or level of income of another Person. The amount of any Contingent Obligation shall be equal to the amount of the obligation so Guaranteed or otherwise supported or, if
not a fixed and determinable amount, the maximum amount so Guaranteed or otherwise supported. 
 “Control Agreement” means,
with respect to any deposit account, securities account, commodity account, securities entitlement or commodity contract, an agreement, in form and substance reasonably satisfactory to Agent, among Agent, the financial institution or other Person at
which such account is maintained or with which such entitlement or contract is carried and the Loan Party maintaining such account or owning such entitlement or contract, effective to grant “control” (within the meaning of Articles 8 and 9
under the applicable UCC) over such account to Agent. 
 “Conversion Shares” has the meaning set forth in
Section 3.1(z). 
 “Convertible Note Documents” means, collectively, the 2.25% Convertible Note Documents and the
3.25% Convertible Note Documents (which, for the avoidance of doubt, shall include the indenture and each other document or agreement from time to time entered into in connection with any Permitted 3.25% Convertible Note Refinancing, in each case,
to the extent such indenture, documents or agreements are permitted pursuant to the terms of the definition of “Permitted 3.25% Convertible Note Refinancing). 

  
 8 

 “Convertible Securities” means any Stock or securities (other than Options)
directly or indirectly convertible into or exchangeable or exercisable for shares of Common Stock. 
 “Copyrights” has the
meaning set forth in the Security Agreement. 
 “Copyright Security Agreement” means any copyright security agreement
executed and delivered by a Loan Party to Agent, on behalf of the Secured Parties, as the same may be amended, restated, supplemented or otherwise modified and in effect from time to time. 

“Correction” means the repair, modification, adjustment, relabeling, destruction, or inspection (including patient
monitoring) of a product or device without its physical removal from its point of use to some other location. 
 “Current Balance
Sheet” has the meaning set forth in the definition of “Enterprise Value.” 
 “DEA” means the Drug
Enforcement Administration of the United States of America, any comparable state or local Governmental Authority, any comparable Governmental Authority in any non-United States jurisdiction, and any successor
agency of any of the foregoing. 
 “Deerfield Facility Entity” has the meaning set forth in the preamble to this Agreement.

 “Default” means any event which, with the giving of notice, lapse of time or fulfillment of any other applicable
condition (or any combination of the foregoing), would constitute an Event of Default. 
 “Disbursements” has the meaning
set forth in Section 2.2(a)(ii). 
 “Dispose” and “Disposition” mean (a) the sale, lease,
license, transfer, assignment, conveyance or other disposition of any assets or property (including any transfer or conveyance of any assets or property pursuant to a division or split of a limited liability company or other entity or Person into
two or more limited liability companies or other entities or Persons) and (b) the sale or transfer by the Borrower or any Subsidiary of the Borrower of any Stock issued by any Subsidiary of the Borrower. 

“Disqualified Stock” means any Stock which, by its terms (or by the terms of any security or other Stock into which it is
convertible or for which it is exchangeable), or upon the happening of any event or condition, (a) matures or is mandatorily redeemable (other than solely for Stock that does not constitute Disqualified Stock), pursuant to a sinking fund
obligation or otherwise, or is redeemable (in each case, other than solely for Stock that does not constitute Disqualified Stock) at the option of the holder thereof, in whole or in part, on or prior to the date that is one year and one day
following the Maturity Date (excluding any provisions requiring redemption upon a “change in control” or similar event, provided that such “change in control” or similar event results in the occurrence of the payment in full in
cash of all of the Obligations (other than (i) unasserted contingent indemnification obligations and (ii) Obligations under the Warrants and the Registration Rights Agreement that are not due and payable at the time such other Obligations
are paid in full in cash)), (b) is convertible into or exchangeable for (i) debt securities or (ii) any Stock referred to in (a) above, in each case, at any time on or prior to the date that is one year and one day following the
Maturity Date at the time such Stock was issued, or (c) is entitled to receive scheduled dividends or distributions in cash prior to the date that is one year and one day following the Maturity Date. 

“Dollars” and the “$” sign mean the lawful currency of the United States of America. 

“Domestic Subsidiary” means any Subsidiary incorporated, organized or otherwise formed under the laws of the United
States, any state thereof or the District of Columbia. 

  
 9 

 “Drug Application” means a new drug application, an abbreviated drug
application, or a product license application for any Product, as appropriate, as those terms are defined in the FDCA. 

“DTC” has the meaning set forth in Section 3.1(qq). 

“EBITDA” means, at any date of determination, an amount equal to (a) Net Income of the Successor Entity for the most
recently completed trailing four quarter measurement period, plus (b) in each case, to the extent deducted in determining Net Income (whether in cash, paid in-kind or otherwise) for such period,
without duplication, (i) Interest Expense of the Successor Entity for such trailing four quarter period, (ii) income taxes of the Successor Entity for such trailing four quarter period, (iii) depreciation and amortization of the
Successor Entity for such trailing four quarter period; provided that, with respect of all components of the foregoing clause (a) and clause (b) of this definition, such amounts shall be limited to those of Successor Entity only
(and not any of its Subsidiaries) unless such Subsidiaries (other than any Excluded Subsidiaries) become Guarantors under the Loan Documents and provide a Lien on all of their assets and property that would constitute Collateral under the Loan
Documents and take such other actions that would be required by Section 5.1(l) (such actions of such Subsidiaries in such instance, the “Successor Entity Subsidiary Joinder Actions”). 

“Eligible Assignee” means (a) a Lender, (b) an Affiliate of a Lender, (c) an Approved Fund, and (d) any
other Person (other than a natural person) approved by Agent; provided, however, that with respect to clause (d) above, no such Person shall include (i) Borrower or any of Borrower’s Affiliates or (ii) unless an Event of
Default has occurred and is continuing, (A) any direct competitor of Loan Parties, in each case, as determined by Agent in its reasonable discretion, (B) any investor or fund that has publicly announced in writing its intention to obtain
control of the Borrower publicly or otherwise to the knowledge of the assigning Lender, or (D) any Person listed in the email delivered by counsel to the Borrower to counsel to the Agent on March 16, 2017 at 5:00 p.m. (Pacific time) and any
Affiliates or Approved Funds of any such Person actually known to the assigning Lender and to the Agent to be Affiliates or Approved Funds of any such Person. 

“Employee” means any employee of any Loan Party or any Subsidiary of any Loan Party. 

“Employee Benefit Plan” means any “employee benefit plan” within the meaning of Section 3(3) of ERISA, under
which (A) any current or former employee, director or independent contractor of the Borrower or any of its Subsidiaries has any present or future right to benefits or compensation and which is contributed to, sponsored by or maintained by the
Borrower or any of its Subsidiaries or (B) the Borrower or any of its Subsidiaries has had or has or could reasonably be expected, individually or in the aggregate, to have any present or future obligation or liability. 

“Enterprise Value” means (a) the Market Cap, minus (b) the amount of the Indebtedness of the Successor
Entity and its Subsidiaries as shown on a consolidated basis on the latest balance sheet publicly filed under the Exchange Act prior to the announcement date of the Successor Entity Transaction (the “Current Balance Sheet”),
plus (c) the amount of cash and Cash Equivalents (without giving effect to clause (f) of the definition of “Cash Equivalents) of the Successor Entity and its Subsidiaries as shown on a consolidated basis on the Current Balance
Sheet. 
 “Environmental Laws” means all Applicable Laws, Authorizations and permits imposing liability or standards of
conduct for or relating to the regulation and protection of human health, safety, the workplace, the environment and natural resources, and including public notification requirements and environmental transfer of ownership, notification or approval
statutes. 

  
 10 

 “Environmental Liabilities” means all Liabilities (including costs of
removal and remedial actions, natural resource damages and costs and expenses of investigation and feasibility studies, including the cost of environmental consultants and attorneys’ costs) that may be imposed on, incurred by or asserted
against any Loan Party or any Subsidiary of any Loan Party as a result of, or related to, any claim, suit, action, investigation, proceeding or demand by any Person, whether based in contract, tort, implied or express warranty, strict liability,
criminal or civil statute or common law or otherwise, arising under any Environmental Law resulting from the ownership, lease, sublease or other operation or occupation of property by any Loan Party or any Subsidiary of any Loan Party, whether on,
prior or after the Agreement Date. 
 “Equipment” means equipment (as that term is defined in the UCC). 

“ERISA” means the Employee Retirement Income Security Act of 1974, as amended and applicable published guidance thereunder.

 “ERISA Affiliate” means collectively the Borrower, any Subsidiary of Borrower and any Person under common control or
treated as a single employer with, Borrower or any Subsidiary of Borrower within the meaning of Code Section 414 (b), (c), (m) or (o) or under ERISA. 

“ERISA Event” means any of the following: (a) a reportable event described in Section 4043(b) or (c) of ERISA
(other than an event for which the 30-day notice period is waived) with respect to a Title IV Plan; (b) the withdrawal of any ERISA Affiliate from a Title IV Plan subject to Section 4063 of ERISA
during a plan year in which it was a substantial employer, as defined in Section 4001(a)(2) of ERISA; (c) the complete or partial withdrawal of any ERISA Affiliate from any Multiemployer Plan; (d) with respect to any Multiemployer
Plan, the filing of a notice of insolvency or termination, or treatment of a plan amendment as termination, under Section 4041A of ERISA; (e) the filing of a notice of intent to terminate a Title IV Plan, or treatment of a plan amendment
as termination, under Section 4041 of ERISA; (f) the institution of proceedings to terminate a Title IV Plan or Multiemployer Plan by the PBGC; (g) the failure to make any required contribution to any Title IV Plan or Multiemployer
Plan when due; (h) the imposition of a Lien under Section 412 or 430(k) of the Code or Section 303 or 4068 of ERISA on any property (or rights to property, whether real or personal) of any ERISA Affiliate; (i) the failure of an
Employee Benefit Plan or any trust thereunder intended to qualify for tax exempt status under Section 401 or 501 of the Code or other Applicable Law to qualify thereunder; (j) a Title IV plan is in “at risk” status within the
meaning of Code Section 430(i); (k) a Multiemployer Plan is in “endangered status” or “critical status” within the meaning of Section 432(b) of the Code; and (l) any other event or condition that constitutes
grounds under Section 4042 of ERISA for the termination of, or the appointment of a trustee to administer, any Title IV Plan or Multiemployer Plan or for the imposition of any Liability upon any ERISA Affiliate under Title IV of ERISA other
than for contributions to Title IV Plans and Multiemployer Plans in the ordinary course and PBGC premiums due but not delinquent. 

“Exercise Price” has the meaning provided therefor in the Warrants. 

“Event of Default” has the meaning set forth in Section 5.4. 

“Exchange Act” means the Securities Exchange Act of 1934, as amended, including the rules and regulations promulgated
thereunder. 
 “Exchanged Deerfield Convertible Notes” has the meaning specified therefor in the recitals hereto. 

“Excluded Accounts” has the meaning set forth in Section 5.1(k). 

  
 11 

 “Excluded Domestic Holdco” means a wholly-owned Domestic Subsidiary
of the Borrower substantially all of the assets of which consist of Stock of Excluded Foreign Subsidiaries held directly or indirectly by such Subsidiary and which does not engage in any business, operations or activity other than that of a holding
company, excluding for purposes of such determination, Indebtedness of such Excluded Foreign Subsidiaries. 
 “Excluded Foreign
Subsidiary” means any Foreign Subsidiary which is a controlled foreign corporation (as defined in the Code) that has not guaranteed or pledged any of its assets to secure, or with respect to which there shall not have been pledged two-thirds or more of the voting Stock to secure, any Indebtedness (other than the Obligations) of a Loan Party. 

“Excluded Property” means, collectively: 

(a) voting shares of any (A) Excluded Foreign Subsidiary of Borrower or (B) Excluded Domestic Holdco, in each case, in excess of 65%
of all of the issued and outstanding voting shares of capital stock of such subsidiary; 
 (b) any lease, license, contract, property right
or agreement as to which, if and to the extent that, and only for so long as, the grant of a security interest therein shall (1) constitute or result in a breach, termination or default under any such lease, license, contract, property right or
agreement or render it unenforceable, (2) be prohibited by any applicable law or (3) require the consent of any third party (in each case of clauses (1), (2) and (3), other than to the extent that any such breach, termination, default,
prohibition or requirement for consent would be rendered ineffective pursuant to Sections 9-406, 9-407, 9-408 or 9-409 of the UCC of any relevant jurisdiction or any other applicable Law), provided that such security interest shall attach immediately to each portion of such lease, license, contract, property rights or
agreement that does not result in any of the consequences specified above; 
 (c) any “intent to use” trademark applications for
which a statement of use has not been filed (but only until such statement is filed); 
 (d) motor vehicles and other assets, in each
instance, in which perfection of a security requires notation on certificates of title with a value, individually, of less than $250,000; 

(e) without in any way limiting clause (a) above, equity interests in any Person (other than wholly owned Subsidiaries) to the extent not
permitted by the terms of such Person’s organizational or joint venture documents (so long as such joint venture was not entered into (or such Subsidiary was not formed) in contravention of the terms of the Loan Documents and such prohibition
did not arise in anticipation of the restrictions under the Loan Documents); 
 (f) any assets financed by purchase money Indebtedness or
Capital Leases, to the extent such purchase money Indebtedness or Capital Lease is permitted hereunder, if the documentation governing such purchase money Indebtedness or Capital Leases securing such purchase money Indebtedness or Capital Leases
prohibits the creation of a security interest or lien thereon or requires the consent of any Person as a condition to the creation of any other security interest or lien on such property or if such contract or other agreement would be breached or
give any party the right to terminate it as a result of creation of such security interest or lien; 
 (g) those assets as to which Agent
determines (in its sole discretion) that the cost of obtaining such a security interest or perfection thereof are excessive in relation to the benefit to Agent and the Lenders of the security to be afforded thereby; and 

  
 12 

 (h) the Bank of America Cash Collateral Account; 

provided, however, notwithstanding anything to the contrary herein or under the other Loan Documents, “Excluded
Property” shall not include (a) any proceeds, products, substitutions, receivables or replacements of Excluded Property (unless such proceeds, products, substitutions, receivables or replacements would otherwise constitute Excluded
Property) or (b) any assets or property provided as security or collateral for the ABL Debt or for which a Lien has been granted in favor of ABL Agent, any ABL Lender or any other Person party to the ABL Debt Documents. 

“Excluded Subsidiary” means (a) any Excluded Domestic Holdco and (b) any Excluded Foreign Subsidiary. 

“Excluded Taxes” means with respect to any Lender, (a) Taxes imposed on (or measured by) such Lender’s net income
or franchise Taxes and branch profits Taxes in each case (i) imposed as a result of such Lender being organized under the laws of, or having its principal office, or applicable lending office located in the jurisdiction imposing such Tax (or
any political subdivision thereof), or (ii) that are Other Connection Taxes, (b) any United States federal withholding Tax imposed on amounts payable to such Lender under the laws in effect at the time such Lender becomes a party to this
Agreement or such Lender changes its lending office, except to the extent such Lender acquired its interest in the Loan from a transferor that was entitled, immediately before such transfer, to receive Additional Amounts with respect to such
withholding Tax pursuant to Section 2.5(a) or was itself so entitled immediately before changing its lending office, (c) any Tax imposed on amounts payable to such Lender directly as a result of such Lender’s failure to comply with
Section 2.5(d) other than as a result of a change in Applicable Law occurring subsequent to the date such Lender became a party to this Agreement, or (d) any United States federal withholding Tax imposed on amounts payable to such Lender
under FATCA. 
 “Existing ABL Agent” has the meaning assigned to such term in the definition of “Existing ABL Credit
Facility” herein. 
 “Existing ABL Credit Facility” means that certain Credit and Security Agreement, dated as of
July 29, 2016, by and among the Borrower, the other Persons party thereto from time to time as “Borrowers” (as defined therein), Midcap Financial Trust, a Delaware statutory trust, as Agent (as defined therein, in such capacity, the
“Existing ABL Agent”) and the financial institutions or other entities from time to time parties thereto, each as a Lender (as defined therein) (in such capacity, the “Existing ABL Lenders”), as amended, restated,
supplemented or otherwise modified prior to the Prior Agreement Date. 
 “Existing ABL Debt Documents” shall have the
meaning of “Loan Documents” (as defined in the Existing ABL Credit Facility). 
 “Existing ABL Lenders” has the
meaning assigned to such term in the definition of “Existing ABL Credit Facility” herein. 
 “Exit Payment” means
the First Out Waterfall Loan Exit Payment and/or the Last Out Waterfall Loan Exit Payment, as the context may require. 

“FATCA” means Sections 1471 through 1474 of the Code as of the Agreement Date (or any amended or successor version that is
substantively comparable and not materially more onerous to comply with), any regulations or official interpretations thereof and any agreements entered into pursuant to Section 1471(b)(1) of the Code and any applicable intergovernmental
agreements entered into with respect to the foregoing. 

  
 13 

 “FCPA” has the meaning set forth in Section 3.1(jj). 

“FDA” means the Food and Drug Administration of the United States of America, any comparable state or local Governmental
Authority, any comparable Governmental Authority in any non- United States jurisdiction, and any successor agency of any of the foregoing. 

“FDCA” means the Federal Food, Drug and Cosmetic Act, as amended, 21 U.S.C. Section 301 et seq., and all regulations
promulgated thereunder. 
 “Federal Reserve Board” means the Board of Governors of the Federal Reserve System or any entity
succeeding to any of its principal functions. 
 “Final Payment” means such cash amount as may be necessary to repay the
outstanding principal amount of the Loans and any other Obligations (including, for the avoidance of doubt, for any applicable Non-Callable Make Whole Amount payable hereunder and the CoC Fee payable
hereunder, but excluding (A) unasserted contingent indemnification obligations and (B) those Obligations under the Warrants and the Registration Rights Agreement or in respect of any Stock), owing by the Borrower and the other Loan Parties
to the Secured Parties pursuant to the Loan Documents; provided that the foregoing shall be subject to the second sentence of Section 6.22. 

“First Amortization Date” has the meaning set forth in Section 2.3(a). 

“First Out Waterfall Disbursement” has the meaning set forth in Section 2.2(a)(i). 

“First Out Waterfall Lender” means any Lender to which any First Out Waterfall Obligations are owing and its successors and
assigns (in each case, in its capacity as such). 
 “First Out Waterfall Loan” is defined in Section 2.2(a)(i) hereof.

 “First Out Waterfall Loan Exit Payment” has the meaning set forth in Section 2.7(d). 

“First Out Waterfall Notes” has the meaning set forth in the definition of “Loan Notes”. 

“First Out Waterfall Obligations” means the Obligations in respect of First Out Waterfall Loans, including any Non-Callable Make Whole Amount, any CoC Fee, the First Out Waterfall Loan Exit Payment, all interest, fees, expenses, costs, liabilities, indebtedness and other obligations (monetary (including post-petition
interest, costs, fees, expense and other amounts, whether allowed or not) or otherwise) of (or owed by) the Borrower and the other Loan Parties under or in connection with the Loan Documents, in each case, howsoever created, arising or evidenced,
whether direct or indirect (including those acquired by assignment), absolute or contingent, now or hereafter existing, or due or to become due, and irrespective of whether the same are added to the principal amount of the First Out Waterfall
Obligations. 
 “First Out Waterfall Pro Rata Share” means, with respect to any First Out Waterfall Lender, the percentage
obtained by dividing (a) the unpaid principal amount of such First Out Waterfall Lender’s portion of the First Out Waterfall Loans, by (b) the unpaid principal amount of all First Out Waterfall Loans. 

“First Out Waterfall Secured Parties” means the Secured Parties (other than the Last Out Secured Parties). 

  
 14 

 “First Out Waterfall Securities” has the meaning set forth in
Section 3.1(z). 
 “Foreign Benefit Plan” means any employee benefit plan that is subject to the laws of a
jurisdiction outside the United States, including those mandated by a government other than that of the United States of America. 

“Foreign Lender” has the meaning set forth in Section 2.5(d). 

“Foreign Subsidiary” means, with respect to any Person, a Subsidiary of such Person, which Subsidiary is not a Domestic
Subsidiary. 
 “GAAP” means generally accepted accounting principles as in effect from time to time in the United States
applied on a consistent basis, subject to the provisions of Section 1.5. 
 “General Intangible” means any
“general intangible” as defined in Article 9 of the UCC, and any personal property, including things in action, other than accounts, chattel paper, commercial tort claims, deposit accounts, documents, goods, instruments, investment
property, letter-of-credit rights, letters of credit, money, and oil, gas or other minerals before extraction, but including payment intangibles and software. 

“Global Excess Liquidity” means, as of any date of determination by Agent, the sum of (a) without duplication of
clause (b) of this definition, unrestricted cash and Cash Equivalents maintained in the deposit accounts or securities accounts of the Loan Parties, in each case, subject to Control Agreements in compliance with the provisions of
Section 5.1(k), plus (b) without duplication of clause (a) of this definition, unrestricted cash and Cash Equivalents of Loan Parties that is in Excluded Accounts maintained by a branch office of the bank or securities intermediary
located outside the United States in an aggregate amount not to exceed the lesser of (i) $10,000,000 and (ii) 20% of clause (a) of this definition, plus (c) without duplication of any cash or Cash Equivalents from any borrowing under
the ABL Debt Documents that would count towards either of clause (a) or clause (b) of this definition and solely to the extent the applicable conditions in Article III of the ABL Credit Agreement (and any additional conditions to
borrowing under the ABL Credit Agreement that may be added or included in the ABL Debt Documents from time to time after the Agreement Date) have been satisfied (or would be satisfied if a borrowing would have been made thereunder) as of such date
of determination after giving effect to any borrowing thereunder and any “Revolver Usage” (as defined in the ABL Credit Agreement as of the Agreement Date) as of such date, the amount of “Availability” (as defined in the ABL
Credit Agreement as of the Agreement Date). 
 “Good Manufacturing Practices” means current good manufacturing practices,
as set forth in 21 C.F.R. Parts 210, 211, 820 and any comparable foreign requirements. 
 “Governmental Authority” means
any nation, sovereign, government, quasi-governmental agency, governmental department, ministry, cabinet, commission, board, bureau, agency, court, tribunal, regulatory authority, instrumentality, judicial, legislative, fiscal or administrative or
public body or entity, whether domestic or foreign, federal, state, local or other political subdivision thereof, having jurisdiction over the matter or matters and Person or Persons in question or having the authority to exercise executive,
legislative, taxing, judicial, regulatory or administrative functions of or pertaining to government, including any central bank, securities exchange, regulatory body, arbitrator, public sector entity, supra-national entity and any self-regulatory
organization. 
 “Guarantee” by any Person means any obligation, contingent or otherwise, of such Person directly or
indirectly guaranteeing any Indebtedness or other obligation of any other Person and, without limiting 

  
 15 

 
the generality of the foregoing, any obligation, direct or indirect, contingent or otherwise, of such Person (a) to purchase or pay (or advance or supply funds for the purchase or payment
of) such Indebtedness or other obligation (whether arising by virtue of partnership arrangements, by agreement to keep-well, to purchase assets, goods, securities or services, to
take-or-pay, or to maintain financial statement conditions or otherwise), or (b) entered into for the purpose of assuring in any other manner the obligee of such
Indebtedness or other obligation of the payment thereof or to protect such obligee against loss in respect thereof (in whole or in part), provided, however, that the term Guarantee shall not include endorsements for collection or
deposit in the Ordinary Course of Business. The term “Guarantee” used as a verb has a corresponding meaning. 

“Guarantor” means each Subsidiary of the Borrower (other than any Excluded Subsidiary) or other Person who provides a
guaranty of the Obligations under the Security Agreement or other Loan Document. 
 “Hazardous Material” means any
substance, material or waste that is classified, regulated or otherwise characterized under any Environmental Law as hazardous, toxic, a contaminant or a pollutant or by other words of similar meaning or regulatory effect, including petroleum or any
fraction thereof, asbestos, polychlorinated biphenyls and radioactive substances. 
 “Healthcare Laws” means all Applicable
Laws relating to the procurement, development, provision, clinical and non-clinical evaluation or investigation, product approval or clearance, manufacture, production, analysis, distribution, dispensing,
importation, exportation, use, handling, quality, reimbursement, sale, labeling, advertising, promotion, or post-market requirements of any drug, medical device, clinical laboratory service, food, dietary supplement or other product (including,
without limitation, any ingredient or component of, or accessory to, the foregoing products) subject to regulation under the FDCA or otherwise regulated by the FDA, or subject to regulation under the Clinical Laboratory Improvement Amendments of
1988 (42 U.S.C. §263a et seq.) and its implementing regulations (42 C.F.R. Part 493) and similar state or foreign laws, controlled substances laws, pharmacy laws, consumer product safety laws, Medicare, Medicaid, and all laws, policies,
procedures, requirements and regulations pursuant to which Regulatory Required Permits are issued, in each case, as the same may be amended from time to time. 

“Immaterial Subsidiaries” shall mean, as of any date of determination, any Subsidiary of the Borrower that is not a Loan
Party that, when measured as of the most recent fiscal quarter end or fiscal year end for which the Borrower has filed its 10-K or 10-Q, when taken together with all
other Immaterial Subsidiaries as of such date, (i) did not have assets with a value in excess of 5.0% of the total property and assets of the Loan Parties and their Subsidiaries on a consolidated basis set forth in the balance sheet included in
such 10-K or 10-Q in accordance with GAAP and on a pro forma basis and (ii) did not have revenues representing in excess of 5.0% of total revenues of the Loan
Parties and their Subsidiaries on a consolidated basis. 
 “In Connection with a Change of Control” means any prepayment,
repayment, redemption or other payment (in each case, whether in full or in part) of the Obligations (other than unasserted contingent indemnification obligations and any Obligations under the Warrants or the Registration Rights Agreement or in
respect of any Stock) that is both (1) made, or that is obligated or required to be made (including as a result of the Lenders’ exercise of the Put Right), hereunder prior to (but not including) the Maturity Date and (2) either: (a) such
prepayment, repayment, redemption or other payment is made (or is obligated or required to be made) at any time during the period that commences 150 days prior to the earlier to occur of (i) the first public announcement of a potential Change of
Control (and, for the avoidance of doubt, where a Change of Control is ultimately consummated before, on the date of or after the Maturity Date) or (ii) the consummation of a Change of Control, and ends on the consummation of a Change of Control,
(b) such prepayment, repayment, redemption or other payment is otherwise made (or is obligated or required to be made) as a result of a Change of Control, or (c) such prepayment, repayment, redemption or other payment is made (or is obligated
or required to be 

  
 16 

 
made, whether through acceleration or otherwise) at any time on or after a Successor Entity Transaction. 

“Indebtedness” means the following with respect to any Person: 

(i) all indebtedness for borrowed money of such Person; 

(ii) the deferred purchase price of assets or services (other than trade payables entered into in the Ordinary Course of
Business and which are not more than 120 days past due and other than items covered by clause (xiv) of this definition) of such Person, which in accordance with GAAP should be shown to be a liability on the balance sheet; 

(iii) all guarantees of Indebtedness by such Person; 

(iv) the face amount of all letters of credit issued or acceptance facilities established for the account of such Person (or
for which such Person is liable), including without duplication, all drafts drawn thereunder; 
 (v) all Capital Lease
Obligations of such Person; 
 (vi) all indebtedness (including indebtedness of other types covered by the other clauses of
this definition) of such Person or another Person secured by any Lien on any assets or property of such Person, whether or not such indebtedness has been assumed or is recourse (with the amount thereof, in the case of any such indebtedness that has
not been assumed by such Person, being measured as the lower of (y) fair market value of such property and (z) the amount of the indebtedness secured); 

(vii) all indebtedness created or arising under any conditional sale or title retention agreement, or incurred as financing, in
either case with respect to assets or property acquired by such Person (even if the rights and remedies of the seller or lender under such agreement in the event of default are limited to repossession or sale of such assets or property); 

(viii) all obligations of such Persons evidenced by notes, bonds, debentures or similar instruments, including obligations so
evidenced incurred in connection with the acquisition of property, assets or businesses; 
 (ix) all obligations of such
Person, whether or not contingent, in respect of Disqualified Stock, valued at, in the case of redeemable preferred Stock, the greater of the voluntary liquidation preference and the involuntary liquidation preference of such Stock plus accrued and
unpaid dividends; 
 (x) all direct or indirect liability, contingent or otherwise, of such Person with respect to any other
Indebtedness, lease, dividend or other obligation of another Person if the primary purpose or intent of the Person incurring such liability, or the primary effect thereof, is to provide assurance to the obligee of such liability that such liability
will be paid or discharged, or that any agreements relating thereto will be complied with, or that the holders of such liability will be protected (in whole or in part) against loss with respect thereto; 

  
 17 

 (xi) all direct or indirect liability, contingent or otherwise, of such
Person under Swap Contracts; 
 (xii) all direct or indirect liability, contingent or otherwise, of such Person to make take-or-pay or similar payments if required regardless of nonperformance by any other party or parties to an agreement; 

(xiii) all direct or indirect liability, contingent or otherwise, of such Person for the obligations of another Person through
any agreement to purchase, repurchase or otherwise acquire such obligation or any assets or property constituting security therefor, to provide funds for the payment or discharge of such obligation or to maintain the solvency, financial condition or
any balance sheet item or level of income of another Person; 
 (xiv) earn-outs, all purchase price adjustments, profit
sharing arrangements, deferred purchase money amounts and similar payment obligations (or continuing obligations of any nature of such Person arising out of purchase and sale contracts) (including in connection with Permitted Acquisitions), but only
to the extent the same (x) have become due and payable and are recorded as a liability on the balance sheet of such Person and (y) are payable in cash; 

(xv) all off-balance sheet liabilities of such Person; or 

(xvi) all obligations arising under non-compete agreements, bonus, deferred
compensation, incentive compensation or similar arrangements, other than those arising in the Ordinary Course of Business. 

“Indemnified Person” has the meaning set forth in Section 6.11(a). 

“Indemnified Taxes” means (a) any Tax imposed on or with respect to any payments made by or on account of any Obligation
of any Loan Party under any Loan Document, other than an Excluded Tax, and (b) to the extent not otherwise described in clause (a) above in this definition, Other Taxes. 

“Indemnity” has the meaning set forth in Section 6.11(a). 

“Initial Warrants” has the meaning set forth in Section 2.8(a). 

“Insolvency Proceeding” means any proceeding commenced by or against any Person under any provision of the Bankruptcy Code or
under any other state or federal bankruptcy or insolvency law, assignments for the benefit of creditors, formal or informal moratoria, compositions, extensions generally with creditors, or proceedings seeking reorganization, arrangement, or other
similar relief. 
 “Intellectual Property” means all Intellectual Property Licenses and all Copyrights, copyright rights,
copyright applications, copyright registrations and like protections in each work of authorship and derivative work, whether published or unpublished, any Patents, patents, patent applications and like protections, including improvements, divisions,
continuations, renewals, reissues, extensions, and continuations-in-part of the same, Trademarks, trademarks, trade names, service marks, mask works, rights of use of
any name, domain names, or any other similar rights, any applications therefor, whether registered or not, know-how, operating manuals, trade secret rights, clinical and
non-clinical data, rights to unpatented inventions, and any claims for damage by way of any past, present, or future infringement of any of the foregoing. 

  
 18 

 “Intellectual Property Licenses” has the meaning set forth in the Security
Agreement. 
 “Intercompany Subordination Agreement” means an intercompany subordination agreement, dated as of the
Agreement Date, executed and delivered by the Loan Parties, each of their Subsidiaries, and Agent, the form and substance of which is reasonably satisfactory to Agent. 

“Intercreditor Agreement” means the Intercreditor Agreement dated as of the Agreement Date by and among Agent and ABL Agent
and acknowledged and agreed by the Loan Parties, as amended, restated, supplemented or otherwise modified from time to time in accordance with the terms thereof. 

“Interest Expense” means, for any period, interest expense for the Successor Entity set forth in the Successor Entity’s
most recent publicly reported income statement; provided that such amounts shall be limited to those incurred by the Successor Entity only (and not any of its Subsidiaries) unless such Subsidiaries (other than any Excluded Subsidiaries) have
completed and consummated the Successor Entity Subsidiary Joinder Actions. 
 “Interest Payment Date” has the meaning set
forth in Section 2.6(a). 
 “Interest Payment Shares” means any shares of Common Stock issued or issuable pursuant to
Section 2.6 and Exhibit 2.6. 
 “Interest Rate” means (a) solely with respect to any period that occurs prior to
(but not including) the Agreement Date, 6.87% per annum for the principal amount of the “Loans” (as defined in the Prior Facility Agreement) and any overdue interest thereon, plus any additional amounts set forth in Section 2.7(b) of
the Prior Facility Agreement, and (b) at all times on or after the Agreement Date, 9.75% per annum for the principal amount of the Loans and any overdue interest thereon, plus any additional amounts set forth in Section 2.7(b). 

“Internal Controls” has the meaning set forth in Section 3.1(u). 

“Inventory” means inventory (as that term is defined in the UCC). 

“Investment” has the meaning set forth in Section 5.2(v). 

“Investment Company Act” means the Investment Company Act of 1940, as amended, including the rules and regulations
promulgated thereunder. 
 “IP” means all Intellectual Property that is necessary for the conduct of the Loan Parties’
business as currently conducted. 
 “IRS” means the United States Internal Revenue Service. 

“Last Out Waterfall Disbursement” has the meaning set forth in Section 2.2(a)(ii). 

“Last Out Waterfall Lender” means any Lender to which any Last Out Waterfall Obligations are owing and its successors and
assigns (in each case, in its capacity as such). For the avoidance of doubt, a Lender may be both a First Out Waterfall Lender and a Last Out Waterfall Lender. 

“Last Out Waterfall Loan” is defined in Section 2.2(a) hereof. 

“Last Out Waterfall Loan Exit Payment” has the meaning set forth in Section 2.7(e). 

  
 19 

 “Last Out Waterfall Notes” has the meaning set forth in the definition of
“Loan Notes”. 
 “Last Out Waterfall Obligations” means the Obligations in respect of Last Out Waterfall Loans,
including, without limitation, any Non-Callable Make Whole Amount, any CoC Fee, the Last Out Waterfall Loan Exit Payment all interest, fees, expenses, costs, liabilities, indebtedness and other obligations
(monetary (including post-petition interest, costs, fees, expense and other amounts, whether allowed or not) or otherwise) of (or owed by) the Borrower and the other Loan Parties under or in connection with the Loan Documents, in each case,
howsoever created, arising or evidenced, whether direct or indirect (including those acquired by assignment), absolute or contingent, now or hereafter existing, or due or to become due, and irrespective of whether the same are added to the principal
amount of the Last Out Waterfall Obligations. 
 “Last Out Waterfall Pro Rata Share” means, with respect to any Last Out
Waterfall Lender, the percentage obtained by dividing (a) the unpaid principal amount of such Last Out Waterfall Lender’s portion of the Last Out Waterfall Loans, by (b) the unpaid principal amount of all Last Out Waterfall Loans.

 “Last Out Waterfall Secured Parties” means the Last Out Waterfall Lenders and each of their respective directors,
partners, officers, employees, agents, counsel and advisors that are Indemnified Persons. 
 “Latest Balance Sheet” has the
meaning set forth in Section 3.1(t). 
 “Lenders” means the lenders party to this Agreement from time to time,
including the First Out Waterfall Lenders and the Last Out Waterfall Lenders, and their successors and assigns. 

“Liabilities” means all claims, actions, suits, judgments, damages, losses, liabilities, obligations, responsibilities,
fines, penalties, sanctions, costs, fees, Taxes, commissions, charges, disbursements and expenses (including those incurred upon any appeal or in connection with the preparation for and/or response to any subpoena or request for document production
relating thereto), in each case of any kind or nature (including interest accrued thereon or as a result thereto and fees, charges and disbursements of financial, legal and other advisors and consultants), whether joint or several, and whether or
not indirect, contingent, consequential, actual, punitive, treble or otherwise. 
 “Lien” means any lien, pledge,
preferential arrangement, mortgage, security interest, deed of trust, charge, assignment, hypothecation, title retention or other encumbrance on or with respect to property or interest in property having the practical effect of constituting a
security interest, in each case with respect to the payment of any obligation with, or from the proceeds of, any asset or revenue of any kind. For purposes of this Agreement and the other Loan Documents, any Loan Party or any Subsidiary shall be
deemed to own subject to a Lien any asset which it has acquired or holds subject to the interest of a vendor or lessor under any conditional sale agreement, capital lease or other title retention agreement relating to such asset. 

“Loan” means any loan made available from time to time by the Lenders to the Borrower pursuant to this Agreement, including
any First Out Waterfall Loans and any Last Out Waterfall Loans, or, as the context may require, the principal amount thereof from time to time outstanding. “Loan” shall include any Disbursement. 

“Loan Disbursement Request” means that certain Loan Disbursement Request, dated as of the Prior Agreement Date, executed and
delivered by the Borrower in favor of the Secured Parties. 
 “Loan Documents” means this Agreement, the Notes, the
Security Agreement, the Control Agreements, the Intercompany Subordination Agreement, the Intercreditor Agreement, the Reaffirmation 

  
 20 

 
Agreement, the Collateral Access Agreements, the Warrants, the Registration Rights Agreement, each Perfection Certificate, each Compliance Certificate, the Loan Disbursement Request, the Patent
Security Agreements, the Trademark Security Agreements, the Copyright Security Agreements, and other documents, agreements and instruments delivered in connection with any of the foregoing (in each case, including all schedules, exhibits, annexes
and other attachments thereto) and dated the Prior Agreement Date, the Agreement Date or subsequent thereto, whether or not specifically mentioned herein or therein, in each case, as amended, restated, supplemented or otherwise modified from time to
time. 
 “Loan Notes” means (x) any note issued to any of the First Out Waterfall Lenders evidencing any First Out
Waterfall Loan or First Out Waterfall Disbursement funded by such First Out Waterfall Lender (or its predecessor) pursuant to the Prior Facility Agreement, as such Loan Note is amended and restated pursuant to this Agreement to be in the form of
convertible loan note attached hereto as Exhibit A-1, and any convertible loan note in substantially such form issued after the Agreement Date to any First Out Waterfall Lender that holds any First Out
Waterfall Loan or First Out Waterfall Disbursement (collectively, the “First Out Waterfall Notes”), and (y) any note issued to any of the Last Out Waterfall Lenders evidencing any Last Out Waterfall Loan or Last Out Waterfall
Disbursement held by such Last Out Waterfall Lender pursuant to this Agreement in the form of loan note attached hereto as Exhibit A-2 (collectively, the “Last Out Waterfall Notes”); in each
case of clause (x) and clause (y), as may be further amended, restated, supplemented or otherwise modified from time to time. 

“Loan Parties” means the collective reference to the Borrower and all of the Guarantors. 

“Loss” has the meaning set forth in Section 6.11(a). 

“Margin Stock” means “margin stock” as such term is defined in Regulation T, U or X of the Federal Reserve Board.

 “Market Cap” means the number of outstanding shares of common stock of the Successor Entity listed on a National
Securities Exchange, multiplied by the per share Volume Weighted Average Price for such common stock as of the Trading Day immediately preceding the announcement of the Successor Entity Transaction. 

“Market Withdrawal” means a Person’s Removal or Correction of a distributed product which involves a minor violation
that would not be subject to legal action by the FDA or which involves no violation (e.g., normal stock rotation practices and routine equipment adjustments and repairs, etc.). 

“Material Adverse Effect” means a material adverse effect on (a) the business, operations, results of operations,
financial condition or properties of the Loan Parties and their Subsidiaries, taken as a whole, (b) the legality, validity or enforceability of any provision of any Loan Document, (c) the ability of any Loan Party to timely perform the
Obligations, (d) the creation, perfection or priority of the Liens, taken as a whole for the Collateral, granted under the Loan Documents, or (e) the rights and remedies of the Secured Parties under any Loan Document. 

“Material Contracts” means (a) the Operative Documents, (b) the Convertible Note Documents, (c) the agreements
listed on Schedule 3.1(aa), (d) the ABL Debt Documents, (e) the Permitted Japan Lifeline Unsecured Debt Documents and (f) each other agreement or contract to which such Loan Party or its Subsidiaries is a party the termination of
which could reasonably be expected, individually or in the aggregate, to result in a Material Adverse Effect; provided that Capped Calls shall not be considered Material Contracts. 

  
 21 

 “Material Intangible Assets” means all of (i) each Loan Party’s
Intellectual Property and (ii) license or sublicense agreements or other agreements with respect to rights in Intellectual Property (including each Intellectual Property License), in each case that are material to the financial condition,
business or operations of the applicable Loan Party. 
 “Maturity Date” means April 2, 2023. 

“Maturity Date Payment of First Out Waterfall Loans” has the meaning set forth in Section 2.3(a). 

“Measurement Period” means, at any date of determination, the most recently completed twelve (12) fiscal months of the
Loan Parties for which (a) the 10-K or 10-Q for such period was filed (or, to the extent earlier, was required by the SEC to be filed) with the SEC or
(b) financial statements are required to be delivered in Section 5.1(aa). 
 “Medicaid” means the medical
assistance programs administered by state agencies and approved by CMS pursuant to the terms of Title XIX of the Social Security Act, codified at 42 U.S.C. 1396 et seq. 

“Medicare” means the program of health benefits for the aged and disabled administered by CMS pursuant to the terms of Title
XVIII of the Social Security Act, codified at 42 U.S.C. 1395 et seq. 
 “Multiemployer Plan” means any multiemployer plan,
as defined in Section 3(37) or 4001(a)(3) of ERISA, as to which any ERISA Affiliate incurs or otherwise has, or could reasonably be expected, individually or in the aggregate, to have, any obligation or Liabilities (including under
Section 4212 of ERISA). 
 “National Securities Exchange” means the New York Stock Exchange, the Nasdaq Global Select
Market or the Nasdaq Global Market (or, in each case, a successor thereto). 
 “Necessary Documents” has the meaning set
forth in Section 3.1(l). 
 “Net Income” means, for any period, the net income (or loss) of the Successor Entity set
forth in the Successor Entity’s most recent publicly reported income statement; provided that such amounts shall be limited to those of the Successor Entity only (and not any of its Subsidiaries) unless such Subsidiaries (other than any
Excluded Subsidiaries) have completed and consummated the Successor Entity Subsidiary Joinder Actions. 
 “Net Revenue”
means, for any period, (a) the Loan Parties’ gross revenues during such period, less (b)(i) trade, quantity and cash discounts allowed by the Loan Parties, (ii) discounts, refunds, rebates, charge backs, retroactive price adjustments
and any other allowances which effectively reduce net selling price, (iii) product returns and allowances, (iv) allowances for shipping or other distribution expenses, (v) set-offs and
counterclaims, and (vi) any other similar and customary deductions used by the Loan Parties in determining net revenues, all, in respect of (a) and (b), as determined in accordance with GAAP and in the Ordinary Course of Business. 

“Non-Callable Make Whole Amount” means, on any date of prepayment or early redemption
of all or any portion of the Loans, an amount in cash equal to all required interest payments due on the Loans that are prepaid from the date of repayment or early redemption through and including the date that is the First Amortization Date,
plus any accrued and unpaid interest and fees and unpaid costs and expenses incurred pursuant to the terms of the Loan Documents. 

“Notes” means the Loan Notes. 

  
 22 

 “Obligations” means all Loans and Disbursements, any Non-Callable Make Whole Amount, any CoC Fee, the Exit Payment, interest, fees, expenses, costs, liabilities, indebtedness and other obligations (monetary (including post-petition interest, costs, fees, expenses and
other amounts, whether allowed or not) or otherwise) of (or owed by) the Borrower and the other Loan Parties under or in connection with the Loan Documents, in each case howsoever created, arising or evidenced, whether direct or indirect (including
those acquired by assignment), absolute or contingent, now or hereafter existing, or due or to become due, and irrespective of whether the same are added to the principal amount of the Obligations. For the avoidance of doubt, “Obligations”
shall include the First Out Waterfall Obligations and the Last Out Waterfall Obligations. 
 “OFAC” has the meaning set
forth in Section 3.1(jj). 
 “OID” means original issue discount. 

“Operating Expenditures” means, with respect to any Person for any period, the amount of all expenditures (whether such
expenditures are paid in cash, financed or otherwise) by such Person and its Subsidiaries during such period that are reported as operating expenses (including expenditures related to research and development, clinical and regulatory affairs,
marketing and sales, and general and administrative) on the income statements of such Person and its Subsidiaries that are included in such Person’s financial statements (including those financial statements required by Section 5.1(h) and
Section 5.1(aa), as applicable), which amount shall (i) be in compliance and accordance with GAAP and any SEC requirements and regulations, but (ii) exclude one-time, non-recurring expenditures that are not regularly incurred in the Ordinary Course of Business of such Person and its Subsidiaries. 

“Operative Documents” means the Loan Documents, the “Loan Documents” (as defined in the ABL Credit Facility as of
the Agreement Date) and the “Subordinated Debt Documents” (as defined in the ABL Credit Facility as of the Agreement Date). 

“Options” means any rights, warrants or options to subscribe for or purchase shares of Common Stock or Convertible
Securities. 
 “Ordinary Course of Business” means, in respect of any transaction involving any Loan Party, the ordinary
course of business of such Loan Party, as conducted by such Loan Party in accordance with past practices, as applicable. 

“Organizational Documents” means, with respect to any Loan Party, the documents by which such Person was organized (such as a
certificate of incorporation, certificate of limited partnership or articles of organization, and including, without limitation, any certificates of designation for preferred stock or other forms of preferred equity) and which relate to the internal
governance of such Person (such as by-laws, a partnership agreement or an operating, limited liability company or members agreement), including any and all shareholder agreements or voting agreements relating
to the capital stock or other equity interests of such Person. 
 “Other Connection Taxes” means with respect to any
Lender, Taxes imposed as a result of a present or former connection between such Lender and the jurisdiction imposing such Tax (except a connection arising solely from such Lender having executed, delivered, become a party to, performed its
obligations or received a payment under, received or perfected a security interest under, engaged in any transaction pursuant to or enforced any Loan Document, or sold or assigned an interest in any Loan Document). 

  
 23 

 “Other Taxes” means any and all present or future stamp, value added or
documentary or any other excise or property Taxes arising from any payment made hereunder or from the execution, delivery, performance, recordation or filing of, or otherwise with respect to, any Loan Document. 

“Outstanding Items” has the meaning set forth in Section 5.1(z). 

“Participant” has the meaning set forth in Section 6.5. 

“Parties” has the meaning set forth in the preamble to this Agreement. 

“Patents” has the meaning set forth in the Security Agreement. 

“Patent Security Agreement” means any patent security agreement executed and delivered by any Loan Party to Agent, on behalf
of the Secured Parties, as the same may be amended, restated, supplemented or otherwise modified and in effect from time to time. 

“PBGC” means the United States Pension Benefit Guaranty Corporation or any successor thereto. 

“Perfection Certificate” means each perfection certificate executed or delivered from time to time by any Loan Party or any
of its Subsidiaries to any Secured Party, in substantially the form of Exhibit B. 
 “Permitted 3.25% Convertible Note
Refinancing” has the meaning provided therefor in the definition of “Permitted Indebtedness.” 
 “Permitted ABL
Credit Facility Liens” has the meaning provided therefor in clause (u) of the definition of “Permitted Liens”. 

“Permitted Acquisition” means any Acquisition by a Loan Party, in each case, to the extent that each of the following
conditions shall have been satisfied: 
 (a) the Borrower shall have delivered to Agent (i) at least ten (10) Business Days prior
to the closing of the proposed Acquisition: (A) a description of the proposed Acquisition; (B) to the extent available, a due diligence package (including, to the extent available, a quality of earnings report); and (C) the most
recent drafts (or, if available, executed counterparts) of the respective agreements, documents or instruments pursuant to which such Acquisition is to be consummated, any available schedules and exhibits to such agreements, documents or instruments
and all other material ancillary agreements, instruments and documents to be executed or delivered in connection therewith, and to the extent required under the related acquisition agreement, all required regulatory and third party approvals and
copies of any environmental assessments and (ii) at the earlier of (A) the time of closing of the proposed Acquisition or (B) as early before the closing of the proposed Acquisition as available, in each case, final, fully executed
copies of the respective agreements, documents or instruments pursuant to which such Acquisition is to be consummated and all schedules and exhibits to such agreements, documents or instruments and all other material ancillary agreements,
instruments and documents executed or delivered in connection therewith; 
 (b) the Loan Parties (including any new Subsidiary to the extent
required by Section 5.1(l)) shall execute and deliver the agreements, instruments and other documents to the extent required by Section 5.1(l); 

(c) no Event of Default or Default has occurred and is continuing, or would exist after giving pro forma effect to, the proposed Acquisition;

  
 24 

 (d) all transactions in connection with such Acquisition shall be consummated, in all
material respects, in accordance with applicable laws; 
 (e) the assets acquired in such Acquisition are for use in the same line of
business as the Loan Parties are currently engaged or a line of business reasonably related thereto; 
 (f) such Acquisition shall not be
hostile and, if applicable, shall have been approved by the board of directors (or other similar body) and/or the stockholders or other equity holders of any Person being acquired in such Acquisition; 

(g) no Indebtedness or Liens are assumed or created (other than Permitted Liens and Permitted Indebtedness) in connection with such
Acquisition; 
 (h) all conditions to “Permitted Acquisitions” (as defined in the ABL Credit Facility as of the Agreement Date)
have been satisfied and Agent shall have received any requested evidence showing satisfaction thereof; and 
 (i) the total consideration
paid or payable (including without limitation, costs and expenses, deferred purchase price, seller notes and other liabilities incurred, assumed or to be reflected on a consolidated balance sheet of the Loan Parties and their Subsidiaries after
giving effect to such Acquisition but excluding (A) any equity interests issued as consideration for such Acquisition and (B) the net proceeds of any issuance of equity interests made after the Agreement Date that are used for purposes of
such Acquisition) (such amounts, collectively, the “Acquisition Consideration”) shall be in an amount not to exceed $15,000,000 in the aggregate for all such Acquisitions during the term of this Agreement; provided,
however, that, in the case of each Acquisition, Agent has received prior to the consummation of such Acquisition evidence satisfactory to Agent that Borrower has, immediately before and immediately after giving effect to the consummation of
such Acquisition, unrestricted cash (it being understood and agreed that cash and Cash Equivalents shall not be considered “restricted” cash for purposes of this proviso solely due to compliance by the Loan Parties with the requirements
set forth in Section 5.1(k)) in one or more deposit accounts subject to a Control Agreement in an aggregate amount equal to or greater than the positive value of the product of (x) eighteen (18) multiplied by (y) the “Monthly
Cash Burn Amount” (as defined in the ABL Credit Facility as of the Agreement Date), as determined as of the last day of the month immediately preceding such Acquisition. 

“Permitted Contingent Obligations” means 

(a) Contingent Obligations arising in respect of the Indebtedness under the Loan Documents; 

(b) Contingent Obligations resulting from endorsements for collection or deposit in the Ordinary Course of Business; 

(c) Contingent Obligations outstanding on the Prior Agreement Date and set forth on Schedule 5.2(iv) (but not including any refinancings,
extensions, increases or amendments to the indebtedness underlying such Contingent Obligations other than extensions of the maturity thereof without any other material change in terms adverse to the Lenders); 

(d) Contingent Obligations incurred in the Ordinary Course of Business with respect to surety and appeal bonds, performance bonds and other
similar obligations not to exceed $2,000,000 in the aggregate at any time outstanding; 

  
 25 

 (e) Contingent Obligations arising under indemnity agreements with title insurers to cause
such title insurers to issue to Agent mortgagee title insurance policies; 
 (f) Contingent Obligations arising with respect to customary
indemnification obligations in favor of purchasers in connection with dispositions of personal property assets permitted under Section 5.2; 

(g) so long as there exists no Event of Default both immediately before and immediately after giving effect to any such transaction, Contingent
Obligations existing or arising under any Swap Contract or Capped Call; provided, however, that such obligations are (or were) entered into by Borrower or an Affiliate of Borrower for the purpose of directly mitigating risks associated
with liabilities, commitments, investments, assets, or property held or reasonably anticipated by such Person and not for purposes of speculation and either (i) with respect to a Swap Contract or a Capped Call, are (or were) entered into in the
Ordinary Course of Business or (ii) with respect to a Capped Call, are (or were) entered into in connection with the 2.25% Convertible Notes, the 3.25% Convertible Notes, any refinancings thereof permitted hereunder or in connection with this
Agreement or any of the other Loan Documents; 
 (h) guarantees by (A) one or more Loan Parties of the obligations of Foreign
Subsidiaries up to $1,000,000 in the aggregate at any time outstanding, (B) any Loan Party of the obligations of any other Loan Party (but, for the avoidance of doubt, excluding any Immaterial Subsidiary that may be a Loan Party where, before
and immediately after giving effect to such guarantee (including any rights of contribution set forth in the Loan Documents or otherwise), the Loan Parties cannot represent and warrant that such Immaterial Subsidiary is Solvent on an individual
basis) and (C) any Foreign Subsidiary of the obligations of any other Foreign Subsidiary; 
 (i) [reserved]; 

(j) Contingent Obligations arising in respect of the Indebtedness under the ABL Debt Documents; and 

(k) other Contingent Obligations not permitted by clauses (a) through (j) above, not to exceed $2,500,000 in the aggregate at any time
outstanding. 
 “Permitted Dispositions” means each of the following: 

(a) dispositions of inventory in the Ordinary Course of Business; 

(b) dispositions of furniture, fixtures and equipment in the Ordinary Course of Business that the applicable Loan Party or Subsidiary
determines in good faith is no longer used or useful in the business of such Loan Party and its Subsidiaries (or such Subsidiary and its subsidiaries); 

(c) to the extent constituting a Disposition, Permitted Investments and Permitted Licenses; 

(d) disposals of obsolete, worn out or surplus tangible personal property; 

(e) without limiting transactions permitted under Section 5.2 hereof, dispositions by any Loan Party to any other Loan Party so long as
each Loan Party (other than, with respect to any transferring Person, an Immaterial Subsidiary) will remain Solvent after giving effect to the transfer; 

  
 26 

 (f) abandonment of Intellectual Property that does not constitute a Material Intangible
Asset; 
 (g) the unwinding or terminating of Swap Contracts or any Capped Call permitted by clause (g) of the definition of
“Permitted Contingent Obligations” either (i) with respect to a Swap Contract or a Capped Call, in the Ordinary Course of Business or (ii) with respect to a Capped Call, that were entered into in connection with the 2.25%
Convertible Notes, the 3.25% Convertible Notes, any Permitted 3.25% Convertible Note Refinancing permitted hereunder or in connection with this Agreement or any of the other Loan Documents; 

(h) dispositions of equipment or real property to the extent that (i) such property is exchanged for credit against the purchase price of
replacement property or (ii) the proceeds of such disposition are promptly applied to the purchase price of such replacement property; 

(i) the entering into of any Permitted License; 

(j) Dispositions by any Foreign Subsidiary to any other Foreign Subsidiary or to any Loan Party; 

(k) Dispositions approved by Agent in writing; 

(l) to the extent constituting a Disposition, the payment of cash and Cash Equivalents in the Ordinary Course of Business; 

(m) other Dispositions (excluding dispositions of Intellectual Property) the proceeds of which, when aggregated with the proceeds of all other
Dispositions made pursuant to this clause (m) are less than $2,500,000 during the term of this Agreement; provided that (i) the consideration received for such assets shall be in an amount at least equal to the fair market value thereof
(determined in good faith by the board of directors (or similar governing body) of the applicable Loan Party that owned such assets), (ii) no less than 75% thereof shall be paid in cash and (iii) no Default or Event of Default then exists or
would arise therefrom; provided that the requirements and conditions set forth in the proviso in clause (m) of the definition of “Permitted Dispositions” in the ABL Credit Facility as in effect as of the Agreement Date have
been completely satisfied; 
 (n) to the extent constituting Dispositions, Recalls of Products (or components of Products) returned to
suppliers in the Ordinary Course of Business as required by Applicable Law or the FDA with the consideration paid for such Products (or such components of Products) returned to the Loan Party or Subsidiary that purchased and returned such Product
(or such components of Products); and 
 (o) (i) Recalls of Products (or components of Products) from customers to the extent required
by Applicable Law or the FDA and (ii) the Dispositions of such Products that were Recalled in the Ordinary Course of Business and for fair market value and on fair market terms. 

“Permitted Indebtedness” means each of the following: 

(a) the Loan Parties’ and their Subsidiaries’ Indebtedness to Agent and each Lender under this Agreement and the other Loan
Documents; 
 (b) Indebtedness incurred as a result of endorsing negotiable instruments received in the Ordinary Course of Business; 

  
 27 

 (c) Capital Leases and purchase money Indebtedness not to exceed $5,000,000 at any time
(whether in the form of a loan or a lease) used solely to acquire equipment used in the Ordinary Course of Business and secured only by such equipment; 

(d) Indebtedness existing on the Agreement Date and described on Schedule 3.1(f) (but not including any refinancings, extensions, increases or
amendments to such Indebtedness other than Permitted Refinancings); 
 (e) so long as there exists no Event of Default both immediately
before and immediately after giving effect to any such transaction, Indebtedness existing or arising under any Swap Contract or Capped Call; provided, however, that such obligations are (or were) entered into by Borrower or an
Affiliate of Borrower for the purpose of directly mitigating risks associated with liabilities, commitments, investments, assets, or property held or reasonably anticipated by such Person and not for purposes of speculation and either (i) with
respect to a Swap Contract or a Capped Call, are (or were) entered into in the Ordinary Course of Business or (ii) with respect to a Capped Call, are (or were) entered into in connection with the 2.25% Convertible Notes, the 3.25% Convertible
Notes, any Permitted 3.25% Convertible Note Refinancing permitted hereunder or in connection with this Agreement or any of the other Loan Documents; 

(f) Indebtedness in the form of insurance premiums financed through the applicable insurance company; 

(g) trade accounts payable arising and paid within 120 days of the date when due and in the Ordinary Course of Business; 

(h) unsecured Indebtedness in an amount not to exceed $4,280,500 pursuant to a promissory note dated on or around the Agreement Date, by the
Borrower in favor of Japan Lifeline Co., Ltd. (the “Permitted Japan Lifeline Unsecured Debt”), so long as (i) no prepayments, repayment, redemptions or payments shall be made with respect to the Permitted Japan Lifeline
Unsecured Debt at any time until ninety-one (91) days after all of the Obligations have been paid in full, (ii) the all-in interest rate and pricing charged
thereon shall not exceed 2.5% per annum and such interest shall not be paid more frequently than annually in arrears, (iii) no fees shall be paid thereon, (iv) such unsecured Indebtedness shall not be assigned or otherwise transferred by
Japan Lifeline Co., Ltd. without the consent of the Agent, (v) Japan Lifeline Co., Ltd. (and any successor or assign thereof) shall enter into a subordination agreement with the Agent, in form and substance reasonably satisfactory to the Agent
and the Lenders, and (vi) subordination provisions are included in such promissory note and any related documents (collectively, the “Permitted Japan Lifeline Unsecured Debt Documents”) in a manner, and in form and substance,
reasonably satisfactory to the Agent and the Lenders and such Permitted Japan Lifeline Unsecured Debt Documents shall be in form and substance reasonably satisfactory to the Agent and the Lenders; 

(i) Subordinated Debt; 
 (j) the
ABL Debt under the ABL Credit Facility, in accordance with the terms of the Intercreditor Agreement and this Agreement; 
 (k) Indebtedness
of the Loan Parties incurred under the 3.25% Convertible Notes in an aggregate principal amount not to exceed the aggregate principal amount outstanding on the Agreement Date after giving effect to any repayments or prepayments thereon on or prior
to the Agreement Date (which, for the avoidance of doubt, shall not be greater than the aggregate principal amount outstanding on the Prior Agreement Date), and, so long as no Event of Default has occurred and is continuing, any refinancing or
extension thereof or new issuance in connection with the exchange thereof and/or a new 

  
 28 

 
issuance all or any portion of the proceeds of which will be used in connection with the repurchase or other refinancing of all or any portion thereof therewith that (i) has an aggregate
outstanding principal amount not greater than $200,000,000 (when taking into account all such existing, refinanced, extended and newly issued Indebtedness), and does not provide for any amortization payments or other principal payments of any kind
in advance of the date that is one year and one day after the Maturity Date, (ii) has a maturity no shorter than the date that is one year and one day after the Maturity Date (in the case of clause (i) and clause (ii), it being
understood that, in each case, any provision requiring an offer to purchase such Indebtedness as a result of a change in control, fundamental change, delisting, asset sale or similar provision or any exercise or conversion of Stock (other than
Disqualified Stock) shall not violate the foregoing restrictions in clause (i) or clause (ii)), (iii) is unsecured, (iv) does not have one or more obligors that are not Loan Parties, (v) contains terms that are prevailing market
terms at the time of issuing or initial borrowing for the type of financing and for the quality of issuer or borrower, as determined by Borrower and its advisors in their reasonable business judgment, (vi) does not have an All-in Yield greater than the lesser of (A) 6% per annum and (B) an All-in Yield that would result in more than $10,000,000 per annum being paid in interest thereunder,
(vii) does not cause Borrower either on an individual basis or together with its Subsidiaries (on a consolidated basis), immediately before, at the time of and immediately after giving effect to such Indebtedness (and after giving effect to the
use of the proceeds thereof), to be no longer be Solvent (or such Persons are not Solvent immediately prior to giving effect thereto), and (vii) if in existence at such time or on the same date, is permitted under the ABL Debt Documents
(collectively, a “Permitted 3.25% Convertible Note Refinancing”); 
 (l) Indebtedness of the Loan Parties incurred under the
2.25% Convertible Notes in an aggregate principal amount not to exceed the aggregate principal amount outstanding on the Agreement Date minus any prepayments, repayments, redemptions or payments thereon made on the Agreement Date or from time to
time thereafter (which, for the avoidance of doubt, such aggregate principal amount shall not be greater than the amount outstanding as of the Prior Agreement Date); 

(m) without limiting the provisions of Section 5.2 with respect to any Investment by a Loan Party, Indebtedness consisting of unsecured
intercompany loans and advances (i) incurred by any Loan Party owing to one or more other Loan Parties, (ii) incurred by any Foreign Subsidiaries owing to any Loan Party solely to the extent constituting a Permitted Investment made by such
Loan Party, or (iii) incurred by any Foreign Subsidiaries owing to any other Foreign Subsidiary; 
 (n) Indebtedness related to
commercial credit cards provided by Bank of America, N.A. (or such other commercial bank permitted under the definition of “Bank of America Cash Collateral Account) that, in the aggregate outstanding at any one time, does not exceed $2,500,000,
which Indebtedness may be secured by Liens permitted pursuant to clause (t) of the definition of Permitted Liens; 
 (o) to the extent
constituting Indebtedness, any Permitted Contingent Obligations; and 
 (p) unsecured Indebtedness incurred in respect of netting services,
overdraft protection and other like services, in each case, incurred in the Ordinary Course of Business; 
 (q) unsecured earn-out obligations and other similar contingent purchase price obligations incurred in connection with a Permitted Acquisition to the extent earned and payable and permitted pursuant to the definition of Permitted
Acquisition and the other terms of this Agreement; and 
 (r) any other unsecured Indebtedness incurred by the Loan Parties or any of their
Subsidiaries in an aggregate outstanding amount not to exceed $2,500,000 at any one time. 
 “Permitted Investments” means
each of the following: 

  
 29 

 (a) Investments (i) shown on Schedule P-1 and
existing on the Agreement Date and (ii) in Subsidiaries made prior to the Agreement Date; 
 (b) Investments in cash and Cash
Equivalents; 
 (c) Investments consisting of the endorsement of negotiable instruments for deposit or collection or similar transactions in
the Ordinary Course of Business; 
 (d) Investments consisting of (i) travel advances and employee relocation loans and other employee
loans and advances in the Ordinary Course of Business, and (ii) loans to employees, officers or directors relating to the purchase of equity securities of Loan Parties or their Subsidiaries pursuant to employee stock purchase plans or
agreements approved by Loan Parties’ board of directors (or other governing body), but the aggregate of all such loans outstanding may not exceed $500,000 at any time; 

(e) Investments (including debt obligations) received in connection with the bankruptcy or reorganization of customers or suppliers and in
settlement of delinquent obligations of, and other disputes with, customers or suppliers arising in the Ordinary Course of Business; 
 (f)
Investments consisting of notes receivable of, or prepaid royalties and other credit extensions, to customers and suppliers who are not Affiliates, in the Ordinary Course of Business, provided, however, that this subpart (f) shall not apply to
Investments of Loan Parties in any Subsidiary; 
 (g) Investments consisting of (i) deposit accounts in which Agent has received a
Control Agreement, and (ii) deposit accounts that are Excluded Accounts (subject to any caps and applicable restrictions set forth in such definition); 

(h) Investments by any Loan Party in any Subsidiary now owned or hereafter created by such Loan Party, which Subsidiary is a Loan Party or has
otherwise provided a Guarantee of the Obligations of the Loan Parties which Guarantee is secured by a Lien granted by such Subsidiary to Agent in all or substantially all of its property of the type described in the Security Agreement and otherwise
made in compliance with Section 5.1(l); 
 (i) Investments by (A) any Loan Party consisting solely of cash and Cash Equivalents in
a Foreign Subsidiary; provided that at the time of the making of such Investment and immediately after giving effect thereto (i) no Event of Default has occurred and is continuing and (ii) Loan Parties have unrestricted (it being
understood and agreed that cash and Cash Equivalents shall not be considered “restricted” cash for purposes of this proviso solely due to compliance by the Loan Parties with the requirements set forth in Section 5.1(k)) cash and Cash
Equivalents in an aggregate amount of not less than $10,000,000, which cash and Cash Equivalents (x) are subject to a first priority perfected lien in favor of Agent for the benefit of Lenders (subject to Permitted Liens), (y) are held in a
deposit account that is subject to a Control Agreement or a securities account subject to a Control Agreement and (z) unless the same could not be reasonably expected to reduce the amounts in such accounts below $10,000,000 at the time of such
Investment and immediately after giving effect thereto, do not include any drawn or committed but unpaid drafts, ACH or EFT transactions and (B) a non-Loan Party Foreign Subsidiary in another non-Loan Party Foreign Subsidiary; provided, that, Investments pursuant to clause (i)(A) above shall be subject to the proviso at the end of this definition; 

(j) Investments by any Loan Party consisting solely of inventory in any wholly-owned Foreign Subsidiaries, to the extent (i) such
Investments are made in the Ordinary Course of Business consistent with its customary practices as in effect on and immediately prior to the Prior 

  
 30 

 
Agreement Date, (ii) no Event of Default then exists or would arise therefrom and (iii) no “Event of Default” (as defined in the ABL Credit Facility as in effect as of the
Agreement Date) then exists or would arise therefrom; provided that (y) no such Investment shall result in an “Overadvance” (as defined in the ABL Credit Facility as in effect as of the Agreement Date) and (z) such
Investments shall be subject to the proviso at the end of this definition; 
 (k) so long as no Default or Event of Default shall have
occurred and be continuing at the time thereof or would result therefrom, Investments consisting solely of cash and Cash Equivalents in joint ventures or similar arrangements in an amount not to exceed $5,000,000 in the aggregate during the term of
this Agreement; provided, that, such Investments shall be subject to the proviso at the end of this definition; 
 (l)
Permitted Acquisitions; 
 (m) Investments deemed to exist under any Swap Contracts or Capped Calls; provided, however, that
such obligations are (or were) entered into by Borrower or an Affiliate of Borrower for the purpose of directly mitigating risks associated with liabilities, commitments, investments, assets, or property held or reasonably anticipated by such Person
and not for purposes of speculation and are (or were) entered into either (i) with respect to a Swap Contract or a Capped Call, in the Ordinary Course of Business or (ii) with respect to a Capped Call, in connection with the 2.25%
Convertible Notes, the 3.25% Convertible Notes, any Permitted 3.25% Convertible Note Refinancing permitted hereunder or in connection with this Agreement or any of the other Loan Documents; and 

(n) other Investments in an amount not exceeding $5,000,000 in the aggregate; provided, that, such Investments shall be subject
to the proviso at the end of this definition; 
 provided, that, Investments pursuant to clauses (i), (j), (k), and (n) of this
definition of “Permitted Investments” shall not exceed $12,000,000 in the aggregate in any calendar year (or such lesser amount provided in the ABL Credit Facility from time to time) and, provided, further, that with respect
to clause (j) above, such Investments consisting solely of Inventory in Foreign Subsidiaries shall be valued at the lesser of cost and book value. 

“Permitted Japan Lifeline Unsecured Debt” has the meaning specified therefor in clause (h) of the definition of
“Permitted Indebtedness”. 
 “Permitted Japan Lifeline Unsecured Debt Documents” has the meaning specified
therefor in clause (h) of the definition of “Permitted Indebtedness”. 
 “Permitted License” means
(a) any non-exclusive license of patent rights of a Loan Party or its Subsidiaries so long as all such Permitted Licenses are granted to third parties in the Ordinary Course of Business, do not result in
a legal transfer of title to the licensed property, and have been granted in exchange for fair consideration, and (b) any exclusive license of patent rights of a Loan Party or its Subsidiaries so long as such Permitted Licenses do not result in
a legal transfer of title to the licensed property, are exclusive solely as to discrete geographical areas outside of the United States, and have been granted in exchange for fair consideration. 

“Permitted Liens” means each of the following: 

(a) Liens existing on the Prior Agreement Date and set forth on Schedule 3.1(d); provided, that to qualify as a Permitted Lien, any such
Lien described on Schedule 3.1(d) shall only secure the Indebtedness that it secures on the Prior Agreement Date; 

  
 31 

 (b) Liens in favor of the Secured Parties under the Loan Documents; 

(c) carriers’, warehousemen’s, mechanics’, landlords’, materialmen’s, repairmen’s or other similar Liens arising
in the Ordinary Course of Business which are not delinquent or remain payable without penalty or which are being contested in good faith and by appropriate proceedings, which proceedings have the effect of preventing the forfeiture or sale of the
assets or property subject thereto and for which adequate reserves in accordance with GAAP are being maintained; 
 (d) Liens for Taxes,
assessments or governmental charges or levies not past due or payable or that are being contested in good faith by appropriate proceedings and for which adequate reserves in accordance with GAAP are being maintained; 

(e) (A) Liens arising from judgments, decrees or attachments in circumstances not constituting an Event of Default or Default and
(B) pledges or cash deposits made in lieu of, or to secure the performance of, judgment or appeal bonds in respect to such judgments and proceedings; 

(f) Liens in favor of financial institutions arising in connection with the Borrower’s or its Subsidiaries’ deposit accounts
maintained in the Ordinary Course of Business held at such institutions to secure standard fees for services charged by, but not financing made available by, such institutions; 

(g) Liens (other than any Lien imposed by ERISA) consisting of pledges or deposits required in the Ordinary Course of Business in connection
with workers’ compensation, unemployment insurance and other social security legislation or to secure the performance of tenders, statutory obligations, surety, stay, customs and appeals bonds, bids, leases, governmental contract, trade
contracts, performance and return of money bonds and other similar obligations (exclusive of obligations for the payment of borrowed money or other funded Indebtedness) or to secure liability to insurance carriers; 

(h) easements, rights of way, restrictions and other similar encumbrances affecting real property which, in the aggregate, are not substantial
in amount, do not materially affect the value or marketability of such real property and which do not in any case materially interfere with the conduct of the business of any Loan Party or its Subsidiaries; 

(i) (i) any interest or title of a lessor, sublessor, licensor or sublicensor under any lease or license not prohibited by this Agreement or (ii) non-exclusive licenses and sublicenses granted by a Loan Party or any Subsidiary of a Loan Party and leases and subleases (by a Loan Party or any Subsidiary of a Loan Party as lessor or sublessor) to third
parties in the Ordinary Course of Business not materially interfering with the business of the Loan Parties or any of their Subsidiaries; 

(j) Liens of a collection bank arising under Section 4-210 of the UCC (or equivalent in foreign
jurisdictions) on items in the course of collection; 
 (k) Liens on any assets or property acquired or held by any Loan Party or any
Subsidiary of any Loan Party securing Indebtedness incurred or assumed for the purpose of financing (or refinancing) all or any part of the cost of acquiring such assets or property and permitted under clause (c) of the definition of
“Permitted Indebtedness”; provided that (i) such Lien attaches solely to the assets or property so acquired in such transaction and the proceeds thereof and (ii) the principal amount of the Indebtedness secured thereby
does not exceed 100% of the cost of such assets or property; 
 (l) Liens securing Capital Leases permitted under clause (c) of the
definition of “Permitted Indebtedness”; 

  
 32 

 (m) Liens arising from the filing of precautionary uniform commercial code financing
statements with respect to any lease not prohibited by this Agreement; 
 (n) Liens arising out of consignment or similar arrangements for
the sale of goods entered into by the Borrower or any Subsidiary of the Borrower in the Ordinary Course of Business; 
 (o) Liens in favor of
customs and revenue authorities arising as a matter of law which secure payment of customs duties in connection with the importation of goods in the Ordinary Course of Business; 

(p) Liens on unearned insurance premiums securing the financing thereof to the extent permitted under clause (f) of the definition of
“Permitted Indebtedness”; 
 (q) [reserved]; 

(r) Liens on assets of the Loan Parties and their Subsidiaries arising in connection with seller notes, earn-outs and other similar payment
obligations constituting Acquisition Consideration in connection with Permitted Acquisitions so long as such Liens are subject at all times to a Subordination Agreement; 

(s) [reserved]; 
 (t) Liens in
favor of Bank of America, N.A. (or such other commercial bank permitted under the definition of “Bank of America Cash Collateral Account”) on the Bank of America Cash Collateral Account; provided that if Borrower is using credit
card services from the agent or a lender under ABL Debt Documents that are required to be secured, Borrower shall promptly use commercially reasonable efforts to terminate the Liens in respect of the Bank of America Cash Collateral Account; and 

(u) Liens granted under the ABL Credit Facility, in accordance with, and to the extent subject to, the terms of the Intercreditor Agreement
(“Permitted ABL Credit Facility Liens”). 
 “Permitted Priority Liens” means (a) solely with respect
to the specific assets or property covered thereby, the Liens granted pursuant to, and in accordance with, clause (u) of the definition of “Permitted Liens ,” (b) Permitted Liens granted over specific property pursuant to clauses (f)
(solely with respect to such applicable deposit accounts), (i) (solely with respect to the interest in such applicable lease, sublease, license or sublicense or the assets owned by such lessor, sublessor, licensor or sublicensor underlying same),
(k) (solely with respect to the property permitted to be secured by such Indebtedness permitted pursuant to clause (c) of the definition of “Permitted Indebtedness”), (l) (solely with respect to the property that is part of the
Capital Lease), (m) (solely with respect to the specific assets covered by such lease that are owned by such lessor), (n) (with respect to the goods permitted to be consigned thereby), (p) (solely with respect to such cash held by such insurance
agency for such insurance premiums), and (t) (solely with respect to the Bank of America Cash Collateral Account) of the definition of “Permitted Liens”, but, in each case, only to the extent only such Lien (i) attaches solely to the
assets or property so acquired in such transaction and the proceeds thereof and (ii) has prior priority to the Permitted ABL Credit Facility Liens, and (c) to the extent not otherwise covered by clause (b) above, non-consensual Permitted Liens that are solely provided by operation of (and in compliance with) Applicable Law. 

“Permitted Refinancing” means Indebtedness constituting a refinancing or extension of Indebtedness evidenced by the permitted
under clause (d) of the definition of “Permitted Indebtedness” and that (a) has an aggregate outstanding principal amount not greater than the aggregate principal amount of the Indebtedness being refinanced or extended,
(b) has a weighted average maturity (measured as of the 

  
 33 

 
date of such refinancing or extension) and maturity no shorter than that of the Indebtedness being refinanced or extended, (c) is not entered into as part of a sale leaseback transaction,
(d) is not secured by a Lien on any assets other than the collateral securing the Indebtedness being refinanced or extended, (e) the obligors of which are the same as the obligors of the Indebtedness being refinanced or extended and
(f) is otherwise on terms no less favorable to Loan Parties and their Subsidiaries, taken as a whole, than those of the Indebtedness being refinanced or extended. 

“Permitted Successor Transaction” means a transaction that satisfies all of the following conditions: (A) the Stock of
the Borrower is acquired by, or the Borrower is merged with, a corporation (each such transaction, a “Successor Entity Transaction”) that (i) is organized in a state of the United States that has both a Market Cap and an
Enterprise Value of at least $2,000,000,000 (as reasonably determined by the Agent), (ii) has common Stock registered under Section 12 of the Exchange Act and listed on a National Securities Exchange, (iii) is current in its reporting
requirements under the Exchange Act and (iv) is in compliance with all applicable listing standards of the National Securities Exchange on which its common stock is listed (such successor corporation, a “Successor Entity”), (B)
before, at the time of and after giving effect to such Successor Entity Transaction, no Event of Default has occurred and is continuing, (C) Agent (for the benefit of the Secured Parties) maintains a first priority security interest (subject
only to the Permitted Priority Liens) in all of the Collateral of the Loan Parties, and the Successor Entity and the Loan Parties shall take such actions and execute and deliver such documents, instruments and agreements required by Agent to
effectuate the foregoing in this clause (i)(C), (D) in connection with any such Successor Entity Transaction, the Successor Entity shall take such actions and execute such documents, instruments and agreements as may be reasonably required by Agent
to assume all of the Obligations on behalf of the Borrower and all Guarantors shall reaffirm and ratify its Guarantee of the Obligations and the Liens securing the Obligations the Borrower and such Guarantors granted under the Loan Documents to
secure such Guarantees and Obligations, in each case, in a manner reasonably satisfactory to the Agent, (E) the Successor Entity and/or the Borrower shall take such actions requested by the Agent or any holder of the Warrants to effectuate the
bargain, intention and agreements previously set forth in the Warrants, the Registration Rights Agreement and the other Loan Documents, (F) before, at the time of and after giving effect to such Successor Entity Transaction, the Successor
Entity (provided that the amounts related to the Successor Entity shall be limited to those incurred by the Successor Entity only (and not any of its Subsidiaries) unless such Subsidiaries (other than any Excluded Subsidiaries) have completed
and consummated the Successor Entity Subsidiary Joinder Actions), the Loan Parties and their Subsidiaries shall have a Total Leverage Ratio on a pro forma basis (after giving effect to the Successor Entity Transaction and any Indebtedness that will
remain or be assumed after such consummation thereof) of no greater than 2:1 and the Successor Entity and the Loan Parties shall deliver a certificate certifying to the same and providing such evidence and calculations thereof that may be reasonably
requested by Agent, (H) the Successor Entity both on an individual basis and together with the Loan Parties and their Subsidiaries (on a consolidated basis), immediately before, at the time of and immediately after giving effect to such
Successor Entity Transaction, is/are Solvent, (I) before, at the time of and after giving effect to such Successor Entity Transaction, the representations and warranties set forth in the Loan Documents (and the Prior Loan Documents) are true,
correct and complete in all material respects (without giving effect to any double materiality) as of the Prior Agreement Date, the Agreement Date and the date thereof (or, if such representation or warranty is made as of such earlier specified
date, as of such earlier specified date), (J) (1) each Subsidiary of the Successor Entity that was a Subsidiary of the Borrower immediately prior to the consummation of the Successor Entity Transaction shall comply with Section 5.1(l) and shall take
such actions and execute and deliver such agreements, instruments and other documents in connection therewith as reasonably requested by Agent and (2) if the Subsidiaries of the Successor Entity immediately prior to giving effect to the Successor
Entity Transaction and that will remain Subsidiaries of the Successor Entity after giving effect to the Successor Entity Transaction are to be included in the components of the definition of “Total Leverage Ratio” (and all components of
the various definitions of the capitalized financial terms used in such definitions and the definitions of each such other capitalized financial term 

  
 34 

 
related thereto) to determine whether clause (F) above is satisfied, such Subsidiaries of the Successor Entity (other than any Excluded Subsidiaries) have completed and consummated the
Successor Entity Subsidiary Joinder Actions in a manner reasonably satisfactory to Agent, and (K) the Successor Entity and the Loan Parties shall deliver a certificate certifying that each of the foregoing conditions in this definition have
been satisfied. 
 “Person” means and includes any natural person, individual, partnership, joint venture, corporation,
trust, limited liability company, limited liability partnership, joint stock company, unincorporated organization, government entity or any political subdivision or agency thereof, or any other entity. 

“PIK Interest Payment” has the meaning set forth in Section 2.6(a). 

“PIK Interest Rate” means 4.75% per annum for the principal amount of the Loans and any overdue interest thereon. 

“Portfolio Interest Certificate” has the meaning set forth in Section 2.5(d). 

“Principal Market” means the NASDAQ Global Select Market (or any successor to the foregoing). 

“Prior Agreement Date” means April 3, 2017. 

“Prior Facility Agreement” has the meaning specified therefor in the recitals hereto. 

“Prior Loan Documents” has the meaning specified therefor in Section 6.29. 

“Pro Rata Loan Share” means, with respect to any Lender, the applicable amount specified opposite such Lender’s name on
Annex A under the column “Total Disbursement Amount” (as such amount may be increased, decreased or otherwise adjusted from time to time in accordance with the terms hereof (including pursuant to any PIK Interest Payment or pursuant to any
assignment and transfers by the Lenders hereunder) and the actual principal amount outstanding related thereto). 
 “Pro Rata
Share” means, with respect to any Lender, the applicable percentage (as adjusted from time to time in accordance with the terms hereof) obtained by dividing (a) such Lender’s Pro Rata Loan Share of the outstanding Loans, by
(b) the total outstanding amount of Loans held by all Lenders. 
 “Products” means, from time to time, any products
currently manufactured, sold, developed, tested or marketed by any Loan Party or any of a Loan Party’s Subsidiaries. 
 “Put
Notice” has the meaning set forth in Section 5.3. 
 “Reaffirmation Agreement” means that certain
Reaffirmation Agreement, dated as of the Agreement Date, by the Loan Parties party thereto in favor of Agent. 
 “Real
Estate” means any real property owned, leased, subleased or otherwise operated or occupied by any Loan Party or any Subsidiary of any Loan Party. 

“Recall” means a Person’s Removal or Correction of a marketed product that the FDA considers to be in violation of the
laws it administers and against which the FDA would initiate legal action (e.g., seizure). 
 “Register” has the meaning
set forth in Section 1.4(b). 

  
 35 

 “Registration Rights Agreement” means that certain Amended and Restated
Registration Rights Agreement dated as of the Agreement Date entered into by the Borrower and the Lenders and substantially in the form of Exhibit E (as may be amended, restated, supplemented or otherwise modified from time to time). 

“Regulation D” means Regulation D of the Board of Governors of the Federal Reserve System as in effect from time to time and
any successor to all or a portion thereof establishing reserve requirements. 
 “Regulatory Required Permit” means any and
all licenses, clearances, exemptions, approvals, registrations, and permits issued by the FDA, DEA or any other applicable Governmental Authority, including, without limitation, Drug Applications, any 510(k) premarket clearance, grant of a de novo
request, premarket approval application (“PMA”), or investigational device exemption (“IDE”), or the foreign equivalent to any of the foregoing necessary for the design, testing, manufacture, processing, assembly, packaging,
labeling, marketing, distribution, commercialization, import, export, or sale of any Product by any applicable Loan Party (or Loan Parties) and its (or their) Subsidiaries as such activities are being conducted by such Loan Party (or Loan Parties)
and its (or their) Subsidiaries with respect to such Product at such time; and any device listings and device establishment registrations under 21 C.F.R. Part 807, and any drug listings and drug establishment registrations under 21 U.S.C.
Section 510, registrations issued by DEA under 21 U.S.C. Section 823 (if applicable to any Product) and those issued by State governments for the conduct of the Loan Parties’ or any of their Subsidiaries’ business. 

“Related Parties” means, with respect to any Person, such Person’s Affiliates and the partners, directors, officers,
employees, agents, trustees, administrators, managers, attorneys, advisors and representatives of such Person and of such Person’s Affiliates. 

“Releases” means any release, threatened release, spill, emission, leaking, pumping, pouring, emitting, emptying, escape,
injection, deposit, disposal, discharge, dispersal, dumping, leaching or migration of Hazardous Material into or through the environment. 

“Removal” means the physical removal of a product from its point of use to some other location for repair, modification,
adjustment, relabeling, destruction or inspection. 
 “Reporting Period” has the meaning set forth in Section 5.1(h).

 “Required First Out Waterfall Lenders” means, at any time, the First Out Waterfall Lenders whose First Out Waterfall Pro
Rata Share aggregate more than fifty percent (50%). 
 “Required Last Out Waterfall Lenders” means, at any time, Last Out
Waterfall Lenders whose Last Out Waterfall Pro Rata Share aggregate more than fifty percent (50%). 
 “Required Lenders”
means, at any time, both the Required First Out Waterfall Lenders and the Required Last Out Waterfall Lenders, unless all of the First Out Waterfall Obligations (other than (y) unasserted contingent indemnification First Out Waterfall
Obligations and (z) those First Out Waterfall Obligations under any Warrant or the Registration Rights Agreement that are not due or payable at the time when all other First Out Waterfall Obligations are paid in full in cash) have been paid in
full in cash and any Last Out Waterfall Obligations remain outstanding, in which case, the term “Required Lenders” shall mean only the Required Last Out Waterfall Lenders. 

“Restricted Payment” means, with respect to any Person, (i) the declaration or making of any dividend payment or other
distribution of assets, properties, cash, rights, obligations or securities on account of any of its Stock, (ii) the purchasing, redemption or other acquisition for value of any of its Stock 

  
 36 

 
(other than, when no Default or Event of Default has occurred or is continuing (or would occur after giving effect to any such purchase, redemption or other acquisition) and to the extent there
would be pro forma compliance with the financial covenants in Sections 5.2(xxiv) through (xxix) (after giving effect to any such purchase, redemption or other acquisition), solely pursuant to the Borrower’s stock option exchange program on
the terms set forth, and specifically described (and without giving effect to any changes thereto that would be adverse to the Secured Parties), in that certain proxy statement of the Borrower filed with the SEC on April 20, 2018, the Borrower
shall have the ability to provide certain qualified employees of the Borrower (which shall not include name executive officers or board of directors of the Borrower and only with respect to “Eligible Participants” (as described therein))
the option to surrender certain “out-of-the-money” or “underwater” options with an exercise price of $6.50 or
greater that are “Eligible Options” (as described therein) for cancellation in exchange for a grant of a lesser number of new restricted stock units of the Borrower that may be settled for shares of the Borrower’s common stock under
the Borrower’s amended and restated 2015 stock incentive plan of the Borrower that is attached to such aforementioned proxy statement (and without giving effect to any material changes thereto), all as further specifically described (and
without giving effect to any material changes thereto) in such proxy statement) now or hereafter outstanding or (iii) the making of any payment or prepayment of principal of, premium, if any, interest, fees, redemption, exchange, purchase,
retirement, defeasance, sinking fund or similar payment with respect to, any Indebtedness subordinated to the Obligations as to right and time of payment or as to other rights and remedies thereunder. For the avoidance of doubt, the entry into, any
payments or deliveries in respect of, and the performance, exercise and/or settlement of the Borrower’s 2.25% Convertible Notes, 3.25% Convertible Notes (including, for the avoidance of doubt, any Permitted 3.25% Convertible Note Refinancing),
Capped Calls, Warrants or under the ABL Credit Facility are not Restricted Payments. 
 “Rights Plan” has the meaning set
forth in Section 3.1(rr). 
 “Sanctioned Entity” means (a) a country or a government of a country, (b) an
agency of the government of a country, (c) an organization directly or indirectly controlled by a country or its government, (d) a Person resident in or determined to be resident in a country, in each case, that is subject to a country
sanctions program administered and enforced by OFAC. 
 “Sanctioned Person” means a Person named on the list of specially
designated nationals maintained by OFAC. 
 “Sanctions” means all economic or financial sanctions or trade embargoes
imposed, administered or enforced from time to time by (a) the U.S. government, including those administered by OFAC or the U.S. Department of State, or (b) the United Nations Security Council, the European Union or Her Majesty’s
Treasury of the United Kingdom. 
 “Sarbanes-Oxley” has the meaning set forth in Section 3.1(kk). 

“Scheduled First Amortization Payment of First Out Waterfall Loans” has the meaning set forth in Section 2.3(a). 

“Scheduled Second Amortization Payment of First Out Waterfall Loans” has the meaning set forth in Section 2.3(a). 

“SDN List” has the meaning set forth in Section 3.1(jj). 

“SEC” means the United States Securities and Exchange Commission. 

  
 37 

 “SEC Documents” means all reports, schedules, forms, statements and other
documents filed by the Borrower with the SEC pursuant to the Securities Act or the Exchange Act since January 1, 2016 (including all financial statements and schedules included therein, all exhibits thereto and all documents incorporated by
reference therein). 
 “Second Amortization Date” has the meaning set forth in Section 2.3(a). 

“Secured Parties” means Agent, the Lenders and all Indemnified Persons. 

“Securities” means the Loans, the Notes, and the related guaranties set forth in the Security Agreement of the Guarantors,
the Interest Payment Shares, the Conversion Shares, the Warrants and the Warrant Shares. 
 “Securities Act” means the
Securities Act of 1933, as amended, including the rules and regulations promulgated thereunder. 
 “Security Agreement”
means the Amended and Restated Guaranty and Security Agreement executed and delivered on the Agreement Date pursuant to which the Loan Parties party thereto continue to grant to Agent for the benefit of the Secured Parties a security interest in all
of their Collateral to secure the Obligations, as amended, restated, supplemented or otherwise modified from time to time. 

“Solvent” means, with respect to any Person as of any date of determination, that, as of such date, (a) the value of the
assets of such Person at a “fair valuation” (as referenced in the Bankruptcy Code) is greater than the total amount of liabilities (including contingent and unliquidated liabilities) of such Person, (b) such Person is able to pay all
liabilities of such Person as such liabilities mature and (c) such Person does not have unreasonably small capital in relation to such Person’s business as contemplated as of the Agreement Date. In computing the amount of contingent or
unliquidated liabilities at any time, such liabilities shall be computed at the amount that, in light of all the facts and circumstances existing at such time, represents the amount that can reasonably be expected to become an actual or matured
liability. 
 “Stock” means (a) all shares of capital stock (whether denominated as common stock or preferred stock),
equity interests, beneficial, partnership or membership interests, joint venture interests, participations or other ownership or profit interests in or equivalents (regardless of how designated) of or in a Person (other than an individual), whether
voting or non-voting; and (b) all securities convertible into or exchangeable for any other Stock and all warrants, options or other rights (other than the 2.25% Convertible Notes, the 3.25% Convertible
Notes, any Permitted 3.25% Convertible Note Refinancing permitted hereunder, any Capped Call transactions, and the Warrants) to purchase, subscribe for or otherwise acquire any other Stock, whether or not presently convertible, exchangeable or
exercisable. 
 “Subordinated Debt” means any Indebtedness of the Loan Parties incurred pursuant to the terms of the
Subordinated Debt Documents and with the prior written consent of Agent, all of which documents must be in form and substance acceptable to Agent in its sole discretion. As of the Agreement Date, there is no Subordinated Debt. 

“Subordinated Debt Documents” means any documents evidencing and/or securing Indebtedness governed by a Subordination
Agreement, all of which documents must be in form and substance acceptable to Agent in its sole discretion. As of the Agreement Date, there are no Subordinated Debt Documents. 

“Subordination Agreement” means any agreement between Agent and another creditor of one or more Loan Parties, as the same may
be amended, supplemented, restated or otherwise modified from time to time in accordance with the terms thereof, pursuant to which the Indebtedness owing from any Loan 

  
 38 

 
Party or Loan Parties and/or the Liens securing such Indebtedness granted by any Loan Party or Loan Parties to such creditor are subordinated in any way to the Obligations and the Liens created
under the Security Agreement, the terms and provisions of such Subordination Agreements to have been agreed to by, and be acceptable to, Agent in the exercise of its sole discretion. 

“Subordination Provisions” has the meaning set forth in Section 5.4(v)(i). 

“Subsidiary” or “Subsidiaries” means, with respect to any Person, (a) any corporation of which an
aggregate of more than fifty percent (50%) of the outstanding capital stock having ordinary voting power to elect a majority of the board of directors of such corporation (irrespective of whether, at the time, capital stock of any other class or
classes of such corporation shall have or might have voting power by reason of the happening of any contingency) is at the time, directly or indirectly, owned legally or beneficially by such Person or one or more Subsidiaries of such Person, or with
respect to which any such Person has the right to vote or designate the vote of more than fifty percent (50%) of such capital stock whether by proxy, agreement, operation of law or otherwise, and (b) any partnership or limited liability company
in which such Person and/or one or more Subsidiaries of such Person shall have an interest (whether in the form of voting or participation in profits or capital contribution) of more than fifty percent (50%) or of which any such Person is a general
partner or may exercise the powers of a general partner. Unless the context otherwise requires, each reference to a Subsidiary shall be a reference to a Subsidiary of a Loan Party. 

“Successor Entity” has the meaning set forth in the definition of “Permitted Successor Transaction.” 

“Successor Entity Subsidiary Joinder Actions” has the meaning set forth in the definition of “EBITDA”. 

“Successor Entity Transaction” has the meaning set forth in the definition of “Permitted Successor Transaction.”

 “Swap Contract” means any agreement, contract or transaction that constitutes a “swap” within the meaning of
Section 1a(47) of the Commodity Exchange Act, not including Capped Calls. 
 “Tax Affiliate” means (a) the
Borrower and its Subsidiaries and (b) any Affiliate of the Borrower with which the Borrower files or is required to file consolidated, combined or unitary tax returns. 

“Taxes” means all present or future taxes, levies, imposts, stamp or other duties, deductions, charges or withholdings
imposed by an Governmental Authority, together with any interest, additions to tax, penalties or other Liabilities with respect thereto. 

“Tax Returns” has the meaning set forth in Section 3.1(p). 

“Third Party Obligation” has the meaning provided therefor in the definition of “Contingent Obligation.” 

“Third Party Payor” means Medicare, Medicaid, TRICARE, and other state or federal health care program, Blue Cross and/or Blue
Shield, private health care insurers and managed care organizations. 
 “Third Party Payor Programs” means all private or
governmental programs providing health care benefits, whether through insurance or otherwise, that are sponsored by a Third Party Payor. 

  
 39 

 “Title IV Plan” means an Employee Benefit Plan subject to Title IV of
ERISA, other than a Multiemployer Plan, to which any ERISA Affiliate incurs or otherwise has or could reasonably be expected to have any obligation or Liabilities (including under Section 4069 of ERISA). 

“Total Leverage Ratio” means, with respect to any measurement period, the ratio of (a) Indebtedness reflected as
liabilities on the Successor Entity’s most recent publicly reported balance sheet as of the last day of such measurement period to (b) EBITDA as of the last day for such measurement period; provided that, in each case of
clause (a) and clause (b), such amounts shall be limited to those incurred by the Successor Entity only (and not any of its Subsidiaries) unless such Subsidiaries (other than any Excluded Subsidiaries) have completed and consummated the
Successor Entity Subsidiary Joinder Actions. 
 “Trademarks” has the meaning set forth in the Security Agreement. 

“Trademark Security Agreement” means any trademark security agreement executed and delivered by any Loan Party to Agent, on
behalf of the Secured Parties, as the same may be amended, restated, supplemented or otherwise modified and in effect from time to time. 

“Trading Day” means any day on which the common Stock of the applicable Person is traded for at least six hours on a National
Securities Exchange. 
 “Transactions” means (a) the repayment of certain existing Indebtedness (including certain of
the 2.25% Convertible Notes and, in connection with any loans funded on the Prior Agreement Date under the Existing ABL Credit Facility or any other obligations outstanding on the Prior Agreement Date under the Existing ABL Credit Facility, all of
the Indebtedness and other obligations evidenced by the Existing ABL Credit Facility and the Existing ABL Debt Documents), (b) the funding of the Disbursements, and (c) the payment of fees, commissions, costs and expenses in connection with
each of the foregoing. 
 “TRICARE” means the program administered pursuant to 10 U.S.C. Section 1071 et seq.,
Sections 1320a-7 and 1320a-7a of Title 42 of the United States Code and the regulations promulgated pursuant to such statutes. 

“Trunk Inventory” means “trunk stock inventory” that is in the possession of sales personnel of the Loan Parties.

 “UCC” means the Uniform Commercial Code of any applicable jurisdiction and, if the applicable jurisdiction shall not
have any Uniform Commercial Code, the Uniform Commercial Code as in effect from time to time in the State of New York. 
 “United
States” and “U.S.” each means the United States of America. 
 “USA Patriot Act” means the
Uniting and Strengthening America by Providing Appropriate Tools Required to Intercept and Obstruct Terrorism Act of 2001, P.L. 107-56, as amended from time to time. 

“Volume Weighted Average Price” for any security as of any Trading Day means the volume weighted average sale price of such
security on the National Securities Exchange on which such security is listed as reported by Bloomberg Financial Markets or an equivalent, reliable reporting service reasonably selected by the Agent (“Bloomberg”). Volume Weighted
Average Price will be determined without regard to after-hours trading or any other trading outside of the regular trading hours. 

“Warrant Distributions” has the meaning set forth in Section 3.1(z). 

  
 40 

 “Warrants” means the Initial Warrants and the Additional Warrants. 

“Warrant Shares” has the meaning set forth in Section 3.1(z). 

Section 1.2 Interpretation. In this Agreement and the other Loan Documents, unless the context
otherwise requires, all words and personal pronouns relating thereto shall be read and construed as the number and gender of the party or parties requires and the verb shall be read and construed as agreeing with the required word and pronoun. The
division of this Agreement and the other Loan Documents into Articles and Sections and the use of headings and captions is for convenience of reference only and shall not modify or affect the interpretation or construction of this Agreement or any
of its provisions. The words “herein,” “hereof,” “hereunder,” “hereinafter” and “hereto” and words of similar import refer to this Agreement (or other applicable Loan Document) as a whole and not to
any particular Article or Section hereof (or thereof). The term “or” has, except where otherwise indicated, the inclusive meaning represented by the phrase “and/or.” The term “documents” and “agreements”
include any and all instruments, documents, agreements, certificates, indentures, notices and other writings, however evidenced. The use in any of the Loan Documents of the word “include” or “including,” when following any
general statement, term or matter, shall not be construed to limit such statement, term or matter to the specific items or matters set forth immediately following such word or to similar items or matters, whether or not non-limiting language (such as “without limitation” or “but not limited to” or words of similar import) is used with reference thereto, but rather shall be deemed to refer to all other items or
matters that fall within the broadest possible scope of such general statement, term or matter. References to a specified Article, Exhibit, Section or Schedule shall be construed as a reference to that specified Article, Exhibit, Section or Schedule
of this Agreement (or other applicable Loan Document). Unless specifically stated otherwise, any reference to any of the Loan Documents means such document as the same shall be amended, restated, supplemented or otherwise modified and from time to
time in effect. The references to “asset” (or “assets”) and “property” (or “properties”) in the Loan Documents are meant to be mean the same and are used throughout the Loan Documents interchangeably, and such
words shall be deemed to refer to any and all tangible and intangible assets and properties, including cash, securities, Stock, accounts and contract rights. Unless otherwise specified herein or therein, all terms defined in any Loan Document shall
have the defined meanings when used in any certificate or other document made or delivered pursuant hereto or thereto. The meanings of defined terms shall be equally applicable to the singular and plural forms of the defined terms. Terms (including
uncapitalized terms) not otherwise defined herein and that are defined in the UCC shall have the meanings therein described. In the computation of periods of time from a specified date to a later specified date, the word “from” means
“from and including”; the word “since” means “since and including”; the words “to” and “until” each mean “to but excluding,” and the word “through” means “to and
including.” If any provision of this Agreement or any other Loan Document refers to any action taken or to be taken by any Person, or which such Person is prohibited from taking, unless otherwise expressly stated, such provision shall be
interpreted to encompass any and all means, direct or indirect, of taking, or not taking, such action. References to any statute or regulation may be made by using either the common or public name thereof or a specific cite reference and, except as
otherwise provided with respect to FATCA, are to be construed as including all statutory and regulatory provisions related thereto or consolidating, amending, replacing, supplementing or interpreting the statute or regulation, and any reference to
any law or regulation, shall, unless otherwise specified, refer to such law or regulation as amended, modified or supplemented from time to time. Whenever any reference is made in any Loan Document to any Person such reference shall be construed to
include such Person’s permitted successors and permitted assigns. Any financial ratios required to be satisfied in order for a specific action to be permitted under any Loan Document shall be calculated by dividing the appropriate component by
the other component, carrying the result to one place more than the number of places by which such ratio is expressed herein or therein and rounding the result up or down to the nearest number (with a
rounding-up if there is no nearest number). Unless otherwise specified, all references in any Loan Document to times of day shall be references to New York City time. Notwithstanding anything to the contrary
in any Loan Document, any 

  
 41 

 
reference to “Organizational Document” or “Organizational Documents” of any Loan Party or any of its Subsidiaries in any Loan Document shall mean such written documents,
agreements and arrangements that are in effect on the Prior Agreement Date after giving effect to the Transactions occurring on the Prior Agreement Date that have been approved by Agent, without giving effect to any amendment, restatement, change,
supplement, waiver or other modification thereto or thereof that is not permitted by Section 5.2(x). The terms “shall” and “will” are used interchangeably in this Agreement and the other Loan Documents and mean for the Loan
Parties and their Subsidiaries to have an absolute obligation to perform or do (or not perform or do) a certain action or event, as the context may require. Any reference to “payment in full”, “paid in full”, “repaid in
full”, “prepaid in full”, “redeemed in full”, “no Obligations remain outstanding” or any other term or word of similar effect used in this Agreement or any other Loan Document with respect to the Loans or the
Obligations shall mean all Obligations (including any Non-Callable Make Whole Amount, any CoC Fee and the Exit Payment) (other than (y) unasserted contingent indemnification obligations and (z) those
Obligations under any Warrant or the Registration Rights Agreement that are not due or payable at the time when all other Obligations are paid in full in cash) have been repaid in full in cash, have been fully performed and no longer remain
outstanding. 
 Section 1.3 Business Day Adjustment. Except as otherwise expressly stated herein or
in any other Loan Document, if the day by which any payment or other performance is due to be made is not a Business Day, that payment or performance shall be made by the next succeeding Business Day unless that next succeeding Business Day falls in
a different calendar month, in which case that payment or other performance shall be made by the Business Day immediately preceding the day by which such payment or other performance is due to be made; provided that interest will continue to
accrue each additional day in connection therewith. 
 Section 1.4 Loan Records. 

(a) The Borrower shall record on its books and records the amount of the Loan, the type and tranche of the Loans (whether the Loan is a First
Out Waterfall Loan or a Last Out Waterfall Loan), the interest rate applicable thereto, all payments of principal and interest thereon and the principal balance thereof from time to time outstanding. 

(b) The Borrower shall establish and maintain at its address referred to in Section 6.1, a record of ownership (the
“Register”) in which the Borrower agrees to register by book entry the interests (including any rights to receive payment hereunder) of each Lender in the Loan (including whether the Lender is a First Out Waterfall Lender or a Last
Out Waterfall Lender and whether the Loan is a First Out Waterfall Loan or a Last Out Waterfall Lender), and any assignment of any such interest or interests. The Borrower shall maintain such Register in accordance with usual and customary business
practices and the Borrower shall record (1) the names and addresses of the Lenders (and any change thereto pursuant to this Agreement), (2) the amount of the Loan (and whether the amount of such Loan is related to a First Out Waterfall Loan or
a Last Out Waterfall Loan) and each funding of any participation therein, (3) the amount of any principal, interest, fee or other amount due and payable or paid, and (4) any other payment received by the Lenders from the Borrower and its
application to the Loan. 
 (c) The Loans made by each Lender are evidenced by this Agreement and the Loan Notes issued pursuant to the Prior
Facility Agreement. On the Agreement Date, the Borrower shall execute and deliver to (x) each First Out Waterfall Lender, a new First Out Waterfall Note and (y) each Last Out Waterfall Lender, a new Last Out Waterfall Note, and after the
Agreement Date the Borrower shall execute and deliver to each Lender (and/or, if applicable and if so requested by any assignee Lender pursuant to the assignment provisions of Section 6.5) on the date of request by such Lender an amended and
restated Loan Note or new Loan Note (which (i) if to a First Out Waterfall Lender, shall be substantially in the form of a First Out Waterfall Note attached hereto as Exhibit A-1, and (ii) if to
a Last Out Waterfall Lender, shall be 

  
 42 

 
substantially in the form of a Last Out Waterfall Note attached hereto as Exhibit A-2 (in each case, with any amendment and restatement mechanics
built in as necessary that are in form and substance reasonably satisfactory to such applicable Lender and the Agent)), in each case, payable to such Lender in an amount equal to the unpaid principal amount of the Loans held by such Lender (which,
at the request of such Lender shall be in the form of separate Loan Notes (taking into account the type and tranche of Loan) for separate or different parts of the Loans (taking into account the type and tranche of Loan) held by such Lender). For
the avoidance of doubt, each “Loan Note” (as defined in the Prior Facility Agreement) issued, executed and/or delivered by the Borrower prior to the Agreement Date remains valid, binding and enforceable against the Borrower and continues
to evidence and cover the Loans and other Obligations owed to such Lender that is the holder or beneficiary of such Loan Note and, effective on the Agreement Date, shall be deemed amended and restated to be in the form of the First Out Waterfall
Loan Note attached hereto as Exhibit A-1 (whether or not the new First Out Waterfall Loan Notes have then been delivered to the First Out Waterfall Lenders as required hereby). On and after the Agreement Date,
the principal of, and accrued and unpaid interest on, the First Out Waterfall Notes (and the First Out Waterfall Loans evidenced thereby) shall be convertible into shares of Common Stock as provided in the First Out Waterfall Notes. Notwithstanding
anything to the contrary contained in this Agreement, the Loans (including any Note(s) evidencing the Loans) are registered obligations, the right, title and interest of the Lenders and their successors and assignees in and to the Loan shall be
transferable only upon notation of such transfer in the Register and no assignment thereof shall be effective until recorded therein. This Section 1.4 shall be construed so that the Loan is at all times maintained in “registered form”
within the meaning of Sections 163(f), 871(h)(2) and 881(c)(2) of the Code. 
 (d) The Borrower, Agent and the Lenders shall treat each
Person whose name is recorded in the Register as a Lender for all purposes of this Agreement. Information contained in the Register with respect to any Lender shall be available for access by the Borrower, Agent or such Lender at any reasonable time
and from time to time upon reasonable prior notice, or when an Event of Default or Default exists, with just notice (whether reasonable or not) by Agent or any such Lender. 

Section 1.5 Accounting Terms and Principles. All accounting determinations required to be made pursuant
hereto shall, unless expressly otherwise provided herein, be made in accordance with GAAP. No change in the accounting principles used in the preparation of any financial statement hereafter adopted by the Borrower or its Subsidiaries (including,
with respect to GAAP, any change in GAAP that would require leases that would be classified as operating leases under GAAP on the Agreement Date to be reclassified as Capital Leases) shall be given effect for purposes of measuring compliance with
any provision of this Agreement or otherwise determining any relevant ratios and baskets which govern whether any action is permitted hereunder unless the Borrower and the Agent agree to modify such provisions to reflect such changes in GAAP, and
unless such provisions are modified, all financial statements and similar documents provided hereunder shall be provided together with a reconciliation between the calculations and amounts set forth therein before and after giving effect to such
changes in GAAP. Notwithstanding any other provision contained herein or in any other Loan Document, all terms of an accounting or financial nature used herein and in the other Loan Documents shall be construed, and all computations of amounts and
ratios referred to herein and in the other Loan Documents shall be made, without giving effect to any election under Statement of Financial Accounting Standards No. 159 (Codification of Accounting Standards
825-10) to value any Indebtedness or other liabilities of any Loan Party or any Subsidiary at “fair value,” as defined therein. 

Section 1.6 Tax Treatment. It is the intention and agreement of the Parties that the changes to the
Borrower’s existing indebtedness owed to the Lenders that are being effectuated pursuant to this Agreement shall be treated for federal income tax purposes as made pursuant to and as part of a plan of recapitalization and reorganization of the
Borrower described in Section 368(a)(1)(E) of the Code. The 

  
 43 

 
Parties shall prepare their income Tax Returns consistent with this treatment unless otherwise required by applicable federal income Tax law. 

Section 1.7 Officers. Any document, agreement or instrument delivered under the Loan Documents that is signed
by an Authorized Officer or another officer of a Loan Party shall be conclusively presumed to have been authorized by all necessary corporate, partnership and/or other action on the part of such Loan Party and such Authorized Officer or other
officer shall be conclusively presumed to have acted on behalf of such Loan Party in such person’s capacity as an officer of such Loan Party and not in any individual capacity. 

Section 1.8 Joint Drafting and Negotiation. The parties hereto have participated jointly in the negotiation
and drafting of this Agreement. In the event an ambiguity or question or intent or interpretation arises, this Agreement shall be construed as if drafted jointly by the parties hereto and no presumption or burden of proof shall arise favoring or
disfavoring any party by virtue of the authorship of any provisions of this Agreement. 
 ARTICLE 2 

AGREEMENT FOR THE LOANS 

Section 2.1 Use of Proceeds. The proceeds of the Disbursements were or will be used solely (i) to
refinance certain of the existing Indebtedness (including a certain amount of the existing 2.25% Convertible Notes), (ii) to provide funds for the Borrower’s working capital and general corporate purposes, and (iii) to pay a portion of the
fees, costs and expenses related to the Prior Facility Agreement and this Agreement. 
 Section 2.2 Disbursements. 

(a) The Disbursements. 

(i) Subject to the terms and conditions of the Prior Facility Agreement and this Agreement and in reliance on the
representations and warranties in the Prior Loan Documents and the Loan Documents, the First Out Waterfall Lenders (or its predecessors) on the Prior Agreement Date severally and not jointly advanced to the Borrower on such date, the principal
amount set forth opposite such First Out Waterfall Lender’s (or its predecessors) name in Annex A of the Prior Facility Agreement under the heading “Disbursement Amount” appearing therein (such advances and loans, the “First
Out Waterfall Loan”). Amounts borrowed under Section 2.2(a) of the Prior Facility Agreement (and/or mentioned in this Section 2.2(a)(i)) are referred to as the “First Out Waterfall Disbursement.” 

(ii) In reliance on the representations and warranties, conditions and terms in this Agreement and the other Loan Documents,
the Last Out Waterfall Lender on the Agreement Date hereby exchanges its Exchanged Deerfield Convertible Notes for a loan under this Agreement in the principal amount set forth opposite the Last Out Waterfall Lender’s name in Annex A of
this Agreement under the heading “Last Out Waterfall Loan Commitment” appearing therein (such loan, the “Last Out Waterfall Loan”). The amount of the Last Out Waterfall Loan is also referred to as the “Last Out
Waterfall Disbursement” (together with the First Out Waterfall Disbursement, the “Disbursements”). 

  
 44 

 (b) No Re-Borrowing of Disbursements or Loans.
Any Loans or Disbursements which are paid, repaid, prepaid or redeemed may not be re-borrowed under any circumstance. 

Section 2.3 Payments; Prepayments; No Call; Non-Callable Make Whole Amount; First Out
Waterfall Note Conversions. 
 (a) The Borrower shall pay in cash on the earliest of (i)(A) the dates set forth in the second column
of the table below, to each of the First Out Waterfall Lenders, based on their First Out Waterfall Pro Rata Share of the outstanding principal amount of the First Out Waterfall Loans and their pro rata share of all other First Out Waterfall
Obligations, in the amounts set forth in the second column of the table below and (B) the dates set forth in the third column of the table below, to each of the Last Out Waterfall Lenders, based on their Last Out Waterfall Pro Rata Share of the
outstanding principal amount of the Last Out Waterfall Loans and their pro rata share of all other Last Out Waterfall Obligations, in the amounts set forth in the third column of the table below (in each case of clause (A)(i) and
clause (A)(ii) above, as such installments may hereafter be adjusted as a result of prepayments made pursuant to this Section 2.3 with the application of any such prepayment being applied and adjusted as set forth in Section 2.3(e)),
(ii) the date the principal amount of the Obligations are declared to be or automatically becomes due and payable following an Event of Default, to each of the Lenders, based on the application set forth in Section 2.3(d), all of the
outstanding Obligations (other than (y) unasserted contingent indemnification obligations and (z) those Obligations under any Warrant or the Registration Rights Agreement that are not due or payable at the time when all other Obligations
are paid in full in cash) , and (iii) on the date provided for in Section 5.3, to each of the Lenders, based on the application set forth in Section 2.3(d), all of the outstanding Obligations (other than (y) unasserted contingent
indemnification obligations and (z) those Obligations under any Warrant or the Registration Rights Agreement that are not due or payable at the time when all other Obligations are paid in full in cash): 

 

					
	 Payment Dates
	  	 Principal Amortization

Payment of First Out Waterfall Loan
	  	 Principal Amortization Payment

of Last Out Waterfall Loan

	April 2, 2021 (the “First Amortization Date”)	  	One-third (1/3rd) of the principal amount of all the First Out Waterfall Loans as of the First Amortization Date after taking into account the PIK Interest Payments added to the
principal of the First Out Waterfall Loans on or before the First Amortization Date (such payment of First Out Waterfall Loans, the “Scheduled First Amortization Payment of First Out Waterfall Loans”)	  	$0
			
	April 2, 2022 (the “Second Amortization Date”)	  	One-half (1/2) of the principal amount of all the First Out Waterfall Loans as of the Second Amortization Date after taking into account the PIK Interest Payments added to the
principal of the First Out Waterfall Loans (including any prior cash payment of the PIK Interest Payments on the First Out Waterfall Loans made as part of the Scheduled First Amortization Payment of First Out Waterfall Loans) on or before the	  	One-half (1/2) of the principal amount of all the Last Out Waterfall Loans as of the Second Amortization Date after taking into account the PIK Interest Payments added to the
principal of the Last Out Waterfall Loans on or before the Second Amortization Date

  
 45 

					
		  	 Second Amortization Date (such payment of First Out Waterfall Loans, the “Scheduled Second Amortization Payment of
First Out Waterfall Loans”)
  
	  	
			
	Maturity Date	  	All remaining outstanding principal amounts of the First Out Waterfall Loans as of the Maturity Date after taking into account the PIK Interest Payments added to the principal of the First Out Waterfall Loans on or
before the Maturity Date (such payment of First Out Waterfall Loans, the “Maturity Date Payment of First Out Waterfall Loans”), or such lesser outstanding amount of the First Out Waterfall Loans, plus all other First Out Waterfall
Obligations outstanding as of the Maturity Date (other than (y) unasserted contingent indemnification obligations and (z) those First Out Waterfall Obligations under any Warrant or the Registration Rights Agreement that are not due or
payable at the time when all other First Lien Waterfall Obligations are paid in full in cash)	  	All remaining outstanding principal amounts of the Last Out Waterfall Loans as of the Maturity Date after taking into account the PIK Interest Payments added to the principal of the Last Out Waterfall Loans on or
before the Maturity Date, plus all other Last Out Waterfall Obligations outstanding as of the Maturity Date (other than unasserted contingent indemnification obligations)

 (b) Any First Out Waterfall Lender which is also a holder of Warrants may, at such First Out Waterfall
Lender’s sole option, in accordance with Section 3(a)(iii) of the applicable Warrant, pay the Exercise Price (as defined in the applicable Warrant) by reducing the principal amount of such First Out Waterfall Lender’s First Out
Waterfall Loans in an amount equal to such Exercise Price, which reduction shall be applied as set forth in Section 2.3(f). For the avoidance of doubt, this Section 2.3(b) is not applicable (and not available) to any Last Out Waterfall
Notes or Last Out Waterfall Loans. 
 (c) Notwithstanding anything to the contrary in any of the Loan Documents, outstanding principal
amounts on the Loans shall not be permitted to be prepaid, repaid, redeemed or paid prior to the First Amortization Date except solely as required or permitted by Section 5.3 or otherwise as set forth in this Section 2.3(c). If any
principal on Loans are prepaid, repaid, redeemed or paid (A) prior to the First Amortization Date for any reason (such as an acceleration of the Loans following the occurrence of an Event of Default, an exercise of any Secured Party’s
rights or remedies available under the Loan Documents, an exercise of any rights or remedies by ABL Agent, an ABL Lender or any other party to the ABL Debt Documents, upon the consummation of a Change of Control, pursuant to Section 5.3, by any
optional prepayment or otherwise), then the amount (in addition to the principal amount of the Loans and any accrued and unpaid interest owed thereon) required to be prepaid, repaid, redeemed or paid shall be the
Non-Callable Make Whole Amount applicable to the principal amount of Loans so prepaid, repaid, redeemed or paid (plus, if In Connection with a Change of Control, the CoC Fee) or (B) on or
after the First Amortization Date but prior to the Maturity Date, In Connection with a Change of Control, then the amount (in addition to the principal amount of the Loans and any accrued and unpaid interest owed thereon) required to be prepaid,
repaid, redeemed or paid shall be the CoC Fee. The Non-Callable Make Whole Amount (together with any applicable CoC Fee) shall be paid by the Borrower to the Lenders based on their Pro Rata Share of the
principal amount of the Loans on the date of such prepayment, repayment, redemption or payment. The Parties acknowledge and agree that, in light of the impracticality and extreme 

  
 46 

 
difficulty of ascertaining actual damages, the Non-Callable Make Whole Amount and any CoC Fee are intended to be a reasonable calculation of the actual
damages that would be suffered by the Secured Parties as a result of any such prepayment, repayment, redemption or payment. The parties hereto further acknowledge and agree that the Non-Callable Make Whole
Amount and the CoC Fee are not intended to act as a penalty or to punish the Borrower for any such prepayment, repayment, redemption or payment. For the avoidance of doubt, other than as set forth above in clause (B) in the second sentence of
this Section 2.3(c), prepayments of the Loans made on or after the First Amortization Date, in whole or in part, are permitted and may be made without premium or penalty. 

(d) Each prepayment, repayment, redemption and payment by the Borrower or any Loan Party (and all proceeds of Collateral) shall be applied as
follows: 
 (i) So long as no Application Event has occurred and in continuing, to (A)(1) all principal amortization
payments of the Loans shall be paid as set forth in Section 2.3(a) and (2) all other principal prepayments, repayments, redemptions and payments and all interest payments shall be paid by the Borrower and the other Loan Parties (and any
such amounts received by Agent shall be apportioned) ratably among the Secured Parties (according to the unpaid principal balance of the principal and interest to which such payments relate held by each Secured Party) and (B) all payments of
fees, expenses and other Obligations (that, for the avoidance of doubt, are not covered in clause (A) above) shall be paid by the Borrower and the other Loan Parties (and any such amounts received by Agent shall be apportioned), other than such
fees, expenses or other Obligations that are, based on the express terms of the Loan Documents, for a Secured Party’s separate account, ratably among the Secured Parties having a Pro Rata Share of the type of Obligation to which such a
particular fee, expense or other Obligation relates. All payments to be made hereunder by the Borrower or the other Loan Parties shall be remitted to the Lenders (other than amounts owed specifically to Agent or such other Secured Party) and all
such payments, and all proceeds of Collateral paid by the Borrower or any other Loan Party to the Lenders or received by Agent (or any other Secured Party), shall be applied, so long as no Application Event has occurred and is continuing, to reduce
the balance of the Loans and other Obligations outstanding. 
 (ii) At any time that an Application Event has occurred and is
continuing, as follows: (i) first, to all fees, costs and expenses (including any attorneys’ fees) owed to Agent under the Loan Documents, (ii) second, ratably to all fees, costs and expenses (including any attorneys’ fees) owed
to any First Out Waterfall Lender under the Loan Documents, (iii) third, ratably to accrued and unpaid interest owed to the First Out Waterfall Lenders under the Loan Documents, (iv) fourth, ratably to the principal amount of the Loans
(including any Non-Callable Make Whole Amount, any CoC Fee and the First Out Waterfall Loan Exit Payment, if applicable) owed to the First Out Waterfall Lenders, (v) fifth, ratably to all other First Out
Obligations (other than any First Out Obligations in respect of any Warrant or the Registration Rights Agreement that are not at such time owing, due or unpaid) owing to Agent or the other First Out Waterfall Secured Parties, and with respect to any
such First Out Waterfall Obligations owed to Agent and the other First Out Waterfall Secured Parties, shall be allocated ratably among Agent and the other First Out Waterfall Secured Parties based on their pro rata share of such other First Out
Waterfall Secured Parties, (vi) sixth, ratably to all fees, costs and expenses (including any attorneys’ fees) owed to any Last Out Waterfall Lender under the Loan Documents, (vii) seventh, ratably to accrued and unpaid interest owed
to the Last Out Waterfall Lenders under the Loan Documents, (viii) eighth, ratably to the principal amount of the Loans (including any Non-Callable Make Whole Amount and any CoC Fee, if applicable) owed

  
 47 

 
to the Last Out Waterfall Lenders, and (ix) ninth, ratably, to all other Last Out Waterfall Obligations owing to any Last Out Waterfall Secured Party, and, with respect to any such Last Out
Waterfall Obligations owed to the Last Out Waterfall Secured Parties, shall be allocated ratably among the Last Out Waterfall Secured Parties based on their pro rata share of such other Last Out Waterfall Obligations. With respect to any
prepayments, repayments, redemptions, payments or distributions in cash, property or other assets that any Last Out Waterfall Lender pays over to Agent or any First Out Waterfall Lender under the terms of this Agreement, such Last Out Waterfall
Lender will be subrogated to the rights of First Out Waterfall Lenders; provided, that no Last Out Waterfall Lender may assert or enforce any such rights of subrogation it may acquire as a result of any prepayment, repayment, redemption,
payment or distribution hereunder until all First Out Waterfall Obligations (other than (y) unasserted contingent indemnification obligations and (z) those First Out Waterfall Obligations under any Warrant or the Registration Rights
Agreement) have been paid in full in cash. Each Last Out Waterfall Lender agrees that any prepayments, repayments, redemptions, payments or distributions in respect of the Last Out Waterfall Obligations received by such Last Out Waterfall Lender in
violation of this Agreement shall be as promptly as practicable paid over to Agent, for the benefit of the First Out Waterfall First Out Waterfall Lenders, in respect of the First Out Waterfall Obligations, in the same form as received, with any
necessary endorsements, to be applied in accordance with this Agreement, and each Last Out Waterfall Lender hereby authorizes Agent to make any such endorsements as agent for the Last Out Waterfall Lenders (which authorization, being coupled with an
interest, is irrevocable). 
 (e) Any principal of any Loan that is prepaid, repaid, redeemed or paid pursuant to Section 2.3(c) or
Section 5.3 shall be applied to the scheduled principal payments of the Loans in the inverse order of maturity. 
 (f) (i) From and
after the Agreement Date, any conversion of principal under a First Out Waterfall Note by any First Out Waterfall Lender or payment by any First Out Waterfall Lender of the Exercise Price of any Warrant by reducing the principal amount of such First
Out Waterfall Lender’s First Out Waterfall Loan in an amount equal to such Exercise Price, shall be applied against, and reduce, the Scheduled First Amortization Payment of First Out Waterfall Loans that is owed to such First Out Waterfall
Lender until the earlier of (A) the time the Scheduled First Amortization Payment of First Out Waterfall Loans that is owed to such converting or exercising First Out Waterfall Lender(s) has been satisfied in full through conversions thereof
and/or payments of the Exercise Price of Warrants, and (B) 5:00 p.m. (New York City time) on the Trading Day immediately preceding the First Amortization Date; (ii) from and after the earlier of the time set forth in clauses (i)(A) and
(i)(B) above, any conversions of principal under a First Out Waterfall Note issued to any such converting First Out Waterfall Lender or payment by any First Out Waterfall Lender of the Exercise Price of any Warrant by reducing the principal amount
of such First Out Waterfall Lender’s First Out Waterfall Loan in an amount equal to such Exercise Price shall be applied against, and reduce, the Scheduled Second Amortization Payment of First Out Waterfall Loans owed to such First Out
Waterfall Lender until the earliest of (A) the time that an aggregate of $60,000,000 has been applied against, and reduced, the Scheduled Amortization Payments pursuant to this clause (ii) and clause (i) above, (B) the time the
Scheduled Second Amortization Payment of First Out Waterfall Loans that is owed to such converting or exercising First Out Waterfall Lender(s) has been satisfied in full through conversions thereof and/or payments of the Exercise Price of Warrants,
and (C) 5:00 p.m. (New York City time) on the Trading Day immediately preceding the Second Amortization Date; and (iii) from and after the earliest of the times set forth in clauses (ii)(A) and (ii)(B) above,
one-half (50%) of any conversion of principal under a First Out Waterfall Note issued to any such converting First Out Waterfall Lender or payment by any First Out Waterfall Lender of the Exercise Price of any
Warrant by reducing the principal amount of such First Out Waterfall Lender’s First Out Waterfall Loan in an amount equal to such Exercise 

  
 48 

 
Price shall be applied against, and reduce, the Scheduled Second Amortization Payment owed to such converting or exercising First Out Waterfall Lender and the other half (50%) shall be applied
against, and reduce, the principal amount payable on the Maturity Date to such converting or exercising First Out Waterfall Lender, until the earlier of (X) the time the Scheduled Second Amortization Payment owed to such converting or
exercising First Out Waterfall Lenders has been satisfied in full through conversions thereof and/or payments of the Exercise Price of Warrants, and (Y) 5:00 p.m. (New York City time) on the Trading Day immediately preceding the Second Amortization
Date; and (iii) thereafter, any conversion of principal under the First Out Waterfall Notes issued to such converting First Out Waterfall Lender(s) or payment by any First Out Waterfall Lender of the Exercise Price of any Warrant by reducing
the principal amount of such First Out Waterfall Lender’s First Out Waterfall Loan in an amount equal to such Exercise Price shall be applied against, and reduce, the principal amount due and payable on the Maturity Date to such converting or
exercising First Out Waterfall Lender . Each Lender and the Borrower acknowledges and agrees that, following the date hereof, to the extent any conversion of any First Out Waterfall Note issued to a converting First Out Waterfall Lender or payment
by any First Out Waterfall Lender of the Exercise Price of any Warrant by reducing the principal amount of such First Out Waterfall Lender’s First Out Waterfall Loan in an amount equal to such Exercise Price reduces the principal payment due
and payable on any date to such converting or exercising First Out Waterfall Lender, such reduction shall be applied to the portion of such payment due under the applicable First Out Waterfall Notes held by each of the converting First Out Waterfall
Lender on a pro rata basis in accordance with each such converting First Out Waterfall Lender’s First Out Waterfall Lender Percentage with respect to the First Out Waterfall Notes. For the avoidance of doubt, this Section 2.3(f) is not
applicable (and not available) to any Last Out Waterfall Notes or Last Out Waterfall Loans. 
 Section 2.4
Payment Details. All payments of the Obligations by the Borrower hereunder and under any of the other Loan Documents shall be made without setoff or counterclaim and shall be paid in cash in Dollars. Payments of any amounts and other
Obligations due to Agent or the Lenders under this Agreement or the other Loan Documents shall be made in Dollars in immediately available funds prior to 2:00 p.m. (New York City time) on such date that any such payment is due, using such wire
information or address for Agent or such applicable Lender that is set forth on Schedule 2.4 or at such other bank or place as Agent or such applicable Lenders shall from time to time designate in a writing delivered to the Borrower at least five
(5) Business Days prior to the date such payment is due. The Borrower shall pay all and any fees, costs and expenses (administrative or otherwise) imposed by banks, clearing houses or any other financial institutions in connection with making
any payments under any of the Loan Documents. 
 Section 2.5 Taxes. 

(a) Any and all payments on account of any Obligation of a Loan Party hereunder or under any other Loan Document (in each case in this
Section 2.5, for the avoidance of doubt, not including Obligations in respect of any Warrant or the Registration Rights Agreement) shall be made, in accordance with this Section 2.5, free and clear of and without deduction or withholding
for any and all present or future Taxes except as required by Applicable Law. If any Loan Party shall be required by Applicable Law to deduct or withhold any Taxes from or in respect of any sum payable hereunder or under any other Loan Document,
(i) such Loan Party shall make such deduction or withholding, (ii) such Loan Party shall pay the full amount deducted or withheld to the relevant Governmental Authority in accordance with Applicable Law, and (iii) to the extent that
the deduction or withholding is made on account of Indemnified Taxes, the sum payable by the applicable Loan Party shall be increased by as much as shall be necessary so that after making the required deduction or withholding (including deductions
or withholdings applicable to additional sums payable under this Section 2.5), each Lender shall receive an amount equal to the sum it would have received had no such deduction or withholding been made (any and all such additional amounts
payable shall hereafter be referred to as the “Additional Amounts”). Within thirty (30) days after the date of any payment of such Taxes, the Borrower shall furnish to the applicable Lender the original or a certified

  
 49 

 
copy of a receipt evidencing payment thereof or other evidence of such payment reasonably satisfactory to such Lender. 

(b) In addition, the Loan Parties agree to pay and authorize each Lender to pay in their name, all Other Taxes. Within 30 days after the date
of any payment of Other Taxes by any Loan Party, the Borrower shall furnish to the applicable Lender the original or a certified copy of a receipt evidencing payment thereof or other evidence of such payment reasonably satisfactory to such Lender.

 (c) The Borrower shall reimburse and indemnify, within ten (10) days after receipt of demand therefor, each Lender for all
Indemnified Taxes (including all Indemnified Taxes imposed on amounts payable under this Section 2.5(c)) paid or payable by such Lender, whether or not such Indemnified Taxes were correctly or legally asserted. A certificate of the applicable
Lender(s) setting forth the amounts to be paid thereunder and delivered to the Borrower shall be conclusive, absent manifest error. 
 (d)
Any Lender that is entitled to an exemption from or reduction of withholding Tax with respect to payments made under any Loan Document shall deliver to the Borrower and the Agent, at the time or times reasonably requested by the Borrower or the
Agent, such properly completed and executed documentation reasonably requested by the Borrower or the Agent as will permit such payments to be made without withholding or at a reduced rate of withholding. In addition, any Lender, if reasonably
requested by the Borrower or the Agent, shall deliver such other documentation prescribed by Applicable Law. Notwithstanding anything to the contrary in the preceding sentence, the completion, execution and submission of such documentation (other
than such documentation set forth below in this Section 2.5(d)) shall not be required if in the Lender’s good faith judgment such completion, execution or submission would subject such Lender to any material unreimbursed cost or expense or
would materially prejudice the legal or commercial position of such Lender. Without limiting the generality of the foregoing each Lender that is a United States person (as such term is defined in Section 7701(a)(30) of the Code) shall, on or
before the date on which the Lender becomes a party to this Agreement, provide to Borrower and the Agent a properly completed and executed IRS Form W-9 certifying that such Lender is not subject to backup
withholding tax. Each Lender that is not a United States person (as such term is defined in Section 7701(a)(30) of the Code) (a “Foreign Lender”) and is entitled to an exemption from or reduction of U.S. federal withholding tax
with respect to payments under this Agreement shall, on or before the date on which such Lender becomes a party to this Agreement, provide Borrower and the Agent with a properly completed and executed IRS Form
W-8ECI, W-8BEN-E, W-8IMY (with proper attachments) or other applicable forms or any other
applicable certificate or document reasonably requested by the Borrower or the Agent and prescribed by Applicable Law as a basis for claiming exemption from or a reduction in U.S. federal withholding Tax, duly completed, together with such
supplementary documentation as may be prescribed by Applicable Law to permit the Borrower to determine the withholding or deduction required to be made and, if such Foreign Lender is relying on the portfolio interest exception of Section 871(h)
or Section 881(c) of the Code (or any successor provision thereto), shall also provide the Borrower with a certificate (the “Portfolio Interest Certificate”) representing that such Foreign Lender is not a “bank” for
purposes of Section 881(c) of the Code (or any successor provision thereto), is not a 10% holder of the Borrower described in Section 871(h)(3)(B) of the Code (or any successor provision thereto), and is not a controlled foreign
corporation receiving interest from a related person (within the meaning of Sections 881(c)(3)(C) and 864(d)(4) of the Code or any successor provisions thereto). If the Foreign Lender is a partnership and one or more direct or indirect partners of
such Foreign Lender are claiming the portfolio interest exemption, such Foreign Lender may provide a Portfolio Interest Certificate on behalf of such partners. Each Lender shall provide new forms (or successor forms) as reasonably requested by the
Borrower or the Agent from time to time and shall notify the Borrower and the Agent in writing within a reasonable time after becoming aware of any event requiring a change in the most recent forms previously delivered by such Lender to the Borrower
or the Agent. 

  
 50 

 (e) If a payment to a Lender under this Agreement would be subject to U.S. federal
withholding tax imposed by FATCA if such Lender were to fail to comply with the applicable reporting requirements of FATCA, such Lender shall deliver to the Borrower, at the times prescribed by law or as reasonably requested by Borrower or the
Agent, such documentation as is required in order for the Borrower or the Agent to comply with its obligations under FATCA, to determine that such Lender has or has not complied with its obligations under FATCA or to determine the amount to deduct
and withhold from such payment. Solely for purposes of this Section 2.5(e), “FATCA” shall include any amendments made to FATCA after the Agreement Date. 

(f) If a Lender determines, in its sole discretion exercised in good faith, that it has received a refund of any Indemnified Taxes as to which
it has been indemnified pursuant to this Section 2.5 (including all Indemnified Taxes imposed on amounts payable under Section 2.5(c)), such Lender shall promptly pay such refund (but only to the extent of indemnity payments made under
this Section 2.5 with respect to the Taxes refunded) to the Borrower, net of all out-of-pocket expense (including any Taxes imposed thereon) of such Lender incurred
in obtaining such refund or making such payment, provided that the Borrower, upon the request of such Lender, agrees to repay the amount paid over to the Borrower (plus any penalties, interest or other charges imposed by the relevant Governmental
Authority) to such Lender if such Lender is required to repay such refund to such Governmental Authority. Notwithstanding anything to the contrary in this Section 2.5(f), in no event shall a Lender be required to pay any amount to the Borrower
pursuant to this Section 2.5(f), the payment of which would place such Lender in a less favorable net after-Tax position than such Lender would have been in if the Tax subject to indemnification and
giving rise to such refund had not been deducted or otherwise imposed and the indemnification payments with respect to such Tax had never been paid. Nothing in this Section 2.5(f) shall require any Lender to disclose any information it deems
confidential (including its tax returns) to any Person, including the Borrower. 
 Section 2.6 Interest. 

(a) From (and including) and after the Prior Agreement Date, the outstanding principal amount of the Loans and any overdue interest shall bear
interest at the Interest Rate (calculated on the basis of a 360-day year for the actual number of days elapsed in each month). From (and including) the Prior Agreement Date until (but not including) the
Agreement Date, interest with respect to the Interest Rate shall be paid in cash to the Lenders quarterly in arrears for the preceding calendar quarter on the on the first Business Day of each calendar quarter, whether by acceleration or otherwise,
commencing on July 1, 2017 and on the first Business Day of each October, January, April and July thereafter through and including the calendar quarter commencing October 1, 2018. From (and including) and after the Agreement Date, interest
with respect to the Cash Interest Rate (which, for the avoidance of doubt, does not include any interest mentioned in the immediately preceding sentence) shall be paid in cash to the Lenders quarterly in arrears for the preceding calendar quarter on
the first Business Day of each calendar quarter, whether by acceleration or otherwise, commencing on July 1, 2017 and on the first Business Day of each October, January, April and July thereafter, and on the maturity (and on any date of
prepayment, repayment, redemption or payment of the principal) of the Loans (each, an “Interest Payment Date”); provided, however, from and after the Agreement Date, that in lieu of making any payment of interest with respect to the
Cash Interest Rate in cash on an Interest Payment Date pursuant to this Section 2.6 (but not interest payable (x) pursuant to the immediately preceding sentence, (y) pursuant to Section 2.7 and (z) with respect to the PIK
Interest Rate) and subject to the conditions set forth in Exhibit 2.6, the Borrower may elect to satisfy all or any part of such payment with respect to First Out Waterfall Loans only (and, for the avoidance of doubt, not any Last Out Waterfall
Loans) by the issuance to the First Out Waterfall Lenders of shares of Freely Tradable Common Shares (as defined in Exhibit 2.6) in accordance with the provisions of Exhibit 2.6; provided that, not later than the first Business Day prior to the
applicable Interest Payment Date, the Borrower shall provide written notice to the Agent of the amount of such payment satisfied pursuant to Exhibit 2.6. From (and including) and after the Agreement Date, interest with respect

  
 51 

 
to the PIK Interest Rate shall be paid in-kind on each Interest Payment Date (which, for the avoidance of doubt, does not include any interest mentioned in
the second sentence of this Section 2.6(a)) by increasing the principal amount of the Loans by an amount equal to the interest that has accrued at the PIK Interest Rate during such period (such payment, a “PIK Interest
Payment”). Following an increase in the principal amount of the Loans as a result of a PIK Interest Payment, the Loans will bear interest at the Interest Rate on such increased principal amount from and after the date of such PIK Interest
Payment and such increased principal amount shall constitute “Obligations”. 
 (b) [Reserved]. 

(c) All interest, fees and other amounts under each Loan Document shall be calculated on the basis of a
360-day year for the actual number of days elapsed. 
 Section 2.7
Yield Enhancement Payment; Default Interest; CoC Fee; Exit Payment. 
 (a) On the Prior Agreement Date, the Borrower
paid in cash in Dollars to such First Out Waterfall Lender (as such First Out Waterfall Lender funding such First Out Waterfall Disbursement directed) a yield enhancement payment in the amount of two and twenty-fifths of one hundred percent (2.25%)
of the principal amount of such First Out Waterfall Disbursement funded by such First Out Waterfall Lender on the Prior Agreement Date as consideration for providing such First Out Waterfall Disbursement, and such payment, at the sole option of the
applicable Lender, was able to be deducted from such First Out Waterfall Disbursement. Such payment was fully earned when it was paid (or when it was deducted from such First Out Waterfall Disbursement) and is not and shall not be refundable for any
reason whatsoever. 
 (b) At the election (which upon such election, to the extent permitted by Applicable Law, such additional interest rate
shall retroactively apply to the first day of existence of such Event of Default) of Agent or the Required Lenders while any Event of Default exists (or automatically while any Event of Default under Section 5.4(a) or 5.4(d) exists), the
Borrower shall pay interest (after as well as before entry of judgment thereon to the extent permitted by Applicable Law) on the Obligations (other than Obligations under any Warrant or the Registration Rights Agreement) and past due interest
thereon, if any, from and after the date of occurrence of such Event of Default, at a rate per annum which is determined by adding (i) with respect to any Event of Default under Section 5.4(a), ten percent (10.0%) per annum to the
Interest Rate then in effect for the Loans and (ii) with respect to any other Event of Default, two percent (2%) per annum to the Interest Rate then in effect for the Loans. Such additional interest shall be payable in cash on demand. 

(c) Upon prepayment, repayment, redemption or payment of any principal of the Loans at any time (including, for the avoidance of doubt, before,
after and on the date of the First Amortization Date but excluding, for the avoidance of doubt, Loans paid in full on the Maturity Date) In Connection with a Change of Control, Borrower shall pay to the Secured Parties the CoC Fee (in addition to
any principal Obligations required to be paid pursuant to Section 5.3 and any applicable Non-Callable Make Whole Amount due pursuant to Section 2.3(c)) based on their Pro Rata Share of the principal
of the Loans on the date of such prepayment, repayment, redemption or payment of such Loans; provided, however that if such prepayment, repayment, redemption or payment is In Connection with a Change of Control but prior to the consummation of the
Change of Control, the CoC Fee shall be due and payable contemporaneously with the consummation of a Change of Control. The CoC Fee shall be non-refundable upon receiving payment thereof. The Parties
acknowledge and agree that, in light of the impracticality and extreme difficulty of ascertaining actual damages occurring In Connection with a Change of Control, the CoC Fee is intended to be a reasonable calculation of the actual damages that
would be suffered by the Secured Parties as a result of any such prepayment, repayment, redemption or payment. The parties hereto 

  
 52 

 
further acknowledge and agree that the CoC Fee is not intended to act as a penalty or to punish the Borrower for any such prepayment, repayment, redemption or payment. 

(d) Notwithstanding anything to the contrary in the Loan Documents, on the date when the remaining First Out Waterfall Loans outstanding are
paid, repaid, redeemed or prepaid (in each case, whether before, at the time of or after the Maturity Date or any acceleration, bankruptcy, insolvency or otherwise), in an amount that causes (or such lesser amount of outstanding First Out Waterfall
Loans that are so paid, repaid, redeemed or prepaid that the First Out Waterfall Lenders have agreed to cause) the principal amount of remaining First Out Waterfall Loans outstanding to be less than $10,000,000, the Borrower shall pay in cash at
such time to the First Out Waterfall Lenders (based on their First Out Waterfall Pro Rata Share of such First Out Waterfall Loans) a non-refundable exit payment (the “First Out Waterfall Loan Exit
Payment”) in a total amount equal to $5,000,000. The Parties acknowledge and agree that the Agent and the First Out Waterfall Lenders would not have entered into this Agreement and the other Loan Documents without the Borrower agreeing to
pay the First Out Waterfall Loan Exit Payment in the aforementioned instances. The Parties further acknowledge and agree that the First Out Waterfall Loan Exit Payment set forth in this Section 2.7(d) is not intended to act as a penalty or to
punish the Borrower or any other Loan Party for any such payment, repayment, redemption or prepayment. 
 (e) Notwithstanding anything to the
contrary in the Loan Documents, on the date when the remaining Last Out Waterfall Loans outstanding are paid, repaid, redeemed or prepaid (in each case, whether before, at the time of or after the Maturity Date or any acceleration, bankruptcy,
insolvency or otherwise), in an amount that causes (or such lesser amount of outstanding Last Out Waterfall Loans that are so paid, repaid, redeemed or prepaid that the Last Out Waterfall Lenders have agreed to cause) the principal amount of
remaining Last Out Waterfall Loans outstanding to be less than $10,000,000, the Borrower shall pay in cash at such time to the Last Out Waterfall Lenders (based on their Last Out Waterfall Pro Rata Share of such Last Out Waterfall Loans) a non-refundable exit payment (the “Last Out Waterfall Loan Exit Payment”) in a total amount equal to $1,113,750. The Parties acknowledge and agree that the Agent and the Last Out Waterfall Lenders
would not have entered into this Agreement and the other Loan Documents without the Borrower agreeing to pay the Last Out Waterfall Loan Exit Payment in the aforementioned instances. The Parties further acknowledge and agree that the Last Out
Waterfall Loan Exit Payment set forth in this Section 2.7(d) is not intended to act as a penalty or to punish the Borrower or any other Loan Party for any such payment, repayment, redemption or prepayment. 

Section 2.8 Delivery of Warrants. 

(a) On the Prior Agreement Date under the Prior Facility Agreement, the Borrower issued to the First Out Waterfall Lenders (or their
predecessors) warrants to purchase 6,470,000 shares of Common Stock at an Exercise Price of $9.23 per share (each as subject to any adjustments provided for therein), each in substantially in the form of Exhibit
C-1 attached hereto (as may be amended, restated, supplemented or otherwise modified from time to time, the “Initial Warrants”), with an expiration date of April 3, 2024. 

(b) [Reserved]. 
 (c) As of the
Agreement Date, the Initial Warrants are allocated among the First Out Waterfall Lenders as set forth on Annex A. 
 (d) On the Agreement
Date, the Borrower shall issue to the First Out Waterfall Lenders, based on such First Out Waterfall Lenders’ First Out Waterfall Pro Rata Share, warrants to purchase 8,750,000 shares of Common Stock at an Exercise Price of $4.71 per share
(each as subject to any adjustments provided for therein), each in substantially in the form of Exhibit C-2 attached hereto (as may 

  
 53 

 
be amended, restated, supplemented or otherwise modified from time to time, the “Additional Warrants”), with an expiration date of August 9, 2025 

(e) The Additional Warrants issued pursuant to Section 2.8(d) shall be allocated on the Agreement Date to the First Waterfall Lenders as
set forth on Annex A. 
 ARTICLE 3 

REPRESENTATIONS AND WARRANTIES 

Section 3.1 Representations and Warranties of the Loan Parties. The Loan Parties, jointly and
severally, represent and warrant (A) with respect to Section 3.1(g)(i)(B), the first two sentences of Section 3.1(i), Section 3.1(y), Section 3.1(z)(A) and (C), Section 3.1(ee), the first sentence of
Section 3.1(mm), Section 3.1(nn), Section 3.1(oo), Section 3.1(rr), Section 3.1(ss) and Section 3.1(tt), at all times, and (B) with respect to all other provisions of Section 3.1, (I) as of the Prior Agreement
Date (in the form and substance thereof in the Prior Facility Agreement) and the Agreement Date (if the form and substance of this Agreement) and (II) as of each date that this Agreement is amended or modified (or any date any consent or waiver
related to this Agreement is entered into or otherwise executed and delivered) in accordance with Section 6.6(b) (but with respect to any representation or warranty that speaks as of an earlier date, such representation and warranty shall
continue to speak only as of such earlier date): 
 (a) Each Loan Party is (i) conducting its business in compliance with its
Organizational Documents and (ii) not in violation of its Organizational Documents. Each Loan Party’s Organizational Documents are in full force and effect. 

(b) No Default or Event of Default has occurred or will result from the transactions contemplated by the Loan Documents. 

(c) Each Loan Party (i) is Solvent and (ii) has not taken action, and no such action has been taken by a third party, for its winding
up, dissolution or liquidation or similar executory or judicial proceeding or for the appointment of a liquidator, custodian, receiver, trustee, administrator or other similar officer for any Loan Party or any or all of its assets or revenues;
provided, however, that, for the avoidance of doubt, no such representation in this Section 3.1(c) is made in respect of any Immaterial Subsidiary. 

(d) No Lien exists on any Loan Party’s assets, except for Permitted Liens. 

(e) The obligation of the Loan Parties to make any payment under this Agreement or the other Loan Documents (together with all charges in
connection therewith) is absolute and unconditional. 
 (f) No Indebtedness of any Loan Party exists other than Permitted Indebtedness. 

(g) Each Loan Party is validly existing as a corporation, limited liability company or limited partnership, as applicable, and is in good
standing under the laws of the jurisdiction of its incorporation, organization or formation, as applicable. Each Loan Party (i) has full power and authority (and all governmental licenses, authorizations, Permits, consents and approvals) to
(A) own its properties and conduct its business (solely with respect to governmental licenses, authorizations, Permits, consents and approvals, except where the failure to have such governmental licenses, authorizations, Permits, consents and
approvals could not reasonably be expected, individually or in the aggregate, to result in a Material Adverse Effect) and (B) to (x) issue the Securities in accordance with the Loan Documents, (y) enter into, and perform its obligations
under, the Loan Documents, including the issuance of the Securities 

  
 54 

 
and the reservation for issuance of the Interest Payment Shares, the Conversion Shares and the Warrant Shares, and (z) consummate the transactions contemplated under the Loan Documents, and
(ii) is duly qualified as a foreign corporation, limited liability company or limited partnership, as applicable, and licensed and in good standing, under the laws of each jurisdiction where its ownership, lease or operation of property or the
conduct of its business requires such qualification or license, in each case of this clause (ii), where the failure to be so qualified, licensed or in good standing could reasonably be expected, individually or in the aggregate, to result in a
Material Adverse Effect. 
 (h) Other than as set forth on Schedule 3.1(h), there is no pending or, to the knowledge of the Loan Parties,
threatened, any action, suit or other proceeding before any Governmental Authority (i) to which any Loan Party is a party, (ii) which purports to affect or pertain to the Loan Documents, the Transactions or any other transaction
contemplated hereby or thereby or (iii) which has as the subject thereof any assets owned by any Loan Party or any of its Subsidiaries, in each case which could reasonably be expected to result in monetary judgments or relief, individually or
in the aggregate, in excess of $2,000,000. Other than as set forth on Schedule 3.1(h), there are no current or, to the knowledge of the Loan Parties, pending, legal actions, suits or other proceedings, in each case which could reasonably be expected
to result in monetary judgments or relief, individually or in the aggregate, in excess of $ 2,000,000, to which any Loan Party or any of its Subsidiaries or any of their respective assets is subject. With respect to each action, suit, proceeding,
claim, event or disclosure listed on Schedule 3.1(h), none of them could reasonably be expected, individually or in the aggregate, to result in a Material Adverse Effect. No injunction, writ, temporary restraining order or any order of any
nature has been issued by any court or other Governmental Authority purporting to enjoin or restrain the execution, delivery or performance of this Agreement or any other Loan Document or directing that the transactions provided for herein or
therein not be consummated as herein or therein provided. Other than as set forth on Schedule 3.1(h), none of the current directors (or equivalent persons) or current officers of the Borrower and its Subsidiaries has been involved as a defendant in
securities-related litigation or other securities-related legal proceedings during the past five years. 
 (i) The execution, delivery and
performance of each of this Agreement and the other Loan Documents, including the issuance of the Securities hereunder, has been, duly authorized by each Loan Party and no further consent or authorization is required by any Loan Party, any Loan
Party’s board of directors (or other equivalent governing body) or the holders of any Loan Party’s Stock. Each of this Agreement and the other Loan Documents has been duly executed and delivered by each of the Loan Parties and constitutes
a valid, legal and binding obligation of each Loan Party, enforceable in accordance with its respective terms, except as such enforceability may be limited by applicable insolvency, bankruptcy, reorganization, moratorium or other similar laws
affecting creditors’ rights generally. The execution, delivery and performance of this Agreement and the other Loan Documents by each Loan Party thereto and the consummation of the transactions (including the issuance of the Securities
hereunder and thereunder) contemplated herein and therein will not (A) conflict with or result in a breach or violation of any of the terms or provisions of, or constitute a default under, or result in the creation or imposition of any Lien
(other than pursuant to the Loan Documents) upon any assets of any such Loan Party pursuant to, any agreement, document or instrument to which such Loan Party is a party or by which any Loan Party is bound or to which any of the assets or property
of any Loan Party is subject, except, with respect to this clause (A), as could not reasonably be expected, individually or in the aggregate, to have a Material Adverse Effect, (B) result in any violation of or conflict with the provisions of
the Organizational Documents, (C) result in the violation of any Applicable Law, (D) result in the violation of any judgment, order, rule, regulation or decree of any Governmental Authority, or (E) violate, conflict with or cause a
breach or a default under any agreement or instrument binding upon it, except, with respect to clauses (C) and (E) only, as could not reasonably be expected, individually or in the aggregate, to have a Material Adverse Effect. No consent,
approval, Authorization or order of, or registration or filing with any Governmental Authority is required for (i) the execution, delivery and performance of this Agreement or 

  
 55 

 
any of the other Loan Documents, and the issuance of the Securities hereunder and thereunder, and (ii) the consummation by any Loan Party of the Transactions or the other transactions
contemplated hereby or thereby, except for (A) the filings necessary to perfect the Liens created by the applicable Loan Documents and (B) any necessary filings with the SEC. 

(j) Other than has been obtained, no Authorization is required for (i) the execution and delivery of this Agreement or the other Loan
Documents, or (ii) the consummation of the Transactions and the other transactions contemplated hereby and thereby, including (other than the Authorization set forth on Schedule 3.1(j)) the issuance and exercise of the Warrants. 

(k) Each Loan Party and its Subsidiaries are in compliance with Applicable Law except as could not reasonably be expected, individually or in
the aggregate, to have a Material Adverse Effect. 
 (l) Except as could not reasonably be expected, individually or in the aggregate, to
have a Material Adverse Effect, (i) (A) each Loan Party holds, and is operating in compliance in all material respects with, all franchises, grants, Authorizations, licenses, permits, easements, consents, certificates and orders of any
Governmental Authority (collectively, “Necessary Documents”) required for the conduct of its business and (B) all Necessary Documents are valid and in full force and effect and (ii) no Loan Party has (A) received
written notice of any revocation, non-renewal, amendment, expiration, suspension, limitation, withdrawal, cancellation or other modification of any of the Necessary Documents and (B) reason to believe
that any of the Necessary Documents will not be renewed in the ordinary course of business. 
 (m) As of the Agreement Date, the Real Estate
listed in Schedule 3.1(m) constitutes all of the Real Estate of each Loan Party and each of its Subsidiaries. Each Loan Party has good and marketable title to all of its assets and property free and clear of all Liens, except Permitted Liens. Except
as could not reasonably be expected, individually or in the aggregate, to have a Material Adverse Effect, the property held under lease by each Loan Party is held under valid, subsisting and enforceable leases with only such exceptions with respect
to any particular lease as do not interfere in any material respect with the conduct of the business of such Loan Party. 
 (n) Each Loan
Party (i) owns, or, to the knowledge of the Loan Parties and their Subsidiaries, has the right to use pursuant to a valid and enforceable written license, all IP, in each case (and without any knowledge qualifier applicable thereto) free and
clear of any Liens other than Permitted Licenses and Permitted Liens. All IP that is registered with or issued by a Governmental Authority that is currently in the name of a Loan Party is, to the knowledge of the Loan Parties and their Subsidiaries,
valid and enforceable. Each patent constituting a Material Intangible Asset is, to the knowledge of the Loan Parties and their Subsidiaries, valid and enforceable and no part of the Material Intangible Assets has been judged invalid or
unenforceable, in whole or in part; and, except as set forth on Schedule 3.1(n), there is no pending or, to the knowledge of the Loan Parties, threatened action, suit, other proceeding or claim by any Person challenging or contesting the
validity, ownership, or enforceability of any Material Intangible Asset, the use thereof by any Loan Party, or other rights of any Loan Party in or to any Material Intangible Asset, and no Loan Party has received any written notice regarding any
such action, suit, other proceeding or claim. With respect to each action, suit, proceeding, claim, challenge, contest, event and disclosure listed on Schedule 3.1(n), none of them could reasonably be expected, individually or in the aggregate,
to result in a Material Adverse Effect. Neither the conduct of the business of any Loan Party, nor any Loan Party, has infringed, misappropriated or otherwise violated, or is infringing, misappropriating or otherwise violating, any Intellectual
Property of any Person, except as could not reasonably be expected, individually or in the aggregate, to result in a Material Adverse Effect. Other than as set forth on Schedule 3.1(h), there is no pending or, to the knowledge of the Loan Parties,
threatened action, suit, other proceeding or claim by any 

  
 56 

 
Person alleging that any Loan Party is infringing, misappropriating or violating, or otherwise using without authorization, any Intellectual Property of any Person, and no Loan Party has received
any written notice regarding, any such action, suit, other proceeding or claim. With respect to each action, suit, proceeding, claim, event or disclosure listed on Schedule 3.1(h), none of them could reasonably be expected, individually or in
the aggregate, to result in a Material Adverse Effect. Other than as set forth in Section 3.b. of the Perfection Certificate dated as of (and delivered by the Loan Parties on) the Agreement Date, no Loan Party is a party to, or bound by, any
options, licenses, franchise or other agreements, written or oral, relating to trademarks, patents, copyrights, other know-how or IP (or granting any right, title or interest in or to any IP) that require
annual payments in excess of $25,000 individually. 
 (o) No Loan Party is, except as could not reasonably be expected, individually or in
the aggregate, to have a Material Adverse Effect, in breach of or otherwise in default under, and no event has occurred which, with notice or lapse of time or both, would constitute such breach or other default in the performance of any agreement or
condition contained in any agreement under which it may be bound, or to which any of its assets is subject. 
 (p) All U.S. federal, state
and local income and franchise and other material Tax returns, reports and statements (collectively, the “Tax Returns”) required to be filed by any Tax Affiliates have been filed with the appropriate Governmental Authorities, all
such Tax Returns are true and correct in all material respects, and all Taxes, assessments and other governmental charges and impositions reflected therein or otherwise due and payable have been paid prior to the date on which any material Liability
may be added thereto for non-payment thereof except for those contested in good faith by appropriate proceedings diligently conducted and for which adequate reserves are maintained on the books of the
appropriate Tax Affiliate in accordance with GAAP. As of the Agreement Date, no material Tax Return is under audit or examination by any Governmental Authority, and no Tax Affiliate has received written notice from any Governmental Authority of any
audit or examination or any assertion of any claim for material Taxes. To the extent material, proper and accurate amounts have been withheld by each Tax Affiliate from their respective employees for all periods in full and complete compliance with
the Tax, social security and unemployment withholding provisions of Applicable Law and such withholdings have been timely paid to the respective Governmental Authorities. No Tax Affiliate has participated in a “listed transaction” within
the meaning of Treasury Regulation Section 1.6011-4(b)(2) or has been a member of an affiliated, combined or unitary group other than the group of which a Tax Affiliate is the common parent. 

(q) The exchange of the Exchanged Deerfield Convertible Notes for the Last Out Waterfall Loans under this Agreement and the other Loan
Documents does not violate or otherwise breach any provision of any of the 3.25% Convertible Note Documents or any other agreements, instruments or documents evidencing any Indebtedness or cause any other holder of any 3.25% Convertible Notes to
become due prior to their stated maturity therein. 
 (r) Except as could not reasonably be expected, individually or in the aggregate, to
have a Material Adverse Effect after the Prior Agreement Date or the Agreement Date, each Loan Party: (i) at all times has complied with all Applicable Laws; (ii) has not received any warning letter or other correspondence or notice from
the any Governmental Authority alleging or asserting noncompliance with any Applicable Laws or any Authorizations; (iii) possesses and complies with the Authorizations, which are valid and in full force and effect; (iv) has not received
written notice that any Governmental Authority has taken, is taking or intends to take action to limit, suspend, cancel, withdraw, modify or revoke any Authorization and has no knowledge that any Governmental Authority is considering such action;
and (v) has filed, obtained, maintained or submitted all reports, documents, forms, notices, applications, records, claims, submissions, renewals and supplements or amendments as required by any Applicable Laws or Authorizations. 

  
 57 

 (s) The Borrower has filed all of the SEC Documents, within the time frames prescribed by
the SEC for the filing of such SEC Documents such that each filing was timely filed with the SEC. The Borrower filed and made publicly available on the SEC’s Electronic Data Gathering, Analysis, and Retrieval system (including any successor
thereto, “EDGAR”) on or prior to the date this representation is made, true, correct and complete copies of the SEC Documents. As of their respective dates, each of the SEC Documents complied in all material respects with the
requirements of the Securities Act and/or the Exchange Act (as applicable) applicable to the SEC Documents. None of the SEC Documents, at the time they were filed with the SEC, contained any untrue statement of a material fact or omitted to state a
material fact required to be stated therein or necessary in order to make the statements therein, in the light of the circumstances under which they were made, not misleading. Since the filing of the SEC Documents, no event has occurred that would
require an amendment or supplement to any of the SEC Documents and as to which such an amendment or a supplement has not been filed and made publicly available on EDGAR (and true, correct and complete copies of such amendment or supplement, if any,
have been delivered to the Secured Parties or their respective representatives) on or prior to the date this representation is made. The Borrower has not received any written comments from the SEC staff that have not been resolved, to the knowledge
of the Borrower, to the satisfaction of the SEC staff. 
 (t) As of their respective dates, the consolidated financial statements of the
Borrower and its Subsidiaries included in the SEC Documents complied as to form in all material respects with applicable accounting requirements and the published rules and regulations of the SEC with respect thereto. Such financial statements have
been prepared in accordance with GAAP, consistently applied (subject, in the case of unaudited quarterly financial statements, to normal year-end adjustments and lack of footnote disclosures), and fairly
present in all material respects the consolidated financial position of the Borrower and its Subsidiaries as of the dates thereof and the consolidated results of their operations, cash flows and changes in stockholders equity for the periods then
ended (subject, in the case of unaudited quarterly financial statements, to normal year-end audit adjustments and lack of footnote disclosures). The accounting firm that expressed its opinion with respect to
the consolidated financial statements included in the Borrower’s most recently filed annual report on 10-K, and reviewed the consolidated financial statements included in the Borrower’s most recently
filed quarterly report on 10-Q, was independent of the Borrower pursuant to the standards set forth in Rule 2-01 of Regulation
S-X promulgated by the SEC and as required by the applicable rules and guidance from the Public Company Accounting Oversight Board (United States), and such firm was otherwise qualified to render such opinion
under Applicable Law and the rules and regulations of the SEC. There is no transaction, arrangement or other relationship between the Borrower (or any of its Subsidiaries) and an unconsolidated or other
off-balance-sheet Person that is required to be disclosed by the Borrower in the SEC Documents that has not been so disclosed in the SEC Documents. Neither the Borrower nor any of its Subsidiaries is required
to file or will be required to file any agreement, note, lease, mortgage, deed or other instrument entered into prior to the date this representation is made and to which the Borrower or any of its Subsidiaries is a party or by which the Borrower or
any of its Subsidiaries is bound that has not been previously filed as an exhibit (including by way of incorporation by reference) to the Borrower’s reports filed or made with the SEC under the Exchange Act. Other than (i) the liabilities
assumed or created pursuant to this Agreement and the other Loan Documents and any fees and expenses in connection therewith, (ii) liabilities accrued for in the latest balance sheet included in the Borrower’s most recent periodic report
(on 10-Q or 10-K) filed prior to the Prior Agreement Date (the date of such balance sheet, the “Latest Balance Sheet Date”), (iii) liabilities incurred
in the ordinary course of business consistent with past practice since the later of the (A) Prior Agreement Date and (B) the Latest Balance Sheet Date and (iv) liabilities set forth on the Schedules to this Agreement, the Borrower and
its Subsidiaries do not have any other material liabilities (whether fixed or unfixed, known or unknown, absolute or contingent, asserted or unasserted, choate or inchoate, liquidated or unliquidated, or secured or unsecured, and regardless of when
any action, claim, suit or proceeding with respect thereto is instituted). Since December 31, 2016, there has been no Material Adverse Effect or any event or circumstance which could reasonably be expected, individually or in the aggregate, to
result in a 

  
 58 

 
Material Adverse Effect. All financial performance projections delivered to any Secured Party, including the financial performance projections delivered on or prior to the Agreement Date, if any,
represent the Borrower’s and its Subsidiaries’ good faith estimate of future financial performance and are based on assumptions believed by the Borrower and its Subsidiaries to be fair and reasonable in light of current market conditions,
it being acknowledged and agreed by Agent and the Lenders that projections as to future events are not to be viewed as facts and that the actual results during the period or periods covered by such projections may differ from the projected results
and such differences may be material. 
 (u) The Borrower and its Subsidiaries maintain a system of internal accounting controls sufficient
to provide reasonable assurance that (i) transactions are executed in accordance with management’s general or specific authorizations, (ii) transactions are recorded as necessary to permit preparation of financial statements in
conformity with GAAP and to maintain asset and liability accountability, (iii) access to assets or incurrence of liability is permitted only in accordance with management’s general or specific authorization and (iv) the recorded
accountability for assets and liabilities is compared with the existing assets and liabilities at reasonable intervals and appropriate action is taken with respect to any differences (such internal accounting controls (including clauses (i) –
(iv) above), collectively, “Internal Controls”). The Borrower and its Subsidiaries have timely filed and made publicly available on EDGAR all certifications, statements and documents required by Rule
13a-14 or Rule 15d-14 under the Exchange Act. The Borrower and its Subsidiaries maintain disclosure controls and procedures required by Rule 13a-15 or Rule 15d-15 under the Exchange Act; such controls and procedures are effective to ensure that the information required to be disclosed by the Borrower and its
Subsidiaries in the reports that they file with or submit to the SEC (A) is recorded, processed, summarized and reported accurately within the time periods specified in the SEC’s rules and forms and (B) is accumulated and communicated
to the Borrower’s (and, to the extent applicable, its Subsidiaries’) management, including its or their principal executive officer and principal financial officer, as appropriate to allow timely decisions regarding required disclosure.
The Borrower and its Subsidiaries maintain internal control (including Internal Controls) over financial reporting required by Rule 13a-15 or Rule 15d-15 under the
Exchange Act; such internal control (including Internal Controls) over financial reporting is effective and does not contain any material weaknesses. 

(v) [Reserved]. 
 (w) (i) No Loan
Party has engaged, and to the knowledge of the Loan Parties, no other Person has engaged in any “prohibited transaction” as defined under Section 406 of ERISA or Section 4975 of the Code that is not exempt under ERISA
Section 408 or Section 4975 of the Code, under any applicable regulations and published interpretations thereunder or under any applicable prohibited transaction, individual or class exemption issued by the Department of Labor, with
respect to any Employee Benefit Plan, except as for such transaction that could not be expected, individually or in the aggregate, to have a Material Adverse Effect, (ii) (A) at no time within the last seven years has the Borrower or any ERISA
Affiliate maintained, sponsored, participated in, contributed to or had any Liability with respect to, and (B) no Loan Party or any ERISA Affiliate has any Liability or obligation in respect of, any Title IV Plan, Multiemployer Plan or any
multiple employer plan for which the Borrower or any ERISA Affiliate has incurred or could incur Liability under Section 4063 or 4064 of ERISA, (iii) each Employee Benefit Plan is and has been operated in compliance with its terms and all
Applicable Laws, including ERISA and the Code, except for such failures to comply that could not reasonably be expected, individually or in the aggregate, to have a Material Adverse Effect, (iv) (A) no ERISA Event has occurred and (B) no
event or condition exists or existed that could reasonably be expected to subject the Borrower or any ERISA Affiliate to any tax, fine, lien, penalty or Liability imposed by ERISA, the Code or other Applicable Law, except for any such ERISA Event or
tax, fine, lien, penalty or liability that could not be expected, individually or in the aggregate, to have a Material Adverse Effect, and (v) no Loan Party maintains or has 

  
 59 

 
any obligation or Liability with respect to any Foreign Benefit Plan that, individually or in the aggregate, could be expected to have a Material Adverse Effect. 

(x) As of the Agreement Date, the Borrower’s Subsidiaries are set forth in Schedule 3.1(x) and the information set forth in Schedule
3.1(x) is true, correct and complete. 
 (y) Subsequent to December 31, 2015, the Borrower has not declared or paid any dividends or
made any distribution of any kind with respect to its Stock, except as permitted hereunder. 
 (z) (A) All of the issued and outstanding
shares of Stock of the Borrower are duly authorized and validly issued, fully paid and nonassessable, have been issued in compliance with all applicable federal and state and foreign securities laws, were not issued in violation of or subject to any
preemptive rights or other rights to subscribe for or purchase securities that have not been waived in writing. The Borrower has reserved for issuance the maximum of 14,300,000 shares of Common Stock initially issuable upon conversion of the First
Out Waterfall Notes (the “Conversion Shares”) (computed without regard to any limitations on the number of shares that may be issued on conversion thereof) and 2,526,800 shares for issuance as Interest Payment Shares pursuant to
Section 2.6 and Exhibit 2.6. The Borrower has reserved for issuance an aggregate number of shares of Common Stock (6,470,000 shares for the Initial Warrants and 8,750,000 shares for the Additional Warrants) sufficient to cover all shares
initially issuable upon exercise of the Warrants (the “Warrant Shares”) (computed without regard to any limitations on the number of shares that may be issued on exercise thereof). The Conversion Shares, the Interest Payment Shares, the
Warrants, the Warrant Shares and any other distributions required to be made now or in the future pursuant to the Warrants (the “Warrant Distributions”) have been duly authorized. The holders of the Initial Warrants are entitled to
the rights set forth in the Initial Warrants. Upon issuance of the Additional Warrants in accordance with the terms of this Agreement, the holders of the Additional Warrants will be entitled to the rights set forth in the Additional Warrants. Upon
exercise of the Warrants in accordance with terms thereof, the Warrant Shares will be validly issued, fully paid and non-assessable and free from all taxes and Liens with respect to the issue thereof, with the
holders thereof being entitled to all rights accorded to a holder of Common Stock. Upon conversion of the First Out Waterfall Notes in accordance with the terms thereof, the Conversion Shares will be validly issued, fully paid and non-assessable and free from all taxes and Liens with respect to the issue thereof, with the holders thereof being entitled to all rights accorded to a holder of Common Stock. Upon issuance in accordance with the
terms of this Agreement (including Exhibit 2.6), the Interest Payment Shares will be validly issued, fully paid and non-assessable and free from all taxes and Liens with respect to the issue thereof, with the
holders thereof being entitled to all rights accorded to a holder of Common Stock. (B) The issuance by the Borrower of the Securities is exempt from registration under the Securities Act and applicable state securities laws. For purposes of
Rule 144 under the Securities Act, (I) the amendments set forth in, and other provisions of, this Agreement and other Loan Documents effect an exchange of securities issued pursuant to the Prior Loan Documents for the First Out Waterfall Loans,
First Out Waterfall Notes (together with the related guaranties set forth in the Security Agreement of the Guarantors) and the Additional Warrants (collectively, the “First Out Waterfall Securities”) under this Agreement,
(II) the holding period for each of the Initial Warrants, the First Out Waterfall Securities and any shares of Common Stock issued as Interest Payment Shares pursuant to this Agreement (including Exhibit 2.6), upon conversion of any of the
First Out Waterfall Notes or upon exercise of any of the Warrants pursuant to a Cashless Exercise, Cashless Major Exercise, Cashless Default Exercise or Note Exchange Exercise (each as defined in the Warrants) shall be deemed to have commenced on
the Prior Agreement Date, and (III) the holding period for each of the Last Out Waterfall Loans and the Last Out Waterfall Notes (together with the related guaranties set forth in the Security Agreement of the Guarantors) shall be deemed to
have commenced on November 2, 2015 (the date the Exchanged Deerfield Convertible Notes were original issued). Provided that a First Out Waterfall Lender is not an Affiliate of the Borrower on the date of issuance of any Interest Payment
Shares to such First Out Waterfall Lender pursuant to this Agreement (including Exhibit 2.6), conversion of any of the 

  
 60 

 
First Out Waterfall Notes by such First Out Waterfall Lender or exercise of any of the Warrants by such First Out Waterfall Lender pursuant to a Cashless Exercise, Cashless Major Exercise,
Cashless Default Exercise or Note Exchange Exercise and has not been an Affiliate of the Borrower within the three-month period immediately preceding such date (which the Borrower shall assume unless advised otherwise in writing by such First Out
Waterfall Lender), the Interest Payment Shares, Conversion Shares or Warrant Shares (as applicable) issued to such First Out Waterfall Lender will be freely transferable, without restriction or limitation (including any volume limitation or current
public information requirement) under Federal or state securities laws, pursuant to Rule 144 under the Securities Act, and will not contain or be subject to a legend or stop transfer order restricting the resale or transferability of thereof. (C) As
of the Agreement Date, all of the Borrower’s authorized, issued and outstanding shares of Stock of the Borrower and each of its Subsidiaries are set forth in Schedule 3.1(z), and, except as set forth in Schedule 3.1(z), there are no
(i) Stock options or other Stock incentive plans, employee Stock purchase plans or other plans, programs or arrangements of the Borrower or any of its Subsidiaries under which Stock options, Stock or other Stock-based or Stock-linked awards are
issued or issuable to officers, directors, employees, consultants or other Persons, (ii) outstanding options, warrants, scrip, rights to subscribe to, calls or commitments of any character whatsoever relating to, or securities or rights
convertible into or exchangeable or exercisable for, any Stock of the Borrower or any of its Subsidiaries, or contracts, commitments, understandings or arrangements by which the Borrower or any of its Subsidiaries is or may become bound to issue
additional Stock of the Borrower or any of its Subsidiaries, or options, warrants or scrip for rights to subscribe to, calls or commitments of any character whatsoever relating to, or securities or rights convertible into or exercisable or
exchangeable for, any shares of Stock of the Borrower or any of its Subsidiaries, (iii) agreements or arrangements under which the Borrower or any of its Subsidiaries is obligated to register the sale of any of their securities or Stock under
the Securities Act (except the Registration Rights Agreement), (iv) outstanding Stock, securities or instruments of the Borrower or any of its Subsidiaries that contain any redemption or similar provisions, or contracts, commitments, understandings
or arrangements by which the Borrower or any of its Subsidiaries is or may become bound to redeem a security of the Borrower other than under the Convertible Note Documents, (v) Stock or other securities or instruments containing anti-dilution
or similar provisions that may be triggered by the issuance of securities of the Borrower or any of its Subsidiaries other than under the Convertible Note Documents or (vi) stock appreciation rights or “phantom stock” plans or
agreements or any similar plans or agreements to which Borrower or any of its Subsidiaries is a party or by which the Borrower or any of its Subsidiaries is otherwise subject or bound. There are no (X) stockholders’ agreements, voting
agreements or similar agreements to which Borrower or any of its Subsidiaries is a party or by which the Borrower or any of its Subsidiaries is otherwise subject or bound, other than in connection with clauses (i), (k) and (n) of the
definition of “Permitted Investments”, (Y) preemptive rights or any other similar rights to which any Stock of the Borrower or any of its Subsidiaries is subject or (Z) any restrictions upon the voting or transfer of any Stock of
the Borrower or any of its Subsidiaries (other than restrictions on transfer imposed by U.S. federal and state securities laws and other than as set forth in the Loan Documents, the ABL Debt Documents and, if such instrument is permitted hereunder
to be secured, the documents governing the Permitted 3.25% Convertible Note Refinancing). (C) The issuance and delivery of the First Out Waterfall Notes and the Warrants does not and, assuming full exercise of the Warrants, full conversion of the
First Out Waterfall Notes and issuance of the maximum number of Interest Payment Shares, the exercise of the Warrants, the conversion of the First Out Waterfall Notes and the issuance of the Warrant Shares, the Conversion Shares and the Interest
Payment Shares, will not: (i) require approval from any Governmental Authority; (ii) obligate the Borrower to issue shares of Common Stock or other securities to any Person (other than the Secured Parties); and (iii) will not result
in a right of any holder of the Borrower’s securities to adjust the exercise, conversion, exchange or reset price under and will not result in any other adjustments (automatic or otherwise) under, any securities of the Borrower. (D) The
Borrower has furnished to Agent and each Lender true, correct and complete copies of each Loan Party’s Organizational Documents and any amendments, restatements, supplements or modifications thereto, and all documents, agreements and
instruments containing the terms of all securities and Stock convertible into, or exercisable or exchangeable 

  
 61 

 
for, Common Stock or other Stock of any Loan Party or its Subsidiaries, and the material rights of the holders thereof in respect thereto. 

(aa) Except for the Operative Documents, the Convertible Note Documents and the agreements set forth on Schedule 3.1(aa), as of the Agreement
Date there are no Material Contracts. The consummation of the transactions contemplated by the Loan Documents will not give rise to a right to termination in favor of any party to any Material Contract (other than any Loan Party), except for such
Material Contracts the noncompliance with which would not reasonably be expected, individually or in the aggregate, to have a Material Adverse Effect. 

(bb) Neither the Borrower nor its Subsidiaries are in breach or default under any Material Contract, and, to the knowledge of the Loan Parties,
no other party to a Material Contract is in default or breach thereunder, except where any breach or default would not reasonably be expected, individually or in the aggregate, to have a Material Adverse Effect. 

(cc) The proceeds of the Loans are intended to be and shall be used solely for the purposes set forth in and permitted by Section 2.1.

 (dd) Except as set forth in Schedule 3.1(dd) and except where any failures to comply could not reasonably be expected, either individually
or in the aggregate, to result in a Material Adverse Effect, each Loan Party and each Subsidiary of each Loan Party (a) is and has been in compliance with all applicable Environmental Laws, including obtaining and maintaining all permits,
licenses, consents, Authorizations and registrations required by any applicable Environmental Law, (b) is not party to, and no Real Estate currently (or to the knowledge of any Loan Party, previously) owned, leased, subleased, operated or
otherwise occupied by or for any such Person is subject to or the subject of, any contractual obligation or any pending or, to the knowledge of any Loan Party, threatened, order, action, investigation, suit, proceeding, audit, Lien, claim, demand,
dispute or notice of violation or of potential liability or similar notice relating in any manner to any Environmental Law, (c) has not caused or suffered to occur a Release of Hazardous Materials at, to or from any Real Estate, (d) does
not currently (or to the knowledge of any Loan Party, did not previously) own, lease, sublease, operate or otherwise occupy any Real Estate that is contaminated by any Hazardous Materials and (e) is not, and has not been, engaged in, and has
not permitted any current or former tenant to engage in, operations in violation of any Environmental Law and knows of no facts, circumstances or conditions reasonably constituting notice of a violation of any Environmental Law, including receipt of
any information request or notice of potential responsibility under the Comprehensive Environmental Response, Compensation and Liability Act or similar Environmental Laws. 

(ee) None of any Loan Party, any Person controlling any Loan Party or any Subsidiary of any Loan Party is (a) a company registered or
required to be registered as an “investment company,” or a company “controlled” by an “investment company” or a “principal underwriter” of a “registered investment company” within the meaning of the
Investment Company Act, or otherwise registered or required to be registered, or subject to the restrictions imposed, by the Investment Company Act, or (b) subject to regulation under the Federal Power Act, the Interstate Commerce Act, any
state public utilities code, or any other federal or state statute, rule or regulation limiting its ability to incur Indebtedness, pledge its assets, perform its obligations under the Loan Documents or which may otherwise render all or any portion
of the Obligations unenforceable. 
 (ff) There are no strikes, boycotts, grievances, work stoppages, slowdowns, lockouts or other job
actions existing, pending (or, to the knowledge of any Loan Party, threatened) against or involving any Loan Party or any Subsidiary of any Loan Party, except for those that could not reasonably be 

  
 62 

 
expected, individually or in the aggregate, to have a Material Adverse Effect. Except as set forth on Schedule 3.1(ff), or except as could not reasonably be expected, individually or in the
aggregate, to have a Material Adverse Effect, as of the Agreement Date, (a) there is no memorandum of understanding, collective bargaining or similar agreement, and there is no ongoing negotiation or duty to negotiate, with any union, labor
organization, works council or similar representative covering any Employee or otherwise binding any Loan Party or any Subsidiary of any Loan Party, (b) to the Loan Parties’ knowledge, no petition for certification or election of any such
representative is existing or pending with respect to any Employee, (c) to the Loan Parties’ knowledge, no such representative has sought certification or recognition with respect to any Employee, and (d) to the Loan Parties’
knowledge, no Employee or his or her representative is engaged in any organizing efforts. Except as could not reasonably be expected, individually or in the aggregate, to have a Material Adverse Effect, all current and former Employees are and have
been correctly classified as exempt or non-exempt under, and are and have been paid in accordance with, all applicable federal, state, and local wage and hour laws. Further, all individuals who perform or have
performed services for any Loan Party or any Subsidiary of any Loan Party are or were correctly classified under each Employee Benefit Plan, ERISA, the Internal Revenue Code and other Applicable Law as common law employees, independent contractors
or other non-employee basis, or leased employees, except as could not reasonably be expected, individually or in the aggregate, to have a Material Adverse Effect. Each Loan Party and Subsidiary of any Loan
Party are in material compliance with all Applicable Laws concerning employment, including without limitation hiring, background checks, compensation, benefits, wages (including payment of overtime), wage deductions and withholdings, classification,
immigration, work authorization, employment eligibility verification, reporting, taxation, occupational health and safety, equal rights, labor relations, accommodations, breaks, notices, employment policies, paid or unpaid time off work,
accessibility, privacy, and workers’ compensation, except for such noncompliance that could not reasonably be expected, individually or in the aggregate, to have a Material Adverse Effect. 

(gg) During five (5) years preceding the Agreement Date, no Loan Party has been known by and has used any other name, whether corporate,
fictitious or otherwise, except as set forth on Schedule 3.1(gg). Schedule 3.1(gg) also lists (a) each Loan Party’s jurisdiction of organization and legal name and (b) each Loan Party’s organizational identification number. Each
Loan Party’s chief executive office or sole place of business, in each case as of the Agreement Date, is at the chief executive office or sole place of business address identified as such in Schedule 3.1(gg) and no Loan Party maintains any
other offices or facilities except as described therein. 
 (hh) The Inventory and Equipment of the Loan Parties is located only at, or in-transit between, the locations identified on Schedule 3.1(hh). With respect to any Inventory and Equipment listed at locations that are outside the United States (and with respect to any Inventory and
Equipment on consignment at any location), (i) any failure of the Agent and the other Secured Parties to (A) be fully protected on the Inventory and Equipment or be fully protected or perfected with respect to any Liens granted to the
Agent (for the benefit of the Secured Parties) on any such Inventory or Equipment, or (B) have absolute or full access to such locations when exercising rights and remedies after the occurrence and during the continuance of an Event of Default,
in each case of clause (i)(A) and clause (i)(B), does not, individually or in the aggregate, cause a Material Adverse Effect to occur, and (ii) as of the Agreement Date, the cost paid by the Loan Parties and their Subsidiaries for
such Inventory and Equipment listed at such locations outside the United States, or on consignment at any location outside the United States, does not exceed $10,000,000. 

(ii) Each Loan Party keeps correct and accurate records itemizing and describing the type, quality and quantity of its and their
Subsidiaries’ Inventory and the book value thereof. 
 (jj) Each Loan Party and each Subsidiary of each Loan Party is in compliance in
all material respects with all Sanctions laws as administered by the U.S. Treasury Department’s Office of 

  
 63 

 
Foreign Assets Control (“OFAC”) and the U.S. State Department. No Loan Party and no Subsidiary of a Loan Party (i) is a Person on the list of the Specially Designated
Nationals and Blocked Persons (the “SDN List”), (ii) is a Person who is otherwise the target of Sanctions laws such that a U.S. Person cannot deal or otherwise engage in business transactions with such Person, (iii) is a
Sanctioned Entity, (iv) is owned or controlled by (including by virtue of such Person being a director or owning voting shares or interests), or acts, directly or indirectly, for or on behalf of, any Person on the SDN List or a
Sanctioned Entity such that the entry into, or performance under, this Agreement or any other Loan Document would be prohibited by U.S. law, (v) has its assets located in Sanctioned Entities, (vi) derives revenues from investments in, or
transactions with Sanctioned Persons or Sanctioned Entities. No proceeds of any Loan will be used to fund any operations in, finance any investments or activities in, or make any payments to, a Sanctioned Person or a Sanctioned Entity. Each Loan
Party and each Subsidiary of each Loan Party is in compliance with all Anti-Money Laundering Laws. No action, suit or proceeding by or before any court or Governmental Authority with respect to compliance with such Anti-Money Laundering Laws is
pending or threatened to the knowledge of each Loan Party and each Subsidiary of each Loan Party. Each Loan Party and each Subsidiary of each Loan Party is in compliance in all material respects with all applicable Anti-Corruption Laws, including
the U.S. Foreign Corrupt Practices Act of 1977 (“FCPA”). None of any Loan Party or any Subsidiary of a Loan Party, nor to the knowledge of any Loan Party or any Subsidiary thereof, any director, officer, agent, employee or other
Person acting on behalf of the Loan Party or any Subsidiary of a Loan Party, has taken any action, directly or indirectly, that would result in a violation of applicable Anti-Corruption Laws. No part of the proceeds of the Loans will be used by any
Loan Party or any of their Affiliates, directly or indirectly, for any payments to any governmental official or employee, political party, official of a political party, candidate for political office or anyone else acting in an official capacity,
in order to obtain, retain or direct business or obtain any improper advantage, in violation of the FCPA. The Loan Party and each Subsidiary of a Loan Party maintains and implements policies and procedures designed to ensure compliance by the Loan
Parties, their Subsidiaries and their respective directors, officers, employees and agents with Sanctions, Anti-Money Laundering Laws and Anti-Corruption Laws. To the extent applicable, each Loan Party and each of its Affiliates is in compliance, in
all material respects, with all Anti-Terrorism Laws. 
 (kk) The Borrower and its Subsidiaries are in all material respects in compliance
with applicable provisions of the Sarbanes-Oxley Act of 2002, as amended, and the rules and regulations thereunder (collectively, “Sarbanes-Oxley”). 

(ll) Neither the Borrower nor any of its Subsidiaries nor, to the Borrower’s or any of its Subsidiaries’ knowledge, any director,
officer or employee, of the Borrower or any of its Subsidiaries, has received or otherwise obtained any material complaint, allegation, assertion or claim, whether written or oral, regarding the accounting or auditing practices, procedures,
methodologies or methods of the Borrower or any of its Subsidiaries or its internal accounting controls, including any complaint, allegation, assertion or claim that the Borrower or any of its Subsidiaries has engaged in questionable accounting or
auditing practices. No attorney representing the Borrower or any of its Subsidiaries, whether or not employed by the Borrower or any of its Subsidiaries, has reported evidence of a material violation of securities laws or breach of fiduciary duty or
similar violation by the Borrower or any of its Subsidiaries or any of their respective officers, directors, employees or agents to the Borrower’s or any of its Subsidiaries’ board of directors (or equivalent governing body) or any
committee thereof or to any director (or equivalent person) or officer of the Borrower or any of its Subsidiaries pursuant to Section 307 of Sarbanes-Oxley, and the SEC’s rules and regulations promulgated thereunder. There have been no
internal or SEC investigations regarding accounting or revenue recognition discussed with, reviewed by or initiated at the direction of the chief executive officer, the principal financial officer or the principal accounting officer (in each case,
or officer holding such equivalent position) of the Borrower or any of its Subsidiaries, the Borrower’s or any of its Subsidiaries’ board of directors (or equivalent governing body) or any committee thereof. 

  
 64 

 (mm) The Borrower is not, and never has been, a “shell company” (as defined in
Rule 12b-2 under the Exchange Act). The Borrower is eligible to register the Warrant Shares for resale by the holders thereof on a registration statement on Form S-3
under the Securities Act. 
 (nn) Neither the Borrower, nor any of its Affiliates, nor any Person acting on its or their behalf, has engaged
or will engage in any form of general solicitation or general advertising (within the meaning of Regulation D under the Securities Act) in connection with the offer, sale or issuance of the Securities. 

(oo) Neither the Borrower, nor any of its Affiliates, nor any Person acting on its or their behalf has, directly or indirectly, made, or will
make, any offers or sales of any security or Stock or solicited any offers to buy any security or Stock, under circumstances that would require registration of any of the Securities under the Securities Act or cause this offering of the Securities
to be integrated with prior offerings by the Borrower for purposes of the Securities Act or any applicable holder of Stock approval provisions of the Principal Market or any other authority. 

(pp) The Common Stock is registered pursuant to Section 12(b) of the Exchange Act, and neither the Borrower nor any of its Subsidiaries
has taken, or will take, any action designed to terminate, or which to the knowledge of the Borrower and its Subsidiaries is likely to have the effect of terminating, the registration of the Common Stock under the Exchange Act, nor has the Borrower
or any of its Subsidiaries received any notification that the SEC is contemplating terminating such registration. Neither the Borrower nor any of its Subsidiaries is in violation of any of the rules, regulations or requirements of the Principal
Market, and, to the knowledge of the Borrower and its Subsidiaries, there are no facts or circumstances that could reasonably lead to suspension or termination of trading of the Common Stock on the Principal Market. For not less than the five years
preceding the Agreement Date, (i) the Common Stock has been listed or designated for quotation, as applicable, on the Principal Market, (ii) trading in the Common Stock has not been suspended or deregistered by the SEC or the Principal
Market, and (iii) neither the Borrower nor any of its Subsidiaries has received any communication, written or oral, from the SEC or the Principal Market regarding the suspension or termination of trading of the Common Stock on the Principal
Market. 
 (qq) The Common Stock is eligible for clearing through The Depository Trust Company (“DTC”), through its
Deposit/Withdrawal At Custodian (DWAC) system, and the Borrower is eligible for and participating in the Direct Registration System (DRS) of DTC with respect to the Common Stock. The transfer agent for the Common Stock is a participant in, and the
Common Stock is eligible for transfer pursuant to, DTC’s Fast Automated Securities Transfer Program. The Common Stock is not, and has not at any time been, subject to any DTC “chill,” “freeze” or similar restriction with
respect to any DTC services, including the clearing of transactions in shares of Common Stock through DTC. 
 (rr) The Borrower and the
Borrower’s board of directors (or equivalent governing body) have taken all necessary action, if any, in order to render inapplicable any control share acquisition, business combination or other similar anti-takeover provision under the
Borrower’s Organizational Documents or the laws of the State of Delaware that is or could become applicable to any of the Secured Parties as a result of the transactions contemplated by the Loan Documents and the Borrower’s fulfilling its
obligations with respect thereto, including the Borrower’s issuance of the Securities and any Secured Party’s ownership of the Securities. As of the Agreement Date, the Borrower has not adopted a stockholders rights plan (or “poison
pill”) or similar arrangement relating to accumulations of beneficial ownership of Common Stock or a change in control of the Borrower (any such plan or arrangement, a “Rights Plan”), and after the Prior Agreement Date, the
Borrower will not have adopted any Rights Plan that in any way interferes with, or otherwise adversely affects, any First Out Waterfall Lender’s (or other holder’s) exercise in full of its rights under the Warrants and the First Out
Waterfall Notes or ownership of 

  
 65 

 
all of the Warrant Shares, the Conversion Shares and the Interest Payment Shares or that otherwise affects or applies to any First Out Waterfall Lender (or such other holder of Warrants or
Warrant Shares) in any respect that is less favorable than its effect on the most favorably treated holder of Stock of the Borrower under such Rights Plan. 

(ss) It is understood and acknowledged by the Borrower that none of the Secured Parties nor holders of the Securities has been asked to agree,
nor has any Secured Party agreed, to desist from purchasing or selling, long and/or short, Stock or other securities of the Borrower, or “derivative” securities or Stock based on Stock or other securities issued by the Borrower or to hold
the Securities for any specified term; and no Secured Party nor holder of Securities shall be deemed to have any affiliation with or control over any arm’s length counterparty in any “derivative” transaction. The Borrower further
understands and acknowledges that (i) one or more Secured Parties or holders of Securities may engage in hedging and/or trading activities at various times during the period that the Securities are outstanding, and (ii) such hedging and/or
trading activities, if any, can reduce the value of the Stock held by the existing holders of Stock of the Borrower, both at and after the time the hedging and/or trading activities are being conducted. The Borrower acknowledges that any such
hedging and/or trading activities do not constitute a breach of any Loan Document or affect the rights of any Secured Party or holder of Securities under any Loan Document. The Borrower further acknowledges that its obligations under the Loan
Documents, including its obligation to issue the Warrant Shares upon exercise of the Warrants and the Conversion Shares upon conversion of the First Out Waterfall Notes, are unconditional and absolute and not subject to any right of set off,
counterclaim, delay or reduction, regardless of any claim any Loan Party may have against any of the Secured Parties and regardless of the dilutive effect that such issuance may have on the ownership of the other stockholders of the Borrower. 

(tt) The Borrower and the other Loan Parties are solely and jointly and severally responsible for the payment of any fees, costs, expenses and
commissions of any placement agent, broker or financial adviser relating to or arising out of the transactions contemplated by the Loan Documents. The Borrower and the other Loan Parties will pay, and hold each of the Secured Parties harmless
against, any liability, loss or expense (including attorneys’ fees, costs and expenses) arising in connection with any claim for any such payment, other than those arising from the gross negligence or willful misconduct of Agent or any Lender
as determined by a final, non-appealable judgment of a court of competent jurisdiction. 
 (uu)
Except as could not reasonably be expected, individually or in the aggregate, to have a Material Adverse Effect, each Loan Party and its Subsidiaries has made all notifications, submissions, and reports required by the FDA, any other Governmental
Authority or any Healthcare Law, and all such notifications, submissions and reports were true, complete, and correct in all respects as of the date of submission to FDA, any other Governmental Authority or to such other Person required by any
Healthcare Law. There has not been any violation of any Healthcare Laws by any Loan Party or its Subsidiaries in its product development efforts, submissions, record keeping and reports to the FDA or any other Governmental Authority that could
reasonably be expected, individually or in the aggregate, to have a Material Adverse Effect. To the knowledge of each Loan Party and each of its Subsidiaries, there are no civil or criminal proceedings relating to any Loan Party or any of its
Subsidiaries or any officer, director or employee of any Loan Party or Subsidiary of any Loan Party that involve a matter within or related to the FDA’s or any other Governmental Authority’s jurisdiction or any off-label promotion or allegations of non-compliance with Healthcare Laws. Other than as expressly set forth on Schedule 3.1(uu), no Loan Party nor any Affiliate thereof
has received any material adverse notice (written or oral) from the FDA or any other Governmental Authority that has not been finally and fully resolved in accordance and compliance with Applicable Law and all FDA and other Governmental Authority
standards, regulations and requirements regarding any Product or regarding (i) any actions or inactions of any Loan Party or any 

  
 66 

 
of its Subsidiaries or any officer, director or employee of any Loan Party or Subsidiaries of any Loan Party, including with respect to any off-label
promotion or (ii) alleging non-compliance with Healthcare Laws. 
 (vv) With respect to any
Product, (i) the Loan Parties and their Subsidiaries have received, and such Product is the subject of, all Regulatory Required Permits needed in connection with the design, testing, manufacture, processing, assembly, packaging, labeling,
marketing, distribution, commercialization, import, export or sale of such Product as currently being conducted by or on behalf of such Loan Parties or Subsidiaries, except where the failure to have such Regulatory Required Permits would not have a
Material Adverse Effect, and (ii) such Product is being designed, tested, manufactured, processed, assembled, packaged, labeled, marketed, distributed, commercialized, imported, exported or sold, as the case may be, except as would not
reasonably be expected, individually or in the aggregate, to have a Material Adverse Effect, in compliance with all Applicable Laws and Authorizations. 

(ww) None of the Loan Parties are in violation of any Healthcare Laws, except where any such violation would not have a Material Adverse
Effect. 
 (xx) Except as could not reasonably be expected, individually or in the aggregate, to have a Material Adverse Effect, each Loan
Party and its Subsidiaries is in compliance with the written procedures, record-keeping and reporting requirements required by (or of) (i) the FDA or any comparable Governmental Authority pertaining to the reporting of adverse events involving
the Products or concerning the actions or inactions of the Loan Parties and their Subsidiaries and the directors, officers and employees of the Loan Parties and their Subsidiaries, including with respect to
off-label promotion, as applicable, and (ii) Healthcare Laws. 
 (yy) No Loan Party is a
participating provider under contract to provide health care services and receive payment or reimbursement for such services under any Third Party Payor Program. 

(zz) To the knowledge of the Loan Parties’ Authorized Officers, neither any of the Loan Parties nor any of the Loan Parties’
officers, directors, employees, equityholders, agents or Affiliates has ever (i) made an untrue statement of material fact, fraudulent statement to the FDA or any other Governmental Authority or in any documents or records prepared or
maintained to comply with the FDCA; (ii) failed to disclose a material fact required to be disclosed to the FDA or any other Governmental Authority; (iii) been investigated by the FDA, National Institutes of Health, Office of the Inspector
General for the Department of Health and Human Services, Department of Justice, or other comparable Governmental Authority for data or healthcare program fraud; or (iv) committed an act, made a statement, or failed to make a statement that
could reasonably be expected to provide a basis for the FDA to invoke its policy respecting “Fraud, Untrue Statements of Material Facts, Bribery, and Illegal Gratuities,” set forth in 56 Fed. Regulation 46191 (September 10, 1991). 

(aaa) No Loan Party has received any written notice that any Governmental Authority, including the FDA, the Office of the Inspector General of
the United States Department of Health and Human Services or the United States Department of Justice has commenced or threatened to initiate any investigation or action against a Loan Party, any action to enjoin a Loan Party, or any of its officers,
directors, employees, equityholders, agents or Affiliates, from conducting their businesses at any facility owned or used by them or for any civil penalty, injunction, seizure or criminal action, in each case, which could reasonably be expected,
individually or in the aggregate, to result in a Material Adverse Effect. 
 (bbb) No Loan Party has received from the FDA a Warning Letter,
Form FDA-483, “Untitled Letter,” other correspondence or notice setting forth allegedly objectionable observations or alleged violations of laws or regulations enforced by the FDA, or any comparable
correspondence from any state or local authority responsible for regulating drug or device products and establishments, or any 

  
 67 

 
comparable correspondence from any foreign counterpart of the FDA, or any comparable correspondence from any foreign counterpart of any state or local authority with regard to any Product or the
manufacture, processing, packing, or holding thereof, in each case, which could reasonably be expected, individually or in the aggregate, to result in a Material Adverse Effect. 

(ccc) None of the Loan Parties has engaged in any material Recalls, Market Withdrawals or other forms of product retrieval from the marketplace
of any Products that has been not been finally and fully completed prior to the Agreement Date in accordance and compliance with Applicable Law and all FDA and other Governmental Authority standards, regulations and requirements. None of the
Products (for the avoidance of doubt, including those in the immediately preceding sentence that have been so finally and fully completed) have been subject to a Recall, Market Withdrawal, or other Correction or Removal, nor is any such action
currently under consideration by Borrower or, to the knowledge of Borrower, any manufacturer or supplier of a Product, that could reasonably be expected, individually or in the aggregate, to result in a Material Adverse Effect. Borrower has not been
restrained in its ability to manufacture, process, distribute, supply, import, export, market, or sell any of the Products, except to the extent that would not reasonably be expected, individually or in the aggregate, to have a Material Adverse
Effect. 
 (ddd) Each Product, except as would not be reasonably be expected, individually or in the aggregate, to have a Material Adverse
Effect, (a) is not adulterated or misbranded within the meaning of the FDCA; (b) is not an article prohibited from introduction into interstate commerce under the provisions of Sections 404, 505 or 512 of the FDCA; (c) has been and/or
shall be manufactured, imported, possessed, owned, warehoused, marketed, promoted, sold, labeled, furnished, distributed and marketed, and each service has been conducted, in accordance with all applicable Authorizations and Applicable Laws; and
(d) has been and/or shall be manufactured in accordance with Good Manufacturing Practices. 
 (eee) No Loan Party is subject to any
proceeding, suit or, to any Loan Party’s knowledge, investigation by any federal, state or local government or quasi-governmental body, agency, board or authority or any other administrative or investigative body (including the Office of the
Inspector General of the United States Department of Health and Human Services) which would reasonably be expected to have, individually or in the aggregate, a Material Adverse Effect on any Loan Party; 

(fff) The Loan Parties have not received any notice, and are not aware, of any violation of applicable antitrust laws, employment or
landlord-tenant laws of any federal, state or local government or quasi-governmental body, agency, board or other authority with respect to the Loan Parties that could reasonably be expected, individually or in the aggregate, to result in a Material
Adverse Effect. 
 (ggg) None of the proceeds from the Loans have been or will be used, directly or indirectly, for the purpose of purchasing
or carrying any Margin Stock, for the purpose of reducing or retiring any Indebtedness which was originally incurred to purchase or carry any Margin Stock or for any other purpose which might cause any of the Loans to be considered a “purpose
credit” within the meaning of Regulation T, U or X of the Federal Reserve Board. No Loan Party nor any of their Subsidiaries is engaged principally, or as one of its important activities, in the business of extending credit for the purpose of
purchasing or carrying any Margin Stock. 
 (hhh) None of the written information (financial or otherwise) (other than projections, other
forward-looking information and industry information) furnished by or on behalf of any Loan Party to Agent or any Lender in connection with the consummation of the transactions contemplated by the Loan Documents contains any untrue statement of a
material fact or omits to state a material fact necessary to make the statements contained herein or therein not materially misleading in light of the circumstances under which such statements were made. 

  
 68 

 (iii) The rate of interest paid under the Notes and other Loan Documents or on any other
Obligations, and the method and manner of the calculation thereof, do not violate any usury law or other Applicable Laws, any of the Organizational Documents, or any of the Loan Documents. 

(jjj) The Loan Parties do not own any stock, partnership interests, limited liability company interest or other equity securities or
Subsidiaries except for Permitted Investments. As of the Agreement Date, set forth on Schedule 3.1(jjj) (as such Schedule may be updated from time to time to reflect changes resulting from transactions permitted under this Agreement) is a complete
and accurate description of the authorized Stock of the Subsidiaries of the Loan Parties, by class, and a description of the number of shares of each such class that are issued and outstanding. 

(kkk) All information set forth in the Schedules is true, accurate and complete in all material respects as of the Agreement Date and any other
subsequent date in which the Loan Parties are requested to update such Schedules. All information set forth in the Perfection Certificate is true, accurate and complete in all material respects as of the Agreement Date and any other subsequent date
in which the Loan Parties are requested to update such certificate. 
 Section 3.2 Borrower
Acknowledgment. The Loan Parties (on their behalf and on their Subsidiaries’ behalf) acknowledge that they have made the representations and warranties referred to in Section 3.1 with the intention of persuading Agent and the
Lenders to enter into the Loan Documents and that Agent and the Lenders have entered into the Loan Documents on the basis of, and in full reliance on, each of such representations and warranties, each of which shall survive the execution and
delivery of this Agreement, the other Loan Documents, the making of any Disbursement and the issuance of the Securities until the later of (a)(i) all of the Obligations are repaid in full and (ii) all of the Warrants have expired or been
terminated and (b) the end of the Reporting Period. 
 Section 3.3 Representations and Warranties of the
Lenders. Each Lender, severally and not jointly, represents and warrants to the Borrower as of the Agreement Date that: 
 (a)
Such Lender (i) acquired the Loans and the Notes (together with the related guaranties set forth in the Security Agreement of the Guarantors) provided by such Lender, the Warrants related to the First Out Waterfall Loans made by such Lender
hereunder, and in the case of the Last Out Waterfall Lender, the Exchanged Deerfield Convertible Notes, and (ii) upon any cash exercise of such Lender’s Warrants, will acquire the Warrant Shares then-issuable upon exercise thereof
for its own account and not with a view towards, or for resale in connection with, the public sale or distribution thereof, except pursuant to sales registered under, or exempted from, the registration requirements of the Securities Act;
provided, however, that by making the representations herein, such Lender does not agree to hold any of the Securities for any minimum or other specific term and reserves the right to assign, transfer or otherwise dispose of any of the
Securities at any time in accordance with or pursuant to a registration statement or an exemption under the Securities Act. 
 (b) Such
Lender is an “accredited investor” as that term is defined in Rule 501(a) of Regulation D. 
 (c) Such Lender understands that the
Securities are being offered and sold to it in reliance on specific exemptions from the registration requirements of the United States federal and state securities laws and that the Borrower is relying in part upon the truth and accuracy of, and
such Lender’s compliance with, the representations, warranties, agreements, acknowledgments and understandings of such Lender set forth herein in order to determine the availability of such exemptions. 

  
 69 

 (d) Such Lender and its advisors, if any, have been furnished with all materials relating to
the business, finances and operations of the Loan Parties and their Subsidiaries and materials relating to the offer and sale of the Securities that have been requested by such Lender. Such Lender and its advisors, if any, have been afforded the
opportunity to ask questions of the Loan Parties. Neither such inquiries nor any other due diligence investigations conducted by such Lender or its advisors, if any, or its representatives shall modify, amend or otherwise affect such Lender’s
right to rely on the representations and warranties of the Loan Parties and their Subsidiaries contained in Article 3 and elsewhere in the Loan Documents. Such Lender can bear the economic risk of a total loss of its investment in the Securities
being offered and has such knowledge and experience in business and financial matters so as to enable it to understand the risks of and investment decision with respect to its investment in the Securities. 

(e) Such Lender understands that no United States federal or state agency or any other government or Governmental Authority has passed on or
made any recommendation or endorsement of the Securities or the fairness or suitability of the investment in the Securities nor have such authorities passed upon or endorsed the merits of the offering of the Securities. 

(f) Such Lender is duly organized and validly existing under the laws of the jurisdiction of its formation. 

(g) Each Loan Document to which such Lender is a party has been duly authorized, executed and delivered by such Lender and constitutes the
valid and legally binding obligation of such Lender, enforceable against such Lender in accordance with its terms, except as such enforceability may be limited by (i) applicable insolvency, bankruptcy, reorganization, moratorium or other
similar laws affecting creditors’ rights generally, and (ii) applicable equitable principles (whether considered in a proceeding at law or in equity). 

(h) Such Lender has the requisite power and authority to enter into and perform its obligations under each of the Loan Documents to which such
Lender is a party. 
 (i) Such Lender understands that the Securities are characterized as “restricted securities” under the U.S.
federal securities laws inasmuch as they were, or are being, acquired from the Borrower (or the Guarantors, as applicable) in a transaction not involving a public offering and that none of the Securities may be resold and/or hedged except pursuant
to an effective registration statement under the Securities Act or an exemption from the registration requirements of the Securities Act, including Rule 144 under the Securities Act, Section 4(a)(7) of the Securities Act or a so-called “4[(a)] and a half” transaction (without limiting the representations and warranties of the Borrower set forth in Section 3.1(z)). 

ARTICLE 4 
 CLOSING
CONDITIONS 
 Section 4.1 Conditions to the Disbursements. The effectiveness of this Agreement
and the other Loan Documents being executed and delivered on the Agreement Date, in each case, shall be subject to the fulfillment and satisfaction of all of the following conditions: 

(a) Agent and the Lenders shall have received executed counterparts of each of the following documents and the Loan Documents and other
agreements, instruments and documents set forth on the closing checklist attached hereto as Exhibit D, each in form and substance satisfactory to Agent: 

(i) this Agreement 

  
 70 

 (ii) the Control Agreements required to be delivered on the Agreement Date
pursuant to this Agreement and the other Loan Documents; 
 (iii) the Security Agreement; 

(iv) the Intercompany Subordination Agreement; 

(v) the Copyright Security Agreement; 

(vi) the Patent Security Agreement; 

(vii) the Intercreditor Agreement; and 

(viii) the Trademark Security Agreement; 

(b) the Additional Warrants shall have been duly executed, issued and delivered to the Lenders in accordance with Section 2.8; 

(c) each representation and warranty by any Loan Party or any of its Subsidiaries contained herein or in any other Loan Document is true,
correct and complete in all material respects (without duplication of any materiality qualified contained therein) as of such date, except to the extent that such representation or warranty expressly relates to an earlier date (in which event such
representations and warranties were true, correct and complete in all material respects (without duplication of any materiality qualifier contained therein) as of such earlier date); 

(d) neither the Borrower nor any of its Subsidiaries shall have any Indebtedness, other than Permitted Indebtedness and all other Indebtedness
shall be paid off pursuant to payoff letters reasonably satisfactory to Agent and any Liens relating thereto shall be terminated in a manner reasonably satisfactory to Agent; 

(e) all actions necessary to establish that Agent (for the benefit of itself and the Lenders) will have perfected first priority security
interests (subject only to the prior priority of the Permitted Priority Liens and Liens in the Collateral under the Loan Documents shall have been taken; 

(f) all fees required to be paid on the Agreement Date pursuant to this Agreement and the other Loan Documents and all costs and expenses
required to be paid on the Agreement Date (including pursuant to Section 6.3) pursuant to this Agreement and the other Loan Documents shall have been paid in cash to the applicable Secured Parties; 

(g) subject to Section 5.1(q), Agent shall have received all documents required to be received pursuant to Section 3.01 and
Section 3.02 of the ABL Credit Facility; 
 (h) all accrued interest on the Exchanged Deerfield Convertible Notes under the 3.25%
Convertible Note Documents through and including the Agreement Date (plus an additional day of interest to the extent all such accrued interest thereon is not paid by the payment deadline time set forth in the 3.25% Convertible Note Documents) shall
have been paid in cash to Deerfield Partners, L.P., as the holder of the Exchanged Deerfield Convertible Notes; 
 (i) no Default or Event of
Default (both under the Prior Loan Documents and the Loan Documents) shall have occurred or would result from the transactions being consummated on the 

  
 71 

 
Agreement Date (including the funding of any loans or disbursements to the Loan Parties or their Subsidiaries by any Person on the Agreement Date and any use of the proceeds thereof); 

(j) [reserved]; 
 (k) the Borrower
shall have delivered to the Secured Parties a letter from the transfer agent for the Common Stock certifying the number of shares of Common Stock outstanding as of a date within two (2) Business Days prior to the Agreement Date; 

(l) [reserved]; 
 (m) Agent shall
have received a certificate from a responsible officer of each Loan Party: 
 (i) attesting to the resolutions of such Loan
Party’s board of directors authorizing its execution, delivery, and performance of the Loan Documents to which it is a party, 

(ii) authorizing specific officers of such Loan Party to execute the same, attesting to the incumbency and signatures of such
specific officers of such Loan Party, 
 (iii) attesting to copies of each Loan Party’s Organizational Documents, as
amended, modified, or supplemented to the Agreement Date, which Organizational Documents shall be (A) certified by an Authorized Person of such Loan Party, and (B) with respect to Organizational Documents that are charter documents,
certified as of a recent date (not more than thirty (30) days prior to the Agreement Date) by the appropriate governmental official, 

(iv) attesting to certificates of status with respect to each Loan Party, dated within ten (10) days of the Agreement
Date, such certificates to be issued by the appropriate officer of the jurisdiction of organization of such Loan Party, which certificates shall indicate that such Loan Party is in good standing in such jurisdiction, 

(v) attesting to certificates of status with respect to each Loan Party, each dated within thirty (30) days of the
Agreement Date, such certificates to be issued by the appropriate officer of the jurisdictions (other than the jurisdiction of organization of such Loan Party) in which such Loan Party’s failure to be duly qualified or licensed would constitute
a Material Adverse Effect, which certificates shall indicate that such Loan Party is in good standing in such jurisdictions, and 

(vi) Agent shall have received all requested collateral access agreements in favor of Agent, from all mortgagees, landlords
and operators of warehouses in which a Loan Party operates or maintains any Collateral; 
 (n) Agent shall have received an opinion of the
Loan Parties’ counsel in form and substance reasonably satisfactory to Agent; and 
 (o) Agent shall have received the ABL Debt
Documents, which shall be in form and substance reasonably satisfactory to the Agent and the Lenders and the Agent and the Lenders shall have received evidence reasonably satisfactory to them that all conditions set forth in the ABL Debt Documents
to make such documents effective and closed and to fund loans thereunder have been satisfied in all 

  
 72 

 
respects. 
 ARTICLE 5 

PARTICULAR COVENANTS AND EVENTS OF DEFAULT 

Section 5.1 Affirmative Covenants. 

For so long as the Obligations (other than unasserted contingent indemnification obligations and other than those Obligations under any Warrant or the
Registration Rights Agreement; provided that Sections 5.1(h), (p), (s) and (aa) shall survive until the end of the Reporting Period) remain outstanding: 

(a) The Loan Parties will and will cause their Subsidiaries to (i) preserve and maintain in full force and effect its organizational
existence and good standing under the Applicable Laws of its jurisdiction of incorporation, organization or formation, as applicable, other than as permitted under Section 5.2(i), and (ii) preserve and maintain all qualifications to do
business in each other jurisdiction not covered by clause (i) above that the failure to be so qualified could reasonably be expected, individually or in the aggregate, to have a Material Adverse Effect. 

(b) The Loan Parties will, and will cause their Subsidiaries to, (i) comply in all material respects with all Applicable Laws, except
where the necessity of compliance therewith is contested in good faith by appropriate proceedings or where failure to do so could not reasonably be expected, individually or in the aggregate, to have a Material Adverse Effect, and (ii) maintain
in effect and enforce policies and procedures designed to ensure compliance by the Loan Parties, their Subsidiaries and their respective directors, officers and employees with Anti-Corruption Laws, Anti-Money Laundering Laws and applicable
Sanctions. 
 (c) The Loan Parties will, and will cause their Subsidiaries to, obtain, make and keep in full force and effect all licenses,
certificates, approvals, registrations, clearances, Authorizations and permits required to conduct their businesses, except where the failure to make and keep such licenses, certificates, approvals, registrations, clearances, authorizations and
permits in full force and effect could not reasonably be expected, individually or in the aggregate, to result in a Material Adverse Effect. 

(d) Each Loan Party will, except as otherwise permitted by this Agreement, maintain, and will cause each of its Subsidiaries to maintain, and
preserve all its assets and property which is used or useful in its business in good working order and condition, ordinary wear and tear excepted and will make all necessary repairs thereto and renewals and replacements thereof, except, in each
case, where the failure to do so could not reasonably be expected, individually or in the aggregate, to have a Material Adverse Effect. 

(e) The Loan Parties will, and will cause each of their Subsidiaries to, maintain with financially sound and reputable insurance companies with
respect to their assets, properties and business, against such hazards and liabilities, of such types and in such amounts, as is customarily maintained by companies in the same or similar businesses similarly situated. All property insurance
policies covering the Collateral are to be made payable to Agent for the benefit of Agent and the Lenders, as their interests may appear, in case of loss, pursuant to a standard lender’s loss payable endorsement with a standard noncontributory
“lender” or “secured party” clause and are to contain such other provisions as Agent may reasonably require to fully protect the Lenders’ interest in the Collateral and to any payments to be made under such policies. All
certificates and endorsements of property and general liability insurance are to be delivered to Agent by the Loan Parties, with the lender’s loss payable (but only in respect of Collateral) and additional insured endorsements in favor of Agent
and will provide for not less than 30 days (10 days in the case of non-payment) prior written notice to Agent of the exercise of any right of cancellation or any

  
 73 

 
modification thereof; provided, however, that, for the avoidance of doubt, Agent need not be named on any workers compensation or D&O policies. If Loan Parties or their
Subsidiaries fail to maintain such insurance, Agent may arrange for such insurance, but at Loan Parties’ expense and without any responsibility on Agent’s part for obtaining the insurance, the solvency of the insurance companies, the
adequacy of the coverage, or the collection of claims. The Loan Parties shall give Agent prompt written notice of any loss exceeding $500,000 covered by any Loan Party’s or any Loan Party’s Subsidiary’s casualty or business
interruption insurance. Upon the occurrence and during the continuance of an Event of Default, Agent shall have the sole right to file claims under any property and general liability insurance policies in respect of the Collateral, to receive,
receipt and give acquittance for any payments that may be payable thereunder, and to execute any and all endorsements, receipts, releases, assignments, reassignments or other documents that may be necessary to effect the collection, compromise or
settlement of any claims under any such insurance policies. A true and complete listing of such insurance, including issuers, coverages and deductibles, will be provided by the Loan Parties to Agent promptly following Agent’s request. 

(f) Each Loan Party will, and will cause each of its Subsidiaries to, pay, discharge and perform as the same shall become due and payable or
required to be performed all Tax liabilities, assessments and governmental charges or levies upon it or its property, unless the same are being contested in good faith by appropriate proceedings diligently prosecuted which stay the enforcement of
any Lien and for which adequate reserves in accordance with GAAP are being maintained by such Person. 
 (g) The Loan Parties will promptly
after knowledge (and, in any event, within two (2) Business Days after knowledge) notify the Agent of the occurrence of (A) any Default or Event of Default and (B) so long as such type of notification would not be material nonpublic
information of the Borrower, any claims (other than in connection with the denial of plan claims in the ordinary course of business), litigation, arbitration, mediation or administrative or regulatory proceedings that are instituted or threatened
against any Loan Party, or claims of infringement by any Person with respect to any Intellectual Property rights of a Loan Party, in each case of this clause (B), to the extent such claim, litigation, arbitration, mediation or administrative or
regulatory proceeding could reasonably be expected, individually or in the aggregate, to have a Material Adverse Effect. 
 (h) From the
Prior Agreement Date until the later of (y) the first date on which no Warrants remain outstanding, and (z) the first date on which the Secured Parties no longer own any Securities (the period ending on such latest date, the
“Reporting Period”), the Borrower and its Subsidiaries will (i) timely (without giving effect to any extensions pursuant to Rule 12b-25 of the Exchange Act) file all reports required to
be filed with the SEC pursuant to the Exchange Act, and the Borrower and its Subsidiaries will not terminate the registration of the Common Stock under the Exchange Act or otherwise terminate its status as an issuer required to file reports under
the Exchange Act, even if the securities laws would otherwise permit any such termination and (ii) deliver to Agent a Compliance Certificate with each of its 10-Q and
10-K filings on the date such filings are made (or, if earlier, are required by the SEC to be made) with the SEC; provided that, with respect to clause (ii) only, solely to the extent any earnings
or revenue report for the same period is publicly reported or is filed with the SEC prior to the time when any 10-Q or 10-K containing the applicable quarterly or annual
financial statements is filed with the SEC and to the extent the earnings or revenue set forth in any such earnings or revenue report would result in a financial covenant default under Section 5.2(xxv), the Compliance Certificate shall instead
be delivered by the Loan Parties to the Agent and the Lenders on the same day as such earnings or revenue report is publicly reported or is filed with the SEC. Each of such reports in Section 5.1(h)(i) above will comply in all material respects
with the applicable requirements of the Exchange Act and each of such reports in Section 5.1(h)(i) above and such Compliance Certificate will not contain any untrue statement of a material fact or omit to state a material fact required to be
stated therein or necessary in order to make the statements therein, in the light of the circumstances under which they were made, not misleading. The consolidated financial statements 

  
 74 

 
included in such reports will comply as to form in all material respects with applicable accounting requirements and the published rules and regulations of the SEC with respect thereto, will be
prepared in accordance with GAAP, consistently applied (subject, in the case of unaudited quarterly financial statements, to normal year-end adjustments and lack of footnote disclosures), and will fairly
present in all material respects the consolidated financial position of the Borrower and its Subsidiaries as of the dates thereof and the consolidated results of their operations, cash flows and changes in stockholders equity for the periods
presented (subject, in the case of unaudited quarterly financial statements, to normal year-end audit adjustments and lack of footnote disclosures). The Borrower hereby agrees that, during the Reporting
Period, the Borrower will send to each Secured Party copies of (A) any notices and other information made available or given to the holders of the Stock of the Borrower generally, contemporaneously with the Borrower’s making available or
giving such notices and other information to such holders of Stock (it being understood and agreed that delivery will be deemed to have occurred if such notices or other information is posted to EDGAR) and (B) all other documents, reports,
financial data and other information not available on EDGAR that does not contain any material nonpublic information of the Borrower, that any Secured Party may reasonably request. 

(i) Each Loan Party will, and will cause each of its Subsidiaries to, with respect to each owned, leased or controlled property, at all times
and without notice, at the sole option of Agent or any Lender: (a) provide access to such property to Agent, the Lenders and their respective representatives and agents, as frequently as Agent or any Lender determines to be appropriate; and
(b) permit Agent or any Lender to conduct field examinations, appraise, inspect, and make extracts and copies (or take originals if reasonably necessary) from all of such Loan Party’s and its Subsidiaries’ books and records, and
evaluate and conduct appraisals and evaluations in any manner and through any medium that Agent or any Lender considers advisable, in each instance, at the Loan Parties’ sole expense. Any Lender may accompany Agent or its representatives in
connection with such inspection. Notwithstanding the foregoing, the Loan Parties will (and will cause each of their respective Subsidiaries to) comply with (and coordinate with Agent and the Lenders and their representatives and agents to make sure
of compliance with) Section 5.1(q) in connection with any such inspection, examination, audit or analysis. 
 (j) Each Loan Party will
ensure that all written information, exhibits and reports furnished to any Secured Party, when taken as a whole, do not and will not contain any untrue statement of a material fact and do not and will not omit to state any material fact or any fact
necessary to make the statements contained therein not materially misleading in light of the circumstances in which made, and will promptly disclose, after knowledge of any defect of a material fact, untrue statement of material fact, material
misstatement or error of a material fact, to Agent and the Lenders and correct any such defect, untrue statement of material fact, material misstatement or error of a material fact that has been discovered therein or in any Loan Document or in the
execution, acknowledgement or recordation thereof; it being acknowledged and agreed that any projections provided to the Secured Parties are not to be viewed as facts, are not a guarantee of financial performance, and are subject to uncertainties
and contingencies. 
 (k) Each Loan Party will enter into, and cause each depository, securities intermediary or commodities intermediary to
enter into, Control Agreements with respect to each deposit, securities, commodity or similar account maintained by such Person (other than (i) deposit accounts exclusively used for payroll, payroll taxes and other employee wage and benefit
payments to or for the benefit of the Borrower’s employees and identified to Agent by the Borrower as such, (ii) zero balance accounts; provided that such accounts have been identified to Agent by the Borrower as such, (iii) such
other petty cash deposit accounts, amounts on deposit in which do not exceed $100,000 in the aggregate at any one time, (iv) escrow, trust and fiduciary accounts, (v) each account of Excluded Foreign Subsidiaries, (vi) deposit account
#XXXXX7912 of TriVascular Canada LLC at Bank of Montreal; provided the aggregate amount on deposit in such deposit account(s) does not exceed 1,000,000 Canadian dollars at any time, and (vii) the Bank of America Cash Collateral Account
(such accounts in clauses (i) through (vii), the 

  
 75 

 
“Excluded Accounts”)) as of and after the Prior Agreement Date; provided that (x) the Loan Parties will have until the date that is forty-five (45) days
following the closing date of any Permitted Acquisition (or such later date as may be agreed to by Agent in its sole reasonable discretion) to comply with the provisions of this Section 5.1(k) with regard to such accounts (other than Excluded
Accounts) of the Loan Parties acquired in connection with such Permitted Acquisition, and (y) for deposit accounts, securities accounts and commodities accounts opened after the Agreement Date, the Loan Parties will have until the date that is
thirty (30) days following the opening of any such new account (or such later date as may be agreed to by Agent in its sole reasonable discretion) to comply with this clause (k). Upon written request by the Agent, the Loan Parties will provide
Agent with written evidence reasonably satisfactory to the Agent as of such Business Day or the next Business Day showing compliance with Section 5.2(xxiv). 

(l) Promptly upon request by Agent, the Loan Parties will (and, subject to the limitations set forth herein and in the other Loan Documents,
will cause each of their Subsidiaries to) take such additional actions and execute such documents as Agent may reasonably require from time to time in order (i) to carry out more effectively the purposes of this Agreement or any other Loan
Document, (ii) to subject to the Liens created by any of the Loan Documents any of the assets or properties, rights or interests covered by any of the Loan Documents, (iii) to perfect and maintain the validity, effectiveness and priority
of any of the Loan Documents and the Liens intended to be created thereby, and (iv) to better assure, grant, preserve, protect and confirm to the Secured Parties the rights granted or now or hereafter intended to be granted to the Secured
Parties under any Loan Document. The Loan Parties will notify Agent in writing prior to (and on) (x) the date of formation or acquisition of any Subsidiary and (y) any division or split of any Loan Party into two or more Subsidiaries,
limited liability companies, other entities or other Persons. Without limiting the generality of the foregoing, the Loan Parties will cause (y) each of their Subsidiaries (other than Excluded Subsidiaries) promptly after (but, in any event,
(A) within fifteen (15) days thereof for any Subsidiary that is not an Immaterial Subsidiary and (B) within thirty (30) days thereof for any Immaterial Subsidiary) the date of the formation or acquisition thereof (and any
Subsidiaries, limited liability companies, other entities or other Persons for which any Loan Party divides or splits itself into), to guaranty the Obligations and to cause each such Subsidiary (and any such Subsidiary, limited liability company,
other entity or other Person for which any Loan Party divides or splits itself into) to grant to Agent, for the benefit of the Secured Parties, a security interest in, subject to the limitations set forth herein and in the Loan Documents, all of
such Subsidiary’s (and, with respect to any such division or split of a Loan Party, all such Subsidiary’s limited liability company’s, other entity’s or other Person’s) assets and property (including any assets or property
allocated, distributed, conveyed or otherwise transferred pursuant to any division or split of any Loan Party into any Subsidiaries, limited liability companies, other entities or other Persons for which any Loan Party divides or splits itself into)
to secure such guaranty and (z) any holder (that is a Loan Party) of the Stock of such Subsidiary to provide, promptly after (but, in any event, (A) within fifteen (15) days thereof for any Subsidiary that is not an Immaterial
Subsidiary and (B) within thirty (30) days thereof for any Immaterial Subsidiary) the date of (x) the formation or acquisition of such Subsidiary or (y) any division or split of any Loan Party into two or more Subsidiaries,
limited liability companies, other entities or other Persons, in each case, supplements and further pledges to the Loan Documents as are necessary (or requested by Agent) to evidence Agent’s Lien in the Stock of such Subsidiary. Furthermore,
the Borrower will notify Agent and the Lenders in writing promptly after (but, in any event, (A) within fifteen (15) days thereof for any Loan Party or any Subsidiary that is not an Immaterial Subsidiary and (B) within thirty
(30) days thereof for any Immaterial Subsidiary) the date of the issuance by or to any Loan Party (other than by the Borrower) of any Stock of any corporation or any other Person that has “opted into” Article 8 of the UCC (in each
case, other than Excluded Property) to have its Stock constitute “securities” under Article 8 of the UCC and each Loan Party will pledge, and will cause each of its Subsidiaries (other than Excluded Subsidiaries) to pledge, all of the
Stock of each of its Subsidiaries (other than Excluded Subsidiaries but including any Subsidiaries, limited liability companies, other entities or other Persons for which any such Loan Party divides or splits itself into), and sixty-five percent
(65%) of the outstanding voting Stock and one hundred percent (100%) of the outstanding 

  
 76 

 
non-voting Stock of each Excluded Foreign Subsidiary and each Excluded Domestic Holdco, directly owned by a Loan Party, in each instance, to Agent, for the
benefit of the Secured Parties, to secure the Obligations, promptly after formation or acquisition (or division or split) of such Subsidiary. The Loan Parties will deliver, or cause to be delivered, to Agent, appropriate resolutions, secretary
certificates, certified Organizational Documents and, if reasonably requested by Agent, legal opinions relating to the matters described in this Section 5.1(l) (which opinions will be in form and substance reasonably acceptable to Agent and, to
the extent applicable, substantially similar to the opinions delivered on the Prior Agreement Date and the Agreement Date), in each instance with respect to (1) each Loan Party or Subsidiary formed or acquired (and each Subsidiary, limited
liability company, other entity or other Person for which a Loan Party divides or splits itself into), (2) each Loan Party or Person (other than a Loan Party) whose Stock is being pledged, and (3) the assets and property that are allocated,
distributed, conveyed or otherwise transferred pursuant to any division or split of any Loan Party into any Subsidiaries, limited liability companies, other entities or other Persons for which any Loan Party divides or splits itself into, in each
case of clauses (1) through (3), after the Prior Agreement Date. In connection with each pledge of Stock, the Loan Parties will deliver, or cause to be delivered, to Agent, irrevocable proxies and Stock powers and/or assignments, as applicable,
duly executed in blank. 
 (m) Each Loan Party will, and will cause each of its Subsidiaries to, comply with, and maintain its Real Estate,
whether owned, leased, subleased or otherwise operated or occupied, in compliance with all applicable Environmental Laws and Healthcare Laws or that is required by orders and directives of any Governmental Authority, except where the failure to
comply could not reasonably be expected, individually or in the aggregate, to result in a Material Adverse Effect. 
 (n) Promptly upon
becoming aware that any of the following events has occurred, the Borrower will provide written notice to the Agent specifying the nature of such event, what action the Loan Party or any ERISA Affiliates has taken, is taking or proposes to take with
respect thereto and, when known, if applicable, any action taken or threatened by the Internal Revenue Service, the Department of Labor or the PBGC with respect thereto: (i) any ERISA Event which could reasonably be expected, individually or in
the aggregate, to have a Material Adverse Effect, (ii) a “prohibited transaction” as defined under Section 406 of ERISA or Section 4975 of the Code that is not exempt under ERISA Section 408 or Section 4975 of the
Code, under any applicable regulations and published interpretations thereunder or under any applicable prohibited transaction, individual or class exemption issued by the Department of Labor, with respect to any Employee Benefit Plan, which could
reasonably be expected, individually or in the aggregate, to have a Material Adverse Effect, or (iii) the imposition of any Lien on any asset of a Loan Party or a Subsidiary of a Loan Party with respect to any Title IV Plan or Multiemployer
Plan. 
 (o) The Borrower agrees to timely file a Form D with respect to the Securities as required under Regulation D and to provide a copy
thereof to each Secured Party promptly after such filing. The Borrower will make all filings and reports relating to the offer and sale of the Securities required under applicable securities or “Blue Sky” laws of the states of the United
States following the Prior Agreement Date. 
 (p) The Borrower will take all actions necessary to cause the Common Stock to remain listed on
the Principal Market during the Reporting Period. The Borrower will not, and will cause each of the Subsidiaries not to, take any action that would be reasonably expected to result in the delisting or suspension or termination of trading of the
Common Stock on the Principal Market. The Loan Parties will pay all fees, costs and expenses in connection with satisfying its obligations under this Section 5.1(p). The Borrower shall take all action necessary to at all times have authorized,
and reserved for the purpose of issuance, a sufficient number of Common Shares to enable the Borrower to satisfy its obligations under the Warrants and the First Out Waterfall Notes (computed without regard to any limitations on the number of shares
that may be issued on exercise or conversion thereof). 

  
 77 

 (q) At or prior to 7:30 a.m. (New York City time) on the first (1st) Business Day following
the Agreement Date, the Borrower will file a Form 8-K with the SEC describing the terms of the transactions contemplated by the Loan Documents and the ABL Credit Facility and the ABL Debt Documents and
including as exhibits to such Form 8-K this Agreement (including the schedules, annexes and exhibit forms hereto), the forms of Notes, the form of Additional Warrant, the Registration Rights Agreement, the
other Loan Documents listed on Schedule 5.1(q) and the ABL Credit Facility and the ABL Debt Documents (such Form 8-K, the “Announcing Form 8-K”).
Subject to the foregoing, no Loan Party will issue any press releases or any other public statements with respect to the transactions contemplated by any Loan Document or disclosing the name of any Secured Party; provided, however,
that the Borrower will be entitled, without the prior approval of any Secured Party, to make any press release or other public disclosure with respect to such transactions (i) in substantial conformity with the Announcing Form 8-K and contemporaneously therewith and (ii) as is required by Applicable Law and regulations (provided that each Secured Party will be consulted by the Borrower in connection with any such press release
or other public disclosure prior to its release and will be provided with a copy thereof by the borrower other than filings required by the Exchange Act to be made with the SEC, which Borrower may make without such consultation or notice). From and
after the Borrower’s filing of the Announcing Form 8-K, no Secured Party shall be in possession of any material nonpublic information received from the Borrower or any of its Subsidiaries or Affiliates or
any of its or their respective officers, directors, employees, attorneys, representatives or agents. Without limiting the foregoing, the Loan Parties represent and warrant that no Loan Document or other agreement, instrument, certificate,
information or other document provided by any Loan Party or any of its Related Parties to any Secured Party on or about the Agreement Date that is not filed as an exhibit to the Announcing Form 8-K
constitutes, or contains, reflects or references any information that constitutes, material nonpublic information with respect to the Borrower or any of its Subidiaries or Affiliates (except to the extent the same information is expressly set forth
in the Announcing Form 8-K or an exhibit thereto). Notwithstanding any other requirement of this Agreement or any other Loan Document, each Loan Party will not, and will cause each of its Subsidiaries and
Affiliates and its and each of their respective officers, directors, employees. Attorneys, representatives and agents to not, provide any Secured Party with any material nonpublic information regarding the Borrower or any of its Subsidiaries or
Affiliates from and after the filing of the Announcing Form 8-K with the SEC without the express prior written consent of such Secured Party. Each Loan Party hereby acknowledges and agrees that no Secured
Party (nor any of such Secured Party’s Affiliates) shall have any duty of trust or confidence with respect to, or any obligation not to trade in any securities on the basis of, any material nonpublic information regarding the Borrower or any of
its Subsidiaries or Affiliates (A) provided by, or on behalf of, the Borrower or any of its Subsidiaries or Affiliates, or any of its or their respective officers, directors, employees, attorneys, representatives or agents, in breach or
violation of any of the representations, covenants, provisions or agreements set forth in this Section 5.1(q) or (B) otherwise possessed (or continued to be possessed) by any Secured Party (or any Affiliate thereof) as a result of any
breach or violation of any representation, covenant, provision or agreement set forth in this Section 5.1(q). Notwithstanding anything to the contrary herein, in the event that any Loan Party believes that a notice or communication to any
Secured Party contains material, nonpublic information relating to any Loan Party, any of its Subsidiaries or Affiliates or any of their respective property or Stock, the Borrower will so indicate to the Secured Parties contemporaneously with
delivery of such notice or communication, and such indication shall provide the Secured Parties the means to refuse to receive such notice or communication; and in the absence of any such indication, the holders of the Securities shall be allowed to
presume that all matters relating to such notice or communication do not constitute material, nonpublic information relating to any Loan Party, any of its Subsidiaries or Affiliates or any of their respective property or Stock. Upon receipt or
delivery by any Loan Party or any of its Subsidiaries of any notice in accordance with the terms of the Loan Documents, unless the Borrower has in good faith determined that the matters relating to such notice do not constitute material, nonpublic
information relating to any Loan Party or any of its Subsidiaries or Affiliates or their respective property or Stock, the Loan Parties will, within one Business Day after any such receipt or delivery publicly disclose such material, nonpublic
information. In the event of a breach of 

  
 78 

 
any of the foregoing covenants by any Loan Party or any of its Subsidiaries or Affiliates, or any of its or their respective officers, directors (or equivalent persons), employees, attorneys,
representatives or agents, in addition to any other remedies provided in the Loan Documents or otherwise available at law or in equity, the Secured Parties shall have the right to make a public disclosure in the form of a press release, public
advertisement or otherwise, of the applicable material nonpublic information regarding the Borrower or its Subsidiaries or Affiliates without the prior approval by any Loan Party or its Subsidiaries or Affiliates, or any of its or their respective
officers, directors (or equivalent persons), employees, attorneys, representatives or agents, and no Secured Party shall have any liability to any Loan Party, any of its Subsidiaries or Affiliates or any of its or their respective officers,
directors (or equivalent persons), employees, equityholders, attorneys, representatives or agents for any such disclosure. 
 (r) The
Borrower acknowledges and agrees that the Securities may be pledged by a holder thereof in connection with a bona fide margin agreement or other loan, financing or Indebtedness secured by the Securities. The pledge of Securities shall not be deemed
to be a transfer, sale or assignment of the Securities under the Loan Documents, and no such holder effecting any such pledge of Securities shall be required to provide any Loan Party or any of its Subsidiaries with any notice thereof or otherwise
make any delivery to any Loan Party pursuant to any Loan Document. The Borrower hereby agrees to execute and deliver such documentation as a pledgee of the Securities may reasonably request in connection with a pledge of the Securities to such
pledgee by a holder of Securities. 
 (s) During the Reporting Period, except as otherwise provided in the Loan Documents, the Borrower will
not in any manner issue or sell any Options or Convertible Securities that are convertible into or exchangeable or exercisable for shares of Common Stock at a price that varies or may vary with the market price of the Common Stock, including by way
of one or more resets to a fixed price or increases in the number of shares of Common Stock issued or issuable, or at a price that upon the passage of time or the occurrence of certain events automatically is reduced or is adjusted or at the option
of any Person may be reduced or adjusted, whether or not based on a formulation of the then current market price of the Common Stock (other than proportional adjustments as a result of subdivisions or combinations of the Common Stock in the form of
stock splits, stock dividends, reverse stock splits, combinations or recapitalizations). For the avoidance of doubt, this clause (s) does not prohibit any convertible notes contemplated under clause (k) of the definition of “Permitted
Indebtedness” with a fixed conversion rate subject to anti-dilution adjustments or other provisions related to the conversion price and/or conversion rate that are broadly similar to the analogous provisions in the 2.25% Convertible Note
Documents or the 3.25% Convertible Note Documents or any Permitted 3.25% Convertible Note Refinancing permitted hereunder. 
 (t) Within five
Business Days after the filing (or, to the extent earlier, the date filing is required by the SEC) of its 10-K or 10-Q with the SEC (and by each date that the financial
statements are required to be delivered in Section 5.1(aa)), as the case may be, the Loan Parties and their Subsidiaries will deliver to Agent an updated Perfection Certificate. Upon the reasonable request of any Secured Party, the Loan Parties
and their Subsidiaries will promptly deliver to such Secured Party such additional business, financial, corporate affairs, perfection certificates, items or documents related to creation, perfection or priority of Agent’s Liens in the
Collateral and other information as any Secured Party may from time to time reasonably request. 
 (u) Except as could not reasonably be
expected, individually or in the aggregate, to have a Material Adverse Effect, the Borrower will, and will cause each Loan Party to, (i) obtain all Regulatory Required Permits necessary for compliance in all respects with Applicable Laws with
respect to the design, testing, manufacturing, developing, processing, assembly, packaging, labeling, distribution, commercialization, import, export, selling or marketing of Products, and (ii) maintain and comply fully and completely in all
respects with all such Regulatory Required Permits. 

  
 79 

 (v) Each Loan Party will comply, and cause each Subsidiary to comply, with the requirements
of all Applicable Laws and Material Contracts, except to the extent that failure to so comply could not reasonably be expected to (a) individually or in the aggregate, have a Material Adverse Effect, or (b) result in any Lien upon either
(i) a material portion of the assets of any such Person in favor of any Governmental Authority, or (ii) any Collateral (other than Permitted Liens). 

(w) The Borrower will, within two Business Days after delivery by a Loan Party or receipt or knowledge thereof, provide written notice to Agent
of any default or event of default under any of the ABL Debt Documents, any of the Convertible Note Documents or any of the Permitted Japan Lifeline Unsecured Debt Documents, and of any amendments, restatements, supplements, waivers or other
modifications to (or any consents to any events or actions under) any of the ABL Debt Documents, any of the Convertible Note Documents or any of the Permitted Japan Lifeline Unsecured Debt Documents or any prepayment of any of the Indebtedness
thereunder. 
 (x) The Loan Parties will keep its Inventory and Equipment (other than Inventory or Equipment that is in-transit, Trunk
Inventory or subject to consignment) only at the locations identified on Schedule 3.1(hh) and their chief executive offices only at the locations identified on Schedule 3.1(gg). 

(y) Each Loan Party and its Subsidiaries will comply with (A) in all respects with all Healthcare Laws and their implementation by any
applicable Governmental Authority, except as could not reasonably be expected, individually or in the aggregate, to have a Material Adverse Effect, and (B) (1) in all respects with all lawful requests of any Governmental Authority
applicable to its Products, except as could not reasonably be expected, individually or in the aggregate, to have a Material Adverse Effect, and (2) in all material respect with requests of any Governmental Authority applicable to its Products
that is required by Applicable Law (or court order or proceeding) to be complied with. Except as could not reasonably be expected, individually or in the aggregate, to have a Material Adverse Effect, all Products developed, manufactured, tested,
distributed, promoted or marketed by or on behalf of any Loan Party or any of its Subsidiaries that are subject to the jurisdiction of the FDA or comparable Governmental Authority shall be (i) developed, tested, manufactured, distributed,
promoted and marketed in compliance with the Healthcare Laws and each other Applicable Law, including Healthcare Laws and other Applicable Laws governing or relating to product approval or premarket notification, good manufacturing practices,
promoting, labeling, advertising, record-keeping, and adverse event reporting, and (ii) tested, investigated, distributed, labeled, promoted, marketed, and sold in compliance with Healthcare Laws and all other Applicable Laws. 

(z) Notwithstanding the conditions precedent set forth in Article 4 or any other provision set forth herein to the contrary above, the
Loan Parties have informed the Agent that certain of such items required to be delivered to the Agent and/or the Lenders or otherwise satisfied as conditions precedent to the effectiveness of this Agreement will not be delivered to Agent and the
Lenders as of the Agreement Date. Therefore, with respect to the items set forth in this Section 5.1(z) below (collectively, the “Outstanding Items”), the Loan Parties will, and the Loan Parties will cause their Subsidiaries
to, deliver (or otherwise satisfy) each Outstanding Item to the satisfaction of the Agent in the form and manner set forth below for such Outstanding Item within twenty (20) days after the Agreement Date (or within such longer time or different
form or manner as the Agent may agree in its sole discretion): 
 (i) Collateral Access Agreements with respect to the leases
of real property located at: (1) 2 Musick and 33 and 35 Hammond, Irvine, County of Orange, CA 92618 U.S.A., and (2) 3910 Brickway Blvd., Santa Rosa, County of Sonoma, CA 95403 U.S.A.; 

(ii) Collateral Access Agreement with respect to Collateral held by UPS at the following locations: (1) 378 Commercial Street,
Malden, MA 02148, (2) 165 Chubb 

  
 80 

 
Avenue, Lyndhurst, NJ 07071, (3) 1130 Commerce Blvd, Swedesboro, NJ 08085, and (4) 2250 Outerloop Drive, Louisville, KY 40219; and 

(iii) Control Agreements with respect to the accounts of the Loan Parties located at (1) Wells Fargo (with respect to the
account ending in 5279), (2) Bank of America (with respect to each of the accounts ending in 1702 and 3910), and (3) Silicon Valley Bank (with respect to the account ending in 5539). 

(aa) If the Borrower is not required to file reports pursuant to Section 13 or 15(d) of the Exchange Act, the Loan Parties will deliver to
Agent and each Lender, as soon as available, but in any event within thirty (30) days after the end of each fiscal month during each fiscal year, an unaudited consolidated and consolidating balance sheet and income statement of Borrower and its
Subsidiaries’ operations during such month and for the portion of the fiscal year then ended, including comparisons to the figures in the corresponding month and
year-to-date portion of the immediately preceding fiscal year of Borrower and its Subsidiaries. Further, if the Borrower is not required to file reports pursuant to
Section 13 or 15(d) of the Exchange Act, the Loan Parties will provide to Agent and each Lender (A) quarterly financial statements for the Borrower and its Subsidiaries and a Compliance Certificate for such period within 45 days after the
end of each fiscal quarter of the Borrower, and an audited annual financial statements and a Compliance Certificate for such period within 120 days after the end of each fiscal year of the Borrower prepared in accordance with GAAP with a report
thereon by the Borrower’s independent certified public accountants, which accountants shall be reasonably acceptable to Agent and (B) on the same day as delivery to ABL Agent, any ABL Lender or any other secured party under the ABL Debt
Documents, any additional financial statements, certificates, reports, notices, agreements, instruments and documents provided under (or in connection with) the ABL Debt Documents. Any such annual audited financial statements, audit or report of the
Borrower’s independent certified public accountants (and any annual audited financial statements, audit or report of the Borrower’s independent certified public accountants on any consolidated financial statements included in any SEC
Document filed during the Reporting Period, and including those required by Section 5.1(h)) shall (i) contain an unqualified opinion (subject to the exception set forth below in clause (ii) of this sentence), stating that such
consolidated financial statements present fairly in all material respects the financial position and condition and results of operations of the Borrower and its Subsidiaries as of the dates and for the periods and have been prepared in conformity
with GAAP applied on a basis consistent with prior years, and (ii) not include any explanatory paragraph expressing substantial doubt as to going concern status (other than any such paragraph arising from the impending maturity of the Loans
solely in the case of the audit delivered with respect to the fiscal year immediately prior to the fiscal year during which the applicable maturity is scheduled). 

Section 5.2 Negative Covenants. 
 For
so long as the Obligations (other than unasserted contingent indemnification obligations and other than those Obligations under any Warrant or the Registration Rights Agreement; provided that Section 5.2(xvii) shall survive until the end
of the Reporting Period) remain outstanding: 
 (i) No Loan Party will, nor will it permit any of its Subsidiaries to,
directly or indirectly, (A) merge with, consolidate with or into, dissolve or liquidate into or convey, transfer, lease or otherwise dispose of (whether in one transaction or in a series of transactions) all or substantially all of its assets
(whether now owned or hereafter acquired) to or in favor of any Person, except (1) a Subsidiary that is not a Loan Party may merge into any Loan Party or any Subsidiary of a Loan Party (provided that, (w) to the extent such
Subsidiary that is not a Loan Party has its equity pledged to Agent, then any Person it merges with must also have its equity pledged to Agent by at least the same percentage and (x) if such merger is with a Loan Party, such Loan Party must be
the surviving entity of any 

  
 81 

 
such merger), (2) a Loan Party may merge into any other Loan Party (provided that, (y) to the extent such Loan Party being merged has its equity pledged to Agent, then any Person it
merges with must also have its equity pledged to Agent by at least the same percentage and (z) to the extent the Borrower is part of such transaction, the Borrower must be the surviving Person), (3) any Subsidiary of the Borrower (other than,
for the avoidance of doubt, the Borrower) may liquidate or dissolve if (i) the Borrower determines in good faith that such liquidation or dissolution is in the best interests of the Borrower and it is not materially disadvantageous to the
Secured Parties and (ii) to the extent such Subsidiary is a Loan Party, any such assets or business held by such subject Subsidiary shall be transferred to, or otherwise owned or conducted by, a Loan Party after giving effect to such
liquidation or dissolution, and (4) in connection with Permitted Acquisitions, or (B) divide (or otherwise split) itself or themselves into two or more limited liability companies or other entities or Persons. None of the Loan Parties will
establish or form any Subsidiary, unless such Subsidiary complies with Section 5.1(l), if applicable, and such Subsidiary (if not an Excluded Subsidiary) executes and/or delivers all other documents, agreements and instruments reasonably
requested by Agent or the Required Lenders to perfect a Lien in favor of Agent (for the benefit of the Secured Parties) on such Subsidiary’s (if not an Excluded Subsidiary) assets and to make such Subsidiary (if not an Excluded Subsidiary) a
Guarantor under the Loan Documents. 
 (ii) No Loan Party will, nor will it permit any of its Subsidiaries to, (a) enter
into any joint venture or any similar arrangement, other than as may be permitted under Permitted Investments or (b) make any Restricted Payments, other than (1) dividends by any direct or indirect Subsidiary of any Loan Party
(A) that are not Loan Parties to its parent or parent entities or (B) that are Loan Parties to its parent or parent entities that are Loan Parties; (2) dividends payable solely in common Stock; (3) repurchases of Stock of former
employees, directors or consultants so long as an Event of Default does not exist at the time of such repurchase and would not exist after giving effect to such repurchase, provided, however, that such repurchase does not exceed
$2,500,000 in the aggregate per fiscal year; (4) any Restricted Payments made under Subordinated Debt Documents to the extent permitted under the terms of the applicable Subordination Agreement; and (5) any Restricted Payments made to the
Secured Parties pursuant to the Loan Documents. 
 (iii) No Loan Party will, nor will it permit any of its Subsidiaries to,
(a) directly or indirectly make, create, incur, assume or suffer to exist any Lien upon or with respect to any of its assets or property, of any kind, whether now owned or hereafter acquired, or any income or profits therefrom, except Permitted
Liens, or (b) directly or indirectly Dispose of (whether in one or a series of transactions) any assets or property (including the Stock of any Subsidiary of any Loan Party, whether in a public or private offering or otherwise, and accounts and
notes receivable, with or without recourse), except Permitted Dispositions or as otherwise expressly permitted by Section 5.2(i). 

(iv) No Loan Party will, nor will it permit any of its Subsidiaries to, directly or indirectly, create, incur, assume,
guarantee, permit to exist or be liable with respect to any Indebtedness, other than Permitted Indebtedness. No Loan Party will, or will permit any Subsidiary to, directly or indirectly, create, assume, incur or suffer to exist any Contingent
Obligations, except for Permitted Contingent Obligations. 
 (v) No Loan Party will, nor will it permit any of its
Subsidiaries to, directly or indirectly, (i) purchase or acquire any Stock, or any obligations or other securities of, or any interest in, any Person, including the establishment or creation of a Subsidiary, or (ii)

  
 82 

 
make or commit to make any Acquisitions, or any other acquisition of any of the assets of another Person other than (A) Permitted Investments or (B) in the Ordinary Course of Business,
or of any business or division of any Person, including by way of merger, consolidation, other combination or otherwise other than Permitted Investments, (iii) make, purchase or acquire any advance, loan, extension of credit (other than trade
payables in the ordinary course of business) or capital contribution to or any other investment in, any Person including the Borrower, any Affiliate of the Borrower or any Subsidiary of the Borrower or (iv) enter into any joint venture or any
similar arrangement (the items described in clauses (i), (ii), (iii) and (iv) are referred to as “Investments”), except for Permitted Investments. 

(vi) No Loan Party will, or will permit any of its Subsidiaries to, use the proceeds of the Loans for any purpose other than as
expressly permitted by Section 2.1. 
 (vii) Except as otherwise disclosed on Schedule 5.2(vii), and except for
transactions that contain terms that are no less favorable to the applicable Loan Party or any Subsidiary, as the case may be, than those which might be obtained from a third party not an Affiliate of any Loan Party, no Loan Party will, or will
permit any Subsidiary to, directly or indirectly, enter into or permit to exist any transaction (including the purchase, sale, lease or exchange of any property or the rendering of any service) with any Affiliate of any Loan Party that is not itself
a Loan Party; provided that, Loan Parties may enter into and maintain written agreements between any Loan Party and any Foreign Subsidiary of a Loan Party for management services for compensation in the Ordinary Course of Business consistent
with past practices that are customary and reasonably appropriate to do for companies in the same industry as the Loan Parties provided by management and officers of the Loan Parties to such Foreign Subsidiaries that do not have certain management
or officers, and such transactions may result in non-interest bearing accounts payables for the unpaid compensation owed by such Foreign Subsidiaries to the Loan Parties for such management services in an
amount not to exceed $40,000,000 (which payables may be equitized by the Loan Parties, provided that (y) equitization of such payables shall not reduce the outstanding amount of payables that count towards the $40,000,000 cap above for purposes
of determining whether the Loan Parties have complied with this provisions (with such equitized amounts deemed to be outstanding at all times thereafter for purposes of the $40,000,000 capped amount) and (z) at the time of any such
equitization, any such Stock received by any Loan Party in connection with such equitization shall be pledged, and a first priority security interest and Lien thereon shall be granted, to the Agent (for the benefit of the Secured Parties) and such
Loan Party shall take such perfection and priority actions reasonably requested by the Agent in accordance with the Loan Documents), in each case of the foregoing in this proviso, so long as (a) any such management or officers of the Loan
Parties involved in such transactions, agreements and arrangements will have sufficient and reasonable time, energy and resources to still represent and service such Loan Parties themselves after taking into such transactions, agreements and
arrangements, (b) any such agreement, instrument, arrangement or document evidencing any of the foregoing transactions, equitization or actions shall be entered into in good faith by such Loan Party, (i) in a manner to not contravene or
impair the Collateral and benefits that are intended to be provided and afforded to the Secured Parties under the Loan Documents, and (ii) without (A) the intention of such Loan Party of causing (or resulting in) the Collateral to be taken
from the Secured Parties and provided to Foreign Subsidiaries that are not Loan Parties at the detriment of the Secured Parties and for the benefit of such Foreign Subsidiaries, and (B) the effect of defrauding the Secured Parties, (c) the
upstream economics received (or potentially to be received) by any applicable Loan Party in 

  
 83 

 
connection with any such transaction, agreement or arrangement described above in this proviso, when combined with the potential downstream economics, time, energy and recourses exhausted or
disposed of in connection therewith shall be reasonably adequate and sufficient to enable the Loan Parties to timely satisfy all of the Obligations and all of their other obligations and agreements under the Loan Documents, (d) all cash, Cash
Equivalents, other assets and proceeds received or provided to the Loan Parties in connection with the foregoing shall all be part of the (and constitute) Collateral and the Agent (for the benefit of the Secured Parties) shall have a first priority
security interest and Lien thereon, (e) at the reasonable request of the Agent, all such account payables will be evidenced by a promissory note issued to the applicable Loan Party by the applicable Foreign Subsidiary and pledged to the Agent
and the original thereof delivered, along with an executed allonge to the Agent in form and substance satisfactory to the Agent, (f) no Default or Event of Default has occurred and is continuing or would result therefrom, and (g) no such
agreement, arrangement, transaction or action could reasonably be expected, individually or in the aggregate, to result in a Material Adverse Effect. 

(viii) No ERISA Affiliate will cause or suffer to exist (a) any event that could result in the imposition of a Lien on any
asset of a Loan Party or a Subsidiary of a Loan Party with respect to any Title IV Plan or Multiemployer Plan, or (b) any other ERISA Event, which other ERISA Event could reasonably be expected, individually or in the aggregate, to have a
Material Adverse Effect. 
 (ix) No Loan Party will, and no Loan Party will permit any of its Subsidiaries to, engage in any
line of business different from those lines of business carried on by it on the Prior Agreement Date and businesses reasonably related thereto. 

(x) Except as permitted under Section 5.2(i), no Loan Party will, and no Loan Party will permit any of its Subsidiaries
to, directly or indirectly amend or otherwise modify any of its Organizational Documents or, after the execution thereof, any agreements or documents evidencing or contemplating any Permitted Acquisition in any respect materially adverse to any
Secured Party. No Loan Party will, or will permit any Subsidiary to, directly or indirectly, amend, restate, supplement, change, waive or otherwise modify any Material Contract, which amendment, restatement, supplement, change, waiver or
modification in any case: (a) is contrary to (or is in violation or breach of) the terms and provisions of this Agreement or any other Loan Document (including the Intercreditor Agreement); or (b) could reasonably be expected to be
materially adverse to the rights, interests or privileges of Agent or the Lenders or their ability to enforce the same (it being understood that any modification that changes the stated maturity date of the 3.25% Convertible Notes to an earlier date
shall be materially adverse to Agent and the Lenders); provided, however, that the foregoing shall not restrict (x) any changes expressly required under the terms of the 2.25% Convertible Notes as of the Prior Agreement Date, the
3.25% Convertible Notes as of the Prior Agreement Date or any indenture governing any Permitted 3.25% Convertible Note Refinancing meeting the requirements set forth in the definition of “Permitted 3.25% Convertible Note Refinancing” or
(y) any modifications of the ABL Credit Facility expressly permitted by the Intercreditor Agreement and not otherwise materially adverse to Agent or the Lenders. 

(xi) No Loan Party will, and no Loan Party will suffer or permit any of its Subsidiaries to, (a) make any significant
change in accounting treatment or reporting practices, except as required by GAAP, (b) change the fiscal year or method for determining the fiscal quarters of any Loan Party or of any Subsidiary of any Loan Party,

  
 84 

 
(c) change its name as it appears in official filings in its jurisdiction of organization or formation, or (d) change its jurisdiction of organization or formation, in the case of clauses
(c) and (d), without at least ten (10) days’ prior written notice to Agent (or such shorter period as may be agreed by Agent in its sole reasonable discretion). 

(xii) No Loan Party will, nor will it permit any of its Affiliates to, (A) declare, pay, make or set aside any amount for
payment in respect of Subordinated Debt, except for payments made in full compliance with and permitted under the Subordination Agreement, (B) amend or otherwise modify the terms of any Subordinated Debt, except for amendments and modifications
made in full compliance with the Subordination Agreement; or (C) declare, pay, make or set aside any amount for payment in respect of any Indebtedness hereinafter incurred that, by its terms, or by separate agreement, is subordinated to the
Obligations, except for payments made in full compliance with and permitted under the subordination provisions applicable thereto. 

(xiii) No Loan Party will, and no Loan Party will permit any of its Subsidiaries to, directly or indirectly, create or
otherwise cause or suffer to exist or become effective any consensual restriction or encumbrance of any kind on the ability of any Loan Party or Subsidiary to pay dividends or make any other distribution on any of such Loan Party’s or
Subsidiary’s Stock or to pay fees, including management fees, or make other payments and distributions to the Borrower or any other Loan Party, except for those in the Loan Documents and the ABL Debt Documents. No Loan Party will, and no Loan
Party will permit any of its Subsidiaries to, directly or indirectly (y) enter into, assume or become subject to any contractual obligation prohibiting or otherwise restricting the existence of any Lien upon any of its assets in favor of Agent,
whether now owned or hereafter acquired or (z) create or otherwise suffer to exist or become effective any consensual encumbrance or restriction of any kind on the ability of any Subsidiary to (1) pay any Indebtedness owed to Borrower or
any of its Subsidiaries, (2) make loans or advances to Borrower or any of its Subsidiaries or (3) transfer any of its property or assets to Borrower or any of its Subsidiaries, except (A) those in the Loan Documents and the ABL Debt
Documents, (B) an encumbrance or restriction consisting of customary non-assignment provisions in leases or licenses entered into in the Ordinary Course of Business, (C) customary provisions in joint venture agreement and other similar
agreements that restrict the transfer of ownership interests in such joint ventures or provisions limiting the disposition or distribution of assets or property (other than dividends on a pro rata basis based on ownership percentage) of the
applicable joint venture, which limitation is applicable only to the assets that are the subject of such agreements; provided that such agreement was not entered into in contravention of the terms of this Agreement, and (D) limitations
set forth in Subordinated Debt (if acceptable to the Agent in its sole discretion). 
 (xiv) No Loan Party will, and no Loan
Party will permit any of its Subsidiaries to fail to comply with the Anti-Money Laundering Laws and Anti-Terrorism Laws. No Loan Party or Subsidiary of a Loan Party, nor to the knowledge of any Loan Party or any of its Subsidiaries, any director,
officer, agent, employee or other Person acting on behalf of any Loan Party or any such Subsidiary, will request or use the proceeds of any Loan, directly or indirectly, (A) for any payments to any Person, including any government official or
employee, political party, official of a political party, candidate for political office or anyone else acting in an official capacity, in order to obtain, retain or direct business or obtain any improper advantage, or otherwise take any action,
directly or indirectly, that would result in a violation of any Anti-Corruption Laws, (B) for the purpose of funding, financing or facilitating any activities, business or transaction of or with any

  
 85 

 
Person on the SDN List or a government of a country or territory subject to comprehensive Sanctions, to the extent such activities, business or transaction would be prohibited by Sanctions if
conducted by a corporation incorporated in the United States or in a European Union member state, (C) in any manner that would result in the violation of any Sanctions applicable to any party hereto, or (D) to fund any activities or
business of or with any Person, or in any country or territory, that, at the time of such funding, is, or whose government is, the subject of sanctions pursuant to any Anti-Terrorism Laws. Furthermore, the Loan Parties will not, directly or
indirectly, use the proceeds of the Transaction, or lend, contribute or otherwise make available such proceeds to any Subsidiary, Affiliate, joint venture partner or other Person, to fund any activities of or business with any Person, or in any
country or territory, that, at the time of such funding, is the subject of Sanctions, or in any other manner that will result in a violation by any Person participating in the Transaction of any Sanctions. No Loan Party will, or will permit any
Subsidiary to, directly or indirectly, knowingly enter into any Material Contracts with any Person on the SDN List. 
 (xv)
No Loan Party will, and no Loan Party will permit any of its Subsidiaries to, engage in a sale leaseback, synthetic lease or similar transaction involving any of its assets, including pursuant to a substantially contemporaneous transaction, whereby
a Loan Party or one of its Subsidiaries sells or transfers all or substantially all of its right, title and interest in an asset and, in connection therewith, acquires or leases back the right to use such asset. 

(xvi) No Loan Party will, and no Loan Party will permit any of its Subsidiaries to, cause or suffer to exist any Release of any
Hazardous Material at, to or from any Real Estate that would violate or form the basis of Liability under any Environmental Law or Healthcare Law, other than such violations or liabilities that could not reasonably be expected, individually or in
the aggregate, to result in a Material Adverse Effect. 
 (xvii) No Loan Party will, and no Loan Party will permit any of its
Subsidiaries to, be an “investment company” or a company “controlled” by an “investment company,” as such terms are defined in the Investment Company Act, or to otherwise be registered or required to be registered, or
be subject to the restrictions imposed by, the Investment Company Act. 
 (xviii) No Loan Party will, and no Loan Party will
permit any of its Subsidiaries to, (A) make any prepayment, payment, redemption or repayment or take any action, with respect to the ABL Debt that is in violation or breach of the Intercreditor Agreement; (B) make any amendment,
restatement, supplement or modification of any ABL Debt Document in violation or breach of the Intercreditor Agreement or that is materially adverse to Agent or the Lenders; or (C) join any Subsidiary or any Affiliate of any Loan Party as a
borrower, guarantor or obligor, or have such Person pledge or grant a Lien on any of its property or assets, under the ABL Debt Documents, unless, in each case, the same Person becomes a Loan Party in the same capacity (and/or pledges and grants
Liens on the same property or assets (and with the same Lien priority and which such Liens shall be subject to the terms of the Intercreditor Agreement)) under the Loan Documents and such Person executes and delivers such agreements, instruments and
documents reasonably requested by Agent to effectuate any of the foregoing in this clause (C) and such Subsidiary or Affiliate shall be subject to the terms of the Intercreditor Agreement. 

  
 86 

 (xix) Notwithstanding anything to the contrary in this Agreement or in any
other Loan Documents, no Loan Party will, and no Loan Party will permit any of its Subsidiaries to, create, incur or suffer to exist any Indebtedness which is subordinated or junior (either in respect of Lien priority or in right of payment or any
combination thereof) to any of the ABL Debt unless such Indebtedness is expressly subordinated or junior to the Obligations (both in terms of Lien priority and in right of payment) on terms and conditions acceptable to Agent and the Lenders; it
being understood and agreed that the foregoing shall in no way limit the incurrence of unsecured Indebtedness otherwise permitted hereunder that is not payment subordinated to the ABL Debt when not also payment subordinated to the same extent to the
Obligations. 
 (xx) No Loan Party will, or will permit any Subsidiary to, declare, pay, make any payment in respect of
(I) the 3.25% Convertible Notes or the 2.25% Convertible Notes, except for: (a) regularly scheduled payments of interest and principal as set forth in the applicable Convertible Note Documents (in addition to allowing any cash principal
payments at maturity of the applicable 3.25% Convertible Notes and the 2.25% Convertible Notes, such amounts may also be paid in the applicable Stock of the Borrower or through any other conversion feature that does not effectively cause more
payments to be made at maturity thereof than the cash principal payments currently provided for in the applicable Convertible Note Documents as of the Prior Agreement Date), (b) in connection with any Permitted 3.25% Convertible Note Refinancing,
(c) the issuance of shares of common stock of the Borrower in connection with any conversion of the 3.25% Convertible Notes, the 2.25% Convertible Notes or any convertible notes that are not Disqualified Stock issued in a Permitted 3.25%
Convertible Note Refinancing, and any cash solely in lieu of fractional shares (but no other cash settlement other than as otherwise permitted by this clause (xx)), (d) payments and conversions (other than for any Disqualified Stock) made in
connection with the repurchase (whether for cash, upon exchange and/or for other consideration), redemption and retirement in respect of the 2.25% Convertible Notes or 3.25% Convertible Notes in a single or series of related transactions;
provided that (1) no Event of Default exists at the time such payments are made or would exist immediately after giving effect thereto and (2) such cash payments are made solely (A) with proceeds received by the Borrower from
the issuance of its common Stock after the Agreement Date for the purpose of making such payment, (B) [reserved] and (C) regarding the 3.25% Convertible Notes, with the proceeds of Indebtedness raised in a Permitted 3.25% Convertible Note
Refinancing, and (e) if the foregoing conditions do not otherwise permit such payment, then, with the express prior written consent of the Agent (which may be withheld in its sole discretion), payments in connection with the retirement,
redemption and repurchase of the 2.25% Convertible Notes or the 3.25% Convertible Notes, or (II) the Permitted Japan Lifeline Unsecured Debt, except with respect to any interest payments expressly permitted under the definition of
“Permitted Japan Lifeline Unsecured Debt. 
 (xxi) (a) No Loan Party will, or permit any Subsidiary to, commingle any of
its assets (including any bank accounts, cash or Cash Equivalents) with the assets of any Person; and (b) no Loan Party will, or permit any Subsidiary to enter into or own any interest in a joint venture that is not itself a corporation or
limited liability company or other legal entity in respect of which the equity holders are not liable for the obligations of such entity as a matter of law. 

(xxii) No Loan Party will, or will permit any Subsidiary to, amend, restate, supplement, change, waive or otherwise modify the
terms of any Indebtedness referred to 

  
 87 

 
in Section 5.2(xx) above (other than with respect to 3.25% Convertible Notes, in connection with a Permitted 3.25% Convertible Note Refinancing) if the effect of such amendment, restatement,
supplement, change, waiver or modification is to (a) increase the interest rate or fees on, or change the manner or timing of payment of, such Indebtedness if in any way adverse to the Agent or the Lenders, (b) accelerate or shorten the
dates upon which payments of principal or interest are due on, or the principal amount of, such Indebtedness, (c) change in a manner adverse to any Loan Party, any of its Subsidiaries, Agent or any Lender any event of default or add or make
more restrictive any covenant with respect to such Indebtedness, (d) change the prepayment provisions of such Indebtedness or any of the defined terms related thereto in a manner adverse to Agent or the Lenders, or (e) change or amend any
other term if such change or amendment would materially increase the obligations of the obligor or confer additional material rights on the holder of such Indebtedness in a manner adverse to any Loan Party, any of its Subsidiaries, Agent or Lenders;
provided, however, that (y) the foregoing shall not restrict any changes expressly required under the terms of the 3.25% Convertible Notes as in effect as of the Prior Agreement Date, the 2.25% Convertible Notes as in effect as of
the Prior Agreement Date or any changes that are permitted to be made hereunder in connection with a Permitted 3.25% Convertible Note Refinancing or any changes expressly required under any indenture governing any Permitted 3.25% Convertible Note
Refinancing that satisfies the conditions and requirements set forth in the definition of “Permitted 3.25% Convertible Note Refinancing” and (z) for the avoidance of doubt, the exchange of the Exchanged Deerfield Convertible Notes for
the Last Out Waterfall Loans under this Agreement shall not be restricted by this Section 5.2(xxiii). The Loan Parties will, prior to entering into any such amendment, restatement, supplement, change, waiver or modification, deliver to Agent
reasonably in advance of the execution thereof, any final or execution form copy thereof. 
 (xxiii) Borrower will not issue
any Stock (a) senior to its shares of Common Stock or (b) convertible into or exercisable or exchangeable for Stock senior to its Common Stock. 

(xxiv) As of (A) the end of the last Business Day of each calendar month and (B) each date that a Borrowing Base
Certificate (as defined in the ABL Credit Facility) is required to be delivered under the ABL Credit Facility or any other ABL Debt Document, the Loan Parties will not permit Global Excess Liquidity to be less than $22,500,000. 

(xxv) No Loan Party will permit the consolidated Net Revenue of the Loan Parties for any Measurement Period, tested quarterly
beginning with the fiscal quarter ending September 30, 2018, to be less than the amounts set forth below:  
  

					
	 Measurement Period Ending
	  	Minimum Net Revenue for Measurement
Period	 
	 September 30, 2018
	  	$	155,000,000	 
	 December 31, 2018
	  	$	145,000,000	 
	 March 31, 2019 and the last day of each fiscal quarter ending thereafter through (and
including) December 31, 2019
	  	$	130,000,000	 

  
 88 

					
	 March 31, 2020 and the last day of each fiscal quarter ending thereafter
	  	$	140,000,000	 

 (xxvi) No Loan Party will permit the consolidated Net Revenue of the Loan Parties for any
fiscal quarter of the Borrower, tested quarterly beginning with the fiscal quarter ending March 31, 2019 and on the last day of each fiscal quarter ending thereafter, to be less than $30,000,000. 

(xxvii) No Loan Party will, or will permit any Subsidiary to, have the aggregate amount of Operating Expenditures made by the
Loan Parties and their Subsidiaries for any Measurement Period, tested for the fiscal quarters of the Borrower ending December 31, 2018 and December 31, 2019, to exceed the amounts set forth below: 

 

					
	 Measurement Period Ending
	  	Amount	 
	 December 31, 2018
	  	$	160,000,000	 
	 December 31, 2019
	  	$	140,000,000	 

 (xxviii) Commencing as of the “Trigger Date” (as defined in the ABL Credit Agreement
as of the Agreement Date), no Loan Party, will, or will permit any Subsidiary, to have a “Fixed Charge Coverage Ratio” (such term, and all components and subcomponents thereof, as defined in the ABL Credit Agreement as of the Agreement
Date) for any Measurement Period, tested quarterly beginning with the fiscal quarter ending September 30, 2018, to be less than 1.00:1.00. 

(xxix) No Loan Party will, or will permit any Subsidiary to, have the aggregate amount of consolidated Capital Expenditures
made by the Loan Parties and their Subsidiaries to exceed the amounts set forth below: 
  

					
	 Fiscal Year
	  	Amount	 
	 2018
	  	$	2,500,000	 
	 2019
	  	$	3,000,000	 
	 2020
	  	$	5,000,000	 
	 2021
	  	$	2,000,000	 

 Section 5.3 Change of Control. 

(a) Lender’s Put Option. The Borrower, on behalf of the Loan Parties and their Subsidiaries, will give Agent written notice of a
Change of Control at least fifteen (15) days prior to the consummation thereof but in any event not later than two (2) Business Days following the first public announcement thereof. Other than with respect to a Permitted Successor
Transaction (in, which case, no such Put Notice may be delivered by the Lenders), the Lenders, within five (5) days after the receipt of such notice, in the exercise of their sole discretion, may deliver a notice to the Borrower (the
“Put Notice”) that 

  
 89 

 
the Final Payment (including, for the avoidance of doubt, any applicable Non-Callable Make Whole Amount and the CoC Fee) shall be due and payable upon the
consummation of such Change of Control, with no further action taken by any Person as of or after the date of such Put Notice. If the Lenders deliver a Put Notice, then simultaneously with consummation of such Change of Control (other than a
Permitted Successor Transaction), the Borrower will make (or cause to be made) the Final Payment (including, for the avoidance of doubt, any applicable Non-Callable Make Whole Amount and the CoC Fee) to the
Lenders as of the date of such Put Notice. In such case of a Put Notice delivered with respect to any Change of Control (other than a Permitted Successor Transaction), the Loan Parties will make arrangements satisfactory to the Agent, as determined
by the Agent in its sole discretion, that the Final Payment will be paid in full to the Lenders, in each case, concurrently with the consummation of such Change of Control (other than a Permitted Successor Transaction) (which arrangements may
include obtaining a written agreement from the acquiring Person, as applicable, that payment of the Final Payment will be made to the Lenders upon the consummation of such Change of Control (other than a Permitted Successor Transaction)). The Loan
Parties hereby acknowledge and agree that, if the Loan Parties or any of their Subsidiaries of Affiliates violate or breach any portion of this Section 5.3(a), the Secured Parties shall have the right to apply for an injunction in any state or
federal courts sitting in the City of New York to prevent the consummation of such Change of Control, unless, if the Lenders have exercised their Put Right, arrangements reasonably satisfactory to the Agent for the Final Payment (including, for the
avoidance of doubt, any applicable Non-Callable Make Whole Amount and the CoC Fee) have been made (or, as applicable, paid) and, if the Lenders have not exercised their Put Right, arrangements reasonably
satisfactory to the Agent in respect of the Loans have been made. The Loan Parties will not, and will not permit any of their Subsidiaries to consummate any Change of Control (other than a Permitted Successor Transaction) without complying in all
respects with the applicable provisions of this Section 5.3(a). Notwithstanding anything to the contrary in this Agreement, for the avoidance of doubt, the Black-Scholes payments or exercises related to a “Major Transaction” (as
defined in any Warrant) that are set forth in the Warrants are in addition to any Final Payment. 
 (b) Borrower’s Prepayment
Right. Notwithstanding anything to the contrary in this Agreement and for the avoidance of doubt, Borrower shall be permitted to prepay the Loans and other Obligations (other than Obligations under the Warrant and the Registration Rights
Agreement, the treatment of which are addressed separately in such agreements) so long as (i) to the extent any such prepayment is made prior to the First Amortization Date, the applicable Non-Callable
Make Whole Amount on the Loans so prepaid is paid at the same time in accordance with Section 2.3(c) and (ii) if In Connection with a Change of Control, the CoC Fee is paid at the time set forth in Section 2.7(c). 

Section 5.4 General Acceleration Provision upon Events of Default. For so long as the Obligations
(other than unasserted contingent indemnification obligations and other than those Obligations under any Warrant or the Registration Rights Agreement) remain outstanding, if one or more of the events specified in this Section 5.4 shall have
happened or occurred and have continued beyond any applicable cure period expressly provided in this Section 5.4 (each, an “Event of Default”), the Required Lenders or Agent may, or Agent (upon written election by the Required
Lenders but subject to the protections for Agent set forth in Section 6.15) shall, by (subject to Section 5.5(a), which, for the avoidance of doubt, shall not require any such notice and shall occur automatically) written notice to the
Borrower, declare the principal of, and accrued and unpaid interest on, all of the Loans and other Obligations or any part of any of them (together with any other amounts accrued or payable under the Loan Documents) to be, and the same shall
thereupon become, immediately due and payable, without any further notice and without any presentment, demand or protest of any kind, all of which are hereby expressly waived by the Borrower and the other Loan Parties, appoint a receiver for the
Loan Parties and their Subsidiaries, and take any further action available at law or in equity or that are provided in the Loan Documents, including the sale or transfer of the Loan and other Obligations and all other rights acquired in connection
with the Loan or the other Obligations or under the Loan Documents: 

  
 90 

 (a) The Borrower or any other Loan Party shall have failed (i) to pay when and as
required to be paid herein or in any other Loan Document, any amount of principal of any Loan, including after maturity of the Loans, or (ii) to pay within three (3) Business Days after the same shall become due, interest on any Loan, any
fee or any other amount or Obligation payable hereunder or pursuant to any other Loan Document. 
 (b) Any Loan Party shall have failed to
comply with or observe (i)(A) Section 1.4, Section 2.1, Section 5.1(a), 5.1(b), 5.1(c), 5.1(e), 5.1(f), 5.1(g), 5.1(h), 5.1(i), 5.1(k), 5.1(l), 5.1(m), 5.1(o), 5.1(p), 5.1(q), 5.1(r), 5.1(s), 5.1(t), 5.1(u), 5.1(v), 5.1(w), 5.1(x),
5.1(y), 5.1(z) or 5.1(aa), Section 5.2 or Section 5.3 of this Agreement, (B) Sections 5.2(a), 5.2(c), 5.2(d), 5.3, 5.4, 5.5, 5.7, 5.9(a), 5.9(c) and 5.10 of the Security Agreement or (C) any provision of any Note,
(ii) Section 5.1 of the Security Agreement and such failure, with respect to this Section 5.2(b)(ii) only, shall not have been cured within ten (10) days after the earlier to occur of (y) the date upon which any officer of
any Loan Party or any of its Subsidiaries becomes aware of such failure and (z) the date upon which written notice thereof is given to any Loan Party or any of its Subsidiaries by any Secured Party or (iii) any covenant contained in any
Loan Document (other than the covenants described in Section 5.4(a), Section 5.4(b)(i) or Section 5.4(b)(ii) above and other than in respect of the Warrants or the Registration Rights Agreement), and such failure, with respect to this
Section 5.2(b)(iii) only, shall not have been cured within thirty (30) days after the earlier to occur of (y) the date upon which any officer of any Loan Party or any of its Subsidiaries becomes aware of such failure and (z) the
date upon which written notice thereof is given to any Loan Party or any of its Subsidiaries by any Secured Party. 
 (c) Any representation,
warranty, or certification, made by any Loan Party in any Loan Document or delivered in writing to Agent or any Lender in connection with this Agreement or any other Loan Document shall have been incorrect, false or misleading in any material
respect (except to the extent that such representation or warranty is qualified by reference to materiality or Material Adverse Effect, to which extent it shall have been incorrect, false or misleading in any respect) as of the date it was made; it
being acknowledged and agreed that any projections provided to the Secured Parties are not to be viewed as facts, are not a guarantee of financial performance, and are subject to uncertainties and contingencies. 

(d) (i) Any Loan Party or any of its Subsidiaries (other than Immaterial Subsidiaries) shall generally be unable to pay its debts as such debts
become due, or shall admit in writing its inability to pay its debts as they come due or shall make a general assignment for the benefit of creditors; (ii) any Loan Party or any of its Subsidiaries (other than Immaterial Subsidiaries) shall
declare a moratorium on the payment of its debts; (iii) the commencement by any Loan Party or any of its Subsidiaries (other than Immaterial Subsidiaries) of proceedings to be adjudicated bankrupt or insolvent, or the consent by it to the
commencement of bankruptcy or insolvency proceedings against it, or the filing by it of a petition or answer or consent seeking reorganization, intervention or other similar relief under any Applicable Law, or the consent by it to the filing of any
such petition or to the appointment of an intervenor, receiver, liquidator, assignee, trustee, sequestrator or other similar official of all or substantially all of its assets; (iv) the commencement against any Loan Party or any of its
Subsidiaries (other than Immaterial Subsidiaries) of a proceeding in any court of competent jurisdiction under any bankruptcy or other Applicable Law (as now or hereafter in effect) seeking its liquidation, winding up, dissolution, reorganization,
arrangement or adjustment, or the appointment of an intervenor, receiver, liquidator, assignee, trustee, sequestrator or other similar official, and any of the following events occur: (A) such Loan Party or such Subsidiary consents to the
institution of such Insolvency Proceeding against it, (B) the petition commencing the Insolvency Proceeding is not timely controverted, (C) the petition commencing any such proceeding shall continue undismissed, or any order, judgment or
decree approving or ordering any of the foregoing shall continue unstayed or otherwise in effect, for a period of sixty (60) calendar days of the date of filing thereof, or (D) an interim trustee is appointed to take possession of all or
any substantial portion of the properties or assets 

  
 91 

 
of, or to operate all or any substantial portion of the business of, such Loan Party or its Subsidiary; (v) the making by any Loan Party or any of its Subsidiaries (other than Immaterial
Subsidiaries) of an assignment for the benefit of creditors, or the admission by it in writing of its inability to pay its debt generally as they become due; or (vi) any other event shall have occurred which under any Applicable Law would have
an effect analogous to any of those events listed above in this Section 5.4(d). 
 (e) One or more judgments, orders or decrees or
settlements shall be rendered against any Loan Party or any Subsidiary of a Loan Party that exceeds by more than $1,000,000 any insurance coverage applicable thereto (to the extent the relevant insurer has been notified of such claim and has not
denied coverage therefor) or one or more non-monetary judgments, orders or decrees or settlements shall be rendered against any Loan Party or any Subsidiary of a Loan Party that could reasonably be expected,
individually or in the aggregate, to result in a Material Adverse Effect, and in either case (i) enforcement proceedings shall have been commenced by any creditor upon any such judgment, order or decree or (ii) there shall be any period of
twenty (20) consecutive days during which such judgment, order or decree shall not have been vacated or discharged or there shall not be in effect (by reason of a pending appeal or otherwise) any stay of enforcement thereof. 

(f) Any authorization of a Governmental Authority necessary for the execution, delivery or performance of any Loan Document or for the validity
or enforceability of any of the Obligations under any Loan Document is not given or is withdrawn or ceases to remain in full force or effect. 

(g) Any Applicable Law shall purport to render any material provision of any Loan Document invalid or unenforceable or shall purport to prevent
or materially delay the performance or observance by any Loan Party or any of its Subsidiaries of the Obligations (which, for the avoidance of doubt, shall not apply to the process of SEC comments in respect of share registration). 

(h) Any Loan Party or any Subsidiary of any Loan Party (i) shall fail to make any payment in respect of any Indebtedness having an
individual principal amount (including undrawn committed or available amounts and including amounts owing to all creditors under any combined or syndicated credit arrangement) in excess of $3,000,000 or having an aggregate principal amount
(including undrawn committed or available amounts and including amounts owing to all creditors under any combined or syndicated credit arrangement) of more than $8,000,000 when due (whether by scheduled maturity, required prepayment, acceleration,
demand or otherwise) and such failure continues after the applicable grace or notice period, if any, specified in the documents relating thereto on the date of such failure; or (ii) shall fail to perform or observe any other condition or
covenant, or any other event shall occur or condition exist, under any agreement or instrument relating to any such Indebtedness of the type covered in Section 5.4(h)(i) above, if the effect of such failure, event or condition is to cause, or
to permit the holder or holders of such Indebtedness or beneficiary or beneficiaries of such Indebtedness (or a trustee or agent on behalf of such holder or holders or beneficiary or beneficiaries) to cause, such Indebtedness to be declared to be
due and payable (or otherwise required immediately to be prepaid, redeemed, purchased or defeased) prior to its stated maturity (without regard to any subordination terms with respect thereto) or cash collateral in respect thereof to be demanded;
provided however that, notwithstanding the foregoing, any event or condition that occurs that permits holders of convertible Indebtedness permitted hereunder to convert such Indebtedness into Stock (other than Disqualified Stock) or such
other consideration permitted pursuant to Section 5.2(xx) pursuant to the terms of the applicable indenture shall not constitute a Default or Event of Default hereunder on such basis alone. 

(i) Any material provision of any Loan Document shall for any reason cease to be valid and binding on or enforceable against any Loan Party or
any Subsidiary of any Loan Party thereto or any Loan Party or any Subsidiary of any Loan Party shall so state in writing or bring an action to limit its 

  
 92 

 
obligations or liabilities thereunder or otherwise contest the validity, binding effect or enforceability of the Loan Documents; or any Loan Document shall for any reason (other than pursuant to
the terms thereof) cease to create a valid security interest in any of the Collateral in excess of such Collateral that has a fair market value of $50,000 as determined by the Agent in its sole reasonable discretion (to the extent that such
perfection or priority is required hereby) purported to be covered thereby or such security interest shall for any reason cease to be a perfected and first priority security interest (subject only to the prior priority of the Permitted Priority
Liens). 
 (j) (i) The occurrence of any ERISA Event that could reasonably be expected, individually or in the aggregate, to have a Material
Adverse Effect or (ii) the imposition of a Lien on any asset of a Loan Party or a Subsidiary of a Loan Party with respect to any Title IV Plan or Multiemployer Plan. 

(k) The occurrence of any Event of Default (as such term is defined in the Warrants). 

(l) The Common Stock shall cease to be registered under the Exchange Act or to be listed on the Principal Market. 

(m) The voluntary withdrawal or institution of any action or proceeding by the FDA or similar Governmental Authority to order the withdrawal of
any Product or Product category from the market or to enjoin a Loan Party, such Loan Party’s Subsidiaries or any representative of a Loan Party or its Subsidiaries from testing, manufacturing, processing, assembly, packaging, labeling,
marketing, importing, exporting, selling or distributing any Product or Product category that has, individually or in the aggregate, resulted (or could reasonably be expected, individually or in the aggregate, to result) in a Material Adverse
Effect, (ii) the institution of any action or proceeding by the DEA, the FDA, or any other Governmental Authority to revoke, suspend, reject, withdraw, limit, or restrict any Regulatory Required Permit held by a Loan Party, its Subsidiaries or
any representative of a Loan Party or its Subsidiaries, which, in each case of this clause (ii), has, individually or in the aggregate, resulted (or could reasonably be expected, individually or in the aggregate, to result) in a Material
Adverse Effect, (iii) the commencement of any enforcement action against a Loan Party, a Loan Party’s Subsidiaries or any representative of a Loan Party or its Subsidiaries (with respect to the business of a Loan Party or its Subsidiaries)
by the DEA, the FDA, or any other Governmental Authority which has, individually or in the aggregate, resulted (or could reasonably be expected, individually or in the aggregate, to result) in a Material Adverse Effect, or (iv) the occurrence
of adverse test results in connection with a Product which has, individually or in the aggregate, resulted (or could reasonably be expected, individually or in the aggregate, to result) in a Material Adverse Effect. 

(n) The introduction of, or any change in, any law or regulation governing or affecting the healthcare industry, including any Healthcare Laws,
that has or could reasonably be expected, individually or in the aggregate, to have a Material Adverse Effect. 
 (o) Any Loan Party defaults
under or breaches any Material Contract (after any applicable grace period contained therein), or a Material Contract shall be terminated by a third party or parties party thereto prior to the expiration thereof (other than in accordance with its
terms) (other than the Warrant), the 3.25% Convertible Notes, any Permitted 3.25% Convertible Note Refinancing, the 2.25% Convertible Notes, any ABL Debt or any ABL Debt Documents or any Permitted Japan Lifeline Unsecured Debt Documents, or there is
a loss of a material right of a Loan Party under any Material Contract to which it is a party, in each case which could reasonably be expected, individually or in the aggregate, to result in a Material Adverse Effect. 

(p) The occurrence of any breach or default under any terms or provisions of any Convertible Note Document, any ABL Debt Document, any
Permitted Japan Lifeline Unsecured Debt 

  
 93 

 
Documents or any Subordinated Debt Document or the occurrence of any event requiring the prepayment or mandatory redemption of any 3.25% Convertible Note (or any Permitted 3.25% Convertible Note
Refinancing thereof or any indenture or related document governing any Permitted 3.25% Convertible Note Refinancing), any 2.25% Convertible Note, any ABL Debt Document, any Permitted Japan Lifeline Unsecured Debt Documents or of any Subordinated
Debt; provided, however, that, notwithstanding the foregoing, any event or condition that occurs that permits holders of convertible Indebtedness permitted hereunder to convert such Indebtedness into Stock (other than Disqualified
Stock) or such other consideration permitted pursuant to Section 5.2(xx) pursuant to the terms of the applicable agreement shall not constitute a Default or Event of Default hereunder on such basis alone. 

(q) The institution by any Governmental Authority of criminal proceedings against any Loan Party. 

(r) Any Loan Party makes any payment on account of any Indebtedness that has been subordinated to any of the Obligations, other than payments
specifically permitted by the terms of such subordination. 
 (s) Any Loan Party or any Subsidiary (A) fails to make any payment when
due (whether by scheduled maturity, required prepayment, acceleration, demand, or otherwise) in respect of the ABL Debt, or (B) fails to observe or perform any other agreement or condition relating to the ABL Debt or contained in any instrument
or agreement evidencing, securing or relating thereto, or any other event occurs, the effect of which default or other event is to cause, or to permit the holder or holders of such ABL Debt or the beneficiary or beneficiaries of any Guarantee
related thereto (or a trustee or agent on behalf of such holder or holders or beneficiary or beneficiaries) to cause, such ABL Debt to be demanded or to become due or to be repurchased, prepaid, defeased or redeemed (automatically or otherwise), or
an offer to repurchase, prepay, defease or redeem such ABL Debt to be made, prior to its stated maturity, or such Guarantee to become payable or cash collateral in respect thereof to be demanded. 

(t) Any provisions of the Intercreditor Agreement shall for any reason be revoked or invalidated, or otherwise cease to be in full force and
effect, other than in accordance with the terms thereof, or any Person shall contest in any manner the validity or enforceability thereof or deny that it has any further liability or obligation thereunder. 

(u) If the obligation of any Guarantor under the guaranty contained in the Security Agreement is limited or terminated by operation of law or
by such Guarantor (other than in accordance with the terms of this Agreement). 
 (v) (i) Any subordination provisions in respect of the
documents evidencing or governing any Subordinated Debt (the “Subordination Provisions”) shall, in whole or in part, terminate, cease to be effective or cease to be legally valid, binding and enforceable against any holder of the
applicable Subordinated Debt; or (ii) any Borrower or any other Loan Party shall, directly or indirectly, disavow or contest in any manner (A) the effectiveness, validity or enforceability of any of the Subordination Provisions,
(B) that the Subordination Provisions exist for the benefit of the Secured Parties or (C) that all payments of principal of or premium and interest on the applicable Subordinated Indebtedness, or realized from the liquidation of any
property of any Loan Party, shall be subject to any of the Subordination Provisions. 
 (w) A Change of Control shall occur. 

(x) The Borrower at any time announces or states in writing that it will not honor its obligations to issue shares of Common Stock to a First
Out Waterfall Lender upon conversion of any of the 

  
 94 

 
First Out Waterfall Notes in accordance with the terms thereof. 
 Section 5.5
Additional Remedies. 
 (a) Automatic Acceleration on Dissolution or Bankruptcy. Notwithstanding any other provisions of this
Agreement, if an Event of Default under Section 5.4(d) shall occur, the principal of the Loans (together with any interest, other amounts and Obligations accrued or payable under this Agreement or the other Loan Documents (including the Exit
Payment, any Non-Callable Make Whole Amount and any CoC Fee, if applicable)) shall thereupon become immediately and automatically due and payable, in each case, without any presentment, demand, protest or
notice of any kind, all of which are hereby expressly waived by the Borrower and the other Loan Parties. 
 (b) Power of Attorney.
Notwithstanding anything to the contrary in this Agreement, the Warrants, and the other Loan Documents, each Loan Party hereby irrevocably and unconditionally constitutes and appoints Agent and any of Agent’s Affiliates, attorneys,
representatives or agents, with full power of substitution, as such Loan Party’s true and lawful attorney-in-fact with full irrevocable and unconditional power and
authority in the place and stead of such Loan Party and in the name of such Loan Party or in its own name, for the purpose of carrying out the terms of this Agreement, the Warrants, and the other Loan Documents, to take any appropriate steps or
actions and to execute and deliver (and perform under on such Loan Party’s behalf) any agreement, document or instrument that may be necessary or desirable to accomplish the purposes and/or effectuate the items and actions set forth in this
Agreement, the Warrants, and the other Loan Documents, in each case, (i) that any such Loan Party fails to take that are required under such documents, agreements or instruments, (ii) during the existence of any Event of Default, or
(iii) in delivering the original shares of Common Stock to be issued under any Warrants to the applicable holder thereof upon such holder exercising its rights pursuant to the terms of such Warrants. 

Section 5.6 Recovery of Amounts Due. If any Obligation or other amount payable hereunder or under any
of the other Loan Documents is not paid as and when due, the Borrower and the other Loan Parties hereby authorize Agent and the Lenders to proceed, to the fullest extent permitted by Applicable Law, without prior notice, by right of set-off, banker’s lien or counterclaim, against any moneys or other assets of the Borrower or any other Loan Party to the full extent of all Obligations or other amounts payable to Agent and/or the Secured
Parties. 
 Section 5.7 Credit Bidding. The Loan Parties and the Lenders hereby irrevocably authorize Agent
based upon the written instruction of the Lenders, to (a) credit bid and in such manner purchase (either directly or through one or more acquisition vehicles) all or any portion of the Collateral at any sale thereof conducted under the
provisions of the Bankruptcy Code, including under Section 363 of the Bankruptcy Code or any similar laws in any other jurisdictions to which a Loan Party is subject, or (b) credit bid and in such manner purchase (either directly or
through one or more acquisition vehicles) all or any portion of the Collateral at any other sale or foreclosure conducted by (or with the consent or at the direction of) Agent (whether by judicial action or otherwise) in accordance with Applicable
Law. In connection with any such credit bid and purchase, the Obligations owed to any Lender shall be entitled to be, and shall be, credit bid on a ratable basis (with Obligations with respect to contingent or unliquidated claims being estimated for
such purpose if the fixing or liquidation thereof would not unduly delay the ability of Agent to credit bid and purchase at such sale or other disposition of the Collateral and, if such claims cannot be estimated without unduly delaying the ability
of Agent to credit bid, then such claims shall be disregarded, not credit bid, and not entitled to any interest in the asset or assets purchased by means of such credit bid) and the Lenders whose Obligations are credit bid shall be entitled to
receive interests (ratably based upon the proportion of their Obligations credit bid in relation to the aggregate amount of Obligations so credit bid) in the asset or assets so purchased (or in the Stock of the acquisition vehicle or

  
 95 

 
vehicles that are used to consummate such purchase). Except as provided above and otherwise expressly provided for herein or in the other Loan Documents, Agent will not execute nor deliver a
release of any Lien on any Collateral. Upon request by Agent or the Borrower at any time, the Lenders will confirm in writing Agent’s authority to release any such Liens on particular types or items of Collateral pursuant to this
Section 5.7. 
 ARTICLE 6 

MISCELLANEOUS 

Section 6.1 Notices. Any notices or other information (including an financial information) required or
permitted to be given under the terms hereof shall be sent by certified or registered mail (return receipt requested) or delivered personally or by courier (including a recognized overnight delivery service) or by facsimile or by electronic mail and
shall be effective five (5) days after being placed in the mail, if mailed by regular United States mail, or upon receipt, if delivered personally or by courier (including a recognized overnight delivery service) or by facsimile, or when
received by electronic mail in each case addressed to a party as follows (or such other address, facsimile or electronic mail address provided by such party to such other parties pursuant to the below (or such later address, facsimile or electronic
mail address provided in accordance herewith): 
 If to the Borrower or any other Loan Party: 

Endologix, Inc. 
 2 Musick 

Irvine, CA 92618 
 E-mail: vmahboob@endologix.com 
 E-mail: jtejedor@endologix.com

 Attn: Vaseem Mahboob, CFO 

Attn: James Tejedor, Treasury Manager 

With a copy to (which shall not be deemed to constitute notice): 

DLA Piper LLP (US) 
 444 West Lake
Street, Suite 900 
 Chicago, IL 60606 

E-mail: gregory.ruback@dlapiper.com 

Attn: Gregory Ruback 
 If to Agent: 

c/o Deerfield Management Company, L.P. 

780 Third Avenue, 37th Floor 

New York, NY 10017 
 Facsimile: 212-599-3075 
 E-mail:
dclark@deerfield.com 
 Attn: David J. Clark, Esq. 

With a copy to (which shall not be deemed to constitute notice): 

Katten Muchin Rosenman LLP 
 2029
Century Park, East, Suite 2600 

  
 96 

 
Los Angeles, CA 90067-3012 
 Facsimile: (310)
788-4471 
 E-mail: Kristopher.ring@kattenlaw.com and
mark.wood@kattenlaw.com 
 Attn: Kristopher J. Ring, Esq. 

Attn: Mark D. Wood, Esq. 
 If to any Lender, the
information for notices included on Schedule 2.4 or pursuant to any assignment agreement assigning any Obligations to any new Lender. 

Section 6.2 Waiver of Notice. Whenever any notice is required to be given to the Lenders or the
Borrower under the any of the Loan Documents, a waiver thereof in writing signed by the Person or Persons entitled to such notice, whether before or after the time stated therein, shall be deemed equivalent to the giving of such notice. 

Section 6.3 Fees, Charges, Costs and Expenses Reimbursement. The Loan Parties agree to pay on or prior
to the Agreement Date and, within ten (10) Business Days (or such later date as the Agent may agree in its sole discretion) after delivery of an invoice therefor after the Agreement Date, (a) all reasonable fees, reasonable costs and
reasonable, out-of-pocket expenses of Agent and the Lenders and of legal counsel to Agent and the Lenders of negotiation, documentation, preparation, execution, delivery
and closing, of the Loan Documents (and the Prior Loan Documents) and in connection with the consummation of the Transactions and the other transactions contemplated hereby and thereby, (b) any consents, amendments, waivers or other
modifications to the Loan Documents (and the Prior Loan Documents) or otherwise in connection with the consummation of the Transactions and the other transactions contemplated hereby and thereby, (c) all fees, costs and expenses of creating and
perfecting Liens in favor of Agent on behalf of the Secured Parties pursuant to any Loan Document (or any Prior Loan Documents), including filing and recording fees, expenses and Taxes, search fees, title insurance premiums, and fees, costs,
expenses and disbursements of counsel to Agent and the Lenders and of counsel providing any opinions that Agent or the Lenders may request in respect of any Loan Documents (or any Prior Loan Documents) or the Liens created pursuant to the Loan
Documents (or any Prior Loan Documents), (d) all costs and expenses incurred by Agent or any Lender in connection with the custody or preservation of any of the Collateral, (e) all costs and expenses, including the reasonable out-of-pocket documented fees, costs and expenses of legal counsel to Agent and the Lenders and reasonable
out-of-pocket documented fees, costs and expenses of accountants, advisors and consultants, incurred by Agent, any Lender and its counsel relating to efforts to protect,
evaluate, assess or dispose of any of the Collateral, (f) all costs and expenses, including fees, costs and expenses of legal counsel to Agent and the Lenders and all fees, costs and expenses of accountants, advisors and consultants and costs
of settlement, incurred by the Agent and the Lenders in enforcing any of the Loan Documents (or the Prior Loan Documents) or any Obligations of, or in collecting any payments due from, any Loan Party hereunder or under the other Loan Documents or
the Prior Loan Documents (including in connection with the sale of, collection from, or other realization upon any of the Collateral or the enforcement of the Loan Documents or the Prior Loan Documents) or in connection with any refinancing or
restructuring of the credit arrangements provided under this Agreement in the nature of a “work-out” or pursuant to any proceeding or event of the type set forth in Section 5.4(d), (g) the cost
of purchasing insurance that the Loan Parties fail to obtain as required by the Loan Documents, (h) providing any notices under the Loan Documents or the Prior Loan Documents that are required or recommended by Applicable Law (i) providing
any new Notes or amended and restated Notes and (j) any other actions taken after the Prior Agreement Date related to the Obligations or the Loan Documents or the Prior Loan Document. Without limiting any of the foregoing provisions of
this Section 6.3, any action taken by any Loan Party under or with respect to any Loan Document or any Prior Loan Document, even if required under any Loan Document or any Prior Loan Document or at the request of the Agent or any other Secured
Party, shall be at the sole expense of such Loan Party, and neither Agent nor any other Secured 

  
 97 

 
Party shall be required under any Loan Document or any Prior Loan Document to reimburse any Loan Party or any Subsidiary of any Loan Party therefor. 

Section 6.4 Governing Law; Venue; Jurisdiction; Service of Process; Waiver of Jury Trial. All
questions concerning the construction, validity, enforcement and interpretation of this Agreement and, unless otherwise expressly stated therein, the other Loan Documents shall be governed by and construed and enforced in accordance with the laws of
the State of New York applicable to contracts made and to be performed in such State. Each Party agrees that all legal proceedings concerning the interpretations, enforcement and defense of the transactions contemplated by this Agreement and, unless
otherwise expressly stated therein, the other Loan Documents (whether brought against a party hereto or its respective Affiliates, directors, officers, shareholders, employees or agents) shall be commenced exclusively in the state and federal courts
sitting in the City of New York, Borough of Manhattan. Each Party hereby irrevocably submits to the exclusive jurisdiction of the state and federal courts sitting in the City of New York, borough of Manhattan for the adjudication of any dispute
hereunder or under the other Loan Documents or in connection herewith or with the other Loan Documents or with any transaction contemplated hereby or discussed herein, and hereby irrevocably waives, and agrees not to assert in any suit, action or
proceeding, any claim that it is not personally subject to the jurisdiction of any such court, or that such suit, action or proceeding is improper or is an inconvenient venue for such proceeding. Each Party hereby irrevocably waives personal service
of process and consents to process being served in any such suit, action or proceeding by mailing a copy thereof via registered or certified mail or overnight delivery (with evidence of delivery) to such Party at the address in effect for notices to
it under this Agreement and agrees that such service shall constitute good and sufficient service of process and notice thereof. Nothing contained herein shall be deemed to limit in any way any right to serve process in any other manner permitted by
law. THE PARTIES HERETO, TO THE EXTENT PERMITTED BY LAW, WAIVE ALL RIGHT TO TRIAL BY JURY IN ANY ACTION, SUIT, OR PROCEEDING ARISING OUT OF, IN CONNECTION WITH OR RELATING TO, THIS AGREEMENT, THE OTHER LOAN DOCUMENTS AND ANY TRANSACTION CONTEMPLATED
HEREBY AND THEREBY. THIS WAIVER APPLIES TO ANY ACTION, SUIT OR PROCEEDING WHETHER SOUNDING IN TORT, CONTRACT OR OTHERWISE. EACH PARTY HERETO (A) CERTIFIES THAT NO OTHER PARTY AND NO AGENT, REPRESENTATIVE OR OTHER PERSON AFFILIATED WITH OR
RELATED TO ANY OTHER PARTY HAS REPRESENTED, EXPRESSLY OR OTHERWISE, THAT SUCH OTHER PARTY WOULD NOT, IN THE EVENT OF LITIGATION, SEEK TO ENFORCE THE FOREGOING WAIVER, AND (B) ACKNOWLEDGES THAT IT AND THE OTHER PARTIES HERETO HAVE BEEN INDUCED
TO ENTER INTO THE LOAN DOCUMENTS, AS APPLICABLE, BY THE MUTUAL WAIVERS AND CERTIFICATIONS IN THIS SECTION 6.4. 

Section 6.5 Successors and Assigns. This Agreement shall bind and inure to the respective successors
and assigns of the Parties, except that no Loan Party may assign or otherwise transfer all or any part of their rights or obligations (including the Obligations) under the Loan Documents without the prior written consent of all of the Lenders (other
than in any Permitted Successor Transaction), and any prohibited assignment by the Loan Parties shall be absolutely void ab initio. Any Lender may assign or transfer its rights or Obligations under the Loan Documents to an Eligible Assignee,
so long as (a) with respect to any assignment to a Person mentioned in clause (d) of the definition of “Eligible Assignee”, the amount of such assignment is for Loans in an aggregate principal amount not less than $5,000,000 (or,
if less, the entire remaining principal amount of Loans held by such Lender); provided that such threshold amount shall be aggregated between such Persons that are assignees mentioned in such clause (d) of the definition of
“Eligible Assignee” that are Affiliates of each other. Upon a Lender’s assignment of any of the Loans held by it in accordance with this Section 6.5, such Lender shall provide notice of the transfer to Borrower (with a copy to
Agent) for recordation in the Register pursuant to Section 1.4. Upon receipt of a notice of a permitted transfer of an interest in a Loan, the Borrower shall record the identity of the transferee and other relevant information in the Register
and the transferee shall (to the extent of the interests 

  
 98 

 
transferred to such transferee) have all the rights and obligations of, and shall be deemed, a Lender with respect to such Loan hereunder or under the other Loan Documents. Notwithstanding
anything to the contrary in any Loan Document, no Lender shall assign or transfer, or provide any participation in, any of the Loans or other Obligations to any Loan Party or any of their Affiliates without the written consent of Agent. If a Lender
sells participating interests in its Loans or other interests hereunder (any such Person, a “Participant”), (i) such Lender’s obligations hereunder with respect to those sold to the Participant shall remain unchanged for all
purposes, (ii) the Borrower and Agent shall continue to deal solely and directly with such Lender in connection with such Lender’s rights and obligations hereunder with respect to those sold to the Participant, and (iii) all amounts
payable by the Borrower shall be determined as if such Lender had not sold such participation and shall be paid directly to such Lender. 

In addition to the other rights provided in this Section 6.5, each Secured Party may grant a security interest in, or otherwise assign as
collateral, any of its rights under the Loan Documents, whether now owned or hereafter acquired (including rights to payments of principal or interest on the Loans), to any holder of, or trustee for the benefit of the holders of, such Secured
Party’s Indebtedness or equity securities; provided however that no such security interest or assignment shall release such Secured Party from any of its obligations hereunder or substitute any such holder of a security interest or assignee for
such Secured Party as a party hereto. 
 Section 6.6 Entire Agreement; Amendments. 

(a) The Loan Documents contain the entire understanding of the Parties with respect to the matters covered thereby and supersede any and all
other written and oral communications, negotiations, commitments and writings with respect thereto. 
 (b) No amendment, restatement,
modification, supplement, change, termination or waiver of any provision of this Agreement or the other Loan Documents (other than the Warrants, the Registration Rights Agreement, any Control Agreement or any similar agreement or any landlord
agreement or bailee or mortgagee waiver, each of which may be amended, restated, modified, supplemented, changed, terminated, waived or consented to in accordance with the terms thereof), and no consent to any departure by any Loan Party therefrom,
shall in any event be effective without the written concurrence of the Borrower, the Agent and the Required Lenders; provided that (1) no such amendment, restatement, modification, supplement, change, termination, waiver or consent to
this Agreement shall, without the consent of each Lender with Obligations directly and adversely affected thereby, do any of the following: (i) reduce any Loan of such Lender; (ii) postpone the Maturity Date or other scheduled final
maturity date of any Loan of such Lender, or postpone the date or reduce the amount of any scheduled payment (but not mandatory prepayment) of principal of any Loan of such Lender; (iii) decrease the interest rate borne by any Loan of such
Lender (other than any waiver of any increase in the interest rate applicable to any of the Loans pursuant to Section 2.7(b)) or the amount of any premium or fees payable hereunder; (iv) amend this proviso of this Section 6.6(b) to
the extent providing for consent by all directly and adversely affected Lenders in a manner to remove such consent; or (v) amend the definitions of “Required Lenders”, “Required First Out Waterfall Lenders” and
“Required Last Out Waterfall Lenders”, (2) any amendment, restatement, supplement, change or other modification (or any waiver or agreement with respect) to the definitions of “Required Lenders”, “Required First Out
Waterfall Lenders” or “Required Last Out Waterfall Lenders” or the proviso in this Section 6.6(b) may be conducted or agreed to with just the consent of each Lender and without the consent of any Loan Party or any of its
Subsidiaries, and (3) any amendment, restatement, modification, change, supplement, change, termination, waiver or consent to this Agreement that (x) affects only the First Out Waterfall Lenders requires only the consent of the Required
First Out Waterfall Lenders and (y) affects only the Last Out Waterfall Lenders requires only the consent of the Required Lenders. 

  
 99 

 (c) No consideration shall be offered or paid (in any form, whether cash, Stock, other
property or otherwise) to any Secured Party to amend, restate, supplement, modify or change or consent to a waiver of (or a diversion from) any provision of any of the Loan Documents unless the same consideration also is offered to all of the
Lenders under the Loan Documents. For clarification purposes, this provision constitutes a separate right granted to each Lender and is not intended for the Borrower or any other Loan Party to treat the Lenders as a class and shall not be construed
in any way as the Lenders acting in concert or otherwise as a group with respect to the purchase, disposition or voting of securities or Stock or otherwise. 

Section 6.7 Severability. If any provision of this Agreement or any of the other Loan Documents shall
be invalid, illegal or unenforceable in any respect under any law, the validity, legality and enforceability of the remaining provisions hereof or thereof shall not in any way be affected or impaired thereby. The Parties shall endeavor in good faith
negotiations to replace the invalid, illegal or unenforceable provisions with valid provisions the economic effect of which comes as close as possible to that of the invalid, illegal or unenforceable provision. 

Section 6.8 Counterparts. This Agreement may be executed in several counterparts, and by each Party on
separate counterparts, each of which and any photocopies, facsimile copies and other electronic methods of transmission thereof shall be deemed an original, but all of which together shall constitute one and the same agreement. 

Section 6.9 Survival; Releases of Guarantees and Liens. 

(a) In addition to Section 3.2, this Agreement and all agreements, representations and warranties and covenants made in the Loan
Documents, and in any document, certificate or statement delivered pursuant thereto or in connection therewith shall be considered to have been relied upon by the other Parties and shall survive the execution and delivery of this Agreement and the
other Loan Documents and the making of the Loan hereunder or thereunder, in each case until termination of such provision in accordance with this Section 6.9, regardless of any investigation made by any such other Party or on its behalf. Agent
and the Lenders shall not be deemed to have waived, by reason of making the Loan, any Event of Default that may arise by reason of such representation or warranty proving to have been false or misleading, notwithstanding that the Lenders may have
had notice or knowledge of any such Event of Default or may have had notice or knowledge that such representation or warranty was false or misleading at the time the applicable Disbursement was made. 

(b) All representations and warranties made hereunder and in any other Loan Document or other document delivered pursuant hereto or thereto or
in connection herewith or therewith shall survive the execution and delivery hereof and thereof (and, with respect to Section 3.1(g)(i)(B), the first two sentences of Section 3.1(i), Section 3.1 (y), Section 3.1 (z)(A) and (C),
Section 3.1(ee), the first sentence of Section 3.1(mm), Section 3.1(nn), Section 3.1(oo), Section 3.1(rr), Section 3.1(ss) and Section 3.1 (tt), shall continue to be made in accordance with the terms hereof and
thereof, including at all times after the execution and delivery hereof and thereof). Such representations and warranties have been or will be relied upon by the Secured Parties, regardless of any investigation made by the Secured Parties or on
their behalf and notwithstanding that any Secured Party may have had notice or knowledge of any Default at the time of any Loan, and shall continue in full force and effect as long as either (i) any Loan or any other Obligation hereunder shall
remain outstanding, unpaid or unsatisfied or (ii) the Maturity Date has not occurred. Notwithstanding anything to the contrary in the Loan Documents, the obligations of the Loan Parties under Section 2.5 and the obligations of the Loan
Parties and the Lenders under this Article 6 shall survive and remain in full force and effect regardless of the consummation of the transactions contemplated hereby, the repayment of the Loans and the other Obligations, the expiration or
termination of the Warrants or the termination of this Agreement or any of the other Loan Documents or any provision hereof or thereof. For the avoidance of doubt and notwithstanding anything to the contrary in any Loan Documents, (a) the

  
 100 

 
making of the representations and warranties herein or in any other Loan Document that relate to the Warrants or any securities laws shall survive the payment in full of the Loans and any other
Obligations until such time that Warrants are fully and completely paid, performed, extinguished and terminated in accordance with their terms, (b) all rights set forth in the Warrants and the Registration Rights Agreement and all transactions
contemplated thereby (other than this Agreement and the other Loan Documents with respect to provisions that are not mentioned herein or therein to survive the payment in full of the Loans) shall continue to, and at all times, exist until
(i) with respect to the Warrants, such Warrants are fully and completely paid, performed, extinguished and terminated in accordance with their terms and (ii) with respect to the Registration Rights Agreement, such Registration Rights
Agreement is fully and completely terminated in accordance with its terms, (c) Sections 5.1(h), (p), (s) and (aa) and Section 5.2(xvii) will survive until the end of the Reporting Period, but all other affirmative and negative covenants,
events of default, fees, penalties and other provisions not expressly surviving pursuant to this Section 6.9 shall terminate upon the payment in full of the Obligations (not including unasserted contingent indemnification obligations or any
Obligations in respect of the Warrants, the Registration Rights Agreement or any Stock) and (d) all Liens granted on the Collateral under any Loan Document shall remain in effect and shall continue to secure the Obligations under the Loan
Documents (x) until all of the Obligations (other than unasserted contingent indemnification obligations and other than any Obligations under any Warrant or the Registration Rights Agreement) have been paid in full in cash in accordance with
such Loan Documents and (y) other than Liens on any Collateral disposed of in a Permitted Disposition or as otherwise agreed in writing by the Required Lenders (or such greater percentage of Lenders required pursuant to Section 6.6) (but
such release shall only be for the Liens on such Collateral so disposed in a Permitted Disposition or as may be agreed in writing by the Required Lenders (or such greater percentage of Lenders required pursuant to Section 6.6)). 

(c) Upon payment in full of all Obligations (other than unasserted contingent indemnification obligations and other than any Obligations in
connection with any Warrant or the Registration Rights Agreement) in cash in accordance with the Loan Documents, subject to the second sentence of Section 6.22, all Collateral shall be automatically released from the Liens created by the
Security Agreement, any other Loan Document or otherwise and all rights of the Secured Parties in the Collateral shall automatically terminate, all without delivery of any instrument or any additional performance by any Person. 

(d) Notwithstanding anything to the contrary contained herein or in any other Loan Document, the Agent is hereby unconditionally authorized and
instructed by each Secured Party (without requirement of notice to or consent of any Secured Party) to take any action to release or terminate any Lien granted under the Loan Documents to secure the Obligations in the Collateral upon
(i) payment in full of all Obligations (other than unasserted contingent indemnification obligations and other than the Obligations under any Warrant or the Registration Rights Agreement) in cash in accordance with the Loan Documents,
(ii) a written agreement by the requisite number of Lenders required by Section 6.6 and (iii) a Permitted Disposition (but solely in the Collateral so disposed of in a Permitted Disposition and not in any other property or assets).

 (e) In each case in accordance with this Section 6.9 whereby a Lien on all or a portion of the Collateral is released, the Agent will (and
each Lender irrevocably authorizes and instructs the Agent to), at the Borrower’s expense, execute and deliver to the applicable Loan Party such documents as such Loan Party may reasonably request to evidence the release of (i) all
Collateral from the Liens granted under the Loan Documents upon payment in full of all Obligations (other than unasserted contingent indemnification obligations and other than the Obligations under any Warrant or the Registration Rights Agreement)
in cash in accordance with the Loan Documents, in each case, in accordance with the terms of the Loan Documents and this Section 6.9, (ii) Collateral permitted to be sold pursuant to clause (d)(ii) of

  
 101 

 
this Section 6.9 (but solely in such Collateral) and (iii) the Liens on that Collateral sold pursuant to a Permitted Disposition (but solely in such Collateral sold pursuant to such
Permitted Disposition). 
 (f) Notwithstanding anything to the contrary in the Loan Documents and for the avoidance of doubt, the holders of
the Warrants and parties to the Registration Rights Agreement shall be entitled to exercise all rights and remedies available to them under law and at equity and under the Warrants and the Registration Rights Agreement for any breaches of provisions
that survive the payment in full of the Obligations (other than the payment in full of unasserted contingent indemnification obligations and other than Obligations under any Warrant or the Registration Rights Agreement). 

Section 6.10 No Waiver. Neither the failure of, nor any delay on the part of, any Party in exercising
any right, power or privilege hereunder, or under any agreement, document or instrument mentioned herein or under any other Loan Document, shall operate as a waiver thereof, nor shall any single or partial exercise of any right, power or privilege
hereunder, under any other Loan Document or under any other agreement, document or instrument mentioned herein, preclude other or further exercise thereof or the exercise of any other right, power or privilege; nor shall any waiver of any right,
power, privilege or default hereunder, under any other Loan Document or under any agreement, document or instrument mentioned herein, constitute a waiver of any other right, power, privilege or default or constitute a waiver of any default of the
same or of any other term or provision. No course of dealing and no delay in exercising, or omission to exercise, any right, power or remedy accruing to Agent or the Lenders upon any breach, Default or Event of Default under this Agreement, any
other Loan Document or any other agreement shall impair any such right, power or remedy or be construed to be a waiver thereof or an acquiescence therein; nor shall the action of Agent or the Lenders in respect of any such breach, Default or Event
of Default or any acquiescence by it therein, affect or impair any right, power or remedy of Agent or the Lenders in respect of any other breach, Default or any Event of Default. All rights and remedies herein or in the other Loan Documents provided
are cumulative and not exclusive of any rights or remedies otherwise provided by (or available at) law or in equity. 
 Section 6.11
Indemnity. 
 (a) The Loan Parties shall, at all times, indemnify and hold harmless (the “Indemnity”) the Secured
Parties and each of their respective directors, partners, officers, employees, agents, counsel and advisors (each, an “Indemnified Person”) in connection with any losses, claims (including the reasonable attorneys’ fees
incurred in defending against such claims), damages, liabilities, penalties or other expenses arising out of, or relating to, the Loan Documents or the Prior Loan Documents, the extension of credit hereunder or the Loan or the other Obligations or
the use or intended use of the Loan or the other Obligations, which an Indemnified Person may incur or to which an Indemnified Person may become subject (each, a “Loss”). The Indemnity shall not apply to the extent that a court or
arbitral tribunal of competent jurisdiction issues a final non-appealable judgment that such Loss of an Indemnified Person resulted from the gross negligence, bad faith or willful misconduct of such
Indemnified Person. The Indemnity is independent of and in addition to any other agreement of any Party under any Loan Document to pay any amount to the Secured Parties, and any exclusion of any obligation to pay any amount under this
Section 6.11(a) shall not affect the requirement to pay such amount under any other section hereof or under any other agreement. For the avoidance of doubt, this Section 6.11 shall not apply to Taxes other than Taxes that represent losses,
claims, damages, etc. arising from any non-Tax claim. 
 (b) An Indemnified Person shall have the
right to retain its own legal counsel with the fees, costs and expenses of such legal counsel and of such Indemnified Person to be paid by the indemnifying Person. The indemnification required by this Section 6.11 shall be made and paid by such
indemnifying Person within ten (10) Business Days of written demand by such Indemnified Person. 

  
 102 

 (c) No settlement of any Loss shall be entered into by such indemnifying Person without the
written consent of the applicable Indemnified Person. 
 (d) No Loan Party shall, nor shall it permit any of its Subsidiaries, assert, and
each Loan Party on behalf of itself and its Subsidiaries, hereby waives, any claim, loss or amount against any Indemnified Person with respect to any special, indirect, consequential or punitive damages (as opposed to direct or actual damages)
arising out of, in connection with, or as a result of, this Agreement or the other Loan Documents or any undertaking or transaction contemplated hereby or thereby. No Indemnified Person shall be liable for any damages arising from the use by
unintended recipients of any information or other materials distributed by it through telecommunications, electronic or other information transmission systems in connection with the Loan Documents or the transactions contemplated hereby or thereby.

 Section 6.12 No Usury. The Loan Documents are hereby expressly limited so that in no contingency
or event whatsoever, whether by reason of acceleration or otherwise, shall the amount paid or agreed to be paid to Agent or the Lenders for the Loan or the other Obligations exceed the maximum amount permissible under Applicable Law. If from any
circumstance whatsoever fulfillment of any provision hereof or any other Loan Document, at the time performance of such provision shall be due, shall involve transcending the limit of validity prescribed by law, then, ipso facto, the
obligation to be fulfilled shall be reduced to the limit of such validity, and if from any such circumstance Agent or the Lenders shall ever receive anything which might be deemed interest under Applicable Law, that would exceed the highest lawful
rate, such amount that would be deemed excessive interest shall be applied to the reduction of the principal amount owing on account of the Loan or the other Obligations, or if such deemed excessive interest exceeds the unpaid balance of principal
of the Loan or the other Obligations, such deemed excess shall be refunded to the Borrower. All sums paid or agreed to be paid to the Lenders for the Loan or the other Obligations shall, to the extent permitted by Applicable Law, be deemed to be
amortized, prorated, allocated and spread throughout the full term of the Loan and the other Obligations until payment in full so that the deemed rate of interest on account of the Loan and the other Obligations is uniform throughout the term
thereof. The terms and provisions of this Section shall control and supersede every other provision of this Agreement, the Notes and the other Loan Documents. 

Section 6.13 Specific Performance. The Loan Parties agree that irreparable damage, for which monetary relief,
even if available, would not be an adequate remedy, would occur in the event that any provision of the Loan Documents is not performed in accordance with its specific terms or is otherwise breached, including if the Loan Parties hereto fail to take
any action required of them hereunder or thereunder to consummate the transactions contemplated by the Loan Documents. In light of the foregoing, the Loan Parties hereby agree that, until all Obligations have been paid in full in accordance with the
Loan Documents, (a) the Secured Parties shall be entitled to an injunction or injunctions, specific performance or other equitable relief to prevent breaches of the Loan Documents and to enforce specifically the terms and provisions hereof and
thereof in the courts described in Section 6.4 without proof of damages or otherwise and (b) the right of specific performance and other equitable relief is an integral part of the transactions contemplated by the Loan Documents and
without that right, the Secured Parties would not have entered into the Loan Documents or have provided Loans or Disbursements hereunder or under the other Loan Documents. The Loan Parties hereby agree not to assert (or have any of their
Subsidiaries or their attorneys, agents or representatives assert or any other Person on their behalf to assert) that a remedy of specific performance or other equitable relief is unenforceable, invalid, contrary to Applicable Law or inequitable for
any reason, and not to assert that a remedy of monetary damages would provide an adequate remedy or that the parties otherwise have an adequate remedy at law. The Loan Parties hereby acknowledge and agree that any Secured Party seeking an injunction
or injunctions to prevent breaches of, or defaults under, the Loan Documents, to prevent any Default or Event of Default and to enforce specifically the terms and provisions of the Loan Documents in accordance with this Section 6.13 shall not
be required to provide any bond or other security in connection with any such injunction or other order or proceeding. The remedies 

  
 103 

 
available to the Secured Parties pursuant to this Section 6.13 shall be in addition to any other remedy which may be available under the Loan Documents, at law, in equity or otherwise. 

Section 6.14 Further Assurances. From time to time, the Loan Parties shall perform any and all acts
and execute and deliver to Agent and the Lenders such additional documents, agreements and instruments as may be reasonably requested by Agent or any of the Lenders to carry out the purposes of any Loan Document or to preserve and protect
Agent’s or the Lenders’ rights as contemplated therein. 
 Section 6.15 Agent. 

(a) Each Lender hereby irrevocably appoints Deerfield Private Design Fund IV, L.P. (together with any successor Agent appointed by Deerfield
Private Design Fund IV, L.P. or any successor Agent that was appointed by the Lenders or any prior Agent) as Agent hereunder and under the other Loan Documents and authorizes Agent to (i) execute and deliver the Loan Documents and accept
delivery thereof on its behalf from any Loan Party, (ii) take such other actions on its behalf and to exercise all rights, powers and remedies and perform the duties as are expressly delegated to Agent under the Loan Documents and
(iii) exercise such powers as are reasonably incidental thereto. Notwithstanding any provision to the contrary contained elsewhere in this Agreement or in any other Loan Document, Agent shall not have any duty or responsibility except those
expressly set forth herein, nor shall Agent have or be deemed to have any fiduciary relationship with any Lender or participant, and no implied covenants, functions, responsibilities, duties, obligations or liabilities shall be read into this
Agreement or any other Loan Document or otherwise exist against Agent. Without limiting the generality of the foregoing sentence, the use of the term “agent” herein and in other Loan Documents with reference to Agent is not intended to
connote any fiduciary or other implied (or express) obligations arising under agency doctrine of any Applicable Law. Instead, such term is used merely as a matter of market custom, and is intended to create or reflect only an administrative
relationship between independent contracting parties. 
 (b) Agent may execute any of its duties under this Agreement or any other Loan
Document by or through agents, employees or attorneys in fact and shall be entitled to advice of counsel and other consultants or experts concerning all matters pertaining to such duties. Agent shall not be responsible for the negligence or
misconduct of any agent or attorney in fact that it selects in the absence of gross negligence or willful misconduct as determined by a final, non-appealable judgment of a court of competent jurisdiction. 

(c) None of Agent nor any of its directors, officers, employees, attorneys, advisors, representatives or agents shall (i) be liable for
any action taken or omitted to be taken by any of them under or in connection with this Agreement or any other Loan Document or the Transactions or the transactions contemplated hereby or thereby (except to the extent resulting from its own gross
negligence or willful misconduct in connection with its duties expressly set forth herein as determined by a final, non-appealable judgment of a court of competent jurisdiction), or (ii) be responsible in
any manner to any Lender or participant for any recital, statement, representation or warranty made by any Loan Party or Affiliate of any Loan Party, or any officer thereof, contained in this Agreement or in any other Loan Document, or in any
certificate, report, statement or other document referred to or provided for in, or received by the Agent under or in connection with, this Agreement or any other Loan Document, or the validity, effectiveness, genuineness, enforceability or
sufficiency of this Agreement or any other Loan Document (or the creation, perfection or priority of any Lien or security interest therein), or for any failure of any Loan Party or any other party to any Loan Document to perform its obligations
(including the Obligations) hereunder or thereunder. Agent shall not be under any obligation to any Lender to ascertain or to inquire as to the observance or performance of any of the agreements contained in, or conditions of, this Agreement or any
other Loan Document, or to inspect the properties, books or records of any Loan Party or any Loan Party’s Subsidiaries or Affiliates. 

  
 104 

 (d) Agent shall be entitled to rely, and shall be fully protected in relying, upon any
writing, communication, signature, resolution, representation, notice, consent, certificate, electronic mail message, affidavit, letter, telegram, facsimile, telex or telephone message, statement or other document or conversation believed by it to
be genuine and correct and to have been signed, sent or made by the proper Person or Persons, and upon advice and statements of legal counsel (including counsel to any Loan Party), independent accountants and other experts selected by Agent. Agent
shall be fully justified in failing or refusing to take any action under this Agreement or any other Loan Document unless it shall first receive such advice or concurrence of the Lenders as it deems appropriate and, if it so requests, shall receive
confirmation from the Lenders of their obligation to indemnify Agent against any and all liabilities and expenses (including any fees and expenses of counsel to Agent) which may be incurred by it by reason of taking or continuing to take any such
action. Agent shall in all cases be fully protected in acting, or in refraining from acting, under this Agreement or any other Loan Document in accordance with a request or consent of the Lenders and such request and any action taken or failure to
act pursuant thereto shall be binding upon each Lender. 
 (e) Agent shall not be deemed to have knowledge or notice of the occurrence of any
Event of Default or Default, unless Agent shall have received written notice from a Lender or any Loan Party referring to this Agreement and the other Loan Documents, describing such Event of Default or Default and stating that such notice is a
“notice of default.” Agent shall take such action with respect to such Event of Default or Default as may be requested by the Lenders; provided that unless and until the Agent has received any such request, the Agent may (but shall not be
obligated to) take such action, or refrain from taking such action, with respect to such Event of Default or Default as it shall deem advisable or in the best interest of itself and the Lenders. 

(f) Each Lender acknowledges that Agent has not made any representation or warranty to it, and that no act by Agent hereafter taken, including
any consent and acceptance of any assignment or review of the affairs of the Loan Parties or any of their Subsidiaries, shall be deemed to constitute any representation or warranty by Agent to any Lender as to any matter, including whether Agent has
disclosed material information in its possession. Each Lender represents to Agent that it has, independently and without reliance upon Agent and based on such documents and information as it has deemed appropriate, made its own appraisal of and
investigation into the business, prospects, operations, property, financial and other condition and creditworthiness of Borrower and the other Loan Parties, and made its own decision to enter into this Agreement and the other Loan Documents and to
extend credit to Borrower hereunder and under the other Loan Documents. Each Lender also represents that it will, independently and without reliance upon Agent and based on such documents and information as it shall deem appropriate at the time,
continue to make its own credit analysis, appraisals and decisions in taking or not taking action under this Agreement and the other Loan Documents, and to make such investigations as it deems necessary or appropriate to inform itself as to the
business, prospects, operations, property, financial and other condition and creditworthiness of Borrower and the other Loan Parties. Except for notices, reports and other documents expressly herein required to be furnished to the Lenders by Agent,
Agent shall not have any duty or responsibility to provide any Lender with any credit or other information concerning the business, prospects, operations, property, financial or other condition or creditworthiness of Borrower or any other Loan Party
which may come into the possession of Agent. 
 (g) Whether or not the transactions contemplated hereby are consummated, each Lender shall
indemnify upon demand Agent and its directors, officers, partners, employees, attorneys, advisors, representatives and agents (to the extent not reimbursed by or on behalf of any Loan Party and without limiting the obligation of Borrower to do so),
according to its applicable Pro Rata Share, from and against any and all losses, claims (including the reasonable attorneys’ fees incurred in defending against such claims), damages, liabilities, penalties or other expenses arising out of, or
relating to, any of Agent’s duties, responsibilities or actions set forth in or that taken pursuant to the Loan Documents; provided that no 

  
 105 

 
Lender shall be liable for any payment to any such Person of any portion of the foregoing to the extent determined by a final, non-appealable judgment by a
court of competent jurisdiction to have resulted from the applicable Person’s own gross negligence or willful misconduct. No action taken in accordance with the directions of the Lenders shall be deemed to constitute gross negligence or willful
misconduct for purposes of this Section 6.15(g). Without limitation of the foregoing, each Lender shall reimburse Agent upon demand for its ratable share of any costs or out of pocket expenses incurred by Agent in connection with the
preparation, execution, delivery, administration, modification, amendment or enforcement (whether through negotiations, legal proceedings or otherwise) of, or legal advice in respect of rights or responsibilities under, this Agreement, any other
Loan Document or any document contemplated by or referred to herein or therein, to the extent that Agent is not reimbursed for such fees, costs and expenses by or on behalf of the Loan Parties. The undertaking in this Section 6.15(g) shall
survive repayment of the Loans and the other Obligations, any foreclosure under, or modification, release or discharge of, any or all of the Loan Documents, termination of this Agreement or the other Loan Documents and the resignation or replacement
of Agent. 
 (h) Agent may resign as Agent upon thirty (30) days’ notice to the Lenders. If Agent resigns under this Agreement, the
Lenders shall appoint from among the Lenders a successor Agent for such successor Agent and the Lenders. If no successor Agent is appointed prior to the effective date of the resignation of Agent, Agent may appoint, after consulting with the
Lenders, a successor Agent from among the Lenders. Upon the acceptance of its appointment as successor Agent hereunder, such successor Agent shall succeed to all the rights, powers and duties of the retiring Agent and the term “Agent”
shall mean such successor Agent, and the retiring Agent’s appointment, powers and duties as Agent shall be terminated. After any retiring Agent’s resignation hereunder as Agent, the provisions of this Section 6.15 shall inure to its
benefit as to any actions taken or omitted to be taken by it while it was Agent under this Agreement and the other Loan Documents. If no successor Agent has accepted appointment as Agent by the date which is 30 days following a retiring Agent’s
notice of resignation, the retiring Agent’s resignation shall nevertheless thereupon become effective and the Lenders shall perform all of the duties of Agent hereunder until such time, if any, as the Lenders appoint a successor Agent as
provided for above. 
 (i) Agent hereby appoints each other Lender and other Secured Party as its agent (and each Lender and other Secured
Party hereby accepts such appointment) for the purpose of perfecting Agent’s Liens in assets which, in accordance with Article 8 or Article 9, as applicable, of the UCC can be perfected by possession or control. Should any Lender or other
Secured Party obtain possession or control of any such Collateral, such Lender or other Secured Party shall notify Agent thereof, and, promptly upon Agent’s request therefor shall deliver possession or control of such Collateral to Agent or in
accordance with Agent’s instructions. 
 Section 6.16 USA Patriot Act. Each Lender that is subject to
the USA Patriot Act (and Agent (for itself and not on behalf of any Lender)) hereby notifies the Loan Parties that, pursuant to the requirements of the USA Patriot Act, it is required to obtain, verify and record information that identifies each
Loan Party, which information includes the name, address and tax identification numbers of each Loan Party and other information that will allow such Lender or Agent to identify each Loan Party in accordance with the USA Patriot Act. In addition, if
Agent or any other Secured Party is required by law or regulation or internal policies to do so, it shall have the right to periodically conduct (a) USA Patriot Act searches, OFAC/PEP searches, and customary individual background checks for the
Loan Parties and (b) OFAC/PEP searches and customary individual background checks for the Loan Parties’ senior management and key principals, and the Loan Parties agree to cooperate in respect of the conduct of such searches and further
agree that the reasonable costs and charges for such searches shall paid for, and reimbursed by, the Loan Parties and be for the account of the Loan Parties. This notice is given in accordance with the requirements of the USA Patriot Act and is
effective for Agent and the Lenders. 

  
 106 

 Section 6.17 Placement Agent. The Borrower and the other
Loan Parties shall be solely responsible for the payment of any fees, costs, expenses and commissions of any placement agent, broker or financial adviser relating to or arising out of the transactions contemplated by the Loan Documents. The Borrower
and the other Loan Parties shall pay, and hold each of the Secured Parties harmless against, any liability, loss or expense (including attorneys’ fees, costs and expenses) arising in connection with any claim for any such payment. 

Section 6.18 No Fiduciary Relationship. No Secured Party has any fiduciary relationship or duty to any Loan
Party arising out of or in connection with, and there is no agency, tenancy or joint venture relationship between the Secured Parties and the Loan Parties by virtue of, any Loan Document or any transaction contemplated therein. 

Section 6.19 Joint and Several. The obligations of the Loan Parties hereunder and under the other Loan
Documents are joint and several. Without limiting the generality of the foregoing, reference is hereby made to Sections 2, 4 and 8.3 of the Security Agreement, to which the obligations of the Loan Parties are subject. 

Section 6.20 No Third Parties Benefited. This Agreement is made and entered into for the sole protection and
legal benefit of the Loan Parties and the Secured Parties party hereto (and the indemnitees mentioned herein), and their successors and permitted assigns, and no other Person shall be a direct or indirect legal beneficiary of, or have any direct or
indirect cause of action or claim in connection with, this Agreement or any of the other Loan Documents. No Secured Party shall have any obligation to any Person not a party to this Agreement or the other Loan Documents. 

Section 6.21 Binding Effect. This Agreement shall become effective when it shall have been executed by each
of the Loan Parties party hereto, each Lender party hereto and Agent and such executed counterparts have been delivered to Agent pursuant to the terms of this Agreement. Thereafter, it shall be binding upon and inure to the benefit of, each Loan
Party hereto and each Secured Party thereto and the indemnitees mentioned herein and, in each case, their respective successors and permitted assigns. 

Section 6.22 Marshaling; Payments Set Aside. No Secured Party shall be under any obligation to marshal any
property in favor of any Loan Party or any other Person or against or in payment of any Obligation. To the extent that any Secured Party receives a payment from the Borrower, from any other Loan Party, from the proceeds of the Collateral, from the
exercise of its rights of setoff, any enforcement action or otherwise, and such payment is subsequently, in whole or in part, invalidated, declared to be fraudulent or preferential, set aside or required to be repaid to a trustee, receiver or any
other party, then to the extent of such recovery, the Obligation or part thereof originally intended to be satisfied, and all Liens, rights and remedies therefor, shall be revived and continued in full force and effect as if such payment had not
occurred. 
 Section 6.23 No Waiver; Cumulative Remedies. No failure to exercise and no delay in
exercising, on the part of any Secured Party, any right, remedy, power or privilege under any Loan Document, shall operate as a waiver thereof; nor shall any single or partial exercise of any right, remedy, power or privilege hereunder preclude any
other or further exercise thereof or the exercise of any other right, remedy, power or privilege. No course of dealing between any Loan Party, any Affiliate of any Loan Party or any Secured Party shall be effective to amend, modify or discharge any
provision of any of the Loan Documents. 
 Section 6.24 Right of Setoff. Each Secured Party and each of its
Affiliates is hereby authorized, without notice or demand (each of which is hereby waived by each Loan Party), at any time and from time to time during the continuance of any Event of Default and to the fullest extent permitted by

  
 107 

 
Applicable Law, to set off and apply any and all deposits (whether general or special, time or demand, provisional or final) at any time held and other Indebtedness, claims or other obligations
at any time owing by any Secured Party or any of its Affiliates to or for the credit or the account of the Borrower or any other Loan Party against any Obligation of any Loan Party now or hereafter existing, whether or not any demand was made under
any Loan Document with respect to such Obligation and even though such Obligation may be unmatured. No Lender shall exercise any such right of setoff without the prior consent of Agent. Each Secured Party agrees promptly to notify Agent after any
such setoff and application made by such Secured Party or its Affiliates. The rights under this Section 6.24 are in addition to any other rights and remedies (including other rights of setoff) that any Secured Party or any of its Affiliates may
have. 
 Section 6.25 Independent Nature of Secured Parties. The obligations of each Secured Party under
the Loan Documents are several and not joint with the obligations of any other Secured Party, and no Secured Party shall be responsible in any way for the performance of the obligations of any other Secured Party under the Loan Documents. Each
Secured Party shall be responsible only for its own representations, warranties, agreements and covenants under the Loan Documents. The decision of each Lender to acquire the Securities pursuant to the Loan Documents has been made by such Lender
independently of any other Lender and independently of any information, materials, statements or opinions as to the business, affairs, operations, assets, properties, liabilities, results of operations, condition (financial or otherwise) or
prospects of the Borrower or any of its Subsidiaries which may have been made or given by any other Secured Party or by any agent, attorney, advisor, representative or employee of any other Secured Party, and no Secured Party or any of its agents,
attorneys, advisors, representatives or employees shall have any liability to any other Secured Party (or any other Person) relating to or arising from any such information, materials, statements or opinions. Nothing contained in the Loan Documents,
and no action taken by any Secured Party pursuant hereto or thereto (including a Lender’s acquisition of Obligations, Notes or Warrants at the same time as any other Secured Party), shall be deemed to constitute the Secured Parties as a
partnership, an association, a joint venture or any other kind of entity, or create a presumption that the Secured Parties are in any way acting in concert or as a group with respect to such Obligations or the transactions contemplated by any of the
Loan Documents. Each Secured Party shall be entitled to independently protect and enforce its rights, including the rights arising out of the Loan Documents, and it shall not be necessary for any other Secured Party to be joined as an additional
party in any proceeding for such purpose. 
 Section 6.26 Sharing of Payments, Etc. If any Lender, directly
or through any of its Affiliates, obtains any payment of any Obligation of any Loan Party (whether voluntary, involuntary or through the exercise of any right of setoff or the receipt of any Collateral or “proceeds” (as defined under the
applicable UCC) of Collateral) (and other than pursuant to Section 6.5) and such payment exceeds the amount such Lender would have been entitled to receive if all payments had gone to, and been distributed in accordance with the provisions of
the Loan Documents, such Lender shall purchase for cash from other Lenders such participations in their Obligations as necessary for such Lender to share such excess payment with such Lenders to ensure such payment is applied as though it had been
applied in accordance with this Agreement; provided, however, that (i) if such payment is rescinded or otherwise recovered from such Lender in whole or in part, such purchase shall be rescinded and the purchase price therefor
shall be returned to such Lender without interest and (ii) such Lender shall, to the fullest extent permitted by Applicable Law, be able to exercise all its rights of payment (including the right of setoff) with respect to such participation as
fully as if such Lender were the direct creditor of the applicable Loan Party in the amount of such participation. 

Section 6.27 Confidentiality. 

(a) Each of the Agent and the Lenders agrees to maintain the confidentiality of the Information (as defined below), except that Information may
be disclosed (i) to its Affiliates and to its 

  
 108 

 
Related Parties (it being understood that the Persons to whom such disclosure is made will be informed of the confidential nature of such Information and instructed to keep such Information
confidential), (ii) to the extent required or requested by any regulatory authority purporting to have jurisdiction over such Person or its Related Parties (including any self-regulatory authority), (iii) to the extent required by Applicable Laws or
regulations or by any subpoena or similar legal process, (iv) to any Secured Party or any other party hereto, (v) in connection with the exercise of any remedies hereunder or under any other Loan Document or any action or proceeding
relating to this Agreement or any other Loan Document or the enforcement of rights hereunder or thereunder, (vi) subject to an agreement containing provisions substantially the same as those of this Section, to (A) any assignee of or
Participant in, or any prospective assignee of or Participant in, any of its rights and obligations under this Agreement or the other Loan Documents or (B) any actual or prospective party (or its Related Parties) to any transaction under which
payments are to be made by reference to the Loan Parties and their obligations, this Agreement, the other Loan Documents or payments hereunder or thereunder, (vii) on a confidential basis to (A) any rating agency in connection with rating
any Loan Party or its Subsidiaries or the credit facilities provided hereunder or (B) the CUSIP Service Bureau or any similar agency in connection with the issuance and monitoring of CUSIP numbers or other market identifiers with respect to the
credit facilities provided hereunder, (viii) with the consent of any Loan Party or any of its Affiliates, (ix) to the extent such Information (A) becomes publicly available other than as a result of a breach of this
Section 6.27(a) or (B) becomes available to any Secured Party or any of its Affiliates on a nonconfidential basis from a source other than the Borrower, or (x) as provided in Section 5.1(q). In addition, the Secured Parties may
disclose the existence of this Agreement and information about this Agreement to market data collectors, similar service providers to the lending industry and service providers to the Secured Parties in connection with the administration of the
Loans and this Agreement and the other Loan Documents. 
 (b) For purposes of this Section, “Information” means all information
received from a Loan Party relating to the Loan Parties or any Subsidiary or any of their respective businesses, other than any such information that is available to Agent or any Lender on a nonconfidential basis prior to disclosure by such Loan
Party or any Subsidiary; provided that, notwithstanding anything to the contrary in the Loan Documents, in the case of information received from the Borrower or any of its Subsidiaries after the Prior Agreement Date, such Information is both
(y) clearly identified at the time of delivery as confidential and (z) provided to the Secured Parties at a time when the Secured Parties have requested in writing to receive material nonpublic information. Any Person required to maintain
the confidentiality of Information as provided in this Section 6.27 shall be considered to have complied with its obligation to do so if such Person has exercised the same degree of care to maintain the confidentiality of such Information as
such Person would accord to its own confidential information. 
 (c) The Loan Parties and their Affiliates agree that they will not issue any
press release announcing the transactions contemplated hereby without the prior written consent of the Agent, unless (and only to the extent that) the Loan Parties or such Affiliate is required to do so under Applicable Law and, in any event the
Loan Parties and their Affiliates will provide the Agent with a copy of, and consult with the Agent before issuing, any such press release or other public disclosure with respect to this Agreement or the other Loan Documents or the transactions
contemplated hereby or thereby and will consider in good faith any comments of the Agent. 
 Section 6.28
Intercreditor Agreement. 
 (a) Notwithstanding anything to the contrary in this Agreement or in any other Loan Document: (i) the
Liens granted to the Agent in favor of the Secured Parties pursuant to the Loan Documents and the exercise of any right related to any Collateral shall be subject, in each case, to the terms of the Intercreditor Agreement, (ii) in the event of
any conflict between the express terms and provisions of this Agreement or any other Loan Document, on the one hand, and of the Intercreditor Agreement, on the 

  
 109 

 
other hand, the terms and provisions of the Intercreditor Agreement, shall control, (iii) any Collateral held by (or in the possession or control of) the ABL Agent (or its agents or bailees)
shall be held as agent and bailee for security, Lien perfection and control purposes in favor of Agent (for the benefit of the Secured Parties) in accordance with the terms of the Intercreditor Agreement and the Loan Documents, and (iv) each
Lender (and, by its acceptance of the benefits of any Loan Document, each other Secured Party) hereunder authorizes and instructs Agent to execute the Intercreditor Agreement on behalf of such Lender, and such Lender agrees to be bound by the terms
thereof. 
 (b) Each Lender (and, by its acceptance of the benefits of any Loan Document, each other Secured Party) hereunder authorizes and
instructs the Agent, as Agent and on behalf of such Lender or other Secured Party, to enter into one or more intercreditor agreements (including any Intercreditor Agreement) from time to time pursuant to, or as contemplated by, the terms of this
Agreement and agrees that it will be bound by the terms and provisions thereof and will take no actions contrary to the terms and provisions thereof. 

Section 6.29 Acknowledgment of Prior Obligations and Continuation Thereof. Each of the Loan Parties
(a) consent to the amendment and restatement of the Prior Facility Agreement by this Agreement (and any other “Loan Documents” (as defined in the Prior Facility Agreement, the “Prior Loan Documents”) that are being
amended and restated); (b) acknowledges and agrees that (i) there are “Obligations” (as defined in the Prior Facility Agreement) owing to the Secured Parties that will continue to be owed and owing to the Secured Parties as
Obligations under this Agreement and the other Loan Documents, including the obligations under the Initial Warrants and the Registration Rights Agreement that existed immediately prior to the effectiveness of this Agreement, and (ii) the prior
grant or grants of Liens or security interests in favor of any of the Agent or the other Secured Parties in such Loan Parties’ properties and assets, under each Prior Loan Document continue to exist and will continue to exist under the Loan
Documents, and each Loan Document to which it is a party shall be in respect of the Obligations of each of the Loan Parties under this Agreement and the other Loan Documents; provided, however, that such security interests or Liens
shall be as modified (if applicable) pursuant to the terms of the Loan Documents applicable thereto which are entered into on the Agreement Date, if any; (c) reaffirms (i) all of the Obligations (as defined in the Prior Facility Agreement)
owing to the Secured Parties, and (ii) all prior or concurrent grants of Liens or security interests in favor of any of the Agent or the Secured Parties under each Prior Loan Document and each Loan Document; provided, however,
that such Liens or security interests shall be as modified (if applicable) pursuant to the terms of the Loan Documents applicable thereto which are entered into on the Agreement Date, if any; and (d) agrees that, except as expressly amended
hereby or unless being amended and restated concurrently herewith, each of the Prior Loan Documents to which it is a party is and shall remain in full force and effect. Each of the Loan Parties hereby confirms and agrees that all outstanding
principal, interest and fees (including such accrued and unpaid principal, interest, and fees set forth in the immediately preceding sentence) and other “Obligations” (as defined in the Priority Facility Agreement) under the Prior Facility
Agreement and the other Prior Loan Documents immediately prior to the Agreement Date shall, from and after the Agreement Date, be, without duplication, Obligations owing and payable pursuant to this Agreement and the other Loan Documents as in
effect from time to time, shall accrue interest thereon as specified in this Agreement, and shall be secured by the Loan Documents. Although each of the Loan Parties has been informed of the matters set forth herein and has acknowledged and agreed
to the same, it understands that no Secured Party shall have any obligation to inform it of such matters in the future or to seek its acknowledgement or agreement to future amendments, restatements, supplements or other modifications, and nothing
herein shall create such a duty. 
 Section 6.30 No Novation. This Agreement does not extinguish the
obligations for the payment of money outstanding under the Prior Facility Agreement or the other Prior Loan Documents or discharge or release the obligations or the Liens or priority of any pledge, security agreement or any other security therefor
or any of the obligations under the Prior Loan Documents (including the Initial Warrants 

  
 110 

 
and the Registration Rights Agreement). Nothing herein contained shall be construed as a substitution or novation of the obligations outstanding under the Prior Facility Agreement, the other
Prior Loan Documents or agreements, instruments or documents securing the same, which shall remain in full force and effect, except as modified hereby or by agreements, instruments or documents executed concurrently herewith. Nothing expressed or
implied in this Agreement shall be construed as a release or other discharge of any Loan Party from any of its obligations or liabilities under the Prior Facility Agreement and the other Prior Loan Documents or any of the security agreements, pledge
agreements, guaranties or other loan documents executed in connection therewith. Each of Loan Parties hereby (a) confirms and agrees that each Prior Loan Document and each Initial Warrant to which it is a party that is not being amended and
restated concurrently herewith is, and shall continue to be, in full force and effect and is hereby ratified and confirmed in all respects except that on and after the Agreement Date, all references in any such Prior Loan Document to
(i) “the Facility Agreement,” “thereto,” “thereof,” “thereunder” or words of like import referring to the Prior Facility Agreement shall mean the Prior Facility Agreement as amended and restated by this
Agreement or (ii) any other Prior Loan Document being amended and restated, “thereto,”, thereof,” thereunder,” or words of like import referring to such Prior Loan Document shall mean such Prior Loan Document as amended and
restated by the corresponding Loan Document; and (b) confirms and agrees that to the extent that any such Prior Loan Document purports to assign or pledge to any of the Agent or the other Secured Parties or to grant to any of the Agent or the
other Secured Parties a security interest in or Lien on, any collateral as security for the obligations of any Loan Party, as the case may be, from time to time existing in respect of the Prior Facility Agreement or the other Prior Loan Documents,
such pledge or assignment or grant of the security interest or Lien is hereby ratified and confirmed in all respects with respect to this Agreement and the other Loan Documents. 

Section 6.31 Survival of Any Existing Unmatured Events of Default and Events of Default. Notwithstanding
anything to the contrary in this Agreement, the other Loan Documents (including the Warrants and the Registration Rights Agreement) or otherwise, except as expressly set forth otherwise in any Loan Document, (a) any “Default” and any
“Event of Default” under the Prior Loan Documents, the Warrants or the Registration Rights Agreement (including any incorrect or inaccurate (or breach of a) representation, warranty or certification made under the Prior Facility Agreement,
any other Prior Loan Document, any Warrant or the Registration Rights Agreement) arising on or prior to the Agreement Date shall continue to exist under this Agreement and the other Loan Documents and (b) such amendments, amendments and
restatements, supplements and modifications made to the Prior Facility Agreement and the other Prior Loan Documents, any Warrant or the Registration Rights Agreement shall not be deemed to be a waiver, forbearance or other modification thereof. Any
representation, warranty or certification made under the Prior Loan Documents, the Warrants and the Registration Rights Agreement that continued to be made after initially being made shall continue to be made under this Agreement, the Loan
Documents, the Warrants and the Registration Rights Agreement, as amended (but, for the avoidance of doubt, without giving effect to any such amendment with respect to the making of such representation, warranty or certification prior to the date of
such amendment), and any incorrectness, inaccurateness or breach of any such representation, warranty or certification shall be a breach or violation under this Agreement, the Loan Documents, the Warrants and the Registration Rights Agreement and
subject to the rights and remedies provided hereunder and thereunder for any such breach or violation of a representation, warranty or certification. 

[SIGNATURE PAGE FOLLOWS] 

  
 111 

 IN WITNESS WHEREOF, the Parties have caused this Agreement to be duly executed as of the
first day written above. 
  

			
	BORROWER:
	
	 ENDOLOGIX, INC.,
 a Delaware
corporation

		
	By:	 	 /s/ Vaseem Mahboob

	Name:	 	Vaseem Mahboob
	Title:	 	Chief Financial Officer
	
	OTHER LOAN PARTIES:
	
	 CVD/RMS ACQUISITION CORP.,
 a
Delaware corporation

		
	By:	 	 /s/ Vaseem Mahboob

	Name:	 	Vaseem Mahboob
	Title:	 	Chief Financial Officer and Secretary
	
	 NELLIX, INC.,
 a Delaware
corporation

		
	By:	 	 /s/ Vaseem Mahboob

	Name:	 	Vaseem Mahboob
	Title:	 	Chief Financial Officer and Secretary
	
	 TRIVASCULAR TECHNOLOGIES, INC.,

a Delaware corporation

		
	By:	 	 /s/ Vaseem Mahboob

	Name:	 	Vaseem Mahboob
	Title:	 	Chief Financial Officer and Secretary
	
	 TRIVASCULAR, INC.,
 a
California corporation

		
	By:	 	 /s/ Vaseem Mahboob

	Name:	 	Vaseem Mahboob
	Title:	 	Chief Financial Officer and Secretary

 [Signature Page to Amended and Restated Facility Agreement] 

			
	 ENDOLOGIX CANADA, LLC,
 a
Delaware limited liability company

		
	By:	 	 /s/ Vaseem Mahboob

	Name:	 	Vaseem Mahboob
	Title:	 	Chief Financial Officer and Secretary
	
	 TRIVASCULAR SALES LLC,
 a
Texas limited liability company

		
	By:	 	 /s/ Vaseem Mahboob

	Name:	 	Vaseem Mahboob
	Title:	 	Chief Financial Officer and Secretary
	
	 RMS/ENDOLOGIX SIDEWAYS MERGER CORP.,

a Delaware corporation

		
	By:	 	 /s/ Vaseem Mahboob

	Name:	 	Vaseem Mahboob
	Title:	 	Chief Financial Officer and Secretary

 [Signature Page to Amended and Restated Facility Agreement] 

			
	LENDERS:
	
	DEERFIELD PRIVATE DESIGN FUND III, L.P.
	
	By: Deerfield Mgmt III, L.P., General Partner
	
	By: J.E. Flynn Capital III, LLC, General Partner
		
	By:	 	 /s/ David J. Clark

	Name:	 	David J. Clark
	Title:	 	Authorized Signatory
	
	DEERFIELD PARTNERS, L.P.
	
	By: Deerfield Mgmt, L.P., General Partner
	
	By: J.E. Flynn Capital, LLC, General Partner
		
	By:	 	 /s/ David J. Clark

	Name:	 	David J. Clark
	Title:	 	Authorized Signatory
	
	DEERFIELD PRIVATE DESIGN FUND IV, L.P.
	
	By: Deerfield Mgmt IV, L.P., General Partner
	
	By: J.E. Flynn Capital IV, LLC, General Partner
		
	By:	 	 /s/ David J. Clark

	Name:	 	David J. Clark
	Title:	 	Authorized Signatory

 [Signature Page to Amended and Restated Facility Agreement] 

			
	AGENT:
	
	DEERFIELD PRIVATE DESIGN FUND IV, L.P.
	
	By: Deerfield Mgmt IV, L.P., General Partner
	
	By: J.E. Flynn Capital IV, LLC, General Partner
		
	By:	 	 /s/ David J. Clark

	Name:	 	David J. Clark
	Title:	 	Authorized Signatory

 [Signature Page to Amended and Restated Facility Agreement] 

 ANNEX A 

DISBURSEMENT AMOUNTS AND WARRANTS 
  

																					
	 Lender
	  	First Out
Waterfall Loan	 	  	Last Out
Waterfall Loan	 	  	Total
Disbursement
Amount	 	  	Fraction
of Total
Initial
Warrants	 	 	Fraction of Total
Additional
Warrants	 
	 Deerfield Private Design Fund III, L.P.
	  	$	40,000,000	 	  	$	0	 	  	$	40,000,000	 	  	 	1/3	 	 	 	1/3	 
	 Deerfield Private Design Fund IV, L.P.
	  	$	40,000,000	 	  	$	0	 	  	$	40,000,000	 	  	 	1/3	 	 	 	1/3	 
	 Deerfield Partners, L.P.
	  	$	40,000,000	 	  	$	40,500,000	 	  	$	80,500,000	 	  	 	1/3	 	 	 	1/3	 
		  	  
	  
	 	  	  
	  
	 	  	  
	  
	 	  	  
	  
	 	 	  
	  
	 
	 Total
	  	$	120,000,000	 	  	$	40,500,000	 	  	$	160,500,000	 	  	 	100	% 	 	 	100	% 
		  	  
	  
	 	  	  
	  
	 	  	  
	  
	 	  	  
	  
	 	 	  
	  
	 

 Exhibit 2.6 

Share Payment Provisions 
 If the Borrower
elects, in lieu of paying in cash any interest due and payable under Section 2.6 of the Amended and Restated Facility Agreement to which this Exhibit is attached (the “Agreement”), to satisfy any such amounts due through the
issuance of Freely Tradeable Shares (as defined below), pursuant to Section 2.6 of the Agreement, the following terms shall apply: 

1. Defined Terms. Capitalized terms used in this Exhibit 2.6 and not otherwise defined herein shall have the meanings
set forth in the Agreement. For purposes of this Exhibit, the following terms shall have the following meanings: 

“Bloomberg” means Bloomberg Financial Markets or an equivalent, reliable reporting service mutually acceptable to and
designated by the Borrower and the Required Lenders. 
 “Credit Amount” has the meaning set forth in
Section 4 of this Exhibit. 
 “Delisting Event” means any of the following: (i) the
Common Stock is not listed on a Principal Market, (ii) trading in the Common Stock on the Principal Market is suspended, or (iii) the Borrower is not in compliance with any material rule or regulation applicable to the trading or listing
of the Common Stock on the Principal Market. 
 “Failure Amount” has the meaning set forth in
Section 8 of this Exhibit. 
 “Freely Tradeable Shares” means any shares of Common Stock
which, at the time of issuance thereof, (i) are duly authorized, validly issued, fully paid and non-assessable; (ii) are eligible for resale by the Lenders, without limitation or restriction
(including any volume limitation or current public information requirement) under state or Federal securities laws, pursuant to Rule 144 under the Securities Act; and (iii) do not bear, and are not subject to, any restrictive legend, stop
transfer or similar restriction. 
 “Interest Payment Shares” means a number of shares of Common Stock equal to the
applicable Share Issuance Amount divided by the Interest Payment Share Price. 
 “Interest Payment Share Price” means, as
of any Interest Payment Date, ninety-six percent (96%) of the lesser of: (i) the Last Bid Price prior to such Interest Payment Date and (ii) the arithmetic average of the Volume Weighted Average
Price per share of Common Stock on each of the ten (10) consecutive Trading Days immediately preceding the Interest Payment Date (the “Measurement Period”); provided, that in the event that a Stock Event is consummated during
the Measurement Period, the Volume Weighted Average Price for all Trading Days during the Measurement Period prior to the effectiveness of such Stock Event shall be appropriately adjusted to reflect such Stock Event. 

“Last Bid Price” means, with respect to any security as of any time of determination, the last bid price on the Principal
Market as reported by, or based upon data reported by, Bloomberg Financial Markets or an equivalent, reliable reporting service mutually acceptable to and designated by the Borrower and the Lenders (“Bloomberg”). 

“Major Transaction” shall have the meaning given to such term in the Warrants. 

“Major Transaction Notice” shall have the meaning given to such term in the Warrants. 

“Market Capitalization” means, as of any date of determination, the product of (i) the number of

 
issued and outstanding shares of Common Stock as of such date (exclusive of any shares of Common Stock issuable directly or indirectly upon exercise of the Warrants or any other Options or
conversion of the Notes or any other Convertible Securities), multiplied by (ii) the closing price per share of Common Stock as of the preceding Trading Day on the Principal Market, as reported by, or based upon data reported by, Bloomberg.

 “Share Delivery Failure” has the meaning set forth in Section 8 of this Exhibit. 

“Share Issuance Amount” has the meaning set forth in Section 3 of this Exhibit. 

“Share Issuance Limit” means 2,526,800 shares of Common Stock, subject to appropriate adjustment for any Stock Events
occurring after August 9, 2018, and a “Lender’s Share Issuance Limit” means such Lender’s First Out Waterfall Pro Rata Share of the Share Issuance Limit. 

“Share Issuance Notice” has the meaning set forth in Section 3 of this Exhibit. 

“Stock Event” shall have the meaning given to such term in the Notes. 

“Trading Day” means any day on which the Common Stock is traded for at least six hours on the Principal Market. 

“Volume Weighted Average Price” means, for the Common Stock as of any Trading Day, the volume weighted average sale price of
the Common Stock on the Principal Market as reported by Bloomberg. Volume Weighted Average Price will be determine without regard to after-hours trading or any other trading outside of the regular trading hours. 

“Withholding Date” means the first date on which the Borrower withholds or determines that it is required to withhold any
Taxes as a result of the provisions of this Exhibit or the issuance of any shares of Common Stock, or consummation of any transactions, as contemplated hereby. 

2. General. Subject to the terms and conditions of this Exhibit, the Borrower’s valid exercise of its share
issuance rights under this Exhibit and subsequent fulfillment of its obligations hereunder (including delivery of all of the requisite Daily Issuance Shares and payment of the Share Issuance Amount, if any) shall be deemed to satisfy its obligation
to pay interest on the applicable Interest Payment Date for which such share issuance right is being exercised. 
 3.
Exercise of Share Issuance Rights. On any date that is not more than fifteen (15) and not less than ten (10) Trading Days prior to any Interest Payment Date, the Borrower may deliver to each of the Lenders notice by electronic mail
or facsimile (a “Share Issuance Notice”) of its intention to issue Freely Tradeable Shares pursuant to the provisions of this Exhibit in order to satisfy interest due on such Interest Payment Date under Section 2.6 of
the Agreement by delivering such Freely Tradeable Shares to the Lenders; provided, however, that the Borrower may not deliver a Share Issuance Notice (a) during the occurrence of a Delisting Event, (b) at any time following
such time as the Borrower has delivered (or is obligated to deliver) a Major Transaction Notice in respect of a Major Transaction, (c) at any time following the occurrence, and during the continuance, of an Event of Default or a Default,
(d) from and after a Withholding Date, (e) if, as of the close of trading on the immediately preceding Trading Day, the Market Capitalization is less than $200,000,000, (f) if the aggregate number of shares of Common Stock issued pursuant
to prior Share Issuance Notices has equaled the Share Issuance Limit, (g) unless all material information regarding the Borrower (including any material information that 

 
may be included in, or reflected by, the Share Issuance Notice, but excluding any material information relating to the Borrower’s operating results for the fiscal quarter in which the Share
Issuance Notice is delivered other than operating results that would trigger non-compliance with a covenant hereunder or in the ABL Credit Facility) has been publicly disclosed in a report filed pursuant to
the Exchange Act or has been otherwise publicly disclosed in a manner calculated to reach the securities marketplace through one of the Borrower’s recognized channels of distribution, (h) unless all shares of Common Stock issuable pursuant
to such Share Issuance Notice are eligible for resale by the Lenders without limitation or restriction, including any volume limitations, under state or Federal securities laws pursuant to Rule 144 under the Securities Act, (i) unless the
Borrower is in compliance with the “current public information” requirement of Rule 144(c) under the Securities Act, (j) if the transfer agent for the Common Stock is not participating in DTC’s Fast Automated Securities Transfer
Program, (k) if any Lender, after consultation with counsel of its choosing, advises the Borrower that the receipt or resale of Common Stock issued or issuable hereunder would result in such Lender being deemed an “underwriter” within
the meaning of Section 2(11) under the Securities Act or (1) if the arithmetic average of the Volume Weighted Average Prices on each of the ten (10) consecutive Trading Days immediately preceding such date is less than $2.00
(collectively, the “Share Issuance Conditions”). Subject to such provisions, a Share Issuance Notice shall be irrevocable, shall specify the aggregate amount of interest subject to such Share Issuance Notice, in each case, broken
out by the amount due each Lender (such amount, a “Share Issuance Amount”). If the Lenders do not confirm receipt of the Share Issuance Notice within three (3) Trading Days of the delivery thereof, the Borrower shall thereafter
use its reasonable best efforts to confirm (by email, telephonically or otherwise) such receipt, and in no event shall the Issuance Period commence unless and until the Lenders have confirmed such receipt. For the avoidance of doubt, the Borrower
may exercise its right under this Exhibit 2.6, and may deliver a Share Issuance Notice, only one time with respect to the interest due and payable on any Interest Payment Date. 

4. Share Issuance. On the applicable Interest Payment Date, by no later than 9:00 a.m., New York City time, the Borrower
shall deliver to each Lender its First Out Waterfall Pro Rata Share of the applicable Interest Payment Shares by causing the transfer agent for the Common Stock to electronically transmit such Interest Payment Shares to such Lender by crediting to
the account of such Lender’s prime broker (as specified by such Lender no later than one Trading Day prior to the Interest Payment Date) with DTC through its Deposit/Withdrawal at Custodian (DWAC) system its First Out Waterfall Pro Rata Share
of such Interest Payment Shares determined pursuant to Section 6 of this Exhibit. Concurrently with the valid delivery of the related Interest Payment Shares on the Interest Payment Date, an amount (the “Credit
Amount”) of interest payable on such Interest Payment Date equal to the product of (x) the number of Interest Payment Shares issued and delivered to a Lender on such date multiplied by (y) the applicable Interest Payment Share
Price, shall be deemed to have been satisfied. 
 All shares of Common Stock issued and delivered pursuant to this
Section 4 shall be Freely Tradeable Shares (and for the avoidance of doubt, only Freely Tradeable Shares shall be deemed to constitute Interest Payment Shares and be applied to any Credit Amount). In connection with the
issuance and delivery of any shares of Common Stock to the Lenders pursuant to this Section 4, the Borrower shall deliver to the Lenders, by no later than the last Business Day prior to the Interest Payment Date for which a
Share Issuance Notice has been delivered, an opinion of counsel reasonably satisfactory to the Lenders, substantially in the form attached as Annex 1 to this Exhibit, relating to all shares of Common Stock to be issued and delivered to the Lenders
(as Freely Tradeable Shares) on the Interest Payment Date. For purposes of determining whether any shares of Common Stock are Freely Tradeable Shares, each Lender represents (and counsel is entitled to rely on the representation for purposes of
issuing the opinion contemplated above), unless it 

 
notifies Borrower otherwise at least five (5) days prior to the applicable Interest Payment Date, that it will not be an Affiliate of the Borrower on the Interest Payment Date and will not
have been an Affiliate of the Borrower within the three-month period immediately preceding the Interest Payment Date. 
 5.
Limitations on Share Issuances. Notwithstanding anything herein to the contrary, the Borrower shall not issue to any Lender, and no Lender may acquire, a number of shares of Common Stock hereunder to the extent that, upon such issuance, the
number of shares of Common Stock then beneficially owned by such Lender and its Affiliates and any other persons or entities whose beneficial ownership of Common Stock would be aggregated with such Lender’s for purposes of Section 13(d) of
the Exchange Act (including shares held by any “group” of which the Lender is a member, but excluding shares beneficially owned by virtue of the ownership of securities or rights to acquire securities (including the Warrants) that have
limitations on the right to convert, exercise or acquire similar to the limitation set forth herein), would exceed 4.985% of the total number of shares of Common Stock then issued and outstanding (the “4.985% Cap”). For purposes
hereof, “group” has the meaning set forth in Section 13(d) of the Exchange Act and applicable regulations of the SEC, and the percentage held by each Lender shall be determined in a manner consistent with the provisions of
Section 13(d) of the Exchange Act. All Share Issuance Notices shall set forth the number of shares of Common Stock then outstanding. Upon written request of any Lender at any time, the Borrower shall, within one (1) Business Day, confirm
orally and in writing to such Lender the number of shares of Common Stock then outstanding. At any time following delivery of a Share Issuance Notice and ending on the last Trading Day prior to the applicable Interest Payment Date, each Lender shall
have the right to deliver notice to the Borrower (a “Cap Notice”) stating the maximum number of shares of Common Stock that may be issued to such Lender without exceeding the maximum number of shares that such Lender may receive
under the 4.985% Cap (the “Maximum Share Amount”), which shall be conclusive and binding upon the Borrower and such Lender. In no event shall (a) the number of shares issued to a Lender pursuant to any Share Issuance Notice
exceed the Maximum Share Amount specified in such Lender’s Cap Notice; or (b) the aggregate number of shares issued to a Lender pursuant to any Share Issuance Notice, together with the shares previously issued to such Lender pursuant to
Share Issuance Notices, exceed such Lender’s Share Issuance Limit. For the avoidance of doubt, the Borrower shall not be entitled, or permitted, to issue an aggregate number of shares of Common Stock pursuant to this Exhibit 2.6 in excess of
the Share Issuance Limit. 
 6. Allocation Among Lenders. Subject to Section 5 of
this Exhibit, all shares of Common Stock issuable to the Lenders pursuant to this Exhibit, all Credit Amounts and all Failure Amounts shall be allocated pro rata among the Lenders based on each Lender’s First Out Waterfall Pro Rata Share, in
each case unless the Lenders notify the Borrower in writing of any different allocation ratio. 
 7. Termination of Right
to Issue Shares. If any of the Share Issuance Conditions is not satisfied at any time following the delivery of a Share Issuance Notice and prior to the Interest Payment Date to which the Share Issuance Notice relates, the Borrower shall
immediately notify each of the Lenders of such failure and the Borrower shall not be permitted to issue shares of common Stock in lieu of the cash interest owed on the such Interest Payment Date. 

8. Failure to Deliver Share Issuance Shares. If the Borrower fails on any Interest Payment Date to cause the delivery of
the Interest Payment Shares required to be delivered on that date, and such failure is not cured within one (1) Trading Day following such Interest Payment Date (a “Share Delivery Failure”), the Share Issuance Amount in respect
to such Interest Payment Date shall not be reduced in respect of such Interest Payment Shares until such shares are 

 
actually issued and delivered, and in addition to all other rights and remedies of the Lenders and the Lenders under this Exhibit, the Agreement and the other Loan Documents, (a) the
Borrower shall promptly pay to each of the Lenders, for each day that such Share Delivery Failure occurs or continues, an amount equal to five percent (5%) of the amount that would have constituted such Lender’s Credit Amount on such day had
such failure not occurred (the “Failure Amount”); and (b) if any Lender is required by its broker to purchase (in an open market transaction or otherwise) or any Lender or such Lender’s brokerage firm otherwise purchases
shares of Common Stock to deliver in satisfaction of a sale by such Lender of the Interest Payment Shares which such Lender was entitled to receive on such Interest Payment Date, then the Borrower shall (1) pay in cash to such Lender the amount
by which (X) such Lender’s total purchase price (including brokerage commissions, if any) for the shares of Common Stock so purchased exceeds (Y) the amount obtained by multiplying (I) the number of Interest Payment Shares that
the Borrower was required to deliver to such Lender on such Interest Payment Date, times (II) the price at which the sell order giving rise to such purchase obligation was executed. 

9. Borrower Reporting. The Borrower shall file with the SEC a Current Report on Form
8-K disclosing its delivery of a Share Issuance Notice, no later than 8:35 a.m., New York City time, on the Trading Day immediately following the date of the Share Issuance Notice. 

 Annex 1 to Exhibit 2.6—Payment Share Provisions 

[Date] 
 [Transfer Agent Name and Address] 

Attention: [                ] 

Re:    Endologix, Inc. (the “Borrower”) 

Ladies and Gentlemen: 
 Pursuant to Section 3 of
Exhibit 2.6 (the “Exhibit”) of that certain Amended and Restated Facility Agreement (the “Facility Agreement”), dated as of August 9, 2018, between the Borrower and the Lenders party thereto from time to time
(each an “Lender” and collectively, the “Lenders”), the Borrower has delivered to the Lenders a Share Issuance Notice (as defined in the Exhibit), dated as of
[                ,             ], pursuant to which the Borrower has elected to satisfy certain payment
obligations under the Facility Agreement by issuing shares of Common Stock to the Lenders. Capitalized terms used but not defined herein shall have the meanings set forth in the Facility Agreement or the Exhibit, as applicable. 

We are counsel for the Borrower and have been requested to furnish to you an opinion with respect to all of the shares of Common Stock of the Borrower that
will be issued to the Lenders in connection the abovementioned Share Issuance Notice (the “Shares”). 
 As a basis for this opinion, we
have received and reviewed (1) the Facility Agreement, including the Exhibit, (2) the Share Issuance Notice, (3) an officer’s certificate from the Borrower and (4) such other documents as we have deemed relevant or
necessary.     
 On the basis of the foregoing and assuming the accuracy of the aforementioned representations of each Lender, it is
our opinion that the Shares may be resold by each Lender without restriction under the Securities Act of 1933, as amended, and, accordingly, the Shares may be issued without any restrictive legend to each Lender or its designee in accordance with
each such Lender’s instructions with respect to Shares delivered to such Lender. 
 Any questions concerning the foregoing opinion should be
communicated to [                                ] of this firm. 

Very truly yours, 
 [_____________________________] 

_____________________________ 

[__________________],[_______________] 

cc:    [Lenders] 

 EXHIBIT A-1 

FORM OF FIRST OUT WATERFALL NOTE 
 THE
SECURITIES REPRESENTED BY THIS NOTE (AS DEFINED BELOW) HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR APPLICABLE STATE SECURITIES LAWS. THE SECURITIES MAY NOT BE OFFERED FOR SALE, SOLD, TRANSFERRED OR ASSIGNED (I) IN
THE ABSENCE OF (A) AN EFFECTIVE REGISTRATION STATEMENT FOR THE SECURITIES UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR APPLICABLE STATE SECURITIES LAWS OR (B) AN OPINION OF COUNSEL, IN A GENERALLY ACCEPTABLE FORM, THAT REGISTRATION IS
NOT REQUIRED UNDER SAID ACT OR APPLICABLE STATE SECURITIES LAWS OR (II) UNLESS SOLD PURSUANT TO RULE 144 UNDER SAID ACT. NOTWITHSTANDING THE FOREGOING, THE SECURITIES MAY BE PLEDGED IN CONNECTION WITH A BONA FIDE MARGIN ACCOUNT OR OTHER LOAN,
FINANCING OR INDEBTEDNESS ARRANGEMENT SECURED BY THE SECURITIES. 
 THE FOLLOWING INFORMATION IS PROVIDED PURSUANT TO TREAS. REG. SECTION 1.1275-3: THE BORROWER (AS DEFINED BELOW) WILL MAKE AVAILABLE ON REQUEST TO HOLDER(S) OF THIS NOTE THE FOLLOWING INFORMATION: ISSUE PRICE, AMOUNT OF ORIGINAL ISSUE DISCOUNT, ISSUE DATE AND YIELD TO
MATURITY. THIS NOTE IS BEING AMENDED AND RESTATED AS PART OF AND PURSUANT TO A PLAN OF RECAPITALIZATION AND REORGANIZATION OF THE BORROWER DESCRIBED IN SECTION 368(A)(1)(E) OF THE INTERNAL REVENUE CODE OF 1986, AS AMENDED. 

FIRST OUT WATERFALL NOTE 
  

			
	First Out Waterfall Lender: _____________________	  	Original Issue Date: April 3, 2017
	Principal Amount: $[__________]	  	[Re-Issuance Date: January 1, 2018]1
		  	Amendment and Restatement Date: August 9, 2018

 FOR VALUE RECEIVED, the undersigned, Endologix, Inc., a Delaware corporation (the
“Borrower”), hereby unconditionally promises to pay to the First Out Waterfall Lender set forth above (the “Lender”) the “Principal Amount” set forth above, or, if less, the aggregate unpaid Principal (as
defined below) amount of the First Out Waterfall Loan (as defined in the Facility Agreement referred to below) of the Lender to the Borrower, payable at such times and in such amounts as are specified in the Facility Agreement. 

The Borrower promises to pay interest on the outstanding Principal amount of the First Out Waterfall Loan and any overdue interest from and
after the Amendment and Restatement Date (as defined below) until such outstanding Principal amount of the First Out Waterfall Loan and any overdue interest are paid in full, payable at such times and at such interest rates as are specified in the
Facility Agreement. The Borrower promises to pay any Non-Callable Make Whole Amount, any CoC Fee and the First Out Waterfall Exit Payment (each, as defined in the Facility Agreement) that is due on the First
Out Waterfall Loan in accordance with the Facility Agreement. 
  

	1 	 NTD: Only to be included for the note that was re-issued on
January 1, 2018 in connection with its transfer to Deerfield Partners. 

  
 EX. A - 1 

 In lieu of making any payment of interest in cash (but not (i) interest payable
pursuant to the second sentence of Section 2.6(a) of Facility Agreement, (ii) interest payable-in-kind or (iii) in connection with any Event of Default or
late payment hereunder or any other interest payable pursuant to Section 2.7 of the Facility Agreement) and subject to the conditions set forth in Section 2.6 of the Facility Agreement and Exhibit 2.6 to the Facility Agreement, the
Borrower may elect to satisfy all or any such payment by the issuance to the Lender of shares of Freely Tradable Common Shares (as defined in Exhibit 2.6) in accordance with the provisions of Exhibit 2.6. 

This First Out Waterfall Note (this “Note”) was originally issued on April 3, 2017[, reissued on
January 1, 2018],2 and amended and restated on August 9, 2018 (the “Amendment and Restatement Date”) and is one of the “First Out Waterfall
Notes”, “Loan Notes” and “Notes” referred to in, and is entitled to the benefits of, the Amended and Restated Facility Agreement, dated as of August 9, 2018 (as the same may be amended, restated, supplemented or
otherwise modified from time to time, the “Facility Agreement”), by and among the Borrower, the other Loan Parties party thereto, the Lenders party thereto and Deerfield Private Design Fund IV, L.P., as agent for the Secured
Parties, and the other Loan Documents. 
 The Facility Agreement, among other things, (a) provides for the making of a First Out
Waterfall Loan by the Lender to the Borrower in an aggregate amount not to exceed at any time outstanding the “Principal Amount” set forth above, the indebtedness of the Borrower resulting from such First Out Waterfall Loan being evidenced
by this Note and (b) contains provisions for acceleration of the maturity of the unpaid Principal amount of this Note upon the happening of certain stated events and also for prepayments pursuant to Section 2.3(c) or Section 5.3 of
the Facility Agreement on account of the Principal hereof prior to the maturity hereof upon the terms and conditions specified therein. 

1. Definitions. 
 (a)
Certain Defined Terms. Capitalized terms used herein without definition are used as defined in the Facility Agreement. For purposes of this Note, the following terms shall have the following meanings: 

(i) “Affiliate” means any person or entity that, directly or indirectly through one or more intermediaries, controls or is
controlled by or is under common control with a person or entity, as such terms are used in and construed under Rule 144 under the Securities Act. With respect to a Lender, any investment fund or managed account that is managed on a discretionary
basis by the same investment manager as such Lender will be deemed to be an Affiliate of such Lender. As used in this definition of “Affiliate,” the term “control” means the possession, directly or indirectly, of the power to
direct or cause the direction of the management and policies of a Person, whether through ownership of voting securities or partnership or other ownership interest, by contract, or otherwise. 

(ii) “Common Stock” means the fully paid and nonassessable shares of the Borrower’s common stock, $0.001 par value per
share. 
 (iii) “Conversion Amount” means the Principal amount to be converted. 

(iv) “Conversion Date” means the date of delivery via facsimile or electronic mail of a Conversion Notice. 

 
  

	2 	 NTD: Only to be included for the note that was re-issued on
January 1, 2018 in connection with its transfer to Deerfield Partners. 

  
 EX. A - 2 

 (v) “Conversion Issuance Limit” means
[            ]3 shares of Common Stock, subject to appropriate adjustment for any Stock Event that occurs after the Amendment and
Restatement Date. 
 (vi) “Conversion Price” means, as of any Conversion Date,
ninety-six percent (96%) of the arithmetic average of the Volume Weighted Average Prices per share of Common Stock on each of the three (3) Trading Days period preceding the Conversion Date (the
“Measurement Period”); provided, that in the event that a stock split, stock combination, reclassification, payment of stock dividend, recapitalization or other similar transaction of such character that the shares of Common Stock
shall be changed into or become exchangeable for a larger or small number of shares (a “Stock Event”) is consummated during the Measurement Period, the Volume Weighted Average Price for all Trading Days during the Measurement Period
prior to the effectiveness of such Stock Event shall be appropriately adjusted to reflect such Stock Event, subject to appropriate adjustment for any Stock Event that occurs after the Amendment and Restatement Date. 

(vii) “Conversion Shares” means fully paid and nonassessable shares of Common Stock issued in connection with the conversion
of a Note. 
 (viii) “First Amortization Cap” means
[            ]4 shares of Common Stock, subject to appropriate adjustment for any Stock Event that occurs after the Amendment and
Restatement Date. 
 (ix) “First Amortization Date” means April 2, 2021. 

(x) “Market Disruption Event” means, with respect to any Trading Day and any security of Borrower, (a) a failure by the
Principal Market to open for trading during its entire regular trading session, (b) the occurrence or existence prior to 1:00 p.m., New York City time, on such day for such securities of Borrower for more than one half-hour period in the
aggregate during regular trading hours of any suspension or limitation imposed on trading (by reason of movements in price exceeding limits permitted by the relevant securities exchange or otherwise) in such securities or in any options, contracts
or future contracts relating to such securities, or (c) to the extent “Volume Weighted Average Price” is determined in accordance with clause (b) of the definition thereof, the suspension of trading for the one-half hour period ending on the scheduled close of trading on such day (by reason of movements in price exceeding limits permitted by the stock exchange or otherwise) in such securities of Borrower. 

(xi) “Monthly Conversion Cap” means [            ]5 shares of Common Stock, subject to appropriate adjustment for any Stock Event that occurs after the Amendment and Restatement Date. 

(xii) “Monthly Conversion Cap Period” means the period commencing on the Amendment and Restatement Date and ending on (and
including) August 31, 2018, and each calendar month that begins after the Amendment and Restatement Date and prior to the Maturity Date. 

(xiii) “Principal” means the outstanding principal amount of this Note as of any date of determination. 

 
  

	3 	 To be equal to Lender’s First Out Waterfall Pro Rata Share of 14,300,000 shares. 

	4 	 To be equal to Lender’s First Out Waterfall Pro Rata Share of 9,500,000 shares. 

	5 	 To be equal to Lender’s First Out Waterfall Pro Rata Share of 5,200,000 shares. 

  
 EX. A - 3 

 (xiv) “Required Lenders” means the Required First Out Waterfall Lenders.

 (xv) “Second Amortization Cap” means [            ]6 shares of Common Stock, subject to appropriate adjustment for any Stock Event that occurs after the Amendment and Restatement Date. 

(xvi) “Second Amortization Date” means April 2, 2022. 

(xvii) “Trading Day” means any day on which the Common Stock is traded for any period on the Principal Market; provided, that
for purposes of the definition of “Conversion Shares,” Trading Day shall not include any Trading Day on which there is a Market Disruption Event. 

(xviii) “Volume Weighted Average Price” for any security as of any Trading Day means (a) the volume
weighted average sale price of such security on the principal U.S. national or regional securities exchange on which such security is traded as reported by Bloomberg Financial Markets or an equivalent, reliable reporting service mutually acceptable
to and hereinafter designated by the Required Lenders and the Borrower (“Bloomberg”), or (b) if no volume weighted average sale price is reported for such security, then the closing price per share of such security, or, if no
closing price per share is reported for such security by Bloomberg, the average of the last bid and last ask price (or if more than one in either case, the average of the average last bid and average last ask prices) on such Trading Day as reported
in the composite transactions for the principal U.S. national or regional securities exchange on which such security is traded. If the security is not listed for trading on a U.S. national or regional securities exchange on the relevant Trading Day,
then the Volume Weighted Average Price will be the average of the mid-point of the last bid and last ask prices of the security in the
over-the-counter market on the relevant Trading Day as reported by OTC Markets Group or similar organization. If the Volume Weighted Average Price cannot be calculated
for such security on such date in the manner provided above, the Volume Weighted Average Price shall be the fair market value as mutually determined by the Borrower and the Lenders holding a majority of the aggregate outstanding Principal amount of
the Notes being converted for which the calculation of the Volume Weighted Average Price is required in order to determine the Conversion Price of such Notes. Volume Weighted Average Price will be determine without regard to after-hours trading or
any other trading outside of the regular trading hours. 
 2. Conversion Rights. This Note may be converted into shares of Common
Stock on the terms and conditions set forth in this Section 2 (subject to Section 2.3(a) of the Facility Agreement). 

(a) Conversion at Option of the Lender. At any time during the period commencing on (and including) the Amendment and Restatement Date
and ending on the close of business on the second business day immediately prior to the Maturity Date, the Lender shall be entitled to convert all or any part of the Principal into Conversion Shares in accordance with this
Section 2 at the Conversion Rate (as defined in Section 2(b)). The Borrower shall not issue any fraction of a share of Common Stock upon any conversion. If the issuance would result in the issuance
of a fraction of a share of Common Stock, then the Borrower shall round such fraction of a share of Common Stock up or down to the nearest whole share (with 0.5 rounded up). 

(b) Conversion Rate. The number of Conversion Shares issuable upon a conversion of any portion of this Note pursuant to
Section 2 shall be determined according to the following formula (the “Conversion Rate”): 
  

 

	6 	 To be equal to Lender’s First Out Waterfall Pro Rata Share of 4,800,000 shares. 

  
 EX. A - 4 

 Conversion Amount 

Conversion Price 
 (c)
Mechanics of Conversion. The conversion of this Note shall be conducted in the following manner: 
 (i) Lender’s Delivery
Requirements. To convert a Conversion Amount into Conversion Shares pursuant to Section 2(a) above on any date, Lender shall (A) transmit by facsimile or electronic mail (or otherwise deliver), for receipt on or
prior to 5:00 p.m. New York City time on such date, a copy of an executed conversion notice in the form attached hereto as Exhibit A (the “Conversion Notice”) to the Borrower (at 2 Musick, Irvine, CA 92618,
Attention: Chief Financial Officer; Email: vmahboob@endologix.com, or at such other office or agency as the Borrower may designate in writing), and (B) if required by Section 2(c)(vi), surrender to a
common carrier for delivery to the Borrower, no later than three (3) Business Days after the Conversion Date, of the original Note being converted (or an indemnification undertaking in customary form with respect to this Note in the case of its
loss, theft or destruction). 
 (ii) Borrower’s Response. Upon receipt or deemed receipt by the Borrower of a copy of a
Conversion Notice, the Borrower (A) shall immediately send, via facsimile, a confirmation of receipt of such Conversion Notice to the Lender and the Borrower’s designated transfer agent (the “Transfer Agent”), which
confirmation shall constitute an instruction to the Transfer Agent to process such Conversion Notice in accordance with the terms herein, and (B) on or before the second (2nd) Business Day
following the date of receipt or deemed receipt by the Borrower of such Conversion Notice (or, if earlier, the end of the standard settlement period for U.S. broker-dealer securities transactions) (the “Share Delivery Date”),
shall credit such aggregate number of Conversion Shares to which the Lender shall be entitled to the Lender’s or its designee’s balance account with The Depository Trust Company (“DTC”) through its Deposit/Withdrawal At
Custodian (DWAC) system, for the number of Conversion Shares to which the Lender shall be entitled. If notwithstanding the provisions of Section 2(c)(vi), the Lender elects to physically surrender this Note for conversion
and the Principal represented by this Note is greater than the Principal being converted, then the Borrower shall, as soon as practicable and in no event later than three (3) Business Days after receipt of this Note and at its own expense,
issue and deliver to the Lender a new Note representing the Principal not converted and cancel this Note. For purposes of Rule 144 under the Securities Act, any Conversion Shares issued to Lender shall be deemed to have been acquired by such Lender
on April 3, 2017 (the date this Note was originally issued). Accordingly, (A) upon any conversion of this Note, the Rule 144 holding period for the Conversion Shares acquired thereupon shall be in excess of one (1) year, and
(B) provided the Lender is not an Affiliate of the Borrower on the Conversion Date and has not been an Affiliate of the Borrower within the three-month period immediately preceding the Conversion Date (the “Unrestricted
Condition”), which the Borrower shall assume and Lender hereby represents unless the Lender advises the Borrower otherwise in writing, the Conversion Shares issued to Lender will be freely transferable, without restriction or limitation
(including any volume limitation) under Federal or state securities laws, pursuant to Rule 144 under the Securities Act and will not contain or be subject to a legend or stop transfer order restricting the resale or transferability of thereof. 

(iii) Dispute Resolution. In the case of a dispute as to the determination of the Conversion Price or the arithmetic calculation of the
Conversion Rate, the Borrower shall instruct the Transfer Agent to issue to the Lender the number of Conversion Shares that is not disputed and shall transmit an explanation of the disputed determinations or arithmetic calculations to the Lender via
facsimile within two (2) Business Days of receipt or deemed receipt of the Lender’s Conversion Notice or other date of determination. If the Lender and the Borrower are unable to agree upon the determination of the Conversion Price or
arithmetic calculation of the Conversion Rate within one (1) Business Day of such disputed determination or arithmetic calculation being transmitted to the Lender, then the Borrower shall 

  
 EX. A - 5 

 
promptly (and in any event within two (2) Business Days) submit via facsimile (A) the disputed determination of the Conversion Price to an independent, reputable investment banking firm
agreed to by the Borrower and the Required Lenders, or (B) the disputed arithmetic calculation of the Conversion Rate to the Borrower’s independent registered public accounting firm, as the case may be. The Borrower shall direct the
investment bank or the accounting firm, as the case may be, to perform the determinations or calculations and notify the Borrower and the Lender of the results no later than two (2) Business Days from the time it receives the disputed
determinations or calculations. Such investment bank’s or accounting firm’s determination or calculation, as the case may be, shall be binding upon all parties absent manifest error, and the fees and expenses of such investment bank or
accountant shall be paid one-half by the Borrower and one-half by the Lender. Notwithstanding the existence of a dispute contemplated by this
paragraph, if requested by the Lender, the Borrower shall issue to the Lender the Conversion Shares not in dispute in accordance with the terms hereof. 

(iv) Record Holder. The person or persons entitled to receive the Conversion Shares issuable upon a conversion of this Note shall be
treated for all purposes as the legal and record holder or holders of such shares of Common Stock upon delivery by the Lender of the Conversion Notice, or in the case of Conversion Shares the issuance of which is subject to a bona fide
dispute that is subject to and being resolved pursuant to, and in compliance with the time periods and other provisions of, the dispute resolution provisions of Section 2(c)(iii), the first Business Day after the resolution
of such bona fide dispute. 
 (v) Borrower’s Failure to Timely Convert. 

(A) Cash Damages. If by the Share Delivery Date, the Borrower shall fail to credit the Lender’s or its designee’s balance
account with DTC with the number of Conversion Shares (free of any restrictive legend, provided the Unrestricted Condition is satisfied), then, in addition to all other available remedies that the Lender may pursue hereunder and under the Facility
Agreement, the Borrower shall pay additional damages to the Lender for each day after the Share Delivery Date such conversion is not timely effected in an amount equal to one and one-half percent (1.5%) of the
product of (I) the number of Conversion Shares not issued to the Lender or its designee on or prior to the Share Delivery Date and to which the Lender is entitled and (II) the Volume Weighted Average Price of the Common Stock on the Share
Delivery Date. Alternatively in lieu of the foregoing damages, subject to Section 2(c)(iii), at the written election of the Lender made in the Lender’s sole discretion, if, on or after the applicable Conversion Date,
the Lender purchases (in an open market transaction or otherwise) shares of Common Stock to deliver in satisfaction of a sale by such Lender of Conversion Shares that such Lender anticipated receiving from the Borrower (such purchased shares,
“Buy-In Shares”), the Borrower shall be obligated to promptly pay to such Lender (in addition to all other available remedies that the Lender may otherwise have), 110% of the amount by which
(A) such Lender’s total purchase price (including brokerage commissions, if any) for such Buy-In Shares exceeds (B) the net proceeds received by such Lender from the sale of a number of shares
equal to up to the number of Conversion Shares such Lender was entitled to receive but had not received on the Share Delivery Date. If the Borrower fails to pay the additional damages set forth in this Section 2(c)(v)(A) within five
(5) Business Days of the date incurred, then the Lender entitled to such payments shall have the right at any time, so long as the Borrower continues to fail to make such payments, to require the Borrower, upon written notice, to immediately
issue, in lieu of such cash damages, the number of shares of Common Stock equal to the quotient of (X) the aggregate amount of the damages payments described herein divided by (Y) the Conversion Price specified by the Lender in the
Conversion Notice. 
 (B) Conversion Failure. If for any reason the Lender has not received all of the Conversion Shares it is
entitled to prior to the tenth (10th) Business Day after the Share Delivery Date with respect to a conversion of this Note (a “Conversion Failure”), then the Lender, upon written 

  
 EX. A - 6 

 
notice to the Borrower (a “Void Conversion Notice”), may void its conversion with respect to, and retain or have returned, as the case may be, any portion of this Note that has
not been converted pursuant to the Lender’s Conversion Notice; provided, that the voiding of the Lender’s Conversion Notice shall not affect the Borrower’s obligations to make any payments that have accrued prior to the date of
such notice pursuant to Section 2(c)(v)(A) or otherwise. A Conversion Failure shall constitute an Event of Default under the Facility Agreement and entitle the Lenders to all payments and remedies provided under the
Facility Agreement upon the occurrence of an Event of Default.
 (vi) Book-Entry. Notwithstanding anything to the contrary set forth
herein, upon conversion or repayment of this Note in accordance with the terms hereof, the Lender shall not be required to physically surrender this Note to the Borrower unless all of the Principal is being converted or repaid. The Lender and the
Borrower shall maintain records showing the Principal converted or repaid and the dates of such conversions or repayments or shall use such other method, reasonably satisfactory to the Lender and the Borrower, so as not to require physical surrender
of this Note upon any such partial conversion or repayment. Notwithstanding the foregoing, if this Note is converted or repaid as aforesaid, the Lender may not transfer this Note unless the Lender first physically surrenders this Note to the
Borrower, whereupon the Borrower will forthwith issue and deliver upon the order of the Lender a new Note of like tenor, registered as the Lender may request, representing in the aggregate the remaining Principal represented by this Note. The Lender
and any assignee, by acceptance of this Note, acknowledge and agree that, by reason of the provisions of this paragraph, following conversion or repayment of any portion of this Note, the Principal of this Note may be less than the “Principal
Amount” stated on the face hereof. 
 (d) Limitations on Conversions. 

(i) Beneficial Ownership. Notwithstanding anything herein to the contrary, the Borrower shall not issue to the Lender, and the Lender
may not acquire, a number of shares of Common Stock upon conversion of this Note or otherwise issue any shares of Common Stock pursuant hereto or the Facility Agreement to the extent that, upon such conversion, the number of shares of Common Stock
then beneficially owned by the Lender and its Affiliates and any other persons or entities whose beneficial ownership of Common Stock would be aggregated with the Lender’s for purposes of Section 13(d) of the Exchange Act (including shares
held by any “group” of which the Lender is a member, but excluding shares beneficially owned by virtue of the ownership of the Warrants or other securities or rights to acquire securities that have limitations on the right to convert,
exercise or purchase similar to the limitation set forth herein) would exceed 4.985% of the total number of shares of common stock then issued and outstanding (the “4.985% Cap”); provided, however, that the 4.985% Cap shall only
apply to the extent that the Common Stock is deemed to constitute an “equity security” pursuant to Rule 13d-1(i) promulgated under the Exchange Act. For purposes hereof, “group” has the
meaning set forth in Section 13(d) of the Exchange Act and applicable regulations of the SEC, and the percentage held by the Lender shall be determined in a manner consistent with the provisions of Section 13(d) of the Exchange Act. Upon
the written request of the Lender, the Borrower shall, within two (2) Trading Days, confirm orally and in writing to the Lender the number of shares of Common Stock then outstanding. 

(ii) Conversion Issuance Limit. Notwithstanding anything to the contrary contained herein, the Borrower shall not issue any shares of
Common Stock upon conversion of this Note (including pursuant to Section 2(c)(v)(A) hereof) to the extent that the issuance of such shares of Common Stock together with any previous issuances of shares of Common Stock under
this Note would exceed the Conversion Issuance Limit, and Section 2.5(c)(v) shall not apply in respect to any excess amount. 
 (iii)
Other Applicable Limitations on Conversion of the Note. Notwithstanding anything to the contrary herein, this Note shall not be convertible, and the Borrower shall not issue shares of 

  
 EX. A - 7 

 
Common Stock upon conversion of this Note (a) at any time after the First Amortization Date, to the extent that the number of shares of Common Stock that would otherwise be issuable to
Lender upon such conversion, together with all shares of Common Stock previously issued to Lender upon conversion of this Note after the First Amortization Date, would exceed the First Amortization Cap, or (b) at any time after
the Second Amortization Date, to the extent that the number of shares of Common Stock that would otherwise be issuable to Lender upon such conversion, together with all shares of Common Stock previously issued to Lender upon conversion of this Note
after the Second Amortization Date, would exceed the Second Amortization Cap, or (c) during any Monthly Conversion Cap Period, to the extent that the number of shares of Common Stock that would otherwise be issuable to Lender upon such
conversion, together with all shares previously issued to Lender upon conversion of this Note during the such Monthly Conversion Cap Period, would exceed the Monthly Conversion Cap. For the avoidance of doubt, if the number of shares of Common Stock
to be issued as set forth in an Conversion Notice transmitted by the Lender to the Borrower would otherwise require the Borrower to issue a number of shares in excess of the Conversion Issuance Limit, the First Amortization Cap (if after the First
Amortization Date), the Second Amortization Cap (if after the Second Amortization Date) or the Monthly Share Cap, the Borrower shall issue to the Lender in accordance herewith the maximum number of shares of Common Stock issuable without exceeding
any such applicable limitation, and Section 2.5(c)(v) shall not apply to any excess amount.  
 3. Voting Rights. Except
as required by law, the Lender shall have no voting rights with respect to any of the Conversion Shares until the Conversion Date relating to the conversion of this Note upon which such Conversion Shares are issuable (or in the case of Conversion
Shares the issuance of which is subject to a bona fide dispute that is subject to and being resolved pursuant to, and in compliance with the time periods and other provisions of, the dispute resolution provisions of
Section 2(c)(iii), the first Business Day after the resolution of such bona fide dispute). 
 4.
Amendment; Waiver. The provisions of this Note may only be waived or amended, restated, supplemented or otherwise modified in accordance with the Facility Agreement. 

5. Specific Shall Not Limit General; Construction. No specific provision contained in this Note shall limit or modify any more general
provision contained herein. This Note shall be deemed to be jointly drafted by the Borrower and all Lenders pursuant to the Facility Agreement and shall not be construed against any Person as the drafter hereof. 

6. Failure or Indulgence Not Waiver. No delay or omission by the Lender in exercising any power or right hereunder shall impair such
right or power or be construed to be a waiver of any default, nor shall any single or partial exercise of any power or right hereunder preclude the full exercise thereof or the exercise of any other power or right. No renewal or extension of this
Note or the Facility Agreement, no delay in the enforcement of payment under this Note or the Facility Agreement, and no delay or omission in exercising any right or power under this Note or the Facility Agreement shall affect the liability of the
Borrower or any endorser of this Note. 
 7. Notices. Whenever notice is required to be given under this Note, unless otherwise
provided herein, such notice shall be given in accordance with Section 6.1 of the Facility Agreement. 
 8. Restrictions on
Transfer. 
 (a) Registration or Exemption Required. This Note has been issued in a transaction exempt from the registration
requirements of the Securities Act. None of the Note or the Conversion Shares issued hereunder may be transferred, sold, assigned, hypothecated or otherwise disposed of except pursuant to an effective registration statement or an exemption to the
registration requirements of the Securities Act and applicable state laws, including Rule 144 under the Securities Act, Section 4(a)(7) of the Securities Act 

  
 EX. A - 8 

 
or a so-called “4[(a)](1) and a half” transaction. 

(b) Assignment. This Note is assignable or transferable, in whole or in part, only to the extent such assignment or transfer is
permitted pursuant to the terms of the Facility Agreement; provided that (i) the Lender shall deliver a written notice to the Borrower, substantially in the form of the Assignment attached hereto as Exhibit B, indicating the Person or
Persons to whom the Note shall be assigned and the respective Principal amount of the Note to be assigned to each assignee. The Borrower shall effect the assignment within three (3) business days, and shall deliver to the assignee(s) designated
by the Lender a Note or Notes of like tenor and terms for the appropriate Principal amount. This Note and the rights evidenced hereby shall inure to the benefit of and be binding upon the successors and assigns of the Lender. The provisions of this
Note are intended to be for the benefit of all Lenders from time to time of this Note, and shall be enforceable by any such Lender. This Note is not (and any rights or obligations hereunder are not) not assignable or transferable by the Borrower
under any circumstance and any such prohibited assignment or transfer is absolutely void ab initio. 
 9. Payment of Collection,
Enforcement and Other Costs. If (a) this Note is placed in the hands of an attorney for collection or enforcement or is collected or enforced through any legal proceeding; or (b) an attorney is retained to represent the Lender in any
bankruptcy, reorganization, receivership of the Borrower or other proceedings affecting Borrower creditors’ rights and involving a claim under this Note, then the Borrower shall pay the costs incurred by the Lender for such collection,
enforcement or action, including reasonable attorneys’ fees and disbursements. Subject to the terms of the Facility Agreement, all payments and issuances of shares of Common Stock hereunder will be free and clear of, and without deduction or
withholding for, any present or future taxes. The Borrower shall pay all and any costs (administrative or otherwise) imposed by the Borrower’s banks, clearing houses, or any other financial institution, in connection with making any payments
and issuing any shares of Common Stock hereunder. The Borrower shall pay all costs and expenses (including attorney’s fees) of the Lender incurred in connection with this Note in accordance with Section 6.3 of the Facility Agreement. 

10. Waiver of Notice. Other than those notices required to be provided by the Lender to the Borrower under the terms of the Facility
Agreement, the Borrower and every endorser of this Note, or the obligations represented hereby, expressly waives diligence, presentment, protest, demand, notice of dishonor, non-payment or default, and notice
of any kind with respect to this Note and the Facility Agreement or the performance of the obligations under this Note and/or the Facility Agreement. 

11. Miscellaneous. This Note is a Loan Document, is entitled to the benefits of the Loan Documents and is subject to certain provisions
of the Facility Agreement, including Sections 1.2 (Interpretation) and 6.4 (Governing Law; Venue; Jurisdiction; Service of Process; Waiver of Jury Trial) thereof. 

12. Additional Interpretative Matters. Unless the context otherwise requires, (a) all references to Sections or Exhibits are to
Sections or Exhibits contained in or attached to this Note, (b) each accounting term not otherwise defined in this Note has the meaning assigned to it in accordance with GAAP, (c) words in the singular or plural include the singular and
plural and pronouns stated in either the masculine, the feminine or neuter gender shall include the masculine, feminine and neuter and (d) the use of the word “including” in this Note shall be by way of example rather than limitation.
If a Stock Event occurs during any period over which an average price is being determined, then an appropriate adjustment will be made to such average to reflect such Stock Event. 

13. Signatures. In the event that any signature to this Note or any amendment hereto is delivered by electronic mail delivery of a
“.pdf” format data file, such signature shall create a valid and 

  
 EX. A - 9 

 
binding obligation of the party executing (or on whose behalf such signature is executed) with the same force and effect as if such “.pdf” signature page were an original thereof.
Notwithstanding the foregoing, the Borrower shall be obligated to deliver to the Lender an original signature to this Note. At the request of any party, each other party shall promptly re-execute an original
form of this Note or any amendment hereto and deliver the same to the other party. No party hereto shall raise the use of electronic mail delivery of a “.pdf” format data file to deliver a signature to this Note or any amendment hereto or
the fact that such signature was transmitted or communicated through the use of electronic mail delivery of a “.pdf” format data file as a defense to the formation or enforceability of a contract, and each party hereto forever waives any
such defense. 
 14. This Note is an amendment and restatement of that certain Loan Note originally issued on April 3, 2017 [and re-issued on January 1, 2018],7 in the principal amount of $[        ] (the “Prior
Note”) and evidences an extension, continuation, and renewal of the indebtedness evidenced by the Prior Note, but this Note replaces the Prior Note with the indebtedness evidenced by the Prior Note now evidenced by this Note. Such Prior
Note shall be of no further force and effect upon execution of this Note. The Borrower hereby acknowledges and agrees that the indebtedness under the Prior Note has not been repaid or extinguished and that the execution hereof does not constitute a
novation of the Prior Note. Moreover, this Note shall be entitled to all security and collateral to which the Prior Note was entitled, without change or diminution in the priority of any lien or security interest granted to secure the Prior Note.

 [Signature Page Follows] 
  

 

	7 	 NTD: Only to be included for the note that was re-issued on
January 1, 2018 in connection with its transfer to Deerfield Partners. 

  
 EX. A - 10 

 IN WITNESS WHEREOF, the Borrower has caused this Note to be executed and delivered by its
duly authorized officer as of the day and year set forth above. 
  

	
	 ENDOLOGIX, INC., 
 a Delaware
corporation

	
	By: ________________________________
	Name: ______________________________
	Title: ______________________________

  
 EX. A - 11 

 Exhibit A 

CONVERSION NOTICE 

Reference is made to the First Out Waterfall Note (the “Note”) of ENDOLOGIX, INC., a Delaware corporation (the
“Borrower”), in the original principal amount of $[                ]. In accordance with and pursuant to the Note, the undersigned hereby elects to
convert the Conversion Amount (as defined in the Note) of the Note indicated below into shares of common stock, par value $0.001 per share (the “Common Stock”), of the Borrower, as of the date specified below. 

Date of
Conversion:                          

Aggregate Conversion Amount to be converted at the Conversion Price (as defined in the Note): 

____________________ 
 Principal,
applicable thereto, to be
converted:                                       
                   
 Please confirm the following information: 

Conversion Price:
                                         
                                         
                                         
                                         
             
 Number of shares of Common Stock to be
issued:                                 Please issue the Common Stock into which the Note
is being converted in the following name and to the following address: 
 Issue to:
                                         
                                         
                                         
                                         
                             

Facsimile
Number:                                        
                         

Authorization:    
                                         
                          

By:                      
                                         
             

Title:                      
                                         
           

Dated:                      
                                         
                    
 DTC Participant
Number and Name:
                                         
                                         
                                         
                          

Account
Number:                                        
                                         
                                         
                                         
                  

 Exhibit B 

ASSIGNMENT 
 (To be
executed by the registered holder 
 desiring to transfer the Note) 

FOR VALUE RECEIVED, the undersigned holder of the attached First Out Waterfall Note (the “Note”) hereby sells, assigns and transfers unto the
person or persons below named the right to receive the principal amount of $                 from Endologix, Inc., a Delaware corporation (the
“Borrower”), evidenced by the attached Note and does hereby irrevocably constitute and appoint                  attorney to transfer the said Note on
the books of the Borrower, with full power of substitution in the premises. 
  

			
	Dated: _______________ 	  	  
 Signature

 Fill in for new registration of Note: 
  

			
	  
 Name
	 	
		 	
	  
 Address
	 	
		 	
	  
 Please print name and address of
assignee
	 	
	(including zip code number)	 	

 NOTICE 
 The signature to the
foregoing Assignment must correspond to the name as written upon the face of the attached Note. 

 EXHIBIT A-2 

FORM OF LAST OUT WATERFALL NOTE 
 THE
SECURITIES REPRESENTED BY THIS CERTIFICATE HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR APPLICABLE STATE SECURITIES LAWS. THE SECURITIES MAY NOT BE OFFERED FOR SALE, SOLD, TRANSFERRED OR ASSIGNED (I) IN THE ABSENCE
OF (A) AN EFFECTIVE REGISTRATION STATEMENT FOR THE SECURITIES UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR APPLICABLE STATE SECURITIES LAWS OR (B) AN OPINION OF COUNSEL, IN A GENERALLY ACCEPTABLE FORM, THAT REGISTRATION IS NOT REQUIRED
UNDER SAID ACT OR APPLICABLE STATE SECURITIES LAWS OR (II) UNLESS SOLD PURSUANT TO RULE 144 UNDER SAID ACT. NOTWITHSTANDING THE FOREGOING, THE SECURITIES MAY BE PLEDGED IN CONNECTION WITH A BONA FIDE MARGIN ACCOUNT OR OTHER LOAN, FINANCING OR
INDEBTEDNESS ARRANGEMENT SECURED BY THE SECURITIES. 
 LAST OUT WATERFALL NOTE 

 

			
	Last Out Waterfall Lender: _____________________	  	
	Principal Amount: $_______	  	___________, 20__

 FOR VALUE RECEIVED, the undersigned, Endologix, Inc., a Delaware corporation (the
“Borrower”), hereby unconditionally promises to pay to the Last Out Waterfall Lender set forth above (the “Last Out Waterfall Lender”) the Principal Amount set forth above (the “Principal Amount”),
or, if less, the aggregate unpaid principal amount of the Last Out Waterfall Loan (as defined in the Facility Agreement referred to below) of the Last Out Waterfall Lender to the Borrower, payable at such times and in such amounts as are specified
in the Facility Agreement. 
 The Borrower promises to pay interest on the outstanding principal amount of the Last Out Waterfall Loan and
any overdue interest from and after the Agreement Date until such outstanding principal amount of the Last Out Waterfall Loan and any overdue interest are paid in full, payable at such times, in such type (such as cash or paid in-kind) and at such interest rates as are specified in the Facility Agreement. The Borrower promises to pay any Non-Callable Make Whole Amount, any CoC Fee and the Exit
Payment that is due on the Last Out Waterfall Loan in accordance with the Facility Agreement. Demand, diligence, presentment, protest and notice of non-payment and protest are hereby waived by the Borrower.

 Principal and interest (and any Non-Callable Make Whole Amount, any CoC Fee and the Exit Payment)
are payable in Dollars (provided that the PIK Interest Payment is paid in-kind pursuant to Section 2.6(a) of the Facility Agreement) to the Last Out Waterfall Lender in the manner set forth in the
Facility Agreement. 
 This Last Out Waterfall Note (this “Last Out Waterfall Note”) is one of the “Last Out Waterfall
Notes”, “Loan Notes” and “Notes” referred to in, and is entitled to the benefits of, the Amended and Restated Facility Agreement, dated as of August 9, 2018 (as the same may be amended, restated,

  
 EX. A-2 - 1 

 
supplemented or otherwise modified from time to time, the “Facility Agreement”), by and among the Borrower, the other Loan Parties party thereto, the Lenders (including the Last
Out Waterfall Lender) party thereto and Deerfield Private Design Fund IV, L.P., as agent for the Secured Parties, and the other Loan Documents. Capitalized terms used herein without definition are used as defined in the Facility Agreement. 

The Facility Agreement, among other things, (a) provides for the making of a Last Out Waterfall Loan by the Last Out Waterfall Lender to
the Borrower in an aggregate amount not to exceed at any time outstanding the Principal Amount, the indebtedness of the Borrower resulting from such Last Out Waterfall Loan being evidenced by this Last Out Waterfall Note and (b) contains
provisions for acceleration of the maturity of the unpaid principal amount of this Last Out Waterfall Note upon the happening of certain stated events and also for prepayments pursuant to Section 2.3(c) or Section 5.3 of the Facility
Agreement on account of the principal hereof prior to the maturity hereof upon the terms and conditions specified therein. 
 This Last Out
Waterfall Note is a Loan Document, is entitled to the benefits of the Loan Documents and is subject to certain provisions of the Facility Agreement, including Sections 1.2 (Interpretation) and 6.4 (Governing Law; Venue; Jurisdiction;
Service of Process; Waiver of Jury Trial) thereof. 
 This Last Out Waterfall Note is assignable or transferable to the extent such
assignment or transfer is permitted pursuant to the terms of the Facility Agreement. 
 Subject to the terms of the Facility Agreement, all
payments will be free and clear of, and without deduction or withholding for, any present or future taxes. The Borrower shall pay all and any costs (administrative or otherwise) imposed by the Borrower’s banks, clearing houses, or any other
financial institution, in connection with making any payments hereunder. 
 The Borrower shall pay all costs and expenses (including
attorney’s fees) of the Last Out Waterfall Lender incurred in connection with this Last Out Waterfall Note in accordance with Section 6.3 of the Facility Agreement. 

Other than those notices required to be provided by the Last Out Waterfall Lender to the Borrower under the terms of the Facility Agreement,
the Borrower and every endorser of this Last Out Waterfall Note, or the obligations represented hereby, expressly waives presentment, protest, demand, notice of dishonor or default, and notice of any kind with respect to this Last Out Waterfall Note
and the Facility Agreement or the performance of the obligations under this Last Out Waterfall Note and/or the Facility Agreement. No renewal or extension of this Last Out Waterfall Note or the Facility Agreement, no delay in the enforcement of
payment of this Last Out Waterfall Note or the Facility Agreement, and no delay or omission in exercising any right or power under this Last Out Waterfall Note or the Facility Agreement shall affect the liability of the Borrower or any endorser of
this Last Out Waterfall Note. 
 No delay or omission by the Last Out Waterfall Lender in exercising any power or right hereunder shall
impair such right or power or be construed to be a waiver of any default, nor shall any single or partial exercise of any power or right hereunder preclude the full exercise thereof or the exercise of any other power or right. The provisions of this
Last Out Waterfall Note may be waived or amended, restated, supplemented or otherwise modified only in a writing signed by the Borrower and the Last Out Waterfall Lender. 

This Last Out Waterfall Note shall be governed by, and be construed and enforced in accordance with, the laws of the State of New York
applicable to contracts made and to be performed in such State. 
 [Signature Page Follows] 

  
 EX. A-2 - 2 

 IN WITNESS WHEREOF, the Borrower has caused this Last Out Waterfall Note to be executed and
delivered by its duly authorized officer as of the day and year set forth above. 
  

			
	 ENDOLOGIX, INC., 
 a Delaware
corporation

		
	By:	 	  

	Name:	 	  

	Title:	 	  

  
 EX. A-2 - 1 

 EXHIBIT B 

FORM OF PERFECTION CERTIFICATE 
  

  
 EX. A-2 - 2 

 EXHIBIT C-1 

FORM OF INITIAL WARRANT 
 THIS WARRANT AND
THE SECURITIES ISSUABLE UPON EXERCISE HEREOF HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), OR ANY STATE SECURITIES LAW. THE SECURITIES MAY NOT BE SOLD, TRANSFERRED OR ASSIGNED IN THE ABSENCE
OF AN EFFECTIVE REGISTRATION STATEMENT UNDER THE SECURITIES ACT, OR PURSUANT TO AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT, INCLUDING PURSUANT TO SECTION 4(A)(7) OF THE SECURITIES ACT OR RULE 144 UNDER THE SECURITIES ACT OR PURSUANT TO
A PRIVATE SALE EFFECTED UNDER APPLICABLE FORMAL OR INFORMAL SEC INTERPRETATION OR GUIDANCE, SUCH AS A SO-CALLED “4[(a)](1) AND A HALF SALE.” NOTWITHSTANDING THE FOREGOING, THE SECURITIES MAY BE
PLEDGED IN CONNECTION WITH A BONA FIDE MARGIN ACCOUNT OR OTHER LOAN OR FINANCING ARRANGEMENT SECURED BY THE SECURITIES. 
 AN INVESTMENT IN THESE SECURITIES
INVOLVES A HIGH DEGREE OF RISK. HOLDERS MUST RELY ON THEIR OWN ANALYSIS OF THE INVESTMENT AND ASSESSMENT OF THE RISKS INVOLVED. 
  

			
	 Warrant to Purchase shares
	  	Warrant Number:

 Warrant to Purchase Common Stock 

of 
 Endologix, Inc.

 THIS CERTIFIES that                      or any
subsequent holder hereof (“Holder”) has the right to purchase from Endologix, Inc., a Delaware corporation (the “Company”),                 
(            ) fully paid and nonassessable shares of the Company’s common stock, $0.001 par value per share (“Common Stock”), subject to adjustment as provided herein, at a
price equal to the Exercise Price (as defined in Section 3 below), at any time during the Term (as defined in Section 1 below). 
 Holder agrees
with the Company that this Warrant to Purchase Common Stock of the Company (this “Warrant” or this “Agreement”) is issued and all rights hereunder shall be held subject to all of the conditions, limitations and provisions set
forth herein. 
 1. Date of Issuance and Term. 
 This
Warrant shall be deemed to be issued on                      (“Date of Issuance”). The term of this Warrant begins on the Date of Issuance
and ends at 5:00 p.m., New York City time, on the date that is seven (7) years after the Date of Issuance (the “Term”). This Warrant was issued pursuant to that certain Facility Agreement (as may be amended, restated, supplemented or
otherwise modified from time to time in accordance with the terms thereof, the “Facility Agreement”) by and among the Company and Deerfield Private Design Fund III, L.P., Deerfield Private Design Fund IV, L.P., Deerfield Partners, L.P. and
Deerfield International Master Fund, L.P., dated as of April 3, 2017, and in conjunction with that certain Registration Rights Agreement (as may be amended, restated, supplemented or otherwise modified from

 
time to time in accordance with the terms thereof, the “Registration Rights Agreement”) by and among the Company and Deerfield Private Design Fund III, L.P., Deerfield Private Design
Fund IV, L.P., Deerfield Partners, L.P. and Deerfield International Master Fund, L.P., dated as of April 3, 2017. 
 Notwithstanding anything herein to
the contrary, the Company shall not issue to Holder, and Holder may not acquire, a number of shares of Common Stock upon exercise of this Warrant to the extent that, upon such exercise, the number of shares of Common Stock then beneficially owned by
Holder and its Affiliates and any other persons or entities whose beneficial ownership of Common Stock would be aggregated with Holder’s for purposes of Section 13(d) of the Securities Exchange Act of 1934, as amended (the “Exchange
Act”) (including shares held by any “group” of which Holder is a member, but excluding shares beneficially owned by virtue of the ownership of securities or rights to acquire securities that have limitations on the right to convert,
exercise or purchase similar to the limitation set forth herein), would exceed 4.985% of the total number of shares of Common Stock then issued and outstanding (the “4.985% Cap”); provided, however, that the 4.985% Cap shall only apply to
the extent that the Common Stock is deemed to constitute an “equity security” pursuant to Rule 13d-1(i) promulgated under the Exchange Act. For purposes hereof, “group” has the meaning set
forth in Section 13(d) of the Exchange Act and applicable regulations of the Securities and Exchange Commission (the “SEC”), and the percentage held by Holder shall be determined in a manner consistent with the provisions of
Section 13(d) of the Exchange Act. Upon the written request of Holder, the Company shall, within two (2) Trading Days, confirm orally and in writing to Holder the number of shares of Common Stock then outstanding. 

For purposes hereof: 
 “Affiliate” means any person or
entity that, directly or indirectly through one or more intermediaries, controls or is controlled by or is under common control with a person or entity, as such terms are used in and construed under Rule 144 (“Rule 144”) under the
Securities Act of 1933, as amended (the “Securities Act”). With respect to a Holder, any investment fund or managed account that is managed on a discretionary basis by the same investment manager as such Holder shall, for purposes hereof,
be deemed to be an Affiliate of such Holder. 
 “Asset Sale” means a transaction covered by the provisions of clause (B) of the definition of
“Major Transaction” involving the sale or transfer of all or substantially all of the assets of the Company (including, for the avoidance of doubt, all or substantially all of the assets of the Company and its Subsidiaries (as defined in
the Facility Agreement), taken as a whole) in connection with which the Company has announced its intention to liquidate and distribute its assets to stockholders. 

“Black-Scholes Value” shall mean the Black-Scholes value of this Warrant, or applicable portion thereof, as determined by use of the Black-Scholes
Option Pricing Model using the criteria set forth on Schedule 1 hereto. 
 “Business Day” means a day other than a Saturday or Sunday or any other
day on which commercial banks are authorized or required by law to close in New York City. 
 “Cashless Default Exercise” shall mean an exercise
of this Warrant as a “Cashless Default Exercise” in accordance with Sections 3(c) and 11(b) hereof. 
 “Cashless Major Exercise” shall
mean an exercise of this Warrant or portion thereof as a “Cashless Major Exercise” in accordance with Sections 3(b) and 5(b)(i) hereof. 

“Cash Out Major Transaction” means a Major Transaction in which the consideration payable to holders of Common Stock in connection with the Major
Transaction consists solely of cash. 

  
 4 

 “Eligible Market” means the New York Stock Exchange, the NASDAQ Capital Market, the NASDAQ Global
Market, the NASDAQ Global Select Market, the NYSE MKT or, in each case, any successor thereto. 
 “Parent Entity” of a Person means an entity
that, directly or indirectly, controls the applicable Person and whose common stock or equivalent equity security is quoted or listed on an Eligible Market, or, if there is more than one such Person or Parent Entity, the Person or Parent Entity with
the largest public market capitalization as of the date of consummation of a Major Transaction. 
 “Person” means an individual, a limited
liability company, a partnership, a joint venture, a corporation, a trust, an unincorporated organization, any other entity and a government or any department or agency thereof. 

“Standard Settlement Period” means the standard settlement period for equity trades effected on securities exchanges in the United States, expressed
in a number of Trading Days, as in effect on the applicable Date of Exercise (as defined in Section 2(b)). 
 “Successor Entity” means any
Person purchasing the Company’s assets or Common Stock, or any successor entity resulting from such Major Transaction, or if the Warrant is to be exercisable for shares of capital stock of a Parent Entity (as defined above), such Person’s
Parent Entity. 
 “Successor Major Transaction” means either a Takeout Major Transaction or an Asset Sale. 

“Successor Major Transaction Consideration” means (i) in the case of a Takeout Major Transaction (other than a Cash Out Major Transaction), the
amount of cash and other assets and the number of securities or other property of the Successor Entity or other entity that would be issuable in such Major Transaction, in respect of a number of shares equal to the Successor Major Transaction
Conversion Share Amount and (ii) in the case of an Asset Sale or a Cash Out Major Transaction, an amount of cash equal to the Black-Scholes Value of the Warrant. 

“Successor Major Transaction Conversion Share Amount” means an amount equal to the Black-Scholes Value of the Warrant (or such applicable portion
subject to a Successor Major Transaction Conversion), divided by the closing price of the Common Stock on the principal securities exchange or other securities market on which the Common Stock is then traded on the Trading Day immediately preceding
the date on which the applicable Major Transaction is consummated. 
 “Takeout Major Transaction” means a transaction covered by the provisions of
clause (A) of the definition of “Major Transaction” in which the shares of Common Stock of the Company are converted into the right to receive cash, securities of another entity and/or other assets. 

“Trading Day” shall mean any day on which the Common Stock is traded for any period on the NASDAQ Global Select Market (“NasdaqGS”) or, if
the NasdaqGS is not the principal trading market for the Common Stock, on the principal securities exchange or other securities market on which the Common Stock is then being traded; provided, however, that during any period in which the Common
Stock is not listed or quoted on the NasdaqGS or any other securities exchange or market, the term “Trading Day” shall mean a Business Day. 
 2.
Exercise. 
 (a) Manner of Exercise. During the Term (or, in respect of a Cashless Major Exercise, the Cashless Major Exercise Period (as
defined below)), this Warrant may be Exercised as to all or any lesser number of whole 

  
 5 

 
shares of Common Stock covered hereby (the “Warrant Shares” or the “Shares”) by sending to the Company the Exercise Form attached hereto as Exhibit A-1 (the “Exercise Form”) duly completed and executed, and, if applicable, the full Exercise Price (as defined below, which may be satisfied by a Cash Exercise, a Cashless Exercise or a Note
Exchange Exercise, as each is defined below) for each share of Common Stock as to which this Warrant is Exercised, at the office of the Company, 2 Musick, Irvine, CA 92618, Attention: Chief Financial Officer; Phone: (949) 595-7200, Email: vmahboob@endologix.com, or at such other office or agency as the Company may designate in writing, by overnight mail or electronic mail (any such exercise of the Warrant being hereinafter
called an “Exercise” of this Warrant). 
 (b) Date of Exercise. The “Date of Exercise” of the Warrant shall, in each case, be the
date that the Exercise Form attached hereto as Exhibit A-1, completed and executed, is sent by electronic mail to the Company, provided that the Exercise Price is satisfied as soon as
practicable thereafter but in no event later than two (2) Business Days following the date of such electronic mail. Alternatively, the Date of Exercise shall be defined as the date the original Exercise Form is received by the Company, if
Holder has not previously sent the Exercise Form by electronic mail. Upon delivery of the Exercise Form to the Company by electronic mail or otherwise, Holder shall be deemed for all corporate purposes to have become the holder of record of the
Warrant Shares with respect to which this Warrant has been Exercised, irrespective of the date such Warrant Shares are credited to Holder’s or its designee’s Depository Trust Company (“DTC”) account or the date of delivery of the
certificates evidencing such Warrant Shares, as the case may be; provided, however, that in the event an Exercise Form in respect of a Cashless Major Exercise is delivered prior to the occurrence of the applicable Major Transaction, Holder shall be
deemed to have become the holder of record of the shares issuable upon such exercise immediately prior to the consummation of such Major Transaction and the Date of Exercise shall in such event be deemed to have occurred on the date of the
occurrence of the Major Transaction. Holder shall not be required to physically surrender this Warrant to the Company until Holder has purchased all of the Warrant Shares available hereunder and the Warrant has been exercised in full, in which case
Holder shall surrender this Warrant to the Company for cancellation within three (3) Trading Days following the date the final Exercise Form is delivered to the Company. Execution and delivery of an Exercise Form with respect to a partial
Exercise shall have the same effect as cancellation of the original Warrant and issuance of a New Warrant evidencing the right to purchase the remaining number of Warrant Shares. 

(c) Delivery of Common Stock Upon Exercise. Within the earlier of (x) three (3) Trading Days and (y) the number of Trading Days comprising the
Standard Settlement Period after any Date of Exercise (but, in the case of a Cash Exercise, within two (2) Business Days following the Company’s receipt of the full Exercise Price, if later) or in the case of a Cashless Default Exercise
(as defined in Section 5(b) below), within the period provided in Section 3(c), as applicable (the “Delivery Period”), the Company shall issue and deliver (or cause its transfer agent (the “Transfer Agent”) to issue and
deliver) in accordance with the terms hereof to or upon the order of Holder that number of shares of Common Stock (“Exercise Shares”) for the portion of this Warrant exercised as shall be determined in accordance herewith. Upon the
Exercise of this Warrant or any part hereof, the Company shall, at its own cost and expense, take all necessary action, including obtaining and delivering an opinion of counsel, to assure that the Transfer Agent shall issue stock certificates in the
name of Holder (or its nominee) or such other persons as designated by Holder and in such denominations as Holder shall specify at Exercise, representing the number of shares of Common Stock issuable upon such Exercise. The Company warrants that no
instructions other than these instructions have been or will be given to the Transfer Agent and that, unless waived by Holder, this Warrant and the Exercise Shares will be free-trading, and freely transferable, and will not contain or be subject to
a legend (or be subject to any stop transfer instruction) restricting the resale or transferability of the Exercise Shares if the Unrestricted Conditions (as defined below) are met. 

  
 6 

 The Company shall be responsible for paying all present or future stamp, court or documentary, intangible,
recording, filing or similar taxes that arise from any payment or issuance made under, from the execution, delivery, performance or enforcement of, or otherwise with respect to, this Warrant.

(d) Delivery Failure. In addition to any other remedies which may be available to Holder, in the event that the Company fails for any reason to effect
delivery of the Exercise Shares by the end of the Delivery Period (a “Delivery Failure”), Holder will be entitled to revoke all or part of the relevant Exercise by delivery of a notice to such effect to the Company whereupon the Company
and Holder shall each be restored to their respective positions immediately prior to the delivery of such notice of revocation, except that the Failure Payments under Section 10(b) shall be payable through the date such notice of revocation is
given to the Company. 
 (e) Legends. 
 (i)
Restrictive Legend. Holder understands that until such time as this Warrant, the Exercise Shares and the Failure Payment Shares (as defined below) have been registered under the Securities Act or otherwise may be sold pursuant to Rule 144 or
an exemption from registration under the Securities Act without any restriction as to the number of securities as of a particular date that can then be immediately sold, this Warrant, the Exercise Shares and the Failure Payment Shares, as
applicable, may bear a restrictive legend in substantially the following form (and a stop-transfer order consistent therewith may be placed against transfer of the certificates for such securities): 

“THE SECURITIES REPRESENTED BY THIS CERTIFICATE HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR APPLICABLE STATE
SECURITIES LAWS. THE SECURITIES MAY NOT BE SOLD, TRANSFERRED OR ASSIGNED IN THE ABSENCE OF AN EFFECTIVE REGISTRATION STATEMENT FOR THE SECURITIES UNDER SAID ACT, OR PURSUANT TO AN EXEMPTION FROM REGISTRATION UNDER SAID ACT INCLUDING PURSUANT TO
SECTION 4(A)(7) OF THE SECURITIES ACT OR RULE 144 UNDER SAID ACT OR PURSUANT TO A PRIVATE SALE EFFECTED UNDER APPLICABLE FORMAL OR INFORMAL SEC INTERPRETATION OR GUIDANCE, SUCH AS A SO-CALLED “4[(a)](1)
AND A HALF” SALE.” NOTWITHSTANDING THE FOREGOING, THE SECURITIES MAY BE PLEDGED IN CONNECTION WITH A BONA FIDE MARGIN ACCOUNT OR OTHER LOAN OR FINANCING ARRANGEMENT SECURED BY THE SECURITIES. 

“THE SALE, TRANSFER OR ASSIGNMENT OF THE SECURITIES REPRESENTED BY THIS CERTIFICATE ARE SUBJECT TO THE TERMS AND CONDITIONS OF A CERTAIN
REGISTRATION RIGHTS AGREEMENT DATED AS OF APRIL 3, 2017, AS AMENDED FROM TIME TO TIME, AMONG THE COMPANY AND CERTAIN HOLDERS OF ITS OUTSTANDING SECURITIES. COPIES OF SUCH AGREEMENT MAY BE OBTAINED AT NO COST BY WRITTEN REQUEST MADE BY THE
HOLDER OF RECORD OF THIS CERTIFICATE TO THE SECRETARY OF THE COMPANY.” 
 (ii) Removal of Restrictive Legends. This Warrant and the certificates
(or electronic book entries, if applicable) evidencing the Exercise Shares and the Failure Payment Shares, as applicable, shall not contain or be subject to any legend restricting the transfer thereof (including the legend set forth above in
subsection 

  
 7 

 
2(e)(i)) or be subject to any stop-transfer instructions: (A) while a registration statement (including a Registration Statement, as defined in the Registration Rights Agreement) covering
the sale or resale of such security is effective under the Securities Act, or (B) following any sale of such Warrant, Exercise Shares and/or Failure Payment Shares pursuant to Rule 144, or (C) if such Warrant, Exercise Shares and/or
Failure Payment Shares are eligible for sale under Rule 144(b)(1), or (D) if such legend is not required under applicable requirements of the Securities Act (including judicial interpretations and pronouncements issued by the staff of the SEC)
(collectively, the “Unrestricted Conditions”). The Company shall cause its counsel to issue a legal opinion to the Transfer Agent promptly after the Effective Date, or at such other time as any of the Unrestricted Conditions have been met,
if required by the Transfer Agent to effect the issuance of this Warrant, the Exercise Shares or the Failure Payment Shares, as applicable, without a restrictive legend or removal of the legend hereunder. If any of the Unrestricted Conditions are
met at the time of issuance of this Warrant, the Exercise Shares or the Failure Payment Shares, then such Warrant, Exercise Shares or Failure Payment Shares, as applicable, shall be issued free of all legends and stop-transfer instructions. The
Company agrees that following the Effective Date, or at such time as the Unrestricted Conditions are met or such legend is otherwise no longer required under this Section 2(e), it will, no later than the earlier of (x) three (3) Trading
Days and (y) the number of Trading Days comprising the Standard Settlement Period following the delivery (the “Unlegended Shares Delivery Deadline”) by Holder to the Company or the Transfer Agent of this Warrant and a certificate
representing Exercise Shares and/or Failure Payment Shares, as applicable, issued with a restrictive legend (such third Trading Day, the “Legend Removal Date”), deliver or cause to be delivered to Holder this Warrant and/or a certificate
(or electronic transfer) representing such shares that is free from all restrictive and other legends (and stop transfer instructions). For purposes hereof, “Effective Date” shall mean the date that the first Registration Statement that
the Company is required to file pursuant to the Registration Rights Agreement has been declared effective by the SEC. 
 (iii) Sale of Unlegended
Shares. Holder agrees that the removal of the restrictive legend from this Warrant and any certificates representing securities as set forth in Section 2(e) above is predicated upon the Company’s reliance that Holder will sell this
Warrant or any Exercise Shares and/or any Failure Payment Shares, as applicable, pursuant to either the registration requirements of the Securities Act, including any applicable prospectus delivery requirements, or an exemption therefrom, and that
if such securities are sold pursuant to a Registration Statement, they will be sold in compliance with the plan of distribution set forth therein. 
 (f)
Cancellation of Warrant. This Warrant shall be canceled upon the full Exercise of this Warrant, and, as soon as practical after the Date of Exercise, Holder shall be entitled to receive Common Stock for the number of shares purchased upon such
Exercise of this Warrant, and if this Warrant is not Exercised in full, Holder shall be entitled to receive a new Warrant (containing terms identical to this Warrant) representing any unexercised portion of this Warrant in addition to such Common
Stock; provided, however, as set forth in Section 2(b), Holder shall not be required to physically surrender this warrant if the Warrant is not Exercised in full. 

(g) Holder of Record. Each person in whose name any Warrant for shares of Common Stock is issued shall, for all purposes, be deemed to be Holder of
record of such shares on the Date of Exercise, irrespective of the date of delivery of the Common Stock purchased upon the Exercise of this Warrant. Prior to the exercise of this Warrant, nothing in this Warrant shall be construed as conferring upon
Holder any rights as a stockholder of the Company. 
 (h) Delivery of Electronic Shares. In lieu of delivering physical certificates representing the
Common Stock issuable upon Exercise or legend removal, or representing Failure Payment Shares, upon written request of Holder, the Company shall use its best efforts to cause the Transfer Agent to electronically transmit the Common Stock issuable
upon Exercise to Holder by crediting the account of Holder’s prime 

  
 8 

 
broker with DTC through its Deposit/Withdrawal at Custodian (DWAC) system. The time periods for delivery and penalties described herein shall apply to the electronic transmittals described
herein. Any delivery not effected by electronic transmission shall be effected by delivery of physical certificates. 
 (i)
Buy-In. In addition to any other rights or remedies available to Holder hereunder or otherwise at law or in equity, if the Company fails to cause its Transfer Agent to deliver to Holder a certificate or
certificates, or electronic shares through DWAC, representing the Exercise Shares pursuant to an Exercise on or before the last day of the Delivery Period (other than a failure caused by any incorrect or incomplete information provided by Holder to
the Company hereunder), and if after such date Holder is required by its broker to purchase (in an open market transaction or otherwise) or Holder or Holder’s brokerage firm otherwise purchases shares of Common Stock to deliver in satisfaction
of a sale by Holder of the Exercise Shares which Holder was entitled to receive upon such Exercise (a “Buy-In”), then the Company shall (1) pay in cash to Holder the amount by which
(x) Holder’s total purchase price (including brokerage commissions, if any) for the shares of Common Stock so purchased exceeds (y) the amount obtained by multiplying (A) the number of Exercise Shares that the Company was
required to deliver to Holder in connection with the Exercise at issue by (B) the price at which the sell order giving rise to such purchase obligation was executed, and (2) at the option of Holder, either reinstate the portion of the
Warrant and equivalent number of Exercise Shares for which such Exercise was not honored (and refund the Exercise Price therefor, to the extent paid by Holder, and/or reinstate the principal amount of any indebtedness used to satisfy the applicable
Exercise Price) or deliver to Holder the number of shares of Common Stock that would have been issued had the Company timely complied with its Exercise and delivery obligations hereunder. For example, if Holder purchases Common Stock having a total
purchase price of $11,000 to cover a Buy-In with respect to an attempted Exercise to cover the sale of Common Stock with an aggregate sale price giving rise to such purchase obligation of $10,000, under
clause (1) of the immediately preceding sentence the Company shall be required to pay Holder $1,000. Holder shall provide the Company written notice indicating the amounts payable to Holder in respect of the
Buy-In, together with applicable confirmations and other evidence reasonably requested by the Company. Nothing herein shall limit Holder’s right to pursue any other remedies available to it hereunder, at
law or in equity including a decree of specific performance and/or injunctive relief with respect to the Company’s failure to timely deliver certificates representing shares of Common Stock upon Exercise of the Warrant as required pursuant to
the terms hereof. 
 (j) HSR Submissions. If Holder determines that, in connection with the exercise of this Warrant, it and the Company are required
to file Premerger Notification Reports with the Federal Trade Commission (the “FTC”) and the United States Department of Justice (“DOJ”) and observe the Waiting Period under the Hart-Scott Rodino Antitrust Improvements Act of
1976, as amended, and the related rules and regulations promulgated thereunder (collectively, the “HSR Act”), the Company agrees to (i) cooperate with Holder in Holder’s preparing and making such submission and any responses to
inquiries of the FTC and DOJ; (ii) prepare and make any submission required to be filed by the Company under the HSR Act and respond to inquiries of the FTC and DOJ in connection therewith; and (iii) reimburse Holder for the cost of the
required filing fee for Holder’s submission under the HSR Act. For the avoidance of doubt, Holder shall bear all of its other costs and expenses in connection with such submission, including any attorneys’ fees associated therewith. 

3. Payment of Warrant Exercise Price for Cash Exercise or Cashless Exercise; Cashless Major Exercise and Cashless Default Exercise. 

(a) Exercise Price. The exercise price shall initially equal $________ per share, subject to adjustment pursuant to the terms hereof (as so adjusted,
the “Exercise Price”), including but not limited to Section 5 below. 

  
 9 

 Payment of the Exercise Price may be made by either of the following, or a combination thereof, at the
election of Holder: 
 (i) Cash Exercise: Holder may exercise this Warrant in cash, bank or cashier’s check or wire transfer (a “Cash
Exercise”); 
 (ii) Cashless Exercise: In lieu of paying all or any portion of the Exercise Price in cash, Holder, at its option, may exercise
this Warrant (in whole or in part) on a cashless basis by making appropriate notation on the applicable Exercise Form, in which event the Company shall issue Holder a number of shares of Common Stock computed using the following formula (a
“Cashless Exercise”): 
 X = Y (A-B)/A 

where: X = the number of shares of Common Stock to be issued to Holder. 

Y = the number of shares of Common Stock for which this Warrant is being Exercised. 

A = the Market Price of one (1) share of Common Stock (for purposes of this Section 3(a)(ii), where “Market Price,” as of
any date, means the Volume Weighted Average Price (as defined herein) of the Company’s Common Stock over the ten (10) consecutive Trading Day period immediately preceding the Date of Exercise or other date in question, as applicable. 

B = the Exercise Price. 
 As used
herein, the “Volume Weighted Average Price” for any security as of any date means the volume weighted average sale price on the NasdaqGS as reported by, or based upon data reported by, Bloomberg Financial Markets or an equivalent, reliable
reporting service mutually acceptable to and hereafter designated by holders of a majority in interest of the Warrants and the Company (“Bloomberg”) or, if the NasdaqGS is not the principal trading market for such security, the volume
weighted average sale price of such security on the principal securities exchange or trading market where such security is listed or traded as reported by Bloomberg, or, if no volume weighted average sale price is reported for such security, then
the last closing trade price of such security as reported by Bloomberg, or, if no last closing trade price is reported for such security by Bloomberg, the average of the bid prices of any market makers for such security that are listed or quoted on
the OTC Bulletin Board, the OTCQX Market, the OTCQB Market or on the “pink” market of OTC Markets Group Inc. If the Volume Weighted Average Price cannot be calculated for such security on such date in the manner provided above, the volume
weighted average price shall be the fair market value as mutually determined by the Company and Holders of a majority in interest of the Warrants being Exercised for which the calculation of the volume weighted average price is required in order to
determine the Exercise Price of such Warrants. 
 (iii) Note Exchange Exercise: In lieu of paying all or any portion of the Exercise Price in cash,
Holder, at its option, may exercise this Warrant (in whole or in part) through a reduction of an amount of principal outstanding under any Notes in accordance with Section 2.3(b) of the Facility Agreement, then held by Holder (a “Note
Exchange Exercise”) 
 For purposes of Rule 144 and subsection (d)(3)(ii) thereof, it is intended, understood and acknowledged that the Common Stock
issuable upon Exercise of this Warrant in a Cashless Exercise transaction or a Note Exchange Exercise transaction shall be deemed to have been acquired at the time this Warrant was issued (in the case of a Cashless Exercise) or at the time the
applicable Note was issued (in the case of a Note Exchange Exercise). Moreover, it is intended, understood and acknowledged that the holding period for the 

  
 10 

 
Common Stock issuable upon Exercise of this Warrant in a Cashless Exercise transaction or a Note Exchange Exercise transaction shall be deemed to have commenced on the date this Warrant was
issued (in the case of a Cashless Exercise) or on the date the applicable Note was issued (in the case of a Note Exchange Exercise). As provided in Section 2(b), Holder shall only be required to physically surrender this Warrant in the event
that Holder is exercising this Warrant in full. 
 (b) Cashless Major Exercise. To the extent Holder shall exercise this Warrant as a Cashless Major
Exercise pursuant to Section 5(b)(i) and 5(b)(iii) below, Holder shall send to the Company (in any manner permitted under Section 2(a)) the Exercise Form indicating that Holder is exercising this Warrant (or any portion thereof) pursuant
to a Cashless Major Exercise, in which event the Company shall issue a number of shares of Common Stock equal to the Black-Scholes Value of the Warrant (or such applicable portion being exercised) divided by the closing price of the Common Stock on
the principal securities exchange or other securities market on which the Common Stock is then traded on the Trading Day immediately preceding the date on which the applicable Major Transaction is consummated, or, if in respect of a Cashless Major
Exercise made after the date of consummation of the applicable Major Transaction, on the Trading Day immediately preceding the date on which the exercise form in respect of such Cashless Major Exercise is delivered. As provided in Section 2(b),
Holder shall only be required to physically surrender this Warrant in the event that Holder is exercising this Warrant in full. Holder shall be permitted to make successive Cashless Major Exercises and send successive Exercise Forms in respect of a
Cashless Major Exercise from time to time at any time during the Cashless Major Exercise Period. 
 (c) Cashless Default Exercise. To the extent
Holder exercises this Warrant as a Cashless Default Exercise pursuant to Section 11(b)(i) below, Holder shall send to the Company (in any manner permitted under Section 2(a)) the Exercise Form indicating that Holder is exercising this
Warrant pursuant to a Cashless Default Exercise, in which event the Company shall issue to Holder, within five (5) Trading Days of the applicable Default Notice, a number of shares of Common Stock (which shares shall be valued at the closing
price of the Common Stock on the principal securities exchange or other securities market on which the Common Stock is then traded on the Trading Day immediately preceding the date on which the Exercise Form in respect of such Cashless Default
Exercise is delivered) equal to the Black-Scholes Value of the remaining unexercised portion of this Warrant (or such portion thereof subject to such exercise) as of the date of such Default Notice (or in the case of an Event of Default referred to
in Section 11(a)(vi), on the Trading Day immediately preceding the date the dividend or distribution is declared or, if not first declared, is paid). As provided in Section 2(b), the Holder shall be permitted to make successive Cashless
Default Exercises and send successive Exercise Forms in respect of a Cashless Default Exercise, from time to time at any time from and after the date of the applicable Default Notice through the Term of this Warrant. 

(d) Dispute Resolution. In the case of a dispute as to the determination of the closing price or the Volume Weighted Average Price of the Company’s
Common Stock or the arithmetic calculation of the Exercise Price, Market Price or the Successor Major Transaction Consideration, or the number of shares issuable upon a Cashless Major Exercise, the Company shall submit the disputed determinations or
arithmetic calculations via electronic mail within two (2) Business Days of receipt, or deemed receipt, of the Exercise Form or Major Transaction Early Termination Notice, or other event giving rise to such dispute, as the case may be, to
Holder. If Holder and the Company are unable to agree upon such determination or calculation within two (2) Business Days of such disputed determination or arithmetic calculation being submitted to Holder, then the Company shall, within two
(2) Business Days submit via electronic mail (i) the disputed determination of the closing price or the Volume Weighted Average Price of the Company’s Common Stock to an independent, reputable investment bank selected by the Company
and approved by Holder, which approval shall not be unreasonably withheld, or (ii) the disputed arithmetic calculation of the Exercise Price, Market Price, any Successor Major Transaction Consideration or number of shares issuable upon a
Cashless Major Exercise to the Company’s independent, outside registered public accountants. The Company shall use its reasonable best efforts to cause the investment bank or the accountants, as the case

  
 11 

 
may be, to perform the determinations or calculations and notify the Company and Holder of the results no later than five (5) Trading Days from the time it receives the disputed
determinations or calculations. Such investment bank’s or accountants’ determination or calculation, as the case may be, shall be binding upon all parties absent demonstrable error, and the Company and Holder shall each pay one half of the
fees and costs of such investment banker or accountant. Notwithstanding the existence of a dispute contemplated by this paragraph, if requested by Holder, the Company shall issue to Holder the Exercise Shares not in dispute in accordance with the
terms hereof. 
 4. Transfer and Registration. 
 (a)
Transfer Rights. Subject to the provisions of Section 8 of this Warrant, this Warrant may be transferred on the books of the Company, in whole or in part, in person or by attorney, upon surrender of this Warrant properly completed and
endorsed. This Warrant shall be canceled upon such surrender and, as soon as practicable thereafter, the person to whom such transfer is made shall be entitled to receive a new Warrant or Warrants as to the portion of this Warrant transferred, and
Holder shall be entitled to receive a new Warrant as to the portion hereof retained. 
 (b) Registrable Securities. The Common Stock issuable upon the
Exercise of this Warrant entitles Holder (and applicable assignees or transferees of such Common Stock) to registration and other rights pursuant to the Registration Rights Agreement. 

5. Adjustments Upon Certain Events. 
 (a)
Recapitalization or Reclassification. If the Company shall at any time effect a stock split, payment of stock dividend, recapitalization, reclassification or other similar transaction of such character that the shares of Common Stock shall be
changed into or become exchangeable for a larger or smaller number of shares, then upon the effective date thereof, the number of shares of Common Stock which Holder shall be entitled to purchase upon Exercise of this Warrant, shall be increased or
decreased, as the case may be, in direct proportion to the increase or decrease in the number of shares of Common Stock by reason of such stock split, payment of stock dividend, recapitalization, reclassification or similar transaction, and the
Exercise Price shall be, in the case of an increase in the number of shares, proportionally decreased and, in the case of decrease in the number of shares, proportionally increased. The Company shall give Holder the same notice it provides to
holders of Common Stock of any transaction described in this Section 5(a). 
 (b) Rights Upon Major Transaction. 

(i) Major Transaction. In the event that a Major Transaction occurs, then (1) in the case of a Successor Major Transaction, Holder, at its option,
may elect to cause the conversion of this Warrant (a “Successor Major Transaction Conversion”), in whole or in part, into the right to receive the Successor Major Transaction Consideration, upon consummation of the Major Transaction, and
(2) in the case of all other Major Transactions, Holder shall have the right to exercise this Warrant (or any portion thereof), at any time and from time to time following the occurrence of such event, as a Cashless Major Exercise. In the event
Holder shall not have exercised any of its rights under clauses (1) or (2) above within the applicable time periods set forth herein, then the Major Transaction shall be treated as an Assumption (as defined below) in accordance with
Section 5(b)(ii) below unless Holder waives its rights under this Section 5(b) with respect to such Major Transaction. Each of the following events shall constitute a “Major Transaction”: 

(A) a consolidation, merger, exchange of shares, recapitalization, reorganization, business combination or other similar event,
(1) following which the holders of Common Stock immediately preceding such consolidation, merger, exchange, recapitalization, reorganization, combination or event either 

  
 12 

 
(a) no longer hold a majority of the shares of Common Stock or (b) no longer have the ability to elect a majority of the board of directors of the Company or (2) as a result of
which shares of Common Stock shall be changed into (or the shares of Common Stock become entitled to receive) the same or a different number of shares of the same or another class or classes of stock or securities of the Company or another entity
(collectively, a “Change of Control Transaction”); 
 (B) the sale or transfer, in one transaction or a series of related
transactions, of (I) all or substantially all of the assets of the Company (including, for the avoidance of doubt, all or substantially all of the assets of the Company and its Subsidiaries, taken as a whole) to any Person other than a
wholly-owned subsidiary of the Company or (II) assets of the Company (including, for the avoidance of doubt, all or substantially all of the assets of the Company and its Subsidiaries, taken as a whole) for a purchase price equal to more than
50% of the Equity Value (as defined below) of the Company. For purposes of this clause (B), “Equity Value” shall mean (I) the product of (x) the number of issued and outstanding shares of Common Stock on the date the Company
delivers the Major Transaction Notice (defined below) multiplied by (y) the per share closing price of the Common Stock on such date on the NasdaqGS as reported by, or based upon data reported by, Bloomberg or, if the NasdaqGS is not the
principal trading market for such security, the closing sale price of such security on the principal securities exchange or trading market where such security is listed or traded as reported by Bloomberg; 

(C) a purchase, tender or exchange offer made to the holders of outstanding shares of Common Stock, such that following such purchase, tender
or exchange offer a Change of Control Transaction shall have occurred; 
 (D) the liquidation, bankruptcy, insolvency, dissolution or winding-up (or the occurrence of any analogous proceeding) affecting the Company; 
 (E) the shares of
Common Stock cease to be listed, traded or publicly quoted on the NasdaqGS and are not promptly re-listed or requoted on the New York Stock Exchange, the NYSE MKT, the NASDAQ Global Market or the NASDAQ
Capital Market; or 
 (F) the Common Stock ceases to be registered under Section 12 of the Exchange Act. 

(ii) Assumption. Any assumption of Company obligations under this paragraph shall be referred to herein as an “Assumption.” Unless otherwise
provided in writing by Holder, the Company shall not consummate a Major Transaction in which the Company is not the surviving entity or as a result of which the Company has a new Parent Entity, unless (A) each Person acquiring the
Company’s assets or Common Stock (or Parent Entity thereof, as applicable), or any other successor entity resulting from such Major Transaction (in each case, a “Successor Entity”), assumes in writing all of the obligations of the
Company under this Warrant, the Facility Agreement (but, other than with respect to the Company’s obligations pursuant to Section 5.1(e) and 5.1(p) of the Facility Agreement and the other provisions of the Facility Agreement that expressly
survive the repayment of the Loans (which shall be assumed in any Assumption), only if there are outstanding Loans under the Facility Agreement immediately following the consummation of the Major Transaction) and the Registration Rights Agreement in
accordance with the provisions of this Section 

  
 13 

 
5(b)(ii) pursuant to written agreements in form and substance reasonably satisfactory to Holder and approved by Holder prior to the consummation of such Major Transaction (such approval not to be
unreasonably withheld or delayed), including agreements to deliver to Holder in exchange for its Warrants a security of the Successor Entity evidenced by a written instrument substantially similar in form and substance to the Warrants, that, among
other things, (1) is exercisable for the appropriate number of shares of the Successor Entity’s capital stock (without regard to the 4.985% Cap or any other restriction or limitation on exercise, provided that such instrument shall contain
a limitation on exercise comparable to that contained in the second paragraph of Section 1 of this Warrant), (2) has an exercise price similar to the then-effective Exercise Price (taking into account any conversion or exchange ratio applicable
to the Common Stock in the Major Transaction) and exercise price adjustment provisions similar to those in the Warrants; or (3) entitles Holder to such additional securities or other consideration as Holder would be entitled pursuant to
Section 5(b)(i) in connection with the Major Transaction; and (4) provides for registration rights similar to those provided by the Registration Rights Agreement, in each case reasonably satisfactory to Holder, and (B) the Successor
Entity (including its Parent Entity) is a publicly traded corporation whose common stock is quoted on or listed for trading on an Eligible Market. For the avoidance of doubt, Holders’ reasonable satisfaction referred to in the immediately
preceding sentence shall be construed only to apply to confirmation that the warrant or other comparable security and registration rights agreement delivered to Holder upon an assumption hereunder shall conform to the requirements of this
Section 5(b)(ii), and this Section 5(b)(ii) shall not be construed as granting consent or approval rights to Holder with respect to the terms of such Major Transaction or to permit Holder to demand any additional consideration in respect
of this Warrant other than as provided herein. Upon the occurrence of any Major Transaction, any Successor Entity shall succeed to, and be substituted for (so that from and after the date of such Major Transaction, the provisions of this Warrant and
the Registration Rights Agreement referring to the “Company” shall refer instead to the Successor Entity), and may exercise every right and power of the Company and shall assume all of the obligations of the Company under this Warrant with
the same effect as if such Successor Entity had been named as the Company herein. Upon consummation of the Major Transaction, the Successor Entity shall deliver to Holder confirmation that there shall be issued upon exercise of this Warrant at any
time after the consummation of the Major Transaction, in lieu of the shares of Common Stock (or other securities, cash, assets or other property) issuable upon the exercise of the Warrants prior to such Major Transaction, such shares of publicly
traded common stock (or their equivalent) of the Successor Entity, as adjusted in accordance with the provisions of this Warrant. The provisions of this Section shall apply similarly and equally to successive Major Transactions and shall be applied
without regard to any limitations on the exercise of this Warrant other than any applicable beneficial ownership limitations. 
 (iii) Major Transaction
Notice; Major Transaction Early Termination Right; Notice of Cashless Major Exercise. At least thirty (30) days prior to the consummation of any Major Transaction, but, in any event, within five (5) Trading Days following the first to
occur of (x) the date of the public announcement of such Major Transaction if such announcement is made before 4:00 p.m., New York City time, or (y) the day following the public announcement of such Major Transaction if such announcement
is made on and after 4:00 p.m., New York City time, the Company shall deliver written notice thereof via electronic mail and overnight courier to Holder (a “Major Transaction Notice”). At any time during the period beginning after
Holder’s receipt of a Major Transaction Notice in respect of a Successor Major Transaction and ending five (5) Trading Days prior to the consummation of such Major Transaction (the “Early Termination Period”), Holder may elect a
Successor Major Transaction Conversion by delivering written notice thereof (“Major Transaction Early Termination Notice”) to the Company, which Major Transaction Early Termination Notice shall indicate the portion of the Warrant (with
reference to the number of shares of Common Stock issuable upon a Cash Exercise of such portion, without regard to the 4.985% Cap) that Holder is electing to be treated as a Successor Major Transaction Conversion. The portion of this Warrant subject
to early termination pursuant to this Section 5(b)(iii), shall be converted into the right to receive the Successor Major Transaction Consideration 

  
 14 

 To the extent Holder shall elect to effect a Cashless Major Exercise in respect of a Major Transaction,
Holder shall deliver its Exercise Form in accordance with Section 3(b), at any time and from time to time following receipt by Holder of the Major Transaction Notice until the later of (x) the Term of this Warrant and (y) the one-year anniversary of the applicable Major Transaction (the “Cashless Major Exercise Period”). For the avoidance of doubt, Holder shall be permitted to make successive Cashless Major Exercises and send
successive Exercise Forms in respect of a Cashless Major Exercise from time to time at any time during the Cashless Major Exercise Period. 
 (iv) Escrow;
Payment of Successor Major Transaction Consideration. Following the receipt of a Major Transaction Early Termination Notice in respect of a Successor Major Transaction from Holder, the Company shall not effect a Successor Major Transaction with
respect to which Holder has elected a Successor Major Transaction Conversion unless either (A) it obtains, as a condition precedent to such Major Transaction, the written agreement of the Successor Entity that payment of the Successor Major
Transaction Consideration shall be made to Holder concurrently with consummation of such Successor Major Transaction, or (B) it shall place the Successor Major Transaction Consideration into an escrow account with an independent escrow agent,
and shall instruct the escrow agent to deliver the Successor Major Transaction Consideration to Holder, concurrently with the consummation of the Major Transaction. Notwithstanding clauses (A) and (B) above, Holder shall be treated on a
pari passu basis with, and shall not have priority to payments to, the holders of Common Stock in connection with a Major Transaction. For purposes of determining the amount required to be placed in escrow pursuant to the provisions of
this subsection (iv) and without affecting the amount of the actual Successor Major Transaction Consideration, the calculation of the price referred to in clause (1) of the first column of Schedule 1 hereto with respect to Stock Price
shall be determined based on the Closing Market Price (as defined on Schedule I) of the Common Stock on the Trading Day immediately preceding the date that the Successor Major Transaction Consideration is deposited with the escrow agent. 

(v) Injunction. Following the receipt of a Major Transaction Early Termination Notice from Holder, in the event that the Company attempts to consummate
a Successor Major Transaction without either (1) placing the Successor Major Transaction Consideration in escrow in accordance with subsection (iv) above, or (2) obtaining the written agreement of the Successor Entity as described in
subsection (iv) above, Holder shall have the right to apply for an injunction in any state or federal court sitting in the City of New York, Borough of Manhattan to prevent the closing of such Major Transaction until the Successor Major
Transaction Consideration is delivered to Holder. 
 An early termination required by this Section 5(b) shall be made in accordance with the provisions
of Section 12. To the extent an early termination required by this Section 5(b) is deemed or determined by a court of competent jurisdiction to be prepayments of the Warrant by the Company, such early termination shall be deemed to be
voluntary prepayments. Notwithstanding anything to the contrary in this Section 5, until the Successor Major Transaction Consideration is paid in full, this Warrant may be exercised, in whole or in part, by Holder into shares of Common Stock,
or in the event the Exercise Date is after the consummation of the Major Transaction, shares of publicly traded common stock (or their equivalent) of the Successor Entity pursuant to Section 5(b). The parties hereto agree that in the event of
the Company’s early termination of any portion of the Warrant under this Section 5(b), Holder’s damages would be uncertain and difficult to estimate because of the parties’ inability to predict future interest rates and the
uncertainty of the availability of a suitable substitute investment opportunity for Holder. Accordingly, any premium due under this Section 5(b) is intended by the parties to be, and shall be deemed, a commercially reasonable estimate of
Holder’s actual loss of its investment opportunity and not as a penalty. 
 (c) Exercise Price Adjusted. As used in this Warrant, the term
“Exercise Price” shall mean the purchase price per share specified in Section 3(a) of this Warrant, until the occurrence of an event stated in this Section 5 or otherwise set forth in this Warrant, and thereafter shall mean said
price as adjusted from time to 

  
 15 

 
time in accordance with the provisions of said subsection. No adjustment made pursuant to any provision of this Section 5 shall have the net effect of increasing the aggregate Exercise Price
payable hereunder or, except as expressly provided in Section 5(a), otherwise increasing the Exercise Price. 
 (d) Adjustments: Additional Shares,
Securities or Assets. In the event that at any time, as a result of an adjustment made pursuant to this Section 5 or otherwise, Holder shall, upon Exercise of this Warrant, become entitled to receive shares and/or other securities or assets
(other than Common Stock) then, wherever appropriate, all references herein to shares of Common Stock shall be deemed to refer to and include such shares and/or other securities or assets; and thereafter the number of such shares and/or other
securities or assets shall be subject to adjustment from time to time in a manner and upon terms as nearly equivalent as practicable to the provisions of this Section 5. 

(e) Notice of Adjustments. Whenever the Exercise Price and/or number or type of securities issuable upon Exercise is adjusted pursuant to the terms of
this Warrant, the Company shall promptly mail to Holder a notice (an “Exercise Price Adjustment Notice”) setting forth the Exercise Price and/or number or type of securities issuable upon Exercise after such adjustment and setting forth a
statement of the facts requiring such adjustment. The Company shall, upon the written request at any time of Holder, furnish to Holder a like Warrant setting forth (i) such adjustment or readjustment, (ii) the Exercise Price at the time in
effect and (iii) the number of shares of Common Stock and the amount, if any, of other securities or property which at the time would be received upon Exercise of the Warrant. For purposes of clarification, whether or not the Company provides
an Exercise Price Adjustment Notice pursuant to this Section 5(e), upon the occurrence of any event that leads to an adjustment of the Exercise Price, Holder would be entitled to receive a number of Exercise Shares based upon the new Exercise
Price, as adjusted, for exercises occurring on or after the date of such adjustment, regardless of whether Holder accurately refers to the adjusted Exercise Price in the Exercise Form. 

6. Fractional Interests. 
 No fractional shares or scrip
representing fractional shares shall be issuable upon the Exercise of this Warrant, but on Exercise of this Warrant, Holder may purchase only a whole number of shares of Common Stock. If, on Exercise of this Warrant, Holder would be entitled to a
fractional share of Common Stock or a right to acquire a fractional share of Common Stock, such fractional share shall be disregarded and the number of shares of Common Stock issuable upon Exercise shall be the next higher whole number of shares.

 7. Reservation of Shares. 
 From and after the date
hereof, the Company shall at all times reserve for issuance such number of authorized and unissued shares of Common Stock (or other securities substituted therefor as herein above provided) as shall be sufficient for the Exercise of this Warrant and
payment of the Exercise Price. If at any time the number of shares of Common Stock authorized and reserved for issuance is below the number of shares sufficient for the Exercise of this Warrant (a “Share Authorization Failure”) (based on
the Exercise Price in effect from time to time), the Company will promptly take all corporate action necessary to authorize and reserve a sufficient number of shares, including calling a special meeting of stockholders to authorize additional shares
to meet the Company’s obligations under this Section 7, in the case of an insufficient number of authorized shares, and using its best efforts to obtain stockholder approval of an increase in such authorized number of shares. The Company
covenants and agrees that upon the Exercise of this Warrant, all shares of Common Stock issuable upon such Exercise shall be duly and validly issued, fully paid and nonassessable and not subject to preemptive rights, rights of first refusal or
similar rights of any Person. The Company covenants and agrees that all shares of Common Stock issuable upon Exercise of this Warrant shall be approved for listing on the NasdaqGS, or, if the NasdaqGS is not the principal

  
 16 

 
trading market for the Common Stock, such principal market on which the Common Stock is traded or listed. 

8. Restrictions on Transfer. 
 (a) Registration or
Exemption Required. This Warrant has been issued in a transaction exempt from the registration requirements of the Securities Act by virtue of Section 4(a)(2) of the Securities Act and Rule 506 thereunder and exempt from registration or
qualification under applicable state securities (or “blue sky”) laws. None of the Warrant, the Exercise Shares or Failure Payment Shares may be pledged, transferred, sold or assigned except pursuant to an effective registration statement
or an exemption to the registration requirements of the Securities Act and applicable state laws, including Section 4(a)(7) of the Securities Act or a so-called “4[(a)](1) and a half”
transaction. 
 (b) Assignment. Subject to Section 8(a), Holder may sell, transfer, assign, pledge, or otherwise dispose of this Warrant, in
whole or in part. Holder shall deliver a written notice to the Company, substantially in the form of the Assignment attached hereto as Exhibit B, indicating the Person or Persons to whom the Warrant shall be assigned and
the respective number of warrants to be assigned to each assignee. The Company shall effect the assignment within three (3) Business Days of its receipt of a completed and executed form of Assignment (the “Transfer Delivery Period”),
and shall deliver to the assignee(s) designated by Holder a Warrant or Warrants of like tenor and terms entitling Holder to purchase the appropriate number of shares. This Warrant and the rights evidenced hereby shall inure to the benefit of and be
binding upon the successors and assigns of Holder. The provisions of this Warrant are intended to be for the benefit of all Holders from time to time of this Warrant, and shall be enforceable by any such Holder. For avoidance of doubt, in the event
Holder notifies the Company that such sale or transfer is a so called “4[(a)](1) and half” transaction, the parties hereto agree that a legal opinion from outside counsel for Holder delivered to counsel for the Company substantially in the
form attached hereto as Exhibit C shall be the only requirement to satisfy an exemption from registration under the Securities Act to effectuate such “4[(a)](1) and half” transaction. 

9. Noncircumvention. 
 The Company hereby covenants and
agrees that the Company will not, by amendment of its certificate of incorporation, bylaws or through any reorganization, transfer of assets, consolidation, merger, scheme of arrangement, dissolution, issue or sale of securities, or any other
voluntary action, avoid or seek to avoid the observance or performance of any of the terms of this Warrant, and will at all times in good faith carry out all the provisions of this Warrant and take all action as may be required to protect the rights
of Holder. Without limiting the generality of the foregoing, the Company (i) shall not increase the par value of any shares of Common Stock receivable upon the exercise of this Warrant above the Exercise Price then in effect, and
(ii) shall take all such actions as may be necessary or appropriate in order that the Company may validly and legally issue fully paid and nonassessable shares of Common Stock upon the exercise of this Warrant. 

10. Events of Failure; Definition of Black Scholes Value. 

(a) Definition. 
 The occurrence of each of the following
shall be considered to be an “Event of Failure.” 
 (i) A Delivery Failure occurs, where a “Delivery Failure” shall be
deemed to have occurred if the Company fails to use its best efforts to deliver Exercise Shares to Holder within any applicable Delivery Period (other than due to the limitation contained in the second paragraph of Section 1); 

  
 17 

 (ii) A Legend Removal Failure occurs, where a “Legend Removal Failure” shall be
deemed to have occurred if the Company fails to use its best efforts to issue this Warrant and/or Exercise Shares without a restrictive legend, or fails to use it best efforts to remove a restrictive legend, when and as required under
Section 2(e) hereof; 
 (iii) a Transfer Delivery Failure occurs, where a “Transfer Delivery Failure” shall be deemed to have
occurred if the Company fails to use its best efforts to deliver a Warrant within any applicable Transfer Delivery Period; and 
 (iv) a
Registration Failure (as defined below). 
 For purpose hereof, “Registration Failure” means that (A) the Company fails to file with the SEC
on or before the Filing Deadline (as defined in the Registration Rights Agreement) any Registration Statement required to be filed pursuant to Section 2(a) of the Registration Rights Agreement, (B) the Company fails to use its reasonable
best efforts to obtain effectiveness with the SEC, prior to the Registration Deadline (as defined in the Registration Rights Agreement), and if such Registration Statement does not become effective prior to the Registration Deadline, as soon as
possible thereafter, of any Registration Statement (as defined in the Registration Rights Agreement) that is required to be filed pursuant to Section 2(a) of the Registration Rights Agreement, or fails to use its reasonable best efforts to keep
such Registration Statement current and effective as required in Section 3 of the Registration Rights Agreement, (C) the Company fails to file any additional Registration Statement required to be filed pursuant to Section 2(a)(ii) of
the Registration Rights Agreement on or before the Additional Filing Deadline or fails to use its reasonable best efforts to cause such new Registration Statement to become effective on or before the Additional Registration Deadline, and if such
effectiveness does not occur within such period, as soon as possible thereafter, (D) the Company fails to file any amendment to any Registration Statement, or any additional Registration Statement required to be filed pursuant to
Section 3(b) of the Registration Rights Agreement within thirty (30) days of the applicable Registration Trigger Date (as defined in the Registration Rights Agreement), or fails to use its reasonable best efforts to cause such amendment
and/or new Registration Statement to become effective within ninety (90) days of the applicable Registration Trigger Date, and, if such effectiveness does not occur within such period, as soon as possible thereafter, (E) any Registration
Statement required to be filed under the Registration Rights Agreement, after its initial effectiveness and during the Registration Period (as defined in the Registration Rights Agreement), lapses in effect or, other than on a day during an
Allowable Grace Period (as defined in the Registration Rights Agreement), sales of all of the Registrable Securities (as defined in the Registration Rights Agreement) cannot otherwise be made thereunder (whether by reason of the Company’s
failure to amend or supplement the prospectus included therein in accordance with the Registration Rights Agreement, the Company’s failure to file and use its reasonable best efforts to obtain effectiveness with the SEC of an additional
Registration Statement or amended Registration Statement required pursuant to Sections 2(a)(ii) or 3(b) of the Registration Rights Agreement, as applicable, or otherwise), or (F) the Company fails to provide a commercially reasonable
written response to any comments to any Registration Statement submitted by the SEC within twenty-five (25) days of the date that such SEC comments are received by the Company. 

(b) Failure Payments; Black-Scholes Determination. The Company understands that any Event of Failure (as defined above) could result in economic loss to
Holder. In the event that any Event of Failure occurs, as compensation to Holder for such economic loss, the Company agrees to pay to Holder an amount payable, at the Company’s option, either (i) in cash or (ii) in shares of Common
Stock that are valued for these purposes at the Volume Weighted Average Price on the date of such calculation (“Failure Payments” and such shares, “Failure Payment Shares”), in each case equal to the total economic loss of Holder
determined on a commercially reasonable basis in connection with such Event of Failure for the relevant period (as recalculated on the first Business Day of each month thereafter for as long as Failure Payments shall continue to accrue) from the
date of such Event of Failure until the Event of Failure is cured; provided, however, that in the event the Company elects to make Failure Payments in Failure Payment Shares, the Company shall issue, and Holder shall only receive, up to such number
of shares of Common Stock in 

  
 18 

 
respect of Failure Payments such that Holder and any other persons or entities whose beneficial ownership of Common Stock would be aggregated with Holder’s for purposes of Section 13(d)
of the Exchange Act (including shares held by any “group” of which Holder is a member, but excluding shares beneficially owned by virtue of the ownership of securities or rights to acquire securities that have limitations on the right to
convert, exercise or purchase similar to the limitation set forth herein) shall not collectively beneficially own greater than 4.985% of the total number of shares of Common Stock of the Company then issued and outstanding, and the balance of such
Failure Payments shall be paid in cash. For purposes of clarification, it is agreed and understood that Failure Payments shall continue to accrue following any Event of Default until the applicable Default Amount is paid in full. The Company shall
satisfy any Failure Payments under this Section pursuant to Section 10(c) below. Failure Payments are in addition to any Shares that Holder is entitled to receive upon Exercise of this Warrant. 

(c) Payment of Accrued Failure Payments. The Failure Payments and Failure Payment Shares representing accrued Failure Payments for each Event of Failure
shall be paid or issued and delivered, as the case may be, on or before the fifth (5th) Business Day of each month following a month in which Failure Payments accrued. Nothing herein shall limit Holder’s right to pursue actual damages (to
the extent in excess of the Failure Payments) for the Company’s Event of Failure, and Holder shall have the right to pursue all remedies available at law or in equity (including a decree of specific performance and/or injunctive relief).
Notwithstanding the above, if a particular Event of Failure results in an Event of Default pursuant to Section 11 hereof, then the Failure Payment, for that Event of Failure only, shall be considered to have been satisfied upon payment to
Holder of an amount equal to the greater of (i) the Failure Payment, or (ii) the Default Amount, payable in accordance with Section 11. 

(d) Maximum Interest Rate. Nothing contained herein or in any document referred to herein or delivered in connection herewith shall be deemed to
establish or require the payment of a rate of interest or other charges in excess of the maximum permitted by applicable law. In the event that the rate of interest or dividends required to be paid or other charges hereunder exceed the maximum
permitted by such law, any payments in excess of such maximum shall be credited against amounts owed by the Company to Holder and thereby refunded to the Company. 

11. Default. 
 (a) Events Of Default. Each of the
following events shall be considered to be an “Event of Default,” unless waived by Holder: 
 (i) Failure To Effect Registration. With
respect to all Registration Failures, a Registration Failure occurs and remains uncured for a period of more than forty-five (45) days (or sixty (60) days in the case where the Company (i) has, by the Filing Deadline (as defined the
Registration Rights Agreement) filed a Registration Statement (as defined in the Registration Rights Agreement) covering this Warrant and the number of shares required by the Registration Rights Agreement, and (ii) has responded in writing to
any comments to the Registration Statement that the Company has received from the SEC, within ten (10) Business Days of such receipt, and nevertheless the SEC has not declared effective a Registration Statement covering the this Warrant and the
Shares by the Registration Deadline (as defined in the Registration Rights Agreement)), and such Registration Failure relates solely to the Company’s failure to have the Registration Statement declared effective by the Registration
Deadline (as defined in the Registration Rights Agreement) and with respect to a Registration Failure provided in clause (E) of the definition of “Registration Failure,” such Registration Failure occurs and remains uncured for a
period of more than forty-five (45) days. 
 (ii) Failure To Deliver Common Stock. A Delivery Failure (as defined above) occurs and remains
uncured for a period of more than twenty (20) days; or at any time, the Company announces or states in writing that 

  
 19 

 
it will not honor its obligations to issue shares of Common Stock to Holder upon Exercise by Holder of the Exercise rights of Holder in accordance with the terms of this Warrant. 

(iii) Legend Removal Failure. A Legend Removal Failure (as defined above) occurs and remains uncured for a period of twenty (20) days; 

(iv) Transfer Delivery Failure. A Transfer Delivery Failure (as defined above) occurs and remains uncured for a period of twenty (20) days; 

(v) Corporate Existence; Major Transaction. (A) The Company has failed to (1) place the Successor Major Transaction Consideration into escrow
and instruct the escrow agent to release the Successor Major Transaction Consideration to the Holder pursuant to Section 5(b)(iii), or (2) obtain the written agreement of the Successor Entity and cause the Successor Entity to make payment
as described in Section 5(b)(iii), (B) the Successor Major Transaction Consideration is not paid contemporaneously with the consummation of the Successor Major Transaction, or (C) with respect to a Major Transaction that is to be treated
as an Assumption under the terms hereof, the Company has failed to meet the Assumption requirements of Section 5(b)(i); or 
 (vi)
Section 13 Breach. During the Dividend Restriction Period, the Company declares or pays any dividend or distribution of any kind to the holders of Common Stock of the Company. 

(b) Mandatory Early Termination. 
 (i) Mandatory Early
Termination Amount; Cashless Default Exercise. The Company shall notify Holder in writing within two (2) Business Days of the occurrence of an Event of Default. If any Events of Default shall occur then, at the option of Holder, such option
exercisable through the delivery of written notice to the Company by such Holder (the “Default Notice”), the Company shall have the right to terminate the outstanding amount of this Warrant and pay to Holder (a “Mandatory Early
Termination”), in full satisfaction of its obligations hereunder by delivery of a notice to such effect to Holder within two (2) Business Days following receipt of the Default Notice, an amount payable in cash (the “Mandatory Early
Termination Amount” or the “Default Amount”) equal to the Black-Scholes Value of the remaining unexercised portion of this Warrant on the date of such Default Notice (or in the case of an Event of Default referred to in
Section 11(a)(vi), on the Trading Day immediately preceding the date the dividend or distribution is declared or, if not first declared, is paid). In the event the Company does not exercise its right to consummate a Mandatory Early Termination,
then Holder shall have the right to exercise this Warrant, at any time and from time to time, pursuant to a Cashless Default Exercise in accordance with Section 3(c) above. 

The Mandatory Early Termination Amount shall be payable within five (5) Business Days following the date of the applicable Default Notice. 

(ii) Liquidated Damages. The parties hereto acknowledge and agree that the sums payable as Failure Payments or pursuant to a Mandatory Early Termination
shall constitute partial liquidated damages and not penalties. The parties further acknowledge that (i) the amount of loss or damages likely to be incurred by Holder is incapable or is difficult to precisely estimate, (ii) the amounts
specified bear a reasonable proportion and are not plainly or grossly disproportionate to the probable loss likely to be incurred by Holder, and (iii) the parties are sophisticated business parties and have been represented by sophisticated and
able legal and financial counsel and negotiated this Agreement at arm’s length. 
 Upon the occurrence of an Event of Default, the Default Amount,
together with all other amounts payable hereunder, shall immediately become due and payable, all without demand, presentment or notice, all of 

  
 20 

 
which hereby are expressly waived, together with all costs, including legal fees and expenses, of collection, and Holder shall be entitled to exercise all other rights and remedies available at
law or in equity. 
 (c) Posting Of Bond. In the event that any Event of Default occurs hereunder, the Company may not raise as a legal defense (in
any Lawsuit, as defined below, or otherwise) or justification to such Event of Default any claim that such Holder or any one associated or affiliated with such Holder has been engaged in any violation of law, unless the Company has posted a surety
bond (a “Surety Bond”) for the benefit of such Holder in the amount of 130% of the aggregate Surety Bond Value (as defined below) of all of Holder’s Warrants (the “Bond Amount”), which Surety Bond shall remain in effect
until the completion of litigation of the dispute and the proceeds of which shall be payable to such Holder to the extent Holder obtains judgment. 
 For
purposes hereof, a “Lawsuit” shall mean any lawsuit, arbitration or other dispute resolution filed by either party herein pertaining to any of this Warrant, the Facility Agreement, the Registration Rights Agreement or any other Loan
Document (as defined in the Facility Agreement). 
 “Surety Bond Value,” for the Warrants shall mean 130% of the of the Black-Scholes Value of the
remaining unexercised portion of this Warrant on the Trading Day immediately preceding the date that such bond goes into effect. 
 (d) Injunction And
Posting Of Bond. In the event that the Event of Default referred to in subsection (a) of this Section 11 pertains to the Company’s failure to deliver unlegended shares of Common Stock to Holder pursuant to a Warrant Exercise,
legend removal request, or otherwise, the Company may not refuse such unlegended share delivery based on any claim that such Holder or any one associated or affiliated with such Holder has been engaged in any violation of law, unless an injunction
from a court, on prior notice to Holder, restraining and or enjoining Exercise of all or part of said Warrant shall have been sought and obtained by the Company and the Company has posted a Surety Bond for the benefit of such Holder in the amount of
the Bond Amount, which Surety Bond shall remain in effect until the completion of litigation of the dispute and the proceeds of which shall be payable to such Holder to the extent Holder obtains judgment. 

(e) Remedies, Other Obligations, Breaches And Injunctive Relief. The remedies provided in this Warrant shall be cumulative and in addition to all other
remedies available under this Warrant, the Facility Agreement, the Registration Rights Agreement and any other Loan Document, at law or in equity (including a decree of specific performance and/or other injunctive relief), and nothing herein shall
limit the right of Holder to pursue actual damages for any failure by the Company to comply with the terms of this Warrant. The Company acknowledges that a breach by it of its obligations hereunder will cause irreparable harm to Holder and that the
remedy at law for any such breach may be inadequate. The Company therefore agrees that, in the event of any such breach or threatened breach (including a breach or threatened breach of Section 13), the holder of this Warrant shall be entitled,
in addition to all other available remedies, to an injunction restraining any breach, without the necessity of showing economic loss and without any bond or other security being required. 

12. Holder’s Early Terminations. 
 (a) Mechanics
of Holder’s Early Terminations. In the event that the Company does not deliver the applicable Successor Major Transaction Consideration or Default Amount or the Exercise Shares in respect of an election of a Successor Major Transaction
Conversion, Cashless Major Exercise, Cashless Default or Exercise, as the case may be, to Holder within the time period or as otherwise required pursuant to the terms hereof, at any time thereafter Holder shall have the option, upon notice to the
Company, in lieu of an election of a Successor Major Transaction Conversion, Cashless Major Exercise, Cashless Default Exercise 

  
 21 

 
or Exercise, as the case may be, to require the Company to promptly return to Holder all or any portion of this Warrant that was submitted for election of a Successor Major Transaction
Conversion, Cashless Major Exercise, Cashless Default Exercise or Exercise, as the case may be. Upon the Company’s receipt of such notice, (x) the applicable election of Successor Major Transaction Conversion, Cashless Major Exercise,
Cashless Default Exercise or Exercise, as the case may be, shall be null and void with respect to such applicable portion of this Warrant, (y) the Company shall immediately return this Warrant, or issue a new Warrant to Holder representing the
portion of this Warrant that was submitted for election of Successor Major Transaction Conversion, Cashless Major Exercise, Cashless Default Exercise or Exercise, as the case may be, and (z) the Exercise Price of this Warrant or such new
Warrant shall be adjusted to the Exercise Price as in effect on the date on which the applicable election of Successor Major Transaction Conversion, Cashless Major Exercise, Cashless Default Exercise or Exercise, as the case may be, is voided.
Holder’s delivery of a notice voiding an election of a Successor Major Transaction Conversion, Cashless Major Exercise, Cashless Default Exercise or Exercise, as the case may be, and exercise of its rights following such notice shall not affect
the Company’s obligations to make any Failure Payments which have accrued prior to the date of such notice with respect to the Warrant subject to such notice. 

13. Dividend Restrictions. 
 Until the earlier of the
expiration of the Term and the date Holder Exercises this Warrant in full (the “Dividend Restriction Period”), the Company shall not declare or pay any dividend or distribution of any kind to the holders of Common Stock of the Company.

 14. Benefits of this Warrant. 
 Nothing in this
Warrant shall be construed to confer upon any person other than the Company and Holder any legal or equitable right, remedy or claim under this Warrant and this Warrant shall be for the sole and exclusive benefit of the Company and Holder. 

15. Governing Law. 
 All questions concerning the
construction, validity, enforcement and interpretation of this Agreement shall be governed by and construed and enforced in accordance with the internal laws of the State of New York, without regard to the principles of conflicts of law thereof.
Each party agrees that all legal proceedings concerning the interpretations, enforcement and defense of the transactions contemplated by this Agreement (whether brought against a party hereto or its respective affiliates, directors, officers,
stockholders, employees or agents) shall be commenced exclusively in the state and federal courts sitting in the City of New York, Borough of Manhattan. Each party hereby irrevocably submits to the exclusive jurisdiction of the state and federal
courts sitting in the City of New York, borough of Manhattan for the adjudication of any dispute hereunder or in connection herewith or with any transaction contemplated hereby or discussed herein, and hereby irrevocably waives, and agrees not to
assert in any suit, action or proceeding, any claim that it is not personally subject to the jurisdiction of any such court, that such suit, action or proceeding is improper or is an inconvenient venue for such proceeding. Each party hereby
irrevocably waives personal service of process and consents to process being served in any such suit, action or proceeding by mailing a copy thereof via registered or certified mail or overnight delivery (with evidence of delivery) to such party at
the address in effect for notices to it under this Agreement and agrees that such service shall constitute good and sufficient service of process and notice thereof. Nothing contained herein shall be deemed to limit in any way any right to serve
process in any other manner permitted by law. The parties hereby waive all rights to a trial by jury. If either party shall commence an action or proceeding to enforce any provisions of this Agreement, then the prevailing party in such action or
proceeding shall be reimbursed by the other party for its reasonable attorneys’ fees and other costs and expenses incurred with the investigation, preparation and prosecution of such action or proceeding. 

  
 22 

 16. Loss of Warrant. 

Upon receipt by the Company of evidence of the loss, theft, destruction or mutilation of this Warrant, and (in the case of loss, theft or destruction) of
indemnity or security reasonably satisfactory to the Company, and upon surrender and cancellation of this Warrant, if mutilated, the Company shall execute and deliver a new Warrant of like tenor and date. 

17. Notice or Demands. 
 Except as otherwise provided
herein, notices or demands pursuant to this Warrant to be given or made by Holder to or on the Company shall be sufficiently given or made if sent by overnight delivery with a nationally recognized overnight courier service, certified or registered
mail, return receipt requested, postage prepaid, and addressed, until another address is designated in writing by the Company, to the address set forth in Section 2(a) above. To the extent any notice or demand pursuant to this Warrant can be
made by electronic mail, such notice or demand given or made by Holder to or on the Company shall be sufficiently given or made if it is sent by electronic mail to the addresses that the Company shall designate in writing from time to time. Notices
or demands pursuant to this Warrant to be given or made by the Company to or on Holder shall be sufficiently given or made if sent by overnight delivery with a nationally recognized overnight courier service or certified or registered mail, return
receipt requested, postage prepaid, and addressed, to the address of Holder set forth in the Company’s records, until another address is designated in writing by Holder. 

17. Construction. 
 Unless the context otherwise requires,
(a) all references to Articles, Sections, Schedules or Exhibits are to Articles, Sections, Schedules or Exhibits contained in or attached to this Warrant, (b) words in the singular or plural include the singular and plural and pronouns
stated in either the masculine, the feminine or neuter gender shall include the masculine, feminine and neuter and (c) the use of the word “including” in this Warrant shall be by way of example rather than limitation. 

18. Signatures. 
 In the event that any signature to this
Warrant or any amendment hereto is delivered by electronic mail delivery of a “.pdf” format data file, such signature shall create a valid and binding obligation of the party executing (or on whose behalf such signature is executed) with
the same force and effect as if such “.pdf” signature page were an original thereof. Notwithstanding the foregoing, the Company shall be obligated to deliver to Holder an original signature to this Warrant. At the request of any party,
each other party shall promptly re-execute an original form of this Warrant or any amendment hereto and deliver the same to the other party. No party hereto shall raise the use of electronic mail delivery of a
“.pdf” format data file to deliver a signature to this Warrant or any amendment hereto or the fact that such signature was transmitted or communicated through the use of electronic mail delivery of a “.pdf” format data file as a
defense to the formation or enforceability of a contract, and each party hereto forever waives any such defense. 

  
 23 

 IN WITNESS WHEREOF, the undersigned has executed this Warrant as of the
             day of             , 20    . 

 

			
	ENDOLOGIX, INC.
		
	By:	 	 
		 	 Print Name:
 Title:

  
 24 

 EXHIBIT A-1 

EXERCISE FORM FOR WARRANT 
 TO:
[                     ] 
 CHECK THE APPLICABLE BOX:

  

			
	☐	  	 Cash Exercise, Cashless Exercise or Note Exchange Exercise

 
 The undersigned hereby irrevocably exercises Warrant Number
         (the “Warrant”) with respect to [            ] shares of Common Stock (the “Common Stock”) of Endologix, Inc., a
Delaware corporation (the “Company”). [IF APPLICABLE: The undersigned hereby encloses $         as payment of the Exercise Price.]

 
 ☐ The undersigned is exercising the Warrant with respect to
[            ] shares of Common Stock pursuant to a Cashless Exercise, and hereby makes payment of the Exercise Price with respect to such shares in full, all in accordance with the
conditions and provisions of the Warrant applicable to such Cashless Exercise.
  

☐ The undersigned is exercising the Warrant with respect to [            ] shares of Common
Stock pursuant to a Note Exchange Exercise. The undersigned hereby agrees to cancel $         of principal outstanding under Notes of the Company held by Holder in satisfaction of the Exercise Price in
accordance with the conditions and provisions of the Warrant applicable to such Note Exchange Exercise.

		
	☐	  	 Cashless Major Exercise
  

The undersigned hereby irrevocably exercises the Warrant with respect to         % of the Warrant currently outstanding
pursuant to a Cashless Major Exercise in accordance with the terms of the Warrant.

		
	☐    	  	 Cashless Default Exercise
  

The undersigned hereby irrevocably exercises the Warrant pursuant to a Cashless Default Exercise, in accordance with the terms of the Warrant.

 1. The undersigned requests that any stock certificates for such shares be issued free of any restrictive legend, if
appropriate, and, if requested by the undersigned, a warrant representing any unexercised portion hereof be issued, pursuant to the Warrant in the name of the undersigned and delivered to the undersigned at the address set forth below. 

2. Capitalized terms used but not otherwise defined in this Exercise Form shall have the meaning ascribed thereto in the Warrant. 

Dated: _______________ 
  

 
 Signature 

 
  

Print Name 
  

 
 Address 

  
 25 

 NOTICE 
 The
signature to the foregoing Exercise Form must correspond to the name as written upon the face of the attached Warrant in every particular, without alteration or enlargement or any change whatsoever. 

  
 26 

 EXHIBIT B 

ASSIGNMENT 
 (To be executed by
the registered holder 
 desiring to transfer the Warrant) 

FOR VALUE RECEIVED, the undersigned holder of the attached warrant (the “Warrant”) hereby sells, assigns and transfers unto the person or persons
below named the right to purchase                  shares of the Common Stock of [ ], a Delaware corporation, evidenced by the attached Warrant and does hereby
irrevocably constitute and appoint                  attorney to transfer the said Warrant on the books of the Company, with full power of substitution in the premises.

  

							
	Dated: _______________ 	 		 	
				
		 		 		 	 
		 		 		 	Signature
		 		 		 	

 Fill in for new registration of Warrant: 
  

			
	  
 Name
	 	
		 	
	  
 Address
	 	
		 	
	  
 Please print name and address of
assignee
	 	
	(including zip code number)	 	

 NOTICE 
 The signature to the
foregoing Assignment must correspond to the name as written upon the face of the attached Warrant in every particular, without alteration or enlargement or any change whatsoever. 

  
 27 

 EXHIBIT C 

FORM OF OPINION 
 ______, 20__ 

[                    ] 

Re: [ ] (the “Company”) 

Dear Sir: 

[                    ]
(“[                    ]”) intends to transfer             Warrants (the
“Warrants”) of the Company to                     
(“                    ”) without registration under the Securities Act of 1933, as amended (the “Securities Act”). In connection
therewith, we have examined and relied upon the truth of representations contained in an Investor Representation Letter attached hereto and have examined such other documents and issues of law as we have deemed relevant. 

Based on and subject to the foregoing, we are of the opinion that the transfer of the Warrants by
             to              may be effected without registration under the Securities Act, provided, however, that the Warrants
to be transferred to              contain a legend restricting its transferability pursuant to the Securities Act and that transfer of the Warrants is subject to a stop order. 

The foregoing opinion is furnished only to
                     and may not be used, circulated, quoted or otherwise referred to or relied upon by you for any purposes other than the purpose
for which furnished or by any other person for any purpose, without our prior written consent. 
 Very truly yours, 

  
 28 

 [FORM OF INVESTOR REPRESENTATION LETTER] 

_____, 20__ 
 [_________________] 

Gentlemen: 

                    
(“        ”) has agreed to purchase                  Warrants (the “Warrants”) of [ ] (the
“Company”) from [                    ]
(“[                    ]”). We understand that the Warrants are “restricted securities.” We represent and warrant that ______ is
a sophisticated institutional investor that would qualify as an “Accredited Investor” as defined in Rule 501 of Regulation D under the Securities Act of 1933, as amended (the “Securities Act”). 

________ represents and warrants as of the date hereof as follows: 

1. That it is acquiring the Warrants and the shares of common stock, $0.001 par value per share underlying such Warrants (the “Exercise
Shares”) solely for its account for investment and not with a view to or for sale or distribution of said Warrants or Exercise Shares or any part thereof in violation of the Securities Act.
                 also represents that the entire legal and beneficial interests of the Warrants and Exercise Shares
                     is acquiring is being acquired for, and will be held for, its account only; 

2. That the Warrants and the Exercise Shares must be held indefinitely unless they are registered under the Securities Act or an exemption from
such registration is available.                      recognizes that the Company has no obligation to register the Warrants, or to comply with any
exemption from such registration; 
 3. That neither the Warrants nor the Exercise Shares may be sold pursuant to Rule 144 adopted under the
Securities Act unless certain conditions are met; 
 We acknowledge that the Company will place stop orders with respect to the Warrants and the Exercise
Shares, and if a registration statement is not effective, the Exercise Shares shall bear the following restrictive legend: 
 “THE
SECURITIES REPRESENTED BY THIS CERTIFICATE HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR APPLICABLE STATE SECURITIES LAWS. THE SECURITIES MAY NOT BE SOLD, TRANSFERRED OR ASSIGNED IN THE ABSENCE OF AN EFFECTIVE
REGISTRATION STATEMENT FOR THE SECURITIES UNDER SAID ACT, OR PURSUANT TO AN EXEMPTION FROM REGISTRATION UNDER SAID ACT INCLUDING PURSUANT TO SECTION 4(A)(7) OF THE SECURITIES ACT OR RULE 144 UNDER SAID ACT OR PURSUANT TO A PRIVATE SALE EFFECTED
UNDER APPLICABLE FORMAL OR INFORMAL SEC INTERPRETATION OR GUIDANCE, SUCH AS A SO-CALLED “4[(a)](1) AND A HALF” SALE. NOTWITHSTANDING THE FOREGOING, THE SECURITIES MAY BE PLEDGED IN CONNECTION WITH A
BONA FIDE MARGIN ACCOUNT OR OTHER LOAN OR FINANCING ARRANGEMENT SECURED BY THE SECURITIES.” 

  
 29 

 “THE SALE, TRANSFER OR ASSIGNMENT OF THE SECURITIES REPRESENTED BY THIS CERTIFICATE ARE
SUBJECT TO THE TERMS AND CONDITIONS OF A CERTAIN REGISTRATION RIGHTS AGREEMENT DATED AS OF APRIL 3, 2017, AS AMENDED FROM TIME TO TIME, AMONG THE COMPANY AND CERTAIN HOLDERS OF ITS OUTSTANDING SECURITIES. COPIES OF SUCH AGREEMENT MAY BE
OBTAINED AT NO COST BY WRITTEN REQUEST MADE BY THE HOLDER OF RECORD OF THIS CERTIFICATE TO THE SECRETARY OF THE COMPANY.” 
 At any time and from time
to time after the date hereof,                      shall, without further consideration, execute and deliver to
[                    ] or the Company such other instruments or documents and shall take such other actions as they may reasonably request to carry
out the transactions contemplated hereby. 
 Very truly yours, 

  
 30 

 Schedule 1 

Black-Scholes Value 
  

					
	 	  	 Calculation Under Sections 3(b) and 5(b)(iii)
	  	 Calculation Under Section 10(b) or 11(b)

			
	Remaining Term	  	Number of calendar days from date of public announcement of the Major Transaction until the last date on which the Warrant may be exercised.	  	Number of calendar days from the date of the Event of Failure, or in the case of an Event of Default, the date of the Default Notice, until the last date on which the Warrant may be exercised.
			
	Interest Rate	  	A risk-free interest rate corresponding to the US$ LIBOR/Swap rate for a period equal to the Remaining Term.	  	A risk-free interest rate corresponding to the US$ LIBOR/Swap rate for a period equal to the Remaining Term.
			
	Cost to Borrow	  	Zero	  	Zero
			
	Volatility	  	 If the first public announcement of the Major Transaction is made at or prior to 4:00 p.m., New York City time, the arithmetic mean of the
historical volatility for the 10, 30 and 50 Trading Day periods ending on the date of such first public announcement, obtained from the HVT or similar function on Bloomberg.
  

If the first public announcement of the Major Transaction is made after 4:00 p.m., New York City time, the arithmetic mean of the historical volatility for the
10, 30 and 50 Trading Day periods ending on the next succeeding Trading Day following the date of such first public announcement, obtained from the HVT or similar function on Bloomberg.
	  	The arithmetic mean of the historical volatility for the 10, 30 and 50 Trading Day periods ending on the date of such determination, obtained from the HVT or similar function on Bloomberg.
			
	Stock Price	  	As selected by Holder in its commercially reasonable discretion in order to produce a commercially reasonable result, any of: (1) the closing price of the Common Stock on NYSE, or, if that is not the principal trading market
for the Common Stock, such principal market on which the Common Stock is traded or listed (the “Closing Market Price”) on the Trading Day immediately preceding the date on which a Major Transaction is consummated, (2) the first
Closing Market	  	The volume Weighted Average Price on the date of such determination.

					
			
		  	Price following the first public announcement of a Major Transaction, (3) the Closing Market Price as of the date immediately preceding the first public announcement of the Major Transaction or (4) the cash amount payable
per share of Common Stock. The Company and Holder acknowledge and agree that any of the above will produce a commercially reasonable result.	  	
			
	Dividends	  	Zero.	  	Zero.
			
	Strike Price	  	Exercise Price as defined in section 3(a).	  	Exercise Price as defined in section 3(a).

 EXHIBIT C-2 

FORM OF ADDITIOANL WARRANT 
 THE
SECURITIES ISSUABLE UPON EXERCISE HEREOF HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), OR ANY STATE SECURITIES LAW. THE SECURITIES MAY NOT BE SOLD, TRANSFERRED OR ASSIGNED IN THE ABSENCE OF
AN EFFECTIVE REGISTRATION STATEMENT UNDER THE SECURITIES ACT, EXCEPT PURSUANT TO AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT, INCLUDING PURSUANT TO SECTION 4(A)(7) OF THE SECURITIES ACT OR RULE 144 UNDER THE SECURITIES ACT OR PURSUANT TO
A PRIVATE SALE EFFECTED UNDER APPLICABLE FORMAL OR INFORMAL SEC INTERPRETATION OR GUIDANCE, SUCH AS A SO-CALLED “4[(a)](1) AND A HALF SALE.” NOTWITHSTANDING THE FOREGOING, THE SECURITIES MAY BE
PLEDGED IN CONNECTION WITH A BONA FIDE MARGIN ACCOUNT OR OTHER LOAN OR FINANCING ARRANGEMENT SECURED BY THE SECURITIES. 
 AN INVESTMENT IN THESE SECURITIES
INVOLVES A HIGH DEGREE OF RISK. HOLDERS MUST RELY ON THEIR OWN ANALYSIS OF THE INVESTMENT AND ASSESSMENT OF THE RISKS INVOLVED. 
 Warrant to Purchase 

[                    ]8 shares 
 Warrant Number: 2018-[    ] 

Warrant to Purchase Common Stock 

of 
 Endologix, Inc.

 THIS CERTIFIES that
[                            ] or any subsequent holder hereof (“Holder”) has the right to purchase
from Endologix, Inc., a Delaware corporation (the “Company”), [                            ]
([                    ]) fully paid and nonassessable shares of the Company’s common stock, $0.001 par value per share (“Common
Stock”), subject to adjustment as provided herein, at a price equal to the Exercise Price (as defined in Section 3 below), at any time during the Exercise Period (as defined in Section 1 below). 

Holder agrees with the Company that this Warrant to Purchase Common Stock of the Company (this “Warrant” or this “Agreement”) is issued
and all rights hereunder shall be held subject to all of the conditions, limitations and provisions set forth herein. 
 18. Date of Issuance and
Term. 
 This Warrant shall be deemed to be issued, and shall be in full force and effect commencing, on August 9, 2018 (“Date of
Issuance”). The exercise period of this Warrant begins on (and includes) February 9, 2019, and ends at 5:00 p.m., New York City time, on August 9, 2025 (the “Exercise Period”). This Warrant was issued pursuant to that
certain Amended and Restated Facility Agreement (as may be amended, restated, supplemented or otherwise modified from time to time in accordance with the terms thereof, the “Facility Agreement”) by and among the Company and Deerfield
Private Design Fund III, L.P., Deerfield Private 
  
  

	8 	 Total number of shares to equal 8,750,000, divided among the funds (1/3 each).

 
Design Fund IV, L.P., and Deerfield Partners, L.P., dated as of August 9, 2018, and in conjunction with that certain Amended and Restated Registration Rights Agreement (as may be amended,
restated, supplemented or otherwise modified from time to time in accordance with the terms thereof, the “Registration Rights Agreement”) by and among the Company and Deerfield Private Design Fund III, L.P., Deerfield Private Design Fund
IV, L.P., and Deerfield Partners, L.P., dated as of August 9, 2018. 
 Notwithstanding anything herein to the contrary, the Company shall not issue to
Holder, and Holder may not acquire, a number of shares of Common Stock upon exercise of this Warrant to the extent that, upon such exercise, the number of shares of Common Stock then beneficially owned by Holder and its Affiliates and any other
persons or entities whose beneficial ownership of Common Stock would be aggregated with Holder’s for purposes of Section 13(d) of the Securities Exchange Act of 1934, as amended (the “Exchange Act”) (including shares held by any
“group” of which Holder is a member, but excluding shares beneficially owned by virtue of the ownership of securities or rights to acquire securities that have limitations on the right to convert, exercise or purchase similar to the
limitation set forth herein), would exceed 4.985% of the total number of shares of Common Stock then issued and outstanding (the “4.985% Cap”); provided, however, that the 4.985% Cap shall only apply to the extent that the Common Stock is
deemed to constitute an “equity security” pursuant to Rule 13d-1(i) promulgated under the Exchange Act. For purposes hereof, “group” has the meaning set forth in Section 13(d) of the
Exchange Act and applicable regulations of the Securities and Exchange Commission (the “SEC”), and the percentage held by Holder shall be determined in a manner consistent with the provisions of Section 13(d) of the Exchange Act. Upon
the written request of Holder, the Company shall, within two (2) Trading Days, confirm orally and in writing to Holder the number of shares of Common Stock then outstanding. 

For purposes hereof: 
 “Affiliate” means any person or
entity that, directly or indirectly through one or more intermediaries, controls or is controlled by or is under common control with a person or entity, as such terms are used in and construed under Rule 144 (“Rule 144”) under the
Securities Act of 1933, as amended (the “Securities Act”). With respect to a Holder, any investment fund or managed account that is managed on a discretionary basis by the same investment manager as such Holder shall, for purposes hereof,
be deemed to be an Affiliate of such Holder. 
 “Asset Sale” means a transaction covered by the provisions of clause (B) of the definition of
“Major Transaction” involving the sale or transfer of all or substantially all of the assets of the Company (including, for the avoidance of doubt, all or substantially all of the assets of the Company and its Subsidiaries (as defined in
the Facility Agreement), taken as a whole) in connection with which the Company has announced its intention to liquidate and distribute its assets to stockholders. 

“Black-Scholes Value” shall mean the Black-Scholes value of this Warrant, or applicable portion thereof, as determined by use of the Black-Scholes
Option Pricing Model using the criteria set forth on Schedule 1 hereto. 
 “Business Day” means a day other than a Saturday or Sunday or any other
day on which commercial banks are authorized or required by law to close in New York City. 
 “Cashless Default Exercise” shall mean an exercise
of this Warrant as a “Cashless Default Exercise” in accordance with Sections 3(c) and 11(b) hereof. 
 “Cashless Major Exercise” shall
mean an exercise of this Warrant or portion thereof as a “Cashless Major Exercise” in accordance with Sections 3(b) and 5(b)(i) hereof. 

  
 4 

 “Cash Out Major Transaction” means a Major Transaction in which the consideration payable to
holders of Common Stock in connection with the Major Transaction consists solely of cash. 
 “Eligible Market” means the New York Stock Exchange,
the NASDAQ Capital Market, the NASDAQ Global Market, the NASDAQ Global Select Market, the NYSE American or, in each case, any successor thereto. 

“Parent Entity” of a Person means an entity that, directly or indirectly, controls the applicable Person and whose common stock or equivalent equity
security is quoted or listed on an Eligible Market, or, if there is more than one such Person or Parent Entity, the Person or Parent Entity with the largest public market capitalization as of the date of consummation of a Major Transaction. 

“Person” means an individual, a limited liability company, a partnership, a joint venture, a corporation, a trust, an unincorporated organization,
any other entity and a government or any department or agency thereof. 
 “Standard Settlement Period” means the standard settlement period for
equity trades effected on securities exchanges in the United States, expressed in a number of Trading Days, as in effect on the applicable Date of Exercise (as defined in Section 2(b)). 

“Stock Event” means a stock split, stock combination, reclassification, payment of stock dividend, recapitalization or other similar transaction of
such character that the shares of Common Stock shall be changed into or become exchangeable for a larger or small number of shares. 
 “Successor
Entity” means any Person purchasing the Company’s assets or Common Stock, or any successor entity resulting from such Major Transaction, or if the Warrant is to be exercisable for shares of capital stock of a Parent Entity (as defined
above), such Person’s Parent Entity. 
 “Successor Major Transaction” means either a Takeout Major Transaction or an Asset Sale. 

“Successor Major Transaction Consideration” means (i) in the case of a Takeout Major Transaction (other than a Cash Out Major Transaction), the
amount of cash and other assets and the number of securities or other property of the Successor Entity or other entity that would be issuable in such Major Transaction, in respect of a number of shares equal to the Successor Major Transaction
Conversion Share Amount and (ii) in the case of an Asset Sale or a Cash Out Major Transaction, an amount of cash equal to the Black-Scholes Value of the Warrant. 

“Successor Major Transaction Conversion Share Amount” means an amount equal to the Black-Scholes Value of the Warrant (or such applicable portion
subject to a Successor Major Transaction Conversion), divided by the closing price of the Common Stock on the principal securities exchange or other securities market on which the Common Stock is then traded on the Trading Day immediately preceding
the date on which the applicable Major Transaction is consummated. 
 “Takeout Major Transaction” means a transaction covered by the provisions of
clause (A) of the definition of “Major Transaction” in which the shares of Common Stock of the Company are converted into the right to receive cash, securities of another entity and/or other assets. 

“Trading Day” shall mean any day on which the Common Stock is traded for any period on the NASDAQ Global Select Market (“NasdaqGS”) or, if
the NasdaqGS is not the principal trading market for the Common Stock, on the principal securities exchange or other securities market on which the Common Stock is then being traded; provided, however, that during any period in which the Common
Stock is not 

  
 5 

 
listed or quoted on the NasdaqGS or any other securities exchange or market, the term “Trading Day” shall mean a Business Day. 

19. Exercise. 
 (a) Manner of Exercise. During the
Exercise Period (or, in respect of a Cashless Major Exercise, the Cashless Major Exercise Period (as defined below)), this Warrant may be Exercised as to all or any lesser number of whole shares of Common Stock covered hereby (the “Warrant
Shares” or the “Shares”) by sending to the Company the Exercise Form attached hereto as Exhibit A-1 (the “Exercise Form”) duly completed and executed, and, if
applicable, the full Exercise Price (as defined below, which may be satisfied by a Cash Exercise, a Cashless Exercise or a Note Exchange Exercise, as each is defined below) for each share of Common Stock as to which this Warrant is Exercised, at the
office of the Company, 2 Musick, Irvine, CA 92618, Attention: Chief Financial Officer; Phone: (949) 595-7200, Email: vmahboob@endologix.com, or at such other office or agency as the Company may
designate in writing, by overnight mail or electronic mail (any such exercise of the Warrant being hereinafter called an “Exercise” of this Warrant). 

(b) Date of Exercise. The “Date of Exercise” of the Warrant shall, in each case, be the date that the Exercise Form attached hereto as
Exhibit A-1, completed and executed, is sent by electronic mail to the Company, provided that the Exercise Price is satisfied as soon as practicable thereafter but in no event later
than two (2) Business Days following the date of such electronic mail. Alternatively, the Date of Exercise shall be defined as the date the original Exercise Form is received by the Company, if Holder has not previously sent the Exercise Form
by electronic mail. Upon delivery of the Exercise Form to the Company by electronic mail or otherwise, Holder shall be deemed for all corporate purposes to have become the holder of record of the Warrant Shares with respect to which this Warrant has
been Exercised, irrespective of the date such Warrant Shares are credited to Holder’s or its designee’s Depository Trust Company (“DTC”) account or the date of delivery of the certificates evidencing such Warrant Shares, as the
case may be; provided, however, that in the event an Exercise Form in respect of a Cashless Major Exercise is delivered prior to the occurrence of the applicable Major Transaction, Holder shall be deemed to have become the holder of record of the
shares issuable upon such exercise immediately prior to the consummation of such Major Transaction and the Date of Exercise shall in such event be deemed to have occurred on the date of the occurrence of the Major Transaction. Holder shall not be
required to physically surrender this Warrant to the Company until Holder has purchased all of the Warrant Shares available hereunder and the Warrant has been exercised in full, in which case Holder shall surrender this Warrant to the Company for
cancellation within three (3) Trading Days following the date the final Exercise Form is delivered to the Company. Execution and delivery of an Exercise Form with respect to a partial Exercise shall have the same effect as cancellation of the
original Warrant and issuance of a new Warrant evidencing the right to purchase the remaining number of Warrant Shares. 
 (c) Delivery of Common Stock
Upon Exercise. Within the earlier of (x) two (2) Trading Days and (y) the number of Trading Days comprising the Standard Settlement Period after any Date of Exercise (but, in the case of a Cash Exercise, within two (2) Business
Days following the Company’s receipt of the full Exercise Price, if later) or in the case of a Cashless Default Exercise (as defined in Section 5(b) below), within the period provided in Section 3(c), as applicable (the “Delivery
Period”), the Company shall issue and deliver (or cause its transfer agent (the “Transfer Agent”) to issue and deliver) in accordance with the terms hereof to or upon the order of Holder that number of shares of Common Stock
(“Exercise Shares”) for the portion of this Warrant exercised as shall be determined in accordance herewith. Upon the Exercise of this Warrant or any part hereof, the Company shall, at its own cost and expense, take all necessary action,
including obtaining and delivering an opinion of counsel, to assure that the Transfer Agent shall issue stock certificates in the name of Holder (or its nominee) or such other persons as designated by Holder and in such denominations as Holder shall
specify at Exercise, representing the number of shares of Common 

  
 6 

 
Stock issuable upon such Exercise. The Company warrants that no instructions other than these instructions have been or will be given to the Transfer Agent and that, unless waived by Holder, this
Warrant and the Exercise Shares will be free-trading, and freely transferable, and will not contain or be subject to a legend (or be subject to any stop transfer instruction) restricting the resale or transferability of the Exercise Shares if the
Unrestricted Conditions (as defined below) are met. 
 The Company shall be responsible for paying all present or future stamp, court or documentary,
intangible, recording, filing or similar taxes that arise from any payment or issuance made under, from the execution, delivery, performance or enforcement of, or otherwise with respect to, this Warrant.

(d) Delivery Failure. In addition to any other remedies which may be available to Holder, in the event that the Company fails for any reason to effect
delivery of the Exercise Shares by the end of the Delivery Period (a “Delivery Failure”), Holder will be entitled to revoke all or part of the relevant Exercise by delivery of a notice to such effect to the Company whereupon the Company
and Holder shall each be restored to their respective positions immediately prior to the delivery of such notice of revocation, except that the Failure Payments under Section 10(b) shall be payable through the date such notice of revocation is
given to the Company. 
 (e) Legends. 
 (i)
Restrictive Legend. Holder understands that until such time as this Warrant, the Exercise Shares and the Failure Payment Shares (as defined below) have been registered under the Securities Act or otherwise may be sold pursuant to Rule 144 or
an exemption from registration under the Securities Act without any restriction as to the number of securities as of a particular date that can then be immediately sold, this Warrant, the Exercise Shares and the Failure Payment Shares, as
applicable, may bear a restrictive legend in substantially the following form (and a stop-transfer order consistent therewith may be placed against transfer of the certificates for such securities): 

“THE SECURITIES REPRESENTED BY THIS CERTIFICATE HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR APPLICABLE STATE
SECURITIES LAWS. THE SECURITIES MAY NOT BE SOLD, TRANSFERRED OR ASSIGNED IN THE ABSENCE OF AN EFFECTIVE REGISTRATION STATEMENT FOR THE SECURITIES UNDER SAID ACT, EXCEPT PURSUANT TO AN EXEMPTION FROM REGISTRATION UNDER SAID ACT INCLUDING PURSUANT TO
SECTION 4(A)(7) OF THE SECURITIES ACT OR RULE 144 UNDER SAID ACT OR PURSUANT TO A PRIVATE SALE EFFECTED UNDER APPLICABLE FORMAL OR INFORMAL SEC INTERPRETATION OR GUIDANCE, SUCH AS A SO-CALLED “4[(a)](1)
AND A HALF” SALE.” NOTWITHSTANDING THE FOREGOING, THE SECURITIES MAY BE PLEDGED IN CONNECTION WITH A BONA FIDE MARGIN ACCOUNT OR OTHER LOAN OR FINANCING ARRANGEMENT SECURED BY THE SECURITIES. 

“THE SALE, TRANSFER OR ASSIGNMENT OF THE SECURITIES REPRESENTED BY THIS CERTIFICATE ARE SUBJECT TO THE TERMS AND CONDITIONS OF A CERTAIN
AMENDED AND RESTATED REGISTRATION RIGHTS AGREEMENT DATED AS OF AUGUST 9, 2018, AS AMENDED FROM TIME TO TIME, AMONG THE COMPANY AND CERTAIN HOLDERS OF ITS OUTSTANDING SECURITIES. COPIES OF SUCH AGREEMENT MAY BE OBTAINED AT NO COST BY WRITTEN

  
 7 

 
REQUEST MADE BY THE HOLDER OF RECORD OF THIS CERTIFICATE TO THE SECRETARY OF THE COMPANY.” 
 (ii)
Removal of Restrictive Legends. This Warrant and the certificates (or electronic book entries, if applicable) evidencing the Exercise Shares and the Failure Payment Shares, as applicable, shall not contain or be subject to any legend
restricting the transfer thereof (including the legend set forth above in subsection 2(e)(i)) or be subject to any stop-transfer instructions: (A) while a registration statement (including a Registration Statement, as defined in the
Registration Rights Agreement) covering the sale or resale of such security is effective under the Securities Act, or (B) following any sale of such Warrant, Exercise Shares and/or Failure Payment Shares pursuant to Rule 144, or (C) if
such Warrant, Exercise Shares and/or Failure Payment Shares are eligible for sale under Rule 144(b)(1), or (D) at any time on or after the date hereof on which Holder’s holding period for purposes of Rule 144 under the Securities Act and
subsection (d)(3)(iii) thereof with respect to such Warrant, Exercise Shares and/or Failure Payment Shares is at least six (6) months and Holder certifies that it is not an “affiliate” (as defined in Rule 144 under the Securities
Act), or (E) if such legend is not required under applicable requirements of the Securities Act (including judicial interpretations and pronouncements issued by the staff of the SEC) (collectively, the “Unrestricted Conditions”). The
Company shall cause its counsel to issue a legal opinion to the Transfer Agent promptly after the Effective Date, or at such other time as any of the Unrestricted Conditions have been met, if required by the Transfer Agent to effect the issuance of
this Warrant, the Exercise Shares or the Failure Payment Shares, as applicable, without a restrictive legend or removal of the legend hereunder. If any of the Unrestricted Conditions are met at the time of issuance of this Warrant, the Exercise
Shares or the Failure Payment Shares, then such Warrant, Exercise Shares or Failure Payment Shares, as applicable, shall be issued free of all legends and stop-transfer instructions. The Company agrees that following the Effective Date, or at such
time as the Unrestricted Conditions are met or such legend is otherwise no longer required under this Section 2(e), it will, no later than the earlier of (x) two (2) Trading Days and (y) the number of Trading Days comprising the
Standard Settlement Period following the delivery (the “Unlegended Shares Delivery Deadline”) by Holder to the Company or the Transfer Agent of this Warrant and a certificate representing Exercise Shares and/or Failure Payment Shares, as
applicable, issued with a restrictive legend, deliver or cause to be delivered to Holder this Warrant and/or a certificate (or electronic transfer) representing such shares that is free from all restrictive and other legends (and stop transfer
instructions). For purposes hereof, “Effective Date” shall mean the date that the first Registration Statement that the Company is required to file pursuant to the Registration Rights Agreement has been declared effective by the SEC. 

(iii) Sale of Unlegended Shares. Holder agrees that the removal of the restrictive legend from this Warrant and any certificates representing securities
as set forth in Section 2(e) above is predicated upon the Company’s reliance that Holder will sell this Warrant or any Exercise Shares and/or any Failure Payment Shares, as applicable, pursuant to either the registration requirements of
the Securities Act, including any applicable prospectus delivery requirements, or an exemption therefrom, and that if such securities are sold pursuant to a Registration Statement, they will be sold in compliance with the plan of distribution set
forth therein. 
 (f) Cancellation of Warrant. This Warrant shall be canceled upon the full Exercise of this Warrant, and, as soon as practical after
the Date of Exercise, Holder shall be entitled to receive Common Stock for the number of shares purchased upon such Exercise of this Warrant, and if this Warrant is not Exercised in full, Holder shall be entitled to receive a new Warrant (containing
terms identical to this Warrant) representing any unexercised portion of this Warrant in addition to such Common Stock; provided, however, as set forth in Section 2(b), Holder shall not be required to physically surrender this warrant if the
Warrant is not Exercised in full. 

  
 8 

 (g) Holder of Record. Each person in whose name any Warrant for shares of Common Stock is issued
shall, for all purposes, be deemed to be Holder of record of such shares on the Date of Exercise, irrespective of the date of delivery of the Common Stock purchased upon the Exercise of this Warrant. Prior to the exercise of this Warrant, nothing in
this Warrant shall be construed as conferring upon Holder any rights as a stockholder of the Company. 
 (h) Delivery of Electronic Shares. In lieu of
delivering physical certificates representing the Common Stock issuable upon Exercise or legend removal, or representing Failure Payment Shares, upon written request of Holder, the Company shall use its best efforts to cause the Transfer Agent to
electronically transmit the Common Stock issuable upon Exercise to Holder by crediting the account of Holder’s prime broker with DTC through its Deposit/Withdrawal at Custodian (DWAC) system. The time periods for delivery and penalties
described herein shall apply to the electronic transmittals described herein. Any delivery not effected by electronic transmission shall be effected by delivery of physical certificates. 

(i) Buy-In. In addition to any other rights or remedies available to Holder hereunder or otherwise at law or in
equity, if the Company fails to cause its Transfer Agent to deliver to Holder a certificate or certificates, or electronic shares through DWAC, representing the Exercise Shares pursuant to an Exercise on or before the last day of the Delivery Period
(other than a failure caused by any incorrect or incomplete information provided by Holder to the Company hereunder), and if after such date Holder is required by its broker to purchase (in an open market transaction or otherwise) or Holder or
Holder’s brokerage firm otherwise purchases shares of Common Stock to deliver in satisfaction of a sale by Holder of the Exercise Shares which Holder was entitled to receive upon such Exercise (a
“Buy-In”), then the Company shall (1) pay in cash to Holder the amount by which (x) Holder’s total purchase price (including brokerage commissions, if any) for the shares of Common
Stock so purchased exceeds (y) the amount obtained by multiplying (A) the number of Exercise Shares that the Company was required to deliver to Holder in connection with the Exercise at issue by (B) the price at which the sell order
giving rise to such purchase obligation was executed, and (2) at the option of Holder, either reinstate the portion of the Warrant and equivalent number of Exercise Shares for which such Exercise was not honored (and refund the Exercise Price
therefor, to the extent paid by Holder, and/or reinstate the principal amount of any indebtedness used to satisfy the applicable Exercise Price) or deliver to Holder the number of shares of Common Stock that would have been issued had the Company
timely complied with its Exercise and delivery obligations hereunder. For example, if Holder purchases Common Stock having a total purchase price of $11,000 to cover a Buy-In with respect to an attempted
Exercise to cover the sale of Common Stock with an aggregate sale price giving rise to such purchase obligation of $10,000, under clause (1) of the immediately preceding sentence the Company shall be required to pay Holder $1,000. Holder shall
provide the Company written notice indicating the amounts payable to Holder in respect of the Buy-In, together with applicable confirmations and other evidence reasonably requested by the Company. Nothing
herein shall limit Holder’s right to pursue any other remedies available to it hereunder, at law or in equity including a decree of specific performance and/or injunctive relief with respect to the Company’s failure to timely deliver
certificates representing shares of Common Stock upon Exercise of the Warrant as required pursuant to the terms hereof. 
 (j) HSR Submissions. If
Holder determines that, in connection with the exercise of this Warrant, it and the Company are required to file Premerger Notification Reports with the Federal Trade Commission (the “FTC”) and the United States Department of Justice
(“DOJ”) and observe the Waiting Period under the Hart-Scott Rodino Antitrust Improvements Act of 1976, as amended, and the related rules and regulations promulgated thereunder (collectively, the “HSR Act”), the Company agrees to
(i) cooperate with Holder in Holder’s preparing and making such submission and any responses to inquiries of the FTC and DOJ; (ii) prepare and make any submission required to be filed by the Company under the HSR Act and respond to
inquiries of the FTC and DOJ in connection therewith; and (iii) reimburse Holder for the cost of the required filing fee for Holder’s submission under the HSR Act. For the avoidance of doubt, Holder shall

  
 9 

 
bear all of its other costs and expenses in connection with such submission, including any attorneys’ fees associated therewith. 

20. Payment of Warrant Exercise Price for Cash Exercise or Cashless Exercise; Cashless Major Exercise and Cashless Default Exercise. 

(a) Exercise Price. The exercise price shall initially equal $[        ]9 per share, subject to adjustment pursuant to the terms hereof (as so adjusted, the “Exercise Price”), including but not limited to Section 5 below. 

Payment of the Exercise Price may be made by any of the following, or a combination thereof, at the election of Holder: 

(i) Cash Exercise: Holder may exercise this Warrant in cash, bank or cashier’s check or wire transfer (a “Cash Exercise”); 

(ii) Cashless Exercise: In lieu of paying all or any portion of the Exercise Price in cash, Holder, at its option, may exercise this Warrant (in whole
or in part) on a cashless basis by making appropriate notation on the applicable Exercise Form, in which event the Company shall issue Holder a number of shares of Common Stock computed using the following formula (a “Cashless Exercise”):

 X = Y (A-B)/A 

where: X = the number of shares of Common Stock to be issued to Holder. 

Y = the number of shares of Common Stock for which this Warrant is being Exercised. 

A = the Market Price of one (1) share of Common Stock (for purposes of this Section 3(a)(ii), where “Market Price,” as of
any date, means the arithmetic average of the Volume Weighted Average Price (as defined below) of the Company’s Common Stock on each of the ten (10) consecutive Trading Days immediately preceding the date in question). 

B = the Exercise Price. 
 As used
herein, the “Volume Weighted Average Price” for any security as of any date means the volume weighted average sale price on the NasdaqGS as reported by, or based upon data reported by, Bloomberg Financial Markets or an equivalent,
reliable reporting service mutually acceptable to and hereafter designated by the Holder and the Company (“Bloomberg”), or, if the NasdaqGS is not the principal trading market for such security, the volume weighted average sale
price of such security on the principal securities exchange or trading market where such security is listed or traded as reported by Bloomberg, or, if no volume weighted average sale price is reported for such security, then the last closing trade
price of such security as reported by Bloomberg, or, if no last closing trade price is reported for such security by Bloomberg, the average of the bid prices of any market makers for such security on the OTC Bulletin Board, the OTCQX Market, the
OTCQB Market or the “pink” market of OTC Markets Group. If the Volume Weighted Average Price cannot be calculated for such security on such date in the manner provided above, the Volume Weighted Average Price shall be the fair market value
as determined by the Company and the Holder. In the event that a Stock Event [Term is not defined. Do you want to reference the term as used in the Note?] is consummated during any period for which the arithmetic average of the Volume Weighted
Average Prices is to be determined (under this Section or otherwise), the 
  

	9 	 To be equal to the closing bid price on the trading day prior to signing.

  
 10 

 
Volume Weighted Average Price for all Trading Days during such period prior to the effectiveness of the Stock Event shall be appropriately adjusted to reflect such Stock Event. 

(iii) Note Exchange Exercise: In lieu of paying all or any portion of the Exercise Price in cash, Holder, at its option, may exercise this Warrant (in
whole or in part) through a reduction of an amount of principal outstanding under any First Out Waterfall Notes in accordance with Section 2.3(b) of the Facility Agreement, then held by Holder (a “Note Exchange Exercise”) 

For purposes of Rule 144 and subsection (d)(3)(ii) thereof, it is intended, understood and acknowledged that (x) this Warrant shall be deemed to have
been acquired on April 3, 2017 (the date the First Out Waterfall Notes were originally issued), and (y) the shares of Common Stock issuable upon Exercise of this Warrant in a Cashless Exercise (including a Cashless Major Exercise or
Cashless Default Exercise) transaction or a Note Exchange Exercise transaction shall be deemed to have been acquired on April 3, 2017. Accordingly, (A) upon any such Exercise, the Rule 144 holding period for the shares of Common Stock
issued thereupon shall be in excess of one (1) year, and (B) provided that Holder is not an “affiliate” (as defined in Rule 144 under the Securities Act) of the Company on the date of such Exercise (which the Company shall assume
unless advised otherwise in writing by Holder), an Unrestricted Condition shall be satisfied with respect to the shares of Common Stock issued thereupon and such shares will be freely transferable, without restriction or limitation (including any
volume limitation or current public information requirement) under Federal or state securities laws, pursuant to Rule 144 under the Securities Act, and will not contain or be subject to a legend or stop transfer order restricting the resale or
transferability of thereof. 
 As provided in Section 2(b), Holder shall only be required to physically surrender this Warrant in the event that Holder
is exercising this Warrant in full. 
 (b) Cashless Major Exercise. To the extent Holder shall exercise this Warrant as a Cashless Major Exercise
pursuant to Section 5(b)(i) and 5(b)(iii) below, Holder shall send to the Company (in any manner permitted under Section 2(a)) the Exercise Form indicating that Holder is exercising this Warrant (or any portion thereof) pursuant to a
Cashless Major Exercise, in which event the Company shall issue a number of shares of Common Stock equal to the Black-Scholes Value of the Warrant (or such applicable portion being exercised) divided by the closing price of the Common Stock on the
principal securities exchange or other securities market on which the Common Stock is then traded on the Trading Day immediately preceding the date on which the applicable Major Transaction is consummated, or, if in respect of a Cashless Major
Exercise made after the date of consummation of the applicable Major Transaction, on the Trading Day immediately preceding the date on which the exercise form in respect of such Cashless Major Exercise is delivered. As provided in Section 2(b),
Holder shall only be required to physically surrender this Warrant in the event that Holder is exercising this Warrant in full. Holder shall be permitted to make successive Cashless Major Exercises and send successive Exercise Forms in respect of a
Cashless Major Exercise from time to time at any time during the Cashless Major Exercise Period. 
 (c) Cashless Default Exercise. To the extent
Holder exercises this Warrant as a Cashless Default Exercise pursuant to Section 11(b)(i) below, Holder shall send to the Company (in any manner permitted under Section 2(a)) the Exercise Form indicating that Holder is exercising this
Warrant pursuant to a Cashless Default Exercise, in which event the Company shall issue to Holder, within five (5) Trading Days of the applicable Default Notice, a number of shares of Common Stock (which shares shall be valued at the closing
price of the Common Stock on the principal securities exchange or other securities market on which the Common Stock is then traded on the Trading Day immediately preceding the date on which the Exercise Form in respect of such Cashless Default
Exercise is delivered) equal to the Black-Scholes Value of the remaining unexercised portion of this Warrant (or such portion thereof subject to such exercise) as of the date of such Default Notice (or in the case of an Event of Default referred to
in Section 11(a)(vi), on the Trading Day immediately preceding the date the dividend or distribution is declared or, if not first declared, 

  
 11 

 
is paid). As provided in Section 2(b), the Holder shall be permitted to make successive Cashless Default Exercises and send successive Exercise Forms in respect of a Cashless Default
Exercise, from time to time at any time from and after the date of the applicable Default Notice through the Exercise Period of this Warrant. 
 (b)
Dispute Resolution. In the case of a dispute as to the determination of the closing price or the Volume Weighted Average Price of the Company’s Common Stock or the arithmetic calculation of the Exercise Price, Market Price or the Successor
Major Transaction Consideration, or the number of shares issuable upon a Cashless Major Exercise, the Company shall submit the disputed determinations or arithmetic calculations via electronic mail within two (2) Business Days of receipt, or
deemed receipt, of the Exercise Form or Major Transaction Early Termination Notice, or other event giving rise to such dispute, as the case may be, to Holder. If Holder and the Company are unable to agree upon such determination or calculation
within two (2) Business Days of such disputed determination or arithmetic calculation being submitted to Holder, then the Company shall, within two (2) Business Days submit via electronic mail (i) the disputed determination of the
closing price or the Volume Weighted Average Price of the Company’s Common Stock to an independent, reputable investment bank selected by the Company and approved by Holder, which approval shall not be unreasonably withheld, or (ii) the
disputed arithmetic calculation of the Exercise Price, Market Price, any Successor Major Transaction Consideration or number of shares issuable upon a Cashless Major Exercise to the Company’s independent, outside registered public accountants.
The Company shall use its reasonable best efforts to cause the investment bank or the accountants, as the case may be, to perform the determinations or calculations and notify the Company and Holder of the results no later than five (5) Trading
Days from the time it receives the disputed determinations or calculations. Such investment bank’s or accountants’ determination or calculation, as the case may be, shall be binding upon all parties absent demonstrable error, and the
Company and Holder shall each pay one half of the fees and costs of such investment banker or accountant. Notwithstanding the existence of a dispute contemplated by this paragraph, if requested by Holder, the Company shall issue to Holder the
Exercise Shares not in dispute in accordance with the terms hereof. 
 21. Transfer and Registration. 

(a) Transfer Rights. Subject to the provisions of Section 8 of this Warrant, this Warrant may be transferred on the books of the Company, in whole
or in part, in person or by attorney, upon surrender of this Warrant properly completed and endorsed. This Warrant shall be canceled upon such surrender and, as soon as practicable thereafter, the person to whom such transfer is made shall be
entitled to receive a new Warrant or Warrants as to the portion of this Warrant transferred, and Holder shall be entitled to receive a new Warrant as to the portion hereof retained. 

(b) Registrable Securities. The Common Stock issuable upon the Exercise of this Warrant entitles Holder (and applicable assignees or transferees of such
Common Stock) to registration and other rights pursuant to the Registration Rights Agreement. 
 22. Adjustments Upon Certain Events. 

(a) Recapitalization or Reclassification. If the Company shall at any time effect a stock split, payment of stock dividend, recapitalization,
reclassification or other similar transaction of such character that the shares of Common Stock shall be changed into or become exchangeable for a larger or smaller number of shares, then upon the effective date thereof, the number of shares of
Common Stock which Holder shall be entitled to purchase upon Exercise of this Warrant, shall be increased or decreased, as the case may be, in direct proportion to the increase or decrease in the number of shares of Common Stock by reason of such
stock split, payment of stock dividend, recapitalization, reclassification or similar transaction, and the Exercise Price shall be, in the case of an increase in the number of shares, proportionally decreased and, in the case of

  
 12 

 
decrease in the number of shares, proportionally increased. The Company shall give Holder the same notice it provides to holders of Common Stock of any transaction described in this
Section 5(a). 
 (b) Rights Upon Major Transaction. 

(i) Major Transaction. In the event that a Major Transaction occurs, then (1) in the case of a Successor Major Transaction, Holder, at its option,
may elect to cause the conversion of this Warrant (a “Successor Major Transaction Conversion”), in whole or in part, into the right to receive the Successor Major Transaction Consideration, upon consummation of the Major Transaction, and
(2) in the case of all other Major Transactions, Holder shall have the right to exercise this Warrant (or any portion thereof), at any time and from time to time following the occurrence of such event, as a Cashless Major Exercise. In the event
Holder shall not have exercised any of its rights under clauses (1) or (2) above within the applicable time periods set forth herein, then the Major Transaction shall be treated as an Assumption (as defined below) in accordance with
Section 5(b)(ii) below unless Holder waives its rights under this Section 5(b) with respect to such Major Transaction. Each of the following events shall constitute a “Major Transaction”: 

(A) a consolidation, merger, exchange of shares, recapitalization, reorganization, business combination or other similar event,
(1) following which the holders of Common Stock immediately preceding such consolidation, merger, exchange, recapitalization, reorganization, combination or event either (a) no longer hold a majority of the shares of Common Stock or
(b) no longer have the ability to elect a majority of the board of directors of the Company or (2) as a result of which shares of Common Stock shall be changed into (or the shares of Common Stock become entitled to receive) the same or a
different number of shares of the same or another class or classes of stock or securities of the Company or another entity (collectively, a “Change of Control Transaction”); 

(B) the sale or transfer, in one transaction or a series of related transactions, of (I) all or substantially all of the assets of the
Company (including, for the avoidance of doubt, all or substantially all of the assets of the Company and its Subsidiaries, taken as a whole) to any Person other than a wholly-owned subsidiary of the Company or (II) assets of the Company
(including, for the avoidance of doubt, all or substantially all of the assets of the Company and its Subsidiaries, taken as a whole) for a purchase price equal to more than 50% of the Equity Value (as defined below) of the Company. For purposes of
this clause (B), “Equity Value” shall mean (I) the product of (x) the number of issued and outstanding shares of Common Stock on the date the Company delivers the Major Transaction Notice (defined below) multiplied by
(y) the per share closing price of the Common Stock on such date on the NasdaqGS as reported by, or based upon data reported by, Bloomberg or, if the NasdaqGS is not the principal trading market for such security, the closing sale price of such
security on the principal securities exchange or trading market where such security is listed or traded as reported by Bloomberg; 
 (C) a
purchase, tender or exchange offer made to the holders of outstanding shares of Common Stock, such that following such purchase, tender or exchange offer a Change of Control Transaction shall have occurred; 

(D) the liquidation, bankruptcy, insolvency, dissolution or winding-up (or the occurrence of any
analogous proceeding) affecting the Company; 

  
 13 

 (E) the shares of Common Stock cease to be listed, traded or publicly quoted on the
NasdaqGS and are not promptly re-listed or requoted on the New York Stock Exchange, the NYSE American, the NASDAQ Global Market or the NASDAQ Capital Market; or 

(F) the Common Stock ceases to be registered under Section 12 of the Exchange Act. 

(ii) Assumption. Any assumption of Company obligations under this paragraph shall be referred to herein as an “Assumption.” Unless otherwise
provided in writing by Holder, the Company shall not consummate a Major Transaction in which the Company is not the surviving entity or as a result of which the Company has a new Parent Entity, unless (A) each Person acquiring the
Company’s assets or Common Stock (or Parent Entity thereof, as applicable), or any other successor entity resulting from such Major Transaction (in each case, a “Successor Entity”), assumes in writing all of the obligations of the
Company under this Warrant, the Facility Agreement (but, other than with respect to the Company’s obligations pursuant to Section 5.1(e) and 5.1(p) of the Facility Agreement and the other provisions of the Facility Agreement that expressly
survive the repayment of the Loans (which shall be assumed in any Assumption), only if there are outstanding Loans under the Facility Agreement immediately following the consummation of the Major Transaction) and the Registration Rights Agreement in
accordance with the provisions of this Section 5(b)(ii) pursuant to written agreements in form and substance reasonably satisfactory to Holder and approved by Holder prior to the consummation of such Major Transaction (such approval not to be
unreasonably withheld or delayed), including agreements to deliver to Holder in exchange for its Warrants a security of the Successor Entity evidenced by a written instrument substantially similar in form and substance to the Warrants, that, among
other things, (1) is exercisable for the appropriate number of shares of the Successor Entity’s capital stock (without regard to the 4.985% Cap or any other restriction or limitation on exercise, provided that such instrument shall contain
a limitation on exercise comparable to that contained in the second paragraph of Section 1 of this Warrant); (2) has an exercise price similar to the then-effective Exercise Price (taking into account any conversion or exchange ratio applicable
to the Common Stock in the Major Transaction) and exercise price adjustment provisions similar to those in the Warrants; (3) entitles Holder to such additional securities or other consideration as Holder would be entitled pursuant to
Section 5(b)(i) in connection with the Major Transaction; and (4) provides for registration rights similar to those provided by the Registration Rights Agreement, in each case reasonably satisfactory to Holder, and (B) the Successor
Entity (including its Parent Entity) is a publicly traded corporation whose common stock is quoted on or listed for trading on an Eligible Market. For the avoidance of doubt, Holder’s reasonable satisfaction referred to in the immediately
preceding sentence shall be construed only to apply to confirmation that the warrant or other comparable security and registration rights agreement delivered to Holder upon an assumption hereunder shall conform to the requirements of this
Section 5(b)(ii), and this Section 5(b)(ii) shall not be construed as granting consent or approval rights to Holder with respect to the terms of such Major Transaction or to permit Holder to demand any additional consideration in respect
of this Warrant other than as provided herein. Upon the occurrence of any Major Transaction, any Successor Entity shall succeed to, and be substituted for (so that from and after the date of such Major Transaction, the provisions of this Warrant and
the Registration Rights Agreement referring to the “Company” shall refer instead to the Successor Entity), and may exercise every right and power of the Company and shall assume all of the obligations of the Company under this Warrant with
the same effect as if such Successor Entity had been named as the Company herein. Upon consummation of the Major Transaction, the Successor Entity shall deliver to Holder confirmation that there shall be issued upon exercise of this Warrant at any
time after the consummation of the Major Transaction, in lieu of the shares of Common Stock (or other securities, cash, assets or other property) issuable upon the exercise of the Warrants prior to such Major Transaction, such shares of publicly
traded common stock (or their equivalent) of the Successor Entity, as adjusted in accordance with the provisions of this Warrant. The provisions of this Section shall apply 

  
 14 

 
similarly and equally to successive Major Transactions and shall be applied without regard to any limitations on the exercise of this Warrant other than any applicable beneficial ownership
limitations. 
 (iii) Major Transaction Notice; Major Transaction Early Termination Right; Notice of Cashless Major Exercise. At least thirty
(30) days prior to the consummation of any Major Transaction, but, in any event, within five (5) Trading Days following the first to occur of (x) the date of the public announcement of such Major Transaction if such announcement is
made before 4:00 p.m., New York City time, or (y) the day following the public announcement of such Major Transaction if such announcement is made on and after 4:00 p.m., New York City time, the Company shall deliver written notice thereof via
electronic mail and overnight courier to Holder (a “Major Transaction Notice”). At any time during the period beginning after Holder’s receipt of a Major Transaction Notice in respect of a Successor Major Transaction and ending five
(5) Trading Days prior to the consummation of such Major Transaction (the “Early Termination Period”), Holder may elect a Successor Major Transaction Conversion by delivering written notice thereof (“Major Transaction Early
Termination Notice”) to the Company, which Major Transaction Early Termination Notice shall indicate the portion of the Warrant (with reference to the number of shares of Common Stock issuable upon a Cash Exercise of such portion, without
regard to the 4.985% Cap) that Holder is electing to be treated as a Successor Major Transaction Conversion. The portion of this Warrant subject to early termination pursuant to this Section 5(b)(iii), shall be converted into the right to
receive the Successor Major Transaction Consideration 
 To the extent Holder shall elect to effect a Cashless Major Exercise in respect of a Major
Transaction, Holder shall deliver its Exercise Form in accordance with Section 3(b), at any time and from time to time following receipt by Holder of the Major Transaction Notice until the later of (x) the last day of the Exercise Period
and (y) the one-year anniversary of the applicable Major Transaction (the “Cashless Major Exercise Period”). For the avoidance of doubt, Holder shall be permitted to make successive Cashless
Major Exercises and send successive Exercise Forms in respect of a Cashless Major Exercise from time to time at any time during the Cashless Major Exercise Period. 

(iv) Escrow; Payment of Successor Major Transaction Consideration. Following the receipt of a Major Transaction Early Termination Notice in respect of a
Successor Major Transaction from Holder, the Company shall not effect a Successor Major Transaction with respect to which Holder has elected a Successor Major Transaction Conversion unless either (A) it obtains, as a condition precedent to such
Major Transaction, the written agreement of the Successor Entity that payment of the Successor Major Transaction Consideration shall be made to Holder concurrently with consummation of such Successor Major Transaction, or (B) it shall place the
Successor Major Transaction Consideration into an escrow account with an independent escrow agent, and shall instruct the escrow agent to deliver the Successor Major Transaction Consideration to Holder, concurrently with the consummation of the
Major Transaction. Notwithstanding clauses (A) and (B) above, Holder shall be treated on a pari passu basis with, and shall not have priority to payments to, the holders of Common Stock in connection with a Major Transaction. For
purposes of determining the amount required to be placed in escrow pursuant to the provisions of this subsection (iv) and without affecting the amount of the actual Successor Major Transaction Consideration, the calculation of the price
referred to in clause (1) of the first column of Schedule 1 hereto with respect to Stock Price shall be determined based on the Closing Market Price (as defined on Schedule 1) of the Common Stock on the Trading Day immediately preceding
the date that the Successor Major Transaction Consideration is deposited with the escrow agent. 
 (v) Injunction. Following the receipt of a Major
Transaction Early Termination Notice from Holder, in the event that the Company attempts to consummate a Successor Major Transaction without either (1) placing the Successor Major Transaction Consideration in escrow in accordance with
subsection (iv) above, or (2) obtaining the written agreement of the Successor Entity as described in subsection (iv) above, Holder shall have the right to apply for an injunction in any state or federal court sitting in the City of
New York, 

  
 15 

 
borough of Manhattan to prevent the closing of such Major Transaction until the Successor Major Transaction Consideration is delivered to Holder. 

An early termination required by this Section 5(b) shall be made in accordance with the provisions of Section 12. To the extent an early termination
required by this Section 5(b) is deemed or determined by a court of competent jurisdiction to be prepayments of the Warrant by the Company, such early termination shall be deemed to be voluntary prepayments. Notwithstanding anything to the
contrary in this Section 5, until the Successor Major Transaction Consideration is paid in full, this Warrant may be exercised, in whole or in part, by Holder into shares of Common Stock, or in the event the date of any Exercise is after the
consummation of the Major Transaction, shares of publicly traded common stock (or their equivalent) of the Successor Entity pursuant to Section 5(b). The parties hereto agree that in the event of the Company’s early termination of any
portion of the Warrant under this Section 5(b), Holder’s damages would be uncertain and difficult to estimate because of the parties’ inability to predict future interest rates and the uncertainty of the availability of a suitable
substitute investment opportunity for Holder. Accordingly, any premium due under this Section 5(b) is intended by the parties to be, and shall be deemed, a commercially reasonable estimate of Holder’s actual loss of its investment
opportunity and not as a penalty. 
 (c) Exercise Price Adjusted. As used in this Warrant, the term “Exercise Price” shall mean the purchase
price per share specified in Section 3(a) of this Warrant, until the occurrence of an event stated in this Section 5 or otherwise set forth in this Warrant, and thereafter shall mean said price as adjusted from time to time in accordance
with the provisions of said subsection. No adjustment made pursuant to any provision of this Section 5 shall have the net effect of increasing the aggregate Exercise Price payable hereunder or, except as expressly provided in Section 5(a),
otherwise increasing the Exercise Price. 
 (d) Adjustments: Additional Shares, Securities or Assets. In the event that at any time, as a result of an
adjustment made pursuant to this Section 5 or otherwise, Holder shall, upon Exercise of this Warrant, become entitled to receive shares and/or other securities or assets (other than Common Stock) then, wherever appropriate, all references
herein to shares of Common Stock shall be deemed to refer to and include such shares and/or other securities or assets; and thereafter the number of such shares and/or other securities or assets shall be subject to adjustment from time to time in a
manner and upon terms as nearly equivalent as practicable to the provisions of this Section 5. 
 (e) Notice of Adjustments. Whenever the
Exercise Price and/or number or type of securities issuable upon Exercise is adjusted pursuant to the terms of this Warrant, the Company shall promptly mail to Holder a notice (an “Exercise Price Adjustment Notice”) setting forth the
Exercise Price and/or number or type of securities issuable upon Exercise after such adjustment and setting forth a statement of the facts requiring such adjustment. The Company shall, upon the written request at any time of Holder, furnish to
Holder a like Warrant setting forth (i) such adjustment or readjustment, (ii) the Exercise Price at the time in effect and (iii) the number of shares of Common Stock and the amount, if any, of other securities or property which at the
time would be received upon Exercise of the Warrant. For purposes of clarification, whether or not the Company provides an Exercise Price Adjustment Notice pursuant to this Section 5(e), upon the occurrence of any event that leads to an
adjustment of the Exercise Price, Holder would be entitled to receive a number of Exercise Shares based upon the new Exercise Price, as adjusted, for exercises occurring on or after the date of such adjustment, regardless of whether Holder
accurately refers to the adjusted Exercise Price in the Exercise Form. 
 23. Fractional Interests. 

No fractional shares or scrip representing fractional shares shall be issuable upon the Exercise of this Warrant, but on Exercise of this Warrant, Holder may
purchase only a whole number of shares of Common Stock. If, on Exercise of this Warrant, Holder would be entitled to a fractional share of Common Stock or a 

  
 16 

 
right to acquire a fractional share of Common Stock, such fractional share shall be disregarded and the number of shares of Common Stock issuable upon Exercise shall be the next higher whole
number of shares. 
 24. Reservation of Shares. 
 From
and after the date hereof, the Company shall at all times reserve for issuance such number of authorized and unissued shares of Common Stock (or other securities substituted therefor as herein above provided) as shall be sufficient for the Exercise
of this Warrant and payment of the Exercise Price. If at any time the number of shares of Common Stock authorized and reserved for issuance is below the number of shares sufficient for the Exercise of this Warrant (a “Share Authorization
Failure”) (based on the Exercise Price in effect from time to time), the Company will promptly take all corporate action necessary to authorize and reserve a sufficient number of shares, including calling a special meeting of stockholders to
authorize additional shares to meet the Company’s obligations under this Section 7, in the case of an insufficient number of authorized shares, and using its best efforts to obtain stockholder approval of an increase in such authorized
number of shares. The Company covenants and agrees that upon the Exercise of this Warrant, all shares of Common Stock issuable upon such Exercise shall be duly and validly issued, fully paid and nonassessable and not subject to preemptive rights,
rights of first refusal or similar rights of any Person. The Company covenants and agrees that all shares of Common Stock issuable upon Exercise of this Warrant shall be approved for listing on the NasdaqGS, or, if the NasdaqGS is not the principal
trading market for the Common Stock, such principal market on which the Common Stock is traded or listed. 
 25. Restrictions on Transfer. 

(a) Registration or Exemption Required. This Warrant has been issued in a transaction exempt from the registration requirements of the Securities Act by
virtue of Section 4(a)(2) of the Securities Act and Rule 506 thereunder and exempt from registration or qualification under applicable state securities (or “blue sky”) laws. None of the Warrant, the Exercise Shares or Failure Payment
Shares may be pledged, transferred, sold or assigned except pursuant to an effective registration statement or an exemption to the registration requirements of the Securities Act and applicable state laws, including Rule 144 under the Securities
Act, Section 4(a)(7) of the Securities Act or a so-called “4[(a)](1) and a half” transaction. 

(b) Assignment. Subject to Section 8(a), Holder may sell, transfer, assign, pledge, or otherwise dispose of this Warrant, in whole or in part.
Holder shall deliver a written notice to the Company, substantially in the form of the Assignment attached hereto as Exhibit B, indicating the Person or Persons to whom the Warrant shall be assigned and the respective
number of warrants to be assigned to each assignee. The Company shall effect the assignment within three (3) Business Days of its receipt of a completed and executed form of Assignment (the “Transfer Delivery Period”), and shall
deliver to the assignee(s) designated by Holder a Warrant or Warrants of like tenor and terms entitling Holder to purchase the appropriate number of shares. This Warrant and the rights evidenced hereby shall inure to the benefit of and be binding
upon the successors and assigns of Holder. The provisions of this Warrant are intended to be for the benefit of all Holders from time to time of this Warrant, and shall be enforceable by any such Holder. For avoidance of doubt, in the event Holder
notifies the Company that such sale or transfer is a so called “4[(a)](1) and half” transaction, the parties hereto agree that a legal opinion from outside counsel for Holder delivered to counsel for the Company substantially in the form
attached hereto as Exhibit C shall be the only requirement to satisfy an exemption from registration under the Securities Act to effectuate such “4[(a)](1) and half” transaction. 

  
 17 

 26. Noncircumvention. 

The Company hereby covenants and agrees that the Company will not, by amendment of its certificate of incorporation, bylaws or through any reorganization,
transfer of assets, consolidation, merger, scheme of arrangement, dissolution, issue or sale of securities, or any other voluntary action, avoid or seek to avoid the observance or performance of any of the terms of this Warrant, and will at all
times in good faith carry out all the provisions of this Warrant and take all action as may be required to protect the rights of Holder. Without limiting the generality of the foregoing, the Company (i) shall not increase the par value of any
shares of Common Stock receivable upon the exercise of this Warrant above the Exercise Price then in effect, and (ii) shall take all such actions as may be necessary or appropriate in order that the Company may validly and legally issue fully
paid and nonassessable shares of Common Stock upon the exercise of this Warrant. 
 27. Events of Failure; Definition of Black Scholes Value. 

(a) Definition. 
 The occurrence of each of the following
shall be considered to be an “Event of Failure.” 
 (i) A Delivery Failure occurs, where a “Delivery Failure” shall be
deemed to have occurred if the Company fails to use its best efforts to deliver Exercise Shares to Holder within any applicable Delivery Period (other than due to the limitation contained in the second paragraph of Section 1); 

(ii) A Legend Removal Failure occurs, where a “Legend Removal Failure” shall be deemed to have occurred if the Company fails to use
its best efforts to issue this Warrant and/or Exercise Shares without a restrictive legend, or fails to use it best efforts to remove a restrictive legend, when and as required under Section 2(e) hereof; 

(iii) a Transfer Delivery Failure occurs, where a “Transfer Delivery Failure” shall be deemed to have occurred if the Company fails
to use its best efforts to deliver a Warrant within any applicable Transfer Delivery Period; and 
 (iv) a Registration Failure (as defined
below). 
 For purpose hereof, “Registration Failure” means that (A) the Company fails to file with the SEC on or before the Additional
Warrant Filing Deadline (as defined in the Registration Rights Agreement) any Registration Statement required to be filed pursuant to Section 2(a) of the Registration Rights Agreement, (B) the Company fails to use its reasonable best
efforts to obtain effectiveness with the SEC, prior to the Additional Warrant Registration Deadline (as defined in the Registration Rights Agreement), and if such Registration Statement does not become effective prior to the Additional Warrant
Registration Deadline, as soon as possible thereafter, of any Registration Statement (as defined in the Registration Rights Agreement) that is required to be filed pursuant to Section 2(a) of the Registration Rights Agreement, or fails to use
its reasonable best efforts to keep such Registration Statement current and effective as required in Section 3 of the Registration Rights Agreement, (C) the Company fails to file any additional Registration Statement required to be filed
pursuant to Section 2(a)(ii) of the Registration Rights Agreement on or before the Additional Filing Deadline (as defined in the Registration Rights Agreement) or fails to use its reasonable best efforts to cause such new Registration Statement
to become effective on or before the Additional Registration Deadline (as defined in the Registration Rights Agreement), and if such effectiveness does not occur within such period, as soon as possible thereafter, (D) the Company fails to file
any amendment to any Registration Statement, or any additional Registration Statement required to be filed pursuant to Section 3(b) of the Registration Rights Agreement within thirty (30) days of the applicable Registration Trigger Date
(as defined in the Registration Rights Agreement), or fails to use its reasonable best efforts to cause such amendment and/or new Registration Statement to become effective within ninety (90) days of the applicable Registration Trigger Date,
and, if such effectiveness does not occur within such period, as 

  
 18 

 
soon as possible thereafter, (E) any Registration Statement required to be filed under the Registration Rights Agreement, after its initial effectiveness and during the applicable
Registration Period (as defined in the Registration Rights Agreement), lapses in effect or, other than on a day during an Allowable Grace Period (as defined in the Registration Rights Agreement), sales of all of the Registrable Securities (as
defined in the Registration Rights Agreement) cannot otherwise be made thereunder (whether by reason of the Company’s failure to amend or supplement the prospectus included therein in accordance with the Registration Rights Agreement, the
Company’s failure to file and use its reasonable best efforts to obtain effectiveness with the SEC of an additional Registration Statement or amended Registration Statement required pursuant to Section 2(a)(ii) or 3(b) of the Registration
Rights Agreement, as applicable, or otherwise), or (F) the Company fails to provide a commercially reasonable written response to any comments to any Registration Statement submitted by the SEC within twenty-five (25) days of the date that
such SEC comments are received by the Company. 
 (b) Failure Payments; Black-Scholes Determination. The Company understands that any Event of Failure
(as defined above) could result in economic loss to Holder. In the event that any Event of Failure occurs, as compensation to Holder for such economic loss, the Company agrees to pay to Holder an amount payable, at the Company’s option, either
(i) in cash or (ii) in shares of Common Stock that are valued for these purposes at the Volume Weighted Average Price on the date of such calculation (“Failure Payments” and such shares, “Failure Payment Shares”), in
each case equal to the total economic loss of Holder determined on a commercially reasonable basis in connection with such Event of Failure for the relevant period (as recalculated on the first Business Day of each month thereafter for as long as
Failure Payments shall continue to accrue) from the date of such Event of Failure until the Event of Failure is cured; provided, however, that in the event the Company elects to make Failure Payments in Failure Payment Shares, the Company shall
issue, and Holder shall only receive, up to such number of shares of Common Stock in respect of Failure Payments such that Holder and any other persons or entities whose beneficial ownership of Common Stock would be aggregated with Holder’s for
purposes of Section 13(d) of the Exchange Act (including shares held by any “group” of which Holder is a member, but excluding shares beneficially owned by virtue of the ownership of securities or rights to acquire securities that
have limitations on the right to convert, exercise or purchase similar to the limitation set forth herein) shall not collectively beneficially own greater than 4.985% of the total number of shares of Common Stock of the Company then issued and
outstanding, and the balance of such Failure Payments shall be paid in cash. For purposes of clarification, it is agreed and understood that Failure Payments shall continue to accrue following any Event of Default until the applicable Default Amount
is paid in full. The Company shall satisfy any Failure Payments under this Section pursuant to Section 10(c) below. Failure Payments are in addition to any Shares that Holder is entitled to receive upon Exercise of this Warrant. 

(c) Payment of Accrued Failure Payments. The Failure Payments and Failure Payment Shares representing accrued Failure Payments for each Event of Failure
shall be paid or issued and delivered, as the case may be, on or before the fifth (5th) Business Day of each month following a month in which Failure Payments accrued. Nothing herein shall limit Holder’s right to pursue actual damages (to
the extent in excess of the Failure Payments) for the Company’s Event of Failure, and Holder shall have the right to pursue all remedies available at law or in equity (including a decree of specific performance and/or injunctive relief).
Notwithstanding the above, if a particular Event of Failure results in an Event of Default pursuant to Section 11 hereof, then the Failure Payment, for that Event of Failure only, shall be considered to have been satisfied upon payment to
Holder of an amount equal to the greater of (i) the Failure Payment, or (ii) the Default Amount, payable in accordance with Section 11. 

(d) Maximum Interest Rate. Nothing contained herein or in any document referred to herein or delivered in connection herewith shall be deemed to
establish or require the payment of a rate of interest or other charges in excess of the maximum permitted by applicable law. In the event that the rate of interest or dividends required to be paid or other charges hereunder exceed the maximum
permitted by such law, any payments 

  
 19 

 
in excess of such maximum shall be credited against amounts owed by the Company to Holder and thereby refunded to the Company. 

28. Default. 
 (a) Events Of Default. Each of the
following events shall be considered to be an “Event of Default,” unless waived by Holder: 
 (i) Failure To Effect Registration. With
respect to all Registration Failures, a Registration Failure occurs and remains uncured for a period of more than forty-five (45) days (or sixty (60) days in the case where the Company (i) has, by the Filing Deadline (as defined the
Registration Rights Agreement) filed a Registration Statement (as defined in the Registration Rights Agreement) covering this Warrant and the number of shares required by the Registration Rights Agreement, and (ii) has responded in writing to
any comments to the Registration Statement that the Company has received from the SEC, within ten (10) Business Days of such receipt, and nevertheless the SEC has not declared effective a Registration Statement covering the this Warrant and the
Shares by the Registration Deadline (as defined in the Registration Rights Agreement)), and such Registration Failure relates solely to the Company’s failure to have the Registration Statement declared effective by the Registration
Deadline (as defined in the Registration Rights Agreement) and with respect to a Registration Failure provided in clause (E) of the definition of “Registration Failure,” such Registration Failure occurs and remains uncured for a
period of more than forty-five (45) days. 
 (ii) Failure To Deliver Common Stock. A Delivery Failure (as defined above) occurs and remains
uncured for a period of more than twenty (20) days; or at any time, the Company announces or states in writing that it will not honor its obligations to issue shares of Common Stock to Holder upon Exercise by Holder of the Exercise rights of
Holder in accordance with the terms of this Warrant. 
 (iii) Legend Removal Failure. A Legend Removal Failure (as defined above) occurs and remains
uncured for a period of twenty (20) days; 
 (iv) Transfer Delivery Failure. A Transfer Delivery Failure (as defined above) occurs and remains
uncured for a period of twenty (20) days; 
 (v) Corporate Existence; Major Transaction. (A) The Company has failed to (1) place the
Successor Major Transaction Consideration into escrow and instruct the escrow agent to release the Successor Major Transaction Consideration to the Holder pursuant to Section 5(b)(iii), or (2) obtain the written agreement of the Successor
Entity and cause the Successor Entity to make payment as described in Section 5(b)(iii), (B) the Successor Major Transaction Consideration is not paid contemporaneously with the consummation of the Successor Major Transaction, or (C) with
respect to a Major Transaction that is to be treated as an Assumption under the terms hereof, the Company has failed to meet the Assumption requirements of Section 5(b)(i); or 

(vi) Section 13 Breach. During the Dividend Restriction Period, the Company declares or pays any dividend or distribution of any kind
to the holders of Common Stock of the Company. 
 (b) Mandatory Early Termination. 

(i) Mandatory Early Termination Amount; Cashless Default Exercise. The Company shall notify Holder in writing within two (2) Business Days of the
occurrence of an Event of Default. If any Events of Default shall occur then, at the option of Holder, such option exercisable through the delivery of written notice to the Company by such Holder (the “Default Notice”), the Company shall
have the right to terminate the outstanding amount of this Warrant and pay to Holder (a “Mandatory Early Termination”), in full 

  
 20 

 
satisfaction of its obligations hereunder by delivery of a notice to such effect to Holder within two (2) Business Days following receipt of the Default Notice, an amount payable in cash
(the “Mandatory Early Termination Amount” or the “Default Amount”) equal to the Black-Scholes Value of the remaining unexercised portion of this Warrant on the date of such Default Notice (or in the case of an Event of Default
referred to in Section 11(a)(vi), on the Trading Day immediately preceding the date the dividend or distribution is declared or, if not first declared, is paid). In the event the Company does not exercise its right to consummate a Mandatory
Early Termination, then Holder shall have the right to exercise this Warrant, at any time and from time to time, pursuant to a Cashless Default Exercise in accordance with Section 3(c) above. 

The Mandatory Early Termination Amount shall be payable within five (5) Business Days following the date of the applicable Default Notice. 

(ii) Liquidated Damages. The parties hereto acknowledge and agree that the sums payable as Failure Payments or pursuant to a Mandatory Early Termination
shall constitute partial liquidated damages and not penalties. The parties further acknowledge that (i) the amount of loss or damages likely to be incurred by Holder is incapable or is difficult to precisely estimate, (ii) the amounts
specified bear a reasonable proportion and are not plainly or grossly disproportionate to the probable loss likely to be incurred by Holder, and (iii) the parties are sophisticated business parties and have been represented by sophisticated and
able legal and financial counsel and negotiated this agreement at arm’s length. 
 Upon the occurrence of an Event of Default, the Default Amount,
together with all other amounts payable hereunder, shall immediately become due and payable, all without demand, presentment or notice, all of which hereby are expressly waived, together with all costs, including legal fees and expenses, of
collection, and Holder shall be entitled to exercise all other rights and remedies available at law or in equity. 
 (c) Posting Of Bond. In the event
that any Event of Default occurs hereunder, the Company may not raise as a legal defense (in any Lawsuit, as defined below, or otherwise) or justification to such Event of Default any claim that such Holder or any one associated or affiliated with
such Holder has been engaged in any violation of law, unless the Company has posted a surety bond (a “Surety Bond”) for the benefit of such Holder in the amount of 130% of the aggregate Surety Bond Value (as defined below) of all of
Holder’s Warrants (the “Bond Amount”), which Surety Bond shall remain in effect until the completion of litigation of the dispute and the proceeds of which shall be payable to such Holder to the extent Holder obtains judgment. 

For purposes hereof, a “Lawsuit” shall mean any lawsuit, arbitration or other dispute resolution filed by either party herein pertaining to any of
this Warrant, the Facility Agreement, the Registration Rights Agreement or any other Loan Document (as defined in the Facility Agreement). 
 “Surety
Bond Value,” for the Warrants shall mean 130% of the of the Black-Scholes Value of the remaining unexercised portion of this Warrant on the Trading Day immediately preceding the date that such bond goes into effect. 

(d) Injunction And Posting Of Bond. In the event that the Event of Default referred to in subsection (a) of this Section 11 pertains to the
Company’s failure to deliver unlegended shares of Common Stock to Holder pursuant to a Warrant Exercise, legend removal request, or otherwise, the Company may not refuse such unlegended share delivery based on any claim that such Holder or any
one associated or affiliated with such Holder has been engaged in any violation of law, unless an injunction from a court, on prior notice to Holder, restraining and or enjoining Exercise of all or part of said Warrant shall have been sought and
obtained by the Company and the Company has posted a Surety Bond for the benefit of such Holder in the amount of the Bond Amount, which Surety Bond shall remain in effect until the completion of litigation of

  
 21 

 
the dispute and the proceeds of which shall be payable to such Holder to the extent Holder obtains judgment. 

(e) Remedies, Other Obligations, Breaches And Injunctive Relief. The remedies provided in this Warrant shall be cumulative and in addition to all other
remedies available under this Warrant, the Facility Agreement, the Registration Rights Agreement and any other Loan Document, at law or in equity (including a decree of specific performance and/or other injunctive relief), and nothing herein shall
limit the right of Holder to pursue actual damages for any failure by the Company to comply with the terms of this Warrant. The Company acknowledges that a breach by it of its obligations hereunder will cause irreparable harm to Holder and that the
remedy at law for any such breach may be inadequate. The Company therefore agrees that, in the event of any such breach or threatened breach (including a breach or threatened breach of Section 13), the holder of this Warrant shall be entitled,
in addition to all other available remedies, to an injunction restraining any breach, without the necessity of showing economic loss and without any bond or other security being required. 

29. Holder’s Early Terminations. 
 (a) Mechanics
of Holder’s Early Terminations. In the event that the Company does not deliver the applicable Successor Major Transaction Consideration or Default Amount or the Exercise Shares in respect of an election of a Successor Major Transaction
Conversion, Cashless Major Exercise, Cashless Default or Exercise, as the case may be, to Holder within the time period or as otherwise required pursuant to the terms hereof, at any time thereafter Holder shall have the option, upon notice to the
Company, in lieu of an election of a Successor Major Transaction Conversion, Cashless Major Exercise, Cashless Default Exercise or Exercise, as the case may be, to require the Company to promptly return to Holder all or any portion of this Warrant
that was submitted for election of a Successor Major Transaction Conversion, Cashless Major Exercise, Cashless Default Exercise or Exercise, as the case may be. Upon the Company’s receipt of such notice, (x) the applicable election of
Successor Major Transaction Conversion, Cashless Major Exercise, Cashless Default Exercise or Exercise, as the case may be, shall be null and void with respect to such applicable portion of this Warrant, (y) the Company shall immediately return
this Warrant, or issue a new Warrant to Holder representing the portion of this Warrant that was submitted for election of Successor Major Transaction Conversion, Cashless Major Exercise, Cashless Default Exercise or Exercise, as the case may be,
and (z) the Exercise Price of this Warrant or such new Warrant shall be adjusted to the Exercise Price as in effect on the date on which the applicable election of Successor Major Transaction Conversion, Cashless Major Exercise, Cashless
Default Exercise or Exercise, as the case may be, is voided. Holder’s delivery of a notice voiding an election of a Successor Major Transaction Conversion, Cashless Major Exercise, Cashless Default Exercise or Exercise, as the case may be, and
exercise of its rights following such notice shall not affect the Company’s obligations to make any Failure Payments which have accrued prior to the date of such notice with respect to the Warrant subject to such notice. 

30. Dividend Restrictions. 
 Until the earlier of the
expiration of the Exercise Period and the date all of the Warrants are exercised in full (the “Dividend Restriction Period”), the Company shall not declare or pay any dividend or distribution of any kind to the holders of Common Stock of
the Company. 
 31. Benefits of this Warrant. 
 Nothing
in this Warrant shall be construed to confer upon any person other than the Company and Holder any legal or equitable right, remedy or claim under this Warrant and this Warrant shall be for the sole and exclusive benefit of the Company and Holder.

  
 22 

 32. Governing Law. 

All questions concerning the construction, validity, enforcement and interpretation of this Agreement shall be governed by and construed and enforced in
accordance with the internal laws of the State of New York, without regard to the principles of conflicts of law thereof. Each party agrees that all legal proceedings concerning the interpretations, enforcement and defense of the transactions
contemplated by this Agreement (whether brought against a party hereto or its respective affiliates, directors, officers, stockholders, employees or agents) shall be commenced exclusively in the state and federal courts sitting in the City of New
York, borough of Manhattan. Each party hereby irrevocably submits to the exclusive jurisdiction of the state and federal courts sitting in the City of New York, borough of Manhattan for the adjudication of any dispute hereunder or in connection
herewith or with any transaction contemplated hereby or discussed herein, and hereby irrevocably waives, and agrees not to assert in any suit, action or proceeding, any claim that it is not personally subject to the jurisdiction of any such court,
that such suit, action or proceeding is improper or is an inconvenient venue for such proceeding. Each party hereby irrevocably waives personal service of process and consents to process being served in any such suit, action or proceeding by mailing
a copy thereof via registered or certified mail or overnight delivery (with evidence of delivery) to such party at the address in effect for notices to it under this Agreement and agrees that such service shall constitute good and sufficient service
of process and notice thereof. Nothing contained herein shall be deemed to limit in any way any right to serve process in any other manner permitted by law. The parties hereby waive all rights to a trial by jury. If either party shall commence an
action or proceeding to enforce any provisions of this Agreement, then the prevailing party in such action or proceeding shall be reimbursed by the other party for its reasonable attorneys’ fees and other costs and expenses incurred with the
investigation, preparation and prosecution of such action or proceeding. 
 33. Loss of Warrant. 

Upon receipt by the Company of evidence of the loss, theft, destruction or mutilation of this Warrant, and (in the case of loss, theft or destruction) of
indemnity or security reasonably satisfactory to the Company, and upon surrender and cancellation of this Warrant, if mutilated, the Company shall execute and deliver a new Warrant of like tenor and date. 

34. Notice or Demands. 
 Except as otherwise provided
herein, notices or demands pursuant to this Warrant to be given or made by Holder to or on the Company shall be sufficiently given or made if sent by overnight delivery with a nationally recognized overnight courier service, certified or registered
mail, return receipt requested, postage prepaid, and addressed, until another address is designated in writing by the Company, to the address set forth in Section 2(a) above. To the extent any notice or demand pursuant to this Warrant can be
made by electronic mail, such notice or demand given or made by Holder to or on the Company shall be sufficiently given or made if it is sent by electronic mail to the addresses that the Company shall designate in writing from time to time. Notices
or demands pursuant to this Warrant to be given or made by the Company to or on Holder shall be sufficiently given or made if sent by overnight delivery with a nationally recognized overnight courier service or certified or registered mail, return
receipt requested, postage prepaid, and addressed, to the address of Holder set forth in the Company’s records, until another address is designated in writing by Holder. 

18. Construction. 
 Unless the context otherwise requires,
(a) all references to Articles, Sections, Schedules or Exhibits are to Articles, Sections, Schedules or Exhibits contained in or attached to this Warrant, (b) words in the singular or plural include the singular and plural and pronouns
stated in either the masculine, the feminine or neuter 

  
 23 

 
gender shall include the masculine, feminine and neuter and (c) the use of the word “including” in this Warrant shall be by way of example rather than limitation. 

19. Signatures. 
 In the event that any signature to this
Warrant or any amendment hereto is delivered by electronic mail delivery of a “.pdf” format data file, such signature shall create a valid and binding obligation of the party executing (or on whose behalf such signature is executed) with
the same force and effect as if such “.pdf” signature page were an original thereof. Notwithstanding the foregoing, the Company shall be obligated to deliver to Holder an original signature to this Warrant. At the request of any party,
each other party shall promptly re-execute an original form of this Warrant or any amendment hereto and deliver the same to the other party. No party hereto shall raise the use of electronic mail delivery of a
“.pdf” format data file to deliver a signature to this Warrant or any amendment hereto or the fact that such signature was transmitted or communicated through the use of electronic mail delivery of a “.pdf” format data file as a
defense to the formation or enforceability of a contract, and each party hereto forever waives any such defense. 

  
 24 

 IN WITNESS WHEREOF, the undersigned has executed this Warrant as of the
         day of             , 20    . 

 

			
	ENDOLOGIX, INC.
		
	By:	 	 
		 	 Print Name:
 Title:

  
 25 

 EXHIBIT A-1 

EXERCISE FORM FOR WARRANT 
 TO:
[                     ] 
 CHECK THE APPLICABLE BOX:

  

			
		
	☐    	  	 Cash Exercise, Cashless Exercise or Note Exchange Exercise

 
 The undersigned hereby irrevocably exercises Warrant Number
         (the “Warrant”) with respect to [            ] shares of Common Stock (the “Common Stock”) of Endologix, Inc., a
Delaware corporation (the “Company”). [IF APPLICABLE: The undersigned hereby encloses $         as payment of the Exercise Price.]

 
 ☐ The undersigned is exercising the Warrant with respect to
[            ] shares of Common Stock pursuant to a Cashless Exercise, and hereby makes payment of the Exercise Price with respect to such shares in full, all in accordance with the
conditions and provisions of the Warrant applicable to such Cashless Exercise.
  

☐ The undersigned is exercising the Warrant with respect to [            ] shares of Common
Stock pursuant to a Note Exchange Exercise. The undersigned hereby agrees to cancel $         of principal outstanding under Notes of the Company held by Holder in satisfaction of the Exercise Price in
accordance with the conditions and provisions of the Warrant applicable to such Note Exchange Exercise.

		
	☐    	  	 Cashless Major Exercise
  

The undersigned hereby irrevocably exercises the Warrant with respect to         % of the Warrant currently outstanding
pursuant to a Cashless Major Exercise in accordance with the terms of the Warrant.

		
	☐    	  	 Cashless Default Exercise
  

The undersigned hereby irrevocably exercises the Warrant pursuant to a Cashless Default Exercise, in accordance with the terms of the Warrant.

 1. The undersigned requests that any stock certificates for such shares be issued free of any restrictive legend, if
appropriate, and, if requested by the undersigned, a warrant representing any unexercised portion hereof be issued, pursuant to the Warrant in the name of the undersigned and delivered to the undersigned at the address set forth below. 

2. Capitalized terms used but not otherwise defined in this Exercise Form shall have the meaning ascribed thereto in the Warrant. 

Dated: _______________ 
  

 
 Signature 

 
  

Print Name 
  

 
 Address 

NOTICE 

  
 26 

 The signature to the foregoing Exercise Form must correspond to the name as written upon the face of the
attached Warrant. 

  
 27 

 EXHIBIT B 

ASSIGNMENT 
 (To be executed by
the registered holder 
 desiring to transfer the Warrant) 

FOR VALUE RECEIVED, the undersigned holder of the attached warrant (the “Warrant”) hereby sells, assigns and transfers unto the person or persons
below named the right to purchase                      shares of the Common Stock of [ ], a Delaware corporation, evidenced by the attached Warrant
and does hereby irrevocably constitute and appoint                      attorney to transfer the said Warrant on the books of the Company, with full
power of substitution in the premises. 
  

			
	Dated: _______________ 	  	  
 Signature

 Fill in for new registration of Warrant: 
  

			
	  
 Name
	 	
		 	
	  
 Address
	 	
		 	
	  
 Please print name and address of
assignee
	 	
	(including zip code number)	 	

 NOTICE 
 The signature to the
foregoing Assignment must correspond to the name as written upon the face of the attached Warrant. 

  
 28 

 EXHIBIT C 

FORM OF OPINION 
 ______, 20__ 

[                    ] 

Re: [ ] (the “Company”) 

Dear Sir: 

[                    ]
(“[                    ]”) intends to transfer              Warrants (the
“Warrants”) of the Company to                  (“                ”)
without registration under the Securities Act of 1933, as amended (the “Securities Act”). In connection therewith, we have examined and relied upon the truth of representations contained in an Investor Representation Letter attached hereto
and have examined such other documents and issues of law as we have deemed relevant. 
 Based on and subject to the foregoing, we are of the opinion that
the transfer of the Warrants by              to              may be effected without registration under the Securities Act[,
provided, however, that the Warrants to be transferred to              contain a legend restricting its transferability pursuant to the Securities Act and that transfer of the Warrants is
subject to a stop order].10 
 The foregoing opinion is furnished only to
                     and may not be used, circulated, quoted or otherwise referred to or relied upon by you for any purposes other than the purpose
for which furnished or by any other person for any purpose, without our prior written consent. 
 Very truly yours, 

 

	10 	 Only if applicable. 

  
 29 

 [FORM OF INVESTOR REPRESENTATION LETTER] 

_____, 20__ 

[                          
      ] 
 Gentlemen: 

                 (“    ”) has agreed to purchase
             Warrants (the “Warrants”) of [ ] (the “Company”) from
[                    ] (“[                ]”). We
understand that the Warrants are “restricted securities.” We represent and warrant that              is a sophisticated institutional investor that would qualify as an
“Accredited Investor” as defined in Rule 501 of Regulation D under the Securities Act of 1933, as amended (the “Securities Act”). 

________ represents and warrants as of the date hereof as follows: 

1. That it is acquiring the Warrants and the shares of common stock, $0.001 par value per share underlying such Warrants (the “Exercise
Shares”) solely for its account for investment and not with a view to or for sale or distribution of said Warrants or Exercise Shares or any part thereof in violation of the Securities Act.
             also represents that the entire legal and beneficial interests of the Warrants and Exercise Shares
                 is acquiring is being acquired for, and will be held for, its account only; 

2. That the Warrants and the Exercise Shares must be held indefinitely unless they are registered under the Securities Act or an exemption from
such registration is available.                  recognizes that the Company has no obligation to register the Warrants, or to comply with any exemption from such
registration; 
 3. That neither the Warrants nor the Exercise Shares may be sold pursuant to Rule 144 adopted under the Securities Act
unless certain conditions are met; 
 We acknowledge that the Company will place stop orders with respect to the Warrants and the Exercise Shares, and if
none of the Unrestricted Conditions (as defined in the Warrants) is satisfied, the Exercise Shares shall bear the following restrictive legend: 

“THE SECURITIES REPRESENTED BY THIS CERTIFICATE HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR APPLICABLE STATE
SECURITIES LAWS. THE SECURITIES MAY NOT BE SOLD, TRANSFERRED OR ASSIGNED IN THE ABSENCE OF AN EFFECTIVE REGISTRATION STATEMENT FOR THE SECURITIES UNDER SAID ACT, OR PURSUANT TO AN EXEMPTION FROM REGISTRATION UNDER SAID ACT INCLUDING PURSUANT TO
SECTION 4(A)(7) OF THE SECURITIES ACT OR RULE 144 UNDER SAID ACT OR PURSUANT TO A PRIVATE SALE EFFECTED UNDER APPLICABLE FORMAL OR INFORMAL SEC INTERPRETATION OR GUIDANCE, SUCH AS A SO-CALLED “4[(a)](1)
AND A HALF” SALE. NOTWITHSTANDING THE FOREGOING, THE SECURITIES MAY BE PLEDGED IN CONNECTION WITH A BONA FIDE MARGIN ACCOUNT OR OTHER LOAN OR FINANCING ARRANGEMENT SECURED BY THE SECURITIES.” 

  
 30 

 “THE SALE, TRANSFER OR ASSIGNMENT OF THE SECURITIES REPRESENTED BY THIS CERTIFICATE ARE
SUBJECT TO THE TERMS AND CONDITIONS OF A CERTAIN AMENDED AND RESTATED REGISTRATION RIGHTS AGREEMENT DATED AS OF AUGUST 9, 2018, AS AMENDED FROM TIME TO TIME, AMONG THE COMPANY AND CERTAIN HOLDERS OF ITS OUTSTANDING SECURITIES. COPIES OF SUCH
AGREEMENT MAY BE OBTAINED AT NO COST BY WRITTEN REQUEST MADE BY THE HOLDER OF RECORD OF THIS CERTIFICATE TO THE SECRETARY OF THE COMPANY.” 
 At any
time and from time to time after the date hereof,                  shall, without further consideration, execute and deliver to
[                ] or the Company such other instruments or documents and shall take such other actions as they may reasonably request to carry out the transactions
contemplated hereby. 
 Very truly yours, 

  
 31 

 Schedule 1 

Black-Scholes Value 
  

					
	 	  	 Calculation Under Sections 3(b) and 5(b)(iii)
	  	 Calculation Under Section 10(b) or 11(b)

	Remaining Term	  	Number of calendar days from date of public announcement of the Major Transaction until the last date on which the Warrant may be exercised.	  	Number of calendar days from the date of the Event of Failure, or in the case of an Event of Default, the date of the Default Notice, until the last date on which the Warrant may be exercised.
			
	Interest Rate	  	A risk-free interest rate corresponding to the US$ LIBOR/Swap rate for a period equal to the remaining Exercise Period.	  	A risk-free interest rate corresponding to the US$ LIBOR/Swap rate for a period equal to the remaining Exercise Period.
			
	Cost to Borrow	  	Zero	  	Zero
			
	Volatility	  	 If the first public announcement of the Major Transaction is made at or prior to 4:00 p.m., New York City time, the arithmetic mean of the
historical volatility for the 10, 30 and 50 Trading Day periods ending on the date of such first public announcement, obtained from the HVT or similar function on Bloomberg.
  

If the first public announcement of the Major Transaction is made after 4:00 p.m., New York City time, the arithmetic mean of the historical volatility for the
10, 30 and 50 Trading Day periods ending on the next succeeding Trading Day following the date of such first public announcement, obtained from the HVT or similar function on Bloomberg.
	  	The arithmetic mean of the historical volatility for the 10, 30 and 50 Trading Day periods ending on the date of such determination, obtained from the HVT or similar function on Bloomberg.
			
	Stock Price	  	As selected by Holder in its commercially reasonable discretion in order to produce a commercially reasonable result, any of: (1) the closing price of the Common Stock on the NasdaqGS, or, if that is not the principal trading
market for the Common Stock, such principal market on which the Common Stock is traded or listed (the “Closing Market Price”) on the Trading Day immediately preceding the date on which a Major Transaction is consummated, (2) the first
Closing Market	  	The volume Weighted Average Price on the date of such determination.

					
		  	Price following the first public announcement of a Major Transaction, (3) the Closing Market Price as of the date immediately preceding the first public announcement of the Major Transaction or (4) the cash amount payable
per share of Common Stock. The Company and Holder acknowledge and agree that any of the above will produce a commercially reasonable result.	  	
			
	Dividends	  	Zero.	  	Zero.
			
	Strike Price	  	Exercise Price as defined in section 3(a).	  	Exercise Price as defined in section 3(a).

 EXHIBIT D 

DEERFIELD / ENDOLOGIX 

CLOSING CHECKLIST 

Facility Agreement Parties: 
  

			
	Term Borrower	  	Endologix, Inc., a Delaware corporation
		
	Term Guarantors (collectively with the Term Borrower, the “Loan Parties”)	  	See attached Schedule A
		
	Term Lenders	  	Deerfield Private Design Fund IV, L.P.; Deerfield Partners, L.P.; and Deerfield Private Design Fund III, L.P.
		
	Term Agent	  	Deerfield Private Design Fund IV, L.P.
		
	Katten	  	Katten Muchin Rosenman LLP, Counsel to Term Agent
		
	DLA	  	DLA Piper LLP (US), Counsel to the Loan Parties

 ABL Agreement Parties: 
  

			
	ABL Borrowers (also referred to as the “Credit Parties”)	  	Endologix, Inc., a Delaware corporation, and as listed on attached Schedule A
		
	ABL Lenders	  	Deerfield Private Design Fund IV, L.P.; Deerfield Partners, L.P.; and Deerfield Private Design Fund III, L.P.
		
	ABL Agent	  	Deerfield ELGX Revolver, LLC
		
	Katten	  	Katten Muchin Rosenman LLP, Counsel to ABL Agent
		
	DLA	  	DLA Piper LLP (US), Counsel to the Credit Parties

 FACILITY AGREEMENT DOCUMENTS AND DELIVERABLES: 

 

									
	 	  	 Document
	  	 Responsible

Party
	  	 Signatures
	  	 Status

	A.	  	DEBT DOCUMENTS – AGREEMENTS
					
	1.	  	Amended and Restated Facility Agreement	  	Katten	  	 Term Borrower
 Term Guarantors

Term Agent
 Term Lenders
	  	Katten revised draft 8/8
					
		  	Annexes to Amended and Restated Facility Agreement	  		  		  	
					
		  	Disbursement Amount and Warrants	  	Katten	  	N/A	  	

									
	 	  	 Document
	  	 Responsible

Party
	  	 Signatures
	  	 Status

		  	Schedules to Amended and Restated Facility Agreement	  		  		  	Final
					
	    	  	 Schedule P-1—Existing Investments
	  	Loan Parties/DLA	  	N/A	  	
					
		  	 Schedule 2.4—List of Agreement Date Lenders and Such Lenders’ Wire Instructions and Information for
Notices
	  	Katten/Agent	  	N/A	  	
					
		  	 Schedule 3.1(d)—Existing Liens
	  	Loan Parties/DLA	  	N/A	  	
					
		  	 Schedule 3.1(f)—Existing Indebtedness
	  	Loan Parties/DLA	  	N/A	  	
					
		  	 Schedule 3.1(h)—Litigation
	  	Loan Parties/DLA	  	N/A	  	
					
		  	 Schedule 3.1(j)—Authorizations
	  	Loan Parties/DLA	  	N/A	  	
					
		  	 Schedule 3.1(m)—Real Estate
	  	Loan Parties/DLA	  	N/A	  	
					
		  	 Schedule 3.1(n)—Intellectual Property
	  	Loan Parties/DLA	  	N/A	  	
					
		  	 Schedule 3.1(x)—Borrower’s Subsidiaries
	  	Loan Parties/DLA	  	N/A	  	
					
		  	 Schedule 3.1(z)—Borrower’s Outstanding Shares of Stock, Options and Warrants
	  	Loan Parties/DLA	  	N/A	  	
					
		  	 Schedule 3.1(aa)—Material Contracts
	  	Loan Parties/DLA	  	N/A	  	
					
		  	 Schedule 3.1(dd)—Environmental
	  	Loan Parties/DLA	  	N/A	  	
					
		  	 Schedule 3.1(ff)—Labor Relations
	  	Loan Parties/DLA	  	N/A	  	
					
		  	 Schedule 3.1(gg)—Jurisdiction of Organization, Legal Name, Organizational Identification Number and Chief
Executive Office
	  	Loan Parties/DLA	  	N/A	  	
					
		  	 Schedule 3.1(jjj)—Stock of the Subsidiaries of the Loan Parties
	  	Loan Parties/DLA	  	N/A	  	
					
		  	 Schedule 3.1(hh)—Inventory Locations
	  	Loan Parties/DLA	  	N/A	  	
					
		  	 Schedule 3.1(uu)—FDA/Governmental Notices
	  	Loan Parties/DLA	  	N/A	  	
					
		  	 Schedule 5.1(q)—Other Loan Documents to Be Form 8-K Exhibits
	  	Katten	  	N/A	  	

  
 4 

									
	 	  	 Document
	  	 Responsible

Party
	  	 Signatures
	  	 Status

					
		  	 Schedule 5.2(iv)—Contingent Obligations
	  	Loan Parties/DLA	  	N/A	  	
					
		  	 Schedule 5.2(vii)—Transactions with Affiliates
	  	Loan Parties/DLA	  	N/A	  	
					
		  	Exhibits to Amended and Restated Facility Agreement	  		  		  	
					
		  	 Exhibit A-1—Form of First Out Waterfall Note
	  	Katten	  	N/A	  	Final
					
		  	 Exhibit A-2—Form of Last Out Waterfall Note
	  	Katten	  	N/A	  	Final
					
		  	 Exhibit B—Form of Perfection Certificate
	  	Katten	  	N/A	  	Final
					
		  	 Exhibit C-1—Form of Initial Warrant
	  	Katten	  	N/A	  	Final
					
		  	 Exhibit C-2—Form of Additional Warrant
	  	Katten	  	N/A	  	Final
					
		  	 Exhibit D—Closing Checklist
	  	Katten	  	N/A	  	Final
					
		  	 Exhibit E—Form of Amended and Restated Registration Rights Agreement
	  	Katten	  	N/A	  	Final
					
		  	 Exhibit F—Form of Compliance Certificate
	  	Katten	  	N/A	  	Final
					
		  	 Exhibit 2.6—Share Payment Provisions
	  	Katten	  	N/A	  	Final
					
	2.	  	First Out Waterfall Notes in favor of each Term Lender	  	Katten	  	Term Borrower	  	Executed
					
	3.	  	Last Out Waterfall Note for Deerfield Partners, L.P.	  	Katten	  	Term Borrower	  	Executed
					
	4.	  	Amended and Restated Guaranty and Security Agreement	  	Katten	  	 Term Borrower
 Term Guarantors

Term Agent
	  	Executed
					
		  	Schedules to Amended and Restated Guaranty and Security Agreement	  	DLA	  		  	Final
					
		  	 Schedule 1–Pledged Equity and Pledged Debt Instruments
	  	Loan Parties/DLA	  	N/A	  	
					
		  	 Schedule 1A—Pledged Investment Property
	  	Loan Parties/DLA	  	N/A	  	
					
		  	 Schedule 2—Filings and Perfection
	  	Loan Parties/DLA	  	N/A	  	
					
		  	 Schedule 3—Grantor Information    
	  	Loan Parties/DLA	  	N/A	  	

  
 5 

									
	 	  	 Document
	  	 Responsible

Party
	  	 Signatures
	  	 Status

		  	 Schedule 4—Places of Business/Location of Collateral
	  	Loan Parties/DLA	  	N/A	  	
					
		  	 Schedule 5—Commercial Tort Claims
	  	Loan Parties/DLA	  	N/A	  	
					
		  	 Schedule 6—Accounts
	  	Loan Parties/DLA	  	N/A	  	
					
		  	 Schedule 7—Real Property
	  	Loan Parties/DLA	  	N/A	  	
					
		  	 Schedule 8—Copyrights
	  	Loan Parties/DLA	  	N/A	  	
					
		  	 Schedule 9—Intellectual Property Licenses
	  	Loan Parties/DLA	  	N/A	  	
					
		  	 Schedule 10—Patents
	  	Loan Parties/DLA	  	N/A	  	
					
		  	 Schedule 11—Trademarks
	  	Loan Parties/DLA	  	N/A	  	
					
	5.	  	 Perfection Certificate
	  	Katten (form)/Loan Parties/DLA (substance)	  	 Term Borrower
 Term Guarantors
	  	Executed
					
	6.	  	UCC-1 Financing Statements for Endologix Canada, LLC	  	Katten	  	N/A	  	Recorded
					
	7.	  	UCC-3 Financing Statement for Endologix Canada, LLC	  	Katten	  	N/A	  	Recorded
					
	8.	  	Original Warrants in favor of each Term Lender	  	Katten	  	Term Borrower	  	Executed
					
	9.	  	Amended and Restated Registration Rights Agreement	  	Katten	  	 Term Borrower
 Term Lenders
	  	Executed
					
	10.	  	Reaffirmation Agreement	  	Katten	  	 Term Borrower
 Term Guarantors

Term Agent
	  	Executed
					
	11.	  	First Supplement to Patent Security Agreement(s)	  	Katten	  	 Applicable Term Borrower/Guarantor(s)
 Term
Agent
	  	Executed
					
		  	Schedule to First Supplement to Patent Security Agreement(s)	  	DLA	  		  	Final
					
	12.	  	First Supplement to Trademark Security Agreement(s)	  	Katten	  	 Applicable Term Borrower/Guarantor(s)
 Term
Agent
	  	Executed
					
		  	Schedule to First Supplement to Trademark Security Agreement(s)	  	DLA	  		  	Final

  
 6 

									
	 	  	 Document
	  	 Responsible

Party
	  	 Signatures
	  	 Status

	13.	  	Executed Insurance Certificates of the Loan Parties and their Subsidiaries evidencing liability and casualty insurance, naming Term Agent on behalf of the Secured Parties as additional insured (liability insurance) or
lender’s loss payee (casualty insurance) and providing for 30 days’ prior written notice before any such policy may be modified or cancelled (or 10 days’ prior written notice in the case of failure to pay any premiums thereunder)	  	DLA	  	Insurance Broker (for insurance certificates)	  	Final (revised versions to come post-closing removing Trivascular Canada)
					
	14.	  	Intercreditor Agreement	  	Katten	  	 Term Borrower
 ABL Borrowers

Term Agent
 ABL Agent
	  	Executed
					
	15.	  	Irrevocable Proxies	  	Katten	  	Applicable Term Guarantors	  	Executed
					
	16.	  	8,677 Shares of Series A Preferred Stock in Cianna Medical, Inc. (with corresponding Stock Power)	  	DLA	  	Term Borrower	  	Executed
					
	17.	  	Intercompany Subordination Agreement	  	Katten	  	 Term Borrower
 Term Guarantors

Term Agent
	  	Executed
		
	B.	  	CERTIFICATES AND MISCELLANEOUS
					
	18.	  	Lien Searches and IP Searches for Loan Parties	  	Katten	  	N/A	  	Final
					
	19.	  	Secretary’s Certificate of each Loan Party, attaching Organization Documents, resolutions, incumbency and good standings	  	DLA	  	Term Guarantors	  	Executed
					
		  	 A. Certificate of Incorporation or Formation
	  	DLA	  	See attached Schedule A	  	See attached Schedule A
					
		  	 B. Bylaws or Operating Agreement
	  	DLA	  	See attached Schedule A	  	See attached Schedule A
					
		  	 C. Resolutions
	  	DLA	  	See attached Schedule A	  	See attached Schedule A
					
		  	 D. Incumbency
	  	DLA	  	See attached Schedule A	  	See attached Schedule A
					
		  	 E.  Good Standings  
	  	DLA	  	See attached Schedule A	  	See attached Schedule A

  
 7 

									
	 	  	 Document
	  	 Responsible

Party
	  	 Signatures
	  	 Status

	20.	  	 Agreement Date Officer’s Certificate from an Authorized Officer of Endologix, Inc. certifying to each of the following:

 
 a)  The conditions set forth in
Section 2.2(a) have been satisfied and the terms set forth in Section 2.2(a) have been completely complied with
  

b)  No Default or Event of Default shall have occurred or would result from the Disbursement or the use of
the proceeds therefrom
  
 c)  All of
the representations and warranties in the Loan Documents are true and correct
  

d)  All conditions set forth in Section 4.1 of the Facility Agreement have been satisfied
	  	DLA	  	 Term Borrower
 Term Guarantors
	  	Executed
					
	21.	  	Solvency Certificate	  	DLA	  	 Term Borrower
 Term Guarantors
	  	Executed
					
	22.	  	Legal Opinion of the Loan Parties	  	DLA	  	DLA	  	Executed
					
	23.	  	Transfer Agent Letter as to shares outstanding    	  	Loan Parties	  	Transfer Agent	  	Executed

  
 8 

									
	 	  	 Document
	  	 Responsible

Party
	  	 Signatures
	  	 Status

	24.	  	 Landlord/Bailee Waivers
  

A. 2 Musick and 35 Hammond, Irvine, County of Orange, CA 92618 U.S.A.

 
 B. 3910 Brickway Blvd., Santa Rosa, County
of Sonoma, CA 95403 U.S.A.
  
 C. UPS
Warehouse Lien Agreement
  

•  378 Commercial Street, Malden, MA 02148

 
 •  165 Chubb Avenue, Lyndhurst,
NJ 07071
  
 •  1130 Commerce
Blvd, Swedesboro, NJ 08085
  

•  2250 Outerloop Drive, Louisville, KY 40219
	  	Loan Parties/DLA	  	 Applicable Loan Parties
 Applicable Landlord

Term Agent
 ABL Agent
	  	 A. Executed
 B. Executed

C. Katten comments 8/6 (to be finalized post-closing)

					
	25.	  	 Account Control Agreements
  

A.Wells Fargo
  

B.Bank of America (with Activation)
  

C.Bank of America (without Activation)
  

D.Silicon Valley Bank (amendment)
	  	Loan Parties/DLA	  	 Applicable Loan Parties
 Applicable Bank

Term Agent
 ABL Agent
	  	 A. Executed
 B. Executed

C. Executed
 D. Executed

					
	26.	  	Executed Insurance Endorsements of the Loan Parties and their Subsidiaries evidencing liability and casualty insurance, naming Term Agent on behalf of the Secured Parties as additional insured (liability insurance) or
lender’s loss payee (casualty insurance) and providing for 30 days’ prior written notice before any such policy may be modified or cancelled (or 10 days’ prior written notice in the case of failure to pay any premiums thereunder)	  	DLA	  	Insurance Carriers (for insurance endorsements)	  	To come post-closing, adding Endologix Canada, LLC and removing ACF Finco

  
 9 

 ABL AGREEMENT DOCUMENTS AND DELIVERABLES 

 

									
	 	  	 Document
	  	 Responsible

Party
	  	 Signatures
	  	 Status

	A.	  	DEBT DOCUMENTS – AGREEMENTS
					
	1.	  	Credit Agreement	  	Katten	  	 ABL Borrowers
 ABL Agent

ABL Lender
	  	Executed
					
		  	Schedules to Credit Agreement	  		  		  	Final
					
		  	Schedule A-1 – Agent’s Account	  	Credit Parties/DLA	  	N/A	  	
					
		  	Schedule A-2 – Authorized Person	  	Credit Parties/DLA	  	N/A	  	
					
		  	Schedule C-1 – Commitments	  	Credit Parties/DLA	  	N/A	  	
					
		  	Schedule D-1 – Designated Account	  	Credit Parties/DLA	  	N/A	  	
					
		  	Schedule E-1 – Approved Account Debtor	  	Credit Parties/DLA	  	N/A	  	
					
		  	Schedule P-1 – Existing Investments	  	Credit Parties/DLA	  	N/A	  	
					
		  	Schedule 4.01(d) – Existing Liens	  	Credit Parties/DLA	  	N/A	  	
					
		  	Schedule 4.01(f) – Existing Indebtedness	  	Credit Parties/DLA	  	N/A	  	
					
		  	Schedule 4.03 – Litigation	  	Credit Parties/DLA	  	N/A	  	
					
		  	Schedule 4.06 – Real Estate	  	Credit Parties/DLA	  	N/A	  	
					
		  	Schedule 4.07 – Intellectual Property	  	Credit Parties/DLA	  	N/A	  	
					
		  	Schedule 4.15 – Borrower’s Subsidiaries	  	Credit Parties/DLA	  	N/A	  	
					
		  	Schedule 4.17 – Borrower’s Outstanding Shares of Stock, Options and Warrants	  	Credit Parties/DLA	  	N/A	  	
					
		  	Schedule 4.18 – Material Contracts	  	Credit Parties/DLA	  	N/A	  	
					
		  	Schedule 4.20 – Environmental	  	Credit Parties/DLA	  	N/A	  	
					
		  	Schedule 4.22 – Labor Relations	  	Credit Parties/DLA	  	N/A	  	
					
		  	Schedule 4.23 – Jurisdiction of Organization, Legal Name, Organizational Identification Number and Chief Executive Office	  	Credit Parties/DLA	  	N/A	  	
					
		  	Schedule 4.33(a) – FDA/ Governmental Notices	  	Credit Parties/DLA	  	N/A	  	
					
		  	Schedule 4.41 – Stock of the Subsidiaries of the Loan Parties	  	Credit Parties/DLA	  	N/A	  	

  
 10 

									
	 	  	 Document
	  	 Responsible

Party
	  	 Signatures
	  	 Status

		  	Schedule 4.45 – Inventory Location	  	Credit Parties/DLA	  	N/A	  	
					
		  	Schedule 6.05 – Contingent Obligations	  	Credit Parties/DLA	  	N/A	  	
					
		  	Schedule 6.07 – Transactions with Affiliates	  	Credit Parties/DLA	  	N/A	  	
					
		  	Exhibits to Credit Agreement	  		  		  	
					
		  	 Exhibit A -1 — Form of Assignment and Acceptance
	  	Katten	  	N/A	  	Final
					
		  	 Exhibit B-1 – Form of Borrowing Base Certificate (Agent)
	  	Katten	  	N/A	  	Final
					
		  	 Exhibit B-2 – Form of Borrowing Base Certificate (Third Party
Agent)
	  	Katten	  	N/A	  	Final
					
		  	 Exhibit C-1 – Form of Compliance Certificate
	  	Katten	  	N/A	  	Final
					
		  	 Exhibit P-1 – Form of Perfection Certificate
	  	Katten	  	N/A	  	Final
					
	2.	  	Original Notes in favor of each ABL Lender	  	Katten	  	ABL Borrower	  	Executed
					
	3.	  	Guaranty and Security Agreement	  	Katten	  	 ABL Borrowers
 ABL Agent
	  	Executed
					
		  	Schedules to Guaranty and Security Agreement	  	DLA	  		  	
					
		  	Schedule 1 – Pledged Equity and Pledged Debt Instruments	  		  		  	
					
		  	 Schedule 1A – Pledged Investment Property
	  		  		  	
					
		  	 Schedule 2 – Filings and Perfection
	  		  		  	
					
		  	 Schedule 3 – Grantor Information
	  		  		  	
					
		  	 Schedule 4 – Places of Business / Location of Collateral
	  		  		  	
					
		  	 Schedule 5 – Commercial Tort Claims
	  		  		  	
					
		  	 Schedule 6—Accounts
	  		  		  	
					
		  	 Schedule 7 – Real Property
	  		  		  	
					
		  	 Schedule 8—Copyrights
	  		  		  	

  
 11 

									
	 	  	 Document
	  	 Responsible

Party
	  	 Signatures
	  	 Status

		  	 Schedule 9 – Intellectual Property Licenses
	  		  		  	
					
		  	 Schedule 10—Patents
	  		  		  	
					
		  	 Schedule 11—Trademarks
	  		  		  	
					
		  	Annexes to Guaranty and Security Agreement	  		  		  	
					
		  	 Annex I – Form of Joinder and Security Agreement
	  		  		  	
					
	4.	  	Perfection Certificate	  	Katten (form)/Credit Parties/DLA (substance)	  	See above	  	See above
					
	5.	  	UCC-1 Financing Statements for each Credit Party	  	Katten	  	N/A	  	Agreed
					
	6.	  	Executed Insurance Certificates of the Credit Parties and their Subsidiaries evidencing liability and casualty insurance, naming the ABL Agent on behalf of the Secured Parties as additional insured (liability insurance) or
lender’s loss payee (casualty insurance) and providing for 30 days’ prior written notice before any such policy may be modified or cancelled (or 10 days’ prior written notice in the case of failure to pay any premiums thereunder)	  	DLA	  	Insurance Broker	  	Final (revised versions to come post-closing removing Trivascular Canada)
					
	7.	  	Intercreditor Agreement	  	Katten	  	See above	  	See above
					
	8.	  	Intercompany Subordination Agreement	  	DLA/Katten	  	 ABL Borrowers
 ABL Agent
	  	Executed
					
	9.	  	Patent Security Agreement(s)	  	Katten	  	 Applicable ABL Borrower(s)
 ABL Agent
	  	Executed
					
		  	Schedule to Patent Security Agreement(s)	  	DLA	  		  	Final
					
	10.	  	Trademark Security Agreement(s)	  	Katten	  	 Applicable ABL Borrower(s)
 ABL Agent
	  	Executed
					
		  	Schedule to Trademark Security Agreement(s)	  	DLA	  		  	Final
		
	B.	  	CERTIFICATES AND MISCELLANEOUS
					
	11.	  	Lien Searches and IP Searches for Credit Parties	  	DLA	  	N/A	  	See above

  
 12 

									
	 	  	 Document
	  	 Responsible

Party
	  	 Signatures
	  	 Status

	12.	  	Secretary’s Certificate of each Credit Party, attaching Organization Documents, resolutions, incumbency and good standings	  	DLA	  	ABL Borrowers	  	
					
		  	 A. Certificate of Incorporation or Formation
	  	DLA	  	See attached Schedule A	  	See attached Schedule A
					
		  	 B. Bylaws or Operating Agreement
	  	DLA	  	See attached Schedule A	  	See attached Schedule A
					
		  	 C. Resolutions
	  	DLA	  	See attached Schedule A	  	See attached Schedule A
					
		  	 D. Incumbency
	  	DLA	  	See attached Schedule A	  	See attached Schedule A
					
		  	 E.  Good Standings
	  	DLA	  	See attached Schedule A	  	See attached Schedule A
	13.	  	 Agreement Date Officer’s Certificate from an Authorized Officer of Endologix, Inc. certifying to each of the following:

 
 a)  Since December 31, 2017, the
absence of any MAE
  
 b)  The
representations and warranties of each Credit Party contained in the Financing Documents are true, correct and complete on and as of the Closing Date, except to the extent that any such representation or warranty relates to a specific date in which
case such representation or warranty is true and correct as of such earlier date
  

c)  All conditions set forth in Section 7.1 of the Facility Agreement have been satisfied

 
 d)  Immediately after such borrowing
and after application of the proceeds thereof or after
	  	DLA	  	ABL Borrowers	  	Executed

  
 13 

									
	 	  	 Document
	  	 Responsible

Party
	  	 Signatures
	  	 Status

		  	 such issuance, the Revolving Loan Outstandings will not exceed the Revolving Loan Limit

 
 e)  Immediately before and after such
advance or issuance, no Default or Event of Default shall have occurred and be continuing
	  		  		  	
					
	14.	  	Solvency Certificate	  	DLA	  	ABL Borrower	  	Executed
					
	15.	  	Borrowing Base Certificate	  	DLA	  	ABL Borrower	  	Final
					
	16.	  	Legal Opinion of the Credit Parties	  	DLA	  	DLA	  	Executed
					
	17.	  	Receipt by the ABL Agent and the ABL Lender of any fees, costs and expenses required to be paid on or before the Closing Date	  	Credit Parties	  	N/A	  	Final
					
	18.	  	Receipt by ABL Agent and ABL Lender at least 3 Business Days prior to the Agreement Date all KYC and anti-money laundering rules and regulations	  	Credit Parties	  	Credit Parties	  	Final
					
	19.	  	Cortland Administrative Services Agreement	  	ABL Agent	  	 Deerfield ELGX Revolver, LLC (Customer)

Cortland Capital Market Services LLC (Administrator)
	  	Executed
					
	20.	  	Cortland Fee Proposal	  	ABL Agent	  		  	Agreed
					
	21.	  	Landlord/Bailee Waivers	  	Credit Parties/DLA	  	See above	  	See above
					
	22.	  	Account Control Agreements	  	Credit Parties/DLA	  	See above	  	See above

  
 14 

									
	 	  	 Document
	  	 Responsible

Party
	  	 Signatures
	  	 Status

	23.	  	Executed Insurance Endorsements of the Credit Parties and their Subsidiaries evidencing liability and casualty insurance, naming the ABL Agent on behalf of the Secured Parties as additional insured (liability insurance) or
lender’s loss payee (casualty insurance) and providing for 30 days’ prior written notice before any such policy may be modified or cancelled (or 10 days’ prior written notice in the case of failure to pay any premiums thereunder)	  	DLA	  	Insurance Carriers	  	To come post-closing, adding Endologix Canada, LLC and removing ACF Finco

 Schedule A 

Secretary’s Certificates 
  

															
	 Borrower/Guarantor
	  	 Loan Party/
Credit Party
	  	 Certificate of
Formation /
Articles
of
Organization
	  	 Operating
Agreement /
Bylaws
	  	 Resolutions
	  	 Incumbency
	  	 Good
Standings

	 Facility Agreement
	  	 ABL
Agreement

	Borrower	  	Borrower	  	Endologix, Inc., a Delaware corporation	  	Rec’d	  	Rec’d	  	Executed	  	Executed	  	Rec’d CA, DE
								
	Guarantor	  	Borrower	  	CVD/RMS Acquisition Corp., a Delaware corporation	  	Rec’d	  	Rec’d	  	Executed	  	Executed	  	Rec’d DE
								
	Guarantor	  	Borrower	  	Nellix, Inc., a Delaware corporation	  	Rec’d	  	Rec’d	  	Executed	  	Executed	  	Rec’d DE
								
	Guarantor	  	Borrower	  	TriVascular Technologies, Inc., a Delaware corporation	  	Rec’d	  	Rec’d	  	Executed	  	Executed	  	Rec’d CA, DE

  
 15 

															
	Guarantor	  	Borrower	  	TriVascular, Inc., a California corporation	  	Rec’d	  	Rec’d	  	Executed	  	Executed	  	Rec’d CA
	Guarantor	  	Borrower	  	Endologix Canada, LLC, a Delaware limited liability company (f/k/a Trivascular Canada, LLC)	  	Rec’d	  	Rec’d	  	Executed	  	Executed	  	Rec’d CA, DE
	Guarantor	  	Borrower	  	TriVascular Sales LLC, a Texas limited liability company	  	Rec’d	  	Rec’d	  	Executed	  	Executed	  	Rec’d TX
	Guarantor	  	Borrower	  	RMS/Endologix Sideways Merger Corp., a Delaware corporation	  	Rec’d	  	Rec’d	  	Executed	  	Executed	  	Rec’d DE

  
 16 

 EXHIBIT E 

FORM OF 
 AMENDED AND
RESTATED REGISTRATION RIGHTS AGREEMENT 
 AMENDED AND RESTATED REGISTRATION RIGHTS AGREEMENT (this “Agreement”), dated as of August 9,
2018, by and among Endologix, Inc., a Delaware corporation (the “Company”), and Deerfield Private Design Fund IV, L.P., Deerfield Partners, L.P. and Deerfield Private Design Fund III, L.P. (each individually, a “Lender” and
together, the “Lenders”). 
 WHEREAS: 
 A. In
connection with the Facility Agreement, dated as of April 3, 2017, by and among the Company, the Lenders, Deerfield International Master Fund, L.P. (the “Prior Lender”), the other Loan Parties (as defined therein) and Deerfield
Private Design Fund IV, L.P., as agent for itself and the other Lenders (as the same has heretofore been amended, modified, restated or otherwise supplemented, the “Existing Facility Agreement”), (i) the Company issued the Initial Warrants
(as defined in the Amended Facility Agreement (as defined below)) to the Lenders in the amounts described in the Existing Facility Agreement, each of which Initial Warrants is exercisable into shares of the Company’s common stock, $0.001 par
value per share (the “Common Stock”); and 
 B. In connection with the Facility Agreement, the Company, the Lenders and the Prior Lender executed
and delivered that certain Registration Rights Agreement, dated as of April 3, 2017 (the “Existing Registration Rights Agreement”). 
 C.
Pursuant to the Existing Registration Rights Agreement, the Company filed with the United States Securities and Exchange Commission (“SEC”) a Registration Statement (File No. 333-217602) on Form
S-3, which registered the resale of an aggregate of 6,470,000 Common Shares issuable upon exercise of the Initial Warrants and was declared effective by the SEC as of May 22, 2017 (the “Existing
Registration Statement”). On May 22, 2017, pursuant to Rule 424(b)(3) under the Securities Act (as defined below), the Company filed a final prospectus as part of the Existing Registration Statement (the “Initial Prospectus”).
For the avoidance of doubt, the Existing Registration Statements and the Initial Prospectus constitute a Registration Statement and Prospectus (each as defined in this Agreement), respectively, under this Agreement. 

D. Effective as of January 1, 2018, the Prior Lender transferred and assigned its Initial Warrants and its rights under the Existing Registration Rights
Agreement to Deerfield Partners, L.P. (the “Warrant Transfer”). 
 F. Contemporaneously with the execution of this Agreement, the Company, the
Lenders, the other Loan Parties (as defined therein) and Deerfield Private Design Fund IV, L.P., as agent for itself and the other Lenders, are entering into an Amended and Restated Facility Agreement, dated as of the date hereof (as the same may
hereafter be amended, modified, restated or otherwise supplemented from time to time, the “Amended Facility Agreement”), which amends and restates the Existing Facility Agreement in its entirety. All capitalized terms used and not
otherwise defined herein shall have the respective meanings set forth in the Amended Facility Agreement. 
 G. The Amended Facility Agreement, among other
things, provides for the issuance of the Additional Warrants (as defined in the Amended Facility Agreement). 
 H. The parties hereto desire to amend and
restate the Existing Registration Rights Agreement to provide for 

  
 17 

 
certain changes relating to the issuance of the Additional Warrants. 
 I. To induce the Lenders to
execute and deliver the Amended Facility Agreement, the Company has agreed to provide certain registration rights under the Securities Act of 1933, as amended, and the rules and regulations thereunder, or any similar successor statute (collectively,
the “Securities Act”), and applicable state securities laws. 
 NOW, THEREFORE, in consideration of the premises and the mutual covenants
contained herein and other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the Company and each of the Lenders hereby agree as follows: 

1. DEFINITIONS. 
 a. As used in this Agreement, the
following terms shall have the following meanings: 
 (i) “Additional Filing Deadline” means, with respect to any Registration Statements that may
be required pursuant to Section 2(a)(ii), (A) the first date or time that such Registrable Securities may then be included in a Registration Statement if such Registration Statement is required because the SEC shall have notified the Company in
writing that certain Registrable Securities were not eligible for inclusion on a previously filed Registration Statement, or (B) if such additional Registration Statement is required for a reason other than as described in (A) above, the
twentieth (20th) day following the date on which the Company first knows, or reasonably should have known, that such additional Registration Statement is required. 

(ii) “Additional Registration Deadline” means, with respect to any additional Registration Statement(s) required pursuant to Section 2(a)(ii),
the thirtieth (30th) day following (A) the first date or time that such Registrable Securities may then be included in a Registration Statement if such Registration Statement is required
because the SEC shall have notified the Company in writing that certain Registrable Securities were not eligible for inclusion on a previously filed Registration Statement, or (B) if such additional Registration Statement is required for a
reason other than as described in (A) above, the fortieth (40th) day following the date on which the Company first knows, or reasonably should have known, that such additional Registration
Statement(s) is required. 
 (iii) “Investor” means any Lender and any transferee or assignee who agrees to become bound by the provisions of this
Agreement in accordance with Section 10 hereof. 
 (iv) “Exchange Act” means the Securities Exchange Act of 1934, as amended, together with
the rules and regulations promulgated thereunder, and any successor statute. 
 (v) “FINRA” means the Financial Industry Regulatory Authority (or
successor thereto). 
 (vi) “Filing Deadline,” for the Registration Statement required pursuant to Section 2(a)(i), shall mean
September 6, 2018, and for each Registration Statement required pursuant to Section 2(a)(ii) shall mean the Additional Filing Deadline. 
 (vii)
“Person” means and includes any natural person, partnership, joint venture, corporation, trust, limited liability company, limited company, joint stock company, unincorporated organization, government entity or any political subdivision or
agency thereof, or any other entity. 
 (viii) “Prospectus” means (i) any prospectus (preliminary or final) included in any Registration
Statement (including the Initial Prospectus), as may be amended or supplemented by any prospectus supplement with respect to the terms of the offering of any portion of the Registrable Securities covered by such Registration

  
 18 

 
Statement and by all other amendments and supplements to such prospectus, including post-effective amendments, and all material incorporated by reference in such prospectus, and (ii) any
“free writing prospectus” as defined in Rule 405 under the Securities Act relating to any offering of Registrable Securities pursuant to a Registration Statement. 

(ix) “Register,” “Registered,” and “Registration” refer to a registration effected by preparing and filing a Registration
Statement or Statements in compliance with the Securities Act and pursuant to Rule 415, and the declaration or ordering of effectiveness of such Registration Statement by the United States Securities and Exchange Commission (the “SEC”).

 (x) “Registrable Securities,” for a given Registration, means (a) any shares of Common Stock (the “Warrant Shares”) issued or
issuable upon exercise of, or otherwise pursuant to, the Warrants (without giving effect to any limitations on exercise set forth in the Warrants), (b) any shares of capital stock issued or issuable as a dividend on or in exchange for or otherwise
with respect to any of the foregoing, (c) any additional shares of Common Stock issuable in connection with any anti-dilution provisions in the Warrants, (d) any other shares of Common Stock issuable pursuant to the terms of the Warrants
or this Agreement, and (e) any securities issued or issuable upon any stock split, dividend or other distribution, recapitalization or similar event with respect to any of the foregoing. 

(xi) “Registration Deadline” shall mean, for purposes of the Registration Statement required pursuant to Section 2(a)(i), the earlier of
(i) the date that is seventy-five (75) days after the date that the applicable Registration Statement is actually filed or (ii) the date that is seventy-five (75) days after the applicable Filing Deadline and, with respect to any
Registration Statement required pursuant to Section 2(a)(ii), the Additional Registration Deadline. 
 (xii) “Registration Statement(s)” means
any registration statement(s) of the Company filed under the Securities Act that covers the resale of any of the Registrable Securities pursuant to the provisions of this Agreement (including the Existing Registration Statement), all amendments and
supplements to such Registration Statement, including post-effective amendments, and all exhibits to, and all material incorporated by reference in, such Registration Statement. 

(xiii) “Rule 415” means Rule 415 under the Securities Act or any successor rule providing for the offering of securities on a continuous basis 

(xiv) “Warrants” means the Warrants (including, for the avoidance of doubt, both the Initial Warrants and the Additional Warrants) issued by the
Company pursuant to the Existing Facility Agreement and the Amended Facility Agreement. 
 2. REGISTRATION. 

a. MANDATORY REGISTRATION. (i) Following the Agreement Date, the Company shall prepare, and, on or prior to the applicable Filing Deadline, file
with the SEC a Registration Statement (the “Mandatory Registration Statement”) on Form S-3 (or, if Form S-3 is not then available, on such form of Registration
Statement as is then available to effect a registration of the Registrable Securities, subject to the consent of the Investors, which consent shall not be unreasonably withheld), covering the resale of all of the Registrable Securities that are not
at that time covered by the Existing Registration Statement (as then in effect and available for resale of the Registrable Securities covered thereby), which Registration Statement, to the extent allowable under the Securities Act and the rules and
regulations promulgated thereunder (including Rule 416), shall state that such Registration Statement also covers such indeterminate number of additional shares of Common Stock as may become issuable upon exercise of or otherwise pursuant to the
Warrants or the Warrant Shares to prevent dilution resulting from stock splits, stock dividends, stock 

  
 19 

 
issuances or similar transactions. The number of shares of Common Stock initially included in such Registration Statement shall be no less than the aggregate number of Warrant Shares that are
then issuable upon exercise of or otherwise pursuant to the Warrants, without regard to any limitations on the Investors’ ability to exercise the Warrants. Each Registration Statement (and each amendment or supplement thereto, and each request
for acceleration of effectiveness thereof) shall be provided to (and shall be subject to the approval, which shall not be unreasonably withheld or delayed, of) the Investors and their counsel prior to its filing or other submission. 

(ii) If for any reason, despite the Company’s use of its best efforts to include all of the Registrable Securities in the Registration Statement filed
pursuant to Section 2 (a)(i) above (and subject to Section 3(q) below), the SEC does not permit all such Registrable Securities to be included in such Registration Statement, or for any other reason any Registrable Securities are not then
included in a Registration Statement (including the Existing Registration Statement), then the Company shall prepare, and, as soon as practicable but in no event later than the Additional Filing Deadline, file with the SEC an additional Registration
Statement covering the resale of all Registrable Securities not already covered by an existing and effective Registration Statement for an offering to be made on a continuous basis pursuant to Rule 415. 

(iii) Unless the SEC does not so permit or otherwise directed by the Buyers, each Registration Statement filed pursuant to this Section 2(a) or
Section 3(b) shall include a combined prospectus for the resale of the Registrable Securities registered by such Registration Statement, the Existing Registration Statement and any other Registration Statement previously filed hereunder, and
shall be deemed a post-effective amendment to the Existing Registration Statement or, other previously filed Registration Statement in accordance with Rule 429 under the Securities Act. 

b. PIGGY-BACK REGISTRATIONS. If at any time prior to the expiration of the Registration Period (as hereinafter defined) the Company shall determine
(i) to file with the SEC a registration statement under the Securities Act relating to an offering for its own account or for the account of any other holder of its equity securities (other than securities being registered on Form S-4 or Form S-8 or their then equivalents relating to equity securities to be issued solely in connection with any acquisition of any entity or business or equity securities
issuable in connection with stock option or other employee benefit plans), and/or (ii) otherwise to effect an underwritten offering of any securities of the Company of a type included in a then effective Registration Statement, the Company
shall send to each Investor written notice of such determination and, if within fifteen (15) days after the effective date of such notice, the Investor shall so request in writing, the Company shall include in such Registration Statement and/or
include in such underwritten offering, as applicable, all or any part of such Investor’s Registrable Securities that the Investor requests to be registered and/or included in the underwritten offering, as applicable, except that if, in
connection with any underwritten offering for the account of the Company, the managing underwriter(s) thereof shall impose a limitation on the number of Registrable Securities which may be included in such offering because, in such
underwriter(s)’ judgment, marketing or other factors dictate such limitation is necessary to facilitate public distribution, then the Company shall be obligated to include in such underwritten offering only such limited portion of the
Registrable Securities with respect to which the Investor has requested inclusion hereunder as the underwriter(s) shall permit; 
 provided,
however, that the Company shall not exclude any Registrable Securities unless the Company has first excluded all outstanding securities to be sold for the accounts of any holders of the Company’s equity securities which are not entitled
by contract to inclusion of such securities in an underwritten offering or are not entitled to pro rata inclusion with the Registrable Securities; and 

provided, further, however, that, after giving effect to the immediately preceding proviso, any exclusion of Registrable Securities shall be
made pro rata with holders of other securities having the contractual right to include such securities in such underwritten offering other than holders of securities entitled to inclusion of 

  
 20 

 
their securities in such underwritten offering by reason of demand registration rights. No right to registration of Registrable Securities under this Section 2(b) shall be construed to limit
any registration required under Section 2(a) hereof. If an Investor’s Registrable Securities are included in an underwritten offering pursuant to this Section 2(b), then such Investor shall, unless otherwise agreed by the Company,
offer and sell such Registrable Securities in such underwritten offering using the same underwriter or underwriters and, subject to the provisions of this Agreement, on the same terms and conditions as other shares of Common Stock included in such
underwritten offering. Notwithstanding anything to the contrary set forth herein, the rights of the Investors pursuant to this Section 2(b) shall only be available in the case of an underwritten offering or in the event the Company fails to
timely file, obtain effectiveness or maintain effectiveness of any Registration Statement to be filed pursuant to Section 2(a) or Section 3(b) in accordance with the terms of this Agreement. 

3. OBLIGATIONS OF THE COMPANY. In connection with any registration of the Registrable Securities hereunder, the Company shall have the following
obligations: 
 a. The Company shall prepare promptly, and file with the SEC as soon as practicable after such registration obligation arises hereunder (but
in no event later than the applicable Filing Deadline), a Registration Statement with respect to the Registrable Securities as provided in Section 2(a), and thereafter use its reasonable best efforts to cause each such Registration Statement
relating to Registrable Securities to become effective as soon as possible after such filing, but in any event shall use its reasonable best efforts to cause each such Registration Statement relating to Registrable Securities to become effective no
later than the Registration Deadline, and shall use its reasonable best efforts to keep each of such Registration Statement and the Existing Registration Statement current and effective pursuant to Rule 415 at all times after its effective date
until such date as is the earlier of (i) the date on which all of the Registrable Securities included in such Registration Statement have been sold and (ii) assuming all of the Warrants will be exercised pursuant to Cash Exercises (as
defined in the Warrants), the date on which all of the Registrable Securities included in such Registration Statement (in the opinion of counsel to the Investors) may be immediately sold to the public without registration or restriction (including
without limitation as to volume by each holder thereof), and without compliance with any “current public information” requirement, pursuant to Rule 144 under the Securities Act (the “Registration Period”), which Registration
Statement (including any amendments or supplements thereto and prospectuses contained therein), except for information provided in writing by an Investor pursuant to Section 4(a), shall not contain any untrue statement of a material fact or
omit to state a material fact required to be stated therein, or necessary to make the statements therein not misleading. In the event that Form S-3 is not available for the registration of the resale of any
Registrable Securities hereunder (but, for the avoidance of doubt, without in any way affecting the Company’s obligation to register the resale of the Registrable Securities on such other form as is available, as provided in Section 2(a)),
(i) the Company shall undertake to file, within twenty (20) days of such time as such form is available for such registration, a post-effective amendment to the Registration Statement then in effect, or otherwise file a Registration Statement
on Form S-3, registering such Registrable Securities on Form S-3; provided that the Company shall maintain the effectiveness of the Registration Statement then in effect
until such time as a Registration Statement (or post-effective amendment) on Form S-3 covering such Registrable Securities has been declared effective by the SEC, and (ii) the Company shall provide that
any Registration Statement on Form S-1 filed hereunder shall incorporate documents by reference (including by way of forward incorporation by reference) to the maximum extent possible. 

b. The Company shall prepare and file with the SEC such amendments (including post-effective amendments) and supplements to each Registration Statement and the
prospectus used in connection with each Registration Statement as may be necessary to keep each Registration Statement current and effective at all times during the Registration Period, and, during the Registration Period, shall comply with the
provisions of the Securities Act with respect to the disposition of all Registrable Securities of the Company 

  
 21 

 
covered by each Registration Statement until such time as all of such Registrable Securities have been disposed of in accordance with the intended methods of disposition by the seller or sellers
thereof as set forth in such Registration Statement. Without limiting the foregoing, no later than August 17, 2018, the Company shall file with the SEC a prospectus supplement that supplements the Initial Prospectus with such information as
shall be necessary to reflect the Warrant Transfer (including to provide that Deerfield Partners, L.P. may resell the Registrable Securities underlying the Initial Warrants pursuant to the Existing Registration Statement and the Initial Prospectus)
and the transactions contemplated by the Amended Facility Agreement, to include updated information with respect to the Lenders to the extent provided by the Lenders in accordance with this Agreement and to include such other information as may be
necessary to enable the Existing Registration Statement to be used for resales of all of the Registrable Securities covered thereby. In the event that on any Trading Day (as defined below) (the “Registration Trigger Date”) the number of
shares available under the Registration Statements filed pursuant to this Agreement is insufficient to cover all of the Registrable Securities issued or issuable upon exercise of or otherwise pursuant to the Warrants, including any additional shares
of Common Stock issued in connection with any anti-dilution provisions contained in the Warrants, without giving effect to any limitations on the Investors’ ability to exercise the Warrants, the Company shall amend the Registration Statements,
or file a new Registration Statement (on the short form available therefor, if applicable), or both, so as to cover the total number of Registrable Securities so issued or issuable (without giving effect to any limitations on exercise contained in
the Warrants) as of the Registration Trigger Date as soon as practicable, but in any event within twenty (20) days after the Registration Trigger Date. The Company shall use its best efforts to cause such amendment and/or new Registration
Statement to become effective as soon as practicable following the filing thereof, but in any event the Company shall cause such amendment and/or new Registration Statement to become effective within sixty (60) days of the Registration Trigger
Date or as promptly as practicable in the event the Company is required to increase its authorized shares. “Trading Day” shall mean any day on which the Common Stock is traded for any period on the NASDAQ Global Select Market (the
“NasdaqGS”), or if not the NasdaqGS, the principal securities exchange or other securities market on which the Common Stock is then being traded. 

c. The Company shall furnish to each Investor and its legal counsel (i) promptly after the same is prepared and publicly distributed, filed with the SEC
or received by the Company, one copy of each Registration Statement and any amendment thereto, each preliminary prospectus and prospectus and each amendment or supplement thereto, and, each letter written by or on behalf of the Company to the SEC or
the staff of the SEC, and each item of correspondence from the SEC or the staff of the SEC, in each case relating to such Registration Statement (other than any portion of any thereof which contains information for which the Company has sought or
intends to seek confidential treatment, which contains or reflects any material non-public information with respect to the Company or its securities or which relates to Company matters that are in the
reasonable judgment of the Company not relevant to the Investor’s interests with respect to the Registrable Securities), and (ii) such number of copies of a prospectus, including a preliminary prospectus, and all amendments and supplements
thereto and such other documents as an Investor may reasonably request in order to facilitate the disposition of the Registrable Securities owned by such Investor; provided that the Company may determine in its reasonable judgment to provide any
such copies in electronic form only. The Company will promptly notify each of the Investors by electronic mail of the effectiveness of each Registration Statement or any post-effective amendment. The Company will promptly respond to any and all
comments received from the SEC, with a view towards causing each Registration Statement or any amendment thereto (including any post-effective amendment to the Existing Registration Statement) to be declared effective by the SEC as soon as
practicable and, as soon as practicable, but in no event later than three (3) business days, following the resolution or clearance of all SEC comments or, if applicable, following notification by the SEC that any such Registration Statement or
any amendment thereto will not be subject to review, shall file a request for acceleration of effectiveness of such Registration Statement to a time and date not later than two (2) business days after the submission of such request. No later
than the first business day after such Registration Statement becomes effective, the 

  
 22 

 
Company will file with the SEC the final prospectus included therein pursuant to Rule 424 (or successor thereto) under the Securities Act. 

d. The Company shall use its reasonable best efforts to (i) register and qualify, in any jurisdiction where registration and/or qualification is required,
the Registrable Securities covered by the Registration Statements under such other securities or “blue sky” laws of such jurisdictions in the United States as the Investors shall reasonably request, (ii) prepare and file in those
jurisdictions such amendments (including post-effective amendments) and supplements to such registrations and qualifications as may be reasonably necessary to maintain the effectiveness thereof during the Registration Period, (iii) take such
other actions as may be reasonably necessary to maintain such registrations and qualifications in effect at all times during the Registration Period, and (iv) take all other actions reasonably necessary or advisable to qualify the Registrable
Securities for sale in such jurisdictions; provided, however, that the Company shall not be required in connection therewith or as a condition thereto to (x) qualify to do business in any jurisdiction where it would not otherwise be required to
qualify but for this Section 3(d), (y) subject itself to general taxation in any such jurisdiction, or (z) file a general consent to service of process in any such jurisdiction. 

e. As promptly as practicable after becoming aware of such event, the Company shall notify each Investor that holds Registrable Securities of the happening of
any event, of which the Company has knowledge, as a result of which the prospectus included in any Registration Statement, as then in effect, includes an untrue statement of a material fact or omits to state a material fact required to be stated
therein or necessary to make the statements therein not misleading, and promptly prepare a supplement or amendment to any Registration Statement to correct such untrue statement or omission, and deliver such number of copies of such supplement or
amendment to each Investor as such Investor may reasonably request. 
 f. The Company shall use its reasonable best efforts to prevent the issuance of any
stop order or other suspension of effectiveness of any Registration Statement, and, if such an order is issued, to obtain the withdrawal of such order at the earliest possible moment and to notify each Investor that holds Registrable Securities
(and, in the event of an underwritten offering, the managing underwriters) of the issuance of such order and the resolution thereof. 
 g. The Company shall
permit a single firm of counsel designated by the Investors (“Legal Counsel”) to review such Registration Statement and all amendments and supplements thereto (as well as all requests for acceleration or effectiveness thereof), a
reasonable period of time prior to their filing with the SEC (not less than five (5) business days but not more than eight (8) business days) and not file any documents in a form to which Legal Counsel reasonably objects and will not
request acceleration of such Registration Statement without prior notice to Legal Counsel. 
 h. The Company shall hold in confidence and not make any
disclosure of information concerning an Investor provided to the Company unless (i) disclosure of such information is necessary to comply with federal or state securities laws, (ii) the disclosure of such information is necessary to avoid
or correct a misstatement or omission in any Registration Statement, (iii) the release of such information is ordered pursuant to a subpoena or other order from a court or governmental body of competent jurisdiction, or (iv) such
information has been made generally available to the public other than by disclosure in violation of this or any other agreement. The Company agrees that it shall, upon learning that disclosure of such information concerning any Investor is sought
in or by a court or governmental body of competent jurisdiction or through other means, give prompt notice to such Investor prior to making such disclosure, and allow such Investor, at its expense, to undertake appropriate action to prevent
disclosure of, or to obtain a protective order for, such information. 
 i. The Company shall use its reasonable best efforts to cause all the Registrable
Securities covered by each Registration Statement to be listed on each securities exchange on which securities of the same class or 

  
 23 

 
series issued by the Company are then listed, if any, if the listing of such Registrable Securities is then permitted under the rules of such exchange, and, to arrange for at least two market
makers to register with the Financial Industry Regulatory Authority, Inc. (“FINRA”) as such with respect to such Registrable Securities. 
 j. The
Company shall provide a transfer agent and registrar, which may be a single entity, for the Registrable Securities not later than the effective date of the initial Registration Statement. 

k. The Company shall cooperate with each Investor that holds Registrable Securities being offered and the managing underwriter or underwriters with respect to
an applicable Registration Statement, if any, to facilitate the timely (i) preparation and delivery of certificates (not bearing any restrictive legends) representing Registrable Securities to be offered pursuant to such Registration Statement,
and enable such certificates to be registered in such names and in such denominations or amounts, as the case may be, or (ii) crediting of the Registrable Securities to be offered pursuant to a Registration Statement to the applicable account
(or accounts) with The Depository Trust Company through its Deposit/Withdrawal At Custodian (DWAC) system, in any such case as such Investor or the managing underwriter or underwriters, if any, may reasonably request. Within three (3) business
days after a Registration Statement which includes Registrable Securities becomes effective, the Company shall deliver, and shall cause legal counsel selected by the Company to deliver, to the transfer agent for the Registrable Securities (with
copies to each Investor) an appropriate instruction and an opinion of such counsel in the form required by the transfer agent in order to issue the Registrable Securities free of restrictive legends. 

l. At the reasonable request of an Investor, the Company shall prepare and file with the SEC such amendments (including post-effective amendments) and
supplements to a Registration Statement and any prospectus used in connection with the Registration Statement as may be necessary in order to change the plan of distribution set forth in such Registration Statement. 

m. The Company shall not, and shall not agree to, allow the holders of any securities of the Company to include any of their securities (other than Registrable
Securities) in any Registration Statement filed pursuant to Section 2(a) or Section 3(b) hereof or any amendment or supplement thereto under Section 3(b) hereof without the consent of Investors holding a
majority-in-interest of the then outstanding Registrable Securities. In addition, the Company shall not include any securities for its own account or the account of
others in any Registration Statement filed pursuant to Section 2(a) or Section 3(b) hereof or any amendment or supplement thereto filed pursuant to Section 3(b) hereof without the consent of Investors holding a majority-in-interest of the then outstanding Registrable Securities. 
 n.
Reserved. 
 o. The Company shall comply with all applicable laws related to a Registration Statement and offering and sale of securities and all applicable
rules and regulations of governmental authorities in connection therewith (including the Securities Act and the Exchange Act and the rules and regulations promulgated by the SEC). 

p. If required by the FINRA Corporate Financing Department, the Company shall promptly effect a filing with FINRA pursuant to FINRA Rule 5110 (or successor
thereto) with respect to the public offering contemplated by resales of securities under the Registration Statement (an “Issuer Filing”), and pay the filing fee required by such Issuer Filing. The Company shall use its reasonable best
efforts to pursue the Issuer Filing until FINRA issues a letter confirming that it does not object to the terms of the offering contemplated by the Registration Statement. 

q. If at any time the SEC advises the Company in writing that the offering of some or all of the Registrable 

  
 24 

 
Securities in a Registration Statement is not eligible to be made on a delayed or continuous basis under the provisions of Rule 415 under the Securities Act, the Company shall use its reasonable
best efforts to persuade the SEC that the offering contemplated by a Registration Statement is a bona fide secondary offering and not an offering “by or on behalf of the issuer” as defined in Rule 415 and that none of the Investors is an
“underwriter.” The Investors shall have the right to participate or have their respective counsel participate in any meetings or discussions with the SEC regarding the SEC’s position and to comment or have their respective counsel
comment on any written submission made to the SEC with respect thereto. No such written submission shall be made to the SEC to which any Investor’s counsel reasonably objects. In the event that, despite the Company’s reasonable best
efforts and compliance with the terms of this Section 3(q), the SEC refuses to alter its position, the Company shall remove from the Registration Statement such portion of the Registrable Securities as the SEC requires in writing be removed
therefrom. Any such cut-back imposed by the SEC as contemplated by this Section 3(q) shall be imposed on a pro rata basis (based upon the Registrable Securities held by each of the Investors). 

r. Notwithstanding anything to the contrary in Section 3(e), at any time after the effective date of the applicable Registration
Statement, the Company may delay the disclosure of material non-public information concerning the Company the disclosure of which at the time is not, in the good faith opinion of the Board of Directors of the
Company and its counsel, in the best interest of the Company and not, in the opinion of counsel to the Company, otherwise required (a “Grace Period”); provided, that the Company shall (i) promptly notify the Investors in
writing of the existence of material non-public information giving rise to a Grace Period (provided that in each notice the Company shall not disclose the content of such material non-public information to any Investor unless otherwise requested in writing by such Investor) and the date on which the Grace Period will begin, and (ii) as soon as such date may be determined, promptly notify
the Investors in writing of the date on which the Grace Period ends; and, provided, further, that (A) no Grace Period shall exceed forty-five (45) consecutive days, (B) during any three hundred sixty five (365) day
period, such Grace Periods shall not exceed an aggregate of seventy-five (75) days, and (C) the first day of any Grace Period must be at least ten (10) business days after the last day of any prior Grace Period (each Grace Period that
satisfies all of the requirements of this Section 3(r) being referred to as an “Allowable Grace Period”). For purposes of determining the length of a Grace Period above, the Grace Period shall begin on and
include the date the Investors receive the notice referred to in clause (i) and shall end on and include the later of the date the Investors receive the notice referred to in clause (ii) and the date referred to in such notice. The
provisions of Section 3(e) hereof shall not be applicable during the period of any Allowable Grace Period, Failure Payments (as defined in the Warrants) shall not accrue on any day during an Allowable Grace Period, and the
unavailability of a Registration Statement for resales of the Registrable Securities on any day during an Allowable Grace Period shall not constitute a “Registration Failure” (as defined in the Warrants). Upon expiration of the Grace
Period, the Company shall again be bound by the first sentence of Section 3(e) with respect to the information giving rise thereto unless such material non-public information is no
longer applicable. 
 4. OBLIGATIONS OF THE INVESTOR. In connection with the registration of the Registrable Securities, each Investor shall have the
following obligations: 
 a. It shall be a condition precedent to the obligations of the Company to complete the registration pursuant to this Agreement with
respect to the Registrable Securities of an Investor that such Investor shall furnish to the Company such information regarding itself, the Registrable Securities held by it and the intended method of disposition of the Registrable Securities held
by it as shall be reasonably required to effect the registration of such Registrable Securities and shall execute such documents in connection with such registration as the Company may reasonably request. At least five (5) business days prior
to the first anticipated filing date of a Registration Statement, the Company shall notify each Investor of the information the Company requires from such Investor. Any such information shall not contain any untrue statement of a material fact or
omit to state a material fact required to be stated therein, or necessary to make 

  
 25 

 
the statements therein not misleading. An Investor must provide such information to the Company at least two (2) business days prior to the first anticipated filing date of such Registration
Statement if such Investor elects to have any Registrable Securities included in the Registration Statement. 
 b. Each Investor, by such Investor’s
acceptance of the Registrable Securities, agrees to cooperate with the Company as reasonably requested by the Company in connection with the preparation and filing of a Registration Statement hereunder, unless such Investor has notified the Company
in writing of such Investor’s election to exclude all of the Investor’s Registrable Securities from such Registration Statement. 
 c. In the event
of an underwritten offering pursuant to Section 2(b) in which any Registrable Securities of any Investor are to be included, such Investor agrees to enter into and perform the Investor’s obligations under an underwriting agreement, in
usual and customary form, including customary indemnification and contribution obligations (as applicable to selling security holders generally), with the managing underwriter of such offering and take such other actions as are reasonably required
in order to expedite or facilitate the disposition of such Investor Registrable Securities. 
 d. Each Investor agrees that, upon receipt of any notice from
the Company of the happening of any event of the kind described in Section 3(e) or 3(f), such Investor will immediately discontinue disposition of Registrable Securities pursuant to the Registration Statement covering such Registrable
Securities until such Investor’s receipt of the copies of the supplemented or amended prospectus contemplated by Section 3(e) or 3(f). 
 e. Each
Investor agrees that it will promptly notify the Company of any material changes in the information set forth in a Registration Statement furnished by or regarding such Investor, other than changes in the number of shares beneficially owned. 

5. REGISTRATION FAILURE. In the event of a Registration Failure (as defined in the Warrants), the Investors shall be entitled to Failure
Payments (as defined in the Warrants) and such other rights as set forth in the Warrants. 
 6. EXPENSES OF REGISTRATION. All reasonable expenses,
other than underwriting discounts and commissions, incurred in connection with registrations, filings or qualifications pursuant to Sections 2 and 3, including, without limitation, all registration, listing and qualification fees, printers and
accounting fees, and the fees and disbursements of counsel for the Company shall be borne by the Company.    The Company shall also reimburse the Investors for the reasonable fees and disbursements of Legal Counsel in the
aggregate amount up to $25,000 per registration in connection with registrations pursuant to Section 2 or 3 of this Agreement. 
 7.
INDEMNIFICATION. In the event any Registrable Securities are included in a Registration Statement under this Agreement: 
 a. The Company will indemnify,
hold harmless and defend (i) each Investor, (ii) the directors, officers, partners, managers, members, employees and agents of each Investor, and each Person who controls any Investor within the meaning of the Securities Act or the
Exchange Act, if any, (iii) any underwriter (as defined in the Securities Act) for each Investor in connection with an underwritten offering pursuant to Section 2(b) hereof, and (iv) the directors, officers, partners and employees of,
and each Person who controls, any such underwriter within the meaning of the Securities Act or the Exchange Act, if any (each, an “Indemnified Person”), against any joint or several losses, claims, damages, liabilities or expenses
(collectively, together with actions, proceedings or inquiries by any regulatory or self-regulatory organization, whether commenced or threatened, in respect thereof, “Claims”) to which any of them may become subject insofar as such Claims
arise out of or are based upon: (i) any untrue statement or alleged 

  
 26 

 
untrue statement of a material fact in any Registration Statement, or any amendment as supplement thereto, or any filing made under state securities laws as required hereby, or the omission or
alleged omission to state therein a material fact required to be stated or necessary to make the statements therein not misleading; (ii) any untrue statement or alleged untrue statement of a material fact contained in any Prospectus, or any
amendment or supplement thereto, or the omission or alleged omission to state therein any material fact necessary to make the statements made therein, in the light of the circumstances under which the statements therein were made, not misleading; or
(iii) any violation or alleged violation by the Company of the Securities Act, the Exchange Act, any other law, including any state securities law, or any rule or regulation thereunder relating to the offer or sale of the Registrable Securities
(the matters in the foregoing clauses (i) through (iii) being, collectively, “Violations”). The Company shall reimburse the Indemnified Person, promptly as such expenses are incurred and are due and payable, for any reasonable legal
fees and other reasonable expenses incurred by them in connection with investigating or defending any such Claim. Notwithstanding anything to the contrary contained herein, the indemnification agreement contained in this Section 7(a) shall not
apply to a Claim arising out of or based upon a Violation to the extent that such Violation occurs in reliance upon and in conformity with information furnished in writing to the Company by or on behalf of any Indemnified Person expressly for use in
connection with the preparation of such Registration Statement or any such amendment thereof or supplement thereto, or (B) to any amounts paid in settlement of any Claim effected without the prior written consent of the Company, which consent
shall not be unreasonably withheld or delayed. Such indemnity shall remain in full force and effect regardless of any investigation made by or on behalf of the Indemnified Person and shall survive the transfer of the Registrable Securities by any of
the Investors pursuant to Section 10. 
 b. Promptly after receipt by an Indemnified Person under this Section 7 of notice of the commencement of
any action (including any governmental action), such Indemnified Person shall, if a Claim in respect thereof is to be made against the Company under this Section 7, deliver to the Company a written notice of the commencement thereof, and the
Company shall have the right to participate in, and, to the extent the Company so desires, to assume control of the defense thereof with counsel mutually satisfactory to the Company and the Indemnified Person, as the case may be; 

provided, however, that an Indemnified Person shall have the right to retain its own counsel with the reasonable fees and expenses to be paid by
the Company, if, in the reasonable opinion of counsel for such Indemnified Person, the representation by such counsel of the Indemnified Person and the Company would be inappropriate due to actual or potential differing interests between such
Indemnified Person and any other party represented by such counsel in such proceeding. The Company shall pay for only one separate legal counsel for the Indemnified Persons, and such legal counsel shall be selected by the Investors. The failure to
deliver written notice to the Company within a reasonable time of the commencement of any such action shall not relieve the Company of any liability to the Indemnified Person under this Section 7, except to the extent that the Company is
actually prejudiced in its ability to defend such action, and shall not relieve the Company of any liability to the Indemnified Person otherwise than pursuant to this Section 7. The Company shall not, without the prior written consent of the
Indemnified Persons, consent to entry of any judgment or enter into any settlement or other compromise with respect to any Claim in respect of which indemnification or contribution may be or has been sought hereunder (whether or not any such
Indemnified Party is an actual or potential party to such action or claim) which does not include as an unconditional term thereof the giving by the claimant or plaintiff to the Indemnified Persons of a full release from all liability with respect
to such Claim or which includes any admission as to fault or culpability on the part of any Indemnified Person. The indemnification required by this Section 7 shall be made by periodic payments of the amount thereof during the course of the
investigation or defense, as any expense, loss, damage or liability is incurred. 
 c. Each Investor will indemnify, hold harmless and defend (i) the
Company, and (ii) the directors, officers, partners, managers, members, employees or agents of the Company, if any (each, a “Company Indemnified 

  
 27 

 
Person”), against any Claims to which any of them may become subject insofar as such Claims arise out of or are based upon any violation or alleged violation by the Company of the Securities
Act, the Exchange Act, any other law, including any state securities law, or any rule or regulation thereunder relating to the offer or sale of the Registrable Securities, which occurs due to the inclusion by the Company in a Registration Statement
of false or misleading information about an Investor, where such information was furnished in writing to the Company by or on behalf of such Investor expressly for the purpose of inclusion in such Registration Statement. Notwithstanding anything
herein to the contrary, the indemnity agreement contained in this Section 7(c) shall not apply to amounts paid in settlement of any Claim if such settlement is effected without the prior written consent of the Investors, which consent shall not
be unreasonably withheld or delayed; and provided, further, however, that an Investor shall be liable under this Section 7(c) for only that amount of a Claim as does not exceed the net amount of proceeds received by such Investor as a
result of the sale of Registrable Securities pursuant to such Registration Statement. 
 d. Promptly after receipt by a Company Indemnified Person under this
Section 7 of notice of the commencement of any action (including any governmental action), such Company Indemnified Person shall, if a Claim in respect thereof is to be made against any Investor under this Section 7, deliver to such
Investor a written notice of the commencement thereof, and such Investor shall have the right to participate in, and, to the extent such Investor so desires, to assume control of the defense thereof with counsel mutually satisfactory to such
Investor and such Company Indemnified Person. 
 8. CONTRIBUTION. If for any reason the indemnification provided for in Section 7(a) or 7(c) (as
applicable) is unavailable to an Indemnified Person or Company Indemnified Person (as applicable) or insufficient to hold it harmless, other than as expressly specified therein, then the indemnifying party shall contribute to the amount paid or
payable by the Indemnified Person or Company Indemnified Person (as applicable) as a result of the Claim in such proportion as is appropriate to reflect the relative fault of the Indemnified Person or Company Indemnified Person (as applicable) and
the indemnifying party (provided that the relative fault of any Company Indemnified Person shall be deemed to include the fault of all other Company Indemnified Persons), as well as any other relevant equitable considerations. No Person guilty of
fraudulent misrepresentation within the meaning of Section 11(f) of the Securities Act shall be entitled to contribution from any Person not guilty of such fraudulent misrepresentation. In no event shall the contribution obligation of an
Investor be greater in amount than the net amount of proceeds received by such Investor as a result of the sale of Registrable Securities giving rise to such contribution obligation pursuant to the applicable Registration Statement (net of the
aggregate amount of any damages or other amounts such Investor has otherwise been required to pay (pursuant to Section 7(c) or otherwise) by reason of such Investor’s untrue or alleged untrue statement or omission or alleged omission).

 9. REPORTS UNDER THE 1934 ACT. With a view to making available to the Investors the benefits of Rule 144 promulgated under the Securities Act
or any other similar rule or regulation of the SEC that may at any time permit the Investors to sell securities of the Company to the public without registration, the Company agrees to: 

a. make and keep public information available, as those terms are understood and defined in Rule 144; 

b. file with the SEC in a timely manner all reports and other documents required of the Company under the Exchange Act so long as the Company remains subject
to such requirements and the filing of such reports and other documents is required for the applicable provisions of Rule 144; and 
 c. so long as any
of the Investors owns Registrable Securities, promptly upon request, furnish to such Investor (i) a written statement by the Company that it has complied with the reporting requirements of the Exchange Act as required for applicable provisions
of Rule 144, (ii) a copy of the most recent annual or 

  
 28 

 
quarterly report of the Company and such other reports and documents so filed by the Company and (iii) such other information as may be reasonably requested to permit such Investor to sell
such Registrable Securities pursuant to Rule 144 without registration. 
 10. ASSIGNMENT OF REGISTRATION RIGHTS. The rights under this Agreement
shall be automatically assignable by each Investor to any transferee of all or any portion of the Registrable Securities if: (i) such Investor agrees in writing with the transferee or assignee to assign such rights, and a copy of such agreement
is furnished to the Company within a reasonable time after such assignment, (ii) the Company is, within a reasonable time after such transfer or assignment, furnished with written notice of (a) the name and address of such transferee or
assignee, and (b) the securities with respect to which such registration rights are being transferred or assigned, and (iii) at or before the time the Company receives the written notice contemplated in clause (ii) of this sentence,
the transferee or assignee agrees in writing with the Company to be bound by all of the provisions contained herein as applicable to the Investors. In the event that the Company receives written notice from an Investor that it has transferred
all or any portion of its Registrable Securities pursuant to this Section, the Company shall have up to ten (10) days to file any amendments or supplements necessary to keep a Registration Statement current and effective pursuant to
Rule 415, and the commencement date of any Event of Failure (as defined in the Warrants) or Event of Default (as defined in the Warrants) under the Warrants caused thereby will be extended by ten (10) days. Each Investor shall at all times
comply with the restrictions on transfer set forth in Section 8 of the Warrant (to the extent applicable to such Investor), which provisions are hereby incorporated by reference and made a part hereof. 

11. AMENDMENT OF REGISTRATION RIGHTS. Provisions of this Agreement may be amended and the observance thereof may be waived (either generally or in a
particular instance and either retroactively or prospectively), only with written consent of the Company and the holders of a majority in interest of then-outstanding Registrable Securities. Any amendment or waiver effected in accordance with this
Section 11 shall be binding upon each of the Investors and the Company. 
 12. MISCELLANEOUS. 

a. A Person is deemed to hold, and be a holder of, shares of Common Stock or other Registrable Securities whenever such Person owns of record or beneficially
through a “street name” holder such shares of Common Stock or other Registrable Securities (or the Warrants or other securities upon exercise, conversion or exchange of which such Registrable Securities are directly or indirectly issuable,
without giving effect to any limitations on exercise, conversion or exchange of the Warrants or other securities), and solely for purposes hereof, Registrable Securities shall be deemed outstanding to the extent they are directly or indirectly
issuable upon exercise, conversion or exchange of the Warrants or other outstanding securities, Registrable Securities, without giving effect to any limits on exercise, conversion or exchange of the Warrants or other securities. If the Company
receives conflicting instructions, notices or elections from two or more Persons with respect to the same Registrable Securities, the Company shall act upon the basis of instructions, notice or election received from the registered owner of such
Registrable Securities (or the Warrants or other securities upon exercise, conversion or exchange of which such Registrable Securities are directly or indirectly issuable). 

b. Any notices required or permitted to be given under the terms hereof shall be sent by certified or registered mail (return receipt requested) or delivered
personally or by courier (including a recognized overnight delivery service) or by electronic mail and shall be effective five days after being placed in the mail, if mailed by regular United States mail, or upon receipt, if delivered personally or
by courier (including a recognized overnight delivery service) or by electronic mail, in each case addressed to a party. The addresses for such communications shall be: 

  
 29 

 If to the Company: 

Endologix, Inc. 
 2 Musick 

Irvine, CA 92618 
 E-mail:
jtejedor@endologix.com 
 Attn: Vaseem Mahboob, CFO 
 Attn:
James Tejedor, Treasury Manager 
 With copy to: 
 DLA Piper LLP
(US) 
 4365 Executive Drive, Suite 1100 
 San Diego, CA 92101

 E-mail: michael.kagnoff@dlapiper.com 

Attn: Michael Kagnoff 
 If to an Investor: 

c/o Deerfield Mgmt, L.P. 
 780 Third Avenue, 37th Floor 
 New York, NY 10017 

Fax: (212) 599-1248 

Email: 
 Attn: David J. Clark, Esq. 

With a copy to: 
 Katten Muchin Rosenman LLP 

575 Madison Avenue 
 New York, NY 10022 

Fax: (212) 940-8776 

Email: mark.fisher@kattenlaw.com and mark.wood@kattenlaw.com 

Attn: Mark I. Fisher, Esq. 

         Mark D. Wood, Esq. 

Each party shall provide notice to the other party of any change in address. 

c. Failure of any party to exercise any right or remedy under this Agreement or otherwise, or delay by a party in exercising such right or remedy, shall not
operate as a waiver thereof. 
 d. Governing Law. All questions concerning the construction, validity, enforcement and interpretation of this Agreement shall
be governed by and construed and enforced in accordance with the internal laws of the State of New York, without regard to the principles of conflicts of law thereof. Each party agrees that all legal proceedings concerning the interpretations,
enforcement and defense of the transactions contemplated by this Agreement (whether brought against a party hereto or its respective affiliates, directors, officers, shareholders, employees or agents) shall be commenced exclusively in the state and
federal courts sitting in the City of New York, borough of Manhattan. Each party hereby irrevocably submits to the exclusive jurisdiction of the state and federal courts sitting in the City of New York, Borough of Manhattan for the adjudication of
any dispute hereunder or in connection herewith or with any transaction contemplated hereby or discussed herein, and hereby irrevocably waives, and agrees not to assert in any suit, action or 

  
 30 

 
proceeding, any claim that it is not personally subject to the jurisdiction of any such court, that such suit, action or proceeding is improper or is an inconvenient venue for such proceeding.
Each party hereby irrevocably waives personal service of process and consents to process being served in any such suit, action or proceeding by mailing a copy thereof via registered or certified mail or overnight delivery (with evidence of delivery)
to such party at the address in effect for notices to it under this Agreement and agrees that such service shall constitute good and sufficient service of process and notice thereof. Nothing contained herein shall be deemed to limit in any way any
right to serve process in any other manner permitted by law. The parties hereby waive all rights to a trial by jury. If either party shall commence an action or proceeding to enforce any provision of this Agreement, then the prevailing party in such
action or proceeding shall be reimbursed by the other party for its reasonable attorneys’ fees and other costs and expenses incurred with the investigation, preparation and prosecution of such action or proceeding. 

e. This Agreement and the Warrants constitute the entire agreement among the parties hereto with respect to the subject matter hereof. This Agreement and the
Warrants (including all schedules and exhibits thereto) supersede all prior agreements and understandings among the parties hereto with respect to the subject matter hereof. 

f. Subject to the requirements of Section 10 hereof, this Agreement shall inure to the benefit of and be binding upon the successors and assigns of each
of the parties hereto, and the provisions of Sections 7 and 8 hereof shall inure to the benefit of, and be enforceable by, each Indemnified Person and Company Indemnified Person (as applicable). 

g. The headings in this Agreement are for convenience of reference only and shall not limit or otherwise affect the meaning hereof. 

h. This Agreement may be executed in two or more counterparts, each of which shall be deemed an original but all of which shall constitute one and the same
agreement. This Agreement, once executed by a party, may be delivered to the other party hereto by electronic transmission of a copy of this Agreement bearing the signature of the party so delivering this Agreement. 

i. Each party shall do and perform, or cause to be done and performed, all such further acts and things, and shall execute and deliver all such other
agreements, certificates, instruments and documents, as the other parties may reasonably request in order to carry out the intent and accomplish the purposes of this Agreement and the consummation of the transactions contemplated hereby. 

j. The Company acknowledges that a breach by it of its obligations hereunder will cause irreparable harm to the Investors by vitiating the intent and purpose
of the transactions contemplated hereby. Accordingly, the Company acknowledges that the remedy at law for breach of its obligations hereunder will be inadequate and agrees, in the event of a breach or threatened breach by the Company of any of the
provisions hereunder, that the Investors shall be entitled, in addition to all other available remedies in law or in equity, to an injunction or injunctions to prevent or cure breaches of the provisions of this Agreement and to enforce specifically
the terms and provisions hereof, without the necessity of showing economic loss and without any bond or other security being required. 
 k. The language
used in this Agreement will be deemed to be the language chosen by the parties to express their mutual intent, and no rules of strict construction will be applied against any party. 

l. In the event that any provision of this Agreement is invalid or unenforceable under any applicable statute or rule of law, then such provision shall be
deemed inoperative to the extent that it may conflict therewith and shall be deemed modified to conform with such statute or rule of law. Any provision hereof which may 

  
 31 

 
prove invalid or unenforceable under any law shall not affect the validity or enforceability of any other provision hereof. 

m. In the event an Investor shall sell or otherwise transfer any of such holder’s Registrable Securities, each transferee shall be allocated a pro rata
portion of the number of Registrable Securities included in a Registration Statement for such transferor. 
 n. There shall be no oral modifications or
amendments to this Agreement. This Agreement may be modified or amended only in writing. 
 o. The Company shall not grant any Person any registration rights
with respect to shares of Common Stock or any other securities of the Company other than registration rights that will not adversely affect the rights of the Investors hereunder (including by limiting in any way the number of Registrable Securities
that could be included in any Registration Statement pursuant to Rule 415) and shall not otherwise enter into any agreement that is inconsistent with the rights granted to the Investors hereunder. 

p. The obligations of each Investor hereunder are several and not joint with the obligations of any other Investor, and no provision of this Agreement is
intended to confer any obligations on any Investor vis-à-vis any other Investor. Nothing contained herein, and no action taken by any Investor pursuant hereto,
shall be deemed to constitute the Investors as a partnership, an association, a joint venture or any other kind of entity, or create a presumption that the Investors are in any way acting in concert or as a group with respect to such obligations or
the transactions contemplated herein. 
 q. Unless the context otherwise requires, (i) all references to Sections, Schedules or Exhibits are to
Sections, Schedules or Exhibits contained in or attached to this Agreement, (ii) words in the singular or plural include the singular and plural, and pronouns stated in either the masculine, the feminine or neuter gender shall include the
masculine, feminine and neuter, and (ii) the use of the word “including” in this Agreement shall be by way of example rather than limitation. 

[Remainder of page left intentionally blank] 

[Signature page follows] 
  

  
 32 

 IN WITNESS WHEREOF, the undersigned Investors and the Company have caused this Amended and
Restated Registration Rights Agreement to be duly executed as of the date first written above. 
  

	
	 COMPANY:
  

	 ENDOLOGIX, INC., a Delaware corporation
  

	By:                                     
                                         
                  
	Name:                                     
                                         
            
	Title:                                     
                                         
              

 IN WITNESS WHEREOF, the undersigned Investors and the Company have caused this Amended and
Restated Registration Rights Agreement to be duly executed as of the date first written above. 
  

			
	INVESTORS:
	
	DEERFIELD PRIVATE DESIGN FUND IV, L.P.
	
	By: Deerfield Mgmt IV, L.P., General Partner
	
	By: J.E. Flynn Capital IV, LLC, General Partner
		
	By:	 	  

	Name:	 	James E. Flynn
	Title:	 	President
	
	DEERFIELD PRIVATE DESIGN FUND III, L.P.
	
	By: Deerfield Mgmt III, L.P., General Partner
	
	By: J.E. Flynn Capital III, LLC, General Partner
		
	By:	 	  

	Name:	 	James E. Flynn
	Title:	 	President
	
	DEERFIELD PARTNERS, L.P.
	
	By: Deerfield Mgmt, L.P., General Partner
	
	By: J.E. Flynn Capital, LLC, General Partner
		
	By:	 	  

	Name:	 	James E. Flynn
	Title:	 	President

 EXHIBIT F 

FORM OF COMPLIANCE CERTIFICATE 

                    ,
20         
 Deerfield Private Design Fund IV, L.P. 

c/o Deerfield Management Company, L.P. 
 780 Third Avenue, 37th Floor 
 New York, New York 10017 

Ladies and Gentlemen: 
 The undersigned,
ENDOLOGIX, INC., a Delaware corporation (“Borrower”) pursuant to Section 5.1(h) [and Section 5.1(aa)]11 of the Amended and
Restated Facility Agreement dated as of [        ], 2018 (as amended, restated, supplemented or otherwise modified from time to time, the “Facility Agreement”) between Borrower, the other Loan
Parties, Deerfield Private Design Fund IV, L.P. (in its capacity as agent for the Secured Parties, the “Agent”) and the “Lenders” from time to time party thereto, hereby delivers this Compliance Certificate (this
“Compliance Certificate”). Capitalized terms used but not otherwise defined herein are used herein as defined in the Facility Agreement. 

[Borrower hereby certifies and warrants to Agent and the Lenders that attached hereto as Annex I is a true, correct and complete copy of its [10-Q][10-K] filing (the “Report”) made with the United States Securities and Exchange Commission (the “SEC”). The Report complies in all
material respects with the applicable requirements of the Exchange Act and does not contain any untrue statement of a material fact or omit to state a material fact required to be stated therein or necessary in order to make the statements therein,
in the light of the circumstances under which they were made, not misleading. The consolidated financial statements included in the Report comply as to form in all material respects with applicable accounting requirements and the published rules and
regulations of the SEC with respect thereto, were prepared in accordance with GAAP, consistently applied [(subject, in the case of unaudited quarterly financial statements, to normal year-end adjustments and
lack of footnote disclosures)]12, and fairly present in all material respects the consolidated financial position of Borrower and its Subsidiaries as of the dates hereof and the consolidated
results of their operations, cash flows and changes in stockholders equity for the periods presented [(subject, in the case of unaudited quarterly financial statements, to normal year-end audit adjustments and
lack of footnote disclosures)]13.]14 [Borrower hereby certifies and warrants to Agent and the Lenders that attached hereto as Annex I is a
true, correct and complete copy of the financial statements and any other materials required under Section 5.1(aa) of the Facility Agreement (the “Statements”). The Statements fairly present in all material respects the
financial position and condition and results of operations, cash flows and changes in stockholders equity of Borrower and its Subsidiaries as of the dates and for the periods and have been prepared in conformity with GAAP applied on a basis
consistent with prior periods.]15 
  

	11 	 The bracketed portion shall only be included during such periods in which the Borrower is not required to file
reports pursuant Section 13 or 15(d) of the Exchange Act. 

	12 	 The bracketed information shall only be included with a 10-Q filing,
but not with a 10-K filing. 

	13 	 The bracketed information shall only be included with a 10-Q filing,
but not with a 10-K filing. 

	14 	 The bracketed portion shall only be included during such periods in which the Borrower is required to file
reports pursuant Section 13 or 15(d) of the Exchange Act. 

	15 	 The bracketed portion shall only be included during such periods in which the Borrower is not required to file
reports pursuant Section 13 or 15(d) of the Exchange Act. 

 Borrower further certifies to Agent and the Lenders that as of the date hereof (a) no
Default or Event of Default or (b) event of default under the ABL Debt Documents or the Convertible Note Documents, in each case, has occurred and is continuing or, if such a Default, Event of Default or event of default has occurred and is
continuing, set forth below is a description of the nature and period of existence of such Default, Event of Default or event of default and what action Borrower has taken, is undertaking and proposes to take with respect thereto. 

As of (a) the last Business Day of each calendar month in the period covered by the [Report][Statements] and (b) each date that a
Borrowing Base Certificate (as defined in the ABL Credit Facility) is required to be delivered under the ABL Credit Facility or any other ABL Debt Document, Global Excess Liquidity is [not] less than $22,500,000 in compliance with the provisions and
terms of Section 5.2(xxiv) of the Facility Agreement. 
 The consolidated Net Revenue of the Loan Parties for the
Measurement Period covered by the [Report][Statements], tested quarterly, is [not] less than $[155,000,000]16 [145,000,000]17 [130,000,000]18 [140,000,000]19 in compliance with the provisions and terms of Section 5.2(xxv) of the Facility Agreement. 

[The consolidated Net Revenue of the Loan Parties for the last fiscal quarter covered in the [Report][Statements] is not less than
30,000,000.]20 
 The aggregate amount of Operating Expenditures made by the Loan
Parties and their Subsidiaries for the Measurement Period covered by the [Reports][Statements] is [not] more than $[160,000,000]21
[140,000,000]22. 
 [The “Fixed Charge Coverage Ratio” (such term, and all
components and subcomponents thereof, as defined in the ABL Credit Agreement as of the Agreement Date) for the Measurement Period covered by the [Reports][Statements] is [not] less than
1.00:1.00.]23 
 The aggregate amount of consolidated Capital Expenditures made by the
Loan Parties and their Subsidiaries does not exceed $[2,500,000]24 [3,000,000]25
[5,000,000]26 [2,000,000]27. 

 

	16 	 Include for Measurement Period ending September 30, 2018. 

	17 	 Include for Measurement Period ending December 31, 2018. 

	18 	 Include for Measurement Period ending March 31, 2019 and the last day of each fiscal quarter ending
thereafter through (and including) December 31, 2019. 

	19 	 Include for Measurement Periods ending March 31, 2020 and the last day of each fiscal quarter ending
thereafter. 

	20 	 Include for Measurement Periods beginning with the fiscal quarter ending March 31, 2019 and on the last
day of each fiscal quarter ending thereafter. 

	21 	 Include for Measurement Period ending December 31, 2018. 

	22 	 Include for Measurement Period ending December 31, 2019. 

	23 	 Include following the “Trigger Date” (as defined in the ABL Credit Agreement as of the Agreement
Date). 

	24 	 Include for Fiscal Year ending 2018. 

	25 	 Include for Fiscal Year ending 2019. 

	26 	 Include for Fiscal Year ending 2020. 

	27 	 Include for Fiscal Year ending 2021. 

 As of the most recent testing date of the financial covenants in the ABL Debt Documents
(including the financial covenants set forth in Article VII of the ABL Credit Facility), Borrower and its Subsidiaries were [not] in compliance with all such financial covenants. 

Detailed calculations of all of the aforementioned financial covenants in the Facility Agreement and the ABL Debt Documents are set forth on
Annex II hereto. All such calculations are true, correct and complete. 
 [If Borrower and its Subsidiaries were not in compliance with
any of the aforementioned financial covenants in the Facility Agreement or the ABL Debt Documents, set forth below is a detailed description and calculation of such noncompliance and what action Borrower has taken, is undertaking and proposes to
take with respect thereto and whether Borrower reasonably and in good faith believes that Borrower and its Subsidiaries will be in compliance in all future periods and testing dates with such financial covenants (and, if not, a detailed description
and calculation of any expected or believed noncompliance in such future periods and for such testing dates): [                    ].] 

Notwithstanding anything to the contrary herein or in any other Loan Document, the provisions of (and the information including in) this
Compliance Certificate (and any Annex hereto) are subject to Section 5.1(q) of the Facility Agreement. 
 [Signature follows on next
page.] 

 IN WITNESS WHEREOF, Borrower has caused this Compliance Certificate to be executed and
delivered by its Responsible Officer on the date first set forth above. 
  

	
	 ENDOLOGIX, INC., a Delaware corporation
  

	By:                                     
                                         
                  
	Name:                                     
                                        
            
	Title:                                     
                                         
              

 ANNEX I 

TO 
 COMPLIANCE
CERTIFICATE 
 ANNEX II 

TO 
 COMPLIANCE
CERTIFICATE 

 Schedule P-1 

Existing Investments 
  

					
	 Name of Issuer
	  	 Description and Value of Security
	  	 Loan Party/Subsidiary

	 Cianna Medical, Inc.
	  	8,677 Shares of Series A Preferred Stock	  	Endologix, Inc.

 Schedule 2.4 

List of Agreement Date Lenders and Such Lenders’ Wire Instructions and Information for Notices 

 

					
	 Name of Lender
	  	 Wire Instructions/ Address for Payments
to
Lender
	  	 Information for Notices

	Deerfield Partners, L.P.	  	 Citibank, N.A. New York
 ABA # 021-000-089
 A/C Morgan Stanley & Co. NY

A/C # 38890774
 Sub A/C Deerfield Partners, L.P.

Sub A/C # 038-036208
	  	 Deerfield Partners, L.P.
 c/o Deerfield
Management Company, L.P.
 780 Third Avenue, 37th Floor
 New
York, NY 10017
 Facsimile: 212-599-3075

E-mail: dclark@deerfield.com

Attn: David J. Clark, Esq.
  

With a copy to (which shall not be deemed to constitute notice):
  

Katten Muchin Rosenman LLP
 575 Madison Avenue

New York NY 10022-2585
 Facsimile: (212) 894-5877
 E-mail: mark.fisher@kattenlaw.com and mark.wood@kattenlaw.com

Attn: Mark I. Fisher, Esq.
 Attn: Mark D. Wood, Esq.

					
	 Name of Lender
	  	 Wire Instructions/ Address for Payments
to
Lender
	  	 Information for Notices

	Deerfield Private Design Fund III, L.P.	  	 Citibank, N.A. New York
 ABA # 021-000-089
 A/C Morgan Stanley & Co. NY

A/C # 38890774
 Sub A/C Deerfield Private Design Fund III,
L.P.
 Sub A/C # 038CDKGC9
	  	 Deerfield Private Design Fund III, L.P.
 c/o
Deerfield Management Company, L.P.
 780 Third Avenue, 37th Floor

New York, NY 10017
 Facsimile: 212-599-3075
 E-mail: dclark@deerfield.com

Attn: David J. Clark, Esq.
  

With a copy to (which shall not be deemed to constitute notice):
  

Katten Muchin Rosenman LLP
 575 Madison Avenue

New York NY 10022-2585
 Facsimile: (212) 894-5877
 E-mail: mark.fisher@kattenlaw.com and mark.wood@kattenlaw.com

Attn: Mark I. Fisher, Esq.
 Attn: Mark D. Wood, Esq.

			
	Deerfield Private Design Fund IV, L.P.	  	 Citibank, N.A. New York
 ABA # 021-000-089
 A/C Morgan Stanley & Co. NY

A/C # 38890774
 Sub A/C Deerfield Private Design Fund IV, L.P.

Sub A/C # 038CDNH16
	  	 Deerfield Private Design Fund IV, L.P.
 c/o
Deerfield Management Company, L.P.
 780 Third Avenue, 37th Floor

New York, NY 10017
 Facsimile: 212-599-3075
 E-mail: dclark@deerfield.com

Attn: David J. Clark, Esq.
  

With a copy to (which shall not be deemed to constitute notice):
  

Katten Muchin Rosenman LLP
 575 Madison Avenue

New York NY 10022-2585
 Facsimile: (212) 894-5877
 E-mail: mark.fisher@kattenlaw.com and mark.wood@kattenlaw.com

Attn: Mark I. Fisher, Esq.
 Attn: Mark D. Wood, Esq.

 Schedule 3.1(d) 

Existing Liens 
 None. 

 Schedule 3.1(f) 

Existing Indebtedness 
 None. 

 Schedule 3.1(h) 

Litigation 
 Vicky Nguyen v.
Endologix, Inc., et al.: (Filed January 3, 2017 in the United States District Court, Central District of California; Case No. 2:17-cv-00017). A putative
shareholder class action pending in the U.S. District Court for the Central District of California. Lead plaintiff in Nguyen asserts multiple causes of action for securities fraud based on allegations that Borrower and two of its executives
misled investors by opining optimistically about Borrower’s prospects for FDA pre-market approval of the Nellix EVAS System. On December 5, 2017, the District Court granted Borrower’s
motion to dismiss lead plaintiff’s First Amended Complaint, with leave to amend. On January 9, 2018, lead plaintiff filed a Second Amended Complaint. Borrower intends to move for dismissal of the Second Amended Complaint with prejudice.
The hearing on Borrower’s Motion to Dismiss lead plaintiff’s Second Amended Complaint has been set for August 10, 2018. 
 Derivative
Lawsuits: As of June 11, 2017, Four shareholders have filed derivative lawsuits on behalf of Borrower, the nominal plaintiff, based on allegations substantially similar to those alleged by lead plaintiff in Nguyen. Those actions
consist of: Sindlinger v. McDermott et al., Case No. BC662280 (Los Angeles Superior Court); Abraham v. McDermott et al., Case No. 30-2018-00968971-CU-BT-CSC (Orange County Superior Court); and Green v. McDermott et al., Case No. 8:17-cv-01155-AB (PLAx), consolidated with Cocco v. McDermott et al., Case No.
8:17-cv-01183-AB (PLAx) (U.S. District Court for the Central District of California). Plaintiffs in the Sindlinger and Green
derivative actions have agreed to stay litigation pending resolution of the Nguyen action. Endologix is currently negotiating a similar agreement with the Abraham plaintiff. A related case, Ahmed v. Endologix, Inc., et al. (Filed
January 11, 2017 in the United States District Court, Central District of California; Case No. 8:17-cv-00061) was consolidated into Nguyen v. Endologix, Inc. 

SEC Investigation: In July 2017, Borrower learned that the United States Securities and Exchange Commission (“SEC”) issued a Formal
Order of Investigation to investigate, among other things, events surrounding the Nellix EVAS System and the prospect of its FDA pre-market approval. Borrower is fully cooperating with the investigation.
Borrower continues to produce materials responsive to the SEC’s subpoenas. 
 Certain Notices: The Loan Parties have received three
unrelated notices from individuals claiming that certain of our products read on certain issued patents held by such individuals. The Loan Parties, after consultation with independent patent counsel, strongly disagree with these claims; however, it
is possible that should these claims proceed to litigation, that Borrower’s aggregate liability arising for monetary judgements or other reliefs arising out of these matters could exceed $2,000,000. Since it is presently not possible to
determine the outcome of any future discussions with these individuals in regard to their patents, and whether or not litigation will ensue, or the outcomes associated with potential litigation, no provision has been made in Borrower’s
financial statements for the ultimate resolution. 

 Schedule 3.1(j) 

Authorizations 
 Borrower is required to
file a Listing of Additional Shares notification with Nasdaq to cover the shares of Common Stock underlying the Additional Warrants, any shares issuable pursuant to the conversion rights set forth in the First Out Waterfall Notes and any shares
issued as Interest Payment Shares. 

 Schedule 3.1(m) 

Real Estate 
 Owned Real Property:

  

			
	 Loan Party or Subsidiary
	  	 Complete street and mailing address, including zip
code

	 N.A.
	  	

 Leased Real Property: 
  

					
	 Loan Party or Subsidiary
	  	 Complete street and mailing

address, including zip code
	  	 Landlord name and contact information

	Endologix, Inc.	  	 2 Musick, Irvine, County of Orange, California 92618 U.S.A.;

33 and 35 Hammond, Irvine, County of Orange, California 92618 U.S.A.
	  	The Northwestern Mutual Life Insurance Company
			
	Endologix International Holdings B.V.	  	Burgemeester Burgerslaan 40, 5245 NH Rosmalen, The Netherlands	  	N.A.
			
	TriVascular Technologies, Inc.	  	3910 Brickway Blvd., Santa Rosa, County of Sonoma, CA 95403 U.S.A.	  	Sonoma Airport Properties LLC
			
	Endologix Singapore Private Limited	  	 10 Anson Road #21-04 & #21-04A

International Plaza Singapore 079903
	  	Stamcorp International Pte Ltd.
			
	Endologix International B.V.	  	Rahmannstraße 11, 65760 Eschborn, Germany	  	N.A.

 Subleased Real Property: 
  

					
	 Loan Party or Subsidiary
	  	 Complete street and mailing

address, including zip code
	  	 Landlord and sublandlord

name and contact information

Other Real Property Operated or Occupied: 
  

					
	 Loan Party or Subsidiary
	  	 Complete street and mailing

address, including zip code
	  	 Nature of use

	ELGX South Korea Ltd.	  	A-311, M-Sate, 114 Beopwon-ro, Songpa-gu, Seoul, South Korea	  	Office

 Schedule 3.1(n) 

Intellectual Property 
 The items disclosed
in Schedule 3.1(h) with the lead-in “Certain Notices”. 
 On May 7, 2018, Borrower received notice
from Medtronic, Inc. (“Medtronic”) that Medtronic believes Borrower’s Ovation product appears to use one or more claims of certain Medtronic patents. Borrower is assessing this claim. Medtronic has invited Borrower to engage in
discussions to obtain a non-exclusive license to these patents. Borrower has a robust patent portfolio at its disposal, and after conducting analysis believes that one or more of Medtronic’s products
appears to use one or more claims of Borrower’s patents. Since it is presently not possible to determine the outcome of any future discussions with Medtronic in regard to the respective parties’ patents, and whether or not litigation will
ensue, or the outcomes associated with potential litigation, no provision has been made in Borrower’s financial statements for the ultimate resolution. 

 Schedule 3.1(x) 

Borrower’s Subsidiaries 
  

													
	 Parent
	  	Percentage
ownership	  	 Name of
Subsidiary
	  	 Jurisdiction of
Subsidiary
	  	Date of
formation of
Subsidiary	  	 Federal
employer ID no.
of Subsidiary
	  	 Organizational
identification no.
of
Subsidiary

	Endologix, Inc.	  	100%	  	Nellix, Inc.	  	Delaware	  	03/20/2001	  	94-3398416	  	3359980
							
	Endologix, Inc.	  	100%	  	CVD/RMS Acquisition Corp.	  	Delaware	  	12/13/1998	  	33-0928438	  	2955166
							
	Endologix, Inc.	  	100%	  	RMS/Endologix Sideways Merger Corp.	  	Delaware	  	05/30/2002	  	03-0512974	  	3530477
							
	Endologix, Inc.	  	100%	  	Endologix Singapore Private Limited	  	Singapore	  	01/13/2015	  	N.A.	  	N.A.
							
	Endologix, Inc.	  	100%	  	ELGX International Holdings GP	  	Cayman Islands	  	07/05/2011	  	N.A.	  	N.A.
							
	Endologix, Inc.	  	100%	  	Endologix New Zealand Co.	  	New Zealand	  	05/31/2012	  	N.A.	  	N.A.
							
	Endologix, Inc.	  	100%	  	ELGX South Korea Ltd.	  	South Korea	  	12/07/2017	  	N.A.	  	N.A.
							
	 Endologix, Inc.
 ELGX International Holdings
GP
	  	99%
 1%
	  	Endologix Bermuda L.P.	  	Bermuda	  	07/24/2012	  	N.A.	  	N.A.
							
	Endologix International Holdings B.V.	  	100%	  	Endologix Poland spolkda z ograniczona odpowiedzialnoscia	  	Poland	  	03/26/2015	  	N.A.	  	N.A.
							
	Endologix Bermuda L.P.	  	100%	  	Endologix International Holdings B.V.	  	The Netherlands	  	08/22/2011	  	N.A.	  	N.A.
							
	Endologix International Holdings B.V.	  	100%	  	Endologix Italia S.r.l.	  	Italy	  	06/04/2012	  	N.A.	  	N.A.
							
	Endologix International holdings B.V.	  	100%	  	Endologix International B.V.	  	The Netherlands	  	08/22/2011	  	N.A.	  	N.A.
							
	Endologix, Inc.	  	100%	  	TriVascular Technologies, Inc.	  	Delaware	  	07/11/2007	  	87-0807313	  	4387054
							
	TriVascular Technologies, Inc.	  	100%	  	TriVascular, Inc.	  	California	  	01/05/1998	  	68-0402620	  	C2065374
							
	TriVascular, Inc.	  	100%	  	TriVascular Sales, LLC	  	Texas	  	08/23/2012	  	46-0859179	  	0801644988

													
	 Parent
	  	Percentage
ownership	  	 Name of
Subsidiary
	  	 Jurisdiction of
Subsidiary
	  	Date of
formation of
Subsidiary	  	 Federal
employer ID no.
of Subsidiary
	  	 Organizational
identification no.
of
Subsidiary

	TriVascular, Inc.	  	100%	  	Endologix Canada, LLC	  	Delaware	  	11/25/2014	  	N.A.	  	5647226
							
	TriVascular, Inc.	  	100%	  	TriVascular Germany GmbH	  	Germany	  	05/14/2012	  	N.A.	  	N.A.
							
	TriVascular, Inc.	  	100%	  	TriVascular Switzerland Sarl	  	Switzerland	  	04/30/2010	  	N.A.	  	N.A.
							
	TriVascular, Inc.	  	100%	  	TriVascular Italia S.R.L.	  	Italy	  	04/08/2010	  	N.A.	  	N.A.

 Schedule 3.1(z) 

Borrower’s Outstanding Shares of Stock, Options and Warrants 

 

									
	 Name of Issuer
	  	 Authorized

Securities
	  	 Issued and

Outstanding Securities
	  	 Certificated
(Yes or No)
	  	 Loan Party/
Subsidiary
Owner

	Endologix, Inc. 	  	170,000,000 Shares of Common Stock, $0.001 par value	  	84,946,471 Shares of Common Stock Issued and 84,557,225 Outstanding28	  	Yes	  	N.A.
	  	5,000,000 Shares of Preferred Stock, $0.001 par value, undesignated	  	Zero Shares of Preferred Stock	  	Yes, when issued	  	N.A.
					
	Nellix, Inc.	  	1,000 Shares of Common Stock, $0.001 par value	  	100 Shares of Common Stock	  	Yes	  	Endologix, Inc.
					
	CVD/RMS Acquisition Corp.	  	100 Shares of Common Stock, $0.001 par value	  	100 Shares of Common Stock	  	Yes	  	Endologix, Inc.
					
	ELGX South Korea, Ltd.	  	20,000 Contribution Units, KRW 5,000 par value	  	20,000 Contribution Units	  	No	  	Endologix, Inc.
					
	RMS/Endologix Sideways Merger Corp.	  	100 Shares of Common Stock, $0.001 par value	  	100 Shares of Common Stock	  	Yes	  	Endologix, Inc.
					
	TriVascular Technologies, Inc.	  	1,000 Shares of Common Stock, $0.001 par value	  	100 Shares of Common Stock	  	Yes	  	Endologix, Inc.
					
	ELGX International Holdings GP	  	Unspecified Number of Partnership Interests	  	Unspecified Number of Partnership Interests	  	No	  	Endologix, Inc.
					
	Endologix Bermuda, L.P.	  	Unspecified Number of Partnership Interests	  	Unspecified Number of Partnership Interests	  	No	  	Endologix, Inc.
					
	Endologix Singapore Private Limited	  	Unspecified Number of Company Interests	  	Unspecified Number of Company Interests	  	No	  	Endologix, Inc.
					
	Endologix New Zealand Co.	  	Unspecified Number of Company Interests	  	Unspecified Number of Company Interests	  	No	  	Endologix, Inc.
					
	TriVascular, Inc.	  	100 Shares of Common stock, $0.01 par value	  	100 Shares of Common Stock	  	No	  	TriVascular Technologies, Inc.

  

	28 	 As of August 7, 2018. There have been no material changes to such amount as of the Agreement Date.

									
	 Name of Issuer
	  	 Authorized

Securities
	  	 Issued and

Outstanding Securities
	  	 Certificated
(Yes or No)
	  	 Loan
Party/
Subsidiary
Owner

									
	Endologix International Holdings B.V.	  	Unspecified Number of Company Interests	  	Unspecified Number of Company Interests	  	No	  	Endologix Bermuda, L.P.
					
	Endologix Poland spolkda z ograniczona odpowiedzialnoscia	  	Unspecified Number of Company Interests	  	Unspecified Number of Company Interests	  	No	  	Endologix International Holdings B.V.
					
	Endologix International B.V.	  	Unspecified Number of Company Interests	  	Unspecified Number of Company Interests	  	No	  	Endologix International Holdings B.V.
					
	Endologix Italia S.r.l	  	Unspecified Number of Company Interests	  	Unspecified Number of Company Interests	  	No	  	Endologix International Holdings B.V.
					
	TriVascular Sales LLC	  	1,000 Units of Membership Interests	  	1,000 Units of Membership Interests	  	No	  	TriVascular, Inc.
					
	Endologix Canada, LLC	  	1,000 Units of Membership Interests	  	1,000 Units of Membership Interests	  	No	  	TriVascular, Inc.
					
	TriVascular Italia Sarl	  	Unspecified Number of Company Interests	  	Unspecified Number of Company Interests	  	No	  	TriVascular, Inc.
					
	TriVascular Germany GmbH	  	Unspecified number of Company Interests	  	Unspecified number of Company Interests	  	No	  	TriVascular, Inc.
					
	TriVascular Switzerland Sárl	  	Unspecified number of Company Interests	  	Unspecified number of Company Interests	  	No	  	TriVascular, Inc.

 Options and Equity Incentive/Compensation Plans: 

Equity Awards: Borrower’s 2015 Stock Incentive Plan as amended (the “2015 Plan”) authorizes the grant of equity awards to
purchase up to 10.3 million shares of Common Stock. As of July 31, 2018, approximately 9.6 million shares were reserved for issuance under outstanding stock options, including stock options granted under equity compensation plans
preceding the 2015 Plan, and 1.6 million shares were subject to unvested restricted stock awards. The outstanding stock options have exercise prices ranging from $1.64 to $17.58 and a weighted average exercise price of $7.28. There have been no
material changes to the items discussed in this paragraph as of the Agreement Date. 
 Amended and Restated 2006 Employee Stock Purchase
Plan (the “ESPP”): As of July 31, 2018, approximately 0.7 million shares of Common Stock were available for issuance under the ESPP. There have been no material changes to such amount as of the Agreement Date. 

2017 Inducement Stock Incentive Plan: The Board has reserved 2,000,000 shares of Borrower’s

 
Common Stock for issuance pursuant to awards granted under the 2017 Inducement Stock Incentive Plan. As of July 31, 2018, approximately 1.5 million shares of Common Stock were available
for issuance under this plan. There have been no material changes to such amount as of the Agreement Date. 
 Non-Plan Inducement Grants: In connection with its merger with TriVascular Technologies, Inc., on February 4, 2016 Borrower issued non-plan inducement stock options
to purchase 1.4 million shares of Common Stock at an exercise price of $7.53 per share, and non-plan inducement restricted stock units for 0.3 million shares of Common Stock. 

Warrants: 
 In connection with its
merger with TriVascular Technologies, Inc. on February 3, 2016, Borrower assumed unexercised out-of-the-money warrants of
TriVascular Technologies, Inc., which converted into warrants to purchase 35,094 shares of Common Stock, 24,272 at an exercise price of $12.58 per share and 10,822 at an exercise price of $28.21 per share. 

Pursuant to the terms of the Prior Facility Agreement, Borrower issued warrants to Lenders to purchase an aggregate of 6,470,000 shares of
Common Stock of Borrower at an exercise price of $9.23 per share. The number of shares of Common Stock of Borrower into which the warrants are exercisable and the exercise price of the warrants will be adjusted to reflect any stock splits,
recapitalizations or similar adjustments in the number of outstanding shares of Common Stock of Borrower. 
 Pursuant to the Agreement,
Borrower is issuing warrants to Lenders to purchase an aggregate of 8,750,000 shares of Common Stock of Borrower at an exercise price equal to the closing bid price on the date of grant. The number of shares of Common Stock of Borrower into which
the warrants are exercisable and the exercise price of the warrants will be adjusted to reflect any stock splits, recapitalizations or similar adjustments in the number of outstanding shares of Common Stock of Borrower. 

Convertible Notes: 
 2.25%
Convertible Notes: On December 10, 2013, Borrower issued $86.3 million aggregate principal amount of 2.25% Convertible Notes. The initial conversion rate of the 2.25% Convertible Notes is 41.6051 shares of Common Stock per $1,000
principal amount of 2.25% Convertible Notes, which represents an initial conversion price of approximately $24.04 per share. On April 3, 2017, Borrower entered into the Prior Facility Agreement with Deerfield and used proceeds from the
Deerfield loan to repurchase $68 million aggregate principal amount of outstanding 2.25% Senior Notes, plus the accrued but unpaid interest thereon, from the holders thereof in privately negotiated transactions. As of the Agreement Date, there
is currently $18.278 million aggregate principal amount of 2.25% Convertible Notes outstanding. 
 3.25% Convertible Notes: On
November 2, 2015, Borrower issued $125.0 million aggregate principal amount of 3.25% Convertible Notes. The initial conversion rate of the 3.25% Convertible Notes is 89.4314 shares of Common Stock per $1,000 principal amount of 3.25%
Convertible Notes, which represents an initial conversion price of approximately $11.18 per share. Pursuant to the terms of the Facility Agreement with Deerfield, $40.5 million of the aggregate principal amount of the 3.25% Convertible Notes
will be cancelled on the Agreement Date, and $84.5 million aggregate principal amount of 3.25% Convertible Notes will remain outstanding thereafter. 

 Pursuant to this Agreement the Borrower may issue, upon exercise under the Notes by Lenders,
Conversion Shares in accordance with the terms of the Notes and Interest Payment Shares in accordance with this Agreement. 
 Other Rights to
Securities of Borrower: 
 In connection with its merger with Nellix, Inc. (“Nellix”), Borrower agreed to issue shares of
Common Stock to the former stockholders of Nellix upon Borrower’s receipt of FDA approval to sell its Nellix EVAS System in the United States (the “PMA Milestone”). The number of shares of Common Stock issuable to the former
stockholders of Nellix upon achievement of the PMA Milestone shall equal the quotient obtained by dividing $15.0 million by the average per share closing price of Common Stock on The Nasdaq Global Select Market for each of the 30 consecutive
trading days ending with the fifth trading day immediately preceding the date of Borrower’s receipt of FDA approval to sell its Nellix EVAS System in the United States, subject to a stock price floor of $4.50 per share, but not
subject to a stock price ceiling. 
 In June 2018, Borrower received the approval of its stockholders to conduct an exchange program
(“Exchange Program”) in which eligible employee stock option holders would have the ability to exchange certain
“out-of-the-money” stock options for restricted stock units (“RSUs”) of Borrower pursuant to fixed exchange
ratios. Borrower intends to consummate this Exchange Program. The material terms of the Exchange Program are as set forth in proposal 6 of the Company’s definitive proxy statement in respect of its annual meeting of stockholders held on
June 14, 2018. 
 Registration Rights 

Registration Rights Agreements dated as of April 3, 2017 and the Agreement Date, respectively, by and among the Borrower the Lenders and
Agent. . 
 Agreement and Plan of Merger and Reorganization, dated October 27, 2010, by and among Borrowerthe, Nepal Acquisition
Corporation, Nellix, Inc., certain of Nellix, Inc.’s stockholders listed therein and Essex Woodlands Health Ventures, Inc., as representative of Nellix, Inc.’s stockholders (Section 6.12 contains registration obligation) 

At-the-Market Equity Offering Sales Agreement, dated
May 31, 2018, by and between Borrower and Stifel, Nicolaus & Company, Incorporated pursuant to which Stifel has agreed to use commercially reasonable efforts to sell on the Company’s behalf up to $50,000,000 in aggregate gross
process of the Company’s common stock pursuant to the terms instructed by the Company. The Company is obligated to pay Stifel at a fixed commission rate of up to 3.0% of the gross sales price of its common stock sold pursuant to the agreement.

 Schedule 3.1(aa) 

Material Contracts 
  

	•	 	 Cross License Agreement dated as of October 26, 2011, by and between Borrower and Bard Peripheral Vascular,
Inc. 

  

	•	 	 Settlement Agreement, dated October 16, 2012 by and among Borrower, Cook Incorporated, Cook Group and Cook
Medical, Inc. 

  

	•	 	 Standard Industrial/Commercial Multi-Tenant Lease—Net, for 2 Musick, Irvine, California and 33 & 35
Hammond, Irvine, dated June 12, 2013, by and between Borrower and The Northwestern Mutual Life Insurance Company. 

  

	•	 	 Lease for Santa Rosa facility for the building located at 3910 Brickway Boulevard, Santa Rosa, California as set
forth in the Third Amendment to Lease, by and between Trivascular, Inc. and Sonoma Airport Properties LLC and the earlier agreements described herein. 

 Schedule 3.1(dd) 

Environmental 
 None. 

 Schedule 3.1(ff) 

Labor Relations 
 None. 

 Schedule 3.1(gg) 

Jurisdiction of Organization, Legal Name, Organizational Identification Number and Chief Executive Office 

 

													
	 Loan Party
	  	 Jurisdiction of
organization
	  	All other
jurisdictions
of
organization
of Loan
Party for 5
years
preceding
the
Agreement
Date	  	 Legal name
	  	All other
legal names
of Loan
Party for 5
years
preceding
the
Agreement
Date	  	Organizational
identification
no.	  	 Location of chief executive office or sole
place of
business: other offices or
facilities

	Endologix, Inc.	  	Delaware	  	N.A.	  	Same as loan party name at left	  	N.A.	  	2338745	  	2 Musick, Irvine, County of Orange, California 92618 U.S.A.
							
	Endologix, Inc.	  	Delaware	  	N.A.	  	Same as loan party name at left	  	N.A.	  	2338745	  	33 and 35 Hammond, Irvine, County of Orange, California 92618 U.S.A.
							
	Nellix, Inc.	  	Delaware	  	N.A.	  	Same as loan party name at left	  	N.A.	  	3359980	  	2 Musick, Irvine, County of Orange, California 92618 U.S.A.
							
	CVD/RMS Acquisition Corp.	  	Delaware	  	N.A.	  	Same as loan party name at left	  	N.A.	  	2955166	  	2 Musick, Irvine, County of Orange, California 92618 U.S.A.
							
	TriVascular Technologies, Inc.	  	Delaware	  	N.A.	  	Same as loan party name at left	  	N.A.	  	4387054	  	3910 Brickway Blvd., Santa Rosa, County of Sonoma, CA 95403 U.S.A
							
	TriVascular, Inc.	  	California	  	N.A.	  	Same as loan party name at left	  	N.A.	  	C2065374	  	3910 Brickway Blvd., Santa Rosa, County of Sonoma, CA 95403 U.S.A
							
	Endologix Canada, LLC	  	Delaware	  	N.A.	  	Same as loan party name at left	  	Trivascular
Canada
LLC	  	5647226	  	3910 Brickway Blvd., Santa Rosa, County of Sonoma, CA 95403 U.S.A

													
	RMS/Endologix Sideways Merger Corp.	  	Delaware	  	N.A.	  	Same as loan party name at left	  	N.A.	  	3530477	  	2 Musick, Irvine, County of Orange, California 92618 U.S.A.
							
	Trivascular Sales LLC	  	Texas	  	N.A.	  	Same as loan party name at left	  	N.A.	  	801644988	  	3910 Brickway Blvd., Santa Rosa, County of Sonoma, CA 95403 U.S.A

 Schedule 3.1(hh) 

Inventory Location 
 The following are all
of the locations where a Loan Party or any of the Loan Parties’ Subsidiaries, respectively, maintains Inventory: 
  

			
	 Complete Address
	  	 Loan Party/Subsidiary

	2 Musick, Irvine, County of Orange, CA 92618 U.S.A.	  	Endologix, Inc.
		
	33 & 35 Hammond, Irvine, County of Orange, CA 92618 U.S.A	  	Endologix, Inc.
		
	3910 Brickway Blvd., Santa Rosa, County of Sonoma, CA 95403 U.S.A.	  	 TriVascular Technologies, Inc.
 TriVascular,
Inc.

		
	 10 Anson Road #21-04 & #21-04A

International Plaza Singapore 079903
	  	Endologix, Inc.
		
	A-311, M-Sate, 114 Beopwon-ro, Songpa-gu, Seoul, South Korea	  	Endologix, Inc.
		
	Burgemeester Burgerslaan 40, 5245 NH Rosmalen, The Netherlands	  	Endologix International Holdings B.V.
		
	Rahmannstraße 11, 65760 Eschborn, Germany	  	Endologix International B.V.

 The following are the names and addresses of all warehousemen, bailees, or other third parties who have possession of any of
the Loan Parties’ Inventory or the Inventory of any of the Loan Parties’ Subsidiaries: 
  

					
	 Name
	  	 Complete Street and Mailing Address, including Zip
Code
	  	 Loan Party/Subsidiary

	UPS	  	 378 Commercial Street, Malden, MA 02148
 165
Chubb Avenue, Lyndhurst, NJ 07071
 1130 Commerce Blvd, Swedesboro, NJ 08085

2250 Outerloop Drive, Louisville, KY 40219
	  	Endologix, Inc.
			
	Rhenus	  	Centaurusweg 123, 5015 TC Tilburg, The Netherlands	  	Endologix International Holdings B.V.
	STOK UK Limited	  	One Fleet Place, London EC4M 7Ws	  	Endologix International B.V.

					
	 Name
	  	 Complete Street and Mailing Address, including Zip
Code
	  	 Loan Party/Subsidiary

			
	TNT Express Korea	  	54 Yangcheon-ro, Gangseo-gu, Seoul 07522	  	Endologix, Inc.

 In addition to the foregoing: 
  

	 	•	 	 In the Ordinary Course of Business, the Loan Party or any of the Loan Parties Subsidiaries’ sales
representatives hold Trunk Inventory in their possession for sales calls and procedures, which Trunk Inventory is not held at a specific location or locations. 

 

	 	•	 	 Certain Inventory of the Loan Party or any of the Loan Parties’ Subsidiaries is held by numerous third
parties on a consignment basis at various locations. 

 Schedule 3.1(uu) 

Governmental Notices Regarding Products 

Ovation® System 

On August 2018, Borrower intends to issue a global field safety notice related to reinforce information contained within the IFU in order to reduce the
occurrence of polymer leaks. 

 Schedule 3.1 (jjj) 

See above Schedule 3.1(z). 

 Schedule 5.1(q) 

Other Loan Documents to Be Form 8-K Exhibits 

Each of the following agreements, instruments and documents, including the schedules, exhibits and annexes thereto: 

 

	 	•	 	 the Agreement 

  

	 	•	 	 the Notes; 

  

	 	•	 	 the Security Agreement; 

 

	 	•	 	 the Intercompany Subordination Agreement; 

 

	 	•	 	 the Intercreditor Agreement; 

 

	 	•	 	 the Reaffirmation Agreement; 

 

	 	•	 	 the Warrants; 

  

	 	•	 	 the Registration Rights Agreement; 

 

	 	•	 	 the Patent Security Agreement; and 

 

	 	•	 	 the Trademark Security Agreement. 

 Schedule 5.2(iv) 

Contingent Obligations 
  

	•	 	 Base Capped Call Confirmation, dated December 4, 2013, between the Borrower and Bank of America, N.A.

  

	•	 	 Additional Capped Call Confirmation, dated December 5, 2013, between the Borrower and Bank of America, N.A.

 The capped call transactions contemplated by the documents listed above relate to the 2.25% Convertible Notes. The capped call
transactions are expected to reduce the potential dilution and/or offset the potential cash payments that the Borrower may be required to make in excess of the principal amount upon conversion of the 2.25% Convertible Notes in the event that the
market price per share of the Borrower’s common stock, as measured under the terms of the capped call transactions, is greater than the strike price of the capped call transactions, which initially corresponds to the $24.04 conversion price of
the 2.25% Convertible Notes. The Borrower will not be required to make any cash payments to Bank of America, N.A. upon the exercise of the options that are a part of the capped call transactions, but rather will be entitled to receive from Bank of
America, N.A. a number of shares of the Borrower’s common stock and/or an amount of cash based on the amount by which the market price per share of Common Stock of the Borrower, as measured under the terms of the capped call transactions, is
greater than the strike price of the capped call transactions during the relevant valuation period. 

 Schedule 5.2(vii) 

Transactions with Affiliates 
 Investments
of Inventory pursuant to clause (j) of the definition of Permitted Investments

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00286-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00286-of-00352.parquet"}]]